{"title": "PDF", "author": "PDF", "url": "https://repository.urosario.edu.co/bitstream/10336/19876/1/GarzonOspina-DiegoEdison-2019.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "id": "PDF", "license": "PDF", "body": "PDF", "comments": "PDF", "commentsbody": "PDF", "raw_text": "PDF", "text": "1 \n \n                                                                               \n  \n  \nIdentificaci\u00f3n de se\u00f1ales de selecci\u00f3n natural en genes de Plasmodium vivax  que \ncodifican prote\u00ednas involucradas en el proceso de invasi\u00f3n para determinar su \npotencial uso en una vacuna antimal\u00e1rica.  \n \n \n \n \n \n \nDiego Edison Garz\u00f3n Ospina  \n \n \n \n \n \n \n \n \n \n \nTesis Doctoral  presentada como requisito para optar al t\u00edtulo  de Doctor en  Ciencias \nBiom\u00e9dicas y Biol\u00f3gicas de la Universidad del Rosario  \n \n \n \nBogot\u00e1, 2018  2 \n \n                                                                               \n  \n  \nIdentificaci\u00f3n de se\u00f1ales de selecci\u00f3n natural en genes de Plasmodium vivax  que \ncodifican prote\u00ednas involucradas en el proceso de invasi\u00f3n para determinar su \npotencial uso en una vacuna antimal\u00e1rica.  \n \n \nEstudiante  \nDiego Edison Garz\u00f3n Ospina  \nBi\u00f3logo, Universidad INCCA de Colombia  \nMagister en Ciencias -Microbiolog\u00eda, Universidad Nacional de Colombia  \n \n \nDirector  \nManuel Alfonso Patarroyo Guti\u00e9rrez M.D., Dr.Sc.  \nJefe del Departamento de Biolog\u00eda Molecular e Inmu nolog\u00eda  \nFundaci\u00f3n Instituto de Inmunolog\u00eda de Colombia (FIDIC)  \n \n \nProfesor Titular, Escuela de Medicina y Ciencias de la Salud  \nUniversidad del Rosario  \n \n \nDOCTORADO EN CIENCIAS BIOM\u00c9DICAS Y BIOL\u00d3GICAS  \nUNIVERSIDAD DEL ROSARIO  \n \n \nBogot\u00e1, 2018  3 \n AGRADECIMIENTOS  \n \nQuiero dar mis agradecimientos y dedicar este trabajo a mi madre : Martha Ospina \nVargas , y a mis hermanos : Yamile Garz\u00f3n Ospina  y Juli\u00e1n David Escobar Ospina , \nquienes me han acompa\u00f1ado y apoyado en todo momento.  A Sindy Paola Buitrago \nPuentes  por su acompa\u00f1a miento  y apoyo durante este tiempo . \n  \nTambi\u00e9n agradecer a l Dr. Manuel Alfonso Patarroyo Guti\u00e9rrez , por haberme acogido en \nsu equipo de trabajo y por apoyarme a lo largo de todos estos a\u00f1os . \n \nQuiero agrade cer y reconocer la labor  de: Andrea Estefan\u00eda Ramos,  Darwin Andr \u00e9s \nMoreno P\u00e9rez, Elizabeth Guti\u00e9rrez V\u00e1squez , Heidy Daniela Ortiz Suarez,  Lady \nJohanna Forero Rodr\u00edguez, Laura Alejandra Ricaurte Contreras , Leidy Paola Reyes , \nLuis Alfredo Baquero, Paola Andrea Camargo Ayala, Sindy Paola Buitrago Puentes, \nRicar do De Le\u00f3n Montero  y Yimara Grosso Paz , quienes aportaron su tiempo, \ndedicaci\u00f3n y esfuerzo, permitiendo la culminaci\u00f3n de este trabajo.  \n \nY finalmente, mis agradecimientos a l Doctorado , a la Universidad del Rosario y a los \nJurados de tesis, quienes amabl emente aceptaron la revisi\u00f3n de este trabajo , por su s \nenriquecedores comentarios y por su tiempo . \n \n \n \n \n \n \n 4 \n CONTENIDO  \n \nLISTA DE TABLAS  ................................ ................................ ................................ ..............  7 \nLISTA DE FIGURAS  ................................ ................................ ................................ ............  8 \nLISTA DE ANEXOS  ................................ ................................ ................................ .............  9 \nLISTA DE PUBLICACIONES  ................................ ................................ ............................  10 \nABRE VIATURAS  ................................ ................................ ................................ ...............  11 \nRESUMEN  ................................ ................................ ................................ ...........................  12 \nABSTRACT  ................................ ................................ ................................ .........................  14 \nINTRODUCCI\u00d3N GENERAL  ................................ ................................ ............................  15 \nCandidatos a vacuna.  ................................ ................................ ................................ ........  19 \nGen\u00e9tica y evoluci\u00f3n, herramientas para el dise\u00f1o de vacunas.  ................................ ....... 20 \nHIPOTESIS DE INVESTIGACI\u00d3N  ................................ ................................ ....................  23 \nOBJETIVOS  ................................ ................................ ................................ .........................  24 \nObjetivo general  ................................ ................................ ................................ ................  24 \nObjetivos espec\u00edficos  ................................ ................................ ................................ ........  24 \nCAPITULO 1  ................................ ................................ ................................ .......................  25 \nIntroducci\u00f3n  ................................ ................................ ................................ ......................  26 \nMetodolog\u00eda  ................................ ................................ ................................ ......................  27 \nObtenci\u00f3n de secuencias y alineamientos . ................................ ................................ .... 27 \nAn\u00e1lisis de las relaciones filogen\u00e9ticas de los genes perte necientes a las familias \nmultig\u00e9nicas . ................................ ................................ ................................ .................  27 \nAn\u00e1lisis de diversidad gen\u00e9tica e inferencia de se\u00f1ales de selecci\u00f3n natural . ..............  28 \nResul tados y Discusi\u00f3n  ................................ ................................ ................................ ..... 30 \nConclusiones  ................................ ................................ ................................ .....................  37 5 \n CAPITULO 2  ................................ ................................ ................................ .......................  39 \nIntroducci\u00f3n  ................................ ................................ ................................ ......................  40 \nMetodolog\u00eda  ................................ ................................ ................................ ......................  41 \nIdentificaci\u00f3n de selecci\u00f3n epis\u00f3dica linaje -espec\u00edfica  ................................ .................  41 \nResultados y discusi\u00f3n  ................................ ................................ ................................ ...... 46 \nEstructura gen\u00e9tica y relaciones filogen\u00e9ticas de la regi\u00f3n msp7  en Plasmodium  spp. 46 \nRelaciones filogen\u00e9ticas de los miembros de msp7  en Plasmodium  ............................  46 \nSelecci\u00f3n positiva linaje -especifica en msp7  ................................ ................................  47 \nConclusiones  ................................ ................................ ................................ .................  49 \nCAPITULO 3  ................................ ................................ ................................ .......................  50 \nIntroducci\u00f3n  ................................ ................................ ................................ ......................  51 \nMetodolog\u00eda  ................................ ................................ ................................ ......................  51 \nVerificaci\u00f3n de la integridad del ADN.  ................................ ................................ ........  51 \nDeterminaci\u00f3n de la presencia de infecciones \u00fanicas por P. vivax  y de diferentes \ngenotipos en las muestra s utilizadas ................................. ................................ .............  52 \nDise\u00f1o de iniciadores y amplificaci\u00f3n por PCR  ................................ ...........................  53 \nPurificaci\u00f3n y Secuenciaci\u00f3n de los fragmentos amplificados.  ................................ .... 53 \nAn\u00e1lisis de la diversidad gen\u00e9tica y de las fuerzas evolutivas en los loci seleccionados.\n ................................ ................................ ................................ ................................ ....... 53 \nResultados y discusi\u00f3n  ................................ ................................ ................................ ...... 55 \nConclusiones  ................................ ................................ ................................ .....................  60 \nCAPITULO 4  ................................ ................................ ................................ .......................  62 \nIntroducci\u00f3n  ................................ ................................ ................................ ......................  63 \nMetodolog\u00eda  ................................ ................................ ................................ ......................  64 \nResultados y discusi\u00f3n  ................................ ................................ ................................ ...... 67 6 \n Conclusiones  ................................ ................................ ................................ .....................  72 \nCONCLUSIONES GENERALES  ................................ ................................ .......................  74 \nPERSPECTIVAS GENERALES  ................................ ................................ .........................  76 \nREFERENCIAS  ................................ ................................ ................................ ...................  77 \nANEXOS  ................................ ................................ ................................ ..............................  87 \nPUBLICACIONES  ................................ ................................ ................................ ...............  91 \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n 7 \n LISTA DE TABLAS  \nTabla  1. Total de muertes causadas por agentes parasitarios en 2013.  ................................  15 \nTabla 2. Estimadores de la  diversidad gen\u00e9tica en 59 genes de P. vivax . ............................  30 \nTabla 3. Raz\u00f3n diversidad nucleot\u00eddica/divergencia ( \u03c0/\u039a), \u00edndice de neutralidad de la \nprueba McDonald -Kreitman (NI) y tasas de sustituci\u00f3n no sin\u00f3nima (d N) y sin\u00f3nima (d S) \npara algunos genes de P. vivax  evaluados.  ................................ ................................ ...........  34 \nTabla 4 . Caracterizaci\u00f3n  in-silico  de las prote\u00ednas MSP7  ................................ ....................  45 \nTabla 5 . Estimadores de diversidad gen\u00e9tica ................................ ................................ ........  57 \nTabla 6. Tasas de divergencia no -sin\u00f3nima (K N) y sin\u00f3nima (K S) ................................ ...... 57 \nTabla 7. Estimadores de diversidad  ................................ ................................ ......................  67 \n \n \n \n \n \n \n \n \n \n \n \n \n \n 8 \n LISTA DE FIGURAS  \nFigura 1. El merozo\u00edto y su estructura interna. ................................ ................................ ..... 16 \nFigura 2.  Ciclo de vida de Plasmodium  spp. ................................ ................................ ........  16 \nFigura 3. Filogenia (A) y tiempos de divergencia (B) de algunas especies del g\u00e9nero \nPlasmodium . ................................ ................................ ................................ .........................  17 \nFigura 4. Metodolog\u00eda del Cap\u00edtulo 1  ................................ ................................ ...................  29 \nFigura 5. Distribuci\u00f3n del polimorfismo dentro de los 59 genes Plasmodium vivax  \nestudiados.  ................................ ................................ ................................ ............................  33 \nFigura 6.  Ventana deslizante de la tasa \u03c9 en la regi\u00f3n C -terminal de PvMSP -1 .................  36 \nFigura 7. Metodolog\u00eda del Cap\u00edtulo 2  ................................ ................................ ...................  42 \nFigura 8. Filogenia de la familia de genes msp7  inferida por el modelo evo lutivo DLTRS  42 \nFigura 9. Representaci\u00f3n esquem\u00e1tica de los loci msp7  en 13 genomas de Plasmodium  .... 44 \nFigura 10. Filogenias de msp7s analizadas por el m\u00e9todo Branch -site REL  ........................  48 \nFigura 11. Lugar de procedencia de las muestras de ADN parasitario en Colombia  ...........  52 \nFigura 12. Metodolog\u00eda del Cap\u00edtulo 3  ................................ ................................ .................  54 \nFigura 13. Patrones de PCR -RFLPs  ................................ ................................ .....................  56 \nFigura 14. Ventanas deslizantes de \u03c0 para 8 ant\u00edg enos de P. vivax  ................................ ...... 58 \nFigura 15. Ventanas deslizantes de la tasa \u03c9 entre especies  ................................ ................  59 \nFigura 16. Metodolog\u00eda del Cap\u00edtulo 4  ................................ ................................ .................  66 \nFigura 17. Ventana deslizante para el locus pvgama ................................ ............................  69 \nFigura 18. Ventana deslizante para el locus pvrbsa  ................................ .............................  70 \nFigura 19 . Actividad de uni\u00f3n de fragmentos de PvGAMA y PvRBSA  .............................  71 \nFigura 20. Ensayos de inhibici\u00f3n de la uni\u00f3n con p\u00e9ptidos de PvCelTOS  ..........................  71 \nFigura 21. Ventana deslizante para el locus pvceltos  ................................ ...........................  72 \nFigura 22. Flujo de trabajo a seguir para seleccionar ant\u00edgenos promisorios a incluir  en el \ndise\u00f1o de vacunas contra agentes infecciosos  ................................ ................................ ...... 75 9 \n  \nLISTA DE ANEXOS  \nAnexo  1 . \u00c1rbol filogen\u00e9tico de la familia msp3  ................................ ................................ .. 87 \nAnexo  2 . Ventanas deslizantes de la tasa \u03c9 (d N/dS o K N/KS) ................................ ..............  88 \nAnexo  3 . Filogenia de la familia msp7  inferida por el m\u00e9todo de m\u00e1xima verosimilitud  .. 89 \nAnexo  4.  Ventana deslizante del gen pvron4  ................................ ................................ ...... 90 \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n 10 \n LISTA DE PUBLICACIONES  \nPublicaci\u00f3n 1:  Garz\u00f3n -Ospina D , Forero -Rodr\u00edguez J, Patarroyo MA.  Inferring natural \nselectio n signals in Plasmodium vivax -encoded proteins having a potential role in \nmerozoite invasion . Infect Genet Evol. 2015 Jul; 33:182 -8. doi: \n10.1016/j.meegid.2015.05.001.  \n \nPublicaci\u00f3n 2:  Garz\u00f3n -Ospina D , Forero -Rodr\u00edguez J, Patarroyo MA.  Evidence of \nfunctiona l divergence in MSP7 paralogous proteins: a molecular -evolutionary and \nphylogenetic analysis . BMC Evol Biol. 2016 Nov 28;16  (1):256.  doi: 10.1186/s12862 -016-\n0830 -x.  \n \nPublicaci\u00f3n 3: Forero -Rodr\u00edguez J, Garz\u00f3n -Ospina D , Patarroyo MA. Low genetic \ndiversity a nd functional constraint in loci encoding Plasmodium vivax P12 and P38 \nproteins in the Colombian population . Malar J. 2014 Feb 18;13:58. doi: 10.1186/1475 -\n2875 -13-58. \n \nPublicaci\u00f3n 4: Forero -Rodr\u00edguez J,  Garz\u00f3n -Ospina D , Patarroyo MA.  Low genetic \ndiversity in the locus encoding the Plasmodium vivax P41 protein in Colombia's parasite \npopulation . Malar J. 2014 Sep 30;13:388. doi: 10.1186/1475 -2875 -13-388. \n \nPublicaci\u00f3n 5: Garz\u00f3n -Ospina D , Forero -Rodr\u00edguez J,  Patarroyo MA.  Heterogeneous \ngenetic diversity pattern  in Plasmodium vivax genes encoding merozoite surface proteins \n(MSP) -7E, -7F and -7L. Malar J. 2014 Dec 13;13:495. doi: 10.1186/1475 -2875 -13-495. \n \nPublicaci\u00f3n 6: Buitrago SP, Garz\u00f3n -Ospina D , Patarroyo MA.  Size polymorphism and low \nsequence diversity in t he locus encoding the Plasmodium vivax rhoptry neck protein 4 \n(PvRON4) in Colombian isolates . Malar J. 2016 Oct 18;15(1):501. doi: 10.1186/s12936 -\n016-1563 -4.  \n \nPublicaci\u00f3n 7: Baquero LA, Moreno -P\u00e9rez DA, Garz\u00f3n -Ospina D , Forero -Rodr\u00edguez J, \nOrtiz -Su\u00e1rez HD , Patarroyo MA. PvGAMA reticulocyte binding activity: predicting \nconserved functional regions by natural selection analysis . Parasit Vectors. 2017 May \n19;10(1):251. doi: 10.1186/s13071 -017-2183 -8. \n \nPublicaci\u00f3n 8: Garz\u00f3n -Ospina D , Buitrago SP, Ramos AE, Pat arroyo MA.  Identifying \nPotential Plasmodium vivax Sporozoite Stage Vaccine Candidates: An Analysis of Genetic \nDiversity and Natural Selection . Front Genet. 2018 Jan 25;9:10. \ndoi:10.3389/fgene.2018.00010.  \n \nPublicaci\u00f3n 9: Camargo -Ayala  PA, Garz\u00f3n -Ospina D , Moreno -P\u00e9rez DA , Ricaurte -\nContreras  LA, Noya  O and Patarroyo  MA. On the evolution and function of Plasmodium \nvivax reticulocyte binding surface antigen (pvrbsa) . Front. Genet. 2018 Sep . 9:372 . doi: \n10.3389/fgene.2018.00372  \n 11 \n ABREVIATURAS  \n \n\u03c0: diversidad nucleot\u00eddica por sitio  \n\u039a: diversidad nucleot\u00eddica  \ndN: tasas de sustituci\u00f3n no -sin\u00f3nima por sitio no -sin\u00f3nimo  \ndS: la tasa de sustituci\u00f3n sin\u00f3nima por sitio sin\u00f3nimo  \nKN: divergencia no -sin\u00f3nima por sitio no -sin\u00f3nimo  \nKS: divergencia sin\u00f3nima po r sitio sin\u00f3nimo   \n\u03c9: tasa evolutiva (omega) = d N/dS o K N/KS \nn: Numero se secuencias analizadas  \nSitios: total de sitios analizados, excluyendo gaps  \nSs: n\u00famero de sitios segregantes (polim\u00f3rficos)  \nS: n\u00famero de sitios singleton  \nPs: n\u00famero de sitios parsimoni osos \nSD: desviaci\u00f3n est\u00e1ndar  \nNI: \u00edndice de neutralidad de la prueba McDonald -Kreitman (NI)  \nORF: marco abierto de lectura  \nMK: prueba de McDonald -Kreitman  \nPn: polimorfismo no -sin\u00f3nimo  \nPs: polimorfismo sin\u00f3nimo   \nDn: divergencia no -sin\u00f3nima  \nDs: divergencia s in\u00f3nima  \nML: m\u00e1xima verosimilitud  \nBY: bayesiano  \nmalERA: Malaria Eradication Research Agenda  12 \n Identificaci\u00f3n de se\u00f1ales de selecci\u00f3n natural en genes de Plasmodium \nvivax  que codifican prote\u00ednas involucradas  en el proceso de invasi\u00f3n para \ndeterminar su potenc ial uso en una vacuna antimal\u00e1rica.  \n \n \nRESUMEN  \n \nPlasmodium vivax , es un endopar\u00e1sito de origen  Asi\u00e1tico  que se dispers\u00f3  alrededor del \nmundo  y, actualmente, es predominante en las regiones tropicales y subtropicales del \nplaneta que se encuentran entre los 15  y 16 \u00b0 C.  P. vivax , presenta una importancia \nbiom\u00e9dica  dado que es el segundo agente responsable de malaria en humanos . Aunque \nnumerosos esfuerzos se han realizado para disminuir el impacto de esta enfermedad, las \ncondiciones sociales y econ\u00f3micas de los lugares m\u00e1s afectados , sumado a  los conflictos \nsociales y pol\u00edticos en varias \u00e1reas end\u00e9micas , hacen del control y eliminaci\u00f3n de est e \npar\u00e1sito  una tarea nada f\u00e1cil. Como si esto no fuera suficiente, la aparici\u00f3n de resistencia a \nlos insecticidas por parte  del vector trasmisor , as\u00ed como de par\u00e1sitos  resistentes a los \nantimal\u00e1ricos, podr\u00eda provocar una recurrencia de esta enfermedad . Teniendo en cuenta lo \nanterior , nuevas estrategias que permitan disminuir la incidencia de malaria por P. vivax  se \nhacen prior itarias.   \n \nUna de las alternativas que podr\u00eda ayudar  al control de la malaria  es el desarrollo de una \nvacuna contra los pat\u00f3genos que la causan . Sin embargo, la elevada diversidad gen\u00e9tica que \nP. vivax  presenta , ha generado uno de los  retos a afrontar  para el dise\u00f1o de una vacuna \ncompletamente efectiva. Actualmente,  se han descrito  varios  ant\u00edgenos  potenciales \ncandidatos a vacuna  contra P. vivax . No obstante, la diversidad gen\u00e9tica de un reducido \nn\u00famero de estos ant\u00edgenos  ha sido evaluada , debido a los req uerimientos de tiempo y \nrecursos econ\u00f3micos . Adicion almente, poco se sabe acerca del rol  real de estos ant\u00edgenos \ndurante el proceso de invasi\u00f3n de este parasito a las c\u00e9lulas hospederas. Es por esto , que \nnuevos enfoqu es, que permitan en un menor tiempo y a  bajo costo  identificar las regiones \nde estos ant\u00edgenos conservadas por selecci\u00f3n natural  (usualmente  asociadas con regiones \nfuncionales)  se hacen necesarios. Estos nuevos enfoques podr\u00edan  entonces servir como  13 \n punto de partida para la identificaci\u00f3n  o prio rizaci\u00f3n  de nuevos y promisorios  candidatos \nvacu nales .   \n \nEste trabajo presenta  los resultados  un enfoque alternativo que permite  hacer un \nacercamiento a la diversidad gen\u00e9tica de ant\u00edgenos de P. vivax , determinando regiones bajo \nselecci\u00f3n negativa , para s er consideradas durante  el dise\u00f1o de una vacuna completamente \nefectiva. Aunque e ste enfoque se utiliz\u00f3  para P. vivax , este podr\u00eda tambi\u00e9n ser  aplicado  en \notros organismos.    \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n 14 \n Identificaci\u00f3n de se\u00f1ales de selecci\u00f3n natural en genes de  Plasmodium \nvivax  que codifican prote\u00ednas involucradas  en el proceso de invasi\u00f3n para \ndeterminar su potencial  uso en una vacuna antimal\u00e1rica.  \n \nABSTRACT  \n \nPlasmodium vivax , an endoparasite that arose  in Asia and spread  around the world , has \nbiomedical impor tance  given that it is the second most important human -malaria parasite . \nAlthough efforts have been made to reduce the impact of this disease, the social and \neconomic conditions of the most affected places, together  with social and political conflicts \nin several endemic areas, make the parasite control and elimination a laborious task . The \nemergence of insecticide  resistance by the transmitting  vector as well as antimalarial -\nresistant parasites  worsen the problem . Therefore, new alternatives to allow reduci ng the \nincidence of the disease have become  a priority.  \n \nAn a ntimalarial vaccine development against the causal pathogens  has been proposed as a  \ncost-effective intervention which would help in controlling malaria . However, the high P. \nvivax genetic diversi ty remains as one of the challenges to overcome for the design of a \nfully effective vaccine. Currently, several potential P. vivax  vaccine candidates have been \ndescribed. Nevertheless , the genetic diversity of a small number of them  has been assessed , \ndue to the high amount of time and economic resources  required . Additionally, there is a \nmodest  knowl edge  about the real role of these antigens during the invasion process  of target \ncells since maintaining an in vitro  culture of this parasite species is partic ularly difficult. \nTherefore,  new approaches that allow identify ing conserved regions by natural selection \nwhich are frequently associated with functional importance , might  be used  as a starting \npoint for the identificat ion or prioritization of new  potentia l vaccine candidates.  \n \nThis work presents a new approach to assess the genetic diversity of potential candidate \nantigens, determining negative ly selected regions that can then be considered  for design ing \na fully  effective vaccine. This approach is not limi ted to P. vivax  and could be useful in  \nother microorganisms . 15 \n INTRODUCCI\u00d3N GENERAL  \n \nLos par\u00e1sitos representan una gran proporci\u00f3n de los organismos vivos del planeta  y son de \nimportancia biom\u00e9dica debido a su impacto en la salud humana (1). De todas las \nenfermedades parasitarias que afectan al ser humano, la malaria es la que produce m\u00e1 s \nmuertes alrededor del mundo (2, 3) (Tabla 1).  \n \nTabla 1. Total de muertes causadas por agentes parasitarios en 2013.  \nParasitosis  Muertes globales \nen 2013  \nMalaria  854.600  \nLeishmaniasis  62.500  \nCriptosporidiosis  41.900  \nAmebiasis  11.300  \nEnfermedad de Chagas  10.600  \nTripanosomiasis Africana  6.900  \nEsquistosomiasis  5.500  \nAscariasis  4.500  \nEquinococo sis 2.200  \nCisticercosis  700 \nTotal de muertes por \nparasitosis  1.000.700  \nModificada  de: Hotez, P., Herricks, J., 2015. PLOS Medicine Pathogens Neglected Tropical Diseases (2). \n \nEsta enfermedad es causa da por par\u00e1sitos intracelulares obligados que pertenecen al \nPhylum  Apicomplexa,  orden Haemosporidia  y g\u00e9nero Plasmodium . Miembros de este \nPhylum  se caracteriza n por la presencia de organelos apicales  (roptrias, micronemas  y \ngr\u00e1nulos densos, Figura 1)  impor tante s durante el proceso de invasi\u00f3n a las c\u00e9lulas \nhospederas . \n \nPlasmodium  spp tiene un ciclo de vida complejo  (Figura 2) , desarroll\u00e1ndose en dos \nhospederos diferentes; uno  intermediario (vertebrados terrestres como reptiles, aves y \nmam\u00edferos (4-6)), donde se desarrolla la fase asexual y un  hospedero definitivo y trasmisor \ndel par \u00e1sito (mosquitos del genero Anopheles ), donde se lleva a cabo la fase sexual . 16 \n  \nFigur a 1. El merozo\u00edto  y su estructura interna.  \n \nModificada  de: Cowman A F y Crabb B S., 2006. Cell (7). \n \nFigura 2. Ciclo de vida de Plasmodium spp. \n \nModificad a de: Galinski M , Meyer  E, Barnwell  J., 2013 . Adv Parasitol  (8). \n \nA la fecha, solo cinco especies de Plasmodium  son capaces de infectar a l ser humano: P. \nfalciparum , P. vivax , P. ovale , P. malariae  (4, 5, 9) y P. knowlesi  (10). P. falciparu m, \nfilogen\u00e9ticamente relacionado con P. reichenowi (11, 12), divergi\u00f3 aproximadamente al \nmismo tiempo en q ue lo hicieron los humanos de los grandes simios Africanos (13) (Figura \n3B). Por su parte, P. vivax , de origen Asi\u00e1tico ( Figura 3A, aunque  un origen Africano es 17 \n probable  (14)), divergi\u00f3 de par\u00e1sitos que infecta n primates no humanos , hace unos 2 \u2013 2,5 \nmillones de a\u00f1os (11), mediante un evento conocido como cambio de hospedero  (15). Por \nlo tanto, P. falciparum  y P. vivax , a pesar de infectar seres humanos, presentan diferentes \nhistorias evolutivas.  \n \nFigura 3. Filogenia (A) y tiempos de divergencia (B) de algunas especies del g \u00e9nero \nPlasmodium . \n \nModificado de : Pacheco, 2011. BMC Evol Biol (11) y Silva, 2015.  Mol Biol Evol (13). \n  \nLa incidencia de P. vivax  ha disminuido desde 2010. Cerca de 6 a  11 millones de casos se \natribuyeron a este par\u00e1sito en 2016, alrededor de 7 millones menos que en 2010  (16). A \npesar de es to, la carga social y econ\u00f3mica causada por la  malaria en los pa\u00edses end\u00e9micos \n(17) sigue siendo grande . Aunque las medidas de control contra este par\u00e1sito parecen ser  \n\u00fatiles, la eliminaci\u00f3n de P. vivax  (as\u00ed c omo la  eliminaci\u00f3n de la malaria) no es una tarea \nsencilla . Las condiciones sociales y econ\u00f3micas de los lugares m\u00e1s  afectados por esta \nenfermedad, as\u00ed como los conflictos sociales y pol\u00edticos en varias \u00e1reas end\u00e9micas , \nrepresentan los principales  desaf\u00edos  para eliminar la malaria (16). Esto, junto con la \ndispersi\u00f3n  de mosquitos resistentes a los insecticidas y de par\u00e1sitos resistent es a los \nmedicamentos, podr\u00eda empeorar el panorama , generando  una recurrencia de la enfermedad  18 \n (18-20). Por lo tanto, nuevas intervenciones  como el dise\u00f1o de una vacuna , se hacen \nnecesarios  (21). As\u00ed, las intervenciones existentes  junto con las nuevas estrategias  podr\u00edan  \ncontribu ir a un mundo libre de malaria (21, 22). \n \nDado que P. falciparum  es el agente m\u00e1s letal  de la enfermedad , el dise\u00f1o de una vacuna se \ncentr \u00f3 durante mucho tiempo en este par\u00e1si to. Sin embargo, dado que en los \u00faltimos a\u00f1os la \ninfecci\u00f3n por P. vivax  est\u00e1 presentando  complicaciones cl\u00ednicas y fallas terap\u00e9uticas , la \nmalERA (del ingl\u00e9s , Mala ria Eradication Research Agenda ), en  2013 , reconoci\u00f3 la \nnecesidad de desarrollar una vacuna c ontra este par\u00e1sito  (23). A pesar de esto, el desarrollo \nde una vacuna  contra P. vivax  se encuentra retrasad o con respecto a P. falciparum  (24), esto  \ndebid o a que l os aspectos de la biolog\u00eda de P. vivax  son generalmente dif\u00edciles de estudiar \nde forma directa , dada la predilecci\u00f3n de este par\u00e1 sito por los reticulocitos (9). Sin \nembargo, datos gen\u00f3micos, trascript\u00f3micos, p rote\u00f3 micos, de marcadores moleculares o \nestudios de gen\u00e9tica de poblaciones , podr\u00edan ser  cruciales para la predicci\u00f3n y evaluaci\u00f3n \nde drogas y vacunas  (1, 25).  \n \nEn los \u00faltimos a\u00f1os, utilizando este tipo de datos ( \u00f3micos) , se han c aracterizado nuevos  \nant\u00edgenos que podr\u00edan ser considerados como candidatos a vacuna  (24, 26-28). No obstante, \nesta caracterizaci\u00f3n es tan s\u00f3lo el  primer paso . Debido a la alta diversidad ( variabilidad) \ngen\u00e9tica que exhibe P. vivax  (25, 29), una vacuna dise\u00f1ada a partir de estos ant\u00edgenos \npodr\u00eda ser poco eficaz, dadas las respuestas inmunes alelo-espec\u00edfica s que el polimorfismo \ndentro de estos ant\u00edgenos podr\u00eda  generar  (30-34). As\u00ed, con el fin de dise\u00f1ar una vacuna \ncompletamente efectiva, se hace necesari o centrar su desarrollo en regiones  conservadas o \ndominios funcionales (35). No obstante, los dominios  funcionales (por ejemplo, aquellos \ninvolucrado s en la interacci\u00f3n pat\u00f3geno -hospedero) de ant\u00edgenos de P. vivax , no ha n \npodido ser dilucidad os sino en un muy reducido grupo de ello s (36-38).  \n \nLas r egiones funcionales de l as prote\u00ednas , por ser cr\u00edtic as para llevar a  cabo diferentes \nprocesos celulares , evolucionan  lentamente , observ\u00e1ndose una correlaci\u00f3n entre la \nconservaci\u00f3n de un fragmento de la mol\u00e9cula con su importancia funcional (39, 40). Por lo \ntanto, determinar estas regiones podr\u00eda ser un punto de partida  para dise\u00f1ar una vacuna 19 \n completamente efectiva , ya que se evitar\u00edan as\u00ed , las respuestas inmunes alelo -espec \u00edficas. \nRecientemente, se ha producido un i ncremento de los datos gen\u00f3micos  (29, 41), \ntrascript\u00f3 micos  (42) y prote \u00f3micos  (43, 44) de P. vivax  y especies filogen \u00e9ticamente \nrelaciona das (10, 45). \u00c9stos, sumados a los  estudio s de variaci\u00f3n gen\u00e9tica en las \npoblaciones natu rales , puede n dar acceso a informaci\u00f3n clave sobre la biolog\u00eda, ecolog\u00eda y \nevoluci\u00f3n  del par\u00e1sito , usando un conjunto cada vez mayor  de herramientas de gen\u00e9tica de \npoblaciones y evoluci\u00f3n molecular.  As\u00ed, la generaci\u00f3n o uso de este tipo de datos y \nherramie ntas, podr\u00eda  ser el punto  de partida para la priorizaci\u00f3n o selecci\u00f3n de  los mejores \nant\u00edgenos  para dise\u00f1ar una vacuna completamente eficaz  contra P. vivax . \n \nCandidatos a vacuna .  \nEl esporozo\u00edto  y el merozo\u00ed to son las formas extracelulares infectivas de Plasmodium  spp, \npor lo tanto, son blancos del sistema inmune. Numerosas prote\u00ednas, tanto de superficie \ncomo de los organelos apicales del par\u00e1sito, participan activamente durante la invasi\u00f3n a la \nc\u00e9lula hospedera. Por lo tanto, e stas mol\u00e9culas son los princi pales blancos a incluir en una \nvacuna, ya que respuestas inmunes dirigidas hacia ellas podr\u00eda n inhibir la invasi\u00f3n (46-48). \nA pesar de la existencia de m\u00faltiples  ant\u00edgenos , no todos son considerados candidatos  \npromisorios. Para su inclusi\u00f3n en una vacuna, los candidatos  deben cumplir con ciertas  \ncaracter\u00edstica s (35, 49):  \n \n1) estar involucrad os en el proceso de invasi\u00f3n a la c\u00e9lula hospedera  \n2) deben ser accesibles a l sistema inmune del hospedero  \n3) inducir respuestas inmunes protectoras , y  \n4) carecer de variabilidad gen\u00e9tica o por lo  menos tener una variabilidad  baja (5). \n \nA pesar de que ya se cuenta con un n\u00famero signifi cativo de ant\u00edgenos en P. vivax  descritos \n(24, 50-58), la diversidad gen\u00e9tica de solo algunos de estos ant\u00ed genos ha sido evaluada . \nEsto debido a  que los estudios usados para tal fin implican , no solo  tiempo , sino tambi\u00e9n la \ndisponibilidad de  recursos econ\u00f3micos, convirti\u00e9ndose en una limitante para el desarrollo \nde una vacuna. A\u00fan m\u00e1s, dada  la predilecci\u00f3n de P. vivax  por los reticulocitos, el papel que 20 \n estos ant\u00edgenos tiene n durante la invasi\u00f3n no ha podido ser del todo descrit o, dadas las \ndificultades t\u00e9cnicas para evaluar la interacci\u00f3n pat\u00f3geno ( P. vivax ) - hospedero \n(reticulocitos).  \n \nGen\u00e9tica y evoluci\u00f3n, herramientas para el  dise\u00f1o de vacunas .  \nLa diversidad gen\u00e9tica en los ant\u00edgenos parasitarios puede  ser, en parte, consecuencia de \npresiones selectivas impuestas por el sistema inmune del hospedero , lo que per mite la \nfijaci\u00f3n o acumulaci\u00f3n de variantes (mutaciones) en la poblaci\u00f3n  parasitaria . Esta presi\u00f3n \nselectiva , puede  entonces, incrementa r la diversidad del par\u00e1sito, l o cual genera el problema \nde las  respuestas inmunes alelo -espec\u00edficas  (49, 59) que disminu yen la eficacia de las \nvacunas (34, 60).  \n \nEstudios poblaciones han permitido , no solo evaluar la diversidad de los ant\u00edgenos , sino \ntambi\u00e9n identificar las fuerzas evolutivas responsables de generar el patr\u00f3n  de variaci\u00f3n  \nobservado  (61-71). Usualmente, los ant\u00edgenos sobre la superficie del par\u00e1sito est\u00e1n \nexpuestos al sistema inmune del hospedero, lo que genera una presi\u00f3n selectiva sobre el \nant\u00edgeno. Teniendo en cuenta que las mutaciones en este grupo de par\u00e1sitos se producen a \nun ritmo mayor que la tasa de mutaci\u00f3n de l\u00ednea base  (49), la aparici\u00f3n de una variante, que \npermita la evasi\u00f3n de la respuesta inmune, se puede presentar a una tasa elevada. Es a \nmutaci\u00f3n (o algunas ya presentes) se fijar\u00e1 en la poblaci\u00f3n, dada la ventaja adaptativa que \nla variante tendr\u00eda, y en este caso , la selecci\u00f3n actuar\u00e1 hacia una direcci\u00f3n, manteniendo el \nmutante ventajoso (selecci\u00f3n positiva). Sin embargo, muchas mutacion es no alcanzan a \nfijarse en la poblaci\u00f3n. \u00c9stas se mantienen circulando en la poblaci\u00f3n , manteniendo \nfrecuencias intermedias o alternando sus frecuencias con el tiempo (selecci\u00f3n balanceante y \nselecci\u00f3n dependiente de frecuencia). En este caso, la selecci\u00f3 n act\u00faa manteniendo las \ndiferentes variantes, ya que un alto n\u00famero de alelos circulando, se convierte en un \nmecanismo de evasi\u00f3n de la respuesta inmune. Por lo tanto, se ha sugerido que ant\u00edgenos o \nregion es con estos tipos de selecci\u00f3n, podr\u00edan ser dianas  de la respuesta inmune y por \nconsiguiente ser evaluados como candidatos a vacuna (72, 73). No obstante, est os \ncandidatos n o necesariamente son las dianas  ideales, debido a su alta diversidad gen\u00e9tica.   \n 21 \n Por otro lado, algunas variantes (mutaciones que alteren la secuencia de la prote\u00edna) \npodr\u00edan tener un efecto contrario a las variantes fijadas /mantenidas  por selecci\u00f3n positiva o \nbalanceante. Por ejemplo, si una variante es reconocida f\u00e1cilmente por el sistema inmune, \n\u00e9sta ser\u00e1 eliminada de la poblaci\u00f3n  parasitaria . As\u00ed mismo, muchas de las mutaciones que \nse generan suelen ser eliminadas \u201cr\u00e1pidamente \u201d debido a que alteran  la funci\u00f3n o estructura \nde la prote\u00edna. Esta eliminaci\u00f3n se debe a la selecci\u00f3n negativa (a veces llamada \npurifica nte), que elimina todas aquellas variantes que tengan un efecto negativo en el \norganismo  (74). Dado que la selecci\u00f3n negativa mantendr\u00e1 conservadas porciones de la \nprote\u00edna donde esta est\u00e1 actuando, l a detecci\u00f3n de este tipo de selecci\u00f3n podr\u00eda  entonces ser \nutilizado para la identif icaci\u00f3n de potenciales candidatos a  vacunas, ya que estos , al ser \nconservados , evitar\u00e1 n respuestas inmunes alelo -espec\u00edfica s. (68, 74-76). A\u00fan m\u00e1s, la \ninferencia de este tipo de selecci\u00f3n podr\u00eda ayudar a delimitar regiones funcionales  dentro de \nlos ant\u00edgenos , debido a que los dominios funcionales  suelen estar  restringid os funcional o \nestructuralmente (39, 40), evolucionando m\u00e1s lentamente . En consecuencia, la regi\u00f3n o \nant\u00edgeno  bajo selecci\u00f3n negativa se mantendr\u00e1  conser vado (a nivel de la secuencia de \nprote\u00edna)  y as\u00ed, si las respuestas inmunes se dirigen hacia estas regiones  (y son protectoras) , \nse obtendr \u00eda una respuesta completamente efectiva . \n \nYa que los ant\u00edgenos  invol ucrados en el proceso de invasi\u00f3n podr\u00edan ser rec onocidos por el \nsistema inmune de hospedero, estos podr\u00edan presentar una alta diversidad gen\u00e9tica. Sin \nembargo, las partes funcionalmente  importantes de la prote\u00edna ( por ejemplo , las regiones \nimplicadas en la interacci\u00f3n par\u00e1sito -hospedero ) debe n estar restringidas funcionalmente , \nmanteni\u00e9ndose conservadas por selecci\u00f3n negativa , dentro y entre las especies  (40). En \nconsecuencia, inferir este tipo de selecci\u00f3n en ant\u00edgenos de P. vivax  (u otro pat\u00f3geno)  \npodr\u00eda usarse para pred ecir regiones bajo restricci\u00f3n funcional , que luego podr\u00edan usarse \ncomo potenciales  candidatas a vacunas.  \n \nEl presente  trabajo  est\u00e1 dividido en tres partes, la primera (Capitulo 1 y 2) donde se analiz\u00f3  \nlos datos gen\u00f3micos disponibles en bases de datos con  el fin de generar un flujo de trabajo \nque permitiese  hacer una selecci\u00f3n preliminar de los ant\u00edgenos parasitarios m\u00e1s promisorios \npara el dise\u00f1o de una vacuna contra P. vivax  que evite las respuestas inmunes alelo -22 \n espec\u00edficas . La segunda  parte  (Capitulo 3 ) analiz\u00f3  por an\u00e1lisis  poblaciones, la diversidad \ngen\u00e9tica de 8 ant\u00edgenos parasitarios, contrastando los resultados obtenidos  en los Cap\u00edtulos \n1 y 3 . La \u00faltima  parte  (Capitulo 4) , demuestra el potencial uso de esta metodolog\u00eda para la \nselecci\u00f3n de ant\u00edgeno s (o regiones dentro de \u00e9stos) promisorios para el dise\u00f1o de una \nvacuna contra P. vivax . \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n 23 \n HIPOTESIS  DE INVESTIGACI\u00d3N  \n \nLa diversidad gen\u00e9tica observada en P. vivax  es mayor a la de P. falciparum  (25, 29), \nposiblemente debido a que P. vivax  no ha experimentado cuellos de botella durante su \nhistoria evolutiva  como P. falciparum  (77-80). As\u00ed, gran parte del  polimorfismo observado \nen esta especie podr\u00eda ser ancestral y muchas de las variantes al\u00e9licas  podr\u00edan haber  surgi do \nantes de la dispersi\u00f3n del parasi to por el mundo  (81). Por lo tanto, el an\u00e1lisis de un n\u00famero \nreducido de secuencias de cepas parasitarias de diferentes regiones del mundo podr\u00eda \nreflejar  la diversidad gen\u00e9tica  un determinado ant\u00edgeno.  Si el an\u00e1lisis de pocas secuencias \nprovenientes de diferentes regiones del mundo refleja la diversidad gen\u00e9tica de un \ndeterminado ant\u00edgeno , entonces  estos resultados ser\u00e1n concordantes  a los obtenidos \nanalizando  un mayor n\u00famero de secuencias , y as\u00ed, podr\u00edan seleccionase ant\u00edgenos con baja \ndiversidad en un menor tiempo, postul\u00e1ndolos como potenciales ant\u00edgenos a ser incluidos \nen una vacuna contra P. vivax .  \n \nPor otra parte, d ado que l os ant\u00edgenos  parasitarios involucrados en el proceso de invasi\u00f3n \npodr\u00edan ser blancos del  sistema inmune de hospedero, \u00e9stos pueden presentan  una alta \ndiversidad gen\u00e9tica  (61, 64, 65, 67, 70, 71, 90, 128, 129). Sin embargo, las partes \nfuncionalmente  importantes de la prote\u00edna ( por ejemplo , aquellas  regiones implicadas en la \ninteracci\u00f3n par\u00e1sito -hospedero) podr\u00edan estar restringidas funcionalmente , manteni\u00e9ndose \nconservadas dentro y entre especies por la acci\u00f3n de la selecci\u00f3n negativa . Por lo tanto , si \nlas regiones conservadas entre especies de un determinado ant\u00edgeno son el resultado de la \nacci\u00f3n de la selecci\u00f3n negativa , entonces estas regiones ser\u00edan funcionalmente importantes \ny podr\u00edan estar involucradas , por ejemplo, en la interacci\u00f3n pat\u00f3geno -hosped ero y as\u00ed ser \nconsideradas como promisorias para ser incluidas durante el dise\u00f1o de una vacuna contra P. \nvivax .  \n \n \n \n 24 \n OBJETIVOS  \n \nObjetivo general  \nInferir se\u00f1ales de selecci\u00f3n natural en ant\u00edgenos de Plasmodium vivax  para identificar y \nseleccionar los candid atos/regiones a vacuna m\u00e1s promisorios para el dise\u00f1o de una vacuna \ncompletamente efectiva contra P. vivax . \n \nObjetivos espec\u00edficos  \n\uf0b7 Analizar 59 genes de P. vivax  previamente reportados como potenciales candidatos a \nvacuna a partir de los datos gen\u00f3micos de 5 aislados parasitarios y 2 especies \nfilogen\u00e9ticamente relacionas depositados en el GenBank.  \n \n\uf0b7 Calcular varios par\u00e1metros de diversidad gen\u00e9tica y detectar se\u00f1ales de selecci\u00f3n \nnatural para cada uno de los 59 genes a partir de los datos gen\u00f3micos obtenidos.  \n \n\uf0b7 Seleccionar los ant\u00edgenos m\u00e1s promisorios a incluir en el dise\u00f1o de vacuna \nantimal\u00e1rica contra P. vivax  a partir de los datos obtenidos.  \n \n\uf0b7 Identificar la presencia de infecciones \u00fanicas y la presencia de diferentes genotipos de \nP. vivax  en muestras de ADN  de aislados naturales obtenidas en  diferentes regiones de \nColombia .  \n \n\uf0b7 Evaluar la diversidad gen\u00e9tica de 8 ant\u00edgenos de P. vivax  y determinar las fuerzas \nevolutivas que generan el patr\u00f3n de variaci\u00f3n observado , a partir de secuencias \nobtenidas de aislados parasitarios de la poblaci\u00f3n Colombiana . \n \n\uf0b7 Implementar la metodolog\u00eda propuesta en este trabajo durante la caracterizaci\u00f3n de \nnuevo s ant\u00edgeno s de P. vivax . \n 25 \n  \n \n \n \n \n \n \n \n \nCAPITULO 1  \nUn enfoque alternativo para la selecci\u00f3n de candidatos promisorios  a \nvacuna  \n \n \n \n \n \n \n \n \n 26 \n Introducci\u00f3n  \nEl desarrollo de una vacuna contra P. vivax  se encuentra retrasado con respecto a P. \nfalciparum , y pocos candidatos a vacuna  han sido propuestos hasta la fecha  (21). En P. \nvivax , la caracterizaci\u00f3n de nuevos potenciales candidatos involucra la b\u00fasqueda de \nsecuencias con un alto porcentaje de similitud  con los ant\u00edgenos previamente descritos en \nP. falciparum  (24). Adicionalmente, o tras alternativas (82) han permitido  por m\u00e9todos \nbioinform\u00e1tico s predecir prote\u00ednas de P. vivax  que podr\u00edan tener  un papel durante el \nproceso de invasi\u00f3 n.  \n \nEstos  estudios han permitido describir cerca de 60 ant\u00edgenos  de P. vivax  que podr\u00edan ser \nconsiderados durante el dise\u00f1o de una vacuna. Sin embargo, la diversidad gen\u00e9tica y las \nfuerzas evolutivas de estas mol\u00e9culas deben ser evaluadas  para dise\u00f1ar una vacuna \ncompletamente efectiva  (21, 83). An\u00e1lisis poblacion ales y de evoluci\u00f3n molecu lar son las \nprincipales estrategias para tal fin. Estas alternativas requieren la secuenciaci\u00f3n de varias \nmuestras  parasitarias,  por lo tanto, realizar tales estudios para todos estos genes implicar\u00eda \ntiempo y recursos  econ\u00f3micos . No obstante , Cornejo et al. (84), utilizando un tama\u00f1o de \nmuestra limitado ( los genomas de 5 aislamientos) han identificado genes con se\u00f1ales  de \nselecci\u00f3n  natural . Este tipo de an\u00e1lisis podr\u00eda ser un punto de partida para detectar posi bles \nnuevos candidatos a vacuna  (73), similar a  previos  enfoque s adoptado s en P. falciparum  \n(72, 85).  \n \nLa primera parte de este trabajo  utiliz\u00f3  tres pruebas  diferentes para detectar se\u00f1ales de \nselecci\u00f3n en 59 ant\u00edgenos de l merozo\u00edto  de P. vivax  previamente caracte rizados . Para este \nfin, la informaci\u00f3n disponible en GenBank  de cinco  genomas de  aislados de P. vivax  de \ndiferentes regiones del mundo y de dos especies estrechamente relacionadas  (P. cynomolgi  \ny P. knowlesi ) fue analizada . Los resultados obtenidos pueden ser utilizados  para \ndeterminar qu\u00e9 ant\u00edgenos deber\u00edan  ser priorizados y evaluados en estudios adicionales \ndirigidos al dise\u00f1o de una vacuna completamente efectiva  contra P. vivax .  27 \n Metodolog\u00eda  \nObtenci\u00f3n de secuencias y alineamientos .   \nSecuencias de 59 gen es (de la cepa adaptada a primates no humanos Sal -I) previamente \nsugeridos como potenciales candidatos a vacuna  (24, 26-28, 50-58, 82, 86-89), fueron  \ndescargadas de la base de datos PlasmoDB  (www.plasmodb.org/plasmo/ ). Cuarenta y ocho \nde estos genes no hab\u00edan  sido analizados previamente por an\u00e1lisis  poblacion ales, mientras \n11, ya han sido evaluados por esta metodolog\u00eda (61-63, 68, 90). Posteriormente, estas  \nsecuencias fueron  utilizadas con el fin de obtener las  hom\u00f3logas  de estos  59 genes de \ncuatro cepas de P. vivax  adaptada s a primates no humanos (Brasil-I, India -VII, Mauritania -I \ny Corea del Norte  (29)) y de dos espe cies filogen\u00e9ticamente relacionadas ( Plasmodium \ncynomolgi  (45) y Plasmodium knowlesi  (10)), mediante  una b\u00fasqueda por tBlasn (29). \nAdicionalmente, s e realiz \u00f3 una b\u00fasqueda en la base de datos GenBank  para obtener \nsecuencias report adas para otras cepas de P. vivax  (VCG -I, Bele m o Corea del Sur).  \n \nAn\u00e1lisis de las relaciones filogen\u00e9ticas de los genes pertenecientes a las familias \nmultig\u00e9nicas .  \nAlgunos genes incluidos en el an\u00e1lisis pertenecen a familias multig\u00e9nicas, por lo tanto, \nprevio a los an\u00e1lisis de diversidad gen\u00e9tica y de selecci\u00f3n natural, se realiz \u00f3 la \nidentificaci\u00f3n de las relaciones de ortolog\u00eda dentro de cada familia multig\u00e9nica. Una \ncombinaci\u00f3n de 3 criterios fue utiliz ada para esta identificaci\u00f3n, e stos incluyen:  \n  \na. una se\u00f1al filogen\u00e9tica (topo log\u00eda de un \u00e1rbol filogen\u00e9tico)   \nb. similitud de secuencia (distancia gen\u00e9tica) , y  \nc. sintenia (posic i\u00f3n gen\u00f3mica similar)  \n \ncomo ha sido previamente  descrito  (91-94). \n \nLas secuencias de P. vivax , P. cynomolgi  y P. knowlesi  de las familias sera, msp3, msp7, \nclag, Pfam A y Pfam d, fueron  alineadas independientemente con todos los miembros de sus \nrespectivas familias utilizando el m\u00e9todo  MUSCLE (95). El mejor modelo evolutivo para 28 \n cada familia fue seleccionado por el criterio de informaci\u00f3n bayesiano, utilizando el \nprograma MEGA  v.5 (96) y fue utilizado  para inferir \u00e1rboles filogen\u00e9ticos mediante el \nm\u00e9todo de M\u00e1xima verosimilitud (ML). Gaps  y regiones repetitivas no fueron tenidos en \ncuenta para  los an\u00e1 lisis. La confiabilidad de la topolog\u00eda fue evaluada por bootstrap  (1.000 \nrepeticiones). Las distancias gen\u00e9ticas fueron  calculadas usando el programa MEGA v.5 y \nla sintenia fue determinada  teniendo en cuenta estudios previos (91, 92, 94) y la \ninformaci\u00f3n disponible en PlasmoDB ( www.plasmodb.org/plasmo/ ).   \n \nAn\u00e1lisis de diversidad gen\u00e9tica e inferencia de se\u00f1ales de selecci\u00f3n natural .  \nYa con  la identificaci\u00f3n de los genes ort\u00f3logos  putativos  de las familias multig\u00e9nicas , se \nrealiz aron alineamientos m\u00faltiples para todos los 59 genes , usando las secuencias \ndisponibles de cepas de P. vivax  adaptadas a primates y las secuencias ort\u00f3logas de  dos \nespecies filogen\u00e9ticamente relacionadas. A partir de estas secuencias de ADN , se infiri \u00f3 la \nsecuencia de prote\u00ednas, las c uales fueron  alineadas con el m\u00e9todo  MUSCLE (95). A partir \nde este alineamiento , se infiri \u00f3 el alineamiento de ADN (por c odones) usando el programa \nPal2Nal (97). Para todos los an\u00e1lisis , se utiliz \u00f3 la anotaci\u00f3n de la  cepa Sal -I como \nreferencia. A partir de los alineamientos obtenidos , se estim aron varias medidas de la \ndiversidad gen\u00e9tica, utilizando el programa DnaSP v.5 (98).  \n \nRecientemente, Cornejo et al ., (84) identificaron  patrones consistentes con selecci\u00f3n \nnatural en el genoma de  P. vivax  usando la prueba de Hudson, Kreitman y Aguade, la \nversi\u00f3n gen\u00f3mica de la prueba de McDonald -Kreitman (MK) y el estimador D de Tajima  \n(84); sin embargo, no se reportaron  se\u00f1ales de selecci\u00f3n positiva  en los genes del merozo\u00edto  \nimplicados en la invasi\u00f3n. En el presente  trabajo , se evaluar on se\u00f1ales de la  selecci\u00f3n \nnatural (positiva, balanceante y negativa) mediante  la utilizaci\u00f3n de pruebas de \ncomparaci\u00f3n de datos de diferentes especies (99) tales como:  la prueba convencional de \nMK (100) y la raz\u00f3n \u03c0/\u039a  (diversidad nu cleot\u00eddica /divergencia nucleot \u00eddica)  (72, 85). La \nprueba MK se realiz \u00f3 teniendo en cuenta la correcci\u00f3n de di vergencia de Jukes -Cantor \n(101), mediante el uso del s ervidor web http://mkt.uab.es/mkt/MKT.asp  (102). La raz\u00f3n \n\u03c0/\u039a fue evaluada para la identificaci\u00f3n de genes con valores mayores a 0 ,1, lo cual  es \nesperad o en genes bajo selecci\u00f3n balanceante (72, 85).  29 \n Figura 4. Metodolog\u00eda del Cap\u00edtulo 1  \n 30 \n El programa MEGA v.5 (103) fue utili zado para evaluar se\u00f1ales de selecci\u00f3n natural dentro \nde P. vivax , mediante el c\u00e1lculo de las tasas de sustituci\u00f3n no -sin\u00f3nima por sitio no -\nsin\u00f3nimo (d N) y la tasa de sustituci\u00f3n sin\u00f3nima por  sitio sin\u00f3nimo (d S), utilizando el \nm\u00e9todo modificado de Nei -Gojo bori (104). As\u00ed mismo, pa ra inferir patrones de selecci\u00f3n \nnatural que podr\u00eda n haber prevalecido durante la historia evolutiva  de Plasmodium , se \ncalcular on la diferencia entre el n\u00famero promedio de la divergencia no -sin\u00f3nima por sitio \nno-sin\u00f3nimo y el n\u00famero promedio de la divergen cia sin\u00f3nima por sitio sin\u00f3nimo (K N-KS, \nadecuado para detectar selecci\u00f3n pasada (99)), utilizando el m\u00e9todo modificado de Nei -\nGojobori con la correcci\u00f3n de Jukes -Cantor. Diferencias significativas entre d N y dS (o K N y \nKS) fueron  evaluadas por la prueba Z-test o la prueba exacta de Fisher. Adicionalmente, se \nrealiz \u00f3 una ventana deslizante de la tasa \u03c9 ( omega = dN/dS o K N/KS) para determinar \nregiones espec\u00edficas afectadas por tipos particulares de  selecci\u00f3n natural. Regiones con \ngaps  o regiones repetitivas , no fueron  tenidas en cuenta para los an\u00e1lisis. La Figura 4 \nesquematiza la metodolog\u00eda realizada.  \n \nResultados  y Discusi\u00f3n  \nSecuencias de 59 genes de P. vivax  (obtenidas de al menos 5 cepas adaptadas a primates),  \nque codifican potenciales candidatos a vacuna, fueron analizados con respecto a su \ndiversidad gen\u00e9tica y se\u00f1ales de selecci\u00f3n natural (Publicaci\u00f3n  1). Los c\u00e1lculos de los \nestimadores de diversidad mostraron  16 genes altamente polim\u00f3rficos (\u03c0  > 0,01), 35 con un \npolimorfismo intermedio (0 ,009 <  \u03c0 > 0,001) y 8 que mostraron una  baja diversidad \ngen\u00e9tica (\u03c0 <  0,001) (Tabla 2 ). La Figura 5, muestra la distribuci\u00f3 n de los polimorfismo s \ndentro de cada uno de los  59 genes.  \n \nTabla 2. Estimadores de  la diversidad gen\u00e9tica en 59 genes de P. vivax . \n# ID Gen n Sitios  Ss S Ps \u03c0 (SD)  \nGenes sin estudios previos de gen\u00e9tic a de poblaciones  \n1 PVX_000945  pvron -1 6 2340  5 3 2 0,0096 (0 ,0001)  \n2 PVX_000995  pv41  6 1086  14 5 9 0,0064 (0 ,0013)  \n3 PVX_002510  nucleosomal binding protein 1  5 750 2 1 1 0,0013 (0,0003)  \n4 PVX_003800  Pvsera  5 3033  4 4 0 0,0005 (0 ,0005)  31 \n 5 PVX_003805  pvsera , putative  5 3507 436 195 241 0,0728 (0 ,0100)  \n6 PVX_003815  pvsera , truncated, putative  5 1335  15 12 3 0,0049 (0 ,0014)  \n7 PVX_003825  pvsera -4 4 2814  144 113 31 0,0282 (0 ,0072)  \n8 PVX_003830  pvsera -5 6 3090 752 528 224 0,1038 (0 ,0222)  \n9 PVX_003850  pvsera -2 6 3042  12 9 3 0,0016 (0 ,0004)  \n10 PVX_080305  hypothetical protein, conserved  5 804 1 1 0 0,0005 (0 ,0003)  \n11 PVX_081810  hypothetical protein, conserved  5 3921  18 15 3 0,0020 (0 ,0004)  \n12 PVX_081845  hypothetical protein  5 1044  3 1 2 0,0015 (0 ,0003)  \n13 PVX_084720  hypothet ical protein, conserved  5 2720  9 5 4 0,0016 (0 ,0003)  \n14 PVX_086850  pvvir -35, putative  4 662 40 19 21 0,0360 (0 ,0090)  \n15 PVX_086930  pvrhopH1/clag  5 3978  38 30 8 0,0043 (0,0010)  \n16 PVX_090075  pv34  6 1092  1 1 0 0,0003 (0 ,0003)  \n17 PVX_090210  Pvarp 7 82 6 5 1 0,0029 (0 ,0007)  \n18 PVX_091434  pvron -4 6 2097  14 5 9 0,0033 (0 ,0007)  \n19 PVX_092425  hypothetical protein, conserved  4 1950  25 25 0 0,0070 (0 ,0032)  \n20 PVX_092975  erythrocyte binding protein 1  6 3440  36 31 5 0,0038 (0 ,0009)  \n21 PVX_092995  tryptophan -rich antigen  5 1059  25 19 6 0,0105 (0 ,0036)  \n22 PVX_094425  hypothetical protein, conserved  5 3045  3 2 1 0,0005 (0 ,0001)  \n23 PVX_096990  Pv-fam-d protein  5 1136  22 12 10 0,0095 (0 ,0022)  \n24 PVX_097565  Plasmodium exported protein  5 1311  6 6 0 0,0018 (0 ,0003)  \n25 PVX_097670  pvmsp -3\u03b3, putative  6 1743  524 282 242 0,1408 (0 ,0154)  \n26 PVX_097675  pvmsp -3\u03b3, putative  5 1758  445 281 164 0,1268 (0 ,0229)  \n27 PVX_097695  pvmsp -3\u03b1, putative  5 2613  424 240 184 0,0817 (0 ,0126)  \n28 PVX_097700  pvmsp -3, putative  4 3306  770 577 201 0,1332 (0 ,0245)  \n29 PVX_097705  pvmsp -3\u03b1, putative  5 2607  440 264 176 0,0841 (0 ,0110)  \n30 PVX_097710  pvmsp -3, putative  5 3607  867 506 361 0,1229 (0 ,0185)  \n31 PVX_097715  pvmsp -3, putative  5 1286  49 42 7 0,0163 (0 ,0034)  \n32 PVX_097960  pv38  6 1065  4 0 4 0,0022  (0,0004)  \n33 PVX_098585  pvrbp -1, putative  6 8451  39 22 17 0,0020 (0 ,0003)  \n34 PVX_098712  pvrhopH3  6 2673  4 3 1 0,0006 (0 ,0002)  \n35 PVX_101505  Pv-fam-d protein  5 1263  5 2 3 0,0021 (0 ,0004)  \n36 PVX_101555  hypothetical protein  5 2586  167 98 69 0,0337 (0 ,0081 ) \n37 PVX_101605  hypothetical protein  5 582 3 0 3 0,0031 (0 ,0030)  \n38 PVX_109280  pvfam -a 7 753 1 1 0 0,0004 (0 ,0003)  \n39 PVX_112665  tryptophan -rich antigen  5 867 3 1 2 0,0018 (0 ,0004)  \n40 PVX_113775  pv12  7 942 4 2 1 0,0014 (0 ,0006)  \n41 PVX_117230  pvser/thr  5 4122  5 3 2 0,0006 (0,0001)  \n42 PVX_117880  pvron -2 7 6495  31 23 8 0,0016 (0 ,0003)  \n43 PVX_118525  hypothetical protein, conserved  5 5082  19 13 6 0,0017 (0,0004)  \n44 PVX_121885  pvclag , putative  5 4239  63 44 19 0,0069 (0 ,0010)  \n45 PVX_121920  pvrbp -2, like  5 7461  31 15 16 0,0021 (0,0003)  \n46 PVX_123105  hypothetical protein, conserved  5 2114 1 1 0 0,0002 (0 ,0001)  32 \n 47 PVX_123550  hypothetical protein, conserved  5 647 4 3 1 0,0027 (0,0006)  \n48 PVX_123575  thrombospondin -related protein 3  6 966 3 2 1 0,0012 (0 ,0004) \nGenes con estudios previos de gen\u00e9tica de poblaciones  \n1 PVX_003905  pv230 , putative  5 8199 22 14 8 0,0013 (0 ,0002)  \n2 PVX_082695  pvmsp -7K, putative  6 849 7 5 2 0,0033 (0 ,0006)  \n3 PVX_085930  pvrap -1, putative  5 2223 2 2 0 0,0003 (0 ,0002)  \n4 PVX_092275  pvama -1 6 1683  31 18 13 0,0080 (0 ,0010)  \n5 PVX_097590  pvrap -2, putative  5 1203  0 0 0 0,000 (0 ,000) \n6 PVX_097625  pvmsp -8 6 1320  6 3 3 0,0021 (0 ,0006)  \n7 PVX_097720  pvmsp -3\u03b1 6 2016  154 72 82 0,0349 (0 ,0158)  \n8 PVX_097680  pvmsp -3\u03b2 6 2007  329 165 164 0,0747 (0 ,0094)  \n9 PVX_099980  pvmsp -1 6 5058  532 170 362 0,0527 (0 ,0068)  \n10 PVX_110810  Pvdbp  6 3210  45 23 22 0,0063 (0 ,0010)  \n11 PVX_114145  pvmsp -10 6 1288  5 0 5 0,0021 (0 ,0003)  \nn: N\u00fa mero se secuencias analizadas; Sit ios: total de sitios analizados, excluyendo gaps; Ss: n\u00famero de sitios segregantes \n(polim\u00f3rficos); S: n\u00famero de sitios singleton; Ps: n\u00famero de sitios parsimoniosos; \u03c0: diversidad nucleot\u00eddica por sitio; \nSD: d esviaci\u00f3n est\u00e1ndar.  \n \nPrevio a la detecci\u00f3n de se\u00f1ales de selecci\u00f3n natural en estos 59 genes, las relaciones \nfilogen\u00e9ticas de miembros de familias multig\u00e9nicas ( identificaci\u00f3n de ort\u00f3logos putativos) \nfueron establecidas  (Anexo 1) .  \n \nUna vez establecidas l as relaciones de ortolog\u00eda, las se\u00f1ales de selecci\u00f3n fueron detectadas \nmediante  tres enfoques diferentes. Con la prueba MK se detectaron 16 genes bajo selecci\u00f3n \nbalanceante ( \u00edndice de neutralidad  (NI) > 1) y uno bajo selecci\u00f3n positiva ( NI <  1). La \nrelaci\u00f3 n \u03c0/K identific\u00f3  11 genes bajo selecci\u00f3n balanceante (Tabla 3).  Estos genes podr\u00edan \nser blancos del sistema inmune y, por lo tanto , podr\u00edan ser considerados  como potenciales \ncandidatos a vacuna. Sin embargo, el alto polimorfismo dentro de algunos de ellos , \nreducir\u00eda la eficacia de la vacuna  debido a las respuestas inmunes alelo -espec\u00edficas que se \npresentar\u00edan . \n \n 33 \n Figura 5. Distribuci\u00f3n del polimorfismo  dentro de los 59 genes Plasmodium vivax  estudiados.  \n \nLos codones con mutaciones  sin\u00f3nimas (naranja) y no sin\u00f3nima s (rojo) se muestran con l\u00edneas verticales encima de cada gen. En azul se representan las  regiones que codifican el \np\u00e9ptido se\u00f1al , en verde las regiones predichas como  transmembrana les o de anclaje  a GPI, en cian oscuro se representan los dominios s48/45 y en negro las regiones con INDELs  \n(INserci ones o DEL eciones ). 34 \n S\u00f3lo 7 genes mostraron se\u00f1ales de selecci\u00f3n balanceante por ambas pruebas (\u03c0/K y MK). \nUna baja correlaci\u00f3n entre estas pruebas ha sido previamente demostrada (72). Esto podr\u00eda \nser debido al efecto de la selecci\u00f3n negativa d\u00e9bil, que puede producir un exceso de \npolimorfismo, pero a bajas frecuencias. Sin embargo, el valor del  NI > 1 (o Pn/P s > Dn/Ds) \nencontr ado en este estudio , parece deberse al alto n\u00famero de sustituciones sin\u00f3nimas entre \nlas especies (Ds), resultando en un Pn/Ps > Dn/Ds. El alto n\u00famero de sustituciones \nsin\u00f3nimas  entre las especies, sugiere que la evoluci\u00f3n ha mantenido las secuencias de \nprote\u00ednas conservadas en ambas, por lo que una restricci\u00f3n funcional/estructural parece ser \nprobable. Esto sugiere que  algunos genes podr\u00edan no estar bajo selecci\u00f3n balanceante, sino \nbajo una selecci\u00f3n negativa. Esta interpretaci\u00f3n fue soportada por el hecho de que se \nencontr\u00f3 valores bajos de \u03c9 y valores negativos estad\u00edsticamente significativos en la prueba \nKN-KS (Tabla 3 y Anexo 2 ). \n \nTabla 3. Raz\u00f3n diversidad nucleot\u00eddica/divergencia ( \u03c0/\u039a), \u00edndice de neutralidad de la prueba \nMcDonald -Kreitman (NI) y tasas de sustituci\u00f3n no sin\u00f3nima (d N) y sin\u00f3nima (d S) para algunos \ngenes de P. vivax  evaluados.  \n# ID Gen Pcyn  Pkno  Pcyn  Pkno  \ndN (SE)  dS (SE)  \n\u03c0/\u039a \u03c0/\u039a NI p-value  NI p-value  \nGenes sin estudios previos  de gen\u00e9tica de poblaciones  \n2 PVX_ 000995  pv41  0,045 0,033 3,218 0,031 2,960 0,044 0,0052 (0 ,0022)  0,0098 (0 ,0041) * \n4 PVX_003800  pvsera  0,003 0,002 0,781 0,831 2,476 0,507 0,0002 (0 ,0002)  0,0014 (0 ,0008)\u2021  \n5 PVX_003805  pvsera , putative  0,325  - 2,592 0,000  -  - 0,0729 (0 ,0046)  0,0725 (0 ,0060) \n7 PVX_003825  pvsera -4 0,164  - 2,949 0,000  -  - 0,0257 (0 ,0027)  0,0347 (0 ,0044)\u2020  \n8 PVX_003830  pvsera -5  -  -  -  -  -  - 0,1028 (0 ,0048)\u2022  0,0791 (0 ,0057)  \n11 PVX_081810  hypothetical protein, conserved  0,024 0,014 2,014 0,158 2,069 0,165 0,0015 (0 ,0005) 0,0032 (0 ,0011)\u2021  \n13 PVX_084720  hypothetical protein, conserved  0,008 0,006 10,919 0,000 8,928 0,000 0,0020 (0 ,0007)  0,0006 (0 ,0005)  \n14 PVX_086850  pvvir -35, putative  0,265  - 1,335 0,552  -  - 0,0407 (0 ,0071)\u2c76  0,0240 (0 ,0081)  \n15 PVX_086930  pvrhopH1/ clag 0,032 0,023 9,252 0,000 10,703 0,000 0,0048 (0 ,0010)  0,0029 (0 ,0011)  \n18 PVX_091434  pvron -4 0,021 0,016 3,262 0,024 0,649 0,465 0,0032 (0 ,0014)  0,0037 (0 ,0016)  \n19 PVX_092425  hypothetical protein, conserved  0,066 0,048 0,591 0,238 0,709 0,420 0,0045 (0,0015)  0,0104 (0 ,0028)\u25ca \n21 PVX_092995  tryptophan -rich antigen  0,057  - Null 0,027  -  - 0,0142 (0 ,0032)\u2022  0,0000 (0 ,0000)  \n25 PVX_097670  pvmsp -3\u03b3, putative  0,756  - 1,499  0,092  -  - 0,1601 (0 ,0074)\u2022  0,0906 (0 ,0080)  \n26 PVX_097675  pvmsp -3\u03b3, putative  0,615   - 1,556  0,031  -  - 0,1412 (0 ,0072)\u2022  0,0880 (0 ,0082)  \n27 PVX_097695  pvmsp -3\u03b1, putative   -  -  -  -  -  - 0,0885 (0 ,0048)\u25ca  0,0689 (0 ,0059)  \n28 PVX_097700  pvmsp -3, putative   -  -  -  -  -  - 0,1397 (0 ,0054)\u25ca  0,1160 (0 ,0074)  \n29 PVX_097705  pvmsp -3\u03b1, putative   -  -  -  -  -  - 0,0864 (0 ,0047)\u2021  0,0705 (0 ,0062)  35 \n 30 PVX_097710  pvmsp -3, putative   -  -  -  -  -  - 0,1359 (0 ,0055)\u2022  0,0956 (0 ,0059)  \n31 PVX_097715  pvmsp -3, putative  0,077 0,049 0,647  0,337 0,973   0,956 0,0136 (0 ,0024)  0,0225 (0 ,0050)\u2020  \n33 PVX_098585  pvrbp -1, putative  0,014  - 2,441 0,056  -  - 0,0024 (0 ,0004)\u2020  0,0008 (0 ,0004)  \n36 PVX_101555  hypothetical protein  0,263  - 2,115 0,003  -  - 0,0401 (0 ,0040)\u2022  0,0169 (0 ,0031)  \n40 PVX_113775  pv12  0,006 0,005 Null 0,002 Null 0,000 0,0020 (0 ,0010)  0,0000 (0 ,0000)  \n41 PVX_117230  pvser/thr  0,007 0,004 0,389  0,384 0,430  0,438 0,0001 (0 ,0001)  0,0018 (0 ,0009)\u25ca  \n42 PVX_117880  pvron -2 0,011 0,008 4,859 0,000 4,507 0,000 0,0016 (0 ,0004)  0,0016 (0 ,0006)  \n43 PVX_118525  hypothetical protein, conserved  0,014 0,009 1,125  0,877 1,479  0,395 0,0013 (0 ,0004)  0,0030 (0 ,0010)\u25ca  \n44 PVX_121885  pvclag , putative  0,096 - 0,966 0,904  -  - 0,0059 (0 ,0011)  0,0095 (0 ,0019)\u25ca  \n47 PVX_123550  hypothetical protein, conserved  0,048 0,029 9062  0,025  2,437  0,376 0,0016 (0 ,0011)  0,0059 (0 ,0041)  \nGenes con estudios previos  de gen\u00e9tica de poblaciones  \n1 PVX_003905  pv230  0,005 0,004 2,7 0,025 2 0,093 0,0012 (0 ,0004)  0,0016 (0 ,0006)  \n4 PVX_092275  pvama -1 0,056 0,045 6,923 0,000 4,876 0,000 0,0066 (0 ,0017)  0,0085 (0 ,0029)  \n7 PVX_097720  pvmsp -3\u03b1 0,259  - 0,571 0,030  -  - 0,0324 (0 ,0035)  0,0416 (0 ,0054)\u2020  \n8 PVX_097680  pvmsp -3\u03b2 0,533  - 1,312 0,254  -  - 0,0819 (0 ,0051)\u2020  0,0558 (0 ,0063)  \n9 PVX_099980  pvmsp -1 0,274 0,203 2,300 0,000 2,744 0,000 0,0485 (0 ,0028)  0,0464 (0 ,0037)  \n10 PVX_110810  Pvdbp  0,050 0,015 2,924 0,013 3,228 0,005 0,0074 (0 ,0012)  0,0032 (0 ,0013)  \n11 PVX_114145  pvmsp -10 0,010 0,006 0,289 0,252 0,801 0,856 0,0011 (0 ,0008)  0,0046 (0 ,0025) * \n-: El valor de la prueba no pudo ser estimado ya que no se encontraron secuencias ort\u00f3logas; Null: El \u00edndice de \nneutralidad (NI) no pudo ser estimado debido a que el polimorfismo neutral (o no neutral) es igual a 0; SE: error \nest\u00e1ndar; Pcyn: Valor obtenido al comparar las secuencias de P. vivax con P. cynomolgi; Pkno: Valor obtenido al \ncomparar las secuencias de P. viv ax con P. knowlesi. El v alor de p para el NI de pv230, p vmsp -1 y pvama -1 no pu do ser \nestimado en el servidor web; por lo tanto, se calcularon con el programa DnaSP, que no considera la correcci\u00f3n de \nJukes -Cantor.  *: p < 0 ,06; \u2c76: p < 0 ,05; \u2021; p < 0 ,04; \u25ca: p  < 0,01; \u2020: p < 0 ,002; \u2022: p < 0 ,0001. Se muestran s\u00f3lo genes en \nlos que se detect\u00f3 una se\u00f1al de selecci\u00f3n . \n \nLos resultados de la prueba dN y dS mostraron 12 genes con se\u00f1ales de selecci\u00f3n positiva, 9 \ncon se\u00f1ales de  selecci\u00f3n negativa (Tabla 3), mientras que para los restantes, la neutralidad \nno pu do ser descartad a. Esto sugiere que genes como pvsera 5, pvvir 35, los miembros de la \nfamilia  pvmsp3 , pvrbp 1, PVX_092995 y PVX_101555 podr\u00edan estar bajo presi\u00f3n del \nsistema inmune, fijando  o acumula ndo mutaciones de tipo no -sin\u00f3nimo  como mecanismo \nde evasi\u00f3n. Por lo tanto,  una vacuna basada en las prote\u00ednas codificadas por estos genes , \npodr\u00eda tener una baja e fectividad debido a su alto polimorfismo.  Por otra parte, la s prote\u00ednas \ncodificadas por  genes bajo selecci\u00f3n ne gativa  podr\u00edan ser tenidas en cuenta para el \ndesarrollo de vacunas  (68, 74-76). Genes tales como pv41 , PVX_0 92425, pvclag  \n(PVX_121885) o pvmsp 10, podr\u00edan ser buenos candidatos a vacuna,  ya que la selecci\u00f3n 36 \n negativa podr\u00eda ser consecuencia de restricciones funcionales y, por lo tanto , las respuestas \ninmunes alelo -espec\u00edficas  ser\u00edan abolidas . \n \nLas presiones select ivas (o la restricci\u00f3n  funcional/estructural) no son iguales a lo largo de  \ntoda la mol\u00e9cula , por lo tanto,  diferentes tipos de selecci\u00f3n podr\u00eda actuar sobre \u00e9sta (90). \nPara determinar c\u00f3mo se han acumulado las mutaciones sin\u00f3nimas y no sin\u00f3nimas en estos \ngenes , se realiz\u00f3 un a ventana deslizante de las tasas \u03c9 ( dN/dS o K N/KS) permitiendo  \nidentificar  dominios /regiones  bajo selecci\u00f3n positiva ( \u03c9 > 1 ) o negativa  (\u03c9 < 1). El an\u00e1lisis \nde ventana d esliza nte, mostr\u00f3  que varios genes que carecen de valores  significativos de d N \no d S, tienen dominios con un valor \u03c9 > 1, mientras otras regiones presentaban  valores de \u03c9 \n< 1 ( Anexo 2 ). Interesantemente, las r egiones con un  valor de \u03c9 < 1, coinciden con  aquellas \nregiones donde dominios funcionales han sido descritos, sugiriendo que estos dominios \ntienen restricciones funcionales, debido a su rol en la invasi\u00f3n del par\u00e1sito  a la c\u00e9lula \nhospedera (Figu ra 6 y Anexo 2 ). \n \nFigura 6. Ventana deslizante de la tasa \u03c9 en la regi\u00f3n C -terminal de PvMSP -1 \n \nEl fragmento de PvMSP -1 de 33 kDa est\u00e1 involucrado en el reconocimiento de la c\u00e9lula hospedera (38). Las regiones \nespec\u00edficas que interact\u00faan con los reticulocitos (resaltadas e n cuadros p \u00farpura ) presentan una baja divergencia ( \u03c9 < 1), \nmientras las regiones no funcionales presentan una alta divergencia ( \u03c9 > 1). El p\u00e9ptido 2 muestra una alta divergencia \nque podr\u00eda ser el resultad o de adaptaciones especie -espec\u00edfica s (105, 106), lo que eleva el valor \u03c9 . Este resultado \nconcuerda con an\u00e1lisis poblaciones previos de este fragmento  (107). \n 37 \n Teniendo en cuenta lo anterior , se buscaron este tipo de regiones (con \u03c9 < 1) en genes con \nse\u00f1ales de selecci\u00f3n negativa. Por ejemplo, l os genes pvron 2 y pvron 4 presentaron regiones \ncon valores \u03c9 < 1 hacia los extremos 3\u2019 . Consecuentemente, la regi\u00f3n  C-terminal de las \nprote\u00ednas PvRON2 y PvRON 4 podr\u00eda n ser las regiones funcionales . As\u00ed mismo, miembros \nde la fa milia 6-Cys ( pv12 , pv41  y pv38 ) con dominio s s48/46, mostraron una  baja \ndiversidad gen\u00e9tica , donde los dominios s48/46 mostraron un exceso de sustituc iones \nsin\u00f3nimas entre especies , generando un NI > 1 y valores \u03c9 ( KN/KS) < 1, lo cual es \nconsistente con la acci\u00f3n de la selecci\u00f3n negativa . Por lo tanto, estos do minios parecen \nestar bajo restricciones funcionales , convirti\u00e9ndolos en potenciales candidatos a vacuna que \neviten las respuestas inmunes alelo -espec\u00edficas.  Otras prote\u00ednas  con este tipo de patrones \nson pvrhopH1 /clag, pvser /Thr, PVX_081810 y PVX_092425, po r lo que estos podr\u00edan \ntambi\u00e9n ser considerados durante el dise\u00f1o de  una vacuna  (Publicaci\u00f3n 1) .  \n \nConclusiones  \nEl uso de tres pruebas  diferentes permiti\u00f3 la identifica ci\u00f3n de  se\u00f1ales  consistentes con \nselecci\u00f3n natural. Miembros de la s familias multig\u00e9nica s pvsera  y pvmsp 3 mostraron \nse\u00f1ales de  selecci\u00f3n positiva, probablemente debido a  que las prote\u00ednas codificadas son \nreconocidas por el  sistema inmune,  sin embargo, no parece n ser los candidatos m\u00e1s \napropiados para el desarrollo de vacunas , debido a su alto  polimorfismo.  \n \nLas prote\u00ednas codificadas por pvclag , pvser /thr, pvrhopH1 /clag7 , pvron2 , pvron4 , pv12 , \npv38 , pv41 , PVX_081810 y PVX_092425 (o dominios dentro de ell as), mostraron  patrones \nesperados en regiones bajo restricciones  funcionales , por lo tanto , podr\u00edan ser consideradas \ncomo los candidatos m\u00e1s adecuados y as\u00ed, ser priorizad as para estudios posteriores ( an\u00e1lisis  \npoblacion ales y funcionales) para el desarrollo de una vacuna contra P. vivax  que evite  las \nrespuestas inmunes alelo -espec\u00edficas . \n \nEl enfo que ac\u00e1 utilizado (Figura 4 ) podr\u00eda entonces ser una herramienta \u00fatil para la \nselecci\u00f3n de candidatos promisorios a vacuna. Los ant\u00edgenos para tener en cuenta deben \npresentar : 38 \n  \na. una diversidad gen\u00e9tica limitada o, al menos, un dominio con este  patr\u00f3n  \nb. una se \u00f1al de selecci\u00f3n negativa  (dS > d N o K S > K N), as\u00ed como un \u03c9 < 1.  \n \nSin embargo, los genes bajo selecci\u00f3n positiva  (\u03c9 > 1), podr\u00edan tomarse en cuenta si estos \npresentan dominios con un a diversidad gen\u00e9tica limitada y valores bajos en la tasa \u03c9.  Los \nresulta dos de este cap\u00edtulo fueron publicado s y est\u00e1n  disponibles bajo la siguiente \nreferencia:   \n \nPublicaci\u00f3n 1:  Garz\u00f3n -Ospina D , Forero -Rodr\u00edguez J, Patarroyo MA.  Inferring natural \nselection signals in Plasmodium vivax -encoded proteins having a potential role in  \nmerozoite invasion . Infect Genet Evol. 2015 Jul; 33:182 -8. doi: \n10.1016/j.meegid.2015.05.001.  \n \n \n \n \n \n \n 39 \n  \n \n \n \n \n \n \n \n \n \n \nCAPITULO 2 \nAdaptaciones linaje -espec \u00edficas, un a limitante para la selecci\u00f3n de \nant\u00edgenos basados en el enfoque propuesto . \n \n \n \n \n \n \n \n \n \n \n \n 40 \n Introducc i\u00f3n \nEstudios p revios han mostrado que la regi\u00f3n C -terminal de miembros de la familia \nmultig\u00e9nica MSP7 de P. vivax  (pvmsp 7) son altamente conservados (63, 90), inclusive \nentre par\u00e1logos (90). Por esta raz\u00f3n , el dominio C -terminal de los ant\u00edgenos codi ficados por \nlos genes pvmsp7  podr\u00edan ser buenos candidatos a vacuna (63, 90). Entre el grupo de  genes \nanalizados en el Cap\u00edtulo  1, se encontraba el gen msp7K, miembro altamente conservado en \nP. vivax  (63), quien no mostr\u00f3 patrones que nos permitieran seleccionarlo como potencial \ncandidato, a pesar de ha berlo propuesto previamente (63). Los resultados obtenidos para \neste gen en el Cap\u00edtulo  1, no mostraron se\u00f1ales de selecci\u00f3n negativa entre especies y por el \ncontrario mostraron que pvmsp7K es altamente diverg ente entre P. vivax  y P. cynomolgi .  \n \nTrabajos p revios en el gen msp1 (del ingl\u00e9s , Merozoite Surface Protein 1 ) han sugerido que \n\u00e9ste presenta se\u00f1ales de  selecci\u00f3n positiva  linaje -espec\u00edfic as (105, 106), observ\u00e1ndose una \nalta divergencia en este gen  entre P. vivax  y especies de Plasmodium  que infectan \ncercopit\u00e9cidos (primates del viejo mundo). Esta divergencia p or selecci\u00f3n positiva  coincide  \ncon la radiaci\u00f3n  de los  macacos asi\u00e1ticos hace 3 a 6 millones de a\u00f1os [26, 65] , sugiriendo \nque esta  selecci\u00f3n , podr\u00eda ser el resultado de adaptaciones a nuevos hospederos  disponibles  \nhace 3 a 6 millones de a\u00f1os  atr\u00e1s . Teniend o en cuenta que en P. falciparum  las prote\u00ednas \nMSP1 y MSP 7 forma n un complejo implicad o en la invasi\u00f3n [9,  10] y dada la presencia de \nambas prote\u00ednas en P. vivax , \u00bfpodr\u00eda n entonces  los miembros de la familia msp7 de P. \nvivax , estar bajo las mismas presione s selectivas de msp1? \n \nSi los genes pvmsp 7 divergieron por selecci\u00f3n positiva como consecuencia de la adaptaci\u00f3n \na los seres humanos durante el cambio de hospedero (15), esto podr\u00eda incrementar la tasa \u03c9, \nincrementando la divergencia entre especies, y por ende, msp7K ser\u00eda descartado como \npotencial candidato a vacuna. Con el fin de evaluar esta hip\u00f3tesis  se reconstruyeron las  \nrelaciones filogen\u00e9ticas de la familia msp7 en Plasmodium  y se evalu\u00f3  la presencia de \nse\u00f1ales de selecci\u00f3n linaje -espec\u00edfica.   \n 41 \n Metodolog\u00eda   \nUsando una aproximaci\u00f3n similar a la previamente reportada (92), se identificaron \nmiembros de la familia msp7 en 13 especies de Plasmodium  y se establecieron las \nrelaciones de ortolog\u00eda . Las s ecuencias de ADN de miembros de  msp7  identificad os fueron \nusadas para deducir su respectiva secuencia  de amino\u00e1cidos , para posteriormente,  ser \nalineadas usando el m\u00e9todo  MUSCLE (95). El m\u00e9todo  DLRTS (108) se utiliz\u00f3 con el fin \nde inferir el \u00e1rbol de los genes msp7  teniendo en cuenta  la filogenia de Plasmodium  spp. \nAdicionalmente, se infiriero n \u00e1rboles filogen\u00e9ticos utilizando m\u00e9todos de m\u00e1xima \nverosimilitud (ML, con el programa  RAxML (109)) y Bayesiano (BY  con el programa  \nMrBayes (110)) con el modelo JTT +G +F (seleccionado como el mejor modelo evolutivo \npor el m\u00e9todo  ProtTest (111)). Esto s an\u00e1lisis se realizaron en la plataforma CIPRES Science \nGatewa y (112, 113). \n \nIdentificaci\u00f3n de selecci\u00f3n  epis\u00f3dica linaje -espec \u00edfica \nEl modelo Branch -site REL  se utiliz\u00f3 para evaluar la presencia de linajes (ramas)  en la \nfilogenia de la familia msp7 , donde un porcentaje de sitios presenten  una selecci\u00f3n \ndiversificada epis\u00f3dica  (114). El m\u00e9todo  MUSCLE se us\u00f3 para alinear independientemente \nlas secuencias de amino\u00e1cidos de cada grupo  ort\u00f3lo go (Figuras 8 y 9), para posteriormente \ninferir  el alineamiento por codones de cada grupo ort\u00f3logo con el programa  PAL2NAL \n(97). El mejor modelo evolutivo para cada alineamiento (para ADN y prote\u00ednas) fue \ndeterminado usando los programas  jModelTest (115) y ProtTest (111), respectivamente. \nLos alineamientos y filogenias inferidas por ML para cada alineamiento fueron utilizadas \ncomo entrada  para correr el m\u00e9todo  Branch -site REL  en el paquete  HyPhy (116). \nAdicionalmente, el servidor web Datamonkey  (117) fue utilizado para este mismo an\u00e1lisis.  \nFinalmente, el  m\u00e9todo MEME (118) se utiliz\u00f3 para inferir qu\u00e9 sitios estaban bajo selecci\u00f3n \npositiva epis\u00f3dica en cada grupo de ort\u00f3logos .  \n \n \n \n 42 \n Figura 7. Metodolog\u00eda del Cap\u00edtulo 2  \n \nFigura 8. Filogenia de la familia de g enes msp7  inferida por el modelo evolutivo DLTRS  43 \n \n \nA. Filogenia del g\u00e9nero  Plasmodium  utilizada  para inferir  el \u00e1rbol MSP7  por el m\u00e9todo DLTRS. B. \u00c1rbol MSP7 inferido \na partir del \u00e1rbol de l g\u00e9nero  Plasmodium . Los n\u00fameros representan clados diferentes, mien tras que los n\u00fameros en las \nramas son valores de probabilidad posteriores. Nueve clados principales fueron identificados en el \u00e1rbol. Las prote\u00ednas \nse agrupan de acuerdo con las relaciones filogen\u00e9ticas del par\u00e1sito, los clados 1 (rojo) y 2 (amarillo) son los m\u00e1s \nancestrales y el clado 5 (violeta) tambi\u00e9n podr\u00eda ser ancestral . Las secuencias  del linaje de  par\u00e1sitos que infectan \ncercopit\u00e9cidos se representan en verde, las  prote\u00ednas del linaje de par\u00e1sitos que infectan roedores  en azul y el linaje de \npar\u00e1sito s que infectan hom\u00ednidos en gris.  \n 44 \n Figura 9. Representaci\u00f3n esquem\u00e1tica de los loci msp7  en 13 genomas de Plasmodium  \n \nLos genes que flanquean la regi\u00f3n que contiene la familia  msp7 en las especies de Plasmodium est\u00e1n representado s por recuadros de color naranja. Los recuadros de colores \ndentro de las secuencias flanqueantes representan los genes msp7 en cada especie, mientras que los recuadros negros simboliza n los pseudogenes. Los genes se nombraron en  \norden alfab\u00e9tico de izquier da a derecha. Las l\u00edneas punteadas conectan genes ort\u00f3logos. Todos los genes est\u00e1n representados a escala, pero la distancia entre ellos no es \nrepresentativa. Los signos de interrogaci\u00f3n indican  relaciones de ortolog\u00eda  que no fueron claramente establecidas . A diferencia de  los par\u00e1sitos que infectan hom\u00ednidos , las \nespecies de linaje de par\u00e1sitos que infectan cercopit\u00e9cidos y roedores  parecen tener historias evolutivas similares con respecto a la expansi\u00f3n de msp7. Los recuadros grises son \ngenes espec\u00edficos del linaje y que no pertenecen a la familia msp7 (las representaciones de estos \u00faltimos genes no est\u00e1n a escala).  45 \n Tabla 4. Caracterizaci\u00f3n in-silico  de las prote\u00ednas MSP7  \n  Genes  msp7   \n  A B C D E F G H I J K L M \nP. vivax  SP y y y y y y y y y - y y y \nMSP7_C  y y y - y y y y y y y y - \nP. cynomo lgi SP y y y y - y y y y - y y y \nMSP7_C  y y y - y y y y y y y y - \nP. inui  SP y - y y y - y y      \nMSP7_C  y y y y y - y y      \nP.  knowlesi  SP y y y y y         \nMSP7_C  y - y y y         \nP. coatneyi  SP y - y y y         \nMSP7_C  y - y y y         \nP. chabaudi  SP y y y y          \nMSP7_C  y y y -          \nP. vinckei v.  SP y y y y          \nMSP7_C  y y y -          \nP. vinckei p.  SP y y y y \n         MSP7_C  y y y - \n         \nP. bergh ei SP y y y y \n         MSP7_C  y y y - \n         \nP. yoelii  SP y y y y \n         MSP7_C  y y y - \n         \nP. falciparum  SP y y - y y y y \n      MSP7_C  y y y y y y y y y \n    \nP. reichenowi  SP y - y y y y y \n      MSP7_C  y y y y y y y y y \n    \nP. gallinac eum SP y \n            MSP7_C  y \n            Las prote\u00ednas MSP7  fueron evaluad as con respecto  a la presencia de p\u00e9ptido  se\u00f1al (SP) y del dominio  \nMSP_7C ( n\u00famero  de acceso en Pfam : PF12948 ), caracter\u00edstico  de los miembros  de esta familia. Con la letra \n\u201cy\u201d se indica la presencia de l p\u00e9ptido se\u00f1al o del dominio. Aquellas prote\u00ednas que no presenta ron estas \nestructuras se indican con el s\u00edmbolo \u201c -\u201c. \n \n 46 \n Resultados y discusi\u00f3n  \nEstructura gen\u00e9tica y relaciones filogen\u00e9ticas de la regi\u00f3n msp7 en Plasmodium spp.  \nLa reg i\u00f3n cromos\u00f3mica en P. vivax , donde la familia msp7  est\u00e1 ubicada, es delimitada por \nlos genes PVX_082640 y PVX_082715 (92, 93, 119), por lo tanto , ort\u00f3logos a \u00e9stos fueron \nidentificados  en las dem\u00e1s especies (Figura 9 ). Dado que las prote\u00ednas MSP7 parecen ser \ncodificadas por un \u00fanico ex\u00f3n (54), las regiones cromos\u00f3micas entre l os genes que \ndelimitan la familia , fueron analizadas con  la herramienta ORFFinder  y GeneRunner . Este \nan\u00e1lisis identifico 79 marcos abiertos de lectura (ORFs por sus siglas en ingl\u00e9s , Publicaci\u00f3n \n2) con la misma orientaci\u00f3n de trascripci\u00f3n ( Figura 9 ). Estos  ORF fueron nombrados en \norden alfab\u00e9tico con respect o a su aparici\u00f3n despu\u00e9s del gen PVX_082640 ( o sus ort\u00f3logos  \nen cada especie ). Posteriormente, se determin\u00f3 la presencia del p\u00e9ptido se\u00f1al y del dominio  \nMSP_7C (Tabla 4 ). El n\u00famero de genes msp7  var\u00eda  de especie a especie,  sugiriendo que  \neventos de duplicaci\u00f3n (o deleci\u00f3n ) han ocurrido de manera especie -espec\u00edfica. Esto \nconfirma resultados previos (92, 119), donde se ha sugerido que esta familia evoluciona \nbajo el modelo de nacimi ento y muerte de genes (Figura 9 ).  \n \nRelaciones filogen\u00e9ticas de los miembros de msp7 en Plasmodium  \nEl m\u00e9todo DLTRS  (108, 120) fue utilizado para reconciliar el \u00e1rbol de los genes msp7  con \nla filogenia del g\u00e9nero . En el  \u00e1rbol inferido por este m\u00e9todo  (Figura 8 ) se observan 9 \ngrupos principales. Los grupos 1, 2, 3a, 3b, 3c, 4 y 5 representan grupos ort\u00f3logos, mientras \nen los grupos 3d y 6 se agrupan tanto ort\u00f3logos como par\u00e1logos.  Este agrupamiento fue \nsimilar al observad o en las filogenias inferidas por ML y BY (Anexo 3).  El grupo 1 \n(MSP7A/H) fue el gen m\u00e1s ancestral, seguido por el grupo 2 , el cua l incluye secuencias de \npar\u00e1sito s que infectan cercopit\u00e9cidos  y roedores. En P. gallinaceum , se observ\u00f3 un gen con \nuna longitu d mayor a los otros msp7 , pero a\u00fan no es claro si este gen  es ort\u00f3logo al gen m\u00e1s \nancestral ( msp7A/H ). Como s \u00f3lo se encontr\u00f3 un gen msp7  en el genoma de P. gallinaceum , \nla expansi\u00f3n de la familia msp7  debi\u00f3 haber ocurrido despu\u00e9s de la radiaci\u00f3n de par\u00e1sit os \nde mam\u00edferos hace 40 millones de a\u00f1os (11).    \n 47 \n Selecci\u00f3n positiva linaje -especifica en msp7  \nMSP1 es la prote\u00edna que media la interacci\u00f3n inicial entre los merozo\u00edto s y los gl\u00f3bulos \nrojos (121-124). Estudios previos han mostrado  que el gen msp1  presenta se\u00f1ales de \nselecci\u00f3n positiva. Esta selecci\u00f3n ocurri\u00f3 en alg\u00fan momento y dentro de s \u00f3lo algun os \nlinajes ancestral es (selecci\u00f3n positiva epis\u00f3dica  linaje -espec \u00edfica) dentro del grupo de \npar\u00e1sitos de cercopit\u00e9cidos (105, 125) y esto ser\u00eda  el resultado de la adaptaci\u00f3n de \npoblaciones ancestrales del par\u00e1sito a las nuevas especies de macacos que surgieron  hace \n3,7 a 5 ,1 millones de a\u00f1os (105) o durante el cambio de hospedero que dio origen a P. vivax  \n(15). Dado que MSP7 forma un complejo con MSP1 (121, 123, 124), MSP7  deber\u00eda estar \nbajo las mismas presiones selectivas y por lo tanto , se\u00f1ales de selecci\u00f3n linaje -espec \u00edfica \npodr\u00eda n estar pr esentes en los miembros de esta familia. Varias ramas (linajes) mostraron \nse\u00f1ales de selecci\u00f3n positiva  en miembros de la familia msp7 . Como en MSP1 (105, 125), \nmuchas de estas rama s eran ramas internas (Figura 10 A, E, F and G). La mayor cantidad de \ncodones bajo selecci\u00f3n positiva se localiz\u00f3 en las regiones centrales de msp7  y pocos en los \nextremos 5\u2019 o 3 \u2019. Estudios previos han mostrado que la regi\u00f3n central es la m\u00e1s polim\u00f3rfica \ny parece estar involucrada en la evasi\u00f3n  de la respuesta  inmune  (90). Los siti os \nseleccionados positivamente  en las regiones centrales de las prote\u00ednas MSP7, podr\u00edan ser la \nconsecuencia de la evasi\u00f3n a la respuesta inmune del h ospedero , lo que permitir\u00eda la \nadaptaci\u00f3n  del par\u00e1sito . Por otro lado, los sitios bajo selecci\u00f3n positiva  en la regi\u00f3n C -\nterminal , podr\u00edan ser el resultado de la coevoluci\u00f3n entre el receptor del hospedero  y los \nligandos MSP7 del par\u00e1sito o del resultado de la adquisici\u00f3n de nuevas funciones \n(Publicaci\u00f3n 2).   \n  \nSi la selecci\u00f3n posit iva ha actuado de manera lin aje-espec \u00edfica, se observar\u00e1 una alta \ndivergencia entre las secuencias de especies relacionadas. Mientras  un determinado \namino\u00e1cido se fij\u00f3 en un linaje (o especie) por selecci\u00f3n positiva en una determinada \nposici\u00f3n, en los otros linajes (o especies), amin o\u00e1cidos diferentes podr\u00edan present arse en \nesa misma posici\u00f3n. Por lo tanto, esto generar\u00e1 un incremento en la tasa \u03c9 cuando se \ncomparan las secuencias. As\u00ed, aunque se trate de regiones funcionalmente importantes, la \npresencia de la selecci\u00f3n positiva linaje -espec \u00edfica en esta regi\u00f3n , har\u00e1 que la tasa \u03c9 sea alta  48 \n y, por lo tanto, regio nes funcionales con este patr\u00f3n, ser\u00e1n descartadas si se sigue el \nenfoque presentado en el Cap\u00edtulo 1.  \n \nFigura 10. Filogenias de msp7s  analizadas por el m\u00e9todo Branch -site REL  \n \nCada gr upo ort\u00f3logo  identificado en la Figura 9  fue analizado por el m\u00e9todo Branch -site REL. El color sobre las ramas \nindica el tipo de selecci\u00f3n (rojo \u03c9 > 13,  selecci\u00f3n positiva;  azul \u03c9 \u2264 1, selecci\u00f3n negativa) mientras el color gris \nrepresenta un \u03c9 = 1 (neutral idad). La longitud de cada color representa el porcentaje de sitios en la clase \ncorrespondiente encontrada por Branch -site REL . A. Clado  1; B. pviv/pcynmsp7B y 7E; C. pviv/pcynmsp7C y \npinumsp7B; D. pviv/pcynmsp7F y pinumsp7C; E. pviv/pcynmsp7G, pkno/pcoams p7C y pinumsp7D; F. \npviv/pcynmsp7H/7I, pkno/pcoamsp7D y pinumsp7E; G. Clad o 2; H. pviv/pcynmsp7L y pinumsp7H y I. Clado  4. En la \nparte inferior de cada filogenia hay una representaci\u00f3n a escala del gene msp7 correspondiente . Los cuadros azul oscuro  \ndentro de este esquema representan la regi\u00f3n N -terminal, los marrones claros simbolizan la regi\u00f3n central y los cuadros 49 \n morados , el dominio MSP_7C. Los n\u00fameros dentro de las casillas representan el n\u00famero de codones bajo selecci\u00f3n \npositiva inferida por los m\u00e9todo s MEME, SLAC, FEL, REL y FUBAR utilizando el servidor web Datamonkey.  \n \nConclusiones  \nLa familia msp7  es el resultado de procesos  de duplicaci\u00f3n diferencial en Plasmodium  spp, \nlo que gene ra que el n\u00famero de copias var\u00ede de una especie a otra. Estos genes ha n fijado \nmutaciones por sele cci\u00f3n positiva de manera linaje -espec\u00edfica. Este tipo de selecci\u00f3n genera \nun incremento en las tasas evolutivas , a pesar de que se trate de regiones funcionalmente \nimportantes,  por lo tanto, se\u00f1al es de selecci\u00f3n positiva linaje -espec \u00edficas podr\u00edan \nrepresentar una limitante cuando se seleccione n genes como candidatos a vacuna siguiendo \nel enfoque presentado en el Cap\u00edtulo 1.  \n \nLos resultados de este cap\u00edtulo fueron publicados y est\u00e1n  disponibles bajo la siguiente \nreferencia:  \n \nPublicaci\u00f3n 2:  Garz\u00f3n -Ospina D , Forero -Rodr\u00edguez J, Patarroyo MA.  Evidence of \nfunctional divergence in MSP7 paralogous proteins: a molecular -evolutionary and \nphylogenetic analysis . BMC Evol Biol. 2016 Nov 28;16  (1):256.  doi: 10.1186/s12862 -016-\n0830 -x.  \n \n \n \n \n \n \n \n \n \n \n \n 50 \n  \n \n \n \n \n \n \n \n \n \n \n \nCAPITULO 3  \nValidaci\u00f3n del enfoque alternativo presentado en el Cap\u00edtulo  1 para la \nselecci\u00f3n de candidatos a vacuna.  \n \n \n \n \n \n \n \n 51 \n Introducci\u00f3n  \nEl desarrollo de una vacuna antimal\u00e1rica es una de las estrategias propuestas para el control \nde la malaria . Sin embargo, en P. vivax , pocos ant\u00edgenos han sido caracterizados como \ncandidatos promisorios a ser incluidos dentro de una vacuna (126, 127). Adicionalmente, l a \nalta diversidad  gen\u00e9tica presente en  algunos de los ant\u00edgenos  parasitarios (61, 64, 65, 67, \n70, 71, 90, 128, 129) ha obstaculizado el desarrollo de una va cuna debido  a las respuestas \ninmunes alelo -espec\u00edficas  que esta diversidad podr\u00eda genera r (32, 34, 59). Por tal motivo, la \nevaluaci\u00f3n de la diversidad gen\u00e9tica de los ant\u00edgenos parasitarios es esencial durante el \ndise\u00f1o de una vacuna completamente efectiva. No obstante , llevar a cabo estos estudios \npara todos y cada uno de los genes candidatos, implicar\u00eda tiempo y recursos econ\u00f3micos, \nconvirti\u00e9ndose en una nueva limitante para el desarrollo de una vacuna contra este \npat\u00f3geno. En el Cap\u00edtulo  1 de este proyecto , se propuso  un flujo de trabajo que permite  \nrealizar una selecci\u00f3n de ant\u00edgenos promisorios en un menor tiempo.  Sin embargo, con el \nfin d e validar este flujo de trabajo, se realizaron an\u00e1lisis poblacionales para determinar si lo \nobservado a partir de 5 secuencias de asilados de diversas partes del m undo , coincide con \nlos an\u00e1lisis realizados a partir de un n\u00famero mayor de secuencias . \n \nMetodolog\u00eda   \nEntre los genes seleccionados en el C ap\u00edtulo 1 como candidatos promisorios , se destacan \ntres miembros de la familia del dominio de 6 -cisteinas (6 -Cys), tres  prote\u00ednas de roptrias, \nalgunos ant\u00edgenos de membrana y una prote\u00edna hipot\u00e9tica. Algunos de estos fueron \nseleccionados para ser analizados mediante an\u00e1lisis poblacionales  y as\u00ed val idar los datos \nobtenidos en el C ap\u00edtulo 1 . Adicionalmente, miembros de la fa milia msp7  fueron tambi\u00e9n \nseleccionados para estos an\u00e1lisis.    \n \nVerificaci\u00f3n de la integridad del ADN.  \nEl ADN parasitario utilizado fue extra\u00eddo a partir de muestras de sangre total provenientes \nde diferen tes regiones del pa\u00eds (Figura 11 ) obtenidas desde el 2007 hasta el 2016.  La \npresencia e integridad del ADN parasitario (almacenado a -20 oC) fue verifica do por la \namplificaci\u00f3n por PCR de la subunidad ribosomal 18S de P. vivax . Los productos de PCR 52 \n fueron  evaluados por electr oforesis en gel de agarosa al 1,5%, con el marcador de peso \nHyperladder I.  \n \nFigura 11. Lugar de procedencia de las muestras de ADN parasitario en Colombia   \n \nA. Procedencia de las muestras de ADN gen\u00f3mico obtenido entre el 2007 y el 2016. B. Procedencia de las  secuencias de \nlas cepas de referencia  \n \nDeterminaci\u00f3n de la presencia de infecciones \u00fanicas por P. vivax y de diferentes genotipos  \nen las muestras utilizadas . \nLa t\u00e9cnica de PCR -RPLFs fue implementada c on el fin de determinar  si las muestras \npositivas para  P. vivax  correspond \u00edan a infecciones \u00fanicas. Adicionalmente, esto permit i\u00f3 \nevaluar la presencia de diferentes genotipos en las muestras . Un fragmento del gen  msp1  (o \nmsp3 ) fue amplificado por PCR con iniciadores previamente reportados (130, 131). Los \nampl\u00edmeros fueron  entonces digeridos con las enzimas de restricci\u00f3n Alu -I y Mnl -I (Alu-I y \nHha-I para msp3 ). Los productos de esta digesti\u00f3n fueron  evaluados por electroforesis en \ngel de agarosa al 3%, con el marcador de peso Hyperladder V.  Adicionalmente, algunos de \nlos ampl\u00edmeros de msp3  fueron secuenciados para confirmar la presencia de infecciones \n\u00fanicas.   53 \n  \nDise\u00f1o de iniciadores  y amplificaci\u00f3n por PCR  \nEl dise\u00f1o de los iniciadores para la amplificaci\u00f3n del genes seleccionados, se realiz \u00f3 con el \nprograma Gene Runner  (Hastings software, Inc.) y el servidor en -l\u00ednea Oligoanalizer  (IDT\u00ae \nIntegrated DNA Technologies , https://www.idtdna.com/calc/analyzer ), utilizando para \u00e9 sto, \nlos datos gen\u00f3micos de la cepa  Sal-I de P. vivax . Se dise\u00f1\u00f3  un juego de iniciadores para la \namplificaci\u00f3n de cada gen, y de ser necesario, ot ros para la secuenciaci\u00f3n . La optimizaci\u00f3n \nde las condiciones de PCR para la amplificaci\u00f3n de los genes, se realiz \u00f3 utilizando los  \niniciadores  dise\u00f1ados previamente. Para \u00e9sta, se utiliz \u00f3 la enzima de alta fidelidad KAPA -\nHiFi HotStart Readymix  (kapabiosyst ems\u00ae) y ADN gen\u00f3mico de la cepa VCG -I como \ncontrol positivo. Una vez optimizadas las condiciones de PCR, se amplific \u00f3 el ADN \nparas itario de al menos 30 muestras procedentes de Colombia  (Publicaciones 3 - 6).  \n \nPurificaci\u00f3n y Secuenciaci\u00f3n de los fragmento s amplificado s. \nLos productos de PCR fueron  purificados con el kit de purificaci\u00f3n UltraClean PCR Clean -\nup (MOBIO\u00ae), siguiendo las recomendaciones del fabricante. Los fragmentos purificados \nfueron  verificados por medio de electr oforesis en gel de agarosa al  1,5%, con el marcador \nde peso Hyperladder I.  Para el gen pvron4  se realiz \u00f3 la clonaci\u00f3n de este fragmento en  el \nvector pGEM -T (Publicaci\u00f3n 6 ). Los productos de PCR purificados o el ADN plasm\u00eddico \nfueron  secuenciados bidireccionalmente con los iniciadores de amplificaci\u00f3n o los \niniciadores universales  T7 y SP6 . La secuenciaci\u00f3n se realiz\u00f3  utilizando el kit BigDye  \nTerminator en Macrogen, Se\u00fal, Corea del Sur. Al menos dos productos de PCRs \nindependientes o dos pl\u00e1smidos por muestra , fueron  enviados a secuenci aci\u00f3n. \n \nAn\u00e1lisis de la diversidad gen\u00e9tica y de las fuerzas evolutivas en los loci seleccionados.  \nSe analizar on y ensamblar on los electroferogramas obtenidos por secuenciaci\u00f3n usando el \nprograma CLC DNA  workbench  (CLC bio, Cambridge, MA, USA). Una vez corr egidas las \nsecuencias, \u00e9stas fueron  comparadas y analizadas frente a secuencias de referencia  y de \nespecies filogen\u00e9ticamente relacionadas disponibles en bases de datos.  \n 54 \n Figura 12. Metodolog\u00eda del Cap\u00edtulo 3  \n \n 55 \n Con las secuencias  de la poblaci\u00f3n Colombiana, se realiz aron alineamiento s de las \nsecuencias derivadas de amino\u00e1cidos con el m\u00e9todo  MUSCLE (95) y a partir de \u00e9ste, se \ninfiri \u00f3 el alineamiento de ADN usando el programa Pal2Nal (97). A p artir de este \u00faltimo \nalineamiento y usando el programa  DnaSP v.5 (98), se calcular on el n\u00famero de sitios \nsegregantes y la diversidad nucleot\u00eddica por sitio.  \n \nSe evaluar on se\u00f1ales de selecci\u00f3n natural utilizando m\u00e9todo s basados en el c\u00e1lculo de \nsustituciones de tipo sin\u00f3nimo y no -sin\u00f3nimo. Usando el programa MEGA v.5 (103), se \ncalcularon  el n\u00famero promedio de s ustituciones sin\u00f3nimas por sitio sin\u00f3nimo (d S) y el \nn\u00famero promedio de sustituciones no -sin\u00f3nimas por sitio no -sin\u00f3nimo (d N) empleando el \nm\u00e9todo modificado  de Nei -Gojobori (104). Por otra parte, para determinar se\u00f1ales de \nselecci\u00f3n natural entre especies, se calcul \u00f3 el n\u00famero prom edio de divergencias sin\u00f3nimas \npor sitio sin\u00f3nimo (K S) y el n\u00famero promedio de divergencias no -sin\u00f3nimas por sitio no -\nsin\u00f3nimo (K N), empleando el m\u00e9todo modificado de Nei -Gojobori, teniendo en cuenta la \ncorrecci\u00f3n de Jukes -Cantor (101). Las diferencias estad\u00edsticas entre estas tasas se \ndeterminar on aplicando la prueba Z-test, incorporada en el programa MEGA. Presiones \nselectivas por sitio (cod\u00f3n) fueron  inferidas calculando las tasas de sustituciones sin\u00f3nimas \ny no -sin\u00f3nimas mediante los m\u00e9todos SLAC, FEL, REL, IFEL (132), MEME (118) y \nFUBAR (133), implementados en el servidor en l\u00ednea Datamonkey (117), con previa \nevaluaci\u00f3n de recombinaci\u00f3n por el m\u00e9todo GARD (134).  \n \nResultados y discusi\u00f3n  \nMuestras de ADN parasitario provenientes de  diferentes regiones del pa\u00eds  (Figura 11), \nfueron utilizadas para la  amplificaci\u00f3n de  los genes pv12 , pv38 , pv41 , pvmsp7E, pvmsp7F, \npvmsp7L, pvron4 y pvceltos . Previo a l a amplificaci\u00f3n de estos genes, se realiz\u00f3 una \naproximaci\u00f3n para la detecci\u00f3n de infecciones  por cepa \u00fanica mediante  PCR -RFLP.  \nAdicionalmente, esta t\u00e9cnica permiti\u00f3 identificar la presencia de diferentes genotipos en la s \nmuestras utilizadas (Figura 13 ). \n \n 56 \n Figura 13. Patrones de PCR -RFLPs  \n                     \nA. Amplifi caci\u00f3n del fragmento 2 de pvmsp 1; Carril 1: Muestra con infecci\u00f3n m\u00faltiple, carriles del 2 -5: Algunas de las \nmuestras utilizadas en este es tudio, C+: ADN de la cepa VCG -I, C-: control negativo, C -2: ADN cepa FVO de P. \nfalciparum, MP: marcador de peso. B. Carriles del 1 -11: Algunas de las m uestras utilizadas en este estudio,  panel \nsuperior fragmentos de digesti\u00f3n con Alu -I, panel inferior  fragmentos de digesti\u00f3n con Mnl -I, MP: marcador de peso.  \n \nFragmentos de los genes pv12 , pv38  (Publicaci\u00f3n 3 ), pv41  (Publicaci\u00f3n 4 ), pvmsp7E, \npvmsp7F, pvmsp7L (Publicaci\u00f3n 5 ), pvron4 (Publicaci\u00f3n 6 ) y pvceltos (manuscrito en \npreparaci\u00f3n) fueron amplificados y secuenciados. A partir de las secuencias obtenidas , \nvarios par\u00e1metros de diversidad para cada gen fueron calculados (Tabla 5). Estos \npar\u00e1metros fueron entonces comparados con los obtenidos al analizar s \u00f3lo secuencias de \ncepas  de referencia (Tabla 5).  Poste riormente, estos mismos par\u00e1metros fueron calculados a \npartir de alineamientos con todas las secuencias disponibles a la fecha para  cada gen.  \n \nVentanas deslizantes de la diversidad nucleot\u00eddica por sitio (\u03c0), fueron obtenidas a  partir de \nestos 3 sets de d atos (Figura 14). Adicionalmente, a partir de estos 3 set s de datos, fueron \ncalculadas las diferencias entre K N y K S (Tablas 6), as\u00ed como ventanas deslizantes para la \ntasa evolutiva \u03c9 (K N/KS, Figura 15 ). Los resultados observados en las Figuras 14 y 15, as \u00ed \ncomo las tablas 5 y 6 , muestran una concordancia entre los datos obtenidos a partir de 5 \ncepas de P. vivax  de diferentes regiones del mundo y los an\u00e1lisis realizados a partir de un \nn\u00famero mayor de secuencias.  \n \n \n57 \n Tabla 5. Estimador es de diversidad gen\u00e9tica  \n  Datos Capitulo 1  Datos Capitulo 3  Datos con secuencias \ndisponibles  \nGen n Sitios  Ss \u03c0 n Sitios  Ss \u03c0 n Sitios  Ss \u03c0 \npv12  7 942 4 0,0014 (0 ,0006)  70 1047  1 0,0003 (0 ,0001)  156 930 19 0,0011 (0 ,0001)  \npv38  6 1065  4 0,0022 (0 ,0004)  46 1062  8 0,0024 (0 ,0002)  132 1035  19 0,0027 (0 ,0002)  \npv41  6 1086  14 0,0064 (0 ,0013)  30 1115  10 0,0028 (0 ,0005)  119 1116  33 0,0047 (0 ,0003)  \npvmsp7E  5 1047  147 0,0651 (0 ,0167)  31 1044  164 0,0558 (0 ,0004)  44 1047  171 0,0548 (0 ,0044)  \npvmsp7F  6 1164  2 0,0007 (0 ,0002)  36 1176  2 0,0007 (0 ,0004)  120 1146  8 0,0009 (0 ,0001)  \npvmsp7L  6 1212  3 0,0008 (0 ,0004)  31 1212  4 0,0006 (0 ,0001)  122 1212  13 0,0010 (0 ,0001)  \npvron4  6 2097  14 0,0033 (0 ,0007)  73 2464  5 0,0004 (0 ,0009)  159 2172  29 0,0006 (0 ,0001)  \npvceltos  5 588 3 0,0024 (0,0010)  62 546 1 0,0008 (0 ,0001)  209 546 7 0,0018 (0 ,0001)  \nLos estimadores de la diversidad gen\u00e9tica se calcularon utilizando las secuencias obtenidas de cepas de referencia (datos \nCapitulo 1), con secuencias obtenidas en Colombia (datos Cap\u00edtulo 3 ) y a partir de las secuencias de cepas de referencia, \nde las secuencias colombianas y de todas las secuencia s disponibles a la fecha obtenidas de PlasmoDB o GenBank como \nun \u00fanico set de datos. n: n\u00famero de secuencias  analizada s, sitios: total de sitios analizados (sin incluir gaps ), Ss: n\u00famero \nde sitios segregados, \u03c0: diversidad de nucle\u00f3tidos por sitio.  \n \nTabla 6. Tasas de divergencia no -sin\u00f3nima ( KN) y sin\u00f3nima ( KS) \n    Datos Capitulo 1  Datos Capitulo 3  Datos con secuencias \ndisponibles  \nGen n KN-KS n KN-KS n KN-KS \npv12  7 -0,268 (0 ,031)*  70 -0,029 (0 ,003)*  156 -0,013 (0 ,002)*  \npv38  6 -0,288 (0 ,033)*  46 -0,054 (0 ,007)*  132 -0,022 (0 ,003)*  \npv41  6 -0,149 (0 ,019)*  30 -0,040 (0 ,005)*  119 -0,012 (0 ,003)*  \npvmsp7E  5 -0,073 (0 ,023)*  31 -0,023 (0 ,012)**  44 -0,020 (0 ,011)**  \npvmsp7F  6 -0,014 (0 ,010) 36 -0,002 (0 ,002) 120 0,000 (0 ,001) \npvmsp7L  6 -0,018 (0,012) 31 -0,003 (0 ,003) 122 -0,001 (0 ,001) \npvron4  6 -0,187 (0 ,015)*  73 -0,022 (0 ,002)*  159 -0,011 (0 ,001)* \npvceltos  5 -0,019 (0 ,012) 62 -0,006 (0 ,003)** 209 -0,002 (0,002) \n*: p <0 ,001 \n**: p < 0 ,03 \n \n \n \n 58 \n Figura 14. Ventanas deslizantes de \u03c0 para 8 ant\u00edgenos de P. vivax  \n \nLa di versidad nucleot\u00eddica por sitio  fue calculada mediante ventanas deslizantes para 8 ant\u00edgenos de P. vivax para \ncomparar l os resultados de los tres set s de datos (datos Capitulo 1 [azul, incluye solo las cepas de referencia], datos \nCapitulo 2 [rojo, incluye las secuencias obtenidas de la poblaci\u00f3n parasitaria de Colombia] y secuencias (seq) \ndisponibles [verde, incluye las sec uencias de las cepas, las de par\u00e1sitos colombianos y otras secuencias disponibles en \nbases de datos]) . A. pv12, B. pv38, C. pv41. D. pvmsp7E, E. pvmsp7F, F.  pvmsp7L, G. pvron4 y H. pvceltos.  59 \n Figura 15. Ventanas deslizante s de la t asa \u03c9 entre especie s \n \nVentanas deslizantes de la tase \u03c9 entre especies (K N/KS) para 8 ant\u00edgenos de P. vivax fueron calculadas para comparar los resultados de los tres sets  de datos (datos Capitulo 1 \n[azul, incluye solo las cepas de referencia], datos Capi tulo 2 [rojo, incluye las secuencias obtenidas de la poblaci\u00f3n parasitaria de Colombia] y secuencias (seq) disponibles \n[verde, incluye las secuencias de las cepas, las de par\u00e1sitos colombianos y otras secuencias disponibles en bases de datos]) . A. pv12, B.  pv38, C. pv41. D. pvmsp7E, E. pvmsp7F, \nF. pvmsp 7L, G. pvron4 y H. pvceltos.   60 \n Conclusiones  \nA partir de al menos 30 muestras de ADN parasitario obtenido de regiones end\u00e9micas de \nmalaria en Colombia , se amplificaron y secuenciaron los genes pv12 , pv38 , pv41 , pvmsp7E, \npvmsp7F, pvmsp7L, pvron4 y pvceltos . A partir de estas secuencias, se obtuvieron datos de \ndiferentes estimadores de diversidad gen\u00e9tica, as\u00ed como de la tasa evolutiva \u03c9. Estos \nresultados mostraron una concordancia con aquellos obtenidos en el Ca p\u00edtulo 1 de este \ntrabajo. Por lo tanto, el enfoque implementado en el Cap\u00edtulo 1 , se convierte en una \naproximaci\u00f3n alternativa para la selecci\u00f3n de candidatos  promisorios  a vacuna, desde el \npunto de vista que los candidatos  deben ser altamente conservados para evitar las \nrespuestas alelo -espec\u00edficas que disminuyen la eficacia de las vacuna s. Adicionalmente, la \nevaluaci\u00f3n de la tasa evolutiva \u03c9 podr\u00eda ayudar a la identificaci\u00f3n de regiones \nfuncionalmente restringidas dentro de los ant\u00edgenos parasitarios.  \n      \nLos resultados de este cap\u00edtulo fueron publicados y est\u00e1n disponibles bajo las sig uientes \nreferencias:  \n \nPublicaci\u00f3n 3:  Forero -Rodr\u00edguez J, Garz\u00f3n -Ospina D , Patarroyo MA. Low genetic \ndiversity and functional constraint in loci encoding Plasmodium vivax P12 and P38 \nproteins in the Colombian population . Malar J. 2014 Feb 18;13:58. doi: 10 .1186/1475 -\n2875 -13-58. \n \nPublicaci\u00f3n 4: Forero -Rodr\u00edguez J,  Garz\u00f3n -Ospina D , Patarroyo MA.  Low genetic \ndiversity in the locus encoding the Plasmodium vivax P41 protein in Colombia's parasite \npopulation . Malar J. 2014 Sep 30;13:388. doi: 10.1186/1475 -2875 -13-388. \n \nPublicaci\u00f3n 5: Garz\u00f3n -Ospina D , Forero -Rodr\u00edguez J,  Patarroyo MA.  Heterogeneous \ngenetic diversity pattern in Plasmodium vivax genes encoding merozoite surface proteins \n(MSP) -7E, -7F and -7L. Malar J. 2014 Dec 13;13:495. doi: 10.1186/1475 -2875 -13-495. \n 61 \n Publicaci\u00f3n 6: Buitrago SP, Garz\u00f3n -Ospina D , Patarroyo MA.  Size polymorphism and low \nsequence diversity in the locus encoding the Plasmodium vivax rhoptry neck protein 4 \n(PvRON4) in Colombian isolates . Malar J. 2016 Oct 18;15(1):501. doi: 10.1186/s1293 6-\n016-1563 -4.  \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n 62 \n  \n \n \n \n \n \n \n \n \n \n \nCAPITULO 4  \nImplementaci\u00f3n del enfoque del Cap\u00edtulo 1 durante la caracterizaci\u00f3n de \nnuevos ant\u00edgenos de P. vivax . \n \n \n \n \n \n \n \n \n \n \n 63 \n Introducci\u00f3n  \nEn 2013 , la malERA (del ingl\u00e9s  Malaria Eradication Research Agenda ) reconoci\u00f3 la \nnecesidad de desarrollar  de una vacuna contra P. vivax  debido a las complicaciones que la \ninfecci\u00f3n por este par\u00e1sito est\u00e1 generando en diferentes zonas end\u00e9micas  (23). Con respecto \na P. falciparum , la investigaci\u00f3n en P. vivax  se encuentra retrasada debido a la compleja \nbiolog\u00eda de este par\u00e1sito (135), y a la fecha pocos candidatos  a vacuna han sido evaluados \nen fases cl\u00ednicas (21). Uno de los principales factores de este retraso  es la predilecci\u00f3n de P. \nvivax  por los reticulocitos, los cuales son c\u00e9lulas rojas inmaduras que no suelen superar  el \n1% de las c\u00e9lulas circulantes en sangre perif\u00e9rica  (136, 137). Debido a que P. vivax  invade \nexclusivamente est e tipo celular, los cultivos in vitro  de este par\u00e1 sito son de corta duraci\u00f3n \ny, por lo tanto, no ha sido posible realizar las mismas aproximaciones hechas en P. \nfalciparum  (138, 139). En P. vivax  se han descrito m\u00e1s de 50 ant\u00edgenos expresados en el \nestadio sangu\u00edneo (el merozo\u00edto ) (24, 26, 28, 87, 140, 141), pero las regiones de interacci\u00f3n \ncon los reticulocitos s \u00f3lo han sido establecid as para un reducido n\u00famero de ellos (36-38, \n142). Adicionalmente, P. vivax  presenta casi el doble de la diversidad gen\u00e9tica de P. \nfalciparum  (29), y \u00e9sto, es un problema  adicional para el desarrollo de una vacuna.         \n \nPara dise\u00f1ar una vacuna contra P. vivax , siguiendo la misma estrategia utilizada en P. \nfalcipar um (138, 139), se hace entonces necesario , no s\u00f3lo la identificaci\u00f3n de ant\u00edgenos \nparasitarios, sin o adem\u00e1s, se deben establecer las regiones de interacci\u00f3n pat\u00f3geno -\nhospedero, as\u00ed como la diversidad de esos ant\u00edgenos (u regiones espec\u00edficas ). Sin embargo, \npara evaluar estos aspectos , ser\u00eda necesario,  primero, contar una fuente permanente de \nreticulocit os que permitiera realizar ensayos de uni\u00f3n con la prote\u00edna completa y diferentes \nfragmentos de la mol\u00e9cula , siendo \u00e9sta, precisamente una de las limitantes que no ha \npermitido avanzar con los ensayos de uni\u00f3n. Segundo, la diversidad de estos ant\u00edgenos se \nhace en determinadas poblaciones, amplificando y secuenciando  al menos 30 muestras \nparasitari as (21).  \n \nEl enfoque presentado en este trabajo est\u00e1 basado en la premisa que es posible  hacer un \nacercamiento a la diversidad de un ant\u00edgeno a partir de pocos asilados de diferentes 64 \n regiones del mundo. Los resultados del Cap\u00edtulo 1  de este trabajo , muestran que dominios \ninvolucrados en la interacci\u00f3n parasito -gl\u00f3bulo rojo son conservados entre especies y \nmostraron se\u00f1ales de selecci\u00f3n negativa (\u03c9 < 1). Por lo tanto, este enfoque, adem\u00e1s de \nproporcionar informaci\u00f3n de las regiones ideales para el dise\u00f1o de una vacuna (conservadas \npor selecci\u00f3n negativa), podr\u00eda tambi\u00e9n delimitar qu\u00e9 regiones d e un ant\u00edgeno podr\u00edan ser \nevaluadas en ensayos funcionales y as\u00ed, en lugar de utilizar toda la mol\u00e9cula (36-38), s\u00f3lo \nuna parte de ella ser\u00eda utilizada, optimiz ando los recursos disponibles. As\u00ed, p ara determinar \nla utilidad del enfoque presentado en este trabajo durante  el desarrollo de una vacuna \naltamente efectiva contra P. vivax , \u00e9ste fue implementado durante la caracterizaci\u00f3n de \nnuevos ant\u00edgenos de P. vivax  (publicaciones 7 -9). \n \nMetodolog\u00eda   \nCon la colaboraci\u00f3n del grupo de Biolog\u00eda molecular de la FIDIC, quienes describen \nnuevos ant\u00edgenos de P. vivax , se seleccionaron tres ant\u00edgenos : PvGAMA, PvRBSA y \nPvCelTOS. Paralelamente a  la caracterizaci\u00f3n de estos ant\u00ed genos  (143), se implement\u00f3  la \nmetodolog\u00eda  de la Figura 4, con el fin de t ener una aproximaci\u00f3n a la diversidad gen\u00e9tica y \nlas fuerzas evolutivas de estos  loci.  \n \nSecuencias de ADN que codifican para pvgama , pvrbsa  y pvceltos  de 5 cepas de P. vivax   \n(Sal-I, Brazil -I, India -VII, Mauritania -I y Corea del Norte (29)) y ort\u00f3logos de  al menos  dos \nespecies filogen\u00e9ticamente relacionadas ( P. cynomolgi  y P. knowlesi ) (144) fueron \nobtenidas  y alineadas (siguiendo los mismos pasos mencio nados en anteriores Cap\u00edtulos) . \nA partir de las secuencias de P. vivax , la diversidad nucleot\u00eddica por sitio ( \u03c0) fue estimada . \nUsando las secuencias de  P. vivax  junto con las de especies relacionadas , se estim\u00f3 una \nventana deslizante de la tasa \u03c9 (KN/KS). Sitios bajo selecci\u00f3n entre especies fueron \ninferidos usando los algoritmos SLAC, FEL, REL (132), MEME (118) y FUBAR (133) en \nel servidor Datamonkey , con previa evaluaci\u00f3n de recombinaci\u00f3n por el m\u00e9todo GARD \n(134).  \n 65 \n A partir de los resultados de los an\u00e1lisis anteriores , se seleccionaron al menos dos \nfragmentos de los ant\u00edgenos pvgama  (CR1, CR 2, VR 1 y VR2) y pvrbsa  (pvrbsa -A y \npvrbsa -B), los cuales fueron  evaluados en ensayos de uni\u00f3n , para determinar su \nparticipaci\u00f3n en la interacci\u00f3n pat\u00f3geno -hospedero. Estos experimentos fueron realizados \npor el grupo de Biolog\u00eda Molecular de la FIDIC. Brevemente,  los fragmentos seleccionados \nfueron amplificados por PCR, purificados y ligados a un vector de expresi\u00f3n. El pl\u00e1smido \nrecombinante fue utilizado para transformar c\u00e9lulas E. coli  BL21 -DE3. Las c\u00e9lulas \nrecombinantes fueron utilizadas para la expresi\u00f3n cada fragmento de forma soluble , como \nha sido descrito previamente (140). Posteriormente, los fragmentos recombinantes  fueron \npurificad os por cromatogra f\u00eda de afinidad en fase s\u00f3lida , utilizando una resina Ni+2-NTA \n(Qiagen, Valencia, CA, USA ). \n \nLa uni\u00f3n de estos fragmentos  a reticulocitos humanos (obtenidos de sangre de cord\u00f3n \numbilical (SCU) de ni\u00f1os reci\u00e9n nacidos ), fue analizada por triplicado a trav\u00e9s de \ncitometr\u00eda de flujo.  2x107 de reticulocitos  fueron incubados con 25\u00b5g de cada prote\u00edna \nrecombinante por 16h a 4\u00b0C  y 4 RPM en un agitador de tubos . Posteriormente, l as muestras \nse incubaron con el anticuerpo monoclonal anti -His-PE (diluci\u00f3n 1:40, MACSmolecular -\nMiltenyi Biotec, San Diego, CA, USA) en oscuridad y sin agitaci\u00f3n.  Los reticulocitos \nfueron marcados con los anticuerpos monoclonales anti -CD45 -APC (diluci\u00f3n 1:80, Becton \nDickinson, Franklin Lakes, NJ, USA) y anti -CD71 -APC -H7, respectivamente. \nPosteriorme nte, la uni\u00f3n de las mol\u00e9culas a reticulocitos (CD71+CD45 -) fue cuantificada \nanalizando 100.000 eventos en un cit\u00f3metro FACS Canto II (BD, San Diego, CA, USA) y \nel programa FACS Diva (145). Las regi ones II y III/IV de DBP fueron usadas como control \nde uni\u00f3n positivo y negativo, respectivamente .  \n \nPara PvCelTOS, se realiz\u00f3 un ensayo de competici\u00f3n (inhibici\u00f3n de la uni\u00f3n de la prote\u00edna \nrecomb\u00ednate), el cual fue ll evado a cabo por el grupo de Receptor -Ligando de la FIDIC.  \nBrevemente, en experimentos iniciales , la prote\u00edna PvCelTOS recombinante mostr\u00f3 ser \ncapaz de interactuar con c\u00e9lulas HeLA. Para determinar las regiones dentro de la prote\u00edna \nresponsables de esta in teracci\u00f3n, p\u00e9ptidos de 20 amino\u00e1cidos cubriendo la totalidad de la 66 \n secuencia, fueron sintetizados. Estos fueron pre -incubados en un radio molar de 1:20 \n(prote\u00edna :p\u00e9ptido ) con 2x107 c\u00e9lulas de la linea HeLA por una hora a 4 \u00b0C y 4 RPM en un \nagitador de tubos . Posteriormente, esta mezcla fue incubada con la prote\u00edna PvCelTOS \nrecombinante y el porcentaje de inhibici\u00f3n de la actividad de uni\u00f3n de PvCelTOS se \ncuantific\u00f3 mediante el an\u00e1lisis de 100.000 eventos usando un cit\u00f3metro FACS Canto II \n(Biosciences) y el s oftware FACSDiva (BD).  \n \nFigura 16. Metodolog\u00eda del Cap\u00edtulo  4 \n 67 \n Resultados  y discusi\u00f3n  \nEl an\u00e1lisis de la s secuencias de los loci pvgama , pvrbsa  y pvceltos  a partir de 5 cepas de P. \nvivax , mostr \u00f3 que estos son genes con una limitada  diversidad gen\u00e9tica (Tabla 6). Estos \ndatos fueron concordantes  cuando se analiz\u00f3 un mayor n\u00famero de secuencias ( Tabla 6 y \nPublicaciones 8 y 9).  \n \nTabla 7. Estimadores  de diversidad  \n  Datos Cepas  Datos con secuencias disponibles  \nGen n Sitios  Ss \u03c0 n Sitios  Ss \u03c0 \npvgama  6 2013  5 0,0006 (0,0004)  75 2067  25 0,0009 (0,0001 ) \npvrbsa  5 1290  22 0,0073 (0 ,0022)  232 1354  47 0,0085 (0 ,0002)  \npvceltos  5 588 3 0,0024 (0 ,0010)  209 546 7 0,0018 (0 ,0001)  \nn: n\u00famero  de secuencia utilizadas. Sitios: n\u00famero total d e sitios analizados. Ss: n\u00famero de sitios \nsegregrantes. \u03c0: diversidad nucleot\u00eddica por sitio.  \n \nDe acuerdo con  los resultados  de la ventana deslizante de las tasas \u03c9 (Figuras 17 y 18 ), se \nseleccionar on al menos 2 regiones por cada gen : las primera s (pvgama  CR1, CR2  y pvrbsa -\nA) en donde se observ \u00f3 una baja diversidad entre especies y se\u00f1ales de selecci\u00f3n negativa  \n(\u03c9 < 1 y codones bajo selecci\u00f3n negativa ). La s segunda s regiones  (pvgama  VR1, VR2 y \npvrbsa -B) fueron regiones donde se observ\u00f3 un valor de \u03c9 > 1, algunos sitios bajo \nselecci\u00f3n positiva  y fue ron variable s entre especies de Plasmodium . Estos  fragmentos \nfueron  expresados de forma recombinante en un sistema procari\u00f3tico y ev aluados por \ncitometr\u00eda de flujo  para determinar si estas regiones permiten la inte racci\u00f3n entre el \npat\u00f3geno y el hospedero.   \n \nTanto para PvGAMA como para PvRBSA , las regiones  de estas prote\u00ednas que mostraron \nser conservadas  entre especies y con se\u00f1ales de selecci\u00f3n negativa  (PvGAMA CR1 , CR2  y \nPvRBSA -A) mostraron una uni\u00f3n a los reticulo citos humanos que fue estad\u00edsticamente \nsignificativa con respecto al control negativo (regi\u00f3n DBP -III/IV, que no interact\u00faa con \nestas c\u00e9lulas) y a las regiones sin se\u00f1ales de selecci\u00f3n negativa (PvGAMA VR2 y \nPvRBSA -B) (Figura 19 ). Esto sugiere que las regi ones conservadas entre especies y con 68 \n se\u00f1ales de selecci\u00f3n negativa de PvGAMA y PvRBSA son regiones que permiten la \ninteracci\u00f3n entre el par\u00e1sito y los reticulocitos humanos, por lo que podr\u00eda n ser \nconsiderad as durante el dise\u00f1o de una vacuna contra P. viv ax.  \n \nPor otra parte, para PvCelTOS, debido a su cor ta longitud, se sintetizaron p\u00e9ptidos no \nsobrepuestos de 20 amino\u00e1cidos, los cuales fueron utilizados para ensayos de inhibici\u00f3n de \nla uni\u00f3n. Los result ados de estos ensayos (Figura 20), muestran que los p\u00e9ptidos que \ninhiben la uni\u00f3n de PvCelTOS a la s c\u00e9lulas diana,  concuerdan con las regiones donde se \nobserv\u00f3  un \u03c9 < 1 y donde codones bajo selecci\u00f3n negativa fueron localizados ( Figura 21  y \nPublicaci\u00f3n 8).  Un \u03c9 mayor a 1 fue observado en la regi\u00f3n C -terminal de la prote\u00edna, cerca \nde la regi\u00f3n que est\u00e1 inhibiendo la uni\u00f3n de PvCelTOS a la c\u00e9lula diana . En P. vivax , esta \nregi\u00f3n es predicha por estar expuesta al sistema inmune del hospedero (Publicaci\u00f3n 8  y \n(146)) y estudios previos han mostrado que esta regi\u00f3n es  antig\u00e9nica en infecciones \nnaturales en P. vivax  (146). Por lo tanto, esta prote\u00edna es un potencial candidato a vacuna, \ndebido a que es reconocid a por el sistema inmune del hospedero y a que es la regi\u00f3n \nfuncional de la prote\u00edna.       \n \nTodos estos resultados muestran que el enfoque propuesto en el Cap\u00edtulo 1 puede ser \nutilizado para tener una aproximaci\u00f3n de la diversidad gen\u00e9tica de un determinado  ant\u00edgeno  \npero,  adem\u00e1s, tambi\u00e9n permite establecer las posibles regiones involucradas en la \ninteracci\u00f3n pat\u00f3geno -hospedero. Otros resultados obtenidos por diferentes grupos  soportan \nel uso de este enfoque. PvGAMA fue descrito en 2016 por un grupo coreano  (147). La \nprote\u00edna fue dividida en 7 fragmentos diferentes y cada fragmento fue evaluado con \nrespecto a su habilidad de uni\u00f3n. Los fragmentos que mostraron uni\u00f3n (147), coinciden con \nel fragmento identificado en el presente trabajo  como conservado entre especies, con un \u03c9 \n< 1 y varios codones seleccionados negativamente.      69 \n Figura 17. Ventana deslizante para el locus pvgama  \n \nLos valores \u03c9 de gama  (dN/dS) dentro de P. vivax se muestran en azul, mientras l a tasa de divergencia \u03c9 (K N / KS) entre las especies que infectan primates y P. vivax se muestran \nen morado . Una representaci\u00f3n del gen gama  se presenta debajo de la ventana deslizante que indica el p\u00e9ptido se\u00f1al , la regi\u00f3n repetida y el anclaje a GPI. Los sitios bajo \nselecci\u00f3n negativa  est\u00e1n representados por l\u00edneas verdes y los sitios seleccionados positivamente entre especies se muestran por l\u00edneas rojas.  \n \n 70 \n  \nFigura 18. Ventana deslizante para el locus pvrbsa  \n \nLos valores \u03c9 de rbsa (dN/dS) dentro de P. vivax se muestran en azul, mientras la tasa de divergencia \u03c9 (K N / KS) entre las especies que infectan primates y P. vivax se muestran en \nmorado . Una representaci\u00f3n del gen rbsa se presenta debajo de la ventana deslizante que indica  el p\u00e9ptido se\u00f1al  y las h\u00e9lices transmembranales. Los sitios bajo selecci\u00f3n \nnegativa  est\u00e1n representados por l\u00edneas verdes y los sitios seleccionados positivamente entre especies se muestran por l\u00edneas rojas.  71 \n Figura 19. Actividad de uni\u00f3n de fragmentos de PvGAMA y PvRBSA  \n \nAn\u00e1lisis de citometr\u00eda de flujo mostrando  el porcentaje de uni\u00f3n de los fragmentos recombinantes de las prote\u00ednas \nPvGAMA (A) y PvRBSA (B) a reticulocitos humanos. Como control de uni\u00f3n (positivo) , se utiliz\u00f3 la r egi\u00f3n II de DBP que \npreviamente se ha reportado se une a los reticulocitos , y como control negativo , la regi\u00f3n III y IV (37). C\u00e9lulas CD71 -\nCD45 -: Normocitos; CD7 1+ CD45 -: Reticulocitos . Panel A: CR1  y CR2 son las regiones con patr\u00f3n de restricci\u00f3n \nfuncional en PvGAMA. VR1 y VR2  son regiones variables de PvGAMA. H: control de histidinas. Panel B: F indica la \nprote\u00edna PvRBSA completa, A, la regi\u00f3n identificada bajo restricci\u00f3n funcional y B, la regi\u00f3n variable.  \n \nFigura 20. Ensayos de inhibici\u00f3n d e la uni\u00f3n con p\u00e9ptidos de PvCelTOS  \n \nSecuencias de 20 amino\u00e1cidos (p\u00e9ptidos) correspondientes a la prote\u00edna PvCelTOS. Se observa el porcentaje de \ninhibici\u00f3n de la uni\u00f3n de la prote\u00edna completa que cada p\u00e9ptido present\u00f3 .   \n \n 72 \n Figura 21. Ventana deslizante para el locus pvceltos  \n \nLos valores de \u03c9 (d N/dS) para pvceltos se muestran en magen ta, mientras la divergencia \u03c9 ( KN/KS) entre P. vivax y P. \ncynomolgi es mostrada en azul. Un diagram a del gen se presenta debajo de la ventana deslizante. La regi\u00f3n que codifica \nel p\u00e9ptido se\u00f1al se indica en caf\u00e9 y los sitios bajo selecci\u00f3n positiva y negativa se indican en rojo y verde, \nrespectivamente.  Las secuencias de los p\u00e9ptidos que mostraron una inhibici\u00f3n de la uni\u00f3n de la prote\u00edna recombinante \nson mostradas  en morado. Estos p\u00e9ptidos coincide n con las regiones donde se observaron sitios bajo selecci\u00f3n negativa.  \n \nRecientemente, ensayos funcionales para PvRON4 fueron realizados (148), identificando \nque la regi\u00f3n C -terminal de esta prote\u00edna interact\u00faa  con los reticulocitos humanos. Esto s \nresultados (148) concuerda n con los obtenidos en este trabajo (Anexo 4 y Publicaci\u00f3n 6) \nque sugiri\u00f3 que la regi\u00f3n C -terminal de PvRON4 est\u00e1 restringida  \nfuncional/estructuralmente  (regi\u00f3n conservada entre especies, con un \u03c9 < 1 y codones bajo \nselecci\u00f3n negativa) . \n \nConclusiones  \nDe acuerdo a la teor\u00eda neutral de evoluci\u00f3n molecular (39), dentro de una prote\u00edna, l as \nregiones funcionales suelen evolucionar m\u00e1s lentame nte y, por lo tanto , son conser vadas. \nEsa conservaci\u00f3n suele ser man tenida por la selecci\u00f3n negativa , debido a que cualquier 73 \n alteraci\u00f3n en la secuencia de amino\u00e1cidos podr\u00eda afectar la funci\u00f3n de la pro te\u00edna. Por lo \ntanto, la predicci\u00f3n de regiones bajo restricci\u00f3n funcional podr\u00eda  ser utilizada  como una \nalternativa para determinar las regiones involucr adas en la interacci\u00f3n pat\u00f3geno -hospedero. \nAs\u00ed, en vez de analizar m\u00faltiples y peque\u00f1os fragmentos de l a prote\u00edna, este enfoque podr\u00eda \nutilizarse para ubicar regiones funcionales potenciales en P. vivax  y as\u00ed realizar ensayos de \nuni\u00f3n s \u00f3lo con aquellas regiones con se\u00f1ales de selecci\u00f3n negativa, optimizando los \nreticulocitos, que son la limitante para reali zar estos estudios . Adicionalmente, al ser estas \nregiones conservadas, se podr\u00edan usar durante el desarrollo de una vacuna antimal\u00e1rica para \nas\u00ed evitar las respuestas alelo -espec\u00edficas  de disminuyen la eficacia de la s vacunas.  \n \nLos resultados de este cap\u00edt ulo fueron publicados y est\u00e1n disponibles bajo las siguientes \nreferencias:  \n \nPublicaci\u00f3n 7: Baquero LA, Moreno -P\u00e9rez DA, Garz\u00f3n -Ospina D , Forero -Rodr\u00edguez J, \nOrtiz -Su\u00e1rez HD, Patarroyo MA. PvGAMA reticulocyte binding activity: predicting \nconserved function al regions by natural selection analysis . Parasit Vectors. 2017 May \n19;10(1):251. doi: 10.1186/s13071 -017-2183 -8. \n \nPublicaci\u00f3n 8: Garz\u00f3n -Ospina D , Buitrago SP, Ramos AE, Patarroyo MA.  Identifying \nPotential Plasmodium vivax Sporozoite Stage Vaccine Candidat es: An Analysis of Genetic \nDiversity and Natural Selection . Front Genet. 2018 Jan 25;9:10. \ndoi:10.3389/fgene.2018.00010.  \n \nPublicaci\u00f3n 9: Camargo -Ayala  PA, Garz\u00f3n -Ospina D , Moreno -P\u00e9rez DA , Ricaurte -\nContreras  LA, Noya  O and Patarroyo  MA. On the evolution a nd function of Plasmodium \nvivax reticulocyte binding surface antigen (pvrbsa) . Front. Genet. 2018 Sep . 9:372  doi: \n10.3389/fgene.2018.00372 . \n \n 74 \n CONCLUSIONES GENERALES  \n \nEste trabajo present\u00f3 y valid \u00f3 el potencia l de un enfoque alternativo para la selecci\u00f3n de \nant\u00edgenos  promisorios para el dise\u00f1o de una vacuna altamente efectiva contra P. vivax . A \npartir de los datos (secuencias  gen\u00f3micas ) de 5 cepas de P. vivax , fue posible hacer una \naproximaci\u00f3n de la diversidad gen\u00e9tica de varios ant\u00edgenos parasitarios. Es tos datos son \nsimilares a los obtenidos si se analizan un mayor n\u00famero de secuencias. Adiciona lmente, a \npartir de estos datos, fue posible determinar regiones que presentan un patr\u00f3n consistente \ncon restricciones funcionales (regi\u00f3n conservada entre especi es, con un \u03c9 < 1 y codones \nbajo selecci\u00f3n negativa). Al analizar aquellas regiones con un patr\u00f3n de restricci\u00f3n \nfuncional  mediante ensayos de uni\u00f3n , se pudo establecer que estas regiones juegan un papel \ndurante la interacci\u00f3n pat\u00f3geno -hospedero , lo que sop orta la utilizaci\u00f3n de este enfoque \ndurante la selecci\u00f3n de candidatos.  \n \nAunque este enfoque present\u00f3 buenos resultados, tambi\u00e9n tiene limitaciones. La presencia \nde se\u00f1ales de selecci\u00f3n positiva linaje -espec \u00edfica, puede incrementar la tasa \u03c9, lo que \ndesca rtar\u00eda el ant\u00edgeno (u una regi\u00f3n  particular de \u00e9ste) como candidato promisorio . No \nobstante, la identificaci\u00f3n de este tipo de se\u00f1ales, junto con la identificaci\u00f3n de codones \nbajo selecci\u00f3n negativa, podr\u00eda ser utilizada para hacer frente a esta limitaci\u00f3n . Teniendo en \ncuenta toda la informaci\u00f3n presentada  en este trabajo , junto con las herramientas \nbioinform\u00e1ticas disponibles , se dise\u00f1\u00f3  la Figura 22, que muestra una alternativa a seguir \npara la selecci\u00f3n de ant\u00edgenos  promisorios a vacuna . \n \nEste trabajo eva lu\u00f3 la diversidad gen\u00e9tica e infiri\u00f3 se\u00f1ales consistentes con selecci\u00f3n \nnatural de diferentes ant\u00edgenos de P. vivax . De acuerdo con los resultados obtenidos, los \nant\u00edgenos (o regiones bajo restricci\u00f3n funcional dentro de estos): pvclag , pvser /thr, \npvrhopH1 /clag7 , pvron2 , PVX_092425  (Publicaci\u00f3n 1), pv12 , pv38  (Publicaci\u00f3n 1 y 3) , \npv41  (Publicaci\u00f3n 1 y 4),  pvron4  (Publicaci\u00f3n 1 y 6),  pvgama  (Publicaci\u00f3n 7),  pvrbsa  \n(Publicaci\u00f3n 9) y pvceltos  (as\u00ed como los ant\u00edgenos del estadio esporozo\u00edto  pvp52 , pvp36 , 75 \n pvspat r, pvplp1 , pvmcp1 , pvtlp , y pvmb2 , Publicaci\u00f3n 8) son ant\u00edgenos promisorios a \nevaluar durante el dise\u00f1o de una vacuna contra P. vivax  altamente efectiva.      \n \nFigura 22. Flujo de trabajo a seguir para seleccionar ant\u00edgenos promiso rios a incluir \nen el dise\u00f1o de vacunas contra agentes infecciosos  \n 76 \n PERSPECTIVAS GENERALES  \n \nEn este trabajo de describi\u00f3 y valido un enfoque alternativo para la selecci\u00f3n de ant\u00edgenos \npromisorios a ser considerados durante el dise\u00f1o de una vacuna contra P. vivax  que evite \nlas respuestas inmunes alelo -espec\u00edficas. Cerca de 20 ant\u00edgenos fueron sugeridos como \npromisorios. Sin embargo, debido a los alcances de este trabajo, s \u00f3lo las regiones predichas \ncomo funcionalmente importantes de 3 de estos fueron corro boradas experimentalmente . \nPor lo tanto, futuros estudios funcionales en los restantes 16 ant\u00edgenos, as\u00ed como, de otros \nant\u00edgenos no incluidos en este trabajo, podr\u00edan ser llevados a cabo tomando como base los \nresultados obtenidos  y as\u00ed determinar el rol d e \u00e9stos durante el proceso de invasi\u00f3n de P. \nvivax  a los reticulocitos humanos.   \n \nPor otra parte, estudios de antigenicidad, inmunogenicidad y protec ci\u00f3n,  podr\u00edan ser \nllevados a cabo con los ant\u00edgenos ac\u00e1 descritos como promisorios (o regiones restringida s \nfuncionalmente dentro de ellos ), para as\u00ed evaluar si estos pueden ser considerado s \ncandidatos a vacuna y ser incluidos en ensayos precl\u00ednicos de una vacuna contra P. vivax . \n \nFinalmente, e l enfoque presentado en este trabajo podr\u00eda ser aplicado a otros pa t\u00f3genos, \ndurante la  b\u00fasqueda de potenciales candidatos a vacuna.  \n \n \n \n \n \n \n \n \n \n 77 \n REFERENCIAS  \n \n1. de Meeus T, McCoy KD, Prugnolle F, Chevillon C, Durand P, Hurtrez -Bousses S, et \nal. Population genetics and molecular epidemiology or how to \"d ebusquer la bete\". \nInfect Genet Evol. 2007 Mar;7(2):308 -32. \n2. Hotez P, Herricks J. One Million Deaths by Parasites.  USA. \nhttp://blogs.plos.org/speakingofme dicine/2015/01/16/one -million -deaths -parasites/:  \nPLOS Medicine Pathogens Neglected Tropical Diseases; 2015 [cited 2015 July 13 \n2015].  \n3. Global, regional, and national age -sex specific all -cause and cause -specific mortality \nfor 240 causes of death, 1990 -2013: a systematic analysis for the Global Burden of \nDisease Study 2013. Lancet. 2015 Jan 10;385(9963):117 -71. \n4. Escalante AA, Ayala FJ. Phylogeny of the malarial genus Plasmodium, derived from \nrRNA gene sequences. Proceedings of the National Academy of Sc iences of the United \nStates of America. 1994 Nov 22;91(24):11373 -7. \n5. Rich SM, Ayala FJ. Progress in malaria research: the case for phylogenetics. Advances \nin parasitology. 2003;54:255 -80. \n6. Schaer J, Perkins SL, Decher J, Leendertz FH, Fahr J, Weber N, et al. High diversity of \nWest African bat malaria parasites and a tight link with rodent Plasmodium taxa. \nProceedings of the National Academy of Sciences of the United States of America. \n2013 Oct 22;110(43):17415 -9. \n7. Cowman AF, Crabb BS. Invasion of red blood cells by malaria parasites. Cell. 2006 \nFeb 24;124(4):755 -66. \n8. Galinski MR, Meyer EV, Barnwell JW. Plasmodium vivax: modern strategies to study \na persistent parasite's life cycle. Advances in parasitology. 2013;81:1 -26. \n9. Coatney GR, National Insti tute of Allergy and Infectious Diseases (U.S.). The primate \nmalarias. Bethesda, Md.,: U.S. National Institute of Allergy and Infectious Diseases; \nfor sale by the Supt. of Docs., U.S. Govt. Print. Off., Washington; 1971.  \n10. Pain A, Bohme U, Berry AE, Munga ll K, Finn RD, Jackson AP, et al. The genome of \nthe simian and human malaria parasite Plasmodium knowlesi. Nature. 2008 Oct \n9;455(7214):799 -803. \n11. Pacheco MA, Battistuzzi FU, Junge RE, Cornejo OE, Williams CV, Landau I, et al. \nTiming the origin of human malarias: the lemur puzzle. BMC Evol Biol. 2011;11:299.  \n12. Hayakawa T, Culleton R, Otani H, Horii T, Tanabe K. Big bang in the evolution of \nextant malaria parasites. Mol Biol Evol. 2008 Oct;25(10):2233 -9. \n13. Silva JC, Egan A, Arze C, Spouge JL, Harris DG . A new method for estimating species \nage supports the coexistence of malaria parasites and their Mammalian hosts. Mol Biol \nEvol. 2015 May;32(5):1354 -64. \n14. Liu W, Li Y, Shaw KS, Learn GH, Plenderleith LJ, Malenke JA, et al. African origin \nof the malaria parasite Plasmodium vivax. Nat Commun. 2014;5:3346.  \n15. Mu J, Joy DA, Duan J, Huang Y, Carlton J, Walker J, et al. Host switch leads to \nemergence of Plasmodium vivax malaria in humans. Mol Biol Evol. 2005 \nAug;22(8):1686 -93. \n16. WHO. World malaria report 20 17: Geneva: World Health Organization; 2017. \nLicence: CC BY -NC-SA 3.0 IGO; 2017 [cited 2018 05/04/2018]. Available from: 78 \n http://apps.who.int/iris/bitstr eam/handle/10665/259492/9789241565523 -\neng.pdf?sequence=1 . \n17. Suh KN, Kain KC, Keystone JS. Malaria. CMAJ. 2004 May 25;170(11):1693 -702. \n18. Maxmen A. Malaria surge feared. Nature. 2012 May 15;485(7398):293.  \n19. Huijben S, Paaijmans KP. Putting evolution in elimination: Winning our ongoing battle \nwith evolving malaria mosquitoes and parasites. Evol Appl. 2018 Apr;11(4):415 -30. \n20. Price RN, von Seidlein L, Valecha N, Nosten F, Baird JK, White NJ. Global extent of \nchloroquine -resistant Plasmodium vivax: a s ystematic review and meta -analysis. \nLancet Infect Dis. 2014 Oct;14(10):982 -91. \n21. Barry AE, Arnott A. Strategies for designing and monitoring malaria vaccines \ntargeting diverse antigens. Front Immunol. 2014;5:359.  \n22. White NJ, Pukrittayakamee S, Hien TT,  Faiz MA, Mokuolu OA, Dondorp AM. \nMalaria. Lancet. 2014 Feb 22;383(9918):723 -35. \n23. Garrido -Cardenas JA, Mesa -Valle C, Manzano -Agugliaro F. Genetic approach towards \na vaccine against malaria. Eur J Clin Microbiol Infect Dis. 2018 Jun 28.  \n24. Patarroyo MA,  Calderon D, Moreno -Perez DA. Vaccines against Plasmodium vivax: a \nresearch challenge. Expert Rev Vaccines. 2012 Oct;11(10):1249 -60. \n25. Luo Z, Sullivan SA, Carlton JM. The biology of Plasmodium vivax explored through \ngenomics. Ann N Y Acad Sci. 2015 Apr;1 342:53 -61. \n26. Arevalo -Pinzon G, Curtidor H, Abril J, Patarroyo MA. Annotation and characterization \nof the Plasmodium vivax rhoptry neck protein 4 (PvRON4). Malar J. 2013 Oct \n5;12:356.  \n27. Arevalo -Pinzon G, Curtidor H, Patino LC, Patarroyo MA. PvRON2, a ne w \nPlasmodium vivax rhoptry neck antigen. Malar J. 2011;10:60.  \n28. Moreno -Perez DA, Saldarriaga A, Patarroyo MA. Characterizing PvARP, a novel \nPlasmodium vivax antigen. Malar J. 2013;12:165.  \n29. Neafsey DE, Galinsky K, Jiang RH, Young L, Sykes SM, Saif S, e t al. The malaria \nparasite Plasmodium vivax exhibits greater genetic diversity than Plasmodium \nfalciparum. Nat Genet. 2012 Sep;44(9):1046 -50. \n30. Ellis RD, Sagara I, Doumbo O, Wu Y. Blood stage vaccines for Plasmodium \nfalciparum: current status and the way  forward. Hum Vaccin. 2010 Aug;6(8):627 -34. \n31. Fluck C, Smith T, Beck HP, Irion A, Betuela I, Alpers MP, et al. Strain -specific \nhumoral response to a polymorphic malaria vaccine. Infect Immun. 2004 \nNov;72(11):6300 -5. \n32. Genton B, Reed ZH. Asexual blood -stage malaria vaccine development: facing the \nchallenges. Curr Opin Infect Dis. 2007 Oct;20(5):467 -75. \n33. Ouattara A, Takala -Harrison S, Thera MA, Coulibaly D, Niangaly A, Saye R, et al. \nMolecular basis of allele -specific efficacy of a blood -stage malaria vaccine: vaccine \ndevelopment implications. J Infect Dis. 2013 Feb 1;207(3):511 -9. \n34. Takala SL, Plowe CV. Genetic diversity and malaria vaccine design, testing and \nefficacy: preventing and overcoming 'vaccine resistant malaria'. Parasite Immunol. \n2009 Sep ;31(9):560 -73. \n35. Richie TL, Saul A. Progress and challenges for malaria vaccines. Nature. 2002 Feb \n7;415(6872):694 -701. 79 \n 36. Urquiza M, Patarroyo MA, Mari V, Ocampo M, Suarez J, Lopez R, et al. Identification \nand polymorphism of Plasmodium vivax RBP -1 pep tides which bind specifically to \nreticulocytes. Peptides. 2002 Dec;23(12):2265 -77. \n37. Ocampo M, Vera R, Eduardo Rodriguez L, Curtidor H, Urquiza M, Suarez J, et al. \nPlasmodium vivax Duffy binding protein peptides specifically bind to reticulocytes. \nPeptid es. 2002 Jan;23(1):13 -22. \n38. Rodriguez LE, Urquiza M, Ocampo M, Curtidor H, Suarez J, Garcia J, et al. \nPlasmodium vivax MSP -1 peptides have high specific binding activity to human \nreticulocytes. Vaccine. 2002 Jan 31;20(9 -10):1331 -9. \n39. Kimura M. The neut ral theory of molecular evolution. Cambridge Cambridgeshire ; \nNew York: Cambridge University Press; 1983.  \n40. Graur D, Zheng Y, Price N, Azevedo RB, Zufall RA, Elhaik E. On the immortality of \ntelevision sets: \"function\" in the human genome according to the  evolution -free gospel \nof ENCODE. Genome Biol Evol. 2013;5(3):578 -90. \n41. Carlton JM, Adams JH, Silva JC, Bidwell SL, Lorenzi H, Caler E, et al. Comparative \ngenomics of the neglected human malaria parasite Plasmodium vivax. Nature. 2008 \nOct 9;455(7214):757 -63. \n42. Bozdech Z, Mok S, Hu G, Imwong M, Jaidee A, Russell B, et al. The transcriptome of \nPlasmodium vivax reveals divergence and diversity of transcriptional regulation in \nmalaria parasites. Proceedings of the National Academy of Sciences of the United \nStates of America. 2008 Oct 21;105(42):16290 -5. \n43. Chen JH, Jung JW, Wang Y, Ha KS, Lu F, Lim CS, et al. Immunoproteomics profiling \nof blood stage Plasmodium vivax  infection by high -throughput screening assays. \nJournal of proteome research. 2011 Dec 3;9(1 2):6479 -89. \n44. Moreno -Perez DA, Degano R, Ibarrola N, Muro A, Patarroyo MA. Determining the \nPlasmodium vivax VCG -1 strain blood stage proteome. Journal of proteomics. 2014 \nOct 11.  \n45. Tachibana S, Sullivan SA, Kawai S, Nakamura S, Kim HR, Goto N, et al. P lasmodium \ncynomolgi genome sequences provide insight into Plasmodium vivax and the monkey \nmalaria clade. Nat Genet. 2012 Sep;44(9):1051 -5. \n46. Good MF. Towards a blood -stage vaccine for malaria: are we following all the leads? \nNature reviews. 2001 Nov;1(2) :117-25. \n47. O'Donnell RA, de Koning -Ward TF, Burt RA, Bockarie M, Reeder JC, Cowman AF, \net al. Antibodies against merozoite surface protein (MSP) -1(19) are a major component \nof the invasion -inhibitory response in individuals immune to malaria. The Journal  of \nexperimental medicine. 2001 Jun 18;193(12):1403 -12. \n48. Rojas -Caraballo J, Mongui A, Giraldo MA, Delgado G, Granados D, Millan -Cortes D, \net al. Immunogenicity and protection -inducing ability of recombinant Plasmodium \nvivax rhoptry -associated protein 2 in Aotus monkeys: a potential vaccine candidate. \nVaccine. 2009 May 11;27(21):2870 -6. \n49. Farooq F, Bergmann -Leitner ES. Immune Escape Mechanisms are Plasmodium's \nSecret Weapons Foiling the Success of Potent and Persistently Efficacious Malaria \nVaccines. Cl in Immunol. 2015 Sep 2.  \n50. Angel DI, Mongui A, Ardila J, Vanegas M, Patarroyo MA. The Plasmodium vivax \nPv41 surface protein: identification and characterization. Biochem Biophys Res \nCommun. 2008 Dec 26;377(4):1113 -7. 80 \n 51. Mongui A, Angel DI, Gallego G, Rey es C, Martinez P, Guhl F, et al. Characterization \nand antigenicity of the promising vaccine candidate Plasmodium vivax 34kDa rhoptry \nantigen (Pv34). Vaccine. 2009 Dec 11;28(2):415 -21. \n52. Mongui A, Angel DI, Moreno -Perez DA, Villarreal -Gonzalez S, Almonaci d H, \nVanegas M, et al. Identification and characterization of the Plasmodium vivax \nthrombospondin -related apical merozoite protein. Malar J. 2010;9:283.  \n53. Mongui A, Perez -Leal O, Rojas -Caraballo J, Angel DI, Cortes J, Patarroyo MA. \nIdentifying and charac terising the Plasmodium falciparum RhopH3 Plasmodium vivax \nhomologue. Biochem Biophys Res Commun. 2007 Jul 6;358(3):861 -6. \n54. Mongui A, Perez -Leal O, Soto SC, Cortes J, Patarroyo MA. Cloning, expression, and \ncharacterisation of a Plasmodium vivax MSP7 fam ily merozoite surface protein. \nBiochem Biophys Res Commun. 2006 Dec 22;351(3):639 -44. \n55. Moreno -Perez DA, Mongui A, Soler LN, Sanchez -Ladino M, Patarroyo MA. \nIdentifying and characterizing a member of the RhopH1/Clag family in Plasmodium \nvivax. Gene. 2011  Jul 15;481(1):17 -23. \n56. Perez -Leal O, Mongui A, Cortes J, Yepes G, Leiton J, Patarroyo MA. The Plasmodium \nvivax rhoptry -associated protein 1. Biochem Biophys Res Commun. 2006 Mar \n24;341(4):1053 -8. \n57. Perez -Leal O, Sierra AY, Barrero CA, Moncada C, Marti nez P, Cortes J, et al. \nIdentifying and characterising the Plasmodium falciparum merozoite surface protein 10 \nPlasmodium vivax homologue. Biochem Biophys Res Commun. 2005 Jun \n17;331(4):1178 -84. \n58. Perez -Leal O, Sierra AY, Barrero CA, Moncada C, Martinez P , Cortes J, et al. \nPlasmodium vivax merozoite surface protein 8 cloning, expression, and \ncharacterisation. Biochem Biophys Res Commun. 2004 Nov 26;324(4):1393 -9. \n59. Zambrano -Villa S, Rosales -Borjas D, Carrero JC, Ortiz -Ortiz L. How protozoan \nparasites eva de the immune response. Trends Parasitol. 2002 Jun;18(6):272 -8. \n60. Thera MA, Doumbo OK, Coulibaly D, Laurens MB, Ouattara A, Kone AK, et al. A \nfield trial to assess a blood -stage malaria vaccine. N Engl J Med. 2011 Sep \n15;365(11):1004 -13. \n61. Figtree M, P asay CJ, Slade R, Cheng Q, Cloonan N, Walker J, et al. Plasmodium vivax \nsynonymous substitution frequencies, evolution and population structure deduced from \ndiversity in AMA 1 and MSP 1 genes. Molecular and biochemical parasitology. 2000 \nApr 30;108(1):53 -66. \n62. Garzon -Ospina D, Romero -Murillo L, Patarroyo MA. Limited genetic polymorphism \nof the Plasmodium vivax low molecular weight rhoptry protein complex in the \nColombian population. Infect Genet Evol. 2010 Mar;10(2):261 -7. \n63. Garzon -Ospina D, Romero -Muri llo L, Tobon LF, Patarroyo MA. Low genetic \npolymorphism of merozoite surface proteins 7 and 10 in Colombian Plasmodium vivax \nisolates. Infect Genet Evol. 2011 Mar;11(2):528 -31. \n64. Gomez A, Suarez CF, Martinez P, Saravia C, Patarroyo MA. High polymorphism in \nPlasmodium vivax merozoite surface protein -5 (MSP5). Parasitology. 2006 Dec;133(Pt \n6):661 -72. \n65. Martinez P, Suarez CF, Cardenas PP, Patarroyo MA. Plasmodium vivax Duffy binding \nprotein: a modular evolutionary proposal. Parasitology. 2004 Apr;128(Pt 4) :353-66. 81 \n 66. Martinez P, Suarez CF, Gomez A, Cardenas PP, Guerrero JE, Patarroyo MA. High \nlevel of conservation in Plasmodium vivax merozoite surface protein 4 (PvMSP4). \nInfect Genet Evol. 2005 Oct;5(4):354 -61. \n67. Mascorro CN, Zhao K, Khuntirat B, Sattabo ngkot J, Yan G, Escalante AA, et al. \nMolecular evolution and intragenic recombination of the merozoite surface protein \nMSP -3alpha from the malaria parasite Plasmodium vivax in Thailand. Parasitology. \n2005 Jul;131(Pt 1):25 -35. \n68. Pacheco MA, Elango AP, Rah man AA, Fisher D, Collins WE, Barnwell JW, et al. \nEvidence of purifying selection on merozoite surface protein 8 (MSP8) and 10 \n(MSP10) in Plasmodium spp. Infect Genet Evol. 2012 Jul;12(5):978 -86. \n69. Putaporntip C, Jongwutiwes S, Ferreira MU, Kanbara H, Ud omsangpetch R, Cui L. \nLimited global diversity of the Plasmodium vivax merozoite surface protein 4 gene. \nInfect Genet Evol. 2009 Sep;9(5):821 -6. \n70. Putaporntip C, Jongwutiwes S, Seethamchai S, Kanbara H, Tanabe K. Intragenic \nrecombination in the 3' portio n of the merozoite surface protein 1 gene of Plasmodium \nvivax. Molecular and biochemical parasitology. 2000 Jul;109(2):111 -9. \n71. Putaporntip C, Udomsangpetch R, Pattanawong U, Cui L, Jongwutiwes S. Genetic \ndiversity of the Plasmodium vivax merozoite surfa ce protein -5 locus from diverse \ngeographic origins. Gene. 2010 May 15;456(1 -2):24 -35. \n72. Tetteh KK, Stewart LB, Ochola LI, Amambua -Ngwa A, Thomas AW, Marsh K, et al. \nProspective identification of malaria parasite genes under balancing selection. PLoS \nOne.  2009;4(5):e5568.  \n73. Weedall GD, Conway DJ. Detecting signatures of balancing selection to identify \ntargets of anti -parasite immunity. Trends Parasitol. 2010 Jul;26(7):363 -9. \n74. Suzuki Y. Natural selection on the influenza virus genome. Mol Biol Evol. 20 06 \nOct;23(10):1902 -11. \n75. Mazumder R, Hu ZZ, Vinayaka CR, Sagripanti JL, Frost SD, Kosakovsky Pond SL, et \nal. Computational analysis and identification of amino acid sites in dengue E proteins \nrelevant to development of diagnostics and vaccines. Virus Gen es. 2007 \nOct;35(2):175 -86. \n76. Suzuki Y. Negative selection on neutralization epitopes of poliovirus surface proteins: \nimplications for prediction of candidate epitopes for immunization. Gene. 2004 Mar \n17;328:127 -33. \n77. Rich SM, Licht MC, Hudson RR, Ayala  FJ. Malaria's Eve: evidence of a recent \npopulation bottleneck throughout the world populations of Plasmodium falciparum. \nProceedings of the National Academy of Sciences of the United States of America. \n1998 Apr 14;95(8):4425 -30. \n78. Hughes AL, Verra F. An cient polymorphism and the hypothesis of a recent bottleneck \nin the malaria parasite Plasmodium falciparum. Genetics. 1998 Sep;150(1):511 -3. \n79. Griffing SM, Viana GM, Mixson -Hayden T, Sridaran S, Alam MT, de Oliveira AM, et \nal. Historical shifts in Brazil ian P. falciparum population structure and drug resistance \nalleles. PLoS One. 2013;8(3):e58984.  \n80. McCollum AM, Mueller K, Villegas L, Udhayakumar V, Escalante AA. Common \norigin and fixation of Plasmodium falciparum dhfr and dhps mutations associated with  \nsulfadoxine -pyrimethamine resistance in a low -transmission area in South America. \nAntimicrob Agents Chemother. 2007 Jun;51(6):2085 -91. 82 \n 81. Rodrigues PT, Valdivia HO, de Oliveira TC, Alves JMP, Duarte A, Cerutti -Junior C, et \nal. Human migration and the spr ead of malaria parasites to the New World. Sci Rep. \n2018 Jan 31;8(1):1993.  \n82. Restrepo -Montoya D, Becerra D, Carvajal -Patino JG, Mongui A, Nino LF, Patarroyo \nME, et al. Identification of Plasmodium vivax proteins with potential role in invasion \nusing sequ ence redundancy reduction and profile hidden Markov models. PLoS One. \n2011;6(10):e25189.  \n83. Arnott A, Barry AE, Reeder JC. Understanding the population genetics of Plasmodium \nvivax is essential for malaria control and elimination. Malar J. 2012;11:14.  \n84. Cornejo OE, Fisher D, Escalante AA. Genome -Wide Patterns of Genetic \nPolymorphism and Signatures of Selection in Plasmodium vivax. Genome Biol Evol. \n2014;7(1):106 -19. \n85. Ochola LI, Tetteh KK, Stewart LB, Riitho V, Marsh K, Conway DJ. Allele frequency -\nbased and polymorphism -versus -divergence indices of balancing selection in a new \nfiltered set of polymorphic genes in Plasmodium falciparum. Mol Biol Evol. 2010 \nOct;27(10):2344 -51. \n86. Mongui A, Angel DI, Guzman C, Vanegas M, Patarroyo MA. Charac terisation of the \nPlasmodium vivax Pv38 antigen. Biochem Biophys Res Commun. 2008 Nov \n14;376(2):326 -30. \n87. Moreno -Perez DA, Areiza -Rojas R, Florez -Buitrago X, Silva Y, Patarroyo ME, \nPatarroyo MA. The GPI -anchored 6 -Cys protein Pv12 is present in detergent -resistant \nmicrodomains of Plasmodium vivax blood stage schizonts. Protist. 2013 \nJan;164(1):37 -48. \n88. Moreno -Perez DA, Montenegro M, Patarroyo ME, Patarroyo MA. Identification, \ncharacterization and antigenicity of the Plasmodium vivax rhoptry neck protein  1 \n(PvRON1). Malar J. 2011;10:314.  \n89. Patarroyo MA, Perez -Leal O, Lopez Y, Cortes J, Rojas -Caraballo J, Gomez A, et al. \nIdentification and characterisation of the Plasmodium vivax rhoptry -associated protein \n2. Biochem Biophys Res Commun. 2005 Nov 25;337(3 ):853 -9. \n90. Garzon -Ospina D, Lopez C, Forero -Rodriguez J, Patarroyo MA. Genetic diversity and \nselection in three Plasmodium vivax merozoite surface protein 7 (Pvmsp -7) genes in a \nColombian population. PLoS One. 2012;7(9):e45962.  \n91. Arisue N, Kawai S, Hir ai M, Palacpac NM, Jia M, Kaneko A, et al. Clues to evolution \nof the SERA multigene family in 18 Plasmodium species. PLoS One. \n2011;6(3):e17775.  \n92. Garzon -Ospina D, Cadavid LF, Patarroyo MA. Differential expansion of the merozoite \nsurface protein (msp) -7 gene family in Plasmodium species under a birth -and-death \nmodel of evolution. Mol Phylogenet Evol. 2010 May;55(2):399 -408. \n93. Garzon -Ospina D, Forero -Rodriguez J, Patarroyo MA. Heterogeneous genetic diversity \npattern in Plasmodium vivax genes encoding mer ozoite surface proteins (MSP) -7E, -\n7F and -7L. Malar J. 2014;13:495.  \n94. Rice BL, Acosta MM, Pacheco MA, Carlton JM, Barnwell JW, Escalante AA. The \norigin and diversification of the merozoite surface protein 3 (msp3) multi -gene family \nin Plasmodium vivax and related parasites. Mol Phylogenet Evol. 2014 Sep;78:172 -84. \n95. Edgar RC. MUSCLE: multiple sequence alignment with high accuracy and high \nthroughput. Nucleic Acids Res. 2004;32(5):1792 -7. 83 \n 96. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S.  MEGA5: molecular \nevolutionary genetics analysis using maximum likelihood, evolutionary distance, and \nmaximum parsimony methods. Mol Biol Evol. 2011 Oct;28(10):2731 -9. \n97. Suyama M, Torrents D, Bork P. PAL2NAL: robust conversion of protein sequence \nalignme nts into the corresponding codon alignments. Nucleic Acids Res. 2006 Jul \n1;34(Web Server issue):W609 -12. \n98. Librado P, Rozas J. DnaSP v5: a software for comprehensive analysis of DNA \npolymorphism data. Bioinformatics. 2009 Jun 1;25(11):1451 -2. \n99. Nielsen  R. Molecular signatures of natural selection. Annu Rev Genet. 2005;39:197 -\n218. \n100. McDonald JH, Kreitman M. Adaptive protein evolution at the Adh locus in \nDrosophila. Nature. 1991 Jun 20;351(6328):652 -4. \n101. Jukes THaCRC. Evolution of protein molecules.  In H. N. Munro, ed., Mammalian \nProtein Metabolism. New York: Academic Press; 1969.  \n102. Egea R, Casillas S, Barbadilla A. Standard and generalized McDonald -Kreitman test: a \nwebsite to detect selection by comparing different classes of DNA sites. Nucleic A cids \nRes. 2008 Jul 1;36(Web Server issue):W157 -62. \n103. Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: Molecular \nEvolutionary Genetics Analysis version 6.0. Mol Biol Evol. 2013 Dec;30(12):2725 -9. \n104. Zhang J, Rosenberg HF, Nei M. Positive Da rwinian selection after gene duplication in \nprimate ribonuclease genes. Proceedings of the National Academy of Sciences of the \nUnited States of America. 1998 Mar 31;95(7):3708 -13. \n105. Sawai H, Otani H, Arisue N, Palacpac N, de Oliveira Martins L, Pathiran a S, et al. \nLineage -specific positive selection at the merozoite surface protein 1 (msp1) locus of \nPlasmodium vivax and related simian malaria parasites. BMC Evol Biol. 2010;10:52.  \n106. Tanabe K, Escalante A, Sakihama N, Honda M, Arisue N, Horii T, et al. Recent \nindependent evolution of msp1 polymorphism in Plasmodium vivax and related simian \nmalaria parasites. Molecular and biochemical parasitology. 2007 Nov;156(1):74 -9. \n107. Parobek CM, Bailey JA, Hathaway NJ, Socheat D, Rogers WO, Juliano JJ. Differing \npatterns of selection and geospatial genetic diversity within two leading Plasmodium \nvivax candidate vaccine antigens. PLoS Negl Trop Dis. 2014 Apr;8(4):e2796.  \n108. Sjostrand J, Tofigh A, Daubin V, Arvestad L, Sennblad B, Lagergren J. A Bayesian \nmethod for analyzing lateral gene transfer. Syst Biol. 2014 May;63(3):409 -20. \n109. Stamatakis A. RAxML version 8: a tool for phylogenetic analysis and post -analysis of \nlarge phylogenies. Bioinformatics. 2014 May 1;30(9):1312 -3. \n110. Ronquist F, Teslenko M, van der Ma rk P, Ayres DL, Darling A, Hohna S, et al. \nMrBayes 3.2: efficient Bayesian phylogenetic inference and model choice across a \nlarge model space. Syst Biol. 2012 May;61(3):539 -42. \n111. Abascal F, Zardoya R, Posada D. ProtTest: selection of best -fit models of protein \nevolution. Bioinformatics. 2005 May 1;21(9):2104 -5. \n112. Miller MA, Pfeiffer, W., and Schwartz, T. Creating the CIPRES Science Gateway for \ninference of large phylogenetic trees. Proceedings of the Gateway Computing \nEnvironments Workshop (GCE), 14 N ov 2010, New Orleans, LA pp 1 - 8. 2010.  \n113. Miller MA, Schwartz T, Pickett BE, He S, Klem EB, Scheuermann RH, et al. A \nRESTful API for Access to Phylogenetic Tools via the CIPRES Science Gateway. \nEvol Bioinform Online. 2015;11:43 -8. 84 \n 114. Kosakovsky Pond SL, Murrell B, Fourment M, Frost SD, Delport W, Scheffler K. A \nrandom effects branch -site model for detecting episodic diversifying selection. Mol \nBiol Evol. 2011 Nov;28(11):3033 -43. \n115. Darriba D, Taboada GL, Doallo R, Posada D. jModelTest 2: more models , new \nheuristics and parallel computing. Nat Methods. 2012 Aug;9(8):772.  \n116. Pond SL, Frost SD, Muse SV. HyPhy: hypothesis testing using phylogenies. \nBioinformatics. 2005 Mar 1;21(5):676 -9. \n117. Delport W, Poon AF, Frost SD, Kosakovsky Pond SL. Datamonkey  2010: a suite of \nphylogenetic analysis tools for evolutionary biology. Bioinformatics. 2010 Oct \n1;26(19):2455 -7. \n118. Murrell B, Wertheim JO, Moola S, Weighill T, Scheffler K, Kosakovsky Pond SL. \nDetecting individual sites subject to episodic diversifying  selection. PLoS Genet. \n2012;8(7):e1002764.  \n119. Kadekoppala M, Holder AA. Merozoite surface proteins of the malaria parasite: the \nMSP1 complex and the MSP7 family. Int J Parasitol. 2010 Aug 15;40(10):1155 -61. \n120. Sjostrand J, Sennblad B, Arvestad L, Lage rgren J. DLRS: gene tree evolution in light \nof a species tree. Bioinformatics. 2012 Nov 15;28(22):2994 -5. \n121. Kauth CW, Woehlbier U, Kern M, Mekonnen Z, Lutz R, Mucke N, et al. Interactions \nbetween merozoite surface proteins 1, 6, and 7 of the malaria par asite Plasmodium \nfalciparum. J Biol Chem. 2006 Oct 20;281(42):31517 -27. \n122. Garcia Y, Puentes A, Curtidor H, Cifuentes G, Reyes C, Barreto J, et al. Identifying \nmerozoite surface protein 4 and merozoite surface protein 7 Plasmodium falciparum \nprotein fami ly members specifically binding to human erythrocytes suggests a new \nmalarial parasite -redundant survival mechanism. J Med Chem. 2007 Nov \n15;50(23):5665 -75. \n123. Pachebat JA, Ling IT, Grainger M, Trucco C, Howell S, Fernandez -Reyes D, et al. The \n22 kDa com ponent of the protein complex on the surface of Plasmodium falciparum \nmerozoites is derived from a larger precursor, merozoite surface protein 7. Molecular \nand biochemical parasitology. 2001 Sep 28;117(1):83 -9. \n124. Mello K, Daly TM, Morrisey J, Vaidya AB,  Long CA, Bergman LW. A multigene \nfamily that interacts with the amino terminus of plasmodium MSP -1 identified using \nthe yeast two -hybrid system. Eukaryot Cell. 2002 Dec;1(6):915 -25. \n125. Muehlenbein MP, Pacheco MA, Taylor JE, Prall SP, Ambu L, Nathan S, e t al. \nAccelerated diversification of nonhuman primate malarias in Southeast Asia: adaptive \nradiation or geographic speciation? Mol Biol Evol. 2015 Feb;32(2):422 -39. \n126. Carvalho LJ, Daniel -Ribeiro CT, Goto H. Malaria vaccine: candidate antigens, \nmechanism s, constraints and prospects. Scand J Immunol. 2002 Oct;56(4):327 -43. \n127. Jones TR, Hoffman SL. Malaria vaccine development. Clin Microbiol Rev. 1994 \nJul;7(3):303 -10. \n128. Escalante AA, Lal AA, Ayala FJ. Genetic polymorphism and natural selection in the \nmalaria parasite Plasmodium falciparum. Genetics. 1998 May;149(1):189 -202. \n129. Chenet SM, Tapia LL, Escalante AA, Durand S, Lucas C, Bacon DJ. Genetic diversity \nand population structure of genes encoding vaccine candidate antigens of Plasmodium \nvivax. Mala r J. 2012;11:68.  85 \n 130. Imwong M, Pukrittayakamee S, Gruner AC, Renia L, Letourneur F, Looareesuwan S, \net al. Practical PCR genotyping protocols for Plasmodium vivax using Pvcs and \nPvmsp1. Malar J. 2005 Apr 27;4:20.  \n131. Bruce MC, Galinski MR, Barnwell JW, S nounou G, Day KP. Polymorphism at the \nmerozoite surface protein -3alpha locus of Plasmodium vivax: global and local \ndiversity. Am J Trop Med Hyg. 1999 Oct;61(4):518 -25. \n132. Kosakovsky Pond SL, Frost SD. Not so different after all: a comparison of methods f or \ndetecting amino acid sites under selection. Mol Biol Evol. 2005 May;22(5):1208 -22. \n133. Murrell B, Moola S, Mabona A, Weighill T, Sheward D, Kosakovsky Pond SL, et al. \nFUBAR: a fast, unconstrained bayesian approximation for inferring selection. Mol Biol  \nEvol. 2013 May;30(5):1196 -205. \n134. Kosakovsky Pond SL, Posada D, Gravenor MB, Woelk CH, Frost SD. Automated \nphylogenetic detection of recombination using a genetic algorithm. Mol Biol Evol. \n2006 Oct;23(10):1891 -901. \n135. Bourgard C, Albrecht L, Kayano A,  Sunnerhagen P, Costa FTM. Plasmodium vivax \nBiology: Insights Provided by Genomics, Transcriptomics and Proteomics. Front Cell \nInfect Microbiol. 2018;8:34.  \n136. Moreno -Perez DA, Ruiz JA, Patarroyo MA. Reticulocytes: Plasmodium vivax target \ncells. Biol Cell . 2013 Jun;105(6):251 -60. \n137. Malleret B, Li A, Zhang R, Tan KS, Suwanarusk R, Claser C, et al. Plasmodium vivax: \nrestricted tropism and rapid remodeling of CD71 -positive reticulocytes. Blood. 2015 \nFeb 19;125(8):1314 -24. \n138. Patarroyo ME, Patarroyo MA. E merging rules for subunit -based, multiantigenic, \nmultistage chemically synthesized vaccines. Acc Chem Res. 2008 Mar;41(3):377 -86. \n139. Rodriguez LE, Curtidor H, Urquiza M, Cifuentes G, Reyes C, Patarroyo ME. Intimate \nmolecular interactions of P. falciparum  merozoite proteins involved in invasion of red \nblood cells and their implications for vaccine design. Chem Rev. 2008 \nSep;108(9):3656 -705. \n140. Moreno -Perez DA, Baquero LA, Chitiva -Ardila DM, Patarroyo MA. Characterising \nPvRBSA: an exclusive protein from P lasmodium species infecting reticulocytes. \nParasit Vectors. 2017 May 18;10(1):243.  \n141. Arevalo -Pinzon G, Bermudez M, Curtidor H, Patarroyo MA. The Plasmodium vivax \nrhoptry neck protein 5 is expressed in the apical pole of Plasmodium vivax VCG -1 \nstrain sch izonts and binds to human reticulocytes. Malar J. 2015 Mar 7;14:106.  \n142. Arevalo -Pinzon G, Bermudez M, Hernandez D, Curtidor H, Patarroyo MA. \nPlasmodium vivax ligand -receptor interaction: PvAMA -1 domain I contains the \nminimal regions for specific interact ion with CD71+ reticulocytes. Sci Rep. 2017 Aug \n30;7(1):9616.  \n143. Moreno -P\u00e9rez DA. Determinaci\u00f3n del proteoma de la cepa VCG1 de Plasmodium \nvivax y caracterizaci\u00f3n de mol\u00e9culas candidatas para su inclusi\u00f3n en el desarrollo de \nuna vacuna. Bogot\u00e1: Universid ad del Rosario y Universidad de Salamanca . 2017.  \n144. Escalante AA, Cornejo OE, Freeland DE, Poe AC, Durrego E, Collins WE, et al. A \nmonkey's tale: the origin of Plasmodium vivax as a human malaria parasite. Proc Natl \nAcad Sci U S A. 2005 Feb 8;102(6):1980 -5. \n145. Baquero LA, Moreno -Perez DA, Garzon -Ospina D, Forero -Rodriguez J, Ortiz -Suarez \nHD, Patarroyo MA. PvGAMA reticulocyte binding activity: predicting conserved 86 \n functional regions by natural selection analysis. Parasites & vectors. 2017 May \n19;10(1):25 1. \n146. Rodrigues -da-Silva RN, Soares IF, Lopez -Camacho C, Martins da Silva JH, Perce -da-\nSilva DS, Teva A, et al. Plasmodium vivax Cell -Traversal Protein for Ookinetes and \nSporozoites: Naturally Acquired Humoral Immune Response and B -Cell Epitope \nMapping i n Brazilian Amazon Inhabitants. Front Immunol. 2017;8:77.  \n147. Cheng Y, Lu F, Wang B, Li J, Han JH, Ito D, et al. Plasmodium vivax GPI -anchored \nmicronemal antigen (PvGAMA) binds human erythrocytes independent of Duffy \nantigen status. Sci Rep. 2016 Oct 19;6 :35581.  \n148. Bermudez M, Arevalo -Pinzon G, Rubio L, Chaloin O, Muller S, Curtidor H, et al. \nReceptor -ligand and parasite protein -protein interactions in Plasmodium vivax: \nAnalysing rhoptry neck proteins 2 and 4. Cell Microbiol. 2018 Jul;20(7):e12835.  \n \n \n 87 \n ANEXOS  \nAnexo  1. \u00c1rbol  filogen\u00e9tico de la familia msp3  \n \nLos genes ort\u00f3logos deben  agruparse en una relaci\u00f3n uno a uno. Se muestra s \u00f3lo el \u00e1rbol de la familia msp3, los \u00e1rboles restantes pueden ser consultados  en el Su plemento 2 d e la \npublicaci\u00f3n 1 (https://www.sciencedirect.com/science/article/pii/S156713481500163X ).  88 \n Anexo  2. Ventanas deslizantes  de la tasa \u03c9 (d N/dS o K N/KS) \n \nLa raz\u00f3n  dN/dS dentro P. vivax es mostrad a en azul, mientras la raz\u00f3n de la divergencia K N/KS entre P. vivax y P. cynomolgi , y entre P. vivax and P. knowlesi , es mostrada  en rojo \ny verde, respectivamente. S \u00f3lo se muestran las venta nas de los genes pv 41 y msp10, las ventanas deslizantes restantes pueden ser consultadas en el s uplemento 3 de la publicaci\u00f3n \n1 (https://www.sciencedirect.com/science/article/pii/S156713481500 163X ). En msp10, la regi\u00f3n 3\u2019 que mostr \u00f3 un \u03c9 < 1 codi fica para los dominios EGF -like, involucrados en \ninteracciones prote\u00edna -prote\u00edna.  89 \n Anexo  3. Filogenia de la familia msp7 inferida por el m\u00e9todo de m\u00e1xima verosimilitud  \n \nLos n \u00fameros (bas ados en los n\u00fameros de la Figura 7 ) representan los diferentes clados, mientras que los n\u00fameros en las ramas son los valores de l bootstrap y de la probabilidad \nposterior. Trece clados fueron identificados en el \u00e1rbol; sin embargo, los clados 1 y  6 no fueron claramente respaldados por los valores del bootstrap o los valores de \nprobabilidad posteriores. Las prote\u00ednas se agrupan de acuerdo con las relaciones filogen\u00e9ticas del par\u00e1sito, siendo los clado s 1 (rojo) y 2 (amarillo) los m\u00e1s ancestrales; el clado \n5 tambi\u00e9n podr\u00eda ser un cl\u00faster ancestral . Las secuencias de los  clados del linaje de par\u00e1sitos que infectan cercopit\u00e9cidos se representan en verde, las prote\u00ednas del linaje de \npar\u00e1sitos que infectan roedor es en azul y el linaje de par\u00e1sitos que in fectan hom\u00ednido s en gris. El grupo de prote\u00ednas en marr\u00f3n es un a duplicaci\u00f3n observada s \u00f3lo en l a especie P. \ninui. Tanto los \u00e1rboles ML como BY mostraron topolog\u00edas similares, por lo que  s\u00f3lo se muestra el \u00e1rbol ML.  90 \n Anexo  4. Venta na deslizante del gen pvron4  \n \nLos valores \u03c9 de ron4 (d N/dS) dentro de P. vivax se muestran en verde , mientras la tasa de divergencia \u03c9 (K N / KS) entre las especies que infectan primates y P. vivax se muestran \nen azul (para las especies evolutivamente m\u00e1s cercanas a P. vivax) y rojas (m\u00e1s distantes). Una representaci\u00f3n del gen ron4 se presenta debajo de la ventana deslizante que indica \nel p\u00e9ptido se\u00f1al (azul), la regi\u00f3n repetida (negra) y el  dominio putativo de esterasa /lipasa (p\u00farpura). Lo s SNP s identific ados en  P. vivax se mue stran como l\u00edneas discontinuas. La \nnumeraci\u00f3n est\u00e1 basa da en el alineamiento  del archivo adicional 2  de la Publicaci\u00f3n 6 . Los sitios bajo selecci\u00f3n negativa  est\u00e1n representados por l\u00edneas verdes claras (dentro de \nP. vivax) y verde os curo (entre las especies ), mientras que los sitios seleccionados positivamente entre especies se muestran por l\u00edneas rojas.  Detalles de esta figura pueden ser \nconsultado s en la Publicaci\u00f3n 6 ( https://malariajournal.biomedcentral.com/articles/10.1186/s12936 -016-1563 -4).  91 \n PUBLICACIONES  \n \nPublicaci\u00f3n 1:  Garz\u00f3n -Ospina D , Forero -Rodr\u00edguez J, Patarroyo MA.  Inferring natural \nselection signals in Plasmodium vivax -encoded pro teins having a potential role in \nmerozoite invasion . Infect Genet Evol. 2015 Jul; 33:182 -8. doi: \n10.1016/j.meegid.2015.05.001.  \n \nPublicaci\u00f3n 2:  Garz\u00f3n -Ospina D , Forero -Rodr\u00edguez J, Patarroyo MA.  Evidence of \nfunctional divergence in MSP7 paralogous proteins:  a molecular -evolutionary and \nphylogenetic analysis . BMC Evol Biol. 2016 Nov 28;16  (1):256.  doi: 10.1186/s12862 -016-\n0830 -x.  \n \nPublicaci\u00f3n 3: Forero -Rodr\u00edguez J, Garz\u00f3n -Ospina D , Patarroyo MA. Low genetic \ndiversity and functional constraint in loci encoding  Plasmodium vivax P12 and P38 \nproteins in the Colombian population . Malar J. 2014 Feb 18;13:58. doi: 10.1186/1475 -\n2875 -13-58. \n \nPublicaci\u00f3n 4: Forero -Rodr\u00edguez J,  Garz\u00f3n -Ospina D , Patarroyo MA.  Low genetic \ndiversity in the locus encoding the Plasmodium viva x P41 protein in Colombia's parasite \npopulation . Malar J. 2014 Sep 30;13:388. doi: 10.1186/1475 -2875 -13-388. \n \nPublicaci\u00f3n 5: Garz\u00f3n -Ospina D , Forero -Rodr\u00edguez J,  Patarroyo MA.  Heterogeneous \ngenetic diversity pattern in Plasmodium vivax genes encoding meroz oite surface proteins \n(MSP) -7E, -7F and -7L. Malar J. 2014 Dec 13;13:495. doi: 10.1186/1475 -2875 -13-495. \n \nPublicaci\u00f3n 6: Buitrago SP, Garz\u00f3n -Ospina D , Patarroyo MA.  Size polymorphism and low \nsequence diversity in the locus encoding the Plasmodium vivax rh optry neck protein 4 \n(PvRON4) in Colombian isolates . Malar J. 2016 Oct 18;15(1):501. doi: 10.1186/s12936 -\n016-1563 -4.  \n 92 \n Publicaci\u00f3n 7: Baquero LA, Moreno -P\u00e9rez DA, Garz\u00f3n -Ospina D , Forero -Rodr\u00edguez J, \nOrtiz -Su\u00e1rez HD, Patarroyo MA. PvGAMA reticulocyte binding activity: predicting \nconserved functional regions by natural selection analysis . Parasit Vectors. 2017 May \n19;10(1):251. doi: 10.1186/s13071 -017-2183 -8. \n \nPublicaci\u00f3n 8: Garz\u00f3n -Ospina D , Buitrago SP, Ramos AE, Patarroyo MA.  Ident ifying \nPotential Plasmodium vivax Sporozoite Stage Vaccine Candidates: An Analysis of Genetic \nDiversity and Natural Selection . Front Genet. 2018 Jan 25;9:10. \ndoi:10.3389/fgene.2018.00010.  \n \nPublicaci\u00f3n 9: Camargo -Ayala  PA, Garz\u00f3n -Ospina D , Moreno -P\u00e9rez DA , Ricaurte -\nContreras  LA, Noya  O and Patarroyo  MA. On the evolution and function of Plasmodium \nvivax reticulocyte binding surface antigen (pvrbsa) . Front. Genet. 2018 Sep . 9:372  doi: \n10.3389/fgene.2018.00372  Short communication\nInferring natural selection signals in Plasmodium vivax -encoded proteins\nhaving a potential role in merozoite invasion\nDiego Garz\u00f3n-Ospinaa,b, Johanna Forero-Rodr\u00edgueza, Manuel A. Patarroyoa,b,\u21d1\naMolecular Biology and Immunology Department, Fundaci\u00f3n Instituto de Inmunolog\u00eda de Colombia (FIDIC), Carrera 50 No. 26-20, Bogot\u00e1 DC, Colombia\nbBasic Sciences Department, School of Medicine and Health Sciences, Universidad del Rosario, Carrera 24 No. 63C-69, Bogot\u00e1 DC, Colombia\narticle info\nArticle history:\nReceived 5 February 2015Received in revised form 30 April 2015Accepted 2 May 2015\nAvailable online 2 May 2015\nKeywords:\nPlasmodium vivax\nAnti-malarial vaccine\nNatural selection signalAllele-speci\ufb01c responseabstract\nDetecting natural selection signals in Plasmodium parasites antigens might be used for identifying poten-\ntial new vaccine candidates. Fifty-nine Plasmodium vivax -Sal-I genes encoding proteins having a potential\nrole in invasion were used as query for identifying them in recent P. vivax strain genome sequences and\ntwo closely-related Plasmodium species. Several measures of DNA sequence variation were then calcu-\nlated and selection signatures were detected by using different approaches. Our results may be used\nfor determining which genes expressed during P. vivax merozoite stage could be prioritised for further\npopulation genetics or functional studies for designing a P. vivax vaccine which would avoid\nallele-speci\ufb01c immune responses.\n/C2112015 Elsevier B.V. All rights reserved.\n1. Introduction\nMalaria is a disease caused by Plasmodium parasites ( Cox, 2010 ).\nPlasmodium falciparum is the best characterised species, whereas\nresearch into Plasmodium vivax has been more limited ( Arnott\net al., 2012; Patarroyo et al., 2012 ). Likewise, anti- P. vivax vaccine\ndevelopment is behindhand and few vaccine candidates have been\nproposed to date. Characterising potential new candidates\ninvolved the search for sequences having a high level of identity\nwith P. falciparum antigens ( Patarroyo et al., 2012 ). Recently,\nRestrepo-Montoya et al. (2011) has led to categorising several P.\nvivax proteins having a potential role in invasion by bioinformatics\napproaches.\nThe proteins characterised in the aforementioned studies could\nbe used for P. vivax asexual-blood vaccine development since they\nseem to be implicated in invasion; however, these molecules\u2019\ngenetic diversity and evolutionary forces must be ascertained by\npopulation genetics analysis to design a completely effective vac-\ncine ( Arnott et al., 2012; Barry and Arnott, 2014 ). The most com-\nmonly used tests in population genetics are based on the allelefrequency spectrum and require the sequencing of many isolates;\ntherefore, performing such studies for all these genes wouldinvolve much time and resources. However, Cornejo et al. (2014) ,\nusing a limited sample size (Genomes from 5 isolates) have identi-\n\ufb01ed genes having signatures consistent with selection. This kind of\nanalysis could be a starting point for detecting potential new vac-\ncine candidates ( Weedall and Conway, 2010 ), similar to the\napproach adopted for P. falciparum (Ochola et al., 2010; Tetteh\net al., 2009 ).\nThe present study has used three different approaches for\ndetecting selection signals within 59 previously-characterised\nmerozoite antigens using the sequences from \ufb01ve P. vivax isolates\nand two closely-related species. The results may be used fordetermining which antigens might be prioritised and evaluated\nin further studies aimed at designing a completely effective\nvaccine.\n2. Material and methods\n2.1. Target sequences and alignments\nSequences were obtained for 59 protein-encoding genes from\nthe Salvador I isolate (Sal-I); these genes had been previously char-acterised by adopting a molecular approach ( Arevalo-Pinzon et al.,\n2011, 2013; Moreno-Perez et al., 2013b; Patarroyo et al., 2012 )o r\nsuggested as promising vaccine candidates by having a potential\nrole in invasion ( Restrepo-Montoya et al., 2011 )(Supplementary\ndata 1 ). Forty-eight genes had not been subjected to previous pop-\nulation genetic analysis and 11 have been previously evaluated.\nhttp://dx.doi.org/10.1016/j.meegid.2015.05.001\n1567-1348/ /C2112015 Elsevier B.V. All rights reserved.\u21d1Corresponding author at: Molecular Biology and Immunology Department,\nFundaci\u00f3n Instituto de Inmunolog\u00eda de Colombia (FIDIC), Carrera 50 No. 26-20,\nBogot\u00e1 DC, Colombia.\nE-mail addresses: degarzon@gmail.com (D. Garz\u00f3n-Ospina), lady2007_10@\nhotmail.com (J. Forero-Rodr\u00edguez), mapatarr.\ufb01dic@gmail.com (M.A. Patarroyo).Infection, Genetics and Evolution 33 (2015) 182\u2013188\nContents lists available at ScienceDirect\nInfection, Genetics and Evolution\njournal homepage: www.else vier.com/locate/meegid\nThese sequences were used as query for searching for them in the\navailable genomic P. vivax isolate sequences ( Neafsey et al., 2012 )\nand two closely-related species ( Plasmodium cynomolgi and\nPlasmodium knowlesi )(Pain et al., 2008; Tachibana et al., 2012 ) using\nthe tBlastn tool from the protozoa genomic NCBI database. A tBlastnsearch in GenBank database was made regarding sequences\nreported for other stains (VCG-I, Belen or South Korea).\nSome genes belong to multigene families; therefore orthologous\nidenti\ufb01cation should be performed. A combination of criteria was\nused for identifying putative orthologues, including a phylogenetic\nsignal (tree topology), sequence similarity (genetic distance) and\nsynteny (similar genomic position), as previously described\n(Arisue et al., 2011; Garzon-Ospina et al., 2010, 2014; Rice et al.,\n2014 ).P. vivax ,P. cynomolgi and P. knowlesi sera ,msp-3 ,msp-7 ,clag,\npfam-a and pfam-d genes were aligned with all members of their\nfamilies, respectively using MUSCLE ( Edgar, 2004 ), followed by\nmanual edition. The best evolutionary model was selected for eachalignment by Bayesian Information Criterion, using MEGA software\n(Tamura et al., 2011 ). Maximum likelihood phylogenetic trees\nwere then inferred using the respective model; all gaps andambiguously-aligned regions were removed. Topology reliability\nwas evaluated by bootstrapping (1000 iterations). Multiple align-\nments were then made (by MUSCLE) for single-copy genes using\nsequences from isolates, together with P. cynomolgi and P. knowlesi\northologous sequences.\n2.2. Genetic diversity and natural selection analysis\nDnaSP software ( Librado and Rozas, 2009 ) was used for estimat-\ning several measures regarding DNA sequence variation. Cornejo\net al. (2014) had previously identi\ufb01ed patterns consistent with nat-\nural selection acting across the P. vivax genome by using the\ntwo-dimensional Hudson, Kreitman and Aguade (HKA) test, thegenome-wide version of the McDonald\u2013Kreitman (MK) test and\nTajima D estimator; however, natural selection signals were not\nfound for several genes involved in merozoite invasion. We\nassessed natural selection by conventional MK test ( McDonald\nand Kreitman, 1991 ) and\np/Kratio. The MK test was performed tak-\ning the Jukes\u2013Cantor divergence correction into account ( Jukes,\n1969 ) by using a web server ( Egea et al., 2008 ). The p/Kratio\nwas evaluated for identifying genes having a high value correlated\nwith balancing selection ( Ochola et al., 2010; Tetteh et al., 2009 ).\nMEGA software was used to assess selection signals within P. vivax\nby calculating the non-synonymous substitution per site rate ( dN)\nand synonymous substitution per site rate ( dS) by the modi\ufb01ed\nNei\u2013Gojobori method ( Zhang et al., 1998 ). Likewise, to infer natu-\nral selection signatures which could have prevailed duringPlasmodium evolutionary history (using P. vivax ,P. cynomolgi and\nP. knowlesi sequences as data set) the difference between the aver-\nage number of non-synonymous divergence substitutions per\nnon-synonymous site rate and of synonymous divergence substi-\ntutions per synonymous site rate ( K\nN\u2013KS) was inferred using the\nmodi\ufb01ed Nei\u2013Gojobori method with Jukes\u2013Cantor correction.Signi\ufb01cant differences were evaluated by Z-test (when\nnon-synonymous and synonymous substitutions > 10) or Fisher\u2019sexact test (when non-synonymous and synonymous substitu-\ntions < 10). Furthermore, a sliding window for d\nN/dSand KN/KS\nratios ( x) was performed; gaps and ambiguously aligned regions\nwere removed for analysis. Genetic diversity and selection were\nassessed by Sal-I annotation as reference.\nThe most suitable antigens for vaccine development regarding\nour approach should have limited diversity or at least a domain\nhaving this pattern. Such genes/domains should have a natural\nnegative selection signal (and x< 1). However, genes underpositive selection might be taken into account if provided with\ndomains having both limited diversity and low xvalues.\n3. Results\n3.1. Diversity analysis\nSequences from 59 previously identi\ufb01ed P. vivax\nprotein-encoding genes having a potential role in invasion wereanalysed here. Sequence analysis revealed premature stop codons\nin PVX_096990 and PVX_097710 genes in Mauritania-I and\nBrazil-I isolates, respectively. Few genes were absent or incomplete\nin some isolates; i.e. the PVX_003825 gene was not found in a North\nKorean isolate whereas PVX_092425 was incomplete at the 5\n0-end,\nPVX_086850 and PVX_086930 were missing in the Brazil-Iisolate, PVX_097700 was absent in the Mauritania-I isolate and\nPVX_097710 appeared not to be present in the India-VII isolate in\nwhich the PVX_096990 gene was incomplete at the 5\n0-end.\nGenetic diversity measurement revealed 16 highly polymorphic\ngenes ( p> 0.01), 35 with intermediate polymorphism\n(0.009 < p> 0.001) and 8 having low genetic diversity ( p< 0.001)\n(Table 1 and Supplementary data 1 ).Fig. 1 shows the nucleotide\npolymorphism distribution within the aforementioned 59 genes.\nPhylogenetic trees were then inferred to determinate\nputative orthologous relationships for the multigene families(Supplementary data 2 ). Putative orthologues had to be clustered\nin a clade in a one-to-one relationship and had to have a similar\ngenomic position. The clades formed in some families agreed with\nprevious reports ( Arisue et al., 2011; Garzon-Ospina et al., 2010;\nRice et al., 2014 ). Hence, 34 of these 59 genes were found in both\nP. cynomolgi and P. knowlesi species, whereas another 15 genes\nwere only present in P. cynomolgi ; 10 genes appeared to be exclu-\nsive to P. vivax .\n3.2. Natural selection signatures in P. vivax genes\nThree different approaches were used for screening natural\nselection signals. The neutral index (NI) from the MK test showed\nthat 16 genes had excess polymorphism regarding divergence\n(NI > 1) and only one had NI < 1, while the p/Kratio showed 11\ngenes which might be under balancing selection ( Table 2 and\nSupplementary data 1 ).\nA statistically signi\ufb01cant dN>dSwas found in 12 genes while 9\nhad signi\ufb01cant dN<dSvalues ( Table 2 and Supplementary data 1 ).\nThe KN\u2013KSdifference gave negative selection between species for\n35 genes whereas another 10 displayed positive selection\n(Supplementary data 1 ). Some genes had a different natural selec-\ntion signal from that previously reported ( Tachibana et al., 2012 ),\nprobably since we used sequences from 5 isolates, unlike\nTachibana et al., who only used the Sal-I isolate. Some genes eval-\nuated here were not assessed in the aforementioned report.\nSince the Nei\u2013Gojobori method is a conservative test, we per-\nformed a sliding window for the xrate ( dN/dSand/or KN/KS) for\nidentifying speci\ufb01c domains within genes having a determined\nselective signal ( Supplementary data 3 ). Several genes lacking sig-\nni\ufb01cant dNordSrates displayed a particular domain having\ndN/dS\u00b1 1 but also KN/KS< 1 throughout sequences. Members of\npvmsp-3 and pvsera multigene families had KN/KS> 1 values\nthroughout all genes, suggesting high divergence between P. vivax\nand related species.\n4. Discussion\nA vaccine focusing on P. vivax is urgently needed for malaria\ncontrol; however, its design has been delayed, mainly due to slowD. Garz\u00f3n-Ospina et al. / Infection, Genetics and Evolution 33 (2015) 182\u2013188 183antigen characterisation. Natural selection signatures found in\nantigens could be a starting point for identifying potential new\nvaccine candidates ( Arnott et al., 2012; Ochola et al., 2010;\nSuzuki, 2006; Tetteh et al., 2009; Weedall and Conway, 2010 ).\nThe MK and HKA tests assume that most accumulated diversity fol-\nlows the neutral model (mainly affected by demographic effects)and this would lead to identifying genes departing from this pat-\ntern as being under selection ( Cornejo et al., 2014 ).Cornejo et al.\n(2014) found P. vivax genes under positive selection by using mod-\ni\ufb01ed versions of the aforementioned tests; however, most genes\nfound are not involved in host\u2013merozoite interactions and could\nnot therefore be used in vaccine development.Table 1\nMeasurement of DNA sequence variation for the 59 P. vivax genes.\n# ID Name n Sites Ss SP s p(SD)\nGenes lacking previous population genetics analysis\n1 PVX_000945 pvron-1 6 2340 5 3 2 0.0096 (0.0001)\n2 PVX_000995 pv41 6 1086 14 5 9 0.0064 (0.0013)\n3 PVX_002510 Nucleosomal binding protein 1 5 750 2 1 1 0.0013 (0.0003)\n4 PVX_003800 pvsera 5 3033 4 4 0 0.0005 (0.0005)\n5 PVX_003805 pvsera , putative 5 3507 436 195 241 0.0728 (0.0100)\n6 PVX_003815 pvsera , truncated, putative 5 1335 15 12 3 0.0049 (0.0014)\n7 PVX_003825 pvsera-4 4 2814 144 113 31 0.0282 (0.0072)\n8 PVX_003830 pvsera-5 6 3090 752 528 224 0.1038 (0.0222)\n9 PVX_003850 pvsera-2 6 3042 12 9 3 0.0016 (0.0004)\n10 PVX_080305 Hypothetical protein, conserved 5 804 1 1 0 0.0005 (0.0003)\n11 PVX_081810 Hypothetical protein, conserved 5 3921 18 15 3 0.0020 (0.0004)12 PVX_081845 Hypothetical protein 5 1044 3 1 2 0.0015 (0.0003)13 PVX_084720 Hypothetical protein, conserved 5 2720 9 5 4 0.0016 (0.0003)14 PVX_086850 pvvir-35 , putative 4 662 40 19 21 0.0360 (0.0090)\n15 PVX_086930 pvrhopH1/clag 5 3978 38 30 8 0.0043 (0.0010)\n16 PVX_090075 pv34 6 1092 1 1 0 0.0003 (0.0003)\n17 PVX_090210 pvarp 7 682 6 5 1 0.0029 (0.0007)\n18 PVX_091434 pvron-4 6 2097 14 5 9 0.0033 (0.0007)\n19 PVX_092425 Hypothetical protein, conserved 4 1950 25 25 0 0.0070 (0.0032)\n20 PVX_092975 Erythrocyte binding protein 1 6 3440 36 31 5 0.0038 (0.0009)\n21 PVX_092995 Tryptophan-rich antigen 5 1059 25 19 6 0.0105 (0.0036)22 PVX_094425 Hypothetical protein, conserved 5 3045 3 2 1 0.0005 (0.0001)\n23 PVX_096990 Pv-fam-d protein 5 1136 22 12 10 0.0095 (0.0022)\n24 PVX_097565 Plasmodium exported protein 5 1311 6 6 0 0.0018 (0.0003)\n25 PVX_097670 pvmsp-3\nc, putative 6 1743 524 282 242 0.1408 (0.0154)\n26 PVX_097675 pvmsp-3 c, putative 5 1758 445 281 164 0.1268 (0.0229)\n27 PVX_097695 pvmsp-3 a, putative 5 2613 424 240 184 0.0817 (0.0126)\n28 PVX_097700 pvmsp-3 , putative 4 3306 770 577 201 0.1332 (0.0245)\n29 PVX_097705 pvmsp-3 a, putative 5 2607 440 264 176 0.0841 (0.0110)\n30 PVX_097710 pvmsp-3 , putative 5 3607 867 506 361 0.1229 (0.0185)\n31 PVX_097715 pvmsp-3 , putative 5 1286 49 42 7 0.0163 (0.0034)\n32 PVX_097960 pv38 6 1065 4 0 4 0.0022 (0.0004)\n33 PVX_098585 pvrbp-1 , putative 6 8451 39 22 17 0.0020 (0.0003)\n34 PVX_098712 pvrhopH3 6 2 6 7 3431 0.0006 (0.0002)\n35 PVX_101505 Pv-fam-d protein 5 126 3523 0.0021 (0.0004)\n36 PVX_101555 Hypothetical protein 5 2586 167 98 69 0.0337 (0.0081)37 PVX_101605 Hypothetical protein 5 582 3 0 3 0.0031 (0.0030)\n38 PVX_109280 pvfam-a 7 753 1 1 0 0.0004 (0.0003)\n39 PVX_112665 Tryptophan-rich antigen 5 867 3 1 2 0.0018 (0.0004)\n40 PVX_113775 pv12 7 942 4 2 1 0.0014 (0.0006)\n41 PVX_117230 pvser/thr 5 4 1 2 2532 0.0006 (0.0001)\n42 PVX_117880 pvron-2 7 6495 31 23 8 0.0016 (0.0003)\n43 PVX_118525 Hypothetical protein, conserved 5 5082 19 13 6 0.0017 (0.0004)\n44 PVX_121885 pvclag , putative 5 4239 63 44 19 0.0069 (0.0010)\n45 PVX_121920 pvrbp-2 , like 5 7461 31 15 16 0.0021 (0.0003)\n46 PVX_123105 Hypothetical protein, conserved 5 2114 1 1 0 0.0002 (0.0001)47 PVX_123550 Hypothetical protein, conserved 5 647 4 3 1 0.0027 (0.0006)48 PVX_123575 Thrombospondin-related protein 3 6 966 3 2 1 0.0012 (0.0004)\nGenes having previous population genetics analysis\n1 PVX_003905 pv230 , putative 5 8199 22 14 8 0.0013 (0.0002)\n2 PVX_082695 pvmsp-7K , putative 6 849 7 5 2 0.0033 (0.0006)\n3 PVX_085930 pvrap-1 , putative 5 2223 2 2 0 0.0003 (0.0002)\n4 PVX_092275 pvama-1 6 1683 31 18 13 0.0080 (0.0010)\n5 PVX_097590 pvrap-2 , putative 5 1203 0 0 0 0.0000 (0.0000)\n6 PVX_097625 pvmsp-8 6 1320 6 3 3 0.0021 (0.0006)\n7 PVX_097720 pvmsp-3\na 6 2016 154 72 82 0.0349 (0.0158)\n8 PVX_097680 pvmsp-3 b 6 2007 329 165 164 0.0747 (0.0094)\n9 PVX_099980 pvmsp-1 6 5058 532 170 362 0.0527 (0.0068)\n10 PVX_110810 pvdbp 6 3210 45 23 22 0.0063 (0.0010)\n11 PVX_114145 pvmsp-10 6 1288 5 0 5 0.0021 (0.0003)\nn: number of sequences analysed; sites: total sites analysed, excluding gaps; Ss: number of segregating sites; S: number of singleton sites; Ps: number of informative-\nparsimonious sites; p: nucleotide diversity per site; SD: standard deviation. The data reported here showed that several genes had limited diversity; however, global P. vivax\nparasite populations are not equivalent and new allele variants could exist. Population genetics analysis of different populations should thus be p erformed for evaluating the\nextent of genetic diversity in natural isolates.184 D. Garz\u00f3n-Ospina et al. / Infection, Genetics and Evolution 33 (2015) 182\u2013188The 59 genes evaluated here did not display selection signa-\ntures in the report mentioned above; however, according to the\np/Kratio and conventional MK tests, 11 and 16 protein-encoding\ngenes, respectively ( Table 2 and Supplementary data 1 ) appeared\nbe under balancing selection, suggesting that they are immune sys-\ntem targets and could thus be evaluated as vaccine candidates.\nHowever, high protein polymorphism within some of them would\nreduce vaccine effectiveness due allele-speci\ufb01c immune responses.\nOnly 7 genes showed balancing selection signals by both p/K\nand MK tests. Low correlation between them has previously been\nshown ( Tetteh et al., 2009 ), suggesting that the MK test had low\npower for detecting balancing selection ( Tetteh et al., 2009;\nWeedall and Conway, 2010 ). Such low power could be due to the\neffect of weak negative selection thereby leading to excess poly-morphism, but just at low frequencies ( Fay et al., 2002 ).\nHowever, our statistical results showed that the NI (or(Pn/Ps)/(Dn/Ds)) for several genes mainly re\ufb02ected a high number\nof synonymous substitutions between species (Ds) rather than a\nhigh Pn, lowering Dn/Ds and thus increasing NI. This implied that\nthe major factor in causing NI > 1 could was not balancing selection\nwithin species but long-term purifying selection (between spe-\ncies). This interpretation was supported by the fact that we also\nfound low\nxvalues and negative statistical signi\ufb01cant values for\ntheKN\u2013KStest. The high synonymous substitution number found\nbetween species and the low xvalues thus suggested that evolu-\ntion had ensured that protein sequences remained conserved in\nboth species by \ufb01xing substitutions (after speciation) which did\nnot alter the amino acids; a functional/structural constraint would\nthen have been likely. Therefore, some genes could not have been\nsubject to balancing selection but rather negative selection. Both\nkinds of selection might be important for vaccine development.\nBalancing selection detected parasite antigens subject to immunepressure whereas negative selection identi\ufb01ed genes having func-\ntional constraint which could avoid allele-speci\ufb01c responses.\nAccording to dNand dSresults, 12 genes had positive selection\nsignals, 9 were under negative selection and neutrality could notbe ruled out for the remaining genes. This suggested that genes\nsuch as pvsera-5 ,pvvir-35 , members of pvmsp-3 family, pvrbp-1 ,\nPVX_092995 and PVX_101555 appeared to be under immune pres-sure, \ufb01xing or accumulating several non-synonymous mutations as\nan evasion mechanism. Vaccine effectiveness would thus be\nreduced due to their high polymorphism.\nThe negatively selected genes found could be taken into account\nfor vaccine development ( Mazumder et al., 2007; Pacheco et al.,\n2012; Suzuki, 2004, 2006 ). Genes such as pv41 , PVX_092425,\npvclag (PVX_121885) or pvmsp-10 could be good vaccine candi-\ndates since negative selection might be a consequence of func-tional constraints within them, conserving the encoded protein\nand therefore allele-speci\ufb01c immune responses could thus be\navoided. Although some genes had negative selection signatures,\nsuch as pvsera (PVX_003825) and pvmsp-3 (PVX_097715), they\nwere high polymorphic at protein level, therefore making themunsuitable as candidates. This result could have been due to differ-\nent selective pressure acting on the above genes. Some regions\ncould be under negative selection but others accumulated\nnon-synonymous substitution as an immune evasion mechanism.\nSince selective pressures (or functional/structural constraint)\nare not the same throughout a full encoded protein sequence, sev-eral genes under selection might not have been found as the Nei\u2013\nGojobori method is a conservative test (as are the HKA and MK\ntests). Regardless of such dif\ufb01culties, a sliding window for the\nd\nN/dSratio would allow speci\ufb01c domains to be identi\ufb01ed within\ngenes where the non-synonymous and synonymous substitutionswere accumulated at different rates and therefore different kinds\nFig. 1. Polymorphism distribution within the 59 Plasmodium vivax genes studied here. Codons having non-synonymous (red) and synonymous (orange) mutations are shown\nwith vertical lines above each gene. Signal peptide-encoding regions (blue), predicted transmembrane helices or GPI anchors (green), s48/45 domai ns (dark cyan) and regions\nhaving INDELs (insertion and/or deletions (black)) are indicated.D. Garz\u00f3n-Ospina et al. / Infection, Genetics and Evolution 33 (2015) 182\u2013188 185Table 2\nNucleotide diversity and divergence ratios ( p/K), McDonald\u2013Kreitman index (neutral index: NI) and non-synonymous ( dN) and synonymous ( dS) rates for 59 P. vivax genes.\n# ID Name Pcyn Pkno Pcyn Pkno dN(SE) dS(SE)\np/K p/K NI p-Value NI p-Value\nGenes lacking previous population genetics analysis\n2 PVX_000995 pv41 0.045 0.033 3.218 0.031 2.960 0.044 0.0052 (0.0022) 0.0098 (0.0041)*\n4 PVX_003800 Pvsera 0.003 0.002 0.781 0.831 2.476 0.507 0.0002 (0.0002) 0.0014 (0.0008)/C224\n5 PVX_003805 pvsera , putative 0.325 \u2013 2.592 0.000 \u2013 \u2013 0.0729 (0.0046) 0.0725 (0.0060)\n7 PVX_003825 pvsera-4 0.164 \u2013 2.949 0.000 \u2013 \u2013 0.0257 (0.0027) 0.0347 (0.0044)/C160\n8 PVX_003830 pvsera-5 \u2013 \u2013 \u2013 \u2013 \u2013 \u2013 0.1028 (0.0048)/C150.0791 (0.0057)\n11 PVX_081810 Hypothetical protein, conserved 0.024 0.014 2.014 0.158 2.069 0.165 0.0015 (0.0005) 0.0032 (0.0011)/C224\n13 PVX_084720 Hypothetical protein, conserved 0.008 0.006 10.919 0.000 8.928 0.000 0.0020 (0.0007) 0.0006 (0.0005)14 PVX_086850 pvvir-35 , putative 0.265 \u2013 1.335 0.552 \u2013 \u2013 0.0407 (0.0071)\n**0.0240 (0.0081)\n15 PVX_086930 pvrhopH1/clag 0.032 0.023 9.252 0.000 10.703 0.000 0.0048 (0.0010) 0.0029 (0.0011)\n18 PVX_091434 pvron-4 0.021 0.016 3.262 0.024 0.649 0.465 0.0032 (0.0014) 0.0037 (0.0016)\n19 PVX_092425 Hypothetical protein, conserved 0.066 0.048 0.591 0.238 0.709 0.420 0.0045 (0.0015) 0.0104 (0.0028)e\n21 PVX_092995 Tryptophan-rich antigen 0.057 \u2013 Null 0.027 \u2013 \u2013 0.0142 (0.0032)/C150.0000 (0.0000)\n25 PVX_097670 pvmsp-3 c, putative 0.756 \u2013 1.499 0.092 \u2013 \u2013 0.1601 (0.0074)/C150.0906 (0.0080)\n26 PVX_097675 pvmsp-3 c, putative 0.615 \u2013 1.556 0.031 \u2013 \u2013 0.1412 (0.0072)/C150.0880 (0.0082)\n27 PVX_097695 pvmsp-3 a, putative \u2013 \u2013 \u2013 \u2013 \u2013 \u2013 0.0885 (0.0048)e0.0689 (0.0059)\n28 PVX_097700 pvmsp-3 , putative \u2013 \u2013 \u2013 \u2013 \u2013 \u2013 0.1397 (0.0054)e0.1160 (0.0074)\n29 PVX_097705 pvmsp-3 a, putative \u2013 \u2013 \u2013 \u2013 \u2013 \u2013 0.0864 (0.0047)/C2240.0705 (0.0062)\n30 PVX_097710 pvmsp-3 , putative \u2013 \u2013 \u2013 \u2013 \u2013 \u2013 0.1359 (0.0055)/C150.0956 (0.0059)\n31 PVX_097715 pvmsp-3 , putative 0.077 0.049 0.647 0.337 0.973 0.956 0.0136 (0.0024) 0.0225 (0.0050)/C160\n33 PVX_098585 pvrbp-1 , putative 0.014 \u2013 2.441 0.056 \u2013 \u2013 0.0024 (0.0004)/C1600.0008 (0.0004)\n36 PVX_101555 Hypothetical protein 0.263 \u2013 2.115 0.003 \u2013 \u2013 0.0401 (0.0040)/C150.0169 (0.0031)\n40 PVX_113775 pv12 0.006 0.005 Null 0.002 Null 0.000 0.0020 (0.0010) 0.0000 (0.0000)\n41 PVX_117230 pvser/thr 0.007 0.004 0.389 0.384 0.430 0.438 0.0001 (0.0001) 0.0018 (0.0009)e\n42 PVX_117880 pvron-2 0.011 0.008 4.859 0.000 4.507 0.000 0.0016 (0.0004) 0.0016 (0.0006)\n43 PVX_118525 Hypothetical protein, conserved 0.014 0.009 1.125 0.877 1.479 0.395 0.0013 (0.0004) 0.0030 (0.0010)e\n44 PVX_121885 pvclag , putative 0.096 \u2013 0.966 0.904 \u2013 \u2013 0.0059 (0.0011) 0.0095 (0.0019)e\n47 PVX_123550 Hypothetical protein, conserved 0.048 0.029 9.062 0.025 2.437 0.376 0.0016 (0.0011) 0.0059 (0.0041)\nGenes having previous population genetics analysis\n1 PVX_003905 pv230 0.005 0.004 2.700 0.025 2.300 0.093 0.0012 (0.0004) 0.0016 (0.0006)\n4 PVX_092275 pvama-1 0.056 0.045 6.923 0.000 4.876 0.000 0.0066 (0.0017) 0.0085 (0.0029)\n7 PVX_097720 pvmsp-3 a 0.259 \u2013 0.571 0.030 \u2013 \u2013 0.0324 (0.0035) 0.0416 (0.0054)/C160\n8 PVX_097680 pvmsp-3 b 0.533 \u2013 1.312 0.254 \u2013 \u2013 0.0819 (0.0051)/C1600.0558 (0.0063)\n9 PVX_099980 pvmsp-1 0.274 0.203 2.300 0.000 2.744 0.000 0.0485 (0.0028) 0.0464 (0.0037)\n10 PVX_110810 Pvdbp 0.050 0.015 2.924 0.013 3.228 0.005 0.0074 (0.0012) 0.0032 (0.0013)\n11 PVX_114145 pvmsp-10 0.010 0.006 0.289 0.252 0.801 0.856 0.0011 (0.0008) 0.0046 (0.0025)*\n\u2013: value could not be estimated because orthologous sequences were not found; null: neutral index (NI) could not be estimated due to neutral (or non-ne utral) polymorphism being equal to 0; SE: standard error; Pcyn: value\nobtained by comparison with Plasmodium cynomolgi ; Pkno: value obtained by comparison with Plasmodium knowlesi . The NI and p-value for pv230 ,pvmsp-1 and pvama-1 could not be estimated in the web server; therefore they\nwere calculated with DnaSP, which did not consider the Jukes\u2013Cantor divergence correction.Only genes having a natural selection signal are shown.\n*p< 0.06.\n**p< 0.05.\n/C224p< 0.04.\nep< 0.01.\n/C160p< 0.002.\n/C15p< 0.0001.186 D. Garz\u00f3n-Ospina et al. / Infection, Genetics and Evolution 33 (2015) 182\u2013188of selection could be assumed (e.g. positive: x> 1, negative:\nx< 1). Hence, although a particular gene might have either high\ndiversity or/and positive selection, they could have functional\ndomains under constraint and thus vaccine development should\nbe focused on such domains ( Richie and Saul, 2002 ).\nSliding window analysis revealed that several genes lacking sig-\nni\ufb01cant dNordSvalues had x> 1 domains whilst others had x<1 .\nAccording to our results, pvama- 1 had dN=dS; however, some\ndomains had a high dN/dSratio (>2 from nucleotides 120 to 139,\n370 to 434, 810 to 849, 1115 to 1174 and 1290 to 1329), therebyagreeing with a previous report ( Gunasekera et al., 2007 ). Low\nK\nN/KSratios were found throughout the entire sequence\n(Supplementary data 2 ); consequently, the non-synonymous sub-\nstitutions \ufb01xed in domains having dN/dS> 1 could facilitate\nimmune evasion while conserved regions (having low xvalues)\nmight have functional constrains due to their interaction with\nRON proteins ( Vulliez-Le Normand et al., 2012 ) or host cells\n(Kato et al., 2005 ).pv230 had neither signi\ufb01cant dNordSrates, in\nspite of negative selection having been reported ( Doi et al.,\n2011 ).dN/dSvalues above 1 were found in this gene (nucleotides\n509\u2013605 and 1256\u20131280), suggesting that dNwas higher than dS\nin these regions, whereas the remaining gene regions having\nx< 1 might have been under negative selection due to the pres-\nence of the s48/45 domains which are involved in invasion(Garcia et al., 2009 ).\nRegarding pvmsp-10 , the sliding window gave high divergence\n(KN/KS> 1) at the 50-end unlike 3 \u2019-end which had low divergence\n(KN/KS< 1). It has been previously shown that polymorphism is\nmainly found at the 50-end ( Pacheco et al., 2012 ), whereas the\n30-end (encoding EGF-like domains) is high conserved within\n(Garzon-Ospina et al., 2011 ) and between ( Pacheco et al., 2012 )\nspecies, probably because this region is the functional one(Pacheco et al., 2012 ).pvmsp-1 has similar behaviour; functional\nbinding regions have been reported for its encoded protein(Rodriguez et al., 2002 ). This gene had d\nN=dSand high divergence\nbetween P. vivax and closely-related species ( Supplementary data\n2). However, the peptides involved in binding to target cells mostly\nhad low xvalues ( Supplementary data 4 ). Accord to these results\n(and the aforementioned ones for pvama-1 and pv230 ), we thus\nhypothesise that functionally important regions (e.g. thoseinvolved in binding to target cells) would consist of \ufb01xed synony-\nmous substitutions (after speciation) producing low\nx(dN/dS\nand/or KN/KS) values. Thus, regions having low xvalues would\nbe highly conserved, likely due to them being under functional\nconstraint. Consequently, these regions could be considered for\nvaccine development to avoid allele-speci\ufb01c immune responses.\nThe above genes have been previously evaluated by population\ngenetics and some of them are considered vaccine candidates. Wethus searched for similar patterns in genes which have not previ-\nously been studied. pvron-2 and pvron-4 had regions having\nx> 1 (1.4, nucleotides 1893\u20131932 and 2.4, nucleotides 766\u2013877,\nrespectively) suggesting that these could be targets for immune\nresponses. However, the 30-ends in both genes had low divergence\n(x< 0.6). Thus, the C-terminus of PvRON-2 and PvRON-4 proteins\nmight have been subject to functional constraint and would thus\nmake them potential vaccine candidates for avoiding\nallele-speci\ufb01c immune responses. Further analysis should be per-\nformed to evaluate whether these regions are involve in parasite\ninteraction.\nGenes such as pv41 ,pvfam-d ,pv38 , PVX_101605, pvclag and\npvrbp-2 like had low diversity and had a region having dN/dSvalues\naround 0.4 or near to 1 ( Supplementary data 3 ). Regarding the\nin\ufb02uenza virus, a dN/dSlarger that 0.3 is associated with escape\nmutants ( Suzuki, 2006 ); consequently, these particular domains\ncould have been the outcome of immune pressure whereas theremaining gene sequences were conserved within and between\nspecies. An interesting pattern was observed in 6-cystein proteinfamily members ( pv12 ,pv41 and pv38 ); they are immune system\ntargets ( Chen et al., 2010; Mongui et al., 2008; Moreno-Perez\net al., 2013a ) but have low genetic diversity and d\nS>dN(not signif-\nicant). Nevertheless, all these genes had an excess of synonymoussubstitutions between species, providing signi\ufb01cant values by MK\ntest and low K\nN/KSratios. These results suggested that the encoded\nprotein sequences might be subject to functional/structural con-straint since there was low divergence between P. vivax and P.\ncynomolgi (or P. knowlesi ); thus, proteins\u2019 biological structures\nencoded by these genes have been maintained in the long-term\nand, consequently, NI > 1 could have resulted from negative selec-\ntion. Hence, similar to pv230 (Doi et al., 2011 ), these 6-cystein pro-\ntein family members might be subject to negative selection due to\nfunctional/structural constraint, since s48/45 domains are present,\nmaking them attractive vaccine candidates.\nProteins encoded by pvrhopH1/clag ,pvser/thr , PVX_081810 and\nPVX_092425 genes could also be considered for a vaccine. These\ngenes had limited diversity, displayed negative selection signa-\ntures and domains having low KN/KSratios. pvrhopH1/clag had little\ndivergence for almost all sequences at the 50-end. pvser/thr\ndomains having low KN/KSvalues covered conserved 323\u2013773,\n1173\u20131773 and 2184\u20133284 nucleotides whereas PVX_081810and PVX_092425 genes had K\nN/KSvalues at the 30-end.\nConsequently, these regions could be considered during vaccinedevelopment to avoid allele-speci\ufb01c immune responses. Further\nanalysis should be performed regarding these domains.\nA limitation of our approach is that specie-speci\ufb01c adaptation\nduring P. vivax host-switch led to KN/KS> 1 and therefore func-\ntional domains could not be conserved between species(Garzon-Ospina et al., 2014 ) and these domains (genes) were con-\nsequently discarded by us.\n5. Conclusions\nDespite previous data ( Cornejo et al., 2014 ) not having dis-\nplayed selection signals in the 59 genes used here, we did identify\nsome signatures consistent with natural selection. Members of the\npvsera and pvmsp-3 multigene families were subject to positive\nselection, likely due to the encoded proteins being targets for animmune response; however, they would not be the most appropri-\nate ones for vaccine development due to their high polymorphism.\nProteins encoded by pvclag ,pvser/thr ,pvrhopH1/clag ,pvron-2 ,\npvron-4 ,pv12 ,pv38 ,pv41 , PVX_081810 and PVX_092425 genes\n(or domains within them) had the patterns expected in regionshaving functional constrains; they could therefore be the most\nsuitable candidates and may be prioritised for further studies (pop-ulation genetics and/or functional ones) for developing a P. vivax\nvaccine which would avoid allele-speci\ufb01c immune responses.\nGenetic diversity and evolutionary forces for pv12 ,pv38\n(Forero-Rodriguez et al., 2014a ) and pv41 (Forero-Rodriguez\net al., 2014b ) have been assessed recently; the data reported in\nsuch studies has agreed with the aforementioned results, suggest-ing that our approach provides a suitable platform for selecting\npotential vaccine candidates.\nAcknowledgments\nWe would like to thank Jason Garry for translating and revising\nthe manuscript. This work was \ufb01nanced by the \u2018\u2018ColombianScience, Technology and Innovation Department (COLCIENCIAS)\u2019\u2019\nthrough contract RC # 0309-2013.D. Garz\u00f3n-Ospina et al. / Infection, Genetics and Evolution 33 (2015) 182\u2013188 187Appendix A. Supplementary data\nSupplementary data associated with this article can be found, in\nthe online version, at http://dx.doi.org/10.1016/j.meegid.2015.05.\n001.\nReferences\nArevalo-Pinzon, G., Curtidor, H., Abril, J., Patarroyo, M.A., 2013. Annotation and\ncharacterization of the Plasmodium vivax rhoptry neck protein 4 (PvRON4).\nMalar. J. 12, 356 .\nArevalo-Pinzon, G., Curtidor, H., Patino, L.C., Patarroyo, M.A., 2011. PvRON2, a new\nPlasmodium vivax rhoptry neck antigen. Malar. J. 10, 60 .\nArisue, N., Kawai, S., Hirai, M., Palacpac, N.M., Jia, M., Kaneko, A., Tanabe, K., Horii, T.,\n2011. Clues to evolution of the SERA multigene family in 18 Plasmodium\nspecies. PLoS ONE 6, e17775 .\nArnott, A., Barry, A.E., Reeder, J.C., 2012. Understanding the population genetics of\nPlasmodium vivax is essential for malaria control and elimination. Malar. J. 11,\n14.\nBarry, A.E., Arnott, A., 2014. Strategies for designing and monitoring malaria\nvaccines targeting diverse antigens. Front. Immunol. 5, 359 .\nCornejo, O.E., Fisher, D., Escalante, A.A., 2014. Genome-wide patterns of genetic\npolymorphism and signatures of selection in Plasmodium vivax . Genome Biol.\nEvol. 7, 106\u2013119 .\nCox, F.E., 2010. History of the discovery of the malaria parasites and their vectors.\nParasit. Vectors 3, 5 .\nChen, J.H., Jung, J.W., Wang, Y., Ha, K.S., Lu, F., Lim, C.S., Takeo, S., Tsuboi, T., Han, E.T.,\n2010. Immunoproteomics pro\ufb01ling of blood stage Plasmodium vivax infection\nby high-throughput screening assays. J. Proteome Res. 9, 6479\u20136489 .\nDoi, M., Tanabe, K., Tachibana, S., Hamai, M., Tachibana, M., Mita, T., Yagi, M., Zeyrek,\nF.Y., Ferreira, M.U., Ohmae, H., Kaneko, A., Randrianarivelojosia, M.,Sattabongkot, J., Cao, Y.M., Horii, T., Torii, M., Tsuboi, T., 2011. Worldwide\nsequence conservation of transmission-blocking vaccine candidate Pvs230 in\nPlasmodium vivax . Vaccine 29, 4308\u20134315 .\nEdgar, R.C., 2004. MUSCLE: multiple sequence alignment with high accuracy and\nhigh throughput. Nucleic Acids Res. 32, 1792\u20131797 .\nEgea, R., Casillas, S., Barbadilla, A., 2008. Standard and generalized McDonald\u2013\nKreitman test: a website to detect selection by comparing different classes ofDNA sites. Nucleic Acids Res. 36, W157\u2013W162\n.\nFay, J.C., Wyckoff, G.J., Wu, C.I., 2002. Testing the neutral theory of molecular\nevolution with genomic data from Drosophila. Nature 415, 1024\u20131026 .\nForero-Rodriguez, J., Garzon-Ospina, D., Patarroyo, M.A., 2014a. Low genetic\ndiversity and functional constraint in loci encoding Plasmodium vivax P12 and\nP38 proteins in the Colombian population. Malar. J. 13, 58 .\nForero-Rodriguez, J., Garzon-Ospina, D., Patarroyo, M.A., 2014b. Low genetic\ndiversity in the locus encoding the Plasmodium vivax P41 protein in\nColombia\u2019s parasite population. Malar. J. 13, 388 .\nGarcia, J., Curtidor, H., Pinzon, C.G., Vanegas, M., Moreno, A., Patarroyo, M.E., 2009.\nIdenti\ufb01cation of conserved erythrocyte binding regions in members of the\nPlasmodium falciparum Cys6 lipid raft-associated protein family. Vaccine 27,\n3953\u20133962 .\nGarzon-Ospina, D., Cadavid, L.F., Patarroyo, M.A., 2010. Differential expansion of the\nmerozoite surface protein (msp)-7 gene family in Plasmodium species under a\nbirth-and-death model of evolution. Mol. Phylogenet. Evol. 55, 399\u2013408 .\nGarzon-Ospina, D., Forero-Rodriguez, J., Patarroyo, M.A., 2014. Heterogeneous\ngenetic diversity pattern in Plasmodium vivax genes encoding merozoite surface\nproteins (MSP)-7E, -7F and -7L. Malar. J. 13, 495 .\nGarzon-Ospina, D., Romero-Murillo, L., Tobon, L.F., Patarroyo, M.A., 2011. Low\ngenetic polymorphism of merozoite surface proteins 7 and 10 in Colombian\nPlasmodium vivax isolates. Infect. Genet. Evol. 11, 528\u2013531 .\nGunasekera, A.M., Wickramarachchi, T., Neafsey, D.E., Ganguli, I., Perera, L.,\nPremaratne, P.H., Hartl, D., Handunnetti, S.M., Udagama-Randeniya, P.V.,\nWirth, D.F., 2007. Genetic diversity and selection at the Plasmodium vivax\napical membrane antigen-1 (PvAMA-1) locus in a Sri Lankan population. Mol.\nBiol. Evol. 24, 939\u2013947 .\nJukes, T.H.a.C.R.C., 1969. Evolution of protein molecules. In: Munro, H.N. (Ed.),\nMammalian Protein Metabolism. Academic Press, New York .\nKato, K., Mayer, D.C., Singh, S., Reid, M., Miller, L.H., 2005. Domain III of Plasmodium\nfalciparum apical membrane antigen 1 binds to the erythrocyte membrane\nprotein Kx. Proc. Natl. Acad. Sci. U.S.A. 102, 5552\u20135557 .\nLibrado, P., Rozas, J., 2009. DnaSP v5: a software for comprehensive analysis of DNA\npolymorphism data. Bioinformatics (Oxford, England) 25, 1451\u20131452 .\nMazumder, R., Hu, Z.Z., Vinayaka, C.R., Sagripanti, J.L., Frost, S.D., Kosakovsky Pond,\nS.L., Wu, C.H., 2007. Computational analysis and identi\ufb01cation of amino acid\nsites in dengue E proteins relevant to development of diagnostics and vaccines.Virus Genes 35, 175\u2013186\n.McDonald, J.H., Kreitman, M., 1991. Adaptive protein evolution at the Adh locus in\nDrosophila. Nature 351, 652\u2013654 .\nMongui, A., Angel, D.I., Guzman, C., Vanegas, M., Patarroyo, M.A., 2008.\nCharacterisation of the Plasmodium vivax Pv38 antigen. Biochem. Biophys.\nRes. Commun. 376, 326\u2013330 .\nMoreno-Perez, D.A., Areiza-Rojas, R., Florez-Buitrago, X., Silva, Y., Patarroyo, M.E.,\nPatarroyo, M.A., 2013a. The GPI-anchored 6-Cys protein Pv12 is present in\ndetergent\u2013resistant microdomains of Plasmodium vivax blood stage schizonts.\nProtist 164, 37\u201348 .\nMoreno-Perez, D.A., Saldarriaga, A., Patarroyo, M.A., 2013b. Characterizing PvARP, a\nnovel Plasmodium vivax antigen. Malar. J. 12, 165 .\nNeafsey, D.E., Galinsky, K., Jiang, R.H., Young, L., Sykes, S.M., Saif, S., Gujja, S.,\nGoldberg, J.M., Young, S., Zeng, Q., Chapman, S.B., Dash, A.P., Anvikar, A.R.,\nSutton, P.L., Birren, B.W., Escalante, A.A., Barnwell, J.W., Carlton, J.M., 2012. The\nmalaria parasite Plasmodium vivax exhibits greater genetic diversity than\nPlasmodium falciparum . Nat. Genet. 44, 1046\u20131050 .\nOchola, L.I., Tetteh, K.K., Stewart, L.B., Riitho, V., Marsh, K., Conway, D.J., 2010. Allele\nfrequency-based and polymorphism-versus-divergence indices of balancing\nselection in a new \ufb01ltered set of polymorphic genes in Plasmodium falciparum .\nMol. Biol. Evol. 27, 2344\u20132351 .\nPacheco, M.A., Elango, A.P., Rahman, A.A., Fisher, D., Collins, W.E., Barnwell, J.W.,\nEscalante, A.A., 2012. Evidence of purifying selection on merozoite surfaceprotein 8 (MSP8) and 10 (MSP10) in Plasmodium spp. Infect. Genet. Evol. 12,978\u2013986\n.\nPain, A., Bohme, U., Berry, A.E., Mungall, K., Finn, R.D., Jackson, A.P., Mourier, T.,\nMistry, J., Pasini, E.M., Aslett, M.A., Balasubrammaniam, S., Borgwardt, K.,\nBrooks, K., Carret, C., Carver, T.J., Cherevach, I., Chillingworth, T., Clark, T.G.,\nGalinski, M.R., Hall, N., Harper, D., Harris, D., Hauser, H., Ivens, A., Janssen, C.S.,Keane, T., Larke, N., Lapp, S., Marti, M., Moule, S., Meyer, I.M., Ormond, D., Peters,\nN., Sanders, M., Sanders, S., Sargeant, T.J., Simmonds, M., Smith, F., Squares, R.,\nThurston, S., Tivey, A.R., Walker, D., White, B., Zuiderwijk, E., Churcher, C., Quail,\nM.A., Cowman, A.F., Turner, C.M., Rajandream, M.A., Kocken, C.H., Thomas, A.W.,\nNewbold, C.I., Barrell, B.G., Berriman, M., 2008. The genome of the simian and\nhuman malaria parasite Plasmodium knowlesi . Nature 455, 799\u2013803 .\nPatarroyo, M.A., Calderon, D., Moreno-Perez, D.A., 2012. Vaccines against\nPlasmodium vivax : a research challenge. Expert Rev. Vaccines 11, 1249\u20131260 .\nRestrepo-Montoya, D., Becerra, D., Carvajal-Patino, J.G., Mongui, A., Nino, L.F.,\nPatarroyo, M.E., Patarroyo, M.A., 2011. Identi\ufb01cation of Plasmodium vivax\nproteins with potential role in invasion using sequence redundancy reduction\nand pro\ufb01le hidden Markov models. PLoS One 6, e25189 .\nRice, B.L., Acosta, M.M., Pacheco, M.A., Carlton, J.M., Barnwell, J.W., Escalante, A.A.,\n2014. The origin and diversi\ufb01cation of the merozoite surface protein 3 (msp3)multi-gene family in Plasmodium vivax and related parasites. Mol. Phylogenet.\nEvol. 78, 172\u2013184\n.\nRichie, T.L., Saul, A., 2002. Progress and challenges for malaria vaccines. Nature 415,\n694\u2013701 .\nRodriguez, L.E., Urquiza, M., Ocampo, M., Curtidor, H., Suarez, J., Garcia, J., Vera, R.,\nPuentes, A., Lopez, R., Pinto, M., Rivera, Z., Patarroyo, M.E., 2002. Plasmodium\nvivax MSP-1 peptides have high speci\ufb01c binding activity to human\nreticulocytes. Vaccine 20, 1331\u20131339 .\nSuzuki, Y., 2004. Negative selection on neutralization epitopes of poliovirus surface\nproteins: implications for prediction of candidate epitopes for immunization.Gene 328, 127\u2013133\n.\nSuzuki, Y., 2006. Natural selection on the in\ufb02uenza virus genome. Mol. Biol. Evol. 23,\n1902\u20131911 .\nTachibana, S., Sullivan, S.A., Kawai, S., Nakamura, S., Kim, H.R., Goto, N., Arisue, N.,\nPalacpac, N.M., Honma, H., Yagi, M., Tougan, T., Katakai, Y., Kaneko, O., Mita, T.,\nKita, K., Yasutomi, Y., Sutton, P.L., Shakhbatyan, R., Horii, T., Yasunaga, T.,\nBarnwell, J.W., Escalante, A.A., Carlton, J.M., Tanabe, K., 2012. Plasmodium\ncynomolgi genome sequences provide insight into Plasmodium vivax and the\nmonkey malaria clade. Nat. Genet. 44, 1051\u20131055 .\nTamura, K., Peterson, D., Peterson, N., Stecher, G., Nei, M., Kumar, S., 2011. MEGA5:\nmolecular evolutionary genetics analysis using maximum likelihood,evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 28,2731\u20132739\n.\nTetteh, K.K., Stewart, L.B., Ochola, L.I., Amambua-Ngwa, A., Thomas, A.W., Marsh, K.,\nWeedall, G.D., Conway, D.J., 2009. Prospective identi\ufb01cation of malaria parasite\ngenes under balancing selection. PLoS One 4, e5568 .\nVulliez-Le Normand, B., Tonkin, M.L., Lamarque, M.H., Langer, S., Hoos, S., Roques,\nM., Saul, F.A., Faber, B.W., Bentley, G.A., Boulanger, M.J., Lebrun, M., 2012.\nStructural and functional insights into the malaria parasite moving junctioncomplex. PLoS Pathog. 8, e1002755\n.\nWeedall, G.D., Conway, D.J., 2010. Detecting signatures of balancing selection to\nidentify targets of anti-parasite immunity. Trends Parasitol. 26, 363\u2013369 .\nZhang, J., Rosenberg, H.F., Nei, M., 1998. Positive Darwinian selection after gene\nduplication in primate ribonuclease genes. Proc. Natl. Acad Sci. U.S.A. 95, 3708\u20133713\n.188 D. Garz\u00f3n-Ospina et al. / Infection, Genetics and Evolution 33 (2015) 182\u2013188RESEARCH ARTICLE Open Access\nEvidence of functional divergence in\nMSP7 paralogous proteins: a molecular-\nevolutionary and phylogenetic analysis\nDiego Garz\u00f3n-Ospina1,2, Johanna Forero-Rodr\u00edguez1and Manuel A. Patarroyo1,3*\nAbstract\nBackground: The merozoite surface protein 7 (MSP7) is a Plasmodium protein which is involved in parasite invasion;\nt h eg e n ee n c o d i n gi tb e l o n g st oam u l t i g e n ef a m i l y .I t has been proposed that MSP7 paralogues seem to be\nfunctionally redundant; however, recent experiments have suggested that they could have different roles.\nResults: The msp7 multigene family has been described in newly available Plasmodium genomes; phylogenetic\nrelationships were established in 12 species by using dif ferent molecular evolution ary approaches for assessing\nfunctional divergence amongst MSP7 members. Gene expansion and contraction rule msp7 family evolution; however,\nsome members could have had concerted evolution. Molecular evolutionary analysis showed that relaxed and/or\nintensified selection modulated Plasmodium msp7 paralogous evolution. Furthermore, episodic diversifying selection\nand changes in evolutionary rates suggested that some paralogous proteins have diverged functionally.\nConclusions: Even though msp7 has mainly evolved in line with a birth-and-death evolutionary model, gene\nconversion has taken place between some paralogous genes allowing them to maintain their functional redundancy.\nOn the other hand, the evolutionary rate of some MSP7 paralogs has become altered, as well as undergoing relaxed or\nintensified (positive) selection, suggesting functional divergence. This could mean that some MSP7s can form differentparasite protein complexes and/or recognise different host receptors during parasite invasion. These results highlight\nthe importance of this gene family in the Plasmodium genus.\nKeywords: Plasmodium , Multigene family, msp7 , Episodic positive selection, Functional divergence, Relaxed selection,\nIntensified selection\nBackground\nDNA duplication is an important source of novelty re-\ngarding evolution, providing the basis for new molecular\nactivities [1, 2]. The genomes from the three kingdomsof life have been modulated by this mechanism, having\nmultiple copies of genes [2]. Multigene families might\nevolve in line with a concerted or birth-and-death evo-lutionary model [3]; paralogous genes keep the same\nfunction in the former due to gene conversion whilst\nparalogous genes could lose or acquire a new function ina birth-and-death model. Since functional importance ishighly correlated with evolutionary conservation [4, 5],molecular biologists have used evolutionary approaches to\ninfer functional changes in paralogous genes/proteins\nusing DNA/amino acid sequences [5 \u20138].\nGene duplication seems to be recurrent in Plasmodium\ngenus. These parasites are able to infect several verte-brates such as birds, rodents and primates. More than 200species have been described to date. Clustering in different\nlineages occurs according to host (bird/reptile-parasite,\nrodent-parasite, monkey-parasite and hominid-parasitelineages) [9, 10]. Several genes produced by gene duplica-\ntion are involved in host-cell invasion [11 \u201314]. MSP7 is a\nmerozoite surface protein encoded by a gene belonging to\na multigene family located in chromosome 13 in hominid-\nand rodent-parasites but in chromosome 12 in monkey-\nparasites. This family has a different copy numberamongst Plasmodium species [15, 16]. These genes are\n* Correspondence: mapatarr.fidic@gmail.com\n1Molecular Biology and Immunology Department, Fundaci\u00f3n Instituto de\nInmunolog\u00eda de Colombia (FIDIC), Carrera 50#26-20, Bogot\u00e1, DC, Colombia\n3School of Medicine and Health Sciences, Universidad del Rosario, Carrera\n24#63C-69, Bogot\u00e1, DC, Colombia\nFull list of author information is available at the end of the article\n\u00a9 The Author(s). 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0\nInternational License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and\nreproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link tothe Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.Garz\u00f3n-Ospina et al. BMC Evolutionary Biology  (2016) 16:256 \nDOI 10.1186/s12862-016-0830-xexpressed simultaneously but they are independently\nregulated [17 \u201320]. Functional assays have shown that P.\nfalciparum MSP7 (MSP7I) is proteolytically processed; the\nresulting 22 kDa C-terminal region fragment is not cova-lently associated with MSP1 [7] and has cross-reactivity\nwith other MSP7 proteins [17]. Furthermore, this frag-ment appears be involved in invasion by binding to red\nblood cells [21]. The C-terminal regions in P. yoelii from\ndifferent MSP7s seem to be necessary to interact with\nthe 83 kDa MSP1 fragment [17]. The MSP7 knockout\nreduces the normal growth rate of the mutant parasite\ninP. berghei ; however, it becomes restored a few days\nlater [22].\nThe msp7 family appears to follow the birth-and-death\nevolutionary model; some gene copies have been main-tained in the genome for a long time and others appear\nto be more recent [15]. This family has had a complex\nevolutionary history regarding P. vivax . The C-terminal\nregion is involved in gene conversion [23]. Moreover,\nthis region is highly conserved and under negative selec-\ntion, suggesting functional/structural constraint [23 \u201325];\nby contrast, some P. vivax MSP7 proteins \u2019central regions\nhave high genetic diversity, maintained by balancing selec-tion, possibly as an immune evasion mechanism [23, 24].\nRecent protein-protein interaction assays have shown\nthat MSP7 proteins do not appear to bind to the samehost receptor [26]; moreover, these proteins seem tobe forming different protei n complexes in the parasite\n[7, 27 \u201330], maybe to perform different parasite-host\ninteractions. Such results flout the functional redun-dancy hypothesis [15, 18]; functional divergence in\nMSP7 paralogs thus appears to be probable. This study\nhas analysed data concerning msp7 multigene family evo-\nlution, including 13 available Plasmodium genomes by\nevaluating their phylogenetic relationships and adoptingdifferent and new molecular evolutionary approaches forassessing functional divergence amongst MSP7 proteins.\nMethods\nSequence data, alignments and phylogenetic tree\nreconstruction\nGenome sequences from 11 Plasmodium species (and\none subspecies, GenBank access number: P. reichenowi,\nGCA_000723685.1; P. falciparum, GCA_000002765.1;\nP. vivax, GCA_000002415.2; P. cynomolgi, GCA_000\n321355.1; P. inui, GCA_000524495.1; P. knowlesi,\nGCA_000006355.1; P. coatneyi, GCA_000725905.1 ;P .\nchabaudi, GCA_000003075.2; P. vinckei, GCA_000709\n005.1 and GCA_000524515.1; P. yoelii, GCA_000003\n085.2 and P. berghei, GCA_000005395.1) as well as the\npartial genome sequences from P. gallinaceum (Wellcome\nTrust Sanger Institute, http://www.sanger.ac.uk/resources/\ndownloads/protozoa/plasmodium-gallinaceum.html) were\nanalysed to obtain msp7 multigene family genomic regions.The msp7 gene copy number for these 13 genomes was\nestablished, as reported previously [15, 24].\nAll gene sequences found were used to deduce amino\nacid sequences by using Gene Runner software; these se-\nquences were then screened to distinguish the MSP_7C\ndomain using the Pfam server [31] (domain access num-ber: PF12948). All amino acid sequences were then\naligned using the MUSCLE algorithm [32] and manually\nedited by GeneDoc software [33]. The best amino acidsubstitution model was selected by Akaike \u2019s information\ncriterion using the ProtTest algorithm [34]; the JTT +G + F model was used to infer phylogenetic tress usingmaximum likelihood (ML) and Bayesian (BY) methods.\nRAxML was used for ML analysis [35] and topology\nreliability was evaluated by bootstrap, using 1000 repli-cates. A Metropolis-coupled Markov chain Monte Carlo\n(MCMC) algorithm was used for BY analysis [36] with\nMrBayes [37]. This analysis was run until reaching astandard deviation of split frequencies (ASDSF) value\nlower than 0.01; sump and sumt commands were used\nfor tabulating posterior probabilities and building aconsensus tree; in additi on to ASDSF, the PSRF para-\nmeter was used for monitoring convergence. Bothanalyses were performed at CIPRES Science Gateway[38, 39]. A recent evolutionary multigene family model\ncalled DLRTS [40] was also performed; this method\ni n f e r sag e n et r e eb ye v o l v i n gd o w no nag i v e ns p e c i e stree (with divergence times) by means of duplication,\nloss and transfer events according to a birth-death-like\nprocess [40, 41]. The species tree was inferred with afragment of cytochrome C oxidase subunit 2 and di-\nvergence times were obtained from Pacheco et al. [42].\nDLRTS was run using the MCMC algorithm for 10million generations.\nGene conversion amongst msp7 members\nIt has been shown that some msp7 family members\n(msp7H and msp7I ) have evolved by gene conversion,\nthereby contributing to these members \u2019homogenisation\n[23]. msp7 sequences were obtained from 6 P. vivax iso-\nlates (Salvador-I, Mauritania-I, India-VII, North Korean,Brazil-I and ctg isolate) [43, 44] and used to assess\nwhether this pattern has also taken place in other msp7\nmembers. Betran \u2019s method was used for gene conver-\nsion amongst paralogous genes [45] as well as the\nGENECONV algorithm [46]. DnaSP software was usedfor the former method [47] where only conversion\ntracts larger than 10 nucleotides were considered whilst\nRDP3 v3.4 software was used for GENECONV [48],considering just conversion tracts having p< 0.01. The\nsame approach was followed for P. falciparum msp7\ngenes, using the 3D7, FCR3, RO33, 7G8, K1, T9/102and w2mef isolates.Garz\u00f3n-Ospina et al. BMC Evolutionary Biology  (2016) 16:256 Page 2 of 13Identifying episodic diversifying selection on msp7\ntree branches\nThe random effects branch-site model (Branch-site REL)\nwas used for assessing whether msp7 multigene family\nlineages had been subject to episodic diversifying selec-tion [49]. This method identifies branches where a per-centage of sites have evolved under episodic diversifying\nselection. The MUSCLE algorithm was used for inde-\npendently aligning each orthologous cluster \u2019s amino acid\nsequences (Figs. 1 and 2); PAL2NAL software [50] was\nthen used for inferring codon alignments from the\naligned amino acid sequences. The best evolutionarymodels for DNA and protein alignments were inferred\nby using jModelTest [51] and ProtTest [34], respectively.\nML phylogenetic trees were obtained for DNA and pro-tein alignments for each orthologous cluster and used as\nphylogenetic framework to perform the Branch-site REL\nmethod using the HyPhy software package [52]; addi-tionally, the Datamonkey web server [53] was also used\nto perform this method. The MEME method [54] from\nDatamonkey server was used to infer which sites wereunder episodic positive selection in each cluster.\nEvolutionary analysis for testing functional divergence\nFunctional redundancy was previously proposed for the\nMSP7 family by using sequences from seven species [15].The sequence number in this research was increasedand two different phylogeny-based approaches were\nused to assess functional divergence or redundancybetween MSP7 members; one involved using DIVERGE\nv.3 software [55] to estimate type-I functional diver-\ngence [5] which is an indicator of functional changesbetween members of a multigene family [5, 6, 56 \u201361].\nThis method is based on (site-specific) shifted evolu-tionary rates. It assesses whether there has been asignificant change in evolution rate after duplication\n(or speciation) events by calculating the coefficient of\ndivergence ( \u03b8\nD) and determining (e.g. by a Likelihood\nratio test [5]) whether it is statistically significant for\nrejecting the null hypothesis (no functional divergence).\nThe software then computes a posterior probability fordetecting amino acids responsible for such divergence.\nTaking into account that new functions in paralogous\nproteins might emerge after gene duplication wheneverselective strength is relaxed or whether positive selec-\ntion is intensified, a second approach was used with the\nRELAX method [62]. This method allows partitioning aphylogeny into two subsets of branches to determine\nwhether selective strength was relaxed or intensified in\none of these subsets (test br anch) relative to the other\n(reference branch). The Datamonkey web server was\nused for this analysis.\nFig. 1 Schematic representation of the chromosomal msp7 loci in 13 Plasmodium genomes. The genes flanking the msp7 chromosome region in\nPlasmodium species are represented by orange boxes . The coloured boxes within flanking sequences represent msp7 genes in each species whilst\nblack boxes symbolise pseudogenes. The genes are given in alphabetical order from left to right. The dashed lines connect orthologous genes. All\ngenes are represented to scale, but the distance between them is not representative. Question marks refer to what were not clearly orthologous\nrelationships. By contrast with hominid-parasites, species from monkey-parasite and rodent-parasite lineages seem to have similar evolutionary\nhistories regarding msp7 expansion. The grey boxes are lineage-specific genes only found in hominid-parasite species, as they do not belong to\nthemsp7 family (the latter gene representations are not to scale)Garz\u00f3n-Ospina et al. BMC Evolutionary Biology  (2016) 16:256 Page 3 of 13Fig. 2 msp7 gene family phylogeny inferred by the DLTRS evolutionary model. aSpecies tree used for generating the MSP7 tree. bMSP7 tree created\nby evolving down the species tree. Numbers represent different clades whilst numbers on branches are posterior probability values. Nine major clades\nwere identified on the tree. Proteins were clustered in agreement with parasite phylogenetic relationships, clades 1 ( red), 2 (yellow )a n d5( purple )b e i n g\nthe most ancestral ones. The clades clustering genes from monkey-parasite lineage are depicted in green, proteins from rodent-parasite lineage in b lue\nand hominid-parasite lineage in grey. The P. inui specie-specific duplicate was not considered in this analysis. Due to the family \u2019s complex evolutionary\nhistory (which includes gene conversion, intragenic recombination, positive and/or balancing selection) the MCMC analysis did not converge and\ntherefore the duplication/lost rates were not obtained even though a tree reconciliation similar to other topologies was inferred (BY and ML)Garz\u00f3n-Ospina et al. BMC Evolutionary Biology  (2016) 16:256 Page 4 of 13Results\nmsp7 chromosomal locus genetic structure in\nPlasmodium spp\nWhole genome sequences from 11 Plasmodium species,\n1 subspecies and 1 partial draft genome sequence were\nscreened for describing the msp7 chromosomal locus.\nThe msp7 locus is circumscribed by PVX_082640 and\nPVX_082715 genes in P. vivax [15, 16, 24]; genes\nsharing high similarity to them were thus searched inthe remaining species. Since MSP7 proteins appear be\nencoded by a single exon [63], the contigs enclosing\nflanking genes were analysed using ORFFinder andGene Runner software to identify open reading frames\n(ORFs) encoding proteins larger than 200 amino acids.\nSeventy-nine ORFs (Additional file 1) in 13 genomeshaving the same transcription orientation were found\n(Fig. 1). These ORFs had 0.6 to 1.3 kilobases (kb) but P.\ngallinaceum msp7 had a 3.1 kb length. Like previous\nstudies [15, 16, 24], the copy number was different inPlasmodium spp. P. vivax and P. cynomolgi had the\nl a r g e s tc o p yn u m b e r( 1 2O R F s )w h i l s tt h el o w e s tc o p y\nnumber was found in P. gallinaceum (just one gene).\nShorter fragments (having more than 30% similaritywith the identified ORFs) were also found in P. vivax ,\nP. cynomolgi ,P. falciparum and P. reichenowi .T h e s e\nORFs (and small fragments) were named in alphabeticalorder regarding PVX_082640 and its homologous genes(Fig. 1 and Additional file 1).\nData regarding P. inui ,msp7B (pinumsp7B ) was in-\ncomplete due to gaps in the contig whilst pcynmsp7J ,\npcynmsp7L ,pcoamspB ,preimsp7D and pvinvmsp7A had\npremature stop codons. However, pcynmsp7L could en-\ncode a full MSP7 protein since it was shown to haveintron donor/acceptor sites by GeneScan [64] screening,\nas previously shown [24]. Despite GeneScan not showing\nan intron/exon structure for pvinvmsp7A , it has putative\ndonor/acceptor sites (Additional file 2). The Phobius\nalgorithm was used for determining the presence of\nsignal peptides within ORFs and Pfam for the MSP_7Cdomain; some genes did not have a signal peptide or the\ncharacteristic MSP_7C domain in the C-terminal region\n(Table 1).\nThe Plasmodium msp7 family \u2019s phylogenetic relationships\nPhylogenetic relationships for this family were identifiedas previously described [15, 24, 65, 66]. A multiple align-\nment was performed for deducing 80 msp7 genes \u2019amino\nacid sequences (excluding the shorter gene fragments\nand P. gallinaceum gene). A phylogenetic tree was then\ninferred by using ML and BY methods with the JTT +G + F model; both topologies gave similar branch pat-terns, displaying 12 major clades (Additional file 3), with\nclade 1 clustering sequences from 12 Plasmodium species\nconsidered in this study, clade 2 another 10 of them andclade 5 clustering the last gene in the chromosomal region\nfrom rodent-parasites, P. vivax and P. cynomolgi .T h e\nremaining clades put together sequences according toPlasmodium lineages (i.e. MSP7 sequences from the\nmonkey-parasite lineage were in clades 3, clade 4clustered the sequences from rodent-parasite lineage andclades 6 clustered sequences from the hominid-parasite\nlineage). Clades 1, 2, 3a, 3b, 4 and 6b only contained\northologous proteins whilst clades 3c and 3d had ortholo-gous and paralogous proteins from monkey-parasite\nlineage, the clade 6a clustered sequences from hominid-\nparasite lineage whilst the sequence in clade 7 appeared tobe exclusive to P. inui . In addition to previous studies\n[15], the DLTRS model was implemented which recon-ciles the gene tree to the species tree [40, 41]. The fractionof sampled values discarded as burn-in during analysisTable 1 In-silico characterisation of putative MSP7 proteins\nmsp7 genes\nABCDEFGHI JKLM\nP. vivax SP y y y y y y y y y - y y y\nMSP7_C y y y - y y y y y y y y -\nP. cynomolgi SP y y y y - y y y y - y y yMSP7_C y y y - y y y y y y y y -\nP. inui SP y - y y y - y yMSP7_C y y y y y - y y\nP. knowlesi SP y y y y yMSP7_C y - y y y\nP. coatneyi SP y - y y yMSP7_C y - y y y\nP. chabaudi SP y y y yMSP7_C y y y -\nP. vinckei v. SP y y y yMSP7_C y y y -\nP. vinckei p. SP y y y yMSP7_C y y y -\nP. berghei SP y y y yMSP7_C y y y -\nP. yoelii SP y y y yMSP7_C y y y -\nP. falciparum SP y y - y y y yMSP7_C y y y y y y y y y\nP. reichenowi SP y - y y y y yMSP7_C y y y y y y y y y\nP. gallinaceum SP yMSP7_C y\nEighty-three sequences between flanking genes were screening for identifying\na signal peptide and the characteristic MSP_7C domain (Pfam access number:\nPF12948). y: proteins having a signal peptide according to the Phobius\nalgorithm or a MSP_7C domain in a Pfam search. -: proteins appeared not tohave a signal peptide or MSP_7C domainGarz\u00f3n-Ospina et al. BMC Evolutionary Biology  (2016) 16:256 Page 5 of 13was 0.25 but the MCMC chain did not converge after\nmore than 10 million generations, therefore, gene duplica-\ntion, loss or transfer rates were not obtained. However,the reconciliation of the msp7 gene tree to the Plasmo-\ndium species tree was obtained. The tree inferred by\nDLTRS had 9 major clades (Fig. 2), thereby agreeingwith the ML and BY clades (Fig. 2 and Additional file 3).\nIn all phylogenies (Fig. 2 and Additional file 3) the se-\nquences without the MSP_7C domain (PvivMSP7D,PcynMSP7D, PknoMSP7B and PcoaMSP7B) appeared to\nbe phylogenetically related to sequences having an\nMSP_7C domain. However, this relationship was onlysupported by posterior probabilities but not by bootstrap-\nping (Fig. 2 and Additional file 3). Furthermore, these se-\nquences, like others not containing an MSP_7C domain,had noticeable similarity (>48%) with MSP7 members at\nthe N-terminal end (Additional file 4).\nSince PgalMSP7A is larger than other MSP7s, we did\nnot take it into account for the aforementioned analysis;then, only the MSP_7C domain was used for inferring\ntheir phylogenetic relationships to determine whetherPgalMSP7A was orthologous to MSP7A/H. The branch\npattern from this topology (Additional file 5) was similar\nto the phylogeny obtained by using all sequences (Fig. 2,Additional files 3 and 5). PgalMSP7A clustered with\nMSP7A; however, posterior probability and bootstrapping\nwere low. PgalMSP7A did not cluster with any otherMSP7 in DLTRS tree; instead it appeared as an outgroup.\nGene conversion amongst msp7 genes\nAn atypical pattern in the clades clustering MSP7H/7I\nand MSP7B/7E/7G was observed in the phylogenies in-\nferred above (Fig. 2, Additional files 3 and 5). Contraryto what would have been expected, PvivMSP7B wasclustered with PvivMSP7E and PvivMSP7G and not with\ntheir respective orthologues; likewise, PvivMSP7H and\nPvivMSP7I seemed to share a common origin. It haspreviously been reported that gene conversion takes\nplace between PvivMSP7H and 7I [23]. We obtained the\npvivmsp7 s sequences from 6 P. vivax isolates to assess\nwhether gene conversion takes place in PvivMSP7B, 7E\nand 7G. Alignments for pvivmsp7C ,7Hand 7Iand\nanother for pvivmsp7B ,7Eand 7Gwere performed;\nBetran \u2019s method and the GENECONV algorithm were\nthen used, displaying recombination tracks between iso-\nlates but also between paralogous genes. The Betranalgorithm found 2 conversion tracks between pvivmsp7C\nand 7I, whilst there were 3 conversion tracks between\npvivmsp7B and 7Eand another two between pvivmsp7E\nand 7G. Figure 3 shows the conversion tracks found by\nGENECONV. The same approach was followed for P.\nfalciparum by using different reference isolates. By con-\ntrast with P. vivax, pfmsp7 members did not seem to be\naffected by gene conversion since no conversion trackswere found amongst them (data not shown).\nEpisodic positive selection on msp7 branches\nPrevious studies have shown ancestral positive selectionregarding the msp1 gene in the monkey-parasite lineage\n[67, 68]. Such episodic positive selection could have oc-curred in order to adapt to newly-appeared macaquespecies [67]. Since MSP1 and MSP7 form a protein\ncomplex [7, 18, 29] involved in parasite invasion, both\nproteins should have similar selective pressures. Sincethis has been assessed just for msp7E and 7L[24], the\nBranch-site REL method was used here for assessingwhether other lineages are subject to episodic diversifyingselection in msp7 evolutionary history; evidence was\nFig. 3 Schematic representations of gene conversion tracks identified by the GENECONV method. Each gene is represented by a colour bar\n(pvivmsp7C (blue),pvivmsp7H (red),pvivmsp7I (green ),pvivmsp7B (purple ),pvivmsp7E (fuchsia ), and pvivmsp7G (orange )); a different coloured rectangle is a\ngraphical representation of sequence fragments potentially originating from gene conversion. Conversion tracks were mainly located in the 3 \u2032-ends.\nThe % value refers to the similarity value for the sequence region involved in gene conversion (or intragenic recombination)Garz\u00f3n-Ospina et al. BMC Evolutionary Biology  (2016) 16:256 Page 6 of 13found of strong episodic diversifying selection in a few in-\nternal branches and in several external branches (Fig. 4\nand Additional file 6). Regarding rodent-parasites, thelineages leading to MSP7A and 7B in P. vinckei vinckei ;P.\nvinckei petteri ,P. chabaudi (Fig. 4a) and P. berghei (Fig. 4i)\nwere under selection. Just one internal branch (the P.\nberghei /P. yoelii MSP7C ancestor, Fig. 4g) displayed\nepisodic selection. Concerning monkey-parasites, a per-centage of sites regarding the lineages leading to MSP7AinP. vivax ,P. cynomolgi and P. inui as well as the P. inui /\nP. knowlesi/P. coatneyi and P. knowlesi /P. coatneyi lineage\nancestors (Fig. 4a) were under very strong episodic posi-tive selection ( \u03c9> 33). Likewise, the lineages that gave rise\ntoP. cynomolgi MSP7B, 7E, P. vivax MSP7B, 7E (Fig. 4b);\nP. inui 7B (Fig. 4c); P. vivax 7F (Fig. 4d); P. knowlesi\n7C, P. cynomolgi 7G, P. inui 7D (Fig. 4e); P. coatneyi\n7D,P. knowlesi 7D,P. vivax 7H, P. inui 7E,P. cynomolgi\n7I (Fig. 4f) and P. vivax 7L (Fig. 4h) also were under\nFig. 4 Phylogenies analysed for episodic selection. Each orthologous cluster was analysed by the Branch-site REL method. The shade of each\ncolour on branches indicates strength of selection ( redshows \u03c9>13, blue\u03c9\u22641 and grey\u03c9= 1). The size of each colour represents the percentage\nof sites in the corresponding class found by Branch-site REL. Branches have been classified as undergoing episodic diversifying selection by\nthep-value corrected for multiple testing u sing the Holm-Bonferroni method at p< 0.05. a.c l a d e1 ; b.pviv/pcynmsp7B and 7E;c.pviv/pcynmsp7C and\npinumsp7B ;d.pviv/pcynmsp7F and pinumsp7C ;e.pviv/pcynmsp7G ,pkno/pcoamsp7C and pinumsp7D ;f.pviv/pcynmsp7H/7I ,pkno/pcoamsp7D and pinumsp7E ;\ng. clade 2; h.pviv/pcynmsp7L and pinumsp7H andi. clade 4. At the bottom of each phyloge ny there is a scale representation of msp7s .T h e blue boxes\nrepresent the encoded N -terminal region, the light brown ones symbolise the central region and the purple boxes the MSP_7C domain. Numbers within\nboxes represent the number of codons under positive selection inferred by MEME, SLAC, FEL, REL and FUBAR methods using the Datamonkey web serverGarz\u00f3n-Ospina et al. BMC Evolutionary Biology  (2016) 16:256 Page 7 of 13positive selection. Very strong episodic positive selection\nwas observed in the P. knowlesi /P. coatneyi 7C, P. inui\n7D/P. vivax 7G, P. coatneyi /P. knowlesi 7D,P. inui 7E/P.\ncynomolgi 7I /P. vivax 7I and P. cynomolgi /P. vivax MSP7I\nancestral branches (Fig. 4 and Additional file 6).\nEvolutionary analysis for testing functional divergence\nGu\u2019s type-I functional divergence and RELAX methods\nwere used to identify functional divergence amongst\nMSP7 proteins. Pairwise comparisons between paralogous\nproteins (e.g. from different clades) as well as between\northologues (e.g. proteins from different parasite lineagebut within the same clade), showed high coefficient of\ndivergence ( \u03b8D) values (Table 2); between 10 and 20% of\nthe sites had a significant change in their evolutionary rate\n(Additional file 7). Likewise, we found either a relaxed\nselection or an intensified selection amongst MSP7 para-\nlogues (Table 2 and Additional file 8).\nDiscussion\nIt has been suggested that DNA duplication is the mainsource of evolutionary innovation [1, 2] since duplicate\nDNA fragments might evolve to new functions. However,\nacquiring new functions (neofunctionalisation) is not\nTable 2 In silico assessment of functional divergence between paralogous and orthologous MSP7 proteins\n# Cluster A Compared to Cluster B \u03b8D LRT\u03b8D RELAX ( p-value)\n1 Clade 1 Primate-parasites Clade 1 Rodent-parasites 0.54 4.74aNP\n2 Clade 1 Primate-parasites Clade 3d Primate-parasites (B/E) \u22120.21 0.00 Intensification (0.0038)\n3 Clade 1 Rodent-parasites Clade 3d Primate-parasites (B/E) 0.78 15.19aNP\n4 Clade 1 Primate-parasites Clade 3d Primate-parasites (C/H/E/D/I) 0.34 4.25aIntensification (0.00006)\n5 Clade 1 Primate-parasites Clade 3c Primate-parasites (G/C/D) 0.90 14.46aRelaxation (1)\n6 Clade 1 Rodent-parasites Clade 3c Primate-parasites (G/C/D) 0.54 8.89aNP\n7 Clade 1 Rodent-parasites Clade 3d Primate-parasites (C/H/E/D/I) 0.37 13.01aNP\n8 Clade 1 Primate-parasites Clade 2 Primate-parasites 0.45 3.79 Relaxation (0,2)\n9 Clade 1 Primate-parasites Clade 2 Rodent-parasites 0.20 0.76 NP\n10 Clade 1 Rodent-parasites Clade 2 Primate-parasites 0.74 13.21aNP\n11 Clade 1 Rodent-parasites Clade 2 Rodent-parasites 0.93 24.39aIntensification (9.1e-7)\n12 Clade 2 Primate-parasites Clade 2 Rodent-parasites 0.87 12.60aNP\n13 Clade 1 Primate-parasites Clade 4 Rodent-parasites 0.15 0.14 NP14 Clade 1 Rodent-parasites Clade 4 Rodent-parasites 0.69 22.20\naRelaxation (0.4)\n15 Clade 3d Primate-parasites (B/E) Clade 3d Primate-parasites (C/H/E/D/I) 0.03 0.14 Intensification (0.04)16 Clade 3d Primate-parasites (B/E) Clade 2 Primate-parasites 0.72 18.91\naIntensification\n17 Clade 3d Primate-parasites (B/E) Clade 2 Rodent-parasites 0.31 4.99aNP\n18 Clade 3d Primate-parasites (B/E) Clade 4 Rodent-parasites 0.35 7.76aNP\n19 Clade 3d Primate-parasites (B/E) Clade 3c Primate-parasites (G/C/D) 0.37 3.91aIntensification (2.8e-7)\n20 Clade 2 Primate-parasites Clade 3d Primate-parasites (C/H/E/D/I) 0.93 37.86aIntensification (0.0002)\n21 Clade 3d Primate-parasites (C/H/E/D/I) Clade 2 Rodent-parasites 0.81 20.90aNP\n22 Clade 3d Primate-parasites (C/H/E/D/I) Clade 4 Rodent-parasites 0.72 15.04aNP\n23 Clade 2 Primate-parasites Clade 4 Rodent-parasites 1.0 27.64aNP\n24 Clade 3c Primate-parasites (G/C/D) Clade 3d Primate-parasites (C/H/E/D/I) 0.45 9.55aRelaxation (0.000008)\n25 Clade 2 Primate-parasites Clade 3c Primate-parasites (G/C/D) 1.0 23.68aRelaxation (0.5)\n26 Clade 3c Primate-parasites (G/C/D) Clade 2 Rodent-parasites 0.46 3.04 NP\n27 Clade 3c Primate-parasites (G/C/D) Clade 4 Rodent-parasites 0.44 3.94aNP\n28 Clade 4 Rodent-parasites Clade 2 Rodent-parasites 0.57 8.56aIntensification (0.03)\nThe coefficients of divergence ( \u03b8D) and their LRT values from pairwise cluster comparisons in the msp7 multigene family. LRT \u03b8Dis the (log) score for the likelihood\nratio test against the null hypothesis ( \u03b8D=0 )[ 5]. It is the output of DIVERGE and it follows a chi-square distribution with one degree of freedom; thus, values\ngreater than or equal to 3.84 (a) indicate functional divergence between pairwise clusters. Selection intensity (relaxation or intensification) found by the RELAX\nmethod is shown for paralogous pairwise comparisons (see Additional file 8). Comparisons 2, 4 and 15 revealed fewer positive selected sites on test branches than\non reference branches as well as an intensification of negative selected sites and non-significant \u03b8D. Comparisons 11, 19, 20 and 28 revealed an increased proportion of\npositive selected sites on the test branches, having an intensification of this kind of selection, while the proportion of negative selected sites st ayed the same or\ndecreased. The \u03b8Dvalues were statistically significant. Comparisons 5 and 24 gave a statistically significant \u03b8Dand relaxed selection (on test branches). NP: analysis was\nnot performed because proteins came from different speciesGarz\u00f3n-Ospina et al. BMC Evolutionary Biology  (2016) 16:256 Page 8 of 13always the duplicate \u2019s outcome [69]. There are other fates\nfor paralogous fragments such as non-functionalisation\n(or pseudogenisation), subfunctionalisation [69] or evenfunctional redundancy. Encoded-protein gene duplication\nin parasitic organisms involved in host recognition\ncould provide an advantage, regardless of whether suchduplicates increase host recognition ability. Plasmo-\ndium genomes have a lot of genes as multigene families\n[11\u201314, 44], some of them are functionally equivalent\nwhilst others have functionally diverged (they recognise\nd i f f e r e n th o s tr e c e p t o r s )[ 7 0 \u201373].\nThe msp7 family has been previously described in\neight species [15, 16, 24], displaying different expansion.The present study has analysed 4 new species and com-\npleted analysis for P. reichenowi . An unequal copy gene\nnumber was found in Plasmodium species, suggesting\nlineage or specie-specific duplications or deletions. Wealso found genes which have become pseudogenes,thereby confirming the birth-and-death model of evolu-\ntion for this family (Fig. 1). Then again, phylogenetic\nanalysis was used for establishing phylogenetic relation-ships amongst msp7 paralogues. According to the phylo-\ngenetic trees (Fig. 2 and Additional file 3), MSP7A/H(clade 1) was the most ancestral gene, followed by clade2 which is shared by monkey- and rodent-parasites.\nClade 5 was also an old clade since it is shared amongst\nmonkey- and rodent-parasites; however, not all monkey-parasites had this copy and it thus became lost in P.\nknowlesi ,P. coatneyi and P. inui . Moreover, these pro-\nteins in monkey- and rodent-parasites did not have theMSP_7C domain. The remaining clades were clustered\nin agreement with Plasmodium species \u2019relationships\n(e.g. P. vivax genes clustered with P. cynomolgi genes)\nand they were syntenic, suggesting they are orthologues.These expansions reproduced the genus phylogenetic rela-\ntionships. Species belonging to monkey-parasite lineagehad the highest copy number. P. vivax and P. cynomolgi\n(sister taxa) shared the whole msp7 repertory. P. inui is\nthe phylogenetically closest species to the aforementionedones, having 7 orthologues followed by P. knowlesi and\nP. coatneyi having 5 orthologues. The latter species are\nsister taxa sharing a common ancestor as well as the\nwhole msp7 repertory. The monkey-parasite lineage is a\nsister taxon to rodent-parasite lineage. At least two\northologous genes were found within these two lineages\nwhilst only one gene was shared between these and the\nhominid-parasite lineage (Fig. 1). The most ancientPlasmodium lineage is the bird/reptile-parasite. We\nanalysed P. gallinaceum and found just one large msp7\ngene. According to the MSP7 C-terminal phylogenetictree (Additional file 5), it is still unclear whether this\nl a r g eg e n ei so r t h o l o g o u s to the most ancestral gene\n(msp7A /H). As we did not find any more msp7 genes in\nthe P. gallinaceum partial genome, gene expansionshould have taken place after mammal-parasite radi-ation 40 million year ago [42].\nWe found 83 sequences between bordering genes in\nthe 13 genomes (Fig. 1 and Additional file 1); however,\n11 protein sequences did not have the MSP_7C domain\nat the C-terminal end, though some of them did clusterwith MSP7 proteins (those containing the MSP_7C do-\nmain). Proteins lacking such domain had high similarity\nwith MSP7s at the N-terminal end (Additional file 4).This suggested that proteins lacking an MSP_7C domain\n(MSP7-like) are incomplete duplicates or have lost the\ndomain throughout Plasmodium evolutionary history.\nOn the other hand, groups clustering paralogous pro-\nteins (3d clade) displayed an unusual pattern (Fig. 2 andAdditional file 3). Proteins such as Pviv/PcynMSP7E andPviv/PcynMSP7B seemed to be more similar within\nspecies than between species. A similar branch pattern\nwas observed in the MSP_7C phylogenetic tree (Addi-tional file 5), where PvivMSP7B was more similar to\nPvivMSP7E than PcynMSP7B. Likewise, PvivMSP7H\nwas more similar to PvivMSP7I whilst PcynMSP7H clus-tered together with PcynMSP7I. A previous study has\nshown that gene conversion takes place in pvivmsp7H\nand 7Igenes [23]; such branching pattern is therefore a\nconsequence of gene conversion. We also observed geneconversion tracks amongst P. vivax reference isolates in\nthe aforementioned genes, suggesting that this mechanism\nalso occurs in pvivmsp7B ,7Eand 7G; however, such genes\nare not near each other (Fig. 1) and there was no completegene homogenisation. Therefore, it is not clear whetherthis mechanism is taking place at present or they are\nancient gene conversion events.\nParasite invasion involves several protein-protein in-\nteractions between parasite and host. MSP1 is the pro-tein mediating initial interaction, this protein and\nMSP7 form a complex involved in parasite-host inter-action [7, 18, 21, 29]. MSP1 has shown an episodic\npositive selection signal throughout its evolutionary\nhistory [67, 68]; such positive selection is shown at an-cestral branches and is likely the result of adapting to\nnewly-appeared macaque species 3.7 \u20135.1 million years\nago [67] or during human switching [74]. Since MSP7is in a complex with MSP1 [7, 18, 29], the former should\nhave similar selective pressures and therefore similarbehaviour. We have found several lineages under strong\ndiversifying selection ( \u03c9> 10 [49], Additional file 6). As in\nMSP1 [67, 68], few internal branches were under episodic\nselection (Fig. 4a, e, f and g); this pattern could be the out-\ncome of adaptation to new hosts during Plasmodium\nsympatric speciation, as has been suggested for other anti-\ngens [67, 68]. On the other hand, several external lineages\n(branches) were under selection. This could be the\noutcome of changes in evolutionary rates throughoutmsp7 paralogous evolution which have been favoured byGarz\u00f3n-Ospina et al. BMC Evolutionary Biology  (2016) 16:256 Page 9 of 13selection since they may have promoted adaptation to a\nnew host or acquiring new molecular activities.\nPrevious work did not recognise codons under positive\nselection [15]; however, here we identified codons underselection by using improved and/or newly developed\nmethods (Fig. 4). The greatest amount of codons underpositive selection was located in central msp7 regions\nand a few at 5 \u2032or 3 \u2032-ends. Population genetics studies\nhave shown the central region to be the most poly-morphic and it seems to be involved in immune evasion\n[23, 24]. The positive selected sites found amongst species\nin central regions could thus be the consequence of hostadaptation to avoid host immune responses. On the other\nhand, positive selected sites at the encoding C-terminal re-\ngion could be the outcome of coevolution between hostreceptor and parasite MSP7 ligands and also the result of\nthe acquisition of new roles (Additional file 8).\nDespite functional redundancy having been suggested\nfor the MSP7 family [15, 18], some groups have shownthat MSP7 proteins appear not to bind to the same host\nreceptor [26]. Likewise, some PvivMSP7 proteins seemto be forming different protein complexes in the parasite\n[7, 27 \u201330] which might allow different parasite-host in-\nteractions. We could not find evidence of functional di-\nvergence in MSP7 paralogues when comparing different\nclades (e.g. clade 1 against clade 2) in a previous in silico\nstudy [15]. This could have been because orthologousproteins might use different regions to interact with a\nhost or with their own parasite proteins. The P. falcipa-\nrum (hominid-parasite lineage) MSP1 region involved in\nhost recognition is the 19 kDa fragment [75]; neverthe-less, the 33 kDa fragment in P. vivax (monkey-parasite\nlineage) facilitates parasite-host interaction [76]. There-\nfore, even though they are orthologous, both proteins\nhave differences in their evolutionary rates within func-\ntional regions [77]. Whether this behaviour also tookplace in MSP7, DIVERGE gave false negatives regarding\nfunctional divergence. We thus analysed MSP7 proteins\nfrom other Plasmodium species to assess functional\ndivergence amongst MSP7 clades (paralogous) but also\nwithin clades (orthologous). Unlike a previous study\n[15], just the MSP7 C-terminal region was analysed here,\ntaking into account that this region has the domain\n(MSP_7C) defining members of this family, it is the onlyMSP7 region in the protein complex [7], in P. vivax\nMSP7s C-terminal regions are highly conserved andunder negative selection whilst other regions are highlypolymorphic [23 \u201325] and most regions binding to red\nblood cells are in the MSP7 C-terminal region [21]. Wehave found changes in evolutionary rates amongst par-alogous proteins in this region. The coefficients of diver-\ngence ( \u03b8\nD) were statistically significantly larger than 0\nbetween some clades (Table 2 and Additional file 7),\nsuggesting that some MSP7s have diverged functionally.Such divergence could mean that different MSP7 pro-\nteins could form different parasite protein complexes or\nthat MPS7s could interact with different host receptors.We also found changes in evolutionary rates within\nclades (between orthologues) leading to large \u03b8\nDvalues\n(e.g. between monkey-parasite MSP7A and rodent-parasite\nMSP7A). This could have been due to functional diver-\ngence or different protein regions carrying out the function\n(as previously shown for MSP1 [75, 76]).\nIt has been demonstrated that duplicated genes ex-\nperience a brief period of relaxed selection early in theirhistory [69]. This relaxation could have led to pseudo-genisation or, rarely, evolving to new functions [69].\nMoreover, positive selection in duplicates could also\nlead to them acquiring new molecular activities [62];relaxed selection or intensification of positive selection\nmust thus be identified in MSP7s having functional di-\nvergence. Our DIVERGE results were consistent withRELAX results (Table 2). Proteins showing functional\ndivergence also displayed functional constraint relax-\nation or intensification of positive selection. However,some clades having high \u03b8\nDdid not show relaxation or\nintensification. This could have been due to episodic posi-tive selection. This kind of selection acts very quickly andinvolves a switch from negative selection to positive selec-\ntion and back to negative selection [62]. Episodic selection\nwas found in all msp7 paralogous clusters by two different\napproaches (Fig. 4, Additional files 6 and 7); consequently,\nepisodic positive selection allowing functional divergence\ncould not have been detected by RELAX.\nOn the other hand, some paralogous proteins had no\nstatistical \u03b8\nDvalues; they also displayed intensification of\nnegative selection, thereby suggesting that they are func-tionally equivalent. Furthermore, functional redundancy\nin MSP7H, 7I and/or 7B and 7E could be favoured by\ngene conversion; some MSP7 members could thereforeevolve by \u201cpartial gene conversion \u201daffecting some but\nnot all MSP7 paralogous proteins.\nConclusion\nWe have described the msp7 family in different Plasmo-\ndium species, using different phylogenetic and molecular\nevolution analyses. Although msp7 evolved mainly in\nline with a birth-and-death evolutionary model, somemembers have evolved in a concerted way. Gene conver-sion has taken place between some paralogous genes\nallowing gene sequence homogenisation, these paralo-\ngous genes consequently keeping the same function.However, some gene conversion tracks could be ancient\nand thus the homogenisation has been lost. In addition,\nsome paralogous proteins did not show changes in theirevolutionary rates; thus, MSP7A, 7B, 7C, 7E, 7H and 7I\nin monkey-parasites seem to be functionally equivalent\ncopies. Other MSP7 members showed alteration in theirGarz\u00f3n-Ospina et al. BMC Evolutionary Biology  (2016) 16:256 Page 10 of 13evolutionary rate as well as relaxed or intensified (positive)\nselection; functional divergence may thus have occurred\nin them. Such functional divergence could enable MSP7F,7G, 7K and 7L (from monkey-parasites) and MSP7A, 7B\nand 7C (from rodent-parasites) to form different parasite\nprotein complexes and/or recognise different host recep-tors during invasion. In fact, protein-protein assays have\nshown that PvivMSP7A interacts with PvivTRAg56.2 [30]\nwhilst PvivMSP7L has been found forming a complexwith a member of the MSP3 family [27]. Moreover,\nPvivMSP7G (but not 7C or 7L) is able to bind to human\nP-selectin whilst PberMSP7C binds better to mouse P-selectin than PberMSP7A [26]. The results described here\nhighlight this family \u2019s importance in the Plasmodium\ngenus. Further functional assays should be performed\nbased on these results to gain a deeper understanding of\nthe biology of Plasmodium invasion.\nAdditional files\nAdditional file 1: Eighty-tree sequences from MSP7 family found in 13\nPlasmodium genomes. The PlasmoDB accession numbers for msp7 genes\nfrom eight species are shown. (TXT 88 kb)\nAdditional file 2: Putative donor/acceptor sites in P. vinckei vinckei\nmsp7A . (PDF 42 kb)\nAdditional file 3: msp7 gene family phylogeny inferred by the maximum\nlikelihood method. Numbers represent different clades (based on Fig. 2\nnumbers from main text) whilst numbers on branches are bootstrap and\nposterior probability values. Thirteen major clades were identified on the\ntree; however, clades 1 and 6 were not clearly supported by bootstrapvalues. Proteins were clustered in agreement with parasite phylogeneticrelationships, clades 1 (red) and 2 (yellow) being the most ancestral ones;\nclade 5 could also be an old cluster. The clades clustering genes from\nmonkey-parasite lineage are depicted in green, proteins from rodent-parasitelineage in blue and hominid-parasite lineage in grey. The protein cluster inbrown is a P. inui specie-specific duplicate. Both ML and BY trees showed\nsimilar topologies, but only the ML tree is shown. Some internal brancheswere inconsistent between BY and ML trees. Since msp7 family has a complex\nevolutionary history (having gene conversion, intragenic recombination and/or natural selection) the tree inference is affected. However, external branches\nwere consistent in both topologies as well as in Fig 2 \u2019s tree. In BY analysis,\nthe settings for prior and likelihood were: prset aamodel = fixed (JONES);\nprset statefreqpr = fixed (empirical); lset rates = gamma (JTT + G + F). Morethan 11 million generations were required for reaching an ASDSF value\nlower than 0.01. The PSRF parameter was also used for monitoring\nconvergence (PSRF: 1.000). (TIF 3836 kb)\nAdditional file 4: Similarity values in the N-terminal region between\nMSP7 proteins and sequences lacking an MSP_7C domain. (PDF 24 kb)\nAdditional file 5: Phylogenetic tree inferred with the C-terminal (MSP_7C)\ndomain. Mammal-parasite MSP7 sequ ences containing the MSP_7C domain\nand the PgalMSP7 C-terminal domain were aligned and phylogenetic trees\nwere then inferred. PgalMSP7 clustered with the most ancestral MSP7 protein\n(clade 1, see Fig. 2 in the main text) though this group was not supported by\nbootstrap and/or posterior probability. The remaining sequences clusteredaccording to host-parasite lineages. Numbers on branches show bootstrapand posterior probabilities values. Clades shown in red and yellow were the\nmost ancestral ones. The clades clustering genes from monkey-parasite\nlineage are depicted in green, proteins from rodent-parasite lineage in blueand hominid-parasite lineage in grey. Both ML and BY trees showed similartopologies but only the ML tree is shown. Numbers outside the clades\nrepresent the number of clades in Fig. 2 from the main text. (TIF 3038 kb)Additional file 6: Episodic positive selection on MSP7 branches. \u03c9+ values\nreflect the maximum likelihood est imate rate of positive selection. p-value\nobtained after Holm-Bonferroni multiple testing correction. The Branch-site\nREL method was performed by HyPhy software using both amino acid and\nDNA phylogenies. The Datamonkey web server was also used for calculatingthis method. The number of sites under episodic positive selection wasidentified by MEME using Datamonkey. The letters in the first panel\ncorrespond to the letters in Fig. 4 from the main text. (PDF 292 kb)\nAdditional file 7: Putative sites involved in functional divergence.\nDIVERGE computed a posterior probability for detecting putative amino\nacids responsible for functional divergence in pairwise comparisons\nhaving statistical significant \u03b8\nDvalues. Such putative sites were highlighted\nin green and sites in the C-terminal region (MSP_7C domain) under positive\nselection found by the MEME method were tagged with a red plus symbol(+). Since functional divergence could involve relaxation of functional\nconstraint or could be due to positive selection, a perfect correlation\nbetween putative amino acids responsible for divergence and positiveselection would not have been expected. Positive selection might beinvolved in the acquisition of a new role but could also be the outcome of\nadaptation to a new host during Plasmodium \u2019s evolutionary history. Positive\nselected sites were inferred using the clade (e.g. sequences within clade 1) but\nnot using the sequences from the comparison (e.g. Clade 1 Primate-parasitesvs Clade 2 Primate-parasites). (PDF 478 kb)\nAdditional file 8: Selection intensity (functional constraint relaxation or\nselection intensification) throughout msp7 paralogous genes using the\npartitioned descriptive model. Three \u03c9parameters (positive, negative and\nneutral) and the relative proportion of sites are plotted for test (blue) and\nreference (red) branches. The grey vertical dashed line at \u03c9= 1 represents\nneutral evolution. The numbers in parenthesis indicate the comparison\nnumber in Table 2 from the main text. Comparisons 2, 4 and 15 show thatthe percentage of positive selected sites decreased on test branches; they\nalso showed an intensification of negative selected sites (on test branches),\nhaving non-significant \u03b8\nD. These results suggested functional redundancy.\nComparisons 11, 19, 20 and 28 displayed an increased percentage ofpositive selected sites having an intensification of this kind of selection\non the test branches whilst the percentage of negative selected sites\nremained equivalent or decreased. The \u03b8\nDvalues in these comparisons\nwere statistically significant, suggesting functional divergence. Comparison24 showed a statistically significant \u03b8\nDand relaxed selection, indicating\nfunctional divergence. (TIF 6617 kb)\nAbbreviationsASDSF: A standard deviation of split frequencies; Branch-site REL: Random\neffects branch-site method; BY: Bayesian method; DLTRS: Duplications, losses,\ntransfers, rates & sequence evolution; HyPhy: Hypothesis testing using\nphylogenies; Kb: Kilobases; MCMC: Metropolis-coupled Markov chain MonteCarlo; MEME: Mixed effects model of evolution; ML: Maximum likelihood;MSP3: Merozoite surface protein 3; MSP7: Merozoite surface protein 7;\nORFs: Open reading frames; PvivTRAg56.2: P. vivax tryptophan-rich antigen\n56.2; RDP: Recombination detection program; \u03b8\nD: Coefficient of divergence;\n\u03c9: Omega rate (d N/dS)\nAcknowledgements\nWe would like to thank Jason Garry for translating and reviewing themanuscript.\nFunding\nThis work was financed by the Departamento Administrativo de Ciencia,\nTecnolog\u00eda e Innovaci\u00f3n (COLCIENCIAS) through grant RC # 0309-2013.\nAvailability of data and materials\nThe datasets supporting this article \u2019s results are available in the Dryad Digital\nRepository (http://dx.doi.org/10.5061/dryad.3qk84) [78].\nAuthors \u2019contributions\nDG-O devised and designed the study, performed the molecular evolutionary\nanalysis and wrote the manuscript. JF-R participated in designing the study, the\nmolecular evolutionary analysis and writing the manuscript. MAP coordinated\nthe study and helped to write the manuscript. All the authors have read andapproved the final version of the manuscript.Garz\u00f3n-Ospina et al. BMC Evolutionary Biology  (2016) 16:256 Page 11 of 13Competing interests\nThe authors declare that they have no competing interests.\nConsent for publication\nNot applicable.\nEthics approval and consent to participate\nNot applicable.\nAuthor details\n1Molecular Biology and Immunology Department, Fundaci\u00f3n Instituto de\nInmunolog\u00eda de Colombia (FIDIC), Carrera 50#26-20, Bogot\u00e1, DC, Colombia.\n2PhD Programme in Biomedical and Biological Sciences, Universidad del\nRosario, Carrera 24#63C-69, Bogot\u00e1, DC, Colombia.3School of Medicine and\nHealth Sciences, Universidad del Rosario, Carrera 24#63C-69, Bogot\u00e1, DC,\nColombia.\nReceived: 15 September 2016 Accepted: 17 November 2016\nReferences\n1. Ohno S. Evolution by gene duplication. London, New York: Allen & Unwin;\nSpringer-Verlag; 1970.\n2. Zhang J. Evolution by gene duplication: an update. Trends Ecol Evol. 2003;\n18(6):292 \u20138.\n3. Nei M, Rooney AP. Concerted and birth-and-death evolution of multigene\nfamilies. Annu Rev Genet. 2005;39:121 \u201352.\n4. Kimura M. The neutral theory of molecular evolution. Cambridge\nCambridgeshire, New York: Cambridge University Press; 1983.\n5. Gu X. Statistical methods for testing functional divergence after gene\nduplication. Mol Biol Evol. 1999;16(12):1664 \u201374.\n6. Gaucher EA, Gu X, Miyamoto MM, Benner SA. Predicting functional\ndivergence in protein evolution by site-specific rate shifts. Trends Biochem\nSci. 2002;27(6):315 \u201321.\n7. Pachebat JA, Ling IT, Grainger M, Trucco C, Howell S, Fernandez-Reyes D,\nGunaratne R, Holder AA. The 22 kDa component of the protein complex on thesurface of Plasmodium falciparum merozoi t e si sd e r i v e df r o mal a r g e rp r e c u r s o r ,\nmerozoite surface protein 7. Mol Biochem Parasitol. 2001;117(1):83 \u20139.\n8. Kondrashov FA, Rogozin IB, Wolf YI, Koonin EV. Selection in the evolution of\ngene duplications. Genome Biol. 2002;3(2):RESEARCH0008.\n9. Duval L, Fourment M, Nerrienet E, Rousset D, Sadeuh SA, Goodman SM,\nAndriaholinirina NV, Randrianarivelojosia M, Paul RE, Robert V, et al. Africanapes as reservoirs of Plasmodium falciparum and the origin and\ndiversification of the Laverania subgenus. Proc Natl Acad Sci U S A. 2010;\n107(23):10561 \u20136.\n10. Hall N. Genomic insights into the other malaria. Nat Genet. 2012;44(9):962 \u20133.\n11. Tachibana S, Sullivan SA, Kawai S, Nakamura S, Kim HR, Goto N, Arisue N,\nPalacpac NM, Honma H, Yagi M, et al. Plasmodium cynomolgi genomesequences provide insight into Plasmodium vivax and the monkey malariaclade. Nat Genet. 2012;44(9):1051 \u20135.\n12. Singh V, Gupta P, Pande V. Revisiting the multigene families: Plasmodium\nvar and vir genes. J Vector Borne Dis. 2014;51(2):75 \u201381.\n13. Sundararaman SA, Plenderleith LJ, Liu W, Loy DE, Learn GH, Li Y, Shaw KS,\nAyouba A, Peeters M, Speede S, et al. Genomes of cryptic chimpanzeePlasmodium species reveal key evolutionary events leading to human\nmalaria. Nat Commun. 2016;7:11078.\n14. Gupta A, Thiruvengadam G, Desai SA. The conserved clag multigene family\nof malaria parasites: essential roles in host-pathogen interaction. Drug Resist\nUpdat. 2015;18:47 \u201354.\n15. Garzon-Ospina D, Cadavid LF, Patarroyo MA. Differential expansion of the\nmerozoite surface protein (msp)-7 gene family in Plasmodium speciesunder a birth-and-death model of evolution. Mol Phylogenet Evol. 2010;55(2):399 \u2013408.\n16. Kadekoppala M, Holder AA. Merozoite surface proteins of the malaria\nparasite: the MSP1 complex and the MSP7 family. Int J Parasitol. 2010;40(10):1155 \u201361.\n17. Mello K, Daly TM, Long CA, Burns JM, Bergman LW. Members of the\nmerozoite surface protein 7 family with similar expression patterns differ inability to protect against Plasmodium yoelii malaria. Infect Immun. 2004;72(2):1010 \u20138.18. Mello K, Daly TM, Morrisey J, Vaidya AB, Long CA, Bergman LW. A multigene\nfamily that interacts with the amino terminus of plasmodium MSP-1 identifiedusing the yeast two-hybrid system. Eukaryot Cell. 2002;1(6):915 \u201325.\n19. Bozdech Z, Mok S, Hu G, Imwong M, Jaidee A, Russell B, Ginsburg H, Nosten F,\nDay NP, White NJ, et al. The transcriptome of Plasmodium vivax reveals\ndivergence and diversity of transcriptional regulation in malaria parasites. Proc\nNatl Acad Sci U S A. 2008;105(42):16290 \u20135.\n20. Zhu L, Mok S, Imwong M, Jaidee A, Russell B, Nosten F, Day NP, White NJ,\nPreiser PR, Bozdech Z. New insights into the Plasmodium vivax\ntranscriptome using RNA-Seq. Sci Rep. 2016;6:20498.\n21. Garcia Y, Puentes A, Curtidor H, Cifuentes G, Reyes C, Barreto J, Moreno A,\nPatarroyo ME. Identifying merozoite surface protein 4 and merozoite surface\nprotein 7 Plasmodium falciparum protein family members specifically\nbinding to human erythrocytes suggests a new malarial parasite-redundant\nsurvival mechanism. J Med Chem. 2007;50(23):5665 \u201375.\n22. Tewari R, Ogun SA, Gunaratne RS, Crisanti A, Holder AA. Disruption of\nPlasmodium berghei merozoite surface protein 7 gene modulates parasite\ngrowth in vivo. Blood. 2005;105(1):394 \u20136.\n23. Garzon-Ospina D, Lopez C, Forero-Rodriguez J, Patarroyo MA. Genetic\ndiversity and selection in three Plasmodium vivax merozoite surface protein\n7 (Pvmsp-7) genes in a Colombian population. PLoS One. 2012;7(9):e45962.\n24. Garzon-Ospina D, Forero-Rodriguez J, Patarroyo MA. Heterogeneous genetic\ndiversity pattern in Plasmodium vivax genes encoding merozoite surfaceproteins (MSP) -7E, \u22127 F and -7 L. Malar J. 2014;13:495.\n25. Garzon-Ospina D, Romero-Murillo L, Tobon LF, Patarroyo MA. Low genetic\npolymorphism of merozoite surface proteins 7 and 10 in Colombian\nPlasmodium vivax isolates. Infect Genet Evol. 2011;11(2):528 \u201331.\n26. Perrin AJ, Bartholdson SJ, Wright GJ. P-selectin is a host receptor for\nPlasmodium MSP7 ligands. Malar J. 2015;14:238.\n27. Hostetler JB, Sharma S, Bartholdson SJ, Wright GJ, Fairhurst RM, Rayner JC. A\nLibrary of Plasmodium vivax Recombinant Merozoite Proteins Reveals NewVaccine Candidates and Protein-Protein Interactions. PLoS Negl Trop Dis.2015;9(12):e0004264.\n28. Lin CS, Uboldi AD, Epp C, Bujard H, Tsuboi T, Czabotar PE, Cowman AF.\nMultiple Plasmodium falciparum Merozoite Surface Protein 1 ComplexesMediate Merozoite Binding to Human Erythrocytes. J Biol Chem. 2016;291(14):7703 \u201315.\n29. Kauth CW, Woehlbier U, Kern M, Mekonnen Z, Lutz R, Mucke N, Langowski J,\nBujard H. Interactions between merozoite surface proteins 1, 6, and 7 of themalaria parasite Plasmodium falciparum. J Biol Chem. 2006;281(42):31517 \u201327.\n30. Tyagi K, Hossain ME, Thakur V, Aggarwal P, Malhotra P, Mohmmed A,\nSharma YD. Plasmodium vivax Tryptophan Rich Antigen PvTRAg36.6\nInteracts with PvETRAMP and PvTRAg56.6 Interacts with PvMSP7 during\nErythrocytic Stages of the Parasite. PLoS One. 2016;11(3):e0151065.\n31. Finn RD, Coggill P, Eberhardt RY, Eddy SR, Mistry J, Mitchell AL, Potter SC,\nPunta M, Qureshi M, Sangrador-Vegas A, et al. The Pfam protein familiesdatabase: towards a more sustainable future. Nucleic Acids Res. 2016;\n44(D1):D279 \u201385.\n32. Edgar RC. MUSCLE: multiple sequence alignment with high accuracy and\nhigh throughput. Nucleic Acids Res. 2004;32(5):1792 \u20137.\n33. Nicholas KB, Nicholas HBJ. GeneDoc: A tool for editing and annotating\nmultiple sequence alignments. 1997.\n34. Abascal F, Zardoya R, Posada D. ProtTest: selection of best-fit models of\nprotein evolution. Bioinformatics. 2005;21(9):2104 \u20135.\n35. Stamatakis A. RAxML version 8: a tool for phylogenetic analysis and post-\nanalysis of large phylogenies. Bioinformatics. 2014;30(9):1312 \u20133.\n36. Altekar G, Dwarkadas S, Huelsenbeck JP, Ronquist F. Parallel Metropolis\ncoupled Markov chain Monte Carlo for Bayesian phylogenetic inference.\nBioinformatics. 2004;20(3):407 \u201315.\n37. Ronquist F, Teslenko M, van der Mark P, Ayres DL, Darling A, Hohna S,\nLarget B, Liu L, Suchard MA, Huelsenbeck JP. MrBayes 3.2: efficient Bayesianphylogenetic inference and model choice across a large model space. SystBiol. 2012;61(3):539 \u201342.\n38. Miller MA, Pfeiffer W, Schwartz T. Creating the CIPRES Science Gateway for\ninference of large phylogenetic trees. Proceedings of the GatewayComputing Environments Workshop (GCE). New Orleans, LA; 2010. p. 1 \u20138.\nhttp://www.phylo.org/sub_sections/portal/sc2010_paper.pdf.\n3 9 . M i l l e rM A ,S c h w a r t zT ,P i c k e t tB E ,H eS ,K l e mE B ,S c h e u e r m a n nR H ,\nPassarotti M, Kaufman S, O \u2019Leary MA. A RESTful API for Access to\nPhylogenetic Tools via the CIPRES Science Gateway. Evol BioinformaticsOnline. 2015;11:43 \u20138.Garz\u00f3n-Ospina et al. BMC Evolutionary Biology  (2016) 16:256 Page 12 of 1340. Sjostrand J, Tofigh A, Daubin V, Arvestad L, Sennblad B, Lagergren J. A Bayesian\nmethod for analyzing lateral gene transfer. Syst Biol. 2014;63(3):409 \u201320.\n41. Sjostrand J, Sennblad B, Arvestad L, Lagergren J. DLRS: gene tree evolution\nin light of a species tree. Bioinformatics. 2012;28(22):2994 \u20135.\n42. Pacheco MA, Battistuzzi FU, Junge RE, Cornejo OE, Williams CV, Landau I,\nRabetafika L, Snounou G, Jones-Engel L, Escalante AA. Timing the origin of\nhuman malarias: the lemur puzzle. BMC Evol Biol. 2011;11:299.\n43. Carlton JM, Adams JH, Silva JC, Bidwell SL, Lorenzi H, Caler E, Crabtree J,\nAngiuoli SV, Merino EF, Amedeo P, et al. Comparative genomics of theneglected human malaria parasite Plasmodium vivax. Nature. 2008;455(7214):757 \u201363.\n44. Neafsey DE, Galinsky K, Jiang RH, Young L, Sykes SM, Saif S, Gujja S,\nGoldberg JM, Young S, Zeng Q, et al. The malaria parasite Plasmodium\nvivax exhibits greater genetic diversity than Plasmodium falciparum. Nat\nGenet. 2012;44(9):1046 \u201350.\n45. Betran E, Rozas J, Navarro A, Barbadilla A. The estimation of the number and\nthe length distribution of gene conversion tracts from population DNAsequence data. Genetics. 1997;146(1):89 \u201399.\n46. Sawyer S. Statistical tests for detecting gene conversion. Mol Biol Evol. 1989;\n6(5):526 \u201338.\n47. Librado P, Rozas J. DnaSP v5: a software for comprehensive analysis of DNA\npolymorphism data. Bioinformatics. 2009;25(11):1451 \u20132.\n48. Martin DP, Lemey P, Lott M, Moulton V, Posada D, Lefeuvre P. RDP3: a flexible\nand fast computer program for analyzing recombination. Bioinformatics. 2010;26(19):2462 \u20133.\n49. Kosakovsky Pond SL, Murrell B, Fourment M, Frost SD, Delport W, Scheffler K. A\nrandom effects branch-site model for detecting episodic diversifying selection.\nMol Biol Evol. 2011;28(11):3033 \u201343.\n50. Suyama M, Torrents D, Bork P. PAL2NAL: robust conversion of protein\nsequence alignments into the corresponding codon alignments. Nucleic\nAcids Res. 2006;34(Web Server issue):W609 \u201312.\n51. Darriba D, Taboada GL, Doallo R, Posada D. jModelTest 2: more models,\nnew heuristics and parallel computing. Nat Methods. 2012;9(8):772.\n52. Pond SL, Frost SD, Muse SV. HyPhy: hypothesis testing using phylogenies.\nBioinformatics. 2005;21(5):676 \u20139.\n53. Delport W, Poon AF, Frost SD, Kosakovsky Pond SL. Datamonkey 2010: a\nsuite of phylogenetic analysis tools for evolutionary biology. Bioinformatics.2010;26(19):2455 \u20137.\n54. Murrell B, Wertheim JO, Moola S, Weighill T, Scheffler K, Kosakovsky Pond\nSL. Detecting individual sites subject to episodic diversifying selection. PLoSGenet. 2012;8(7):e1002764.\n55. Gu X, Zou Y, Su Z, Huang W, Zhou Z, Arendsee Z, Zeng Y. An update of\nDIVERGE software for functional divergence analysis of protein family. MolBiol Evol. 2013;30(7):1713 \u20139.\n56. Yan J, Cai Z. Molecular evolution and functional divergence of the cytochrome\nP450 3 (CYP3) Family in Actinopterygii (ray-finned fish). PLoS One.2010;5(12):e14276.\n57. Zhao Z, Liu H, Luo Y, Zhou S, An L, Wang C, Jin Q, Zhou M, Xu JR.\nMolecular evolution and functional divergence of tubulin superfamily in thefungal tree of life. Sci Rep. 2014;4:6746.\n58. Wang Y, Gu X. Functional divergence in the caspase gene family and\naltered functional constraints: statistical analysis and prediction. Genetics.2001;158(3):1311 \u201320.\n59. Zhou H, Gu J, Lamont SJ, Gu X. Evolutionary analysis for functional\ndivergence of the toll-like receptor gene family and altered functional\nconstraints. J Mol Evol. 2007;65(2):119 \u201323.\n60. McNally D, Fares MA. In silico identification of functional divergence\nbetween the multiple groEL gene paralogs in Chlamydiae. BMC Evol Biol.\n2007;7:81.\n61. Song W, Qin Y, Zhu Y, Yin G, Wu N, Li Y, Hu Y. Delineation of plant caleosin\nresidues critical for functional divergence, positive selection and\ncoevolution. BMC Evol Biol. 2014;14:124.\n62. Wertheim JO, Murrell B, Smith MD, Kosakovsky Pond SL, Scheffler K. RELAX:\ndetecting relaxed selection in a phylogenetic framework. Mol Biol Evol.\n2015;32(3):820 \u201332.\n63. Mongui A, Perez-Leal O, Soto SC, Cortes J, Patarroyo MA. Cloning, expression,\nand characterisation of a Plasmodium vivax MSP7 family merozoite surface\nprotein. Biochem Biophys Res Commun. 2006;351(3):639 \u201344.\n64. Burge C, Karlin S. Prediction of complete gene structures in human\ngenomic DNA. J Mol Biol. 1997;268(1):78 \u201394.65. Arisue N, Kawai S, Hirai M, Palacpac NM, Jia M, Kaneko A, Tanabe K, Horii T.\nClues to evolution of the SERA multigene family in 18 Plasmodium species.\nPLoS One. 2011;6(3):e17775.\n66. Rice BL, Acosta MM, Pacheco MA, Carlton JM, Barnwell JW, Escalante AA.\nThe origin and diversification of the merozoite surface protein 3 (msp3)\nmulti-gene family in Plasmodium vivax and related parasites. Mol\nPhylogenet Evol. 2014;78:172 \u201384.\n67. Sawai H, Otani H, Arisue N, Palacpac N, de Oliveira Martins L, Pathirana S,\nHandunnetti S, Kawai S, Kishino H, Horii T, et al. Lineage-specific positive\nselection at the merozoite surface protein 1 (msp1) locus of Plasmodium\nvivax and related simian malaria parasites. BMC Evol Biol. 2010;10:52.\n68. Muehlenbein MP, Pacheco MA, Taylor JE, Prall SP, Ambu L, Nathan S, Alsisto S,\nRamirez D, Escalante AA. Accelerated diversification of nonhuman primate\nmalarias in Southeast Asia: adaptive radiation or geographic speciation? Mol\nBiol Evol. 2015;32(2):422 \u201339.\n69. Lynch M, Conery JS. The evolutionary fate and consequences of duplicate\ngenes. Science. 2000;290(5494):1151 \u20135.\n70. Orlandi PA, Klotz FW, Haynes JD. A malaria invasion receptor, the 175-\nkilodalton erythrocyte binding antigen of Plasmodium falciparum recognizesthe terminal Neu5Ac(alpha 2 \u20133)Gal- sequences of glycophorin A. J Cell Biol.\n1992;116(4):901 \u20139.\n71. Maier AG, Duraisingh MT, Reeder JC, Patel SS, Kazura JW, Zimmerman PA,\nCowman AF. Plasmodium falciparum erythrocyte invasion throughglycophorin C and selection for Gerbich negativity in human populations.Nat Med. 2003;9(1):87 \u201392.\n72. Triglia T, Duraisingh MT, Good RT, Cowman AF. Reticulocyte-binding protein\nhomologue 1 is required for sialic acid-dependent invasion into humanerythrocytes by Plasmodium falciparum. Mol Microbiol. 2005;55(1):162 \u201374.\n73. Stubbs J, Simpson KM, Triglia T, Plouffe D, Tonkin CJ, Duraisingh MT, Maier\nAG, Winzeler EA, Cowman AF. Molecular mechanism for switching of P.falciparum invasion pathways into human erythrocytes. Science. 2005;309(5739):1384 \u20137.\n74. Mu J, Joy DA, Duan J, Huang Y, Carlton J, Walker J, Barnwell J, Beerli P,\nCharleston MA, Pybus OG, et al. Host switch leads to emergence ofPlasmodium vivax malaria in humans. Mol Biol Evol. 2005;22(8):1686 \u201393.\n75. Urquiza M, Rodriguez LE, Suarez JE, Guzman F, Ocampo M, Curtidor H,\nSegura C, Trujillo E, Patarroyo ME. Identification of Plasmodium falciparum\nMSP-1 peptides able to bind to human red blood cells. Parasite Immunol.\n1996;18(10):515 \u201326.\n76. Rodriguez LE, Urquiza M, Ocampo M, Curtidor H, Suarez J, Garcia J, Vera R,\nPuentes A, Lopez R, Pinto M, et al. Plasmodium vivax MSP-1 peptides have\nhigh specific binding activity to human reticulocytes. Vaccine. 2002;20(9 \u201310):\n1331 \u20139.\n77. Parobek CM, Bailey JA, Hathaway NJ, Socheat D, Rogers WO, Juliano JJ.\nDiffering patterns of selection and geospatial genetic diversity within twoleading Plasmodium vivax candidate vaccine antigens. PLoS Negl Trop Dis.\n2014;8(4):e2796.\n78. Garz\u00f3n-Ospina D, Forero-Rodr\u00edguez JA. PM: Data from: Evidence of\nfunctional divergence in MSP7 paralogous proteins: a molecular-\nevolutionary and phylogenetic analysis. Dryad Digital Repository 2016, http://\ndx.doi.org/10.5061/dryad.1q26f.\n\u2022  We accept pre-submission inquiries  \n\u0081  Our selector tool helps you to \ufb01nd the most relevant journal\n\u0081  We provide round the clock customer support \n\u0081  Convenient online submission\n\u0081  Thorough peer review\n\u0081  Inclusion in PubMed and all major indexing services \n\u0081  Maximum visibility for your research\nSubmit your manuscript at\nwww.biomedcentral.com/submitSubmit your next manuscript to BioMed Central \nand we will help you at every step:Garz\u00f3n-Ospina et al. BMC Evolutionary Biology  (2016) 16:256 Page 13 of 13RESEARCH Open Access\nLow genetic diversity and functional constraint in\nloci encoding Plasmodium vivax P12 and P38\nproteins in the Colombian population\nJohanna Forero-Rodr\u00edguez1,2\u2020, Diego Garz\u00f3n-Ospina1,3\u2020and Manuel A Patarroyo1,3*\nAbstract\nBackground: Plasmodium vivax is one of the five species causing malaria in human beings, affecting around 391\nmillion people annually. The development of an anti-malarial vaccine has been proposed as an alternative for\ncontrolling this disease. However, its development has been hampered by allele-specific responses produced by the\nhigh genetic diversity shown by some parasite antigens. Evaluating these antigens \u2019genetic diversity is thus essential\nwhen designing a completely effective vaccine.\nMethods: The gene sequences of Plasmodium vivax p12 (pv12 ) and p38(pv38 ), obtained from field isolates in\nColombia, were used for evaluating haplotype polymorphism and distribution by population genetics analysis. The\nevolutionary forces generating the variation pattern so observed were also determined.\nResults: Both pv12 and pv38 were shown to have low genetic diversity. The neutral model for pv12 could not be\ndiscarded, whilst polymorphism in pv38 was maintained by balanced selection restricted to the gene \u2019s5 \u2032region.\nBoth encoded proteins seemed to have functional/structural constraints due to the presence of s48/45 domains,\nwhich were seen to be highly conserved.\nConclusions: Due to the role that malaria parasite P12 and P38 proteins seem to play during invasion in\nPlasmodium species, added to the Pv12 and Pv38 antigenic characteristics and the low genetic diversity observed,\nthese proteins might be good candidates to be evaluated in the design of a multistage/multi-antigen vaccine.\nKeywords: 6-Cys, pv12 ,pv38 , s48/45 domain, Functional constraint, Plasmodium vivax , Genetic diversity,\nAnti-malarial vaccine\nBackground\nMalaria is a disease caused by protozoan parasites from\nthePlasmodium genus ,five of which cause the disease\nin human beings ( Plasmodium falciparum, Plasmodium\nvivax, Plasmodium ovale, Plasmodium malariae andPlasmodium knowlesi ) [1,2]. This parasite is transmitted\nby the bite of an infected Anopheles female mosquito.\nAround 3.3 billon people are at risk of malaria annually,mainly in tropical and subtropical areas of the world,children aged less than five years and pregnant women\nbeing the most vulnerable [3]. Plasmodium falciparum is\nresponsible for the disease \u2019s most lethal form, being pre-\ndominantly found on the African continent whilst P. vivax\nis widely distributed around the world. Even though it has\nbeen thought that infection caused by the latter species\nwas benign, recent studies have shown that P. vivax can\ncause clinical complications [4]. It has been found that\n2,488 million people are at risk of becoming infected by P.\nvivax on the continents of Asia and America, 132 to 391\nmillion cases occurring annually [5].\nIn spite of control strategies having been introduced in\ndifferent countries, malaria continues to be a public health\nproblem due to the parasite \u2019s resistance to anti-malarial\ntreatments [6] and the vector \u2019s resistance to insecticides\n[7], among other causes. More effective measures have* Correspondence: mapatarr.fidic@gmail.com\n\u2020Equal contributors\n1Molecular Biology and Immunology Department, Fundaci\u00f3n Instituto de\nInmunolog\u00eda de Colombia (FIDIC), Carrera 50 No. 26-20, Bogot\u00e1, DC,\nColombia\n3School of Medicine and Health Sciences, Universidad del Rosario, Bogot\u00e1,\nDC, Colombia\nFull list of author information is available at the end of the article\n\u00a9 2014 Forero-Rodr\u00edguez et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the\nCreative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use,distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons PublicDomain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in thisarticle, unless otherwise stated.Forero-Rodr\u00edguez et al. Malaria Journal 2014, 13:58\nhttp://www.malariajournal.com/content/13/1/58thus to be implemented for controlling such disease, in-\ncluding the development of an anti-malarial vaccine.\nSeveral antigens have been characterized as promising\ncandidates for inclusion in a vaccine [8,9], however, thegenetic diversity of some of them [10-18] has hampered\nthe development of such vaccine [19,20] as these geneticvariations provoke allele-specific responses [21,22] mak-\ning them become a mechanism for evading the immune\nsystem [23]. It has been necessary to focus vaccine de-velopment on conserved domains or antigens to avoid\nsuch responses [24], since these regions could have func-\ntional constraint and have had slower evolution [25].\nDeveloping a multi-antigen vaccine against the para-\nsite \u2019s blood stage has been focused on blocking all host-\npathogen interactions to stop merozoite entry to redblood cells (RBC) [26]. A group of proteins anchored to\nthe membrane via glycosylphosphatidylinositol (GPI)\nhas been identified in P. falciparum , predominantly lo-\ncated in detergent-resistant membrane (DRM) domains\n[27,28]; they have been implicated in the parasite \u2019si n i -\ntial interaction with RBC [29-33] and some have been\nconsidered as being candidates for being included in a\nvaccine [34,35]. One group of proteins belonging to the\n6-cystein (6-Cys) family is particularly noteworthy amongthese DRMs (i.e., Pf12, Pf38, Pf41 and Pf92) as they have\nbeen characterized by having s48/45 domains (ID in\nPFAM: PF07422). Members of this family are expressedduring different parasite stages [28,36] and some of\nthem (e.g., Pf48/45, Pf230) have been considered as vac-\ncine candidates for the sexual stage [36,37].\nPf12 and Pf38 are expressed during late stages of the\nintra-erythrocyte cycle, each having two high binding pep-tides, suggesting an active role during invasion of RBC[30]. Orthologous genes encoding these proteins have\nbeen characterized recently in P. vivax [38,39]. Both pro-\nteins have a signal peptide, a GPI anchor sequence and\nhave been associated with DRMs [38,39]. Pv12 has two\ns48/45 domains [39] whilst Pv38 has a single domain lo-\ncated towards the C-terminal end [38] .These proteins\nhave been shown to be antigenic [38-40], suggesting that\nthey are exposed to the immune system, probably during\nP. vivax invasion of RBC.\nThe present study involved a population genetics ana-\nlysis for evaluating the genetic diversity of pv12 and\npv38 loci and the evolutionary processes generating this\nvariation pattern; the results revealed these antigens \u2019low\ngenetic diversity in the Colombian population, possiblydue to functional/structural constraints in s48/45 do-\nmains. Since the proteins encoded by these genes share\nstructural characteristics with other vaccine candidates,added to the fact that Pv12 and Pv38 are targets for the\nimmune response [38-40] and have conserved domains,\nthey should be considered when designing a multistage/multi-antigen anti-malarial vaccine.Methods\nEthics statement\nThe parasitized DNA used in this study was extractedfrom total blood collected from different Colombian areas\n(Antioquia, Atl\u00e1ntico, Bogot\u00e1, Caquet\u00e1, Cordoba, Choc\u00f3,\nGuain\u00eda, Guaviare, Magdalena, Meta, Nari\u00f1o, and Tolima)from 2007 to 2010. All P. vivax -infected patients who pro-\nvided blood samples were notified about the object of thestudy and signed an informed consent form if they agreedto participate. All procedures involved in taking blood\nsamples were approved by Fundaci\u00f3n Instituto de Inmu-\nnolog\u00eda de Colombia (FIDIC) ethics committee.\nParasitized DNA presence and integrity\nParasitized DNA presence and integrity in 100 samplesstored at -20\u00b0C (2007-2010) at FIDIC (from different\nareas of Colombia) were evaluated by 18S ribosomal\nRNA gene amplification using specific primers for P.\nvivax (SSU-F 5 \u2032-ATGAACGAGATCTTAACCTGC-3 \u2032\nand SSU-R 5 \u2032-CATCACGATATGTA5TGATAAAGAT-\nTACC-3 \u2032) in a touchdown PCR [41]. The reaction con-\ntained: 1x Mango Taq reaction buffer (Bioline), 2.5 mMMgCl\n2, 0.25 mM dNTPs, 0.5 mM of each primer, 0.1 U\nMango Taq DNA polymerase ( Bioline) and 10-40 ng gDNA\nin 10 mL final volume. The PCR thermal profile was: oneinitial denaturing cycle at 95\u00b0C (5 min), followed by ten\ncycles at 95\u00b0C (20 sec), annealing at 65\u00b0C (30 sec) and anextension step at 72\u00b0C (45 sec). Annealing temperature was\nreduced by 1\u00b0C in each cycle until reaching 55\u00b0C; 35 add-\nitional cycles were run at this temperature followed by afinal extension cycle at 72\u00b0C (10 min). PCR products were\nvisualized by elec trophoresis on 1.5% agarose gel in 1\u00d7\nTAE, using 1 \u03bcL SYBR-Safe (Invitrogen).\nIdentifying infection caused by single Plasmodium vivax\nstrain\nInfection by the single P. vivax strain was identified by\nPCR-RFLP of the pvmsp-1 polymorphic marker. The\npvmsp-1 gene fragment 2 (blocks 6, 7 and 8) was ampli-\nfied using direct 5 \u2032-AAAATCGAGAGCATGATCGCC\nACTGAGAAG-3 \u2032and reverse 5 \u2032-AGCTTGTACTTTC\nCATAGTGGTCCAG-3 \u2032primers [42]. The amplified\nfragments were digested with Alu I and Mnl I restric-tion enzymes, as described elsewhere [42]. The products\nwere visualized by electrophoresis on 3% agarose gel in1\u00d7 TAE, using 1 \u03bcL SYBR-Safe (Invitrogen).\nPCR amplification of pv12 and pv38 genes\nA set of primers was designed for amplifying each of the\ngenes based on Sal-I reference strain sequences (acces-\nsion numbers in PlasmoDB: PVX_113775 for pv12 and\nPVX_097960 for pv38 ). The following primers were\nused: for pv12 ,pv12- direct 5 \u2032-GTACCGCTTAACAC\nCGC-3 \u2032and pv12- reverse 5 \u2032-GCACTACATTATAAAGForero-Rodr\u00edguez et al. Malaria Journal 2014, 13:58 Page 2 of 12\nhttp://www.malariajournal.com/content/13/1/58AAAAGGACC-3 \u2032and for pv38 ,pv38- direct 5 \u2032-CGCT\nTCTTTCACCGCTTC-3 \u2032and pv38- reverse 5 \u2032-CACAC\nATTAACGCTGCTTCG-3 \u2032. The PCR reaction mixture\ncontained 10 mM Tris HCL, 50 mM KCl (GeneAmp\n10\u00d7 PCR Buffer II [Applied Biosystems]), 1.5 mM MgCl 2,\n0.2 mM of each dNTP , 0.5 \u03bcM of each primer, 0.76 U\nAmplitaq Gold DNA polymerase (Applied Biosystems)and 10-40 ng gDNA in a 50 \u03bcL final volume. The PCR\nthermal profile was as follows: one cycle at 95\u00b0C (7 min),\n40 cycles at 95\u00b0C (20 sec), 56\u00b0C (30 sec), 72\u00b0C (1 min) and\na final extension cycle at 72\u00b0C (10 min). PCR products\nwere purified using a commercial UltraClean PCR Clean-up kit (MO BIO). The purified PCR products were se-\nquenced in both directions with the amplification primers\nusing the BigDye method with capillary electrophoresis,using ABI-3730 XL (MACROGEN, Seoul, South Korea).\nTwo independent PCR products were sequenced to en-\nsure that errors were ruled out.\nAnalysing genetic diversity\nThe electropherograms obtained by sequencing wereanalysed and forward and reverse sequences were as-\nsembled using CLC Main workbench software v.5 (CLC\nbio, Cambridge, MA, USA). The pv12 and pv38 genes\nwere analysed and compared to reference sequences\nobtained from several sequencing projects [43,44] (acces-\nsion numbers, pv12: XM_001616094.1, AFBK01001496.1,\nAFNI01000939.1, AFMK01001167.1 and AFNJ01001458.1;\npv38: XM_001613202.1, AFNI01000834.1, AFNJ010000\n90.1, AFMK01001057.1 and AFBK01001340.1) or those\nreported in the GenBank database (accession numbers\nforpv12 : GU476521.1; and for pv38 : JF427569.1 and\nJF427570.1). Gene Runner software was used for trans-\nlating the sequences for deducing the amino acid se-\nquences. These sequences were then aligned using the\nMUSCLE algorithm [45], and manually edited. Aminoacid alignment was then used for inferring DNA using\nPAL2NAL software [46].\nDnaSP software (v.5) [47] was used for evaluating intra-\npopulation genetic polymorphism by calculating: the num-ber of polymorphic segregating sites (Ss), the number of\nsingleton sites (s), the number of parsimony-informativesites (Ps), the number of haplotypes (H), haplotype diver-\nsity (Hd, which was multiplied by (n-1)/n according to\nDepaulis and Veuille [47,48]), the Watterson estimator(\u03b8w) and nucleotide diversity per site ( \u03c0). DNA sequence\nvariation was calculated using the sequences obtainedfrom the aforementioned databases, plus the Colombianones (worldwide isolates, global diversity) and just those\nobtained for the Colombian population (local diversity).\nThe frequency for each Colombian haplotype was also es-timated by count and year.\nTwo test families were used for evaluating the neutral\nmolecular evolution model for the Colombian population:(1) frequency spectrum test, and (2) haplotype test. The\nformer involved calculating Tajima \u2019s D statistics [49], Fu\nand Li \u2019s D* and F* [50] and Fay and Wu \u2019s H statistic [51].\nTajima \u2019s D statistic compares the difference between seg-\nregating sites and the average of nucleotide differences\nbetween two randomly taken sequences. Fu and Li \u2019sD *\nstatistic takes the difference between the number of\nsingleton sites and the total of mutations, whilst F* takes\nthe difference between the number of singleton sites andthe average of nucleotide differences between two ran-\ndomly taken sequences. Fay and Wu \u2019s H statistic is based\non the difference of the average number of nucleotide dif-\nferences between pairs of sequences and the frequency of\nthe derived variants. Fu \u2019s Fs statistic [52], K-test and H-\ntest [48] are tests for calculating haplotype distribution.\nThe Fs statistic compares the number of haplotypes ob-\nserved to the expected number of haplotypes in a random\nsample. K-test and H-test [48] are based on haplotypenumber and haplotype diversity, respectively; these statis-\ntics are conditioned by sample size (n) and the number of\nsegregating sites (Ss). Test significance was determined bycoalescence simulations using DnaSP (v.5) [47] and ALLE-\nLIX software (kindly supplied by Dr Sylvain Mousset).\nSites having gaps were not taken into account in any ofthe tests performed.\nThe effect of natural selection was evaluated regarding\nintra and interspecies; the average number of non-synonymous substitutions per non-synonymous site (d\nN)\nand the average number of synonymous substitutions persynonymous site (d\nS) were calculated for the former by\nusing the modified Nei-Gojobori method [53]. The signifi-\ncant differences between the above were determined by\nusing Fisher \u2019s exact test (suitable for d Nand d S< 10) and\ncodon-based Z-test incorporated in MEGA software (v.5)\n[54]. Differences between d Nand d Sper site were calcu-\nl a t e db yu s i n gS L A C ,F E L ,R E L[ 5 5 ] ,I F E L[ 5 6 ] ,M E M E\n[57], and FUBAR [58] methods. The average number of\nnon-synonymous divergence substitutions per non-\nsynonymous site (K N) and the average number of syn-\nonymous divergence substitutions per synonymous site\n(KS) were calculated using the modified Nei-Gojobori\nmethod [53], with Jukes-Cantor correction [59], to infernatural selection signals which may have prevailed dur-\ning malarial parasite evolutionary history (interspecies;using Plasmodium cynomolgi (accession number BAEJ\n01001076.1) and P. knowlesi (accession number NC_011\n912.1) orthologous sequences ). The significant differ-\nences between K\nNand K Swere determined by using a\ncodon-based Z-test incorporated in MEGA software(v.5) [54]. The McDonald-Kreitman test [60] was alsocalculated; this is based on a comparison of intraspecific\npolymorphism to interspecific divergence (using Plasmo-\ndium cynomolgi (accession number BAEJ01001076.1) and\nP. knowlesi (accession number NC_011912.1) orthologousForero-Rodr\u00edguez et al. Malaria Journal 2014, 13:58 Page 3 of 12\nhttp://www.malariajournal.com/content/13/1/58sequences). This test involved using a web server\n[61], which takes Jukes-Cantor divergence correction\ninto account [59]. All the above tests were calculatedusing the sequences obtained from the databases plus\nthe Colombian ones and just those obtained for the\nColombian population.\nZ\nnS[62] and ZZ [63] statistics were calculated for\nevaluating the influence of linkage disequilibrium (LD)and intragenic recombination, respectively. The minimumnumber of recombination (Rm) events was also calculated;\nthis included calculating effective population size and the\nprobability of recombination between adjacent nucleotidesper generation [64]. Additionally, the GARD method [65]\navailable at the Datamonkey web server [66] was per-\nformed. These tests were performed using the sequencesobtained from the Colombian population.\nResults and discussion\nThe presence of genomic DNA (gDNA) and identification\nof single Plasmodium vivax strain infection\nAn18Ssubunit rRNA gene fragment was amplified from\n100 samples of P. vivax collected from different areas of\nColombia and stored from 2007 to 2010. Seventy-seven\nsamples revealed an amplicon at the expected size, indi-cating the presence of P. vivax gDNA. A region of the\npvmsp-1 gene was then amplified and digested with re-\nstriction enzymes, showing that seven of the 77 samplesproving positive for P. vivax had multiple infections. Only\n70 samples were thus considered for later analysis. Due tothe low number of samples collected from some areas, theywere grouped according to geographical localisation and\nepidemiological conditions (South-west: Choc\u00f3, Nari\u00f1o;\nSouth-east: Caquet\u00e1, Guain\u00eda, Guaviare, Meta; Midwest:Bogota, Tolima; North-west: A tl\u00e1ntico, Antioquia Cordoba,\nMagdalena).\nGenetic diversity in pv12\nSeventy samples amplified a 1,200 base pair (bp) frag-ment corresponding to the pv12 gene (South-west n = 6;\nSouth-east: n = 20; Midwest: n = 8; North-west: n =36).\nThese amplicons were purified and sequenced; the se-\nquences were then analysed, compared to different refer-ence sequences obtained from various sequencing projects\n[43,44] and those having a different haplotype were de-\nposited in the GenBank database (accession numbersKF667328 and KF667329).\nFour single nucleotide polymorphisms (SNP) were ob-\nserved throughout the pv12 gene sequence (Figure 1A)\nlocated in positions 375 (N125K), 379 (T127A), 539\n(L180W) and 662 (N221S). Only one SNP (nucleotide\n375) was found in the Colombian population. A repeatregion was observed; it was formed by previously re-\nported amino acids N[A/V][H/Q] [39], in which an in-\nsertion was observed in the North Korean sequence(Figure 1A, haplotype 1) and deletions in the Colombian\nsequences (Figure 1A, haplotypes 2 and 3).\nSix haplotypes were found in pv12 (Figure 1A and\nTable 1) around the world, four of which are present inColombia at 8.7, 5.8, 10.1, and 75.4% frequency for\nhaplotypes 2, 3, 5 and 6, respectively. Haplotypes 2, 5and 6 were present in the different Colombian locations\n(Additional file 1), haplotype 6 being the most predomin-\nant per year (2007 n = 9; 2008 n = 17; 2009 n = 15; 2010n = 29) and per location, having higher than 70% fre-\nquency (Figure 2A and Additional file 1). The remaining\nhaplotypes were absent or had low frequency (Figure 2Aand Additional file 1). Interestingly, haplotype 3 was\npresent in Colombia during 2009 but absent in the other\nyears studied (Figure 2A). The percentage of samplesfrom the South-east area (some of them presenting\nhaplotype 3) was greater than for other years, suggesting\nthat haplotype 3 was restricted to a particular geograph-ical area (Additional file 1) and/or that this had very low\nfrequency in different Colombian subpopulations. Haplo-\ntype 2 was absent from 2007 to 2008 but present between2009 and 2010 (Figure 2A); differently to haplotype 3, this\nhaplotype was present everywhere, except in the South-\nwest location (Additional file 1). This appeared to beconsistent with previous studies which have reported\nnumerous private haplotypes in American Plasmodium\nvivax populations [67]. These results suggested that the\nColombian population had one predominant pv12 haplo-\ntype and several low frequency alleles, which are geo-\ngraphically isolated or were not detected during someperiods of time. Since P. vivax populations within coun-\ntries seem to be strongly structured [67], new pv12 haplo-\ntypes could appear in other parasite populations.\nThis gene had 0.0004 \u00b1 0.0001 global nucleotide diver-\nsity ( \u03c0) and 0.0003 \u00b1 0.0001 for the Colombian popula-\ntion (Table 1). This value was about 2.5 times less thanthat reported for its orthologue in P. falciparum (\u03c0=\n0.001) [68]; however, both values were low when com-pared to other membrane proteins [10-14,17], suggestingthat this gene is highly conserved in different Plasmo-\ndium species. This value places pv12 among the most\nconserved antigen-encoding genes characterized to date\ninP. vivax .\nMutations in pv12 appear to be selectively neutral\nSeveral tests for evaluating the hypothesis that mutationsinpv12 are neutral were performed. No significant values\nwere found for the Tajima, Fu and Li, Fay and Wu or Fu\ntests (Table 2); likewise, the Colombian population \u2019sn u m -\nber of haplotypes (4) and haplotype diversity (0.406 \u00b10.07) (Table 2) were as expected under neutrality accord-ing to the K-test and H-test. Since neutrality could not be\nruled out, the mutations or haplotypes found in pv12\ncould have been randomly fixed; this might explain theForero-Rodr\u00edguez et al. Malaria Journal 2014, 13:58 Page 4 of 12\nhttp://www.malariajournal.com/content/13/1/58possible geographical isolation of haplotype 3, since differ-\nent alleles could have become fixed in different popula-tions according to the neutral hypothesis. Alternatively,\nthe geographical isolation of haplotype 3 could have re-\nsulted from the structured P. vivax population in America,\nwhere haplotypes may have diversified in situ .\nNatural selection in pv12\nThe gene was split into two regions: region A, nucleotides\n1-546 (amino acids 1-182 including one s48/45 domain)\nand region B, nucleotides 547-1,095 (amino acids 183-365including the other s48/45 domain). Synonymous substi-\ntution per synonymous site (d\nS) and non-synonymous\nsubstitution per non-synonymous site rates (d N)w e r ec a l -\nculated using the gene \u2019s total length to evaluate whether\nnatural selection had any effect on pv12 evolution. Full\nlength gene and split regions had non-significant values\n(Table 3); likewise, when d Nand d Swere estimated for\ns48/45 domains, no significant values were observed(Additional file 2), contrary to that suggested for pf12,\nwhere purifying selection action has been reported [69].The Datamonkey server was used for calculating d\nNand\ndSrates for each codon; no selected sites were found, indi-\ncating (once more) that the gene did not appear to deviatefrom neutrality.\nHowever, assessing how natural selection acts on low\ngenetic diversity antigens is not easy [70]; the fact thatPlasmodium vivax shares its most recent common ances-\ntor with parasites infecting primates (e.g. P. cynomolgi and\nP. knowlesi ) led to inferring patterns which may have\nprevailed during their evolutionary history [70,71]. When\nsynonymous divergence substitution per synonymous site\n(K\nS) and non-synonymous divergence substitution per\nnon-synonymous site (K N) rates were calculated, a signifi-\ncantly higher K Sthan K Nwas found (Table 4). Moreover, a\nsliding window for \u03c9(dN/dSand/or K N/KS) revealed < 1\nvalues throughout the gene (Figure 3), which could have\nbeen a consequence of negative selection. Moreover,\nsignificant values were observed when the McDonald-Kreitman (MK) test was used for comparing intraspe-\ncific polymorphism and interspecific divergence (using\nall the haplotypes found for this gene): P\nN/PS>D N/DS\n(Table 5), revealing (similar to K Srates) a large accumula-\ntion of synonymous substitutions between species, whichcould be interpreted as negative selection. Such accumula-\ntion of interspecies synonymous substitutions suggested\nthat evolution tried to maintain protein structure by elim-inating all deleterious mutations. However, when the MK\ntest was done with haplotypes found in Colombia (and in\nspite of the accumulation of synonymous substitutions be-tween species), no significant values were observed in this\npopulation (Table 5). Although Pv12 is exposed to the im-\nmune system [39,40], it had a high level of conservation.This pattern could have been because pv12 had diverged\nFigure 1 pv12 and pv38 haplotype alignment. A. Alignment of the six haplotypes found in the pv12 gene. Haplotypes 2, 3, 5 and 6 were\nfound in the Colombian population. B.Alignment of the 17 haplotypes found in pv38 , 14 of them found in the Colombian population\n(haplotypes 1, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, and 17). The dots indicate nucleotide identity and dashes indicate nucleotide absence.\nNumbering is based on the Sal-I reference sequence.\nTable 1 Estimators for pv12 and pv38 global and local\ngenetic diversity\nn Gene Sites Ss S Ps H \u03b8w (sd) \u03c0(sd)\nWorldwide isolates\n76 pv12 927 4 3 1 6 0.0009 (0.0005) 0.0004 (0.0001)\n53 pv38 1,035 9 1 8 17 0.0019 (0.0006) 0.0026 (0.0002)\nColombian population70 pv12 1,047 1 0 1 4 0.0002 (0.0002) 0.0003 (0.0001)\n46 pv38 1,062 8 0 8 14 0.0017 (0.0006) 0.0024 (0.0002)\nEstimators of genetic diversity were calculated using the sequences obtained\nfrom databases plus the Colombian ones (worldwide isolates, global diversity)and just those obtained for the Colombian population (Colombian population,local diversity). n: number of isolates, sites: total of sites analysed excludinggaps, Ss: number of segregating sites, S: number of singleton sites, Ps: numberof informative-parsimonious sites, H: number of haplotypes, \u03b8\nw: Watterson\nestimator, \u03c0: nucleotide diversity per site. sd: standard deviation.Forero-Rodr\u00edguez et al. Malaria Journal 2014, 13:58 Page 5 of 12\nhttp://www.malariajournal.com/content/13/1/58by negative selection, due to a possible functional/struc-\ntural constraint imposed by the presence of s48/45 do-mains [72] which seem to play an important role during\nhost cell recognition [30,69,72].\nGenetic diversity in pv38\nOnly 46 out of 70 samples could be amplified for the\npv38 gene, giving a 1,121 bp fragment (South-west n = 6;\nSouth-east: n = 13; Midwest: n = 4; North-west: n = 23).\nThe 46 sequences obtained from Colombian isolates were\ncompared to and analysed regarding reference sequencesobtained from different regions of the world [43,44].\nColombian sequences that have a different haplotype to\nthat of previously reported ones can be found in GenBank(accession numbers KF667330-KF667340).\nNine SNPs were observed in the pv38 gene (Figure 1B),\nmost of which were no-synonymous (nucleotides: 88(R30S), 206/207 (A69V), 209 (R70L), 524/525 (T175N),\n880 (M294L), and 998 (S333N)), similar to that found in\nPf38 [73]. Positions 525 and 969 produced synonymous\nsubstitutions (a change in protein sequence was generated\nwhen the substitution in position 525 was accompanied\nwith another one in position 524). The parasite populationin Colombia has eight of these nine SNPs, all being\ninformative-parsimonious sites. Similar to that reportedfor its orthologue in P. falciparum [73], most substitutions\nwere found in the gene \u2019s5 \u2032region.\nSeventeen haplotypes were identified from alignment\n(including sequences from different regions of the world)\n(Figure 1B), 14 of which were found in Colombia \u2019s para-\nsite population at different frequencies: 11% haplotype 1,\n4% haplotype 5, 2% haplotype 6, 20% haplotype 7, 15%\nhaplotype 8, 7% haplotype 9, 2% haplotype 10, 4% haplo-type 11, 13% haplotype 12, 4% haplotype 13, 2% haplotype\n14, 4% haplotype 15, 7% haplotype 16, and 4% haplotype\n17. Most haplotypes were found in intermediate frequen-cies per year (2007 n = 6; 2008 n = 6; 2009 n = 8; 2010 n =\n26) and none exceeded 50% (Figure 2B). The absence of\nsome haplotypes in determined years, or in some loca-tions, could not just have been due to the low frequency\nwhich they might have had but also to the difference in\nthe number of samples for each year (n = 6 in 2007, n =6 in 2008, n = 8 in 2009 and n = 26 in 2010) or because\nAmerican P. vivax populations appear to be structured\nand therefore several privative haplotypes might be\nfound [67].\n\u03c0in this gene was 0.0026 \u00b1 0.0002 worldwide and\n0.0024 \u00b1 0.0002 in the Colombian population (Table 1),this being 1.3 times lower than that for its orthologue in\nP. falciparum (\u03c0= 0.0034) [68,73] showing that the pv38\nFigure 2 Frequency of the pv12 and pv38 haplotypes present in the Colombian population. A. Frequency per year for the four pv12\nhaplotypes found in the Colombian population: n = 9 in 2007, n = 17 in 2008, n = 15 in 2009 and n = 29 in 2010. B.Frequency per year for the 14\npv38 haplotypes found in the Colombian population. n = 6 in 2007, n = 6 in 2008, n = 8 in 2009 and n = 26 in 2010.\nTable 2 pv12 and pv38 neutrality, linkage disequilibrium and recombination tests for the Colombian population\nN Gene Tajima Fu and Li Fay and\nWu \u2019sHFu \u2019s\nFsK-test H-test (sd) Z ns ZZ RM\nDD * F *\n70 pv12 0.365 0.516 0.548 0.000 0.902 4 0.406 (0.07) ND ND 0\n46 pv38 1.147 1.304 1.473 \u22121.275 \u22124.451 14* 0.890 (0.02)* 0.107 0.125 2\nn: number of isolates.\n*: p < 0.05.ND: not determined.sd: standard deviation.Forero-Rodr\u00edguez et al. Malaria Journal 2014, 13:58 Page 6 of 12\nhttp://www.malariajournal.com/content/13/1/58gene had low diversity, at least in the two main species\naffecting human beings.\nDeviation from the neutral model of molecular evolution\ninpv38\nTajima \u2019sD ,F ua n dL i \u2019s D* and F*, Fay and Wu \u2019sHa n d\nFu\u2019s Fs neutrality tests did not reveal statistically signifi-\ncant values (Table 2), suggesting that the gene might\nfollow the neutral evolution model. However, the pres-ence of 14 haplotypes and 0.890 \u00b1 0.02 haplotype diver-\nsity in the Colombian population was greater than that\nexpected under neutrality according to K-test and H-test results (Table 2). This suggested balanced ancestral\npolymorphism [48], being similar to that reported for\ntheP. falciparum p38 gene which showed evidence of\nbalanced selection in 5 \u2019region [73].\nNatural selection in pv38\nA modified Nei Gojobori method was used for calculat-\ning d Nand d Srates for showing some type of selection\nin the pv38 gene. Similar to that used regarding pv12 ,\nthepv38 gene was divided into two regions: region A,\ncovering position 1-459 (amino acids 1-153) and region\nB, nucleotides 460-1,065 (amino acids 154-355 includingTable 3 Synonymous substitution per synonymous site rate (d S) and non-synonymous substitution per\nnon-synonymous site rate (d N) for pv12 and pv38 genes\nn Gene Region A Region B Full length gene\ndS(se) d N(se) d S(se) d N(se) d S(se) d N(se)\nWorldwide isolates\n76 pv12 0.000 (0.000) 0.001 (0.001) 0.000 (0.000) 0.000 (0.000) 0.000 (0.000) 0.001 (0.000)\n53 pv38 0.001 (0.001) 0.003 (0.002) 0.006 (0.004) 0.001 (0.001) 0.004 (0.002) 0.002 (0.001)\nColombian population\n70 pv12 0.000 (0.000) 0.001 (0.001) 0.000 (0.000) 0.000 (0.000) 0.000 (0.000) 0.000 (0.000)\n46 pv38 0.001 (0.001) 0.003 (0.002) 0.005 (0.004) 0.001 (0.001) 0.004 (0.002) 0.002 (0.001)\ndNand d Srates were estimated by using sequences obtained from databases together with Colombian ones (worldwide isolates) and just with those obtained in\nthe Colombian population. n: number of isolates. pv12 : region A, nucleotides 1-546 and region B, nucleotides 547-1,095. pv38 : region A, nucleotides 1-459 and\nregion B, nucleotides 460-1,065. se: standard error. No statistically significant differences were found.\nTable 4 Synonymous divergence substitution per synonymous site (K S) rate and non-synonymous divergence\nsubstitution per non-synonymous site (K N) rate\nP. vivax/P. Cynomolgi\nn Gene s48/45 domain in region A s48/45 domain in region B Full-length gene\nKS(se) K N(se) K S(se) K N(se) K S(se) K N(se)\nWorldwide isolates\n78 pv12 0.016 (0.003) \u2020 0.005 (0.002) 0.019 (0.004) \u2020 0.003 (0.001) 0.016 (0.002)* 0.004 (0.001)\n54 pv38 - 0.030 (0.007) \u2020 0.005 (0.001) 0.031 (0.004)* 0.007 (0.001)\nColombian isolates71 pv12 0.018 (0.003) \u2020 0.005 (0.001) 0.021 (0.004) \u2020 0.003 (0.001) 0.016 (0.002)* 0.005 (0.001)\n47 pv38 - 0.033 (0.007) \u2020 0.006 (0.001) 0.033 (0.004)* 0.008 (0.001)\nP. vivax/P. knowlesi\nn Gene s48/45 domain in region A s48/45 domain in region B Full-length gene\nK\nS(se) K N(se) K S(se) K N(se) K S(se) K N(se)\nWorldwide isolates78 pv12 0.025 (0.005) \u2020 0.006 (0.002) 0.020 (0.004) \u2020 0.003 (0.001) 0.022 (0.003)* 0.005 (0.001)\n54 pv38 - 0.028 (0.006) \u2020 0.005 (0.001) 0.034 (0.004)* 0.007 (0.001)\nColombian isolates71 pv12 0.027 (0.006) \u2020 0.006 (0.001) 0.022 (0.005) \u2020 0.003 (0.001) 0.023 (0.002)* 0.005 (0.001)\n47 pv38 - 0.031 (0.007) \u2020 0.005 (0.001) 0.038 (0.005)* 0.008 (0.001)\nKNand K Srates were estimated by using sequences obtained from databases (worldwide isolates) together with Colombian ones, and just with those obtained in\nthe Colombian population. n: number of isolates. pv12 s48/45 domain in region A: nucleotides 82-471; pv12 s48/45 domain in region B: nucleotides 589-906; pv38\ns48/45 domain in region B: nucleotides 481-852; -: There are no s48/45 domains in pv38 region A. Numbering is based on the Sal-I reference sequence.\n*: p < 0.000, \u2020: p < 0.002.Forero-Rodr\u00edguez et al. Malaria Journal 2014, 13:58 Page 7 of 12\nhttp://www.malariajournal.com/content/13/1/58the s48/45 domain). There were more d Nsubstitutions in\nregion A than d Ssubstitutions, whilst there were more d S\nsubstitutions in region B than d Nones, even though no\nsignificant values were observed (Table 4 and Additional\nfile 2). Selection tests by codon revealed positive selection\nin codon 70 and negative selection in codons 175 and 323,suggesting that the gene was influenced by selection.\nWhen the long-term effect of natural selection was ex-\nplored by comparing divergence rates (K\nSand K N),pv38\nhad a higher statistically significant K Srate than K N(Table 4), revealing \u03c9values below 1 throughout the gene\n(Figure 3), suggesting divergence by negative selection.\nThe McDonald-Kreitman test revealed statistically sig-\nnificant values (Table 4), when intraspecific polymorphism\nand interspecific divergence was compared, showing P N/\nPS>D N/DS(p < 0.02). This result could have been the re-\nsult of either a negative selection or a balanced selection[61,74]. K-test and H-test results (Table 2) and the pres-\nence of different haplotypes at intermediate frequencies(Figure 2B) suggested that it is most probable that pv38\nFigure 3 Sliding window analysis for \u03c9rates. The\u03c9(dN/dS) values for Plasmodium vivax p12 and p38are shown in blue, whereas the\ndivergence ( \u03c9:KN/KS) between Plasmodium vivax and Plasmodium cynomolgi (Pcyn) and Plasmodium vivax and Plasmodium knowlesi (Pkno) is\ndisplayed in magenta and purple, respectively. A gene diagram is shown below the sliding window. Regions encoding signal peptides (brown),\nGPI anchors (green), s48/45 domains (dark cyan) as well as the N[A/V][H/Q] repeat (black) are indicated. Non-synonymous (red) and synonymous\n(orange) substitutions are shown with vertical lines above each gene.\nTable 5 McDonald-Kreitman test for evaluating the action of natural selection\nP. vivax/P. cynomolgi P. vivax/P. knowlesi\nWorldwide isolates\nFixed Polymorphic P N/PS>D N/DSp-values Fixed Polymorphic P N/PS>D N/DSp-values\npv12 Non-synonymous substitutions 78.66 4 0.002 93.86 4 0.000\nSynonymous substitutions 190.23 0 340.47 0\npv38 Non-synonymous substitutions 85.90 6 0.004 85.14 6 0.003\nSynonymous substitutions 257.31 3 265.94 3\nColombian population\npv12 Non-synonymous substitutions 93.05 1 0.146 115.54 1 0.083\nSynonymous substitutions 197.20 0 347.80 0\npv38 Non-synonymous substitutions 89.22 5 0.023 88.50 5 0.016\nSynonymous substitutions 248.66 3 264.90 3\nThe McDonald-Kreitman test was done using sequences obtained from databases (worldwide isolates) together with Colombian ones, and just with those\nobtained in the Colombian population. The interspecies divergence data were obtained from comparing Plasmodium vivax sequences with two related species:\nPlasmodium cynomolgi and Plasmodium knowlesi . Significant values are shown in italics.Forero-Rodr\u00edguez et al. Malaria Journal 2014, 13:58 Page 8 of 12\nhttp://www.malariajournal.com/content/13/1/58was influenced by balanced selection, similar to that re-\nported for P. falciparum [73]. Such selection seemed to be\ndomain specific. Significant values were observed for\nregion A (p = 0.014) when intraspecific polymorphism\nand interspecific divergence was calculated in each re-\ngion (Additional file 3), this being where most of the substi-tutions found became accumulat ed, whilst neutrality could\nnot be ruled out for region B (p = 0.1). Functional/structuralconstraint due to the presence of an s48/45 domain wasalso probable for pv38 ,g i v e nt h i sr e g i o n \u2019s low diversity,\ntwo negatively selected sites and a statistically signifi-\ncant K\nS>K N.\nLinkage disequilibrium (LD) and recombination\nSeveral statistics were calculated for determining possibleassociations between polymorphisms and/or the presence\nof recombination in pv38 .Z\nnSdid not reveal statistically\nsignificant values, indicating that pv38 polymorphisms\nwere not associated. Lineal regression between linkagedisequilibrium (LD) and nucleotide distance revealed a re-\nduction in LD as nucleotide distance increased, indicatingthat intragenic recombination might have led to new vari-\nations being produced.\nThe ZZ statistic was calculated to confirm whether\nrecombination affected pv38 evolution, showing no sig-\nnificant values (Table 2); however, 2 RM (minimum\nrecombination events) were found. The GARD method(in Datamonkey web server) gave a recombination break-\npoint in position 524. Prior studies have suggested that\nnew haplotypes could be produced through recombin-ation in spite of functional constraints [73]. Intragenic re-\ncombination could thus be one of the factors promoting\ndiversity in the pv38 gene. Crosslinking during recombin-\nation could produce new combinations between the gene \u2019s\n5\u2032(region A) and 3 \u2032region (region B) as the breakpoint\nfound in this gene was located upstream of the region en-coding the s48/45 domain (region B). As only one poly-\nmorphic site was found in pv12 , the aforementioned tests\nwere not carried for this gene.\npv12 and pv38 should be considered for an antimalarial\nvaccine\nThe lack of a totally effective vaccine against human malar-ial parasites is at least partly due to high genetic diversity\nfound in proteins involved in red blood cell invasion. Thesemolecules \u2019constant exposure to the host \u2019s immune system\nallows the fixation of mutations generating an adaptiveadvantage preventing their recognition. Antigens such aspvmsp-1 ,pvdbp ,pvmsp-3 \u03b1,pvmsp-5 ,pvmsp-7C ,pvmsp-\n7H,pvmsp-7I andpvama-1 have shown high genetic diver-\nsity which appears to be maintained by positive-balancingselection [10-15,75-78]; however, other antigens are highly\nconserved despite being exposed to the host \u2019si m m u n es y s -\ntem. Surface antigens such as pvmsp-4 ,pvmsp-7A ,pvmsp-7K,pvmsp-8 ,pvmsp-10 ,pv230 or others in the rhoptries\n(pvrap-1 andpvrap-2 ) appear to evolve more slowly due to\na possible functional constraint in their encoded proteins\n[70,71,79-82]. Thus, most mutations have become elimi-\nnated from the population, maintaining a conserved\nprotein structure, even throughout these parasites \u2019evo-\nlutionary history [70,71]. The latter behaviour seems to\nhave been directing pv12 and pv38 evolution, highlighting\nhigh conservation at both intra- and inter-species level\ndue to the influence of negative selection exerted on s48/\n45 domains which are important for red blood cell recog-\nnition [30]. Although antigens having low genetic diversityare usually not immunogenic [83] nor do they induce\nprotection-inducing responses [84], some limited poly-\nmorphism antigens have been shown to be able to induceimmunogenicity and protection [85]. Therefore, pv12 and\npv38 (or their s48/45 domains) should be evaluated re-\ngarding vaccine development because immune responsesagainst 6-Cys family antigens appear to be directed against\nstructural epitopes in s48/45 domains [86-88], blocking\nsuch domains should prevent invasion [30,88] and beinghighly conserved and having a functional constraint,\nallele-specific immune responses are thus avoided.\nConclusions\nThe p12and p38genes in P. vivax were seen to have low\ngenetic diversity; the regions encoding the s48/45 domains\nseemed to be functionally or structurally constrained. Sev-eral members of the 6-Cys family are found on the surface\nof malaria parasites in every stage [28,36-39,69] and some\nof them (e g, P48/45, P230) are considered to be promis-ing (transmission-blocking) vaccine candidates [36,37,87].\nEpitopes identified by monoclonal antibodies against this\ntype of protein are structural and have been localizedwithin s48/45 domains [86,87] which seem to be involved\nin host-pathogen interaction [30,72]. Since pv12 and pv38\nshare structural characteristics with members of the 6-Cys\nfamily, added to their antigenic characteristics [38-40] and\nthe low genetic diversity found in this study, the proteins\nencoded by these genes or their functionally/structurallyconstrained (conserved) regions could be born in mind\nwhen designing a multistage, multi-antigen subunit-based\nanti-malarial vaccine.\nAdditional files\nAdditional file 1: pv12 and pv38 haplotypes distribution in the\nColombian population. Haplotype distribution found in pv12 (A) and\npv38 (B) from 2007 to 2010.\nAdditional file 2: Synonymous substitution per synonymous site\nrate (d S) and non-synonymous substitution per non-synonymous\nsite rate (d N) in s48/45 domains from pv12 and pv38 genes. No\nstatistically significant differences were found by codon-based Z-test or\nFisher \u2019s exact tests. se: Standard error. pv12 s48/45 domain in region A:\nnucleotides 82-471; pv12 s48/45 domain in region B: nucleotides 589-906;Forero-Rodr\u00edguez et al. Malaria Journal 2014, 13:58 Page 9 of 12\nhttp://www.malariajournal.com/content/13/1/58pv38 s48/45 domain in region B: nucleotides 481-852 -: There is no s48/\n45 domain in the pv38 region. Numbering is based on the Sal-I reference\nsequence.\nAdditional file 3: McDonald-Kreitman test for evaluating the action\nof natural selection in pv12 and pv38 gene regions A and B. The\nMcDonald-Kreitman test was done using sequences obtained from\ndatabases (worldwide isolates) together with Colombian ones, and just\nwith those obtained in the Colombian population. The interspecies\ndivergence data was obtained from comparing Plasmodium vivax\nsequences with two related species: Plasmodium cynomolgi and\nPlasmodium knowlesi . Significant values are underlined. pv12 : region A,\nnucleotides 1-546 and region B, nucleotides 547-1,095. pv38 : region A,\nnucleotides 1-459 and region B, nucleotides 460-1,065.\nCompeting interestsThe authors declare that they have no competing interests.\nAuthors \u2019contributions\nJF-R devised the study, participated in designing it, performed the\nexperiments, made the population genetics analysis and wrote the\nmanuscript. DG-O devised and designed the study, helped perform the\nexperiments, carried out the population genetics analysis and wrote themanuscript. MAP devised and coordinated the study, and helped to writethe manuscript. All the authors have read and approved the final manuscript.\nAcknowledgements\nWe would especially like to thank Dr Sylvain Mousset who provided the\nALLELIX software for our analysis. We would also like to thank Jason Garry\nfor translating the manuscript and Professor Manuel E. Patarroyo for hiscomments and suggestions. This work was financed by the \u201cDepartamento\nAdministrativo de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n (COLCIENCIAS) \u201dthrough\ncontract RC # 0309-2013. JF-R received financing through COLCIENCIAScooperation agreement # 0757-2012.\nAuthor details\n1Molecular Biology and Immunology Department, Fundaci\u00f3n Instituto de\nInmunolog\u00eda de Colombia (FIDIC), Carrera 50 No. 26-20, Bogot\u00e1, DC,\nColombia.2Microbiology postgraduate programme, Universidad Nacional de\nColombia, Bogot\u00e1, DC, Colombia.3School of Medicine and Health Sciences,\nUniversidad del Rosario, Bogot\u00e1, DC, Colombia.\nReceived: 14 September 2013 Accepted: 13 February 2014\nPublished: 18 February 2014\nReferences\n1. Rich SM, Ayala FJ: Progress in malaria research: the case for\nphylogenetics. Adv Parasitol 2003, 54:255 \u2013280.\n2. White NJ: Plasmodium knowlesi : the fifth human malaria parasite.\nClin Infect Dis 2008, 46:172 \u2013173.\n3. WHO: World Malaria Report 2012. Geneva: World Health Organization; 2012.\nhttp://www.who.int/malaria/publications/world_malaria_report_2012/\nwmr2012_no_profiles.pdf.\n4. Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, Anstey NM: Vivax malaria:\nneglected and not benign. Am J Trop Med Hyg 2007, 77:79\u201387.\n5. Gething PW, Elyazar IR, Moyes CL, Smith DL, Battle KE, Guerra CA, Patil AP,\nTatem AJ, Howes RE, Myers MF, George DB, Horby P, Wertheim HF, PriceRN, M\u00fceller I, Baird JK, Hay SI: A long neglected world malaria map:\nPlasmodium vivax endemicity in 2010. PLoS Negl Trop Dis 2012, 6:e1814.\n6. Drug resistance in malaria. http://www.who.int/csr/resources/publications/\ndrugresist/malaria.pdf.\n7. Ranson H, Rossiter L, Ortelli F, Jensen B, Wang X, Roth CW, Collins FH,\nHemingway J: Identification of a novel class of insect glutathione\nS-transferases involved in resistance to DDT in the malaria vectorAnopheles gambiae .Biochem J 2001, 359:295 \u2013304.\n8. Carvalho LJ, Daniel-Ribeiro CT, Goto H: Malaria vaccine: candidate\nantigens, mechanisms, constraints and prospects. Scand J Immunol 2002,\n56:327 \u2013343.\n9. Jones TR, Hoffman SL: Malaria vaccine development. Clin Microbiol Rev\n1994, 7:303 \u2013310.10. Gomez A, Suarez CF, Martinez P, Saravia C, Patarroyo MA: High\npolymorphism in Plasmodium vivax merozoite surface protein-5 (MSP5).\nParasitology 2006, 133:661 \u2013672.\n11. Martinez P, Suarez CF, Cardenas PP, Patarroyo MA: Plasmodium vivax Duffy\nbinding protein: a modular evolutionary proposal. Parasitology 2004,\n128:353 \u2013366.\n12. Putaporntip C, Jongwutiwes S, Seethamchai S, Kanbara H, Tanabe K: Intragenic\nrecombination in the 3 \u2032portion of the merozoite surface protein 1 gene of\nPlasmodium vivax .Mol Biochem Parasitol 2000, 109:111 \u2013119.\n13. Putaporntip C, Udomsangpetch R, Pattanawong U, Cui L, Jongwutiwes S:\nGenetic diversity of the Plasmodium vivax merozoite surface protein-5\nlocus from diverse geographic origins. Gene 2010, 456:24\u201335.\n14. Garzon-Ospina D, Lopez C, Forero-Rodriguez J, Patarroyo MA: Genetic diversity\nand selection in three Plasmodium vivax merozoite surface protein 7\n(Pvmsp-7) genes in a Colombian population. PLoS One 2012, 7:e45962.\n15. Figtree M, Pasay CJ, Slade R, Cheng Q, Cloonan N, Walker J, Saul A:\nPlasmodium vivax synonymous substitution frequencies, evolution and\npopulation structure deduced from diversity in AMA 1 and MSP 1 genes.Mol Biochem Parasitol 2000, 108:53\u201366.\n16. Mascorro CN, Zhao K, Khuntirat B, Sattabongkot J, Yan G, Escalante AA, Cui\nL:Molecular evolution and intragenic recombination of the merozoite\nsurface protein MSP-3alpha from the malaria parasite Plasmodium vivax\nin Thailand. Parasitology 2005, 131:25\u201335.\n17. Escalante AA, Lal AA, Ayala FJ: Genetic polymorphism and natural selection\nin the malaria parasite Plasmodium falciparum .Genetics 1998, 149:189 \u2013202.\n18. Chenet SM, Tapia LL, Escalante AA, Durand S, Lucas C, Bacon DJ: Genetic\ndiversity and population structure of genes encoding vaccine candidateantigens of Plasmodium vivax. Malar J 2012, 11:68.\n19. Takala SL, Plowe CV: Genetic diversity and malaria vaccine design, testing\nand efficacy: preventing and overcoming \u2018vaccine resistant malaria \u2019.\nParasite Immunol 2009, 31:560 \u2013573.\n20. Genton B, Reed ZH: Asexual blood-stage malaria vaccine development:\nfacing the challenges. Curr Opin Infect Dis 2007, 20:467 \u2013475.\n21. Fluck C, Smith T, Beck HP, Irion A, Betuela I, Alpers MP, Anders R, Saul A,\nGenton B, Felger I: Strain-specific humoral response to a polymorphic\nmalaria vaccine. Infect Immun 2004, 72:6300 \u20136305.\n22. Ouattara A, Takala-Harrison S, Thera MA, Coulibaly D, Niangaly A, Saye R,\nTolo Y, Dutta S, Heppner DG, Soisson L, Diggs CL, Vekemans J, Cohen J,\nBlackwelder WC, Dube T, Laurens MB, Doumbo OK, Plowe CV: Molecular\nbasis of allele-specific efficacy of a blood-stage malaria vaccine: vaccine\ndevelopment implications. J Infect Dis 2013, 207:511 \u2013519.\n23. Zambrano-Villa S, Rosales-Borjas D, Carrero JC, Ortiz-Ortiz L: How protozoan\nparasites evade the immune response. Trends Parasitol 2002, 18:272 \u2013278.\n24. Richie TL, Saul A: Progress and challenges for malaria vaccines. Nature\n2002, 415:694 \u2013701.\n25. Kimura M: The neutral theory of molecular evolution. Cambridge\nCambridgeshire. New York: Cambridge University Press; 1983.\n26. O \u2019Donnell RA, De Koning-Ward TF, Burt RA, Bockarie M, Reeder JC, Cowman\nAF, Crabb BS: Antibodies against merozoite surface protein (MSP)-1(19)\nare a major component of the invasion-inhibitory response in individualsimmune to malaria. J Exp Med 2001, 193:1403 \u20131412.\n27. Nagao E, Seydel KB, Dvorak JA: Detergent-resistant erythrocyte membrane\nrafts are modified by a Plasmodium falciparum infection. Exp Parasitol\n2002, 102:57\u201359.\n28. Sanders PR, Gilson PR, Cantin GT, Greenbaum DC, Nebl T, Carucci DJ,\nMcConville MJ, Schofield L, Hodder AN, Yates JR 3rd, Crabb BS: Distinct\nprotein classes including novel merozoite surface antigens in Raft-likemembranes of Plasmodium falciparum .JB i o lC h e m 2005, 280:40169 \u201340176.\n29. Arevalo-Pinzon G, Curtidor H, Vanegas M, Vizcaino C, Patarroyo MA,\nPatarroyo ME: Conserved high activity binding peptides from the\nPlasmodium falciparum Pf34 rhoptry protein inhibit merozoites in vitro\ninvasion of red blood cells. Peptides 2010, 31:1987 \u20131994.\n30. Garcia J, Curtidor H, Pinzon CG, Vanegas M, Moreno A, Patarroyo ME:\nIdentification of conserved erythrocyte binding regions in members of\nthePlasmodium falciparum Cys6 lipid raft-associated protein family.\nVaccine 2009, 27:3953 \u20133962.\n31. Garcia Y, Puentes A, Curtidor H, Cifuentes G, Reyes C, Barreto J, Moreno A,\nPatarroyo ME: Identifying merozoite surface protein 4 and merozoite\nsurface protein 7 Plasmodium falciparum protein family members\nspecifically binding to human erythrocytes suggests a new malarial\nparasite-redundant survival mechanism. J Med Chem 2007, 50:5665 \u20135675.Forero-Rodr\u00edguez et al. Malaria Journal 2014, 13:58 Page 10 of 12\nhttp://www.malariajournal.com/content/13/1/5832. Urquiza M, Rodriguez LE, Suarez JE, Guzman F, Ocampo M, Curtidor H,\nSegura C, Trujillo E, Patarroyo ME: Identification of Plasmodium falciparum\nMSP-1 peptides able to bind to human red blood cells. Parasite Immunol\n1996, 18:515 \u2013526.\n33. Rodriguez LE, Curtidor H, Urquiza M, Cifuentes G, Reyes C, Patarroyo ME:\nIntimate molecular interactions of P. falciparum merozoite proteins\ninvolved in invasion of red blood cells and their implications for vaccine\ndesign. Chem Rev 2008, 108:3656 \u20133705.\n34. Barrero CA, Delgado G, Sierra AY, Silva Y, Parra-Lopez C, Patarroyo MA:\nGamma interferon levels and antibody production induced by twoPvMSP-1 recombinant polypeptides are associated with protectiveimmunity against P. vivax in Aotus monkeys. Vaccine 2005, 23:4048 \u20134053.\n35. Richards JS, Beeson JG: The future for blood-stage vaccines against\nmalaria. Immunol Cell Biol 2009, 87:377 \u2013390.\n36. Van Dijk MR, Van Schaijk BC, Khan SM, Van Dooren MW, Ramesar J,\nKaczanowski S, Van Gemert GJ, Kroeze H, Stunnenberg HG, Eling WM, et al:\nThree members of the 6-cys protein family of Plasmodium play a role in\ngamete fertility. PLoS Pathog 2010, 6:e1000853.\n37. Williamson KC: Pfs230: from malaria transmission-blocking vaccine\ncandidate toward function. Parasite Immunol 2003, 25:351 \u2013359.\n38. Mongui A, Angel DI, Guzman C, Vanegas M, Patarroyo MA: Characterisation\nof the Plasmodium vivax Pv38 antigen. Biochem Biophys Res Commun\n2008, 376:326 \u2013330.\n39. Moreno-Perez DA, Areiza-Rojas R, Florez-Buitrago X, Silva Y, Patarroyo ME,\nPatarroyo MA: The GPI-anchored 6-Cys protein Pv12 is present in\ndetergent-resistant microdomains of Plasmodium vivax blood stage\nschizonts. Protist 2013, 164:37\u201348.\n40. Chen JH, Jung JW, Wang Y, Ha KS, Lu F, Lim CS, Takeo S, Tsuboi T, Han ET:\nImmunoproteomics profiling of blood stage Plasmodium vivax infection\nby high-throughput screening assays. J Proteome Res 2010, 9:6479 \u20136489.\n41. Prajapati SK, Joshi H, Shalini S, Patarroyo MA, Suwanarusk R, Kumar A,\nSharma SK, Eapen A, Dev V, Bhatt RM, Valecha N, Nosten F, Rizvi MA, Dash\nAP:Plasmodium vivax lineages: geographical distribution, tandem repeat\npolymorphism, and phylogenetic relationship. Malar J 2011, 10:374.\n42. Imwong M, Pukrittayakamee S, Gruner AC, Renia L, Letourneur F,\nLooareesuwan S, White NJ, Snounou G: Practical PCR genotyping protocols\nforPlasmodium vivax using Pvcs and Pvmsp1. Malar J 2005, 4:20.\n43. Neafsey DE, Galinsky K, Jiang RH, Young L, Sykes SM, Saif S, Gujja S,\nGoldberg JM, Young S, Zeng Q, Chapman SB, Dash AP, Anvikar AR, SuttonPL, Birren BW, Escalante AA, Barnwell JW, Carlton JM: The malaria parasite\nPlasmodium vivax exhibits greater genetic diversity than Plasmodium\nfalciparum .Nat Genet 2012, 44:1046 \u20131050.\n44. Carlton JM, Adams JH, Silva JC, Bidwell SL, Lorenzi H, Caler E, Crabtree J,\nAngiuoli SV, Merino EF, Amedeo P, Cheng Q, Coulson RM, Crabb BS, DelPortillo HA, Essien K, Feldblyum TV, Fernandez-Becerra C, Gilson PR, GueyeAH, Guo X, Kang \u2019a S, Kooij TW, Korsinczky M, Meyer EV, Nene V, Paulsen I,\nWhite O, Ralph SA, Ren Q, Sargeant TJ, et al: Comparative genomics of the\nneglected human malaria parasite Plasmodium vivax .Nature 2008,\n455:757 \u2013763.\n45. Edgar RC: MUSCLE: multiple sequence alignment with high accuracy and\nhigh throughput. Nucleic Acids Res 2004, 32:1792 \u20131797.\n46. Suyama M, Torrents D, Bork P: PAL2NAL: robust conversion of protein\nsequence alignments into the corresponding codon alignments.Nucleic Acids Res 2006, 34:W609 \u2013W612.\n47. Librado P, Rozas J: DnaSP v5: a software for comprehensive analysis of\nDNA polymorphism data. Bioinformatics 2009, 25:1451 \u20131452.\n48. Depaulis F, Veuille M: Neutrality tests based on the distribution of\nhaplotypes under an infinite-site model. M o lB i o lE v o l 1998,\n15:1788 \u20131790.\n49. Tajima F: Statistical method for testing the neutral mutation hypothesis\nby DNA polymorphism. Genetics 1989, 123:585 \u2013595.\n50. Fu YX, Li WH: Statistical tests of neutrality of mutations. Genetics 1993,\n133:693 \u2013709.\n51. Fay JC, Wu CI: Hitchhiking under positive Darwinian selection. Genetics\n2000, 155:1405 \u20131413.\n52. Fu YX: Statistical tests of neutrality of mutations against population\ngrowth, hitchhiking and background selection. Genetics 1997,\n147: 915 \u2013925.\n53. Zhang J, Rosenberg HF, Nei M: Positive Darwinian selection after gene\nduplication in primate ribonuclease genes. Proc Natl Acad Sci U S A 1998,\n95:3708 \u20133713.54. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S: MEGA5:\nmolecular evolutionary genetics analysis using maximum likelihood,evolutionary distance, and maximum parsimony methods. Mol Biol Evol\n2011, 28:2731 \u20132739.\n55. Kosakovsky Pond SL, Frost SD: Not so different after all: a comparison of\nmethods for detecting amino acid sites under selection. Mol Biol Evol\n2005, 22:1208 \u20131222.\n56. Pond SL, Frost SD, Grossman Z, Gravenor MB, Richman DD, Brown AJ:\nAdaptation to different human populations by HIV-1 revealed by\ncodon-based analyses. PLoS Comput Biol 2006, 2:e62.\n57. Murrell B, Wertheim JO, Moola S, Weighill T, Scheffler K, Kosakovsky Pond\nSL:Detecting individual sites subject to episodic diversifying selection.\nPLoS Genet 2012, 8:e1002764.\n58. Murrell B, Moola S, Mabona A, Weighill T, Sheward D, Kosakovsky Pond SL,\nScheffler K: FUBAR: a fast, unconstrained bayesian approximation for\ninferring selection. Mol Biol Evol 2013, 30:1196 \u20131205.\n59. Jukes TH, Cantor CR: Evolution of protein molecules. InMammalian Protein\nMetabolism. Edited by Munro HN. New York: Academic Press; 1969.\n60. McDonald JH, Kreitman M: Adaptive protein evolution at the Adh locus in\nDrosophila. Nature 1991, 351:652 \u2013654.\n61. Egea R, Casillas S, Barbadilla A: Standard and generalized McDonald-\nKreitman test: a website to detect selection by comparing differentclasses of DNA sites. Nucleic Acids Res 2008, 36:W157 \u2013W162.\n62. Kelly JK: A test of neutrality based on interlocus associations. Genetics\n1997, 146:1197 \u20131206.\n63. Rozas J, Gullaud M, Blandin G, Aguade M: DNA variation at the rp49 gene\nregion of Drosophila simulans : evolutionary inferences from an unusual\nhaplotype structure. Genetics 2001, 158:1147 \u20131155.\n64. Hudson RR, Kaplan NL: Statistical properties of the number of\nrecombination events in the history of a sample of DNA sequences.Genetics 1985, 111:147 \u2013164.\n65. Kosakovsky Pond SL, Posada D, Gravenor MB, Woelk CH, Frost SD:\nAutomated phylogenetic detection of recombination using a genetic\nalgorithm. Mol Biol Evol 2006, 23:1891 \u20131901.\n66. Delport W, Poon AF, Frost SD, Kosakovsky Pond SL: Datamonkey 2010: a\nsuite of phylogenetic analysis tools for evolutionary biology.Bioinformatics 2010, 26:2455 \u20132457.\n67. Taylor JE, Pacheco MA, Bacon DJ, Beg MA, Machado RL, Fairhurst RM,\nHerrera S, Kim JY, Menard D, P\u00f3voa MM, Villegas L, Mulyanto, Snounou G,\nCui L, Zeyrek FY, Escalante AA: The evolutionary history of Plasmodium\nvivax as inferred from mitochondrial genomes: parasite genetic diversity\nin the Americas. Mol Biol Evol 2013, 30:2050 \u20132064.\n68. Tetteh KK, Stewart LB, Ochola LI, Amambua-Ngwa A, Thomas AW, Marsh K,\nWeedall GD, Conway DJ: Prospective identification of malaria parasite\ngenes under balancing selection. PLoS One 2009, 4:e5568.\n69. Tonkin ML, Arredondo SA, Loveless BC, Serpa JJ, Makepeace KA, Sundar N,\nPetrotchenko EV, Miller LH, Grigg ME, Boulanger MJ: Structural and\nbiochemical characterization of Plasmodium falciparum 12 (Pf12) reveals\na unique interdomain organization and the potential for an antiparallel\narrangement with Pf41. J Biol Chem 2013, 288:12805 \u201312817.\n70. Pacheco MA, Ryan EM, Poe AC, Basco L, Udhayakumar V, Collins WE,\nEscalante AA: Evidence for negative selection on the gene encoding\nrhoptry-associated protein 1 (RAP-1) in Plasmodium spp. Infect Genet Evol\n2010, 10:655 \u2013661.\n71. Pacheco MA, Elango AP, Rahman AA, Fisher D, Collins WE, Barnwell JW,\nEscalante AA: Evidence of purifying selection on merozoite surface\nprotein 8 (MSP8) and 10 (MSP10) in Plasmodium spp. Infect Genet Evol\n2012, 12:978 \u2013986.\n72. Arredondo SA, Cai M, Takayama Y, MacDonald NJ, Anderson DE, Aravind L,\nClore GM, Miller LH: Structure of the Plasmodium 6-cysteine s48/45\ndomain. Proc Natl Acad Sci U S A 2012, 109:6692 \u20136697.\n73. Reeder JC, Wapling J, Mueller I, Siba PM, Barry AE: Population genetic\nanalysis of the Plasmodium falciparum 6-cys protein Pf38 in Papua New\nGuinea reveals domain-specific balancing selection. Malar J 2011, 10:126.\n74. Parsch J, Zhang Z, Baines JF: The influence of demography and weak\nselection on the McDonald-Kreitman test: an empirical study in Drosophila.Mol Biol Evol 2009, 26:691 \u2013698.\n75. Ord R, Polley S, Tami A, Sutherland CJ: High sequence diversity and\nevidence of balancing selection in the Pvmsp3alpha gene ofPlasmodium vivax in the Venezuelan Amazon. Mol Biochem Parasitol\n2005, 144: 86\u201393.Forero-Rodr\u00edguez et al. Malaria Journal 2014, 13:58 Page 11 of 12\nhttp://www.malariajournal.com/content/13/1/5876. Kang JM, Ju HL, Kang YM, Lee DH, Moon SU, Sohn WM, Park JW, Kim TS,\nNa BK: Genetic polymorphism and natural selection in the C-terminal 42\nkDa region of merozoite surface protein-1 among Plasmodium vivax\nKorean isolates. Malar J 2012, 11:206.\n77. Zakeri S, Sadeghi H, Mehrizi AA, Djadid ND: Population genetic structure\nand polymorphism analysis of gene encoding apical membrane antigen-1\n(AMA-1) of Iranian Plasmodium vivax wild isolates. Acta Trop 2013,\n126:269 \u2013279.\n78. Ju HL, Kang JM, Moon SU, Kim JY, Lee HW, Lin K, Sohn WM, Lee JS, Kim TS,\nNa BK: Genetic polymorphism and natural selection of Duffy binding\nprotein of Plasmodium vivax Myanmar isolates. Malar J 2012, 11:60.\n79. Garzon-Ospina D, Romero-Murillo L, Tobon LF, Patarroyo MA: Low genetic\npolymorphism of merozoite surface proteins 7 and 10 in Colombian\nPlasmodium vivax isolates. Infect Genet Evol 2011, 11:528 \u2013531.\n80. Garzon-Ospina D, Romero-Murillo L, Patarroyo MA: Limited genetic\npolymorphism of the Plasmodium vivax low molecular weight rhoptry\nprotein complex in the Colombian population. Infect Genet Evol 2010,\n10:261 \u2013267.\n81. Martinez P, Suarez CF, Gomez A, Cardenas PP, Guerrero JE, Patarroyo MA:\nHigh level of conservation in Plasmodium vivax merozoite surface\nprotein 4 (PvMSP4). Infect Genet Evol 2005, 5:354 \u2013361.\n82. Doi M, Tanabe K, Tachibana S, Hamai M, Tachibana M, Mita T, Yagi M,\nZeyrek FY, Ferreira MU, Ohmae H, Kaneko A, Randrianarivelojosia M,\nSattabongkot J, Cao YM, Horii T, Torii M, Tsuboi T: Worldwide sequence\nconservation of transmission-blocking vaccine candidate Pvs230 in\nPlasmodium vivax .Vaccine 2011, 29:4308 \u20134315.\n83. Patarroyo MA, Calderon D, Moreno-Perez DA: Vaccines against Plasmodium\nvivax : a research challenge. Expert Rev Vaccines 2012, 11:1249 \u20131260.\n84. Giraldo MA, Arevalo-Pinzon G, Rojas-Caraballo J, Mongui A, Rodriguez R,\nPatarroyo MA: Vaccination with recombinant Plasmodium vivax MSP-10\nformulated in different adjuvants induces strong immunogenicity but no\nprotection. Vaccine 2009, 28:7\u201313.\n85. Rojas-Caraballo J, Mongui A, Giraldo MA, Delgado G, Granados D, Millan-\nCortes D, Martinez P, Rodriguez R, Patarroyo MA: Immunogenicity and\nprotection-inducing ability of recombinant Plasmodium vivax rhoptry-\nassociated protein 2 in Aotus monkeys: a potential vaccine candidate.Vaccine 2009, 27:2870 \u20132876.\n86. Carter R, Coulson A, Bhatti S, Taylor BJ, Elliott JF: Predicted disulfide-bonded\nstructures for three uniquely related proteins of Plasmodium falciparum ,\nPfs230, Pfs48/45 and Pf12. Mol Biochem Parasitol 1995, 71:203 \u2013210.\n87. Tachibana M, Sato C, Otsuki H, Sattabongkot J, Kaneko O, Torii M, Tsuboi T:\nPlasmodium vivax gametocyte protein Pvs230 is a transmission-blocking\nvaccine candidate. Vaccine 2012, 30:1807 \u20131812.\n88. Feller T, Thom P, Koch N, Spiegel H, Addai-Mensah O, Fischer R, Reimann A,\nPradel G, Fendel R, Schillberg S, Scheuermayer M, Schinkel H: Plant-based\nproduction of recombinant Plasmodium surface protein pf38 and evaluationof its potential as a vaccine candidate. PLoS One 2013, 8:e79920.\ndoi:10.1186/1475-2875-13-58\nCite this article as: Forero-Rodr\u00edguez et al. :Low genetic diversity and\nfunctional constraint in loci encoding Plasmodium vivax P12 and P38\nproteins in the Colombian population. Malaria Journal 2014 13:58.\nSubmit your next manuscript to BioMed Central\nand take full advantage of: \n\u2022 Convenient online submission\n\u2022 Thorough peer review\n\u2022 No space constraints or color \ufb01gure charges\n\u2022 Immediate publication on acceptance\n\u2022 Inclusion in PubMed, CAS, Scopus and Google Scholar\n\u2022 Research which is freely available for redistribution\nSubmit your manuscript at \nwww.biomedcentral.com/submitForero-Rodr\u00edguez et al. Malaria Journal 2014, 13:58 Page 12 of 12\nhttp://www.malariajournal.com/content/13/1/58RESEARCH Open Access\nLow genetic diversity in the locus encoding the\nPlasmodium vivax P41 protein in Colombia \u2019s\nparasite population\nJohanna Forero-Rodr\u00edguez1,2, Diego Garz\u00f3n-Ospina1,3and Manuel A Patarroyo1,3*\nAbstract\nBackground: The development of malaria vaccine has been hindered by the allele-specific responses produced by\nsome parasite antigens \u2019high genetic diversity. Such antigen genetic diversity must thus be evaluated when designing\na completely effective vaccine. Plasmodium falciparum P12, P38 and P41 proteins have red blood cell binding regions\nin the s48/45 domains and are located on merozoite surface, P41 forming a heteroduplex with P12. These three\ngenes have been identified in Plasmodium vivax and share similar characteristics with their orthologues in Plasmodium\nfalciparum. Plasmodium vivax pv12 and pv38 have low genetic diversity but pv41 polymorphism has not been\ndescribed.\nMethods: The present study was aimed at evaluating the P. vivax p41 (pv41 )g e n e \u2019sp o l y m o r p h i s m .D N A\nsequences from Colombian clinical isolates from pv41 gene were analysed for characterising and studying\nthe genetic diversity and the evolutionary forces that produced the variation pattern so observed.Results: Similarly to other members of the 6-Cys family, pv41 had low genetic polymorphism. pv41 3\u2032-end displayed\nthe highest nucleotide diversity value; several substituti ons found there were under posi tive selection. Negatively\nselected codons at inter-species level were identified in the s48/45 domains; p41 would thus seem to have\nfunctional/structural constraints due to the presence of these domains.\nConclusions: In spite of the functional constraints of Pv41 s48/45 domains, immune system pressure seems\nto have allowed non-synonymous substitutions to become fixed within them as an adaptation mechanism;\nincluding Pv41 s48/45 domains in a vaccine should thus be carefully evaluated due to these domains\ncontaining some allele variants.\nKeywords: Plasmodium vivax ,6 - C y s , pv41 , s48/45 domains, Genetic variability, Functional constraint,\nAnti-malarial vaccine\nBackground\nOf the five malaria parasites ( Plasmodium falciparum,\nPlasmodium vivax, Plasmodium malarie, Plasmodium\novale and Plasmodium knowlesi ) affecting human beings,\nP. falciparum is the species causing the most severe clin-\nical manifestations, whilst P. vivax is the species most\nwidely distributed throughout the world, mainly affectingthe Asian and American continents and causing the highestmorbidity outside of Africa. In spite of efforts to date forcontrolling malaria, it continues to be a serious public\nhealth problem; 18.9 million cases of P. vivax occurred in\n2012, children under five years old and pregnant women\nbeing the most vulnerable populations [1].\nAn anti-malarial vaccine represents one of the alterna-\ntive control measures regarding this disease; developinga multi-antigen vaccine against the parasite \u2019s blood stage\nis focused on blocking all interactions with a host cell,thereby avoiding recognition and subsequent invasion.Several antigens have been proposed as vaccine candidates\n[2-4]; however, as many of them have high genetic diver-\nsity [5-12], this is an obstacle regarding such proposal\n* Correspondence: mapatarr.fidic@gmail.com\n1Fundaci\u00f3n Instituto de Inmunolog\u00eda de Colombia (FIDIC), Carrera 50 No.\n26-20, Bogot\u00e1, DC, Colombia\n3School of Medicine and Health Sciences, Universidad del Rosario, Bogot\u00e1,\nDC, Colombia\nFull list of author information is available at the end of the article\n\u00a9 2014 Forero-Rodr\u00edguez et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the\nCreative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use,distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons PublicDomain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in thisarticle, unless otherwise stated.Forero-Rodr\u00edguez et al. Malaria Journal 2014, 13:388\nhttp://www.malariajournal.com/content/13/1/388[13,14] since they induce allele-specific immune responses\n[15]. The genetic diversity of candidate antigens must thus\nbe evaluated [14,16] for selecting the most frequent vari-ants or conserved domains [13,14].\nProteins involved in red blood cell (RBC) invasion have\nbeen characterized in merozoite surface regions known asdetergent-resistant membranes (DRM) [17-19], many of\nthese being potential vaccine candidates [4,20,21]. Such\nDRMs include a group of proteins belonging to the 6-Cysfamily (P12, P38, P41 and P92) which is characterised by\nthe presence of domains containing six conserved cyste-\nines called s48/45 [17,22-24]. The P. falciparum P41\n(Pf41) protein has two high-activity binding peptides in\nthe s48/45 domains [17], thereby suggesting a role in RBC\ninvasion. This protein does not have GPI-anchored do-mains and its presence on merozoite membrane is due to\nthe formation of an inverted heteroduplex with Pf12\n[25,26]. The pv41 gene has recently been characterised in\nP. vivax (pv41 ) [22,27]; this gene encodes a 385 residue-\nlong membrane protein. Similar to its orthologue inP. falciparum , the protein has a signal peptide and two\ns48/45 domains but no GPI-anchor. The P. vivax P41\n(Pv41) protein has been shown to be antigenic [27,28],suggesting that it is exposed to the host immune system,probably during invasion of the host cell.Given that Pv41 has been located on merozoite surface\nand that it has no membrane anchoring domains [22,27],it could be interacting with another protein anchored toparasite surface. This protein \u2019s similarity with its ortholo-\ngue in P. falciparum suggests that Pv41 might form a\ncomplex with Pv12, a protein which has been shown to behighly conserved [29]. The present study was therefore\naimed at using population genetics analysis for evaluating\nthepv41 gene \u2019s genetic diversity by determining the evolu-\ntionary processes producing the locus \u2019s variation pattern.\nThe results showed that pv41 had low genetic diversity,\nthe gene \u2019s3\u2032-end region being the most diverse, fixing\nmutations by positive selection, probably as a mechanism\nfor evading the immune system. Like other members of\nthe 6-Cys family, this gene seemed to have functional con-straints due to the presence of s48/45 domains.\nMethods\nDeclaration of ethical considerations\nThis study involved using thirty P. vivax -infected samples\ncollected between 2007 and 2010 (2007: 5 isolates, 2008: 3isolates, 2009: 8 isolates, 2010: 14 isolates); they had been\nobtained from different regions of Colombia (Figure 1,\nSouth-west: Choc\u00f3, Nari\u00f1o; South-east: Caquet\u00e1, Guain\u00eda,Guaviare, Meta; Midwest: Bogot\u00e1, Tolima; North-west:\nFigure 1 pv41 haplotype distribution in the Colombian population and origin of the reference strain sequences. Panel Ashows the\nhaplotype distribution found in pv41 . Panel Bshows the origin of the reference strain sequences and panel Crepresents haplotype frequency in\nthe Colombian population. Haplotype 1: Sal-I, Brazil-I, haplotype 2: India, haplotype 3: Mauritania, haplotype 4: North Korea, haplotype 5: South\nKorea, haplotype 1 \u20132 and 6 \u201313: Colombian isolates.Forero-Rodr\u00edguez et al. Malaria Journal 2014, 13:388 Page 2 of 10\nhttp://www.malariajournal.com/content/13/1/388Atl\u00e1ntico, Antioquia, C\u00f3rdoba). All P. vivax -infected pa-\ntients who provided blood samples were notified of the\nstudy \u2019s objective and then signed an informed consent\nform. All the procedures involved in taking the samples\nhad already been approved by the Fundaci\u00f3n Instituto de\nInmunolog\u00eda de Colombia \u2019s (FIDIC) ethics \u2019committee.\nGenotyping Plasmodium vivax samples\nPCR-RFLP of the pvmsp-1 polymorphic marker was used\nfor identifying/analysing different genotypes in the sam-\nples and infection by a single P. vivax strain, as described\npreviously [30]. Briefly, this gene \u2019s blocks 6, 7 and 8 were\namplified with direct 5 \u2032-AAAATCGAGAGCATGATCGC\nCACTGAGAAG-3 \u2032and reverse 5 \u2032-AGCTTGTACTTTC\nCATAGTGGTCCAG-3 \u2032primers. The amplified frag-\nments were digested with Alu I and Mnl I restrictionenzymes.\nPCR amplification of the pv41 gene\nPreviously reported primers were used for amplifying\npv41 [22]. The PCR reaction mixture contained 10 mM\nTris HCl, 50 mM KCl (GeneAmp 10X PCR Buffer II\n(Applied Biosystems)), 1.5 mM MgCl 2, 0.2 mM of each\ndNTP , 0.5 \u03bcM of each primer (direct 5 \u2032ATGAAAAGG\nCTCCTCCTGC 3 \u2032and reverse 5 \u2032CTCCTGGAAGGA\nCTTGGC 3 \u2032), 0.76 U Amplitaq Gold DNA polymerase\n(Applied Biosystems) and 40 ng genomic DNA at 50 \u03bcL\nfinal volume. The PCR thermal profile was as follows: onecycle at 95\u00b0C (7 min), 40 cycles at 95\u00b0C (20 sec), 60\u00b0C\n(30 sec), 72\u00b0C (1 min) and a final extension cycle at 72\u00b0C(10 min). The amplification products were purified using\nan UltraClean PCR Clean-up kit (MO BIO). The purified\nPCR products were bidirectionally sequenced with theamplification primers using the BigDye method with\ncapillary electrophoresis, using the ABI-3730 XL se-\nquencer (MACROGEN, Seoul, South Korea). Two inde-pendent PCR products were sequenced per sample to rule\nout errors.\nAnalysing genetic diversity\nCLC Main workbench software v.5 (CLC bio, Cambridge,\nMA, USA) was used for analysing and assembling theelectropherograms obtained by sequencing, giving one\nsequence per sample. The 30 sequences obtained\nfrom Colombian isolates were compared to and ana-lysed regarding reference sequences obtained from several\nsequencing projects [31,32] (PlasmoDB accession number:\nPVX_000995, GenBank accession number: AFNI01000110.1,AFNJ01000259.1, AFMK01000149.1 and AFBK01000223.1)\nor reported in databases (GenBank accession number:\nGU476495.1). These 36 sequences were then compared toPlasmodium cynomolgi (GenBank accession number :\nBAEJ01000104.1) and P. knowlesi orthologous sequences\n(PlasmoDB accession number: PKH_030970), two specieswhich are phylogenetically close to P. vivax [33]. Gene\nRunner software was used for translating all the sequencesfor obtaining the deduced amino acid sequences; theMUSCLE algorithm was then used for aligning such se-\nquences [34] and then edited manually. The PAL2NAL\nweb-based tool [35] was then used for converting proteinalignments into their respective nucleotide alignments.\nDnaSP v.5 software [36] was used for quantifying pv41\ngenetic polymorphism by calculating: the number of seg-regant sites (Ss), the number of singleton sites (s), the\nnumber of parsimony-informative sites (Ps), the number\nof haplotypes (H), haplotype diversity (Hd, multiplied by(n-1)/n, according to Depaulis and Veuille [36,37]), the\nWatterson estimator ( \u03b8\nw), the average number of nu-\ncleotide differences ( k) and nucleotide diversity per site\n(\u03c0). Data was obtained for the reference sequences plus\nthe Colombian sequences (worldwide diversity), as well\nas for just the Colombian sequences (local diversity).\nThe Colombian parasite population sequences were\nused for evaluating the neutral model of molecular evo-lution using tests based on the frequency spectrum ofnucleotide polymorphisms and haplotype distribution.\nTajima \u2019s D test [38], Fu and Li \u2019s D* and F* tests [39], and\nFay and Wu \u2019s H test [40] were calculated for the first\ngroup of tests. Fu \u2019s Fs test [41] and K-test and H-test [37]\nwere calculated as part of the group of tests based on\nhaplotype distribution. The significance of all tests was de-termined by coalescence simulations using DnaSP v.5 [36]\nand ALLELIX software (provided by Dr Sylvain Mousset).\nSites having gaps were not taken into account for all tests.\nThe effect of natural selection was evaluated by calculat-\ning the difference between the average number of non-synonymous substitutions per non-synonymous site (d\nN)\nand the average number of synonymous substitutions per\nsynonymous site (d S) using the modified Nei-Gojobori\nmethod [42]. Significance was determined by using Fisher \u2019s\nexact tests and the Z test incorporated in MEGA v.5 soft-ware [43]. SLAC, FEL, REL [44], IFEL [45], MEME [46]\nand FUBAR methods [47] were used for calculating the \u03c9\n(d\nN/dS) value for each codon in the pv41 alignment.\nThe McDonald-Kreitman test [48] was calculated for\nevaluating the effect of natural selection on p41 during\nthe evolutionary history of P. vivax and related species\n(Plasmodium cynomolgi and P. knowlesi ); this test compared\nintraspecific polymorphism with interspecific divergence\nusing a web server [49], which takes the Jukes-Cantor\ndistance correction regarding divergence per site [50]into account. The Nei-Gojobori modified method\n[42] was also used for calculating the difference between\nnon-synonymous (K\nN) and synonymous (K S)d i v e r g e n c e\nrates using Jukes-Cantor divergence correction [50]. Sig-\nnificant values were determined by using the Z test in-\ncorporate in MEGA v.5 software [43]. SLAC, FEL, REL[44], MEME [46] and FUBAR [47] methods were usedForero-Rodr\u00edguez et al. Malaria Journal 2014, 13:388 Page 3 of 10\nhttp://www.malariajournal.com/content/13/1/388for determining sites under interspecies selection using\nthe P. vivax ,P. cynomolgi and P. knowlesi sequences as\ndata set.\nZnS[51] and ZZ [52] tests were calculated for evaluat-\ning non-random associations between polymorphisms\n(linkage disequilibrium or LD) and the influence of in-tragenic recombination on pv41 . The minimum number\nof recombination events (Rm) [53] was also calculatedand the GARD method [54] available from Datamonkey[55] was used for evaluating recombination processes.\nResults\nGenetic diversity in pv41\nThirty P. vivax -infected samples, obtained from different\nparts of Colombia (Figure 1), were genotyped using thepvmsp-1 polymorphic marker. The RFLP patterns pro-\nduced from pvmsp-1 blocks 6 \u20138 suggested the presence\nof different genotypes in the aforementioned samples aswell as single strain infections in each sample. Taking\ninto account that all these samples have been previously\nused in other studies involving genes having high poly-morphism [6], in which none of the electropherograms\nrevealed overlapping peaks during the sequencing, we\ncan ascertain the absence of multiple infections.\nThe 30 genotyped isolates had a 1,152 base pair (bp) frag-\nment corresponding to the pv41 gene .The sequences ob-\ntained from these 30 isolates (Additional file 1) werecompared to and analysed together with sequences reported\nby several sequencing projects [31,32]. Sequences having a\ndifferent haplotype were deposited in the GenBank database(accession numbers KM212268-KM212275).\nTable 1 gives the values for the estimators of genetic\ndiversity. Seventeen segregant sites were observed in thesequences from different parts of the world, 12 of them\nbeing parsimony-informative sites and five singleton sites;\n13 haplotypes were found (Figure 2). Aligning the proteinsfrom P. vivax isolates from different geographical loca-\ntions revealed substitutions in ten amino acids: N88D,E89V, A258V, Q301H, K312N, M355R, S359H, Y361F,N363D and R373G (numeration based on the Sal-I refer-\nence sequence). Ten segregant sites were found in theColombian population (nine of them being parsimony-informative sites), giving ten haplotypes (haplotypes 1, 2,\n6\u201313) and 0.679 \u00b1 0.083 haplotype diversity. Haplotype 1\nhad 50% frequency, followed by haplotype 11 (13% fre-\nquency) and haplotype 10 (10% frequency); the remaining\nhaplotypes had low frequency (around 3%).\nThe average number of nucleotide differences per\npairs of sequences ( k) was 3.9 when sequences from dif-\nferent parts of the world (worldwide diversity) were ana-lysed and 3.1 for the Colombian population (Table 1).\nLow Watterson estimator ( \u03b8\nw=0.0038 \u00b1 0.0009) and nu-\ncleotide diversity values ( \u03c0= 0.0037 \u00b1 0.0006) were ob-\nserved when the available sequences obtained from thedatabases plus the Colombian ones were analysed; \u03b8\nw\nwas 0.0023 \u00b1 0.0007 and \u03c00.0028 \u00b1 0.0005 for the\nColombian population (Table 1). The nucleotide di-versity analysis for Colombian locations showed that\nthe Midwest was the most diverse at the pv41 locus\nwhilst the lowest value was found in Colombia \u2019s\nSouth-west area (Additional file 2). The gene regionhaving the highest \u03c0value was found between nucle-\notides 1,064 to 1,130.\nEvaluating the effect of natural selection on pv41\nTajima \u2019s D, Fu and Li \u2019s D* and F*, Fay and Wu \u2019sH ,F u \u2019s\nFs and the K- and H-test neutrality tests did not give sta-tistically significant values (Table 2); this meant that neu-trality could not be ruled out. The differences between\nnon-synonymous and synonymous (d\nN-d S) substitu-\ntions rates throughout the gene were evaluated for esti-\nmating the effect of natural selection in pv41 , as well as\nin each s48/45 domain (s48/45 N-Terminal: nucleotide76\u2013351 and s48/45 C-Terminal: nucleotide 784 \u20131,095);Table 1 Genetic diversity estimators for pv41\nn Sites Ss S Ps H \u03b8wk \u03c0\nWorldwide diversity\n36 1,068 17 5 12 13 0.0038 \u00b1 0.0009 3.9 0.0037 \u00b1 0.0006\nLocal diversity\n30 1,115 10 1 9 10 0.0023 \u00b1 0.0007 3.1 0.0028 \u00b1 0.0005\nThe estimators of genetic diversity were calculated by using the sequences\nobtained from the databases plus the Colombian ones (worldwide diversity)and just using those obtained in the Colombian population (local diversity).n: number of isolates, sites: total of sites analysed (excluding gaps), Ss: number ofsegregant sites, S: number of singleton sites, Ps: number of parsimony-informativesites, H: number of haplotypes, k: average number of nucleotide differences by\nsequence pairs, \u03b8\nw: Watterson estimator, \u03c0: nucleotide diversity per site.\nFigure 2 Aligning the haplotypes found in the pv41 gene.\nThe numbers in the upper part indicate the nucleotide position where\na substitution was observed; the dots indicate nucleotide identity.Forero-Rodr\u00edguez et al. Malaria Journal 2014, 13:388 Page 4 of 10\nhttp://www.malariajournal.com/content/13/1/388however, no significant values were found (Table 3). The\nsliding window (Figure 3) for the \u03c9(dN/dS) rate gave a \u03c9\nclose to 1 at the 3 \u2032-end of pv41 , indicating a number of\nnon-synonymous substitutions fixed within P. vivax in\nthis region at a higher rate than in the rest of the se-quence. Tests estimating d\nN/dSfor each site (codon)\nwere then performed for identifying whether individualcodons in pv41 were under selection; seven codons were\nfound to be under positive selection and one codon\nunder negative selection (Figure 3). Substitutions\nV269A, H312Q and G384R were exclusive for theColombian population. The K323N, H370S amino acid\nchanges were found in Colombian isolates and some refer-\nence sequences, whilst the N88D and E89V substitutionswere present in Mauritanian and South Korean sequences,\nrespectively.\nThe McDonald-Kreitman test was calculated for evalu-\nating how selection had acted throughout p41 \u2019s evolu-\ntionary history; it revealed significant values, thereby\nshowing that polymorphism was greater than divergence(p < 0.05) (Table 4). A sliding window for \u03c9divergence\n(K\nN/KS, non-synonymous divergence/synonymous diver-\ngence), obtained by comparing the P. vivax sequences to\nsequences from phylogenetically close species ( P. cyno-\nmolgi and P. knowlesi ), gave values less than 1 in the\ns48/45 domains, as well as in some areas between thesedomains, thereby indicating that K\nStended to be greater\nthan K N. Significant negative values (p < 0.001) were found\nwhen estimating the difference between non-synonymousand synonymous divergence (K\nN-K S)( T a b l e5 ) .T h e\ncodon-based selection tests found 13 positively selectedcodons and 77 negatively selected codons at inter-specieslevel (Figure 3).\nLinkage disequilibrium (LD) and recombination\nThe Z nS, ZZ and RM tests were calculated for determin-\ning possible associations between polymorphism and/orthe presence of recombination in pv41 (Table 2). The\nZnStest gave 0.3627, this being statistically significant\n(p < 0.05). Lineal regression between LD and nucleotide\ndistance gave a slight reduction in LD as nucleotide dis-\ntance increased, suggesting recombination events. Thiswas confirmed when the ZZ test was calculated, giving\n0.2073 (p < 0.05); two minimum recombination sites were\nfound (Table 2). The GARD method (available from theDatamonkey web server) gave a recombination breakpoint\nin position 936 (number based on Sal-I sequence) con-\nfirming than intragenic recombination was involved ingenerating new haplotypes in pv41 .\nDiscussion\nMerozoite-expressed members of the 6-Cys family in P.\nfalciparum (Pf12, Pf38 and Pf41) have high RBC binding\nactivity peptides [17], indicating that these play a roleduring recognition of a host cell. Previous studies have\nshown that members of this family are antigenic\n[23,24,27,28] and highly conserved ( p12and p38) in both\nP. falciparum and P. vivax [26,29,56,57]. This means\nthat they are promising candidates for inclusion in ananti-malarial vaccine, avoiding allele-specific immune re-sponses. The pv41 gene has been shown to be highly con-\nserved when compared to other genes encoding antigensinP. vivax (e.g., pvmsp-7 [6], pvmsp-5 [7,12], pvmsp-3\n[9,10], pvmsp-1 [5,8]).\nThe pv41 nucleotide diversity was low in the Colombian\npopulation; however, \u03c0values and haplotype number were\ndissimilar for each Colombian locality, suggesting different\nevolutionary histories possibly due to a structured popula-\ntion. However, this pattern could have been due to fewsamples having been collected from some locations. The\nuse of neutral markers could lead to confirming whether\nColombia has a structured population.\npv41 nucleotide diversity was higher than that re-\nported for pv12 , but similar to that found in pv38 [29];Table 2 Tests based on the neutral model of molecular evolution, linkage disequilibrium and recombination for the\npv41 gene in the Colombian population\nnTajima Fu and Li Fay\nand Wu HFu FsK-\ntestH-test Zns ZZ RM\nDD * F *\n30 0.79023 0.86738 0.9868 \u22121.857 \u22121.267 10 0.679 \u00b1 0.08 0.3627* 0.2073* 2\n*p <0.05.\nTable 3 Difference between the non-synonymous substitutions per non-synonymous site (d N) and synonymous\nsubstitution per synonymous site (d S) rate\nn s48/45 N-terminal s48/45 C-terminal Complete sequences\nWorldwide isolates d N-dS dN-dS dN-dS\n36 \u22120.0001 \u00b1 0.0008 0.0018 \u00b1 0.0015 \u22120.0005 \u00b1 0.0013\nColombian isolate\n30 0.0000 \u00b1 0.0000 0.0024 \u00b1 0.0015 0.0007 \u00b1 0.0010\nNo statistically significant values were found.Forero-Rodr\u00edguez et al. Malaria Journal 2014, 13:388 Page 5 of 10\nhttp://www.malariajournal.com/content/13/1/388however, fewer haplotypes were found in pv41 compared\ntopv38 (14 haplotypes have been reported for it in the\nColombian population) [29]. Since the Pv41 protein has\nno membrane-anchoring domains, it could be interact-\ning with proteins anchored to the merozoite surface. It\nhas been shown that Pf12 and Pf41 proteins form aninverted heteroduplex on parasite membrane [25,26].\nDue to these proteins \u2019similarity, it is probable that Pv12and Pv41 may also interact in P. vivax .T h i sc o u l d\nexplain the high degree of conservation found in Pv12\n(\u03c0= 0.0004 \u00b1 0.0001 [29]). If Pv41 forms a protein com-\nplex with Pv12, the latter could be masked whilst Pv41\nwould be more exposed to a host \u2019s immune system,\ngreater diversity thus being found in Pv41 ( \u03c0=0 . 0 0 3 7\u00b1\n0.0006) regarding Pv12 ( \u03c0= 0.0004 \u00b1 0.0001). Since such\ncomplex formation would be anti-parallel, the region\nFigure 3 Sliding window of omega values ( \u03c9=d N/dSand K N/KS) for three members of the 6-Cys family expressed in merozoites.\nThe\u03c9values (d N/dS) for Plasmodium vivax pv12 ,pv38 and pv41 genes are shown in red, divergence ( \u03c9=K N/KS) between P. vivax and Plasmodium\ncynomolgi (Pcyn) in purple and between P. vivax and Plasmodium knowlesi (Pkno) in green. The graphical representation of each gene is given\nbelow the respective sliding window, showing the position of the segregant sites and which of them were influenced by natural selection.\nIntraspecies selected sites can be seen in the upper part of each gene and inter-species selected sites are indicated in the lower part. The sites\nwere identified by the Datamonkey server. The schemes for pv12 and pv38 have been modified from Forero-Rodr\u00edguez et al. [29].\nTable 4 McDonald-Kreitman test for evaluating the action of natural selection on the p41gene\nP. vivax/P. cynomolgi P. vivax/P. knowlesi\nWorldwide isolates Fixed Polymorphic NI (p-values) Fixed Polymorphic NI (p-values)\nNon-synonymous substitutions 45.62 11\n4.45 (0.003)61.95 11\n4.12 (0.004)\nSynonymous substitutions 110.71 6 138.81 6\nColombian isolates\nNon-synonymous substitutions 46.69 8\n9.65 (0.000)63.06 8\n8.80 (0.001)\nSynonymous substitutions 112.65 2 138.81 2\nThe McDonald-Kreitman test involved using the sequences obtained from the databases together with the Colombian ones (worldwide isolates), and jus t those\nobtained in the Colombian population (Colombian isolates). The data regarding divergence between species was obtained by comparing P. vivax sequences to\nthat from two related species: P. cynomolgi and P. knowlesi . NI: neutral index.Forero-Rodr\u00edguez et al. Malaria Journal 2014, 13:388 Page 6 of 10\nhttp://www.malariajournal.com/content/13/1/388most exposed to Pv41 would be the C-terminal in which\nhigh fixation of non-synonymous substitutions was ob-served (Figure 3).\nNo significant values were found in the neutrality tests\nbased on the polymorphism frequency spectrum or thehaplotype-based tests (Table 2), meaning that the hypoth-\nesis regarding neutrality could not be ruled out. Such\nhypothesis stated that pv41 haplotypes could be fixed in\ndifferent populations thereby producing a population\nstructure in this locus and new pv41 haplotypes might\nthus appear if new parasites populations are evaluated.\nNo significant values were found when the effect of\nnatural selection was evaluated by means of the differ-\nence between non-synonymous and synonymous substi-tutions (d\nN-dS) in either the whole gene or in each s48/\n45 domain (Table 3). However, the pv41 sliding window\ngave a peak close to 1 at the 3 \u2032-end of the gene (Figure 3);\nseveral non-synonymous mutations would thus seem to\nbe fixed in this region. The codon-based selection tests\nshowed that seven out of the ten codons having mutationsproducing a change in the protein were positively selected\n(Figure 3). Three of these seven codons (V89E, H359S\nand G373R) produced radical substitutions (changing\namino acid physical/chemical properties). The R355M\nsubstitution also produced a radical change but selectionsignals were not identified in this site. Such positively se-\nlected codons were predominantly found towards the\ngene \u2019s3\u2032-end (encoding the protein \u2019sC - t e r m i n a lr e g i o n )\nand could have been fixed to enable evading the immune\nsystem since this region would be more exposed due to\nthe possible antiparallel formation of a Pv12/Pv41com-plex. Substitutions in codons 258, 301 and 312 located in\nthe s48/45 domain could become deleterious due to them\nbeing able to alter the domain \u2019s structure; however, they\nhad positive selection signals. Such substitutions wereconservative and maintained the amino acids \u2019physical-\nchemical characteristics, thereby enabling evasion of theimmune system and maintaining the domain \u2019s structural\nconformation. Interspecies \u03c9values were higher than 1 in\nsome regions of p41, mainly outside s48/45 domains.\nThirteen codons were positively selected at interspecies\nlevel; amino acid fixation would allow immune evasion of\nthe respective host. Alternatively, positive sites found ins48/45 domains (which are involved in red blood cell inva-\nsion [17]) would be a P41 adaptation to the host receptor\nmolecule.\nThe Z\nnStest had significant values, indicating LD. The\nlinked positions were found in the 3 \u2032-end of the gene. The\nmutations found there led to changes in protein sequenceH359S, Y361F and D363N. The first substitution (H359S)\nproduced a radical amino acid change, which was fixed by\npositive selection whilst the other two changes were con-servative without selection signals. Since amino acid\nH359S was fixed by positive selection, this led to Y361F\nand D363N becoming fixed due to the short physical dis-tance between them.\nGenetic diversity in pv41 was produced by point mutations\n(Figure 2); however, the recombination could also have been\nresponsible for the genetic polymorphism found in this gene.\nThe lineal regression between LD and nucleotide distancehad a slight reduction in LD as nucleotide distance increased;\nthis may have been a consequence of recombination pro-\ncesses. The ZZ test gave significant values, suggesting thatrecombination took place in this gene. Two minimum re-\ncombination sites were found and the GARD method\n(available from the Datamonkey web server) identified arecombination breakpoint in position 936, meaning that\nrecombination produced new haplotypes in pv41 .\nThe McDonald-Kreitman (MK) and omega divergence\ntests ( \u03c9=K\nN/KS) were calculated for inferring naturalTable 5 Difference between non-synonymous divergence per non-synonymous site (K N) and synonymous divergence\nper synonymous site (K S)\nP. vivax/P. cynomolgi\nn s48/45 N-terminal s48/45 C-terminal Complete sequences\nWorldwide isolates K N-KS KN-KS KN-KS\n36 \u22120.0151 \u00b1 0.0031* \u22120.0107 \u00b1 0.0032** \u22120.0160 \u00b1 0.0028*\nColombian isolates\n30 \u22120.0178 \u00b1 0.0038* - 0.0126 \u00b1 0.0035** \u22120.0174 \u00b1 0.0030*\nP. vivax/P. knowlesi\nn s48/45 N-terminal s48/45 c-terminal Complete sequences\nWorldwide isolates K N-KS KN-KS KN-KS\n36 \u22120.0196 \u00b1 0.0036* \u22120.0107 \u00b1 0.0034** \u22120.0185 \u00b1 0.0031*\nColombian isolates\n30 \u22120.0233 \u00b1 0.0042* \u22120.0125 \u00b1 0.0036** \u22120.0217 \u00b1 0.0035*\nKN-KSdifference was estimated using the sequences obtained from the databases together with the Colombian ones (worldwide isolates) and just with those\nobtained in the Colombian population (Colombian isolates).\nn: number of isolates. *p <0.000; **p <0.001.Forero-Rodr\u00edguez et al. Malaria Journal 2014, 13:388 Page 7 of 10\nhttp://www.malariajournal.com/content/13/1/388selection signals which might have influence the evolu-\ntionary history of p41. The latter was calculated for the\ngene \u2019s complete length and for each s48/45 domain. Sig-\nnificant values were found in the MK test throughoutthe whole gene (Table 5), polymorphism being greater\nthan divergence; this could have resulted from weaknegative selection or balancing positive selection. The lat-\nter is responsible for keeping allele variants (haplotypes) at\nintermediate frequencies as a mechanism for evading hostimmune responses; however, a major haplotype was found\nin the Colombian population whilst the rest occurred at\nlow frequency. Due to the population structure reportedin America [58], haplotype segregation could have led to\ndifferent frequencies or new haplotypes could have diver-\nsified within American (or Colombian) subpopulations,meaning that if just one population is analysed, then bal-\nancing positive selection signals will not always be de-\ntected with population methods (Tajima, Fu and Li, Fayand Wu, Fu and K-test, and H-test). Alternatively, if bal-\nancing selection has resulted from frequency dependent\nselection, it would be expected that a haplotype wouldbe presented as a major allele during a determined period\nof time and then become replaced by another less frequent\none as an evasion mechanism. These haplotypes \u2019frequency\nmust therefore be evaluated during different intervals of\ntime in several populations involving larger sampling.\nOn the other hand, the \u03c9(K\nN/KS) rate sliding window\nshowed that most values obtained throughout the genewere lower than 1, indicating high synonymous substitu-\ntion fixation following P. vivax /P. cynomolgi /P. knowlesi\ndivergence. The same pattern was observed in pv12 and\npv38 (Figure 3 and [29]). The difference between non-\nsynonymous and synonymous (K\nN-K S) divergence was\nestimated, giving significant negative values (p < 0.001)\ninpv41 as well as in the s48/45 domains of this gene\n(Table 4). A large amount of negatively selected codons\nwere identified which were preferentially located in the\ns48/45 domains (Figure 3). These results suggested that\np41had diverged due to negative selection; such pattern\nwas similar to that previously reported for other mem-\nbers of the P. vivax 6-Cys family [29,56]. pv12 and pv38 ,\nlike pv41 , had various codons under negative selection at\ninterspecies level which were preferentially located in\nthe s48/45 domains (Figure 3). Such accumulation ofinterspecies synonymous substitutions suggested that\nevolution had tried to maintain domain structure in the\ndifferent members of the 6-Cys family by eliminating alldeleterious mutations due to the functional importance\nwhich these domains seem to have [17,59].\nConclusions\n6-Cys family members seem to play a role during host cell\nrecognition [17,59]. Due to the high degree of P12, P38[29] and P41 protein conservation (at both intraspeciesand interspecies level) given by the fixation of a large\namount of synonymous substitutions, these three proteins\nmay have evolved under strong functional constraints,possibly due to the presence of s48/45 domains which\nseem to have served as ligands for recognising the host\ncell [17,59,60]. Consequently, s48/45 domains shouldremain conserved as the resulting mutations could be\ndeleterious; their evolution would thus have been slower\nregarding other functionally less important ones. Pv12,Pv38 and Pv41 thus warrant consideration as valuable can-\ndidates for developing a vaccine. However, a functional\nconstraint does not imply that these regions may not vary.Pv41 s48/45 domains have been seen to have changes in\ntheir protein sequence, which seem to have been positively\nselected. Such changes conserve physical-chemical proper-ties and thus structure/function may not become compro-\nmised, but could enable evasion of the immune response.\nIncluding Pv41 in a vaccine should thus be carefully evalu-ated due to the presence of variants in these regions.\nThis is also another aspect that must be taken into ac-\ncount when developing vaccines. It has been proposedthat a completely effective vaccine requires the inclusion\nof both functional and conserved regions; however, vac-\ncination could thus produce new selective pressure inthese regions and parasites could fix mutations as an\nadaptation mechanism (in spite of their functional im-\nportance) and the appearance of new variants might thusreduce vaccine \u2019s efficacy.\nAdditional files\nAdditional file 1: DNA sequences from 30 isolates obtained in this\nstudy.\nAdditional file 2: Nucleotide diversity ( \u03c0) values for subpopulations\nwithin Colombia. n: number of isolates, Ss: number of segregant sites, S:\nnumber of singleton sites, Ps: number of parsimony-informative sites, H:\nnumber of haplotypes, k: average number of nucleotide differences by\nsequence pairs, \u03c0: nucleotide diversity per site.\nCompeting interestsThe authors declare that they have no competing interests.\nAuthors \u2019contributions\nJF-R devised the study, participated in designing it, performed the\nexperiments, made the population genetics analysis and wrote the\nmanuscript. DG-O devised and designed the study, helped perform the\nexperiments, carried out the population genetics analysis and wrote themanuscript. MAP coordinated the study, and helped to write the manuscript.All the authors have read and approved the final manuscript.\nAcknowledgements\nWe would like to thank Dr Sylvain Mousset for providing the Allelix software\nfor our analysis, Professor Mar\u00eda Isabel Chac\u00f3n for her comments andsuggestions and Jason Garry for translating this manuscript. This work wasfinanced by the \u201cDepartamento Administrativo de Ciencia, Tecnolog\u00eda e\nInnovaci\u00f3n (Colciencias) \u201dthrough contracts RC #0309 \u20132013 and 709 \u20132013.\nJF-R received funding from COLCIENCIAS via cooperation agreement#0719 \u20132013.Forero-Rodr\u00edguez et al. Malaria Journal 2014, 13:388 Page 8 of 10\nhttp://www.malariajournal.com/content/13/1/388Author details\n1Fundaci\u00f3n Instituto de Inmunolog\u00eda de Colombia (FIDIC), Carrera 50 No.\n26-20, Bogot\u00e1, DC, Colombia.2Microbiology Postgraduate Programme,\nUniversidad Nacional de Colombia, Bogot\u00e1, DC, Colombia.3School of\nMedicine and Health Sciences, Universidad del Rosario, Bogot\u00e1, DC,\nColombia.\nReceived: 5 August 2014 Accepted: 27 September 2014\nPublished: 30 September 2014\nReferences\n1. WHO: World Malaria Report 2013. Geneva: World Health Organization; 2013.\nhttp://www.who.int/malaria/publications/world_malaria_report_2013/\nwmr2013_no_profiles.pdf.\n2. Carvalho LJ, Daniel-Ribeiro CT, Goto H: Malaria vaccine: candidate\nantigens, mechanisms, constraints and prospects. Scand J Immunol\n2002, 56:327 \u2013343.\n3. Jones TR, Hoffman SL: Malaria vaccine development. Clin Microbiol Rev\n1994, 7:303 \u2013310.\n4. Patarroyo MA, Calderon D, Moreno-Perez DA: Vaccines against Plasmodium\nvivax : a research challenge. Expert Rev Vaccines 2012, 11:1249 \u20131260.\n5. Figtree M, Pasay CJ, Slade R, Cheng Q, Cloonan N, Walker J, Saul A:\nPlasmodium vivax synonymous substitution frequencies, evolution and\npopulation structure deduced from diversity in AMA 1 and MSP 1 genes.\nMol Biochem Parasitol 2000, 108:53\u201366.\n6. Garzon-Ospina D, Lopez C, Forero-Rodriguez J, Patarroyo MA: Genetic\ndiversity and selection in three Plasmodium vivax merozoite surface\nprotein 7 (Pvmsp-7) genes in a Colombian population. PLoS One 2012,\n7:e45962.\n7. Gomez A, Suarez CF, Martinez P, Saravia C, Patarroyo MA: High polymorphism\nin Plasmodium vivax merozoite surface protein-5 (MSP5). Parasitology 2006,\n133:661 \u2013672.\n8. Kang JM, Ju HL, Kang YM, Lee DH, Moon SU, Sohn WM, Park JW, Kim TS,\nNa BK: Genetic polymorphism and natural selection in the C-terminal\n42 kDa region of merozoite surface protein-1 among Plasmodium vivax\nKorean isolates. Malar J 2012, 11:206.\n9. Mascorro CN, Zhao K, Khuntirat B, Sattabongkot J, Yan G, Escalante AA,\nCui L: Molecular evolution and intragenic recombination of the\nmerozoite surface protein MSP-3alpha from the malaria parasitePlasmodium vivax in Thailand. Parasitology 2005, 131:25\u201335.\n10. Ord R, Polley S, Tami A, Sutherland CJ: High sequence diversity and\nevidence of balancing selection in the Pvmsp3alpha gene ofPlasmodium vivax in the Venezuelan Amazon. Mol Biochem Parasitol 2005,\n144:86\u201393.\n11. Putaporntip C, Jongwutiwes S, Seethamchai S, Kanbara H, Tanabe K:\nIntragenic recombination in the 3 \u2032portion of the merozoite surface\nprotein 1 gene of Plasmodium vivax .Mol Biochem Parasitol 2000,\n109:111 \u2013119.\n12. Putaporntip C, Udomsangpetch R, Pattanawong U, Cui L, Jongwutiwes S:\nGenetic diversity of the Plasmodium vivax merozoite surface protein-5\nlocus from diverse geographic origins. Gene 2010, 456:24\u201335.\n13. Richie TL, Saul A: Progress and challenges for malaria vaccines. Nature\n2002, 415:694 \u2013701.\n14. Takala SL, Plowe CV: Genetic diversity and malaria vaccine design, testing\nand efficacy: preventing and overcoming \u2018vaccine resistant malaria \u2019.\nParasite Immunol 2009, 31:560 \u2013573.\n15. Polley SD, Tetteh KK, Lloyd JM, Akpogheneta OJ, Greenwood BM, Bojang\nKA, Conway DJ: Plasmodium falciparum merozoite surface protein 3 is a\ntarget of allele-specific immunity and alleles are maintained by naturalselection. J Infect Dis 2007, 195:279 \u2013287.\n16. Arnott A, Barry AE, Reeder JC: Understanding the population genetics of\nPlasmodium vivax is essential for malaria control and elimination. Malar J\n2012, 11:14.\n17. Garcia J, Curtidor H, Pinzon CG, Vanegas M, Moreno A, Patarroyo ME:\nIdentification of conserved erythrocyte binding regions in membersof the Plasmodium falciparum Cys6 lipid raft-associated protein family.\nVaccine 2009, 27:3953 \u20133962.\n18. Nagao E, Seydel KB, Dvorak JA: Detergent-resistant erythrocyte membrane\nrafts are modified by a Plasmodium falciparum infection. Exp Parasitol\n2002, 102:57\u201359.19. Sanders PR, Gilson PR, Cantin GT, Greenbaum DC, Nebl T, Carucci DJ,\nMcConville MJ, Schofield L, Hodder AN, Yates JR 3rd, Crabb BS: Distinct\nprotein classes including novel merozoite surface antigens in Raft-likemembranes of Plasmodium falciparum .JB i o lC h e m 2005, 280:40169 \u201340176.\n20. Barrero CA, Delgado G, Sierra AY, Silva Y, Parra-Lopez C, Patarroyo MA:\nGamma interferon levels and antibody production induced by twoPvMSP-1 recombinant polypeptides are associated with protectiveimmunity against P. vivax in Aotus monkeys. Vaccine 2005, 23:4048 \u20134053.\n21. Richards JS, Beeson JG: The future for blood-stage vaccines against\nmalaria. Immunol Cell Biol 2009, 87:377 \u2013390.\n22. Angel DI, Mongui A, Ardila J, Vanegas M, Patarroyo MA: The Plasmodium\nvivax Pv41 surface protein: identification and characterization.\nBiochem Biophys Res Commun 2008, 377: 1113 \u20131117.\n23. Mongui A, Angel DI, Guzman C, Vanegas M, Patarroyo MA: Characterisation\nof the Plasmodium vivax Pv38 antigen. Biochem Biophys Res Commun\n2008, 376:326 \u2013330.\n24. Moreno-Perez DA, Areiza-Rojas R, Florez-Buitrago X, Silva Y, Patarroyo ME,\nPatarroyo MA: The GPI-anchored 6-Cys protein Pv12 is present in\ndetergent-resistant microdomains of Plasmodium vivax blood stage\nschizonts. Protist 2013, 164:37\u201348.\n25. Taechalertpaisarn T, Crosnier C, Bartholdson SJ, Hodder AN, Thompson J,\nBustamante LY, Wilson DW, Sanders PR, Wright GJ, Rayner JC, Cowman AF,\nGilson PR, Crabb BS: Biochemical and functional analysis of two\nPlasmodium falciparum blood-stage 6-cys proteins: P12 and P41. PLoS\nOne 2012, 7:e41937.\n26. Tonkin ML, Arredondo SA, Loveless BC, Serpa JJ, Makepeace KA, Sundar N,\nPetrotchenko EV, Miller LH, Grigg ME, Boulanger MJ: Structural and\nbiochemical characterization of Plasmodium falciparum 12 (Pf12) reveals\na unique interdomain organization and the potential for an antiparallel\narrangement with Pf41. J Biol Chem 2013, 288:12805 \u201312817.\n2 7 . C h e n gY ,L uF ,T s u b o iT ,H a nE T : Characterization of a novel\nmerozoite surface protein of Plasmodium vivax ,P v 4 1 . Acta Trop 2013,\n126: 222 \u2013228.\n28. Chen JH, Jung JW, Wang Y, Ha KS, Lu F, Lim CS, Takeo S, Tsuboi T, Han ET:\nImmunoproteomics profiling of blood stage Plasmodium vivax infection\nby high-throughput screening assays. J Proteome Res 2010, 9:6479 \u20136489.\n29. Forero-Rodriguez J, Garzon-Ospina D, Patarroyo MA: Low genetic diversity\nand functional constraint in loci encoding Plasmodium vivax P12 and\nP38 proteins in the Colombian population. Malar J 2014, 13:58.\n30. Imwong M, Pukrittayakamee S, Gruner AC, Renia L, Letourneur F, Looareesuwan\nS, White NJ, Snounou G: Practical PCR genotyping protocols for Plasmodium\nvivax using Pvcs and Pvmsp1. Malar J 2005, 4:20.\n31. Neafsey DE, Galinsky K, Jiang RH, Young L, Sykes SM, Saif S, Gujja S,\nGoldberg JM, Young S, Zeng Q, Chapman SB, Dash AP, Anvikar AR, SuttonPL, Birren BW, Escalante AA, Barnwell JW, Carlton JM: The malaria parasite\nPlasmodium vivax exhibits greater genetic diversity than Plasmodium\nfalciparum .Nat Genet 2012, 44:1046 \u20131050.\n32. Bozdech Z, Mok S, Hu G, Imwong M, Jaidee A, Russell B, Ginsburg H,\nNosten F, Day NP, White NJ, Carlton JM, Preiser PR: The transcriptome\nofPlasmodium vivax reveals divergence and diversity of transcriptional\nregulation in malaria parasites. Proc Natl Acad Sci U S A 2008,\n105:16290 \u201316295.\n33. Pacheco MA, Battistuzzi FU, Junge RE, Cornejo OE, Williams CV, Landau I,\nRabetafika L, Snounou G, Jones-Engel L, Escalante AA: Timing the origin\nof human malarias: the lemur puzzle. BMC Evol Biol 2011, 11:299.\n34. Edgar RC: MUSCLE: multiple sequence alignment with high accuracy and\nhigh throughput. Nucleic Acids Res 2004, 32:1792 \u20131797.\n35. Suyama M, Torrents D, Bork P: PAL2NAL: robust conversion of protein\nsequence alignments into the corresponding codon alignments.\nNucleic Acids Res 2006, 34:W609 \u2013W612.\n36. Librado P, Rozas J: DnaSP v5: a software for comprehensive analysis of\nDNA polymorphism data. Bioinformatics 2009, 25:1451 \u20131452.\n37. Depaulis F, Veuille M: Neutrality tests based on the distribution\nof haplotypes under an infinite-site model. M o lB i o lE v o l 1998,\n15:1788 \u20131790.\n38. Tajima F: Statistical method for testing the neutral mutation hypothesis\nby DNA polymorphism. Genetics 1989, 123:585 \u2013595.\n39. Fu YX, Li WH: Statistical tests of neutrality of mutations. Genetics 1993,\n133:693 \u2013709.\n40. Fay JC, Wu CI: Hitchhiking under positive Darwinian selection. Genetics 2000,\n155:1405 \u20131413.Forero-Rodr\u00edguez et al. Malaria Journal 2014, 13:388 Page 9 of 10\nhttp://www.malariajournal.com/content/13/1/38841. Fu YX: Statistical tests of neutrality of mutations against population\ngrowth, hitchhiking and background selection. Genetics 1997,\n147:915 \u2013925.\n42. Zhang J, Rosenberg HF, Nei M: Positive Darwinian selection after gene\nduplication in primate ribonuclease genes. Proc Natl Acad Sci U S A 1998,\n95:3708 \u20133713.\n43. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S: MEGA5:\nmolecular evolutionary genetics analysis using maximum likelihood,\nevolutionary distance, and maximum parsimony methods. Mol Biol Evol\n2011, 28:2731 \u20132739.\n44. Kosakovsky Pond SL, Frost SD: Not so different after all: a comparison of\nmethods for detecting amino acid sites under selection. Mol Biol Evol\n2005, 22:1208 \u20131222.\n45. Pond SL, Frost SD, Grossman Z, Gravenor MB, Richman DD, Brown AJ:\nAdaptation to different human populations by HIV-1 revealed bycodon-based analyses. PLoS Comput Biol 2006, 2:e62.\n46. Murrell B, Wertheim JO, Moola S, Weighill T, Scheffler K, Kosakovsky Pond\nSL:Detecting individual sites subject to episodic diversifying selection.\nPLoS Genet 2012, 8:e1002764.\n47. Murrell B, Moola S, Mabona A, Weighill T, Sheward D, Kdosakovsky Pond SL,\nScheffler K: FUBAR: a fast, unconstrained bayesian approximation for\ninferring selection. Mol Biol Evol 2013, 30:1196 \u20131205.\n48. McDonald JH, Kreitman M: Adaptive protein evolution at the Adh locus in\nDrosophila. Nature 1991, 351:652 \u2013654.\n49. Egea R, Casillas S, Barbadilla A: Standard and generalized McDonald-Kreitman\ntest: a website to detect selection by comparing different classes of DNAsites. Nucleic Acids Res 2008, 36:W157 \u2013W162.\n50. Jukes THCRC: Evolution of Protein Molecules. InMammalian Protein\nMetabolism. Edited by Munro HN. New York: Academic Press; 1969.\n51. Kelly JK: A test of neutrality based on interlocus associations. Genetics 1997,\n146:1197 \u20131206.\n52. Rozas J, Gullaud M, Blandin G, Aguade M: DNA variation at the rp49 gene\nregion of Drosophila simulans : evolutionary inferences from an unusual\nhaplotype structure. Genetics 2001, 158:1147 \u20131155.\n53. Hudson RR, Kaplan NL: Statistical properties of the number of\nrecombination events in the history of a sample of DNA sequences.Genetics 1985, 111:147 \u2013164.\n54. Kosakovsky Pond SL, Posada D, Gravenor MB, Woelk CH, Frost SD:\nAutomated phylogenetic detection of recombination using a geneticalgorithm. Mol Biol Evol 2006, 23:1891 \u20131901.\n55. Delport W, Poon AF, Frost SD, Kosakovsky Pond SL: Datamonkey 2010: a\nsuite of phylogenetic analysis tools for evolutionary biology.Bioinformatics 2010, 26:2455 \u20132457.\n56. Doi M, Tanabe K, Tachibana S, Hamai M, Tachibana M, Mita T, Yagi M,\nZeyrek FY, Ferreira MU, Ohmae H, Kaneko A, Randrianarivelojosia M,\nSattabongkot J, Cao YM, Horii T, Torii M, Tsuboi T: Worldwide sequence\nconservation of transmission-blocking vaccine candidate Pvs230 in\nPlasmodium vivax .Vaccine 2011, 29:4308 \u20134315.\n57. Reeder JC, Wapling J, Mueller I, Siba PM, Barry AE: Population genetic\nanalysis of the Plasmodium falciparum 6-cys protein Pf38 in Papua New\nGuinea reveals domain-specific balancing selection. Malar J 2011, 10:126.\n58. Taylor JE, Pacheco MA, Bacon DJ, Beg MA, Machado RL, Fairhurst RM,\nHerrera S, Kim JY, Menard D, Povoa MM, Villegas L, Mulyanto, Snounou G,\nCui L, Zeyrek FY, Escalante AA: The evolutionary history of Plasmodium\nvivax as inferred from mitochondrial genomes: parasite genetic diversity\nin the Americas. Mol Biol Evol 2013, 30:2050 \u20132064.\n59. Cowman AF, Crabb BS: Invasion of red blood cells by malaria parasites.\nCell2006, 124:755 \u2013766.\n60. Arredondo SA, Cai M, Takayama Y, MacDonald NJ, Anderson DE, Aravind L,\nClore GM, Miller LH: Structure of the Plasmodium 6-cysteine s48/45\ndomain. Proc Natl Acad Sci U S A 2012, 109:6692 \u20136697.\ndoi:10.1186/1475-2875-13-388\nCite this article as: Forero-Rodr\u00edguez et al. :Low genetic diversity in the\nlocus encoding the Plasmodium vivax P41 protein in Colombia \u2019s parasite\npopulation. Malaria Journal 2014 13:388.Submit your next manuscript to BioMed Central\nand take full advantage of: \n\u2022 Convenient online submission\n\u2022 Thorough peer review\n\u2022 No space constraints or color \ufb01gure charges\n\u2022 Immediate publication on acceptance\n\u2022 Inclusion in PubMed, CAS, Scopus and Google Scholar\n\u2022 Research which is freely available for redistribution\nSubmit your manuscript at \nwww.biomedcentral.com/submitForero-Rodr\u00edguez et al. Malaria Journal 2014, 13:388 Page 10 of 10\nhttp://www.malariajournal.com/content/13/1/388RESEARCH Open Access\nHeterogeneous genetic diversity pattern in\nPlasmodium vivax genes encoding merozoite\nsurface proteins (MSP) -7E, \u22127F and -7L\nDiego Garz\u00f3n-Ospina1,2\u2020, Johanna Forero-Rodr\u00edguez1\u2020and Manuel A Patarroyo1,2*\nAbstract\nBackground: The msp-7 gene has become differentially expanded in the Plasmodium genus; Plasmodium vivax has\nthe highest copy number of this gene, several of which encode antigenic proteins in merozoites.\nMethods: DNA sequences from thirty-six Colombian clinical isolates from P. vivax (pv)msp-7E ,\u22127Fand -7Lgenes were\nanalysed for characterizing and studying the genetic diversity of these pvmsp-7 members which are expressed during\nthe intra-erythrocyte stage; natural selection signals producing the variation pattern so observed were evaluated.Results: The pvmsp-7E gene was highly polymorphic compared to pvmsp-7F and pvmsp-7L which were seen to have\nlimited genetic diversity; pvmsp-7E polymorphism was seen to have been maintained by different types of positive\nselection. Even though these copies seemed to be species-specific duplications, a search in the Plasmodium cynomolgi\ngenome ( P. vivax sister taxon) showed that both species shared the whole msp-7 repertoire. This led to exploring the\nlong-term effect of natural selection by comparing the orthologous sequences which led to finding signatures for\nlineage-specific positive selection.\nConclusions: The results confirmed that the P. vivax msp-7 family has a heterogeneous genetic diversity pattern; some\nmembers are highly conserved whilst others are hi ghly diverse. The results suggested that the 3 \u2032-end of these genes\nencode MSP-7 proteins \u2019functional region whilst the central region of pvmsp-7E has evolved rapidly. The lineage-specific\npositive selection signals found sug gested that mutations occurring in msp-7s genes during host switch may have\nsucceeded in adapting the ancestral P. vivax parasite population to humans.\nKeywords: Plasmodium vivax, msp-7, Genetic divers ity, Natural selection, Selective sweep\nBackground\nMalaria remains a major public health problem world-\nwide. Plasmodium falciparum is the parasite species caus-\ning the lethal form of the disease whilst Plasmodium\nvivax has long been considered a parasite causing mild\ndisease, thereby diverting attention away from this species\nregarding research; however, recent studies have reportedthat this species also causes severe clinical syndromes\n[1,2]. Even though both species infect humans, they both\nemerged from different evolutionary lineages; whilst P.vivax shares a common ancestor with Asian non-human\nprimate malaria, P. falciparum has diverged from parasites\ninfecting great apes [3].\nThe different evolutionary paths leading to the appearance\nofP. vivax andP. falciparum have also led to important dif-\nferences regarding hosts being invaded by both species [4,5].In spite of such differences, initial interaction between theparasite and red blood cells (RBC) seems to be directed by\nthe MSP-1 protein [6-8] which is present in all species from\nthe genus. MSP-1 forms a complex with MSP-6 and MSP-7inP. falciparum [9-11]; the latter protein is encoded by a\ngene forming part of a multigene family which has been dif-ferentially expanded amongst Plasmodium species [12].\nStudies involving msp-7 family members have shown that\nthe resulting protein products are located on the parasitemembrane and that a 22 kDa C-terminal fragment (derived\n* Correspondence: mapatarr.fidic@gmail.com\n\u2020Equal contributors\n1Molecular Biology and Immunology Department, Fundaci\u00f3n Instituto de\nInmunolog\u00eda de Colombia (FIDIC), Carrera 50 No. 26-20, Bogot\u00e1, DC,\nColombia\n2Basic Sciences Department, School of Medicine and Health Sciences,\nUniversidad del Rosario, Carrera 24 No. 63C-69, Bogot\u00e1, DC, Colombia\n\u00a9 2014 Garz\u00f3n-Ospina et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the\nCreative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use,distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons PublicDomain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in thisarticle, unless otherwise stated.Garz\u00f3n-Ospina et al. Malaria Journal 2014, 13:495\nhttp://www.malariajournal.com/content/13/1/495from proteolytic processing during parasite develop-\nment) [10] has regions interacting with RBC [13]. The\nmsp-7 knockout in P. falciparum (pfmsp-7I )a n d Plas-\nmodium berghei (pbmsp-7B )h a ss h o w nt h a te v e n\nthough its absence is not lethal, it does reduce mutantparasite invasion ability [14,15]. These results, togetherwith prior in silico analysis, have suggested that the\nmembers of this family could have functional redun-dancy [12,15,16] and their protein products (or some ofthem) could thus be involved in invasion. On the other\nhand, antigenicity studies have shown that some of\nthese genes \u2019protein products are recognized by sera\nfrom infected patients [17,18]. Antibodies directed\nagainst these proteins can inhibit parasite invasion of\nRBC [19], whilst immunization with members of thePlasmodium yoelii msp-7 family has shown that they\ncan confer protection in vaccinated mice following ex-perimental challenge [20].\nThe genetic variability patterns observed in msp-7 family\nmembers have been different between P. falciparum andP.\nvivax [21-24]; whilst members of the former species have\nlow polymorphism [23,24], some members of P. vivax\n(pvmsp-7C ,pvmsp-7H and pvmsp-7I ) are highly poly-\nm o r p h i c[ 2 1 ] .H o w e v e r ,o t h e rm e m b e r s ,s u c ha s pvmsp-7A\nandpvmsp-7K , are amongst the most conserved P. vivax an-\ntigens [22]. There are thirteen msp-7 g e n e si nt h i ss p e c i e s \u2019\nchromosome 12; these have been named in alphabeticalorder according to their location regarding the PVX_082640\ngene [12]. Eleven of these genes are transcribed, but only\nseven of them are transcribed during the last hours of theintra-erythrocyte stage [25]. The genetic diversity of four of\nthese seven genes has already been evaluated [21,22]; this\nstudy was therefore aimed at evaluating the genetic variabil-ity of the three remaining members ( pvmsp-7E ,pvmsp-7F\nand pvmsp-7L ) which are expressed during the intra-\nerythrocyte stage. pvmsp-7E displayed high polymorphism\nand its central region had undergone rapid evolution whilst\npvmsp-7F andpvmsp-7L were seen to be highly conserved.\nThe genes \u20193\u2032-ends tended to be conserved by negative se-\nlection, suggesting that they encode the functional region\nfor these proteins. Similar to what happened with the msp-1\ngene [26,27], msp-7 genes seem to have diverged due to\npositive selection, which could have resulted from malaria\nparasites adaptation to different hosts.\nMethods\nEthics statement\nAllP. vivax -infected patients who provided us with the\nblood samples were informed about the purpose of thestudy and all gave their written consent. All procedurescarried out in this study were approved by the ethics\ncommittee of the Fundaci\u00f3n Instituto de Inmunolog\u00eda\nde Colombia.Parasite DNA and genotyping\nThirty-six peripheral blood samples from patientsproving positive for P. vivax malaria by microscope\nexamination were collected from some of Colombia \u2019s\ndepartments (Choc\u00f3 and Nari\u00f1o in the south-west,Guain\u00eda, Guaviare and Meta in the south-east, Tolima inthe Midwest, and Atl\u00e1ntico, Antioquia and C\u00f3rdoba in\nthe north-west) between 2007 and 2010 (nine isolates\nin 2007, seven isolates in 2008, 8 isolates in 2009 andtwelve isolates in 2010). DNA was obtained using a\nWizard Genomic DNA Purification kit (Promega), fol-\nlowing the manufacturer \u2019s instructions, and stored at\n\u221220\u00b0C until use. The parasite samples were genotyped\nby PCR-RFLP of the pvmsp-1 gene as previously de-\nscribed [28]. Samples having single P. vivax msp-1 allele\ninfection were used for PCR amplification.\nPCR amplification and sequencing\nPrimers were designed for amplifying pvmsp-7E ,pvmsp-\n7Fand pvmsp-7L DNA fragments, based on Sal-I se-\nquences (PlasmoDB IDs: PVX_082665, PVX_082670 andPVX_082700, respectively). The pvmsp-7E gene fragment\nwas amplified with 7Edto 5 \u2032GCCGATCTGTTGTCTT\nTTCC 3 \u2032and 7Erev 5 \u2032CCTTACGACACGTCAAATGG\n3\u2032primers . pvmsp-7F was amplified by using 7Fdto 5 \u2032\nTCCTCTCCTTGCTGATACTCC 3 \u2032and 7Frev 5 \u2032CAGC\nCGCTTAAATCACTTC 3 \u2032primers whilst pvmsp-7L was\namplified with 7Ldto 5 \u2032AGTACTATTCTTCTTGCCG\nTCC 3 \u2032and 7Lrev 5 \u2032TCCCCTCAGTAGTAAAACATCG\n3\u2032primers. All PCR reactions were performed using\nKAPA HiFi HotStart Readymix containing 0.3 \u03bcMo fe a c h\nprimer in a final 25 \u03bcL volume. Thermal conditions were\nset as follows: one cycle of 5 min at 95\u00b0C, 30 cycles of20 sec at 98\u00b0C, 15 sec at 63\u00b0C, 30 sec at 72\u00b0C, followed by\na 5 min final extension at 72\u00b0C. PCR products were puri-\nfied using the UltraClean PCR Clean-up (MO BIO) kit,and then sequenced with a BigDye Terminator kit\n(Macrogen, Seoul, South Korea) in both directions. Three\nPCR products obtained from independent PCR amplifica-tions were sequenced per isolate to discard errors. Se-\nquences having a different haplotype to the previously\nreported ones were deposited in the GenBank database(accession numbers KM212276 - KM212302).\nPhylogenetic analysis for Plasmodium cynomolgi msp-7\northologous identification\nA similar approach used for msp-7 identification in other\nPlasmodium species [12] was adopted for identifying msp-\n7genes in Plasmodium cynomolgi (pc) and establishing\ntheir orthologous relationships. The genomic region (ob-tained from GenBank, accession number: NC_020405)encoded by the PCYB_122860 and PCYB_122720 genes\n(homologues to PVX_082640 and PVX_082715 which cir-\ncumscribed the msp-7 region in P. vivax ) was analysedGarz\u00f3n-Ospina et al. Malaria Journal 2014, 13:495 Page 2 of 13\nhttp://www.malariajournal.com/content/13/1/495using ORF Finder [29] and Gen e Runner software for iden-\ntifying open reading frames (ORFs) encoding proteins lar-\nger than 300 amino acids. Deduced amino acid sequencesobtained with Gene Runner were aligned with P. vivax (12\nproteins) and Plasmodium knowlesi (5 proteins) MSP-7 se-\nquences using the MUSCLE algorithm [30]. The bestmodel for amino acid substitutions was selected by Akaike \u2019s\ninformation criterion using the ProtTest program [31].Phylogenetic trees were inferred through Maximum Likeli-hood (ML) and Bayesian (BY) methods using the JTT+G\nmodel. The observed amino acid frequencies (JTT+G+F)\nwere also considered in Bayesi an phylogenetic analysis and\nthe analysis was run for one million generations. ML top-\nology reliability was evaluated by bootstrap, using 1,000 it-\nerations, whilst the sump and sumt commands in Bayesiananalysis were used for tabulat ing posterior probability and\nbuilding consensus trees. MEGA v.5 software was used forML analysis and MrBayes v.3.2 software for assessingBayesian inference. The P. falciparum MSP-7H ( PfMSP-\n7H) sequence was used as outgroup in both methods.\nDNA diversity and evolutionary analysis in pvmsp-7 genes\nCLC Main workbench (CLC bio, Cambridge, MA, USA)software was used to assemble forward and reverse se-quences from three independent PCR fragments per iso-\nlate. Deduced amino acids from Colombian isolates \u2019\npvmsp-7 sequences and those obtained from several se-\nquencing projects (Sal-I, Brazil-I, Mauritania-I, India-VIIand North Korean reference sequences) [4,32] were\naligned using the MUSCLE algorithm [30], followed bymanual editing. PAL2NAL software [33] was then used\nfor inferring codon alignments from the aligned amino\nacid sequences. The T-REKS algorithm [34] was used forsearching for repeats having 90% similarity with the de-\nduced msp-7 amino acid sequences.\nDnaSP v.5 software [35] was used for calculating the\nnumber of polymorphic segregating sites (Ss), the num-ber of singleton sites (s), the number of parsimony-\ninformative sites (Ps), the number of haplotypes (H), theWatterson estimator ( \u03b8\nw) and nucleotide diversity per\nsite ( \u03c0) for all available sequences (reference sequences\nand Colombian ones), as well as for the Colombianpopulation alone. Departure from the neutral model was\nassessed in the Colombian population by frequency\nspectrum-based tests (Tajima \u2019s D, Fu and Li \u2019s D* and F*\nstatistics Fay and Wu \u2019s H) and tests based on the distri-\nbution of haplotypes (Fu \u2019s Fs and K-tests and H-test\n(for the latter test haplotype diversity obtained fromDnaSP software was multiplied by (n-1)/n according to\nDepaulis and Veuille [35,36])). DnaSP v.5 and/or ALLE-\nLIX software were used for these tests, coalescent simu-lations being used for obtaining confidence intervals\n[35]. Positions containing gaps or repeats in the align-\nment were not taken into account.Natural selection was assessed by using the modified\nNei-Gojobori method [37] which calculated non-syn-onymous (d\nN)a n ds y n o n y m o u s( d S) rate substitution.\nDifferences between d Nand d Swere assessed by apply-\ning Fisher \u2019s exact test (suitable for d Nand d S< 10 [38])\nand the Z-test available in MEGA software v.5 [39]. TheDatamonkey web server [40] was used for assessing\ncodon sites under positive or negative selection at popu-\nlation level, along with the IFEL codon-based maximumlikelihood method [41]. Positive or negatively selected\nsites were also assessed by FEL, SLAC, REL [42], MEME\n[43] and FUBAR [44] methods. A <0.1 p-value was con-sidered significant for IFEL, FEL, SLAC and MEME\nmethods, a >50 Bayes factor for REL and a >0.9 poster-\nior probability for FUBAR. Recombination was consid-ered before running these tests. The branch-site REL\nmethod was used for identifying branches (lineages)\nwhen a percentage of sites have evolved under positiveselection for exploring the long-term selection effect.\nNon-synonymous divergence (K\nN) and synonymous di-\nvergence (K S) rate substitutions were also calculated\nusing the modified Nei-Gojobori method [37] withJukes-Cantor correction [45]. Positive and negative se-\nlection at every codon for P. vivax /P. cynomolgi msp-7\nalignments were also evaluated by FEL, SLAC, MEME,\nREL and FUBAR methods.\nLinkage disequilibrium (LD) was evaluated by calculat-\ning the Z\nnSstatistic [46]. Linear regression between LD\nand nucleotide distances was evaluated to ascertain\nwhether recombination was taking place in pvmsp-7\ngenes. Recombination was also assessed by the GARD\nmethod [47] and by ZZ [48] and RM tests [49]. RDP3\nv3.4 software was used for detecting recombinant frag-ments in pvmsp-7 genes [50].\nResults and discussion\nGenotyping natural isolates\nThe thirty-six samples used in this study were genotypedby PCR-RFLP of the pvmsp-1 marker. All samples were\ninfected by a single strain (a single P. vivax msp-1 allele\nwas detected) and considered for PCR amplification ofpvmsp-7 genes. The RFLP pattern confirmed the pres-\nence of different genotypes in the isolates so obtained.\nIn spite of all samples amplifying the pvmsp-1 fragment,\nno amplimers were detected in some samples for some\nof the msp-7 genes ( pvmsp-7E n = 31, pvmsp-7F n=3 6\nandpvmsp-7L n = 31).\nThe msp-7 family structure in Plasmodium cynomolgi and\nphylogenetic analysis\nPrior analysis has suggested that there are several msp-7\nspecies-specific duplications in P. vivax [12]. The recent\nsequencing of the P. cynomolgi genome [51], a species\nphylogenetically close to P. vivax [3], has meant thatGarz\u00f3n-Ospina et al. Malaria Journal 2014, 13:495 Page 3 of 13\nhttp://www.malariajournal.com/content/13/1/495new sequences from this multigene family are now avail-\nable. The P. cynomolgi genomic region flanked by the\nPCYB_122860 and PCYB_122720 genes contained eleven\n0.9 to 1.4 Kb length ORFs having the same transcription\norientation. A shorter 0.5 Kb fragment having 30% similar-\nity with the identified ORFs was also observed. A 314 bp re-gion having 75.8% identity with the 285 bp fragment in P.\nvivax between the pvmsp-7I andpvmsp-7K genes was also\nfound (Figure 1). The P. cynomolgi msp-7 genes (and/or\nfragments) were named in alphabetical order, according to\ntheir location regarding the PCYB_122860 gene (Figure 1).\nContrasting with PlasmoDB annotation, our group foundthat PcMSP-7C, \u22127F,\u22127H,\u22127I,\u22127K proteins might be\nencoded by a single exon like P. vivax MSP-7K [52]\n(Additional file 1). The deduced amino acid sequences fromthese ORFs had a signal peptide, but no membrane-\nanchoring regions. The domain characteristic of the MSP-7\nfamily (MSP_7C, Pfam domain ID: PF12948) was absent inthe deduced PcMSP-7L protein sequences due to a prema-\nture stop codon.\nOrthologous relationships were established for P. cyno-\nmolgi MSP-7 (PcMSP-7) sequences by inferring phyloge-\nnies, using these sequences together with P. vivax (Pv) and\nP. knowlesi (Pk) MSP-7 sequences (Figure 2) with the P.\nfalciparum MSP-7H (PfMSP-7H) as outgroup. The topolo-\ngies revealed eleven clades ha ving good statistical support\n(Figure 2); each P. cynomolgi MSP-7 had a counterpart in\nP. vivax orP. knowlesi . However, clustering for PcMSP-7B\nand PcMSP-7E differed regarding the other MSP-7s.\nPcMSP-7E formed a group with PvMSP-7E (Figure 2A) inML topology, even though not having very high statistical\nsupport (72%). The BY topology method (Figure 2B) gave a\nsubgroup formed by PcMSP-7B and PcMSP-7E whichappeared as an external PvMSP-7B/PvMSP-7E group sug-\ngesting that these genes are inparalogous and, therefore, the\nduplication events occurred after the divergence of P. cyno-\nmolgi andP. vivax .E v e nt h o u g h pcmsp-7B andpcmsp-7E\ndid not form a group with pvmsp-7B and pvmsp-7E ,r e -\nspectively, their location regarding PVX_082640 andPCYB_122860 genes was the same (Figure 1). Moreover,\ngenetic distances between pcmsp-7B andpcmsp-7E (and/or\npvmsp-7B and pvmsp-7E ) were similar to pcmsp-7B andpvmsp-7B (orpcmsp-7E andpvmsp-7E ). Furthermore, gen-\netic distance between pcmsp-7B andpvmsp-7B was smaller\nthan that between pcmsp-7B and pvmsp-7E and the dis-\ntance between pcmsp-7E andpvmsp-7E was less than the\ndistance between pcmsp-7E and pvmsp-7B (Additional\nfile 2). Consequently, there is little probability that duplica-\ntion events following the divergence of these two species in-\ndependently led to the same order of msp-7B andmsp-7E\ngenes. Evidence of gene conversion (mechanism conducting\nparalogous homogenization) between P. vivax msp-7 mem-\nbers has been reported previously [21]; if such mechanismoccurs between msp-7B and msp-7E genes it would be\nexpected that they would become clustered in the phyl-\nogeny and not with their counterparts from a sister taxon;\nhowever, further analysis is needed for confirming suchhypothesis.\nThe aforementioned results have shown that P. vivax\nand P. cynomolgi share the whole msp-7 repertoire de-\nscribed to date, suggesting that the duplications which\ngave rise to the msp-7B ,\u22127C,\u22127E,\u22127F,\u22127I,\u22127Land-7M\ngenes occurred before the divergence between P. vivax\nandP. cynomolgi and after their divergence from P. know-\nlesi, and thus msp-7B ,\u22127C,\u22127E,\u22127F,\u22127I,\u22127Land -7M\nare not exclusive to P. vivax .\npvmsp-7E genetic diversity\n168 segregant sites were found in the pvmsp-7E gene\n(Table 1), showing that this gene is highly polymorphic.The nucleotide diversity ( \u03c0) estimated for this gene\n(Table 1) was comparable to that found in other genes\nencoding surface proteins ( pvmsp-1 [53], pvmsp-3 [54]\nand pvmsp-5 [55,56]) as well as other members of\npvmsp-7 family [21]. Even though genes such as pvmsp-\n1,pvmsp-3 and pvmsp-5 are highly polymorphic, their\ndiversity at protein level is usually located in determinedregions. These regions are usually immune response tar-gets and have thus tended to evolve more rapidly, accu-\nmulating mutations which alter the protein sequence\nand thereby evading the host \u2019s immune system. Around\n60% of the polymorphism found in pvmsp-7E was lo-\ncated at the gene \u2019s central region whilst the gene \u2019s ends\nwere relatively high conserved (Additional files 3 and 4).\nFigure 1 Schematic representation of the msp-7 family in Plasmodium vivax ,P. cynomolgi and P. knowlesi .The genes flanking the msp-7\nchromosome region in these three species are represented by purple boxes. The blue boxes represent P. vivax msp-7 genes, the red ones\nrepresent P. cynomolgi msp-7 genes and the yellow ones represent P. knowlesi msp-7 genes. The genes are given in alphabetical order from left\nto right. The dashed lines connect orthologous genes. All genes are represented to scale, but in P. cynomolgi and P. knowlesi the distance\nbetween them is not representative.Garz\u00f3n-Ospina et al. Malaria Journal 2014, 13:495 Page 4 of 13\nhttp://www.malariajournal.com/content/13/1/495This pattern has been previously observed in other\npvmsp- 7 genes [21].\nRegarding DNA, 23 haplotypes have been found world-\nwide in pvmsp-7E (Table 1 and Additional file 4); fourteen\ndifferent haplotypes have been found in this gene \u2019s3\u2032-end,\nwhilst eleven haplotypes have been found in the central\nregion and five in the 5 \u2032-end (Additional file 3). Nineteen\nof these 23 haplotypes were found in the Colombianpopulation (Table 1 and Additional file 4; haplotype 10:26%; haplotypes 5, 9: 15%; haplotypes 7, 11, 13, 18: 10%;\nand haplotypes 6, 8, 12, 14 \u201317, 19 \u201323: 5%) over the course\nof a 3-year period (2007 \u20132010) without any longitudinal\nor spatial trends. Thirteen haplotypes were found inColombia at amino acid level (Additional file 5); ten hap-\nlotypes having similar frequencies were observed in thepvmsp- 7Ecentral region in the Colombian population\nwhilst three and four haplotypes were distinguishedtowards the N- and C-terminals, respectively (Additionalfile 5).\nThe T-REKS algorithm did not find repeats in the de-\nduced protein sequences. Of the thirty-six sequencesanalysed for this gene, the North Korean sequence had a\npremature stop codon, suggesting that pvmsp-7E is a\npseudogene in this strain; however, the annotation in theBroad institute for the North Korean pvmsp-7E gene (ac-\ncession: PVNG_00513.1) suggests that this could have\nan intron. Further cDNA analysis is needed to confirm\nsuch issue regarding this strain.\npvmsp-7E neutrality and selection tests\nSeveral tests based on the neutral model of molecular evolu-tion were used with pvmsp-7E sequences from the Colom-\nbian population for evaluating whether this gene deviated\nfrom neutral expectations (Table 2 and Additional file 6).\nTests based on the polymorphism frequency spectrum had\nsignificant values (Table 2). Fu and Li \u2019s D* and F* estimators\nFigure 2 msp-7 gene family phylogeny inferred by Maximum Likelihood (A) and Bayesian (B) methods for P. vivax and two closely\nrelated species. The coloured branches show the MSP-7E (red), MSP-7F (green) and MSP-7L (blue) sequences. Sequence clustering reflects\northologous relationships between the msp-7 genes from these three species. The P. falciparum MSP-7F (PfalH) sequence was used as outgroup.\nNumbers over the branches are bootstrap and probability values.\nTable 1 DNA polymorphism measurements for pvmsp-7\ngenes\nn Gene Sites Ss S Ps H \u03b8w(SD) \u03c0(SD)\nWorldwide genetic diversity\n35 msp-7E 1,044 168 8 160 23 0.0390 (0.0030) 0.0573 (0.0040)\n41 msp-7F 1,164 3 1 2 5 0.0006 (0.0003) 0.0008 (0.0001)\n36 msp-7L 1,212 5 1 4 7 0.0010 (0.0004) 0.0006 (0.0001)\nLocal genetic diversity\n31 msp-7E 1,044 164 6 158 19 0.0393 (0.0031) 0.0558 (0.0045)\n36 msp-7F 1,176 2 0 2 4 0.0004 (0.0003) 0.0007 (0.0004)\n31 msp-7L 1,212 4 0 4 6 0.0008 (0.0004) 0.0006 (0.0001)\nSs: number of segregating sites, S: number of singleton sites, Ps: number of\nparsimony-informative sites, H: number of haplotypes, \u03b8W: Watterson\nestimator, \u03c0: nucleotide diversity. (SD): standard deviation. Worldwide genetic\ndiversity: the analysis involved the reference sequences together with theColombian sequences. Local genetic diversity: Analysis for theColombian sequences.Garz\u00f3n-Ospina et al. Malaria Journal 2014, 13:495 Page 5 of 13\nhttp://www.malariajournal.com/content/13/1/495had values greater than zero whilst Fay and Wu \u2019sHe s t i m a -\ntor had statistically significant negative values (Table 2), indi-\ncating deviation from the neu tral model of evolution. In\naddition, the haplotype distrib ution-based tests also gave sta-\ntistically significant values; Fu \u2019s Fs test gave values greater\nthan zero and the haplotype number (18) and haplotypediversity (0.922) were lower than that expected under\nneutrality (Table 2).\nA sliding window for D, D*, F* and H statistics gave\nvalues greater than zero (D, D* and F*) in the gene \u2019sc e n -\ntral region and lower than zero in the 3 \u2032-end, this being\nthe region where the most negative value for H was lo-\ncated (Additional file 7). The gene was divided into three\nfragments: 5 \u2032-end (nucleotide 1 to 390), central (nucleo-\ntide 391 to 747) and 3 \u2032-end (nucleotide 748 to 1158); the\naforementioned neutrality estimators were calculated foreach of them (Additional file 6). Fu and Li \u2019sD *a n dF u \u2019sF s\ntests gave values greater than zero at the 5 \u2032-end whilst\nTajima \u2019sD ,F ua n dL i \u2019s D*, F* and Fu \u2019sF st e s ts c o r e sw e r e\ngreater than zero in the central region. The haplotype\nnumber and haplotype diversity were lower than expectedunder neutrality in the 5 \u2032-end and central region. Only\nFay and Wu \u2019s H tests gave statistically significant values at\nthe 3 \u2032-end (Additional file 6).\nNatural selection seemed to act in different ways\nwithin the pvmsp-7E gene. A sliding window for the\nnon-synonymous substitutions per non-synonymous siteand synonymous substitutions per synonymous site rate\n(d\nN/dS=\u03c9) gave values greater than 1 ( \u03c9> 1) in the cen-\ntral region and a peak at the 3 \u2032-end (Figure 3). The d S\nrate at the 5 \u2032and 3 \u2032-ends was significantly greater than\ndN, whilst d Nwas significantly greater than d Sin this\ngene \u2019s central region (Table 3). Eight positively selected\nsites were identified in the central region and one in the\n3\u2032-end. Twenty-six negatively selected sites were identi-\nfied, mainly in the 5 \u2032-end (9 sites) and 3 \u2032-end (14 sites)\n(Additional files 4 and 8).\nThese results suggested that the central region was\nunder natural positive selection. According to Tajima and\nFu and Li tests (which had significant values higher than\nzero) pvmsp-7E seemed to be under balancing selection\nfavouring the existence of different alleles in the popula-\ntion. This type of selection frequently occurs in antigens\nexposed to the immune system; immune responses there-fore seemed to be directed towards the pvmsp-7E centralregion in which the mutations were accumulated at a\ngreater rate by positive selection (Additional files 4 and 8).\nInterestingly, as Fay and Wu \u2019s H tests gave significant\nnegative values and as K-test and H-test were lower thanexpected under neutrality (Table 2), then a selective sweep\nwould be probable and strong LD and low genetic diver-sity would thus be expected. Z\nnSvalues suggested that\npvmsp-7E had non-random polymorphism association, as\nexpected in a selective sweep (Table 2). However, differ-ently to what was expected, pvmsp-7 had high genetic\ndiversity (Table 1). When recombination is present in alocus under selective sweep, then it would be expectedthat genetic diversity would only become reduced close to\nthe selection site [57]. There was evidence of recombin-\nation throughout the pvmsp-7E gene (Table 1 and Figure 4,\nsee below) and since the deepest H \u201cvalley \u201dwas located at\nthe 3 \u2032-end (Additional file 7), the selective sweep may not\nhave affected the gene completely but just this region. The5\u2032-end and central regions showed no evidence of select-\nive sweep (Additional file 6) and \u03c0was high in the central\nregion and low at the 5 \u2032extreme (Additional file 3). The\n3\u2032-end had significant values in H and Z\nnStests\n(Additional file 6), suggesting that the selection site shouldhave been located in this region. The \u03c0value in 3 \u2032-end\nwas considerably reduced regarding that for the central re-\ngion (Additional file 3). However, the number of SNPs\nseems to be higher than that expected in a selective sweep.Our results suggested that a selective sweep affected the\npvmsp-7E gene, the selection site was located in the gene \u2019s\n3\u2032-end and this seemed to be an incomplete selective\nsweep due to the presence of recombination since not allvariability had been lost. However, if the selective sweep\nhas not been recent, new mutations could have become\nfixed following such sweep [57].\nFu\u2019s Fs test gave values greater than zero (Table 2 and\nAdditional file 6) which may have resulted from a reduc-tion in haplotypes due to a recent bottleneck. Conse-\nquently, a low genetic diversity throughout the genepool is expected in P. vivax Colombia population. Prior\nstudies have shown high genetic diversity in parasitic an-tigens in the Colombian population [21,55], meaningthat such demographic event is highly unlikely. This\ntest \u2019s result may have been due to a reduction of pvmsp-\n7Ehaplotypes by the selective sweep, causing the num-\nber of haplotypes to be lower than that expected.Table 2 Neutrality, linkage disequilibrium and recombination tests for pvmsp-7 genes for the Colombian population\nn Gene Tajima Fu and Li Fay and\nWu \u2019sHFu \u2019s\nFsK-test H-test (SD) Z nS ZZ RM\nDD * F *\n31 msp-7E 1.452 1.603** 1.839* \u221251.002* 7.501** 18* 0.922 (0.02)* 0.246* 0.453* 12\n36 msp-7F 1.401 0.783 1.112 \u22120.365 0.114 4 0.560 (0.07) 0.327 0.000 1\n31 msp-7L \u22120.610 1.054 0.658 0.656 \u22122.453 6 0.578 (0.08) 0.050 \u22120.031 1\nmsp-7E haplotype number (K-test) and diversity (H-test) were lower than expected under neutrality. (SD): standard deviation. *: p <0.05, **: p <0.02.Garz\u00f3n-Ospina et al. Malaria Journal 2014, 13:495 Page 6 of 13\nhttp://www.malariajournal.com/content/13/1/495Figure 3 Sliding window for \u03c9rate. Plasmodium vivax msp-7E ,msp-7F and msp-7L genes \u2019\u03c9(dN/dS) values represented in blue, whilst the\ndivergence omega ( \u03c9:KN/KS) between P. vivax and P. cynomolgi is shown in purple. A diagram of each gene is given below the sliding window.\nIntra-species non-synonymous substitutions (red) and synonymous substitutions (green) are shown by vertical lines above each gene.\nTable 3 Average number of pvmsp-7 gene synonymous substitutions per synonymous site (d S) and non-synonymous\nsubstitutions per non-synonymous site (d N)\nn Gene 5 \u2032-end Central 3 \u2032-end Full-length gene\nWorldwide\nisolatesdS(SE) d N(SE) d S(SE) d N(SE) d S(SE) d N(SE) d S(SE) d N(SE)\n35 msp-7E 0.0488 (0.0118) \u00810.0082 (0.0032) 0.0717 (0.0163) 0.1573 (0.0134) \u00810.0665 (0.0130) \u00810.0171 (0.0045) 0.0626 (0.0078) 0.0551 (0.0055)\n41 msp-7F 0.0000 (0.0000) 0.0000 (0.0000) 0.0000 (0.0000) 0.0013 (0.0012) 0.0000 (0.0000) 0.0018 (0.0018) 0.0000 (0.0000) 0.0011 (0.0007)^\n36 msp-7L 0.0006 (0.0005) 0.0000 (0.0000) 0.0000 (0.0000) 0.0012 (0.0008) 0.0013 (0.0012) 0.0008 (0.0008) 0.0006 (0.0005) 0.0007 (0.0004)\nColombian\nisolates\n31 msp-7E 0.0473 (0.0115) \u00810.0079 (0.0032) 0.0706 (0.0168) 0.1549 (0.0135) \u00810.0633 (0.0124) \u00810.0161 (0.0042) 0.0606 (0.0077) 0.0539 (0.0056)\n36 msp-7F 0.0000 (0.0000) 0.0000 (0.0000) 0.0000 (0.0000) 0.0012 (0.0011) 0.0000 (0.0000) 0.0017 (0.0016) 0.0000 (0.0000) 0.0010 (0.0007)^\n31 msp-7L 0.0000 (0.0000) 0.0000 (0.0000) 0.0000 (0.0000) 0.0012 (0.0009) 0.0010 (0.0010) 0.0009 (0.0008) 0.0004 (0.0004) 0.0007 (0.0004)\nSE: standard error. 5 \u2032-end ( pvmsp-7E : nucleotide 1 \u2013390, pvmsp-7F : nucleotide 1 \u2013432, pvmsp-7L : nucleotide 1 \u2013381), central ( pvmsp-7E : nucleotide 391 \u2013747, pvmsp-7F :\nnucleotide 433 \u20131,053, pvmsp-7L : nucleotide 382 \u2013816) and 3 \u2032-end ( pvmsp-7E : nucleotide 748 \u20131,158, pvmsp-7F : nucleotide 1,054 \u20131,449, pvmsp-7L : nucleotide\n817 \u20131,275). Numbering based on Additional files 4,9and 10. ^: p = 0.06, \u2022: p <0.001.Garz\u00f3n-Ospina et al. Malaria Journal 2014, 13:495 Page 7 of 13\nhttp://www.malariajournal.com/content/13/1/495pvmsp-7F and pvmsp-7L genetic diversity\nIn contrast to pvmsp-7E ,pvmsp-7F andpvmsp-7L had low\ngenetic diversity (Table 1). This genetic diversity was simi-\nlar to that observed in pvmsp-4 [58,59], pvmsp-8 [60],\npvmsp-10 [22,60], pv12 ,pv38 [61], pv41 [ 6 2 ] ,a sw e l la si n\npvmsp-7A andpvmsp-7K [22]. Aligning the Colombian se-\nquences with those obtained from the databases (referencesequences, Additional files 9 and 10) revealed that these\ngenes only had four and six segregant sites, respectively.\nThe \u03c0values and the number of haplotypes for these\ngenes were low (Table 1). The most frequently occurring\npvmsp-7F allele in Colombia was haplotype 2 (61%),\nfollowed by haplotype 1 (19%), haplotype 3 (17%) and\nhaplotype 4 (3%), whilst haplotype 1 (61%) was the most\nfrequent for pvmsp-7L , followed by haplotype 3 (16%),\nhaplotype 2 (14%) and haplotypes 4, 5 and 6 (3%).\npvmsp-7F and pvmsp-7L neutrality and selection tests\nNeutrality for pvmsp-7F and-7Lgenes in the Colombian\npopulation could not be ruled out as no statistically sig-nificant values were found for the tests based on the\nneutral model of molecular evolution (Table 2 andAdditional file 6). Likewise, no natural selection signals\nwere found to be acting on these genes when d\nNand d S\nrates were calculated (Table 3). However, when the effect\nof selection on each codon was evaluated, it was seen\nthat codon 424 regarding pvmsp-7F , was under positive\nselection. Concerning pvmsp-7L , codons 159, 260 and357 showed positive selection signals (Additional files 8,9 and 10).\nIntragene linkage disequilibrium (LD) and recombination\ninpvmsp-7 genes\nAs mentioned above, there were non-random associa-\ntions regarding polymorphism for pvmsp-7E according\nto the Z nStest (Table 2 and Additional file 6). No evi-\ndence of LD was found in pvmsp-7F orpvmsp-7L\n(Table 2 and Additional file 6), indicating that poly-\nmorphism within these genes was not associated. A lin-\near regression between LD and nucleotide distance forpvmsp-7s gave a line sloping downwards as nucleotide\ndistance increased in pvmsp-7E ,s u g g e s t i n gi n t r a g e n e\nrecombination. Twelve minimal recombination (RM)events were found for pvmsp-7E whilst only one RM\nwas found in pvmsp-7F andpvmsp-7L (Table 2). The ZZ\ntest and GARD method suggested recombination inpvmsp-7E (ZZ = p < 0.05 and GARD 2 breakpoints, p <\n0.0004) but not in pvmsp-7F orpvmsp-7L .F i g u r e4\nshows the fragments produced by recombination inpvmsp-7E .\npcmsp-7 and pvmsp-7 genes appear to have diverged by\npositive selection\nNatural selection \u2019s long-term effect on evolutionary\nhistory can be evaluated by comparing the orthologousgenes from phylogenetically-related species [60-64].\nmsp-7E was highly divergent when compared to the\npvmsp-7E and pcmsp-7E genes (Figure 3). In spite of\nmsp-7F and msp-7L being highly conserved in P. vivax ,\nthey also have been shown to be highly divergent when\ncompared to P. cynomolgi orthologous genes (Figure 3).\nThe random effects branch-site model (Branch-site REL)\nwas performed for determining how natural selection\nhad acted during P. vivax andP. cynomolgi evolutionary\nhistory. This test displayed lineage-specific diversifying\nselection signals in msp-7E andmsp-7L (\u03c9> 1, Figure 5).\nMoreover, the sliding window for the non-synonymous\ndivergence per non-synonymous site rate (K\nN) and the\nsynonymous divergence per synonymous site rate (Ks)(divergent omega, K\nN/Ks = \u03c9) gave highly divergent\nareas in the central region and 3 \u2032-end of these three\ngenes (Figure 3). A statistically significant K N>K Swas\nfound in the central region (p < 0.001) in pvmsp-7E\n(Table 4). No significant values were found in msp-7F ,\nbut in msp-7L ,K Swas significantly higher than K N\n(Table 4). However, when intraspecific polymorphismwas compared to interspecific divergence using the\nMcDonald-Kreitman test (MKT) no statistically signifi-\ncant values were found for these genes. The methods forestimating \u03c9values for each codon (SLAC, FEL, REL,\nMEME and FUBAR) identified twenty-five (for msp-7E ),\nfour (for msp-7F ) and seven (for msp-7L ) codons under\nFigure 4 Schematic representation of recombination segments\nidentified in pvmsp-7E by RDP3. Recombination fragments were\nonly found in pvmsp-7E . Each variant is represented by a colour bar;\na segment having a different colour below the bar represents the\nrecombination event so identified.Garz\u00f3n-Ospina et al. Malaria Journal 2014, 13:495 Page 8 of 13\nhttp://www.malariajournal.com/content/13/1/495Figure 5 Positive lineage-specific selection in msp-7E (A) and msp-7L (B) genes. Branches under diversifying selection were identified by\nBranch-site REL method. \u03c9values, the percentage of selected sites (Pr [ \u03c9=\u03c9+]) and p-values are shown.\nTable 4 Average number of msp-7 gene synonymous divergence per synonymous site (K S) and non-synonymous diver-\ngence per non-synonymous site (K N)\nn Gene 5 \u2032end Central 3 \u2032end Full-length gene\nWorldwide\nisolatesKS(SE) K N(SE) K S(SE) K N(SE) K S(SE) K N(SE) K S(SE) K N(SE)\n36 msp-7E 0.0746 (0.0156) \u00810.0126 (0.0034) 0.0813 (0.0185) 0.1976 (0.0191) \u00810.0980 (0.0163) \u00810.0299 (0.0056) 0.0833 (0.0092) 0.0676 (0.0066)\n42 msp-7F 0.0098 (0.0023) \u20200.0047 (0.0009) 0.0146 (0.0029) 0.0141 (0.0022) 0.0086 (0.0022) 0.0100 (0.0022) 0.0110 (0.0014) 0.0096 (0.0010)\n37 msp-7L 0.0140 (0.0031) \u20210.0092 (0.0017) 0.0172 (0.0035) 0.0149 (0.0020) 0.0111 (0.0025) \u20210.0070 (0.0013) 0.0139 (0.0017)* 0.0102 (0.0010)\nColombian\nisolates\n32 msp-7E 0.0755 (0.0151) \u00810.0128 (0.0032) 0.0808 (0.0183) 0.1963 (0.0191) \u00810.0982 (0.0156) \u00810.0305 (0.0053) 0.0834 (0.0089) 0.0676 (0.0065)\n37 msp-7F 0.0111 (0.0027) \u20200.0053 (0.0011) 0.0165 (0.0033) 0.0156 (0.0023) 0.0098 (0.0025) 0.0110 (0.0022) 0.0125 (0.0016) 0.0107 (0.0011)\n32 msp-7L 0.0156 (0.0037) \u20210.0107 (0.0020) 0.0199 (0.0041) 0.0170 (0.0023) 0.0123 (0.0027) \u20210.0081 (0.0015) 0.0157 (0.0019)* 0.0118 (0.0011)\nSE: standard error. 5 \u2032-end ( pvmsp-7E : nucleotide 1 \u2013390, pvmsp-7F : nucleotide 1 \u2013432, pvmsp-7L : nucleotide 1 \u2013381), central ( pvmsp-7E : nucleotide 391 \u2013747, pvmsp-7F :\nnucleotide 433 \u20131,053, pvmsp-7L : nucleotide 382 \u2013816) and 3 \u2032-end ( pvmsp-7E : nucleotide 748 \u20131,158, pvmsp-7F : nucleotide 1,054 \u20131,449, pvmsp-7L : nucleotide 817 \u2013\n1,275). Numbering based on Additional files 4,9and 10.\u2021: p <0.09, *: p <0.04, \u2020: p <0.02, \u2022: p <0.001.Garz\u00f3n-Ospina et al. Malaria Journal 2014, 13:495 Page 9 of 13\nhttp://www.malariajournal.com/content/13/1/495positive selection between pvmsp-7 and pcmsp-7 se-\nquences (Additional files 4, 9, 10 and 11).\nThese results suggested that these genes have become\ndiversified by positive selection; a similar pattern which\nhave been reported for the pvmsp-1 gene [26,27]. Diver-\ngence due to positive selection in msp-1 coinciding with\nAsian macaque radiation [26,65] 3 to 6 million years agomeans that divergence by positive selection in msp-1 ap-\npears to be the result of adaptations to available new\nhosts [26,65]. P. falciparum MSP-1 and MSP-7 form a\nprotein complex involved in invasion [9,10]. Assumingthe formation of a protein complex between MSP-1 andMSP-7 in P. vivax , MSP-7s would be under the same se-\nlective pressures and may thus have evolved in a similarway. Theoretically [66,67], it has been suggested that astrong selective sweep may result in population differen-\ntiation at the hitchhiking locus, provided that the gene\nflow between these populations is low. Since malarialparasites could become diversified by sympatric events\n[68,69], msp-7 (similar to msp-1 ) may have become di-\nversified by positive selection (Figure 5) as a mechanism\nfor adapting the ancestral P. vivax population to a new\nhost during the switch to humans [70] and thus the se-lective sweep detected in msp-7E might have been an ef-\nfect of such adaptation.\nNegative selection within and between species supports\nthe idea that the 3 \u2032-end encodes the functional region in\nMSP-7 proteins\nIn spite of divergence by positive selection, msp-7 func-\ntional regions could have evolved more slowly due to their\nrole during invasion and thus the accumulation of substitu-tions would have been mainly synonymous. K\nS>K Nwas re-\nvealed in msp-7E and msp-7L when comparing P. vivax\nandP. cynomolgi sequences (Table 4). Fifty-seven sites were\nrevealed to be under negative selection in msp-7E ,t w e n t y -\nfour in msp-7F and thirty-six in msp-7L (Additional files 4,\n9, 10 and 11). A large percentage of negatively selected siteswere located in the gene \u2019s3 \u2032-end encoding the msp-7\nfamily \u2019s characteristic domain (MSP7_C, Pfam domain ID:\nPF12948). The protein \u2019s C-terminal region encoded by these\ngenes was highly conserved in pvmsp-7A ,\u22127C,\u22127H,\u22127I,\n\u22127K[21,22], \u22127E,\u22127Fand-7L;f u r t h e r m o r e ,t h i sr e g i o nh a s\nbeen conserved for a long period of time (2.6 to 5.2 millionyears ago [3]), at least in msp-7E (84.8% similarity between\nP. vivax and P. cynomolgi ),\u22127F(86.8%) and -7L(95.4%).\nThe negative selection signals identified at the 3 \u2019-end of\nthese three genes (Additional files 8 and 11) suggested that\nthe biological structure encoded by this region has been\nstable slowly evolving since divergence between P. vivax and\nP. cynomolgi due to its functional importance. These results\nsupport the idea that this region encodes this family \u2019sf u n c -\ntional domain [21].The pvmsp-7 and pcmsp-7 sequences have different gene\nstructures\nMarked differences were observed between P. vivax andP.\ncynomolgi msp-7 genes. pcmsp-7F had a long insertion (one\nhundred ninety-two nucleotides) compared to pvmsp-7F\n(Additional file 9); however, the ORF remained open.pcmsp-7L had a premature stop codon caused by the\ndeletion of one or two nucleotides from the sequence(Additional file 10). The protein encoded by this gene thushad no domain characteristic of this family (MSP7_C, Pfam\ndomain ID: PF12948); however, many synonymous substi-\ntutions between species were observed in the region encod-ing this domain (the gene \u2019s3\u2035-end) when P. vivax andP.\ncynomolgi sequences were compared. Thirteen sites in this\nregion were under negative selection in msp-7L (Additional\nfiles 10 and 11). The GeneScan algorithm [71] was then\nused for searching for exon /intron splice sites in pcmsp-7F\nand pcmsp-7L sequences. GeneScan analysis revealed re-\ngions which could act as donor and acceptor sequences inpcmsp-7L but not in pcmsp-7F .T h e r ew a sat h y m i n ei n\npcmsp-7L nucleotide 609, whilst there was a cytosine in the\nhomologous position in its orthologue in P. vivax (nucleo-\ntide 615 in the Sal-I sequence). Such change may have pro-\nduced a putative donor (GT) site in pcmsp-7L whilst a\nputative acceptor site was lo cated in position 1,030/1,031\n(Additional file 12); an intron region was thus located inpcmsp-7L between nucleotides 608 and 1,031. Such exon-\nintron-exon structure in pcmsp-7L can be observed in the\nannotation of the P. cynomolgi genome available from Plas-\nmoDB; however, the intron predicted in PlasmoDB wasshorter than that predicted by GeneScan. This exon-intron-\nexon structure allowed pcmsp-7L to encode a protein hav-\ning the MSP7_C domain.\nConclusions\nOur results confirmed that the P. vivax msp-7 family has a\nheterogeneous genetic diversity pattern. Some memberswere seen to be highly conserved whilst other had high\ngenetic diversity. Consequently, P. vivax msp-7 genes must\nhave evolved differently from those in P. falciparum which\nhave low polymorphism [23,24]. The PvMSP-7s C-terminalregion (the gene \u2019s3\u2032-end) tended to be conserved within\nand between genes [21]. This region \u2019sc o n s e r v a t i o nt e n d e d\nto be maintained by negative selection in msp-7E ,msp-7F\nandmsp-7L , suggesting that this is the functional region for\nthis group of proteins. On the other hand, PvMSP-7 highly\ndiverse members ( pvmsp-7C ,\u22127H,\u22127I[21] and -7E)w e r e\nseen to have undergone rapid evolution at the protein \u2019s\ncentral region; immune respon ses would thus been directed\nt o w a r d st h i sp o r t i o no ft h ep r o t e i n .N e wa l l e l e sh a v ec o n s e -\nquently arisen in the population and been maintained bybalancing selection as a mechanism for evading an immune\nresponse. In addition to this type of evasion, the P. vivax\nmsp-7 family (similar to that suggested for the pvmsp-3Garz\u00f3n-Ospina et al. Malaria Journal 2014, 13:495 Page 10 of 13\nhttp://www.malariajournal.com/content/13/1/495family [72]) would follow a model of multi-allele diversify-\ning selection where functiona lly redundant paralogues [12]\nwould increase evasion of the immune responses by anti-\ngenic diversity.\nOur results have shown that P. vivax andP. cynomolgi\nshare the whole msp-7 repertoire described to date and\nhave revealed lineage-specific positive selection signals\nwhich are similar to those reported for pvmsp-1 .M u t a -\ntions occurring in msp-7s genes during host switch may\nthus have succeeded in adapting the ancestral P. vivax\nparasite to humans.\nAdditional files\nAdditional file 1: Putative P. cynomolgi msp-7 gene sequences\nobtained from chromosome 12, whole genome shotgun sequence\nGenBank accession number: NC_020405. ORF Finder and Gene\nRunner software were used to identify open reading frames encoding P.\ncynomolgi MSP-7 proteins.\nAdditional file 2: Genetic distance between pcmsp-7B ,pcmsp-7E\nand pvmsp-7B ,pvmsp-7E sequences from 5 P. vivax isolates. The\nnumber of nucleotide differences per site was estimated as well as thestandard error regarding the pvmsp-7E and pvmsp-7B reference\nsequences and the pcmsp-7E and pcmsp-7B sequences.\nAdditional file 3: DNA polymorphism measurements at the 5 \u2032-end,\ncentral region and 3 \u2032-end for pvmsp -7genes in the Colombian\npopulation. Ss: number of segregating sites, S: number of singleton sites,\nPs: number of parsimony-informative sites, H: number of haplotypes, \u03b8\nW:\nWatterson estimator, \u03c0: nucleotide diversity. (SD): standard deviation.\n5\u2032-end ( pvmsp-7E : nucleotide 1 \u2013390, pvmsp-7F : nucleotide 1 \u2013432,\npvmsp-7L : nucleotide 1 \u2013381), central ( pvmsp-7E : nucleotide 391 \u2013747,\npvmsp-7F : nucleotide 433 \u20131,053, pvmsp-7L : nucleotide 382 \u2013816) and 3 \u2032-\nend ( pvmsp-7E : nucleotide 748 \u20131,158, pvmsp-7F : nucleotide 1,054 \u20131,449,\npvmsp-7L : nucleotide 817 \u20131,275). Numbers based on Additional files 4, 9\nand 10.\nAdditional file 4: pvmsp-7E gene alignment. The alignment shows\nthe 23 haplotypes found in pvmsp-7E together with the pcmsp-7E\nhaplotype. Haplotype 1, Sal-I; haplotype 2, Brazil-I; haplotype 3, India-VII;\nhaplotype 4, Mauritania-I; haplotype 5 \u201323, Colombian isolates. Dots\nrepresent nucleotide identity. Codons under positive selection are shown\nin green (intra-species) and turquoise (inter-species) and those under\nnegative selection are shown in yellow (intra-species) and fuchsia(inter-species).\nAdditional file 5: Haplotype alignment at PvMSP-7E protein level in\nColombia. The alignment shows the 13 haplotypes at protein level\nfound in PvMSP-7E. Dots represent amino acid identity.Additional file 6: Neutrality, linkage disequilibrium and\nrecombination tests at the 5 \u2032-end, central region and 3 \u2032-end for\npvmsp-7 genes in the Colombian population. 5\u2032-end ( pvmsp-7E :\nnucleotide 1 \u2013390, pvmsp-7F : nucleotide 1 \u2013432, pvmsp-7L : nucleotide\n1\u2013381), central ( pvmsp-7E : nucleotide 391 \u2013747, pvmsp-7F : nucleotide\n433 \u20131,053, pvmsp-7L : nucleotide 382 \u2013816) and 3 \u2032-end ( pvmsp-7E :\nnucleotide 748 \u20131,158, pvmsp-7F : nucleotide 1,054 \u20131,449, pvmsp-7L :\nnucleotide 817 \u20131,275). Numbers based on Additional files 4, 9 and 10.\n\u0081: p <0.02, *: p <0.05.\nAdditional file 7: Neutrality test sliding window for the pvmsp-7E\ngene. Tajima \u2019s D (blue), Fu and Li \u2019s D* (red), F* (green) and Fay and Wu \u2019s\nH (purple). The gene was divided into 3 regions: the 5 \u2032-end (nucleotide 1\nto 390), central (nucleotide 391 to 747) and 3 \u2032-end region (nucleotide 748\nto 1,158). The bars at the bottom indicate that a test gave significant\nvalues in each region. Numbering based on the alignment shown inAdditional file 4.\nAdditional file 8: Intra-species positively and negatively selected\nsites detected for pvmsp-7 genes. 5\u2032-end ( pvmsp-7E : nucleotide 1 \u2013390,pvmsp-7F : nucleotide 1 \u2013432, pvmsp-7L : nucleotide 1 \u2013381), central\n(pvmsp-7E : nucleotide 391 \u2013747, pvmsp-7F : nucleotide 433 \u20131,053,\npvmsp-7L : nucleotide 382 \u2013816) and 3 \u2032-end ( pvmsp-7E : nucleotide 748 \u2013\n1,158, pvmsp-7F : nucleotide 1,054 \u20131,449, pvmsp-7L : nucleotide 817 \u20131,275).\nNumbers based on Additional files 4, 9 and 10.Additional file 9 pvmsp-7F gene alignment. The alignment shows the\n8 haplotypes found in pvmsp-7F together with pcmsp-7F haplotype.\nHaplotype 1, Sal-I; haplotype 2, Brazil-I and North Korea; haplotype 3,\nIndia-VII; haplotype 4, Mauritania-I; haplotypes 5 \u20138, Colombian isolates.\nDots represent nucleotide identity. Codons under positive selection areshown in green (intra-species) and turquoise (inter-species) and those\nunder negative selection are shown in fuchsia (inter-species).\nAdditional file 10: pvmsp-7L gene alignment. The alignment shows\nthe 7 haplotypes found in pvmsp-7L together with pcmsp-7L haplotype.\nHaplotype 1, Sal-I; haplotype 2, Brazil-I, India-VII and North Korea;\nhaplotype 3, Mauritania-I; haplotypes 4 \u20137, Colombian isolates. The dots\nrepresent nucleotide identity. Codons under positive selection are shown\nin green (intra-species) and in turquoise (inter-species) and those undernegative selection are shown in fuchsia (inter-species).\nAdditional file 11: Inter-species positively and negatively selected\nsites detected for msp-7 genes. 5\u2032-end ( msp-7E : nucleotide 1 \u2013390,\nmsp-7F : nucleotide 1 \u2013432, msp-7L : nucleotide 1 \u2013381), central ( msp-7E :\nnucleotide 391 \u2013747, msp-7F : nucleotide 433 \u20131,053, msp-7L : nucleotide\n382 \u2013816) and 3 \u2032-end ( msp-7E : nucleotide 748 \u20131,158, msp-7F : nucleotide\n1,054 \u20131,449, msp-7L : nucleotide 817 \u20131,275). Numbers based on\nAdditional files 4, 9 and 10.Additional file 12: pcmsp-7L putative donor and acceptor sites.\nAn alignment was made between the Sal-I strain pvmsp-7L sequences,\npcmsp-7L and the sequence resulting from GeneScan analysis\n(pcmsp-7L _mRNA). The red arrows indicate the putative donor and\nacceptor sites in pcmsp-7L .\nCompeting interests\nThe authors declare that they have no competing interests.\nAuthors \u2019contributions\nDG-O and JF-R devised and designed the study, performed the experiments,\nmade the population genetics analysis and wrote the manuscript. MAPcoordinated the study, and helped to write the manuscript. All the authors\nhave read and approved the final manuscript.\nAcknowledgements\nWe would like to thank Jason Garry for tra nslating the manuscript. This work was\nfinanced by the \u201cDepartamento Administrativo de Ciencia, Tecnolog\u00eda e\nInnovaci\u00f3n (COLCIENCIAS) \u201dthrough contracts RC # 0309 \u20132013 and # 0709 \u20132013.\nJF-R received financing through COLCIENCIAS cooperation agreement # 0719 \u201313.\nReceived: 21 October 2014 Accepted: 10 December 2014\nPublished: 13 December 2014\nReferences\n1. Singh J, Purohit B, Desai A, Savardekar L, Shanbag P, Kshirsagar N: Clinical\nManifestations, treatment, and outcome of hospitalized patients with\nPlasmodium vivax malaria in two Indian States: A Retrospective Study.\nMalar Res Treat 2013, 2013: 341862.\n2. Jain V, Agrawal A, Singh N: Malaria in a tertiary health care facility of\nCentral India with special reference to severe vivax: implications formalaria control. Pathog Glob Health 2013, 107:299 \u2013304.\n3. Pacheco MA, Battistuzzi FU, Junge RE, Cornejo OE, Williams CV, Landau I,\nRabetafika L, Snounou G, Jones-Engel L, Escalante AA: Timing the origin of\nhuman malarias: the lemur puzzle. BMC Evol Biol 2011, 11:299.\n4. Carlton JM, Adams JH, Silva JC, Bidwell SL, Lorenzi H, Caler E, Crabtree J,\nAngiuoli SV, Merino EF, Amedeo P, Cheng Q, Coulson RM, Crabb BS, Del\nPortillo HA, Essien K, Feldblyum TV, Fernandez-Becerra C, Gilson PR, GueyeAH, Guo X, Kang \u2019a S, Kooij TW, Korsinczky M, Meyer EV, Nene V, Paulsen I,\nWhite O, Ralph SA, Ren Q, Sargeant TJ, et al:Comparative genomics of the\nneglected human malaria parasite Plasmodium vivax .Nature 2008,\n455:757 \u2013763.Garz\u00f3n-Ospina et al. Malaria Journal 2014, 13:495 Page 11 of 13\nhttp://www.malariajournal.com/content/13/1/4955. Iyer J, Gruner AC, Renia L, Snounou G, Preiser PR: Invasion of host cells by\nmalaria parasites: a tale of two protein families. Mol Microbiol 2007,\n65:231 \u2013249.\n6. Chitnis CE, Blackman MJ: Host cell invasion by malaria parasites.\nParasitol Today 2000, 16:411 \u2013415.\n7. Rodriguez LE, Urquiza M, Ocampo M, Curtidor H, Suarez J, Garcia J, Vera R,\nPuentes A, Lopez R, Pinto M, Rivera Z, Patarroyo ME: Plasmodium vivax\nMSP-1 peptides have high specific binding activity to human\nreticulocytes. Vaccine 2002, 20:1331 \u20131339.\n8. Urquiza M, Rodriguez LE, Suarez JE, Guzman F, Ocampo M, Curtidor H,\nSegura C, Trujillo E, Patarroyo ME: Identification of Plasmodium falciparum\nMSP-1 peptides able to bind to human red blood cells. Parasite Immunol\n1996, 18:515 \u2013526.\n9. Kauth CW, Woehlbier U, Kern M, Mekonnen Z, Lutz R, Mucke N, Langowski\nJ, Bujard H: Interactions between merozoite surface proteins 1, 6, and 7\nof the malaria parasite Plasmodium falciparum .J Biol Chem 2006,\n281:31517 \u201331527.\n10. Pachebat JA, Ling IT, Grainger M, Trucco C, Howell S, Fernandez-Reyes D,\nGunaratne R, Holder AA: The 22 kDa component of the protein complex on the\nsurface of Plasmodium falciparum merozoites is derived from a larger\nprecursor, merozoite surface protein 7. Mol Biochem Parasitol 2001, 117:83\u201389.\n11. Trucco C, Fernandez-Reyes D, Howell S, Stafford WH, Scott-Finnigan TJ,\nGrainger M, Ogun SA, Taylor WR, Holder AA: The merozoite surface protein\n6 gene codes for a 36 kDa protein associated with the Plasmodium\nfalciparum merozoite surface protein-1 complex. Mol Biochem Parasitol\n2001, 112:91\u2013101.\n12. Garzon-Ospina D, Cadavid LF, Patarroyo MA: Differential expansion of the\nmerozoite surface protein (msp)-7 gene family in Plasmodium speciesunder a birth-and-death model of evolution. Mol Phylogenet Evol 2010,\n55:399 \u2013408.\n13. Garcia Y, Puentes A, Curtidor H, Cifuentes G, Reyes C, Barreto J, Moreno A,\nPatarroyo ME: Identifying merozoite surface protein 4 and merozoite\nsurface protein 7 Plasmodium falciparum protein family members\nspecifically binding to human erythrocytes suggests a new malarial\nparasite-redundant survival mechanism. J Med Chem 2007, 50:5665 \u20135675.\n14. Kadekoppala M, O \u2019Donnell RA, Grainger M, Crabb BS, Holder AA: Deletion\nof the Plasmodium falciparum merozoite surface protein 7 gene impairs\nparasite invasion of erythrocytes. Eukaryot Cell 2008, 7:2123 \u20132132.\n15. Tewari R, Ogun SA, Gunaratne RS, Crisanti A, Holder AA: Disruption of\nPlasmodium berghei merozoite surface protein 7 gene modulates\nparasite growth in vivo. Blood 2005, 105:394 \u2013396.\n16. Mello K, Daly TM, Morrisey J, Vaidya AB, Long CA, Bergman LW: A multigene\nfamily that interacts with the amino terminus of Plasmodium MSP-1\nidentified using the yeast two-hybrid system. Eukaryot Cell 2002, 1:915 \u2013925.\n17. Chen JH, Jung JW, Wang Y, Ha KS, Lu F, Lim CS, Takeo S, Tsuboi T, Han ET:\nImmunoproteomics profiling of blood stage Plasmodium vivax infection\nby high-throughput screening assays. J Proteome Res 2010, 9:6479 \u20136489.\n18. Wang L, Crouch L, Richie TL, Nhan DH, Coppel RL: Naturally acquired\nantibody responses to the components of the Plasmodium falciparum\nmerozoite surface protein 1 complex. Parasite Immunol 2003, 25:403 \u2013412.\n19. Woehlbier U, Epp C, Hackett F, Blackman MJ, Bujard H: Antibodies against\nmultiple merozoite surface antigens of the human malaria parasitePlasmodium falciparum inhibit parasite maturation and red blood cell\ninvasion. Malar J 2010, 9:77.\n20. Mello K, Daly TM, Long CA, Burns JM, Bergman LW: Members of the\nmerozoite surface protein 7 family with similar expression patterns differin ability to protect against Plasmodium yoelii malaria. Infect Immun 2004,\n72:1010 \u20131018.\n21. Garzon-Ospina D, Lopez C, Forero-Rodriguez J, Patarroyo MA: Genetic diver-\nsity and selection in three Plasmodium vivax merozoite surface protein 7\n(Pvmsp-7) genes in a Colombian population. PLoS One 2012, 7:e45962.\n22. Garzon-Ospina D, Romero-Murillo L, Tobon LF, Patarroyo MA: Low genetic\npolymorphism of merozoite surface proteins 7 and 10 in ColombianPlasmodium vivax isolates. Infect Genet Evol 2011, 11:528 \u2013531.\n23. Roy SW, Weedall GD, da Silva RL, Polley SD, Ferreira MU: Sequence\ndiversity and evolutionary dynamics of the dimorphic antigen merozoite\nsurface protein-6 and other Msp genes of Plasmodium falciparum .\nGene 2009, 443:12\u201321.\n24. Tetteh KK, Stewart LB, Ochola LI, Amambua-Ngwa A, Thomas AW, Marsh K,\nWeedall GD, Conway DJ: Prospective identification of malaria parasite\ngenes under balancing selection. PLoS One 2009, 4:e5568.25. Bozdech Z, Mok S, Hu G, Imwong M, Jaidee A, Russell B, Ginsburg H,\nNosten F, Day NP, White NJ, Carlton JM, Preiser PR: The transcriptome of\nPlasmodium vivax reveals divergence and diversity of transcriptional\nregulation in malaria parasites. Proc Natl Acad Sci U S A 2008,\n105:16290 \u201316295.\n26. Sawai H, Otani H, Arisue N, Palacpac N, de Oliveira ML, Pathirana S,\nHandunnetti S, Kawai S, Kishino H, Horii T, Tanabe K: Lineage-specific positive\nselection at the merozoite surface protein 1 (msp1) locus of Plasmodium\nvivax and related simian malaria parasites. BMC Evol Biol 2010, 10:52.\n27. Tanabe K, Escalante A, Sakihama N, Honda M, Arisue N, Horii T, Culleton R,\nHayakawa T, Hashimoto T, Longacre S, Pathirana S, Handunnetti S, Kishino\nH:Recent independent evolution of msp1 polymorphism in Plasmodium\nvivax and related simian malaria parasites. Mol Biochem Parasitol 2007,\n156:74\u201379.\n28. Imwong M, Pukrittayakamee S, Gruner AC, Renia L, Letourneur F,\nLooareesuwan S, White NJ, Snounou G: Practical PCR genotyping protocols\nforPlasmodium vivax using Pvcs and Pvmsp1 .Malar J 2005, 4:20.\n29. ORF Finder (Open Reading Frame Finder). [http://www.ncbi.nlm.nih.gov/\nprojects/gorf/]\n30. Edgar RC: MUSCLE: multiple sequence alignment with high accuracy and\nhigh throughput. Nucleic Acids Res 2004, 32:1792 \u20131797.\n31. Abascal F, Zardoya R, Posada D: ProtTest: selection of best-fit models of\nprotein evolution. Bioinformatics 2005, 21:2104 \u20132105.\n32. Neafsey DE, Galinsky K, Jiang RH, Young L, Sykes SM, Saif S, Gujja S,\nGoldberg JM, Young S, Zeng Q, Chapman SB, Dash AP, Anvikar AR, SuttonPL, Birren BW, Escalante AA, Barnwell JW, Carlton JM: The malaria parasite\nPlasmodium vivax exhibits greater genetic diversity than Plasmodium\nfalciparum .Nat Genet 2012, 44:1046 \u20131050.\n33. Suyama M, Torrents D, Bork P: PAL2NAL: robust conversion of protein\nsequence alignments into the corresponding codon alignments.Nucleic Acids Res 2006, 34:W609 \u2013612.\n34. Jorda J, Kajava AV: T-REKS: identification of Tandem REpeats in sequences\nwith a K-meanS based algorithm. Bioinformatics 2009, 25:2632 \u20132638.\n35. Librado P, Rozas J: DnaSP v5: a software for comprehensive analysis of\nDNA polymorphism data. Bioinformatics 2009, 25:1451 \u20131452.\n36. Depaulis F, Veuille M: Neutrality tests based on the distribution of\nhaplotypes under an infinite-site model. Mol Biol Evol 1998, 15:1788 \u20131790.\n37. Zhang J, Rosenberg HF, Nei M: Positive Darwinian selection after gene\nduplication in primate ribonuclease genes. Proc Natl Acad Sci U S A 1998,\n95:3708 \u20133713.\n38. Nei M, Kumar S: Molecular evolution and phylogenetics. Oxford New York:\nOxford University Press; 2000.\n39. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S: MEGA5:\nmolecular evolutionary genetics analysis using maximum likelihood,evolutionary distance, and maximum parsimony methods. Mol Biol Evol\n2011, 28:2731 \u20132739.\n40. Delport W, Poon AF, Frost SD, Kosakovsky Pond SL: Datamonkey 2010: a\nsuite of phylogenetic analysis tools for evolutionary biology.Bioinformatics 2010, 26:2455 \u20132457.\n41. Pond SL, Frost SD, Grossman Z, Gravenor MB, Richman DD, Brown AJ:\nAdaptation to different human populations by HIV-1 revealed by codon-\nbased analyses. PLoS Comput Biol 2006, 2:e62.\n42. Kosakovsky Pond SL, Frost SD: Not so different after all: a comparison of\nmethods for detecting amino acid sites under selection. M o lB i o lE v o l 2005,\n22:1208 \u20131222.\n43. Murrell B, Wertheim JO, Moola S, Weighill T, Scheffler K, Kosakovsky Pond\nSL:Detecting individual sites subject to episodic diversifying selection.\nPLoS Genet 2012, 8:e1002764.\n44. Murrell B, Moola S, Mabona A, Weighill T, Sheward D, Kosakovsky Pond SL,\nScheffler K: FUBAR: a fast, unconstrained bayesian approximation for\ninferring selection. Mol Biol Evol 2013, 30:1196 \u20131205.\n45. Jukes TH, Cantor CR: Evolution of protein molecules. InMammalian Protein\nMetabolism. Edited by Munro HN. New York: Academic Press; 1969.\n46. Kelly JK: A test of neutrality based on interlocus associations. Genetics\n1997, 146:1197 \u20131206.\n47. Kosakovsky Pond SL, Posada D, Gravenor MB, Woelk CH, Frost SD:\nAutomated phylogenetic detection of recombination using a genetic\nalgorithm. Mol Biol Evol 2006, 23:1891 \u20131901.\n48. Rozas J, Gullaud M, Blandin G, Aguade M: DNA variation at the rp49 gene\nregion of Drosophila simulans : evolutionary inferences from an unusual\nhaplotype structure. Genetics 2001, 158:1147 \u20131155.Garz\u00f3n-Ospina et al. Malaria Journal 2014, 13:495 Page 12 of 13\nhttp://www.malariajournal.com/content/13/1/49549. Hudson RR, Kaplan NL: Statistical properties of the number of\nrecombination events in the history of a sample of DNA sequences.\nGenetics 1985, 111:147 \u2013164.\n50. Martin DP, Lemey P, Lott M, Moulton V, Posada D, Lefeuvre P: RDP3: a\nflexible and fast computer program for analyzing recombination.Bioinformatics 2010, 26:2462 \u20132463.\n51. Tachibana S, Sullivan SA, Kawai S, Nakamura S, Kim HR, Goto N, Arisue N,\nPalacpac NM, Honma H, Yagi M, Tougan T, Katakai Y, Kaneko O, Mita T, KitaK, Yasutomi Y, Sutton PL, Shakhbatyan R, Horii T, Yasunaga T, Barnwell JW,Escalante AA, Carlton JM, Tanabe K: Plasmodium cynomolgi genome\nsequences provide insight into Plasmodium vivax and the monkey\nmalaria clade. Nat Genet 2012, 44:1051 \u20131055.\n52. Mongui A, Perez-Leal O, Soto SC, Cortes J, Patarroyo MA: Cloning,\nexpression, and characterisation of a Plasmodium vivax MSP7 family\nmerozoite surface protein. Biochem Biophys Res Commun 2006,\n351:639 \u2013644.\n53. Figtree M, Pasay CJ, Slade R, Cheng Q, Cloonan N, Walker J, Saul A:\nPlasmodium vivax synonymous substitution frequencies, evolution and\npopulation structure deduced from diversity in AMA 1 and MSP 1 genes.Mol Biochem Parasitol 2000, 108:53\u201366.\n54. Mascorro CN, Zhao K, Khuntirat B, Sattabongkot J, Yan G, Escalante AA,\nCui L: Molecular evolution and intragenic recombination of the\nmerozoite surface protein MSP-3alpha from the malaria parasite\nPlasmodium vivax in Thailand. Parasitology 2005, 131:25\u201335.\n55. Gomez A, Suarez CF, Martinez P, Saravia C, Patarroyo MA: High\npolymorphism in Plasmodium vivax merozoite surface protein-5 (MSP5).\nParasitology 2006, 133:661 \u2013672.\n56. Putaporntip C, Udomsangpetch R, Pattanawong U, Cui L, Jongwutiwes S:\nGenetic diversity of the Plasmodium vivax merozoite surface protein-5\nlocus from diverse geographic origins. Gene 2010, 456:24\u201335.\n57. Nurminsky D: Selective sweep. Georgetown, Tex. New York, N.Y: Landes\nBioscience/Eurekah.com; Kluwer Academic/Plenum Publishers; 2005.\n58. Putaporntip C, Jongwutiwes S, Ferreira MU, Kanbara H, Udomsangpetch R,\nCui L: Limited global diversity of the Plasmodium vivax merozoite surface\nprotein 4 gene. Infect Genet Evol 2009, 9:821 \u2013826.\n59. Martinez P, Suarez CF, Gomez A, Cardenas PP, Guerrero JE, Patarroyo MA:\nHigh level of conservation in Plasmodium vivax merozoite surface\nprotein 4 (PvMSP4). Infect Genet Evol 2005, 5:354 \u2013361.\n60. Pacheco MA, Elango AP, Rahman AA, Fisher D, Collins WE, Barnwell JW,\nEscalante AA: Evidence of purifying selection on merozoite surface\nprotein 8 (MSP8) and 10 (MSP10) in Plasmodium spp. Infect Genet Evol\n2012, 12:978 \u2013986.\n61. Forero-Rodriguez J, Garzon-Ospina D, Patarroyo MA: Low genetic diversity\nand functional constraint in loci encoding Plasmodium vivax P12 and\nP38 proteins in the Colombian population. Malar J 2014, 13:58.\n62. Forero-Rodriguez J, Garzon-Ospina D, Patarroyo MA: Low genetic diversity\nin the locus encoding the Plasmodium vivax P41 protein in Colombia \u2019s\nparasite population. Malar J 2014, 13:388.\n63. Chenet SM, Pacheco MA, Bacon DJ, Collins WE, Barnwell JW, Escalante AA:\nThe evolution and diversity of a low complexity vaccine candidate,merozoite surface protein 9 (MSP-9), in Plasmodium vivax and closely\nrelated species. Infect Genet Evol 2013, 20:239 \u2013248.\n64. Pacheco MA, Ryan EM, Poe AC, Basco L, Udhayakumar V, Collins WE,\nEscalante AA: Evidence for negative selection on the gene encoding\nrhoptry-associated protein 1 (RAP-1) in Plasmodium spp. Infect Genet Evol\n2010, 10:655 \u2013661.\n65. Carlton JM, Das A, Escalante AA: Genomics, population genetics and\nevolutionary history of Plasmodium vivax .Adv Parasitol 2013, 81:203 \u2013222.\n66. Slatkin M, Wiehe T: Genetic hitch-hiking in a subdivided population.\nGenet Res 1998, 71:155 \u2013160.\n67. Nurminsky DI: Genes in sweeping competition. Cell Mol Life Sci 2001,\n58:125 \u2013134.\n68. Perez-Tris J, Hellgren O, Krizanauskiene A, Waldenstrom J, Secondi J,\nBonneaud C, Fjeldsa J, Hasselquist D, Bensch S: Within-host speciation of\nmalaria parasites. PLoS One 2007, 2:e235.\n69. Sutherland CJ, Tanomsing N, Nolder D, Oguike M, Jennison C,\nPukrittayakamee S, Dolecek C, Hien TT, do Rosario VE, Arez AP, Pinto J,Michon P, Escalante AA, Nosten F, Burke M, Lee R, Blaze M, Otto TD,\nBarnwell JW, Pain A, Williams J, White NJ, Day NP, Snounou G, Lockhart PJ,\nChiodini PL, Imwong M, Polley SD: Two nonrecombining sympatric formsof the human malaria parasite Plasmodium ovale occur globally. J Infect\nDis2010, 201:1544 \u20131550.\n70. Mu J, Joy DA, Duan J, Huang Y, Carlton J, Walker J, Barnwell J, Beerli P,\nCharleston MA, Pybus OG, Su XZ: Host switch leads to emergence of\nPlasmodium vivax malaria in humans. Mol Biol Evol 2005, 22:1686 \u20131693.\n71. Burge C, Karlin S: Prediction of complete gene structures in human\ngenomic DNA. J Mol Biol 1997, 268:78\u201394.\n72. Rice BL, Acosta MM, Pacheco MA, Carlton JM, Barnwell JW, Escalante AA:\nThe origin and diversification of the merozoite surface protein 3 (msp3)\nmulti-gene family in Plasmodium vivax and related parasites.\nMol Phylogenet Evol 2014, 78C: 172 \u2013184.\ndoi:10.1186/1475-2875-13-495\nCite this article as: Garz\u00f3n-Ospina et al. :Heterogeneous genetic diversity\npattern in Plasmodium vivax genes encoding merozoite surface proteins\n(MSP) -7E, \u22127F and -7L. Malaria Journal 2014 13:495.\nSubmit your next manuscript to BioMed Central\nand take full advantage of: \n\u2022 Convenient online submission\n\u2022 Thorough peer review\n\u2022 No space constraints or color \ufb01gure charges\n\u2022 Immediate publication on acceptance\n\u2022 Inclusion in PubMed, CAS, Scopus and Google Scholar\n\u2022 Research which is freely available for redistribution\nSubmit your manuscript at \nwww.biomedcentral.com/submitGarz\u00f3n-Ospina et al. Malaria Journal 2014, 13:495 Page 13 of 13\nhttp://www.malariajournal.com/content/13/1/495Buitrago et al. Malar J  (2016) 15:501 \nDOI 10.1186/s12936-016-1563-4\nRESEARCH\nSize polymorphism and\u00a0low sequence \ndiversity in\u00a0the locus encoding the Plasmodium \nvivax \u00a0rhoptry neck protein 4 (PvRON4) \nin\u00a0Colombian isolates\nSindy  P . Buitrago1,2, Diego  Garz\u00f3n\u2011Ospina1,3 and  Manuel  A. Patarroyo1,3*\nAbstract  \nBackground:  Designing a vaccine against Plasmodium vivax  has focused on selecting antigens involved in invasion \nmechanisms that must have domains with low polymorphism for avoiding allele \u2011specific immune responses. The \nrhoptry neck protein 4 (RON4) forms part of the tight junction, which is essential in the invasion of hepatocytes and/\nor erythrocytes; however, little is known about this locus\u2019 genetic diversity.\nMethods:  DNA sequences from 73 Colombian clinical isolates from pvron4  gene were analysed for characterizing \ntheir genetic diversity; pvron4  haplotype number and distribution, as well as the evolutionary forces determining \ndiversity pattern, were assessed by population genetics and molecular evolutionary approaches.Results:  ron4  has low genetic diversity in P . vivax  at sequence level; however, a variable amount of tandem repeats at \nthe N \u2011terminal region leads to extensive size polymorphism. This region seems to be exposed to the immune system. \nThe central region has a putative esterase/lipase domain which, like the protein\u2019s C \u2011terminal fragment, is highly con\u2011\nserved at intra \u2011 and inter \u2011species level. Both regions are under purifying selection.\nConclusions:  pvron4  is the locus having the lowest genetic diversity described to date for P . vivax . The repeat regions \nin the N \u2011terminal region could be associated with immune evasion mechanisms while the central region and the \nC\u2011terminal region seem to be under functional or structural constraint. Bearing such results in mind, the PvRON4 \ncentral and/or C \u2011terminal portions represent promising candidates when designing a subunit \u2011based vaccine as they \nare aimed at avoiding an allele \u2011specific immune response, which might limit vaccine efficacy.\nKeywords:  Plasmodium vivax , Rhoptry, Genetic diversity, Tandem repeat, pvron4 , Natural selection,  \nFunctional restriction\n\u00a9 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License \n(http://creativecommons.org/licenses/by/4.0/ ), which permits unrestricted use, distribution, and reproduction in any medium, \nprovided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/\npublicdomain/zero/1.0/ ) applies to the data made available in this article, unless otherwise stated.Background\nMalaria is the parasitic disease having the greatest impact \non public health [ 1]. It is caused by different species \nfrom the Plasmodium  genus, these being widely distrib -\nuted throughout the world\u2019s tropical and sub-tropical regions [ 2]. These parasites cause 140\u2013300 million clini -\ncal cases and more than half a million deaths annually [3, 4]. Plasmodium falciparum  is considered the most \nlethal species, mainly affecting vulnerable populations in sub-Saharan Africa [ 4]. Even though efforts were initially \nconcentrated on controlling this species, reports of ever-increasingly severe cases caused by Plasmodium vivax  \n[5] and the appearance of drug-resistant strains during \nthe last few years [ 6, 7] has made this species a growing \npublic health problem, affecting more than a third of the world\u2019s population, having high prevalence in Asia and South and Central America [ 3, 7, 8].\nDesigning an anti-malarial vaccine against P. vivax  \n(as for P. falciparum ) has been focused on blocking Open AccessMalaria Journa l\n*Correspondence:  mapatarr.fidic@gmail.com \n1 Fundaci\u00f3n Instituto de Inmunolog\u00eda de Colombia (FIDIC), Carrera 50 No. \n26\u201120, Bogot\u00e1 D.C., Colombia\nFull list of author information is available at the end of the articlePage 2 of 12 Buitrago et al. Malar J  (2016) 15:501 \nparasite-host interactions during different parasitic \nstages, especially during the blood phase responsible for the disease\u2019s clinical manifestations [9, 10]. A large \namount of P. vivax antigens have been characterized to date [ 10, 11], however, their genetic diversity should \nbe assessed for selecting the best antigens for vaccine development [10, 12]. Highly polymorphic antigens can \nprovoke allele-specific immune responses leading to pro -\ntection having low efficacy after vaccination. On the con -\ntrary, those having limited diversity are attractive targets for being evaluated as candidates as they avoid an allele-specific immune response [13].\nMost antigens characterized to date have been mero -\nzoite proteins [10, 11], including the microneme AMA1 \nprotein and rhoptry neck (RONs) proteins. The interac -\ntion between these proteins (specifically AMA1\u2013RON2) has been well described in Toxoplasma gondii and P. \nfalciparum,  these being the structural basis for the tight \njunction (TJ), a connective ring through which a parasite enters a host cell [14\u201318].\nThe RON protein complex (characterized in P. falcipa -\nrum ) consists of RON2, RON4 and RON5 proteins [14, \n17, 19]. Even though the mechanisms regarding func -\ntion and interaction between the complex\u2019s proteins are not clear, they are considered important targets for blocking invasion. Various studies have highlighted the potential of AMA1 and RON2 as vaccine candidates, however, current knowledge concerning the other RONs is deficient. Co-localization studies and invasion models described for Plasmodium  spp and T. gondii have led to \nestablishing RON4\u2019s convincing participation in the TJ [15, 17, 20, 21]. Likewise, its expression in the parasite\u2019s \ninvasive forms [21\u201323], the ability to provoke an immune response in natural malarial infections [23] and the pro -\ntein\u2019s conserved nature, specifically towards the C-termi -\nnal (inferred by comparative analysis between Pf RON4 \nand TgRON4 amino acid sequences) [24] suggest that \nthis protein plays an important role for the parasite and could thus be evaluated as vaccine candidate.\nThe P. falciparum RON4 orthologue has recently \nbeen characterized in the P. vivax VCG-I strain (Vivax Colombia Guaviare-I) [22]. PvRON4 (P. vivax RON4) is encoded by a gene having around 2657\u00a0bp in this species, expressed during the last hours of the intra-erythrocyte cycle and secreted from the rhoptry neck. This consists of signal peptide sequence, a low complexity domain formed by two types of tandem repeats, a double spiral alpha helix domain and five conserved cysteines towards the C-terminal [22]; the latter region seems to be highly conserved among P. vivax and parasite species infecting monkeys [25].\nBearing RON4\u2019s potential participation in invasion in \nmind and given that parasite antigen genetic diversity is an obstacle for designing a completely effective vac -\ncine against P. vivax, this study was thus aimed at using Colombian clinical isolates for evaluating pvron4 locus genetic diversity and the evolutionary mechanisms deter -\nmining its variation pattern.\nMethods\nSample collection\nPlasmodium vivax genomic DNA was obtained from 73 clinical isolates collected from 2007 to 2015 (2007: 10, 2008: 12, 2010: 18, and 2015: 33 samples). These came from Colombia\u2019s Pacific coast region (Choc\u00f3 and Nar -\ni\u00f1o departments), Urab\u00e1/lower Cauca/southern C\u00f3rdoba (C\u00f3rdoba and Antioquia departments) and the Orino -\nquia-Amazonia region (Amazonas and Guain\u00eda depart -\nments), representing the three regions having the greatest transmissibility in Colombia [26]. More than 360,000 cases of P. vivax infection were recorded between 2007 and 2015, more than 14\u00a0% of them regarding Colombia\u2019s Pacific coastal region, Urab\u00e1/lower Cauca/southern C\u00f3r -\ndoba 62\u00a0 % while 7.5\u00a0 % of P. vivax cases were recorded in the Orinoquia-Amazonia region. Malaria sympto -\nmatic patients (living in the regions described above) were diagnosed with P. vivax\u00a0 infection by microscopy and then invited to donate 5\u00a0mL of venous blood. Some Amazonia samples were collected and diagnosed, as has been reported elsewhere [27]. Male and female patients aged 16\u201364\u00a0years were invited to participate in the study. DNA was extracted and stored at \u221220\u00a0 \u00b0C before being processed and were genotyped by PCR-RFLP from the pvmsp -3\u03b1 gene.\nAmplifying, cloning and\u00a0sequencing the pvron4 locus\nA set of primers was designed to amplify and clone pvron4 based on Sal-I genomic sequence (GenBank accession number AAKM01000005.1), sequences being as follows: pvron4 dir 5\u2032 CACAGTGCAACCATGTCTCG 3\u2032 (20\u00a0bp) and pvron4 rev 5 \u2032 GCAAGCTAATTTCACAA  \nGTCTTC 3 \u2032 (23\u00a0 bp) primers. Touchdown-PCR was \nused for amplification using the KAPA-HiFi HotStart Readymix enzyme (Kapa Biosystems) in 25\u00a0\u03bcL reactions using VCG-I strain genomic DNA as positive control. Thermal conditions were as follows: a 5\u00a0min denaturing step at 95\u00a0\u00b0C, 10 cycles consisting of 20\u00a0s at 98\u00a0\u00b0C, 15\u00a0s at 68\u00a0\u00b0C (temperature was reduced by one degree per cycle) and 1\u00a0min at 72\u00a0\u00b0C, followed by 35 cycles of 20\u00a0s at 98\u00a0\u00b0C, 15\u00a0s at 60\u00a0\u00b0C, 1\u00a0min at 72\u00a0\u00b0C and a final 5-min extension at 72\u00a0\u00b0C. PCR products were purified using an UltraClean PCR Clean-up purification kit (MOBIO).\nThe amplicons were ligated in pGEM T-easy cloning \nvector and then used for transforming Escherichia coli  \nJM109 strain cells. Recombinant bacteria were selected by the alpha complementation method and their growth Page 3 of 12\n Buitrago et al. Malar J  (2016) 15:501 \nability in the presence of ampicillin. These were con -\nfirmed by PCR using MangoTaq DNA polymerase and \ninternal primers for the gene (intdir: 5\u2032  TGTGGGTGG  \nCGAGAGTG 3\u2032  (17\u00a0 bp), and intrev: 5\u2032  ATATTTCC  \nATTGCTGTACTAGG 3 \u2032 (22\u00a0 bp), designed on Sal-I \ngenomic sequence) using the following thermal condi -\ntions a 5\u00a0min denaturing step at 95\u00a0\u00b0C, 35 cycles of 20\u00a0s at 98\u00a0\u00b0C, 15\u00a0s at 60\u00a0\u00b0C, 1\u00a0min at 72\u00a0\u00b0C and a final 5-min extension at 72\u00a0\u00b0C. The plasmid from the two recombi -\nnant colonies per sample was extracted using an Ultra -\nClean 6 Minute Mini Plasmid Prep kit (MOBIO) and sent to be sequenced using a BigDye Terminator kit (MAC -\nROGEN, Seoul, South Korea), with universal prim -\ners SP6 Promoter Primer (Cat.# Q5011), T7 Promoter Primer (Cat.# Q5021) [28] and a set of internal prim -\ners (pvron4dseq: 5\u2032  CACTAGAAAAGCTAAACATA  \nAACC 3 \u2032 (24\u00a0bp), and pvron4rseq: 5\u2032  ACTCCAATGGT  \nCCTCAAC 3 \u2032 (18\u00a0 bp) designed on the Sal-I genomic \nsequence) for sequencing.\nStatistical analysis of\u00a0pvron4 sequences\nThe electropherograms obtained by sequenc -\ning were assembled using CLC DNA workbench v.3 software (CLC bio, Cambridge, MA, USA). The 73 consensus sequences obtained in this study (Addi -\ntional file\u00a0 1), 7 reference sequences (from the Sal -\nvador-I (Sal-I, GenBank: XM_001615228.1), Mauritania-I (GenBank: AFNI01000694.1), India-VII (GenBank: AFBK01001155.1), Brazil-I (Gen -\nBank: AFMK01001544.1/AFMK01001546.1), North Korea (GenBank: AFNJ01001110.1), ctg (GenBank: AAKM01000005) and P01 (GeneDB: PVP01_0916600.1) strains) and 13 orthologous sequences (from Plasmo -\ndium cynomolgi (GeneBank: BAEJ01000746.1), Plasmo -\ndium knowlesi (GeneBank: NC_011910.1), Plasmodium inui (GeneBank: AMYR01000790.1/AMYR01000791.1), \nPlasmodium fragile  (GeneBank: NW_012192637.1), \nPlasmodium coatneyi (GeneBank: CM002860.1), Plas -\nmodium reichenowi (GeneBank: LVLA01000012.1), P. falciparum  (GeneBank: XM_001347803.2), Plasmodium \nbergei (GeneBank: CAAI01002287.1), Plasmodium yoelii  \n(GeneBank: AABL01000590.1), Plasmodium chabaudi  \n(GeneBank: CAAJ01004050.1), Plasmodium vinckei  \n(GeneBank: AMYS01000107.1), Plasmodium gaboni  \n(GeneBank: LVLB01000012.1), and Plasmodium galli -\nnaceum (Sanger Institute: gal28a.d000001405.Contig1/gal28a.d000000110.Contig1) were used for obtaining the deduced amino acid sequence used for multiple align -\nment with the MUSCLE algorithm [29]. Such alignment was manually edited to ensure correct repeat region alignment and then used for inferring DNA alignment by Pal2Nal software [30]. The T-REKS algorithm was used for identifying repeat regions [31].DnaSP v.5 software [32] was used for calculating \ngenetic diversity regarding Colombian sequences and P. vivax reference sequences alignment using estimators based on single nucleotide polymorphism (SNP) and sequence length (InDels). Tajima [33], Fu and Li [34], Fu [35], Fay and Wu [36] tests were used for evaluating devi -\nations from the neutral model of molecular evolution, bearing coalescence simulations in mind for obtaining confidence intervals and their statistical significance. The repeat regions or those having gaps were not taken into account for analysis.\nThe Nei-Gojobori modified method [37] with MEGA \nv.6 software [38] was used for calculating the average number of synonymous substitutions per synonymous site (d\nS) and the average number of non-synonymous \nsubstitutions per non-synonymous site (dN) at intra-\nspecies level. The average amount of synonymous diver -\ngences per synonymous site (KS) and the average amount \nof non-synonymous divergences per non-synonymous site (K\nN) were calculated by modified Nei-Gojobori \nmethod with Jukes-Cantor correction [39] for determin -\ning natural selection signals throughout Plasmodium  \nspp evolutionary history (using the P. vivax sequences, together with phylogenetically close parasites\u2019 ortholo -\ngous sequences). The differences between intra- and inter-species substitution rates were determined by Fish -\ner\u2019s exact test (recommended when the amount of syn -\nonymous and/or no-synonymous substitutions is fewer than ten) or the Z-test incorporated in MEGA software v6. Additionally, the McDonald\u2013Kreitman (MK) test [40] with Jukes-Cantor correction was used for evaluating neutrality deviations using the Standard & Generalized McDonald\u2013Kreitman Test web server [41, 42].\nA sliding window was used for analysing evolutionary \nrate (\u03c9\u00a0 =\u00a0d\nN/dS and/or KN/KS) by evaluating the effect \nof selection throughout the gene. Individual sites under selection were identified by calculating synonymous and non-synonymous substitution rates per codon using SLAC, FEL, REL, IFEL [43], MEME [44], and FUBAR methods [45] in the Datamonkey online server [46]. Repeat regions or those having gaps were not taken into account for this analysis.\nThe random effects likelihood (REL)-branch-site \nmethod [47] was used for evaluating the existence of line -\nages under episodic diversifying selection in Plasmodium  \nfor the ron4 locus. The MUSCLE algorithm was used for aligning 14 orthologous protein sequences from different species from the genus; this was then used for inferring the best evolutionary model using MEGA software. Phy -\nlogeny was then inferred by using the maximum likeli -\nhood method with the JFF\u00a0 +\u00a0G\u00a0+\u00a0F model. This is used as \nreference for analysing lineage-specific positive selection with the REL-branch-site method in the HyPhy package Page 4 of 12 Buitrago et al. Malar J  (2016) 15:501 \n[48], using a DNA alignment inferred by Pal2Nal from \naligning amino acids.\nEffective\u00a0number of\u00a0codons\nENCprime [49] and DnaSP software were used for esti -\nmating the effective number of codons (ENC). This is a measurement of selective pressure at translational level, leading to protein function loss or gain [49]. This test compares the use of each codon versus a null distribution (uniform use of synonymous codons). ENC values close to 61 indicate that all synonymous codons for each amino acid are used equitably, while values close to 0 suggest bias or preferential codon use [50]. Statistical signifi -\ncance could be affected by gene length or recombination [50]. The codon bias index (CBI) was thus used, which takes values ranging from 0 (uniform use of synonymous codons) to 1 (maximum codon bias) [51].\nLinkage disequilibrium and\u00a0recombination\nLinkage disequilibrium (LD) was evaluated by calculat -\ning the ZnS estimator [52]. A linear regression between \nthis and the nucleotide distance was performed to see whether intragenic recombination occurred in pvron4. Recombination was also evaluated by ZZ estimator [53], the minimum number of recombination events (Rm) [54], the GARD algorithm [55] and the RDP v.3 software [56].\npvron4 locus differentiation and\u00a0population genetic \nstructure\nThe degree of genetic differentiation (or inter-population \nheterogeneity) in the pvron4 locus among Colombian P. vivax malaria-endemic regions was estimated by analysis of molecular variance (AMOVA) and Wright\u2019s fixating index (F\nST), using the Arlequin v.3.1 software [57]. NET -\nWORK v.5 software was used for constructing a median joining network for evaluating possible mutational path -\nways giving rise to pvron4 haplotypes, their distribution and frequencies. This method expresses multiple plau -\nsible evolutionary pathways as cycles, bound by vectors interpreted as extinct ancestral sequences [58].\nPredicting pvron4 putative domains and\u00a0antigenic \npotential\nThe Blastp algorithm from the NCBI web server was used \nfor identifying putative domains in PvRON4 using the Sal-I sequence as reference. The B-cell epitope prediction tool available at the immune epitope database (IEDB) server was used for evaluating PvRON4s antigenic poten -\ntial regarding its antigenicity [59], its hydrophobicity [60], protein solvent availability [61] and its potential linear B-cell epitopes [62]. These tests were done with two PvRON4 haplotypes differentiated by the amount of repeats: haplotype 6 (one copy of GEHGEHAEHGE) and haplotype 17 (seven copies of the repeat), to evaluate the effect of repeat number on protein antigenic behavior.\nResults\npvron4 locus genetic diversity\nSeventy-three sequences from the pvron4 locus obtained from the P. vivax Colombian population (24 from Orino -\nquia-Amazonia, 21 from the Pacific coast and 28 from Urab\u00e1/lower-Cauca/southern C\u00f3rdoba) were analysed. pvron4 was initially annotated from the VCG-I strain as being a 2657\u00a0 bp gene [22], however, the locus analysed from Colombian samples had a variation in length due to two tandem repeats located towards the gene\u2019s 5\u2032-end (Fig.\u00a0 1). These repeats consisted of copies of the GTGG  \nCGAGA nucleotide sequence encoding GES amino acids (repeated one to three times) and a longer sequence CGGAGAGCACGGTGAACACGCTGAACATGGGGA  \nGCA encoding the GEHGEHAEHGE peptide (repeated one to seven times).\nFew SNPs were found. Regarding the 2542 sites ana -\nlysed concerning the Colombian sequences and the refer -\nence ones, the number of SNPs varied from five to eight (Table\u00a0 1). The genetic diversity estimators gave low val -\nues (\u03b8\nw\u00a0=\u00a04.7\u00a0 \u00d7\u00a010\u22124 and \u03c0\u00a0 =\u00a04.1\u00a0 \u00d7\u00a010\u22124) in the P. vivax \nColombian population. Such values remained constant when comparing the Colombian sequences to the refer -\nence ones (Table\u00a0 1). Likewise, the total amount of pvron4 \nhaplotypes identified and haplotype diversity were low (Table\u00a0 1), however, 15 haplotypes in the Colombian pop -\nulation (21 when Colombian and reference sequences are analysed together) and high diversity estimator values (Table\u00a0 1) were found when analysing insertions/deletions \n(InDels) in pvron4. Bearing the SNPs and InDels between the pvron4 reference sequence and Colombian sequences \nin mind, 32 haplotypes were identified (Additional file\u00a02).\nEvaluating the effect of\u00a0selection on\u00a0the pvron4 locus\nNo statistically significant values were found for pvron4 when using the Tajima, Fu and Li, Fay and Wu and Fu estimators (Table\u00a0 2). Likewise, the MK test did not reveal \nany deviations regarding neutrality (Table\u00a0 3), however, \nthe d\nN\u00a0\u2212\u00a0dS difference (Table\u00a0 3) showed that the synony -\nmous substitution rate was higher than the non-synon -\nymous substitution rate (p\u00a0 =\u00a0 0.000, Fisher\u2019s exact test), \nsuggesting that pvron4 was under purifying selection. The sliding windows led to \u03c9\u00a0<\u00a01 values being observed throughout the gene (Fig.\u00a01).\nWhen comparing phylogenetically related species, the \nsliding window gave \u03c9\u00a0<\u00a01 values, with few regions hav -\ning \u03c9\u00a0 \u2265\u00a01 (positions 1172\u20131325, 2955\u20132975 and in posi -\ntion 2955; Fig.\u00a0 1). The K\nN\u00a0\u2212\u00a0KS difference (Table\u00a0 3) gave \nnegative values suggesting that purifying selection has Page 5 of 12\n Buitrago et al. Malar J  (2016) 15:501 \nplayed an important role in this locus\u2019 evolutionary his -\ntory in the genus Plasmodium . On the other hand, four \nnegatively selected sites (28, 112, 149, 643; Fig.\u00a0 1) were \nfound throughout the gene in P. vivax when calculat -\ning selection per codon based on maximum probability \nmethods (SCAL, FEL, IFEL, REL, and FUBAR) and the Bayesian method (MEME), while no sites were found to be under positive selection (Fig.\u00a0 1). These methods \nrevealed 162 sites under negative selection and 21 under positive selection between species (Fig.\u00a01).\nPhylogeny was inferred from orthologous sequences \nfrom 14 Plasmodium  species. This was used as reference framework for the REL-branch-site test. This method led to finding six branches (lineages) having evidence of episodic selection (Fig.\u00a0 2). Three were ancestral branches \n(internal) while the other three (external) had given rise to Plasmodium inui , Plasmodium chabaudi  and Plasmo -\ndium gaboni . The MEME method revealed codons under \ndiversifying episodic selection.\nEffective number of\u00a0codons\nGiven the high conservation of the pvron4 locus, devia -\ntion regarding the effective use of codons was evaluated as a means of selection at translational level. The ENC \nFig. 1 Representation of pvron4 encoding DNA sequence and sliding window for \u03c9 rate. ron4 \u03c9 values (dN/dS) within P . vivax are shown in green \nthroughout. Likewise, \u03c9 divergence rates (KN/KS) between the species infecting primates and P . vivax are shown in blue (for the species evolutionar \u2011\nily closest to P . vivax) and red  (most distant). A representation of the ron4 gene is given below the sliding window indicating signal peptide (blue), \nthe repeat region (black) and the putative esterase/lipase domain (purple). The P . vivax SNP positions are shown as discontinue lines, their number \u2011\ning is based on Additional file 2 alignment. The sites under purifying selection within species are represented by light green lines and dark green \nbetween species while positively selected sites between species are shown by red lines\nTable 1 pvron4 genetic diversity estimators calculated from\u00a0single nucleotide polymorphism and\u00a0sequence length poly -\nmorphism\nGenetic diversity estimators were calculated using the reference sequences obtained from databases together with Colombian isolates as well as for just Colombian \nisolates\u2019 sequences\nn number of isolates analysed, sites total of sites analysed excluding gaps, Ss number of segregating sites, S number of singleton sites, Ps  number of informative-\nparsimonious sites, H number of haplotypes, Hd haplotype diversity, \u03b8w Watterson estimator, \u03c0 nucleotide diversity per siteSingle nucleotide polymorphism Sequence length polymorphism\nn Sites Ss S Ps H Hd \u03b8w \u03c0 Sites No InDels H Hd \u03c0\nColombian and reference isolates\n80 2542 8 3 5 11 0.67 7.6 \u00d7 10\u221244.3 \u00d7 10\u22124408 21 21 0.82 9.9 \u00d7 10\u22124\nColombian isolates\n73 2464 5 0 5 8 0.65 4.7 \u00d7 10\u221244.1 \u00d7 10\u22124289 15 15 0.78 8.0 \u00d7 10\u22124Page 6 of 12 Buitrago et al. Malar J  (2016) 15:501 \nfor pvron4 estimated by ENCprime (N\u2019c\u00a0 =\u00a0 53, scaled \nX2\u00a0=\u00a00.103) and DnaSP (ENC\u00a0 =\u00a055.4, scaled X2\u00a0=\u00a00.159) \ngave values close to 61, with a CBI value of 0.162, sug -\ngesting that there was no bias regarding the effective use \nof codons, thereby ruling out translational selection.\nLinkage disequilibrium and\u00a0recombination\nThe ZnS estimator was used for evaluating LD between \npvron4 polymorphisms, giving 0.15. Linear regression between the LD and nucleotide distance showed a reduc -\ntion in LD as distance increased, thereby suggesting recombination. However, the ZZ estimator gave \u22120.0019 and no minimum recombination sites were detected. Likewise, GARD methods found no breakpoints nor did RDP software reveal recombination tracks.\nThe Plasmodium vivax Colombian population\u2019s genetic \nstructure regarding\u00a0the pvron4 locus\nAn AMOVA between the three Colombian regions was \ncalculated for evaluating pvron4 geospatial genetic diver -\nsity in Colombia, as well as Wright\u2019s fixation index (FST) \nbetween the different populations (regions). AMOVA revealed statistically significant differences between the sub-populations within the regions (F\nSC\u00a0=\u00a0 0.06, p\u00a0=\u00a0 0.04). The Nari\u00f1o sub-population (from the Pacific \nregion) could be responsible for genetic differences regarding each of the other subpopulations (Additional files 3, 4). Calculating the F\nST index between populations \n(regions) gave values close to 0. There was a statistically significant difference between the Urab\u00e1/lower Cauca/southern C\u00f3rdoba and Orinoquia-Amazonia regions (Table\u00a04).\nA median joining network was used for better \nunderstanding the evolutionary relationship between pvron4 haplotypes for describing the set of potential mutational pathways giving rise to the 32 haplotypes available for the locus (Fig.\u00a0 3 and Additional file\u00a0 3). \nThe network showed that the parasite\u2019s populations shared haplotypes, regardless of geographical region, which were related by different mutational pathways and ancestral sequences (median vectors) (Fig.\u00a0 3 and \nAdditional file\u00a0 3). The most frequently occurring hap -\nlotypes were H5 (53.1\u00a0 %), followed by H4 (31.2\u00a0 %), H13 (25\u00a0%), H3 and H20 (12.5\u00a0% each). The presence of unique haplotypes in the Nari\u00f1o (H7, H8 and H10) and Amazonas populations (H21, H22, H2) should be noted as they could be considered rare or specific regional alleles.Table 2 Neutrality, linkage disequilibrium and\u00a0recombination tests for\u00a0the pvron4 gene in\u00a0the Plasmodium vivax Colom-\nbian population\nNo statistically significant values were found in neutrality tests\nZnS average of R^2 for all comparison pairs, ZZ: ZnS\u00a0\u2212\u00a0Za  difference, Rm  minimum amount of recombination events, NP not performed, since not all sequences \nbelonged to the same population\n\u03c4  p\u00a0<\u00a00.05N Gene Tajima Fu and\u00a0Li Fay and\u00a0Wu\u2019s H Fu\u00b4s Fs ZnS ZZ RM\nD D* F*\nColombian and reference isolates\n80 2578 NP NP NP NP NP 0.154\u03c4\u22120.002 0\nColombian isolates\n73 2578 \u22120.037 \u22120.035 \u22120.020 \u22120.039 \u22120.028 0.163\u03c4\u22120.002 0\nTable 3 Difference between\u00a0dN\u00a0\u2212\u00a0dS, KN\u00a0\u2212\u00a0KS and\u00a0the neutral index from\u00a0MK test\nNon-synonymous substitution rate (dN) and synonymous substitution rate (dS) within P . vivax. Non-synonymous (KN) and synonymous (KS) divergence between P . vivax \nand phylogenetically close species. Neutrality index (NI) estimated by McDonald\u2013Kreitman test using Jukes Cantor correction\nP .cyn P . cynomolgi, P .inu P . inui, P .kno P . knowlesi, P .coa P . coatneyi, P .fra P . fragile* p\u00a0<\u00a00.01\n\u03b2  p\u00a0<\u00a00.001P . vivax P . vivax/Plasmodium ssp\nP . knowlesi P . inui P . coatneyi P . cynomolgi P . fragile P .cyn/P .inu P .kno/P .coa/P .fra\ndN \u2212 dS KN \u2212 KS\n\u22120.002* \u22120.011\u03b2\u22120.006\u03b2\u22120.006\u03b2\u22120.009\u03b2\u22120.010\u03b2\u22120.015\u03b2\u22120.025\u03b2\nNI\n0.696 0.597 0.857 1.133 0.919Page 7 of 12\n Buitrago et al. Malar J  (2016) 15:501 \nPredicting pvron4 putative domains and\u00a0antigenic \npotential\nAnalysing the PvRON4 sequence from the Sal-I strain \nrevealed the presence of a putative domain for the ester -\nase/lipase (pfam05057) protein superfamily between amino acids 311\u2013425 (nucleotides 931 to 1275, num -\nbers based on the Sal-I reference sequence, GenBank access number: XM_001615228.1) e-value 1.10e-03. This domain was located after the repeat region and was highly conserved (Fig.\u00a01).\nAccording to antigenicity and B-cell linear epitope pre -\ndiction, there was a potentially antigenic region between positions 41\u2013171 and 178 up to 256 for haplotype 6 and up to position 340 for haplotype 17 (Additional file\u00a0 5). \nThis agreed with hydrophobicity and solvent accessibility predictions so that the PvRON4\u00a0N-terminal region seems to be a potential immune target. By contrast, the central region (following the repeat region) and the C-terminal seemed to be less antigenic, being less solvent-exposed (Additional file\u00a05).\nDiscussion\nVarious proteins contained within the parasite\u2019s apical organelles seem to be crucial for host cell invasion and thus represent promising vaccine targets. RON complex proteins are among the proteins localized in the apical organelles, forming part of the TJ [17, 21, 63, 64]. This \nTJ plays a decisive role in parasite entry to a host cell and closure of the parasitophorous vacuole [17]. The RON4 \nFig. 2 Lineages subject to episodic diversifying selection in ron4. The branches (lineages) under episodic positive selection were identified by the \nBranch\u2011site REL method. The figure shows the \u03c9+ values, the percentage of sites (Pr [\u03c9 = \u03c9+]) and p values. The shade of each colour on branches \nindicates strength of selection (red  shows \u03c9+ > 15, blue \u03c9\u2212 \u2264 1 and grey  \u03c9 = 1). The size of each colour represents the percentage of sites in the \ncorresponding class. Branches have been classified as undergoing episodic diversifying selection by the p value corrected for multiple testing using \nthe Holm\u2011Bonferroni method at p < 0.05\nTable 4 Inter-population FST statistic for\u00a0pvron4\nFST was calculated for parasite populations in three Colombian regions. Values \nclose to 0 indicate low genetic differentiation while values close to 1 indicate \nhigh genetic differentiation. Values below the diagonal indicate the FST value \nand those above the diagonal represent the p values. Values in italics indicate significant differences having p\u00a0<\u00a00.02FST Pacific  \ncoastUrab\u00e1/lower  Cauca/southern  C\u00f3rdobaOrinoquia- Amazonia\nPacific coast 0.44043 0.31836\nUrab\u00e1/lower  \nCauca/southern  C\u00f3rdoba\u22120.00581 0.01465\nOrinoquia\u2011 \nAmazonia0.00542 0.08128Page 8 of 12 Buitrago et al. Malar J  (2016) 15:501 \nprotein located in the invasion complex is present in \nPhylum Apicomplexa members [15, 23, 24], suggesting \nthat it forms part of a conserved invasion pathway. This protein has thus been described as a potential vaccine candidate.\nA vaccine candidate must have several characteristics \n[10, 65]; one of them is to have low genetic diversity to \navoid allele-specific immune responses, which could reduce vaccine efficacy. The analysis of P. falciparum laboratory strains from different geographically origins showed the pfron4 locus as being a highly conserved locus, having just one amino acid substitution [23]. Plas -\nmodium vivax ron4 seems to have the same pattern, as analysing five reference sequences revealed low genetic diversity [25]. This study thus analysed 73 clinical isolates from the Colombian population for confirming pvron4 as a highly conserved gene in P. vivax. In spite of increas -\ning the number of sequences analysed, pvron4 diversity remained low, the present study\u2019s results showing that pvron4 had lower genetic diversity than in a previous report [25]. Only eight SNPs were identified in the 80 available sequences compared to 14 previously identi -\nfied ones [25]. Such high number of previously reported SNPs (i.e., 14) was due to erroneous repeat region align -\nment. pvron4 had a similar pattern to that of other apical organelle proteins [66, 67]. pvrap1 and pvrap2 had 0.0009 \nto 0.001 \u03c0 [67] while pvron4 had a much lower value than \npvrap1, suggesting it had low genetic diversity, the locus being more conserved to date for P. vivax. As it has been suggested for pvrap1 and pvra p2 [67] the low diversity in \npvron4 could be the consequence of functional/structural constraint (see below) due to the key role of this protein in parasite invasion.\nEven though pvron4 was a highly conserved sequence \nregarding SNP occurrence, it had high polymorphism regarding size. Previous studies have identified two types of repeats towards the N-terminal of the encoded pro -\ntein [22]. These repeats were reported as being imperfect copies of amino acids GGEH/SGEH/S and G/AEH. How -\never, the analysis here performed showed that the pvron4 repeat region consisted of two types of repeats having 100\u00a0% identity; the first encoded three GES amino acids (one to three copies) and the second one GEHGEHAE -\nHGE amino acids (one to seven copies). These repeats gave a high number of different haplotypes (alleles) in P. vivax.\nPrevious studies have suggested that tandem repeats \ncould play an important role as host immune response evasion mechanism [68\u201371]. In this study, 21 haplo -\ntypes were identified in PvRON4 when the InDels were \nFig. 3 Median\u2011joining network for Colombian regions. The Figure shows the pvron4 haplotypes identified from the isolates from the three regions \nof Colombia. Haplotypes 22 and 28 were included within haplotype 15 using the contraction star algorithm [86] for simplifying interpretation of the \nnetwork. Each node is a haplotype and its size indicates its frequency. The lines connecting the haplotypes represent the different mutational paths and the median vectors are the ancestral sequences explaining the relationship and evolutionary originPage 9 of 12\n Buitrago et al. Malar J  (2016) 15:501 \nanalysed. PvRON4\u00a0 N-terminal region seems to be the \nmost exposed protein according to solvent availability and hydrophobicity results. This region (between signal peptide and repeat region) seems to be a potential anti -\ngenic target due to this being where the largest amount of potential B-cell linear epitopes was predicted. The repeat sequences identified broadened the solvent-exposed region and the protein\u2019s antigenic potential. The PvRON4\u00a0 N-terminal region could thus be the region exposed to a host\u2019s immune system and repeats could be acting as an immunological smokescreen. Further antigenic and immunogenic studies are needed to con -\nfirm such hypothesis. As the repeat region was highly conserved regarding sequence, it could play an impor -\ntant structural or functional role, as has been suggested recently for the CSP [72, 73].\nWhile the N-terminal region might to be exposed to \nthe immune system, the central and C-terminal regions seem to be under functional constraint. Neutrality tests (e.g., Tajima, Fu and Li) gave no statistically significant values and neutrality was thus not\u00a0 ruled out. If pvron4 \nis under neutrality then it should show high polymor -\nphism unless there is a functional or structural con -\nstraint [74]. Given that this locus was highly conserved regarding sequence, functional/structural constraint is probable. However, selection at translational level could also be responsible for high conservation in the pvron4 \nsequence. Analysing regarding preferential codon use did not reveal bias regarding codon use (ENC\u00a0 =\u00a053\u201355). In \nfact this value was similar to that reported for the com -\nplete genome (ENC\u00a0 =\u00a0 52.18) [75], suggesting that high \npvron4 locus conservation was not due to selection at translational level and could have been a result of strong purifying selection.\nThe d\nS rate was significantly greater than the dN rate \naccording to Fisher\u2019s exact test, suggesting that this locus has evolved under purifying selection. However, it is not easy to evaluate how natural selection acts in highly conserved antigens [66, 76, 77]. Previous studies have \ncompared P. vivax sequences to phylogenetically related \nspecies to evaluate the effect of selection on parasite anti -\ngens [66, 76\u201378]. Sliding window analysis of \u03c9 rate gave \nvalues less than 1 towards the protein\u2019s central region as well as towards the C-terminal. The K\nS was statistically \ngreater than KN and various sites under purifying selec -\ntion between species were detected in these regions, sug -\ngesting that purifying selection plays an important role during the locus\u2019 evolution in the genus. Bearing in mind that functional regions tend to have slower evolution and are usually conserved between species [79], these results suggest that the PvRON4 C-terminal and central regions could be functionally important. The presence of conserved cysteines in the C-terminal portion (usually associated with protein\u2013protein interaction) could be mediating the interaction between RON4 and AMA-1 and/or other RONs [16, 80], while the presence of a puta -\ntive esterase/lipase domain in the protein\u2019s central region could be involved in RON4 entry to the host cell.\nPlasmodium falciparum  and T. gondii studies have \nshown that the RON4 C-terminal region seems to play an important role in invasion [16, 24]. RON4 is located \ninside red blood cells (RBC), anchoring the AMA1/RON2 complex [17, 18, 24]; RON4 must thus be secreted \nand enter RBC during initial invasion stages by a yet-unknown mechanism. The presence of an esterase/lipase domain in the PvRON4 central region could provide a clue regarding the action mechanism. This is one of the protein\u2019s most structured regions, being highly conserved among species and containing several sites under puri -\nfying selection, suggesting a functional/structural role. Therefore, while the PvRON4\u00a0 N-terminal region seems to be associated with evasion of the immune response, the central region (containing the esterase/lipase domain) could be associated with the rupture of ester bonds in the phospholipids constituting host cell membrane. Such rupture would enable RON4 entry to RBC or hepatocyte cytoplasm. Once inside, the RON4 C-terminal region anchors RON proteins, which, in turn, enable AMA1-mediated interaction between the parasite and host cells. It can thus be hypothesized that such putative esterase/lipase domain could play a role regarding RON4 entry to a host cell, however, further functional assays are needed to confirm this.\nIn spite of ron4 being highly conserved between spe -\ncies and that purifying selection seems to be important during this locus\u2019 evolution in Plasmodium , some sites \nunder positive selection were identified, coinciding with the regions where \u03c9\u00a0 >\u00a0 1 was observed. Previous stud -\nies have shown that some antigens (regardless of their genetic diversity) have regions/codons under episodic positive selection, which could have enabled adaptation to different hosts [76, 81, 82]. The topology obtained for \nron4 was similar to that obtained when analysing mito -\nchondrial DNA [83]. The phylogenetic relationships of species infecting rodents and hominids can be seen in ron4 phylogeny, however, such relationships have not been seen for species infecting monkeys. These species have a complex evolutionary history, which includes bio -\ngeographic aspects, adaptation to new macaque hosts and even a change from monkeys to humans [81, 84]. The \nepisodic selection observed here might thus have been a consequence of this group of parasites\u2019 rapid diversifica -\ntion (in the N-terminal region and a small portion of the C-terminal region) thereby enabling RON4 to adapt from an ancestral population to new available hosts, as previ -\nously suggested [76, 81, 82, 84].Page 10 of 12 Buitrago et al. Malar J  (2016) 15:501 \nA relatively high number of haplotypes has been found \nin the pvron4 locus in Colombia, resulting from a com -\nbination of SNPs and tandem repeats. AMOVA analy -\nsis and median joining showed that Colombian regions \nshared most haplotypes and seemed to be genetically similar. However, it was observed that a 6\u00a0% of estimated variation between these regions was due to differences between the subpopulations constituting them. The F\nST \nvalue showed that some subpopulations might not be genetically similar; this could be associated with the pres -\nence of unique haplotypes. This agreed with studies in Colombia involving other parasite antigens [77], as well as mitochondrial DNA studies in America [85], suggest -\ning that the parasite population in America is structured and has limited gene flow. However, since some subpopu -\nlations analysed here had limited sample size, the num -\nber of sequences must be increased for such results to be confirmed.\nConclusions\nDesigning a vaccine which is completely effective against the parasites causing malaria requires antigens having limited genetic diversity to avoid allele-specific immune responses. The pvron4 locus was seen to have low genetic diversity regarding SNPs but had a large amount of hap -\nlotypes due to tandem repeats located in the proteins\u2019 N-terminal, which could be involved in evading the immune response. On the other hand, the central and C-terminal regions are highly conserved, even between species. Such regions are under purifying selection, sug -\ngesting that they are under functionally or structurally constraint. The central region has a putative esterase/lipase domain, leading to the hypothesis that this domain enables RON4 entry to host cells while the C-terminal region anchors the AMA1/RON complex. Bearing the aforementioned results in mind, PvRON4 central/C-ter -\nminal region would seem to be a promising candidate for inclusion when designing a subunit-based vaccine against P. vivax.Abbreviations\nAMA1: apical membrane antigen 1; AMOVA: analysis of molecular variance; BepiPred: B cell epitope prediction; CBI: codon bias index; CSP: circumsporo \u2011\nzoite protein; d\nN: non\u2011synonymous substitutions per non\u2011synonym site; dS: \nsynonyms substitutions per synonym site; ENC: effective number of codons; FEL: fixed effects likelihood; F\nSC: F\u2011statistic, used to estimate the proportion of \ngenetic variability found among populations within groups; FST: Wright\u2019s fixa\u2011\ntion index, used to estimate the proportion of genetic variability found among populations; FUBAR: fast, unconstrained Bayesian approximation for inferring selection; GARD: genetic algorithm recombination detection; IEDB: immune epitope database and analysis resource; IFEL: internal fixed effects likelihood; InDels: insertions/deletions; K\nN: average number of non\u2011synonyms diver \u2011\ngences per non\u2011synonym site; KS: average number of synonyms divergences \nper synonym site; LD: linkage disequilibrium; MEME: mixed effects model of evolution; MK: McDonald\u2013Kretiman test; N\u2019c: ENC prime; PCR\u2013RFLP: polymer \u2011\nase chain reaction\u2011restriction fragment length polymorphism; pfron4: gene encoding Plasmodium falciparum rhoptry neck protein 4; pvmsp\u20113\u03b1: alpha subunit of gene encoding Plasmodium vivax merozoite surface protein\u20113; pvrap1: gene encoding Plasmodium vivax rhoptry\u2011associated protein 1; pvrap2: gene encoding Plasmodium vivax rhoptry\u2011associated protein 2; pvron4: gene encoding Plasmodium vivax rhoptry neck protein 4; RDP3: recombination detection program 3; REL: random effects likelihood; Rm: minimum number of recombination events; RON2: Plasmodium vivax rhoptry neck protein 2; RONs: Rhoptry neck proteins; SLAC: single likelihood ancestor counting; SNP: single nucleotide polymorphisms; Tg RON4: Toxoplasma gondii rhoptry neck protein \n4; TJ: tight junction; VCG\u2011I: Vivax Colombia Guain\u00eda\u2011I.\nAuthors\u2019 contributions\nSPB performed the experiments as well as the population genetics and molecular evolutionary analysis and wrote the manuscript. DG\u2011 O devised and \ndesigned the study participated in the experiments as well as in the popula\u2011tion genetics and molecular evolutionary analysis and writing the manuscript. MAP coordinated the study and helped to write the manuscript. All the authors read and approved the final manuscript.\nAuthor details\n1 Fundaci\u00f3n Instituto de Inmunolog\u00eda de Colombia (FIDIC), Carrera 50 No. \n26\u201120, Bogot\u00e1 D.C., Colombia. 2 Microbiology Postgraduate Program, Univer \u2011\nsidad Nacional de Colombia, Bogot\u00e1 D.C., Colombia. 3 School of Medicine \nand Health Sciences, Universidad del Rosario, Bogot\u00e1 D.C., Colombia. Acknowledgements\nWe would like to thank Jason Garry for translating and reviewing the manu\u2011script. We would also like to thank Johana Barreto Badillo by her technical assistance and Johanna Forero \u2011Rodr\u00edguez and Carlos Fernando Su\u00e1rez for \ntheir valuable comments and suggestions. MAP would like to especially thank Liliana Andrea C\u00f3rdoba for all her love and support during the last couple of years.\nCompeting interests\nThe authors declare that they have no competing interests.Additional files\nAdditional file\u00a01. The sequences of the 73 Colombian isolates obtained in this study, 7 reference sequences and 13 orthologous sequences from the ron4 locus.\nAdditional file\u00a02. Aligning the 32 haplotypes identified for pvron4.Additional file\u00a03. Median\u2013joining network for Colombian departments. \nThe Figure shows the evaluative relationship between the 32 pvron4 haplotypes identified from isolates from five Colombian departments, together with the reference sequence. Haplotypes 22 and 28 were included within haplotype 15 when using the star contraction algo \u2011\nrithm [86] for simplifying interpretation of the network. Each node is a haplotype and its size indicates its frequency. The lines connecting the haplotypes represent mutational paths and the median vectors are the ancestral sequences explaining the evolutionary relationship and origin.Additional file\u00a04. Inter \u2011population FST statistic for pvron4 per department. \nFST was calculated for parasite subpopulations in Colombia. Values close \nto 0 indicate low genetic differentiation while values close to 1 indicate high genetic differentiation. Values below the diagonal indicate the F\nST \nvalue and those above the diagonal represent the p \u2011values. Values in bold \nindicate significant differences having p <0.03.\nAdditional file\u00a05. Predicting potentially antigenic regions in PvRON4. \nPredictive tests for A. Linear B epitopes (threshold=0.35); B. Kolaskar and Tongaonkar antigenicity (threshold=1.00); C. Parker hydrophobicity (threshold=2.31) and D. Accessibility to solvent (threshold=1,000) using haplotype 6 and 17 sequences. The dotted line shows the regions having the greatest probability of being recognised by the immune system according to score on each prediction. The inverted antigenicity values arose from calculating antigenic propensity, regardless of the possible occurrence of amino acids in epitopes and on protein surface.Page 11 of 12\n Buitrago et al. Malar J  (2016) 15:501 \nAvailability of data and material\nThe sequences obtained here and which showed different haplotypes to already\u2011reported ones were stored in the GenBank database, accession numbers KX513800\u2011 KX513824. These sequences, together with the others analysed in this study are available in Additional file 1.\nEthics approval and consent to participate\nThe P . vivax\u2011infected patients from whom parasite genomic DNA was obtained, gave their informed consent after having been notified about the research\u2019s purpose. All procedures were approved by the Fundaci\u00f3n Instituto de Inmunolog\u00eda de Colombia and the Universidad del Rosario\u2019s ethics committees.\nFunding\nThis work was financed by the Departamento Administrativo de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n (COLCIENCIAS) through grant RC # 0309\u20112013. SPB received financing through COLCIENCIAS cooperation agreement # 0555\u20112015.\nReceived: 24 August 2016   Accepted: 7 October 2016\nReferences\n 1. Naghavi M, Wang H, Lozano R, Davis A, Liang X, Zhou M. GBD 2013 mortality and causes of death collaborators. Global, regional, and national age\u2011sex specific all\u2011 cause and cause \u2011specific mortality for 240 causes of \ndeath, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385:117\u201371.\n 2. Hay SI, Guerra CA, Tatem AJ, Noor AM, Snow RW. The global distribution and population at risk of malaria: past, present, and future. Lancet Infect Dis. 2004;4:327\u201336.\n 3. WHO. World malaria report 2015. Geneva: World Health Organiza\u2011tion; 2015. http://www.who.int/malaria/publications/world\u2011malaria\u2011report \u20112015/wmr2015\u2011 without \u2011profiles.pdf?ua=1.\n 4. UNICEF. Achieving the malaria MDG target. Reversing the incidence of malaria 2000\u20132015 http://www.unicef.org/publications/files/Achiev\u2011ing_the_Malaria_MDG_Target.pdf .\n 5. Price RN, Douglas NM, Anstey NM. New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance. Curr Opin Infect Dis. 2009;22:430\u20135.\n 6. Tjitra E, Anstey NM, Sugiarto P , Warikar N, Kenangalem E, Karyana M, et al. Multidrug\u2011resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua Indonesia. PLoS Med. 2008;5:e128.\n 7. Winter DJ, Pacheco MA, Vallejo AF, Schwartz RS, Arevalo \u2011Herrera M, Her \u2011\nrera S, et al. Whole genome sequencing of field isolates reveals extensive genetic diversity in Plasmodium vivax from Colombia. PLoS Negl Trop Dis. 2015;9:e0004252.\n 8. Guerra CA, Howes RE, Patil AP , Gething PW, Van Boeckel TP , Temperley WH, et al. The international limits and population at risk of Plasmodium vivax transmission in 2009. PLoS Negl Trop Dis. 2010;4:e774.\n 9. Birkett AJ, Moorthy VS, Loucq C, Chitnis CE, Kaslow DC. Malaria vaccine R&D in the decade of vaccines: breakthroughs, challenges and opportu\u2011nities. Vaccine. 2013;31(Suppl 2):B233\u201343.\n 10. Barry AE, Arnott A. Strategies for designing and monitoring malaria vac\u2011cines targeting diverse antigens. Front Immunol. 2014;5:359.\n 11. Patarroyo MA, Calderon D, Moreno \u2011Perez DA. Vaccines against Plasmo -\ndium vivax: a research challenge. Expert Rev Vaccines. 2012;11:1249\u201360.\n 12. Arnott A, Barry AE, Reeder JC. Understanding the population genetics of Plasmodium vivax is essential for malaria control and elimination. Malar J. 2012;11:14.\n 13. Takala SL, Plowe CV. Genetic diversity and malaria vaccine design, testing and efficacy: preventing and overcoming \u2018vaccine resistant malaria\u2019 . Parasite Immunol. 2009;31:560\u201373.\n 14. Harvey KL, Gilson PR, Crabb BS. A model for the progression of receptor \u2011\nligand interactions during erythrocyte invasion by Plasmodium falcipa-rum. Int J Parasitol. 2012;42:567\u201373.\n 15. Lebrun M, Michelin A, El Hajj H, Poncet J, Bradley PJ, Vial H, Dubremetz JF. The rhoptry neck protein RON4 re \u2011localizes at the moving junction dur \u2011\ning Toxoplasma gondii invasion. Cell Microbiol. 2005;7:1823\u201333. 16. Takemae H, Sugi T, Kobayashi K, Gong H, Ishiwa A, Recuenco FC, et al. Characterization of the interaction between Toxoplasma gondii rhoptry neck protein 4 and host cellular beta\u2011tubulin. Sci Rep. 2013;3:3199.\n 17. Weiss GE, Gilson PR, Taechalertpaisarn T, Tham WH, de Jong NW, Harvey KL, et al. Revealing the sequence and resulting cellular morphology of receptor \u2011ligand interactions during Plasmodium falciparum invasion of \nerythrocytes. PLoS Pathog. 2015;11:e1004670.\n 18. Cao J, Kaneko O, Thongkukiatkul A, Tachibana M, Otsuki H, Gao Q, et al. Rhoptry neck protein RON2 forms a complex with microneme protein AMA1 in Plasmodium falciparum merozoites. Parasitol Int. 2009;58:29\u201335.\n 19. Paul AS, Egan ES, Duraisingh MT. Host \u2011parasite interactions that guide \nred blood cell invasion by malaria parasites. Curr Opin Hematol. 2015;22:220\u20136.\n 20. Giovannini D, Spath S, Lacroix C, Perazzi A, Bargieri D, Lagal V, et al. Independent roles of apical membrane antigen 1 and rhoptry neck proteins during host cell invasion by apicomplexa. Cell Host Microbe. 2011;10:591\u2013602.\n 21. Boucher LE, Bosch J. The apicomplexan glideosome and adhesins\u2011struc\u2011tures and function. J Struct Biol. 2015;190:93\u2013114.\n 22. Arevalo \u2011Pinzon G, Curtidor H, Abril J, Patarroyo MA. Annotation and char \u2011\nacterization of the Plasmodium vivax rhoptry neck protein 4 (PvRON4). Malar J. 2013;12:356.\n 23. Morahan BJ, Sallmann GB, Huestis R, Dubljevic V, Waller KL. Plasmodium falciparum: genetic and immunogenic characterisation of the rhoptry neck protein PfRON4. Exp Parasitol. 2009;122:280\u20138.\n 24. Alexander DL, Arastu\u2011Kapur S, Dubremetz JF, Boothroyd JC. Plasmodium falciparum AMA1 binds a rhoptry neck protein homologous to TgRON4, a component of the moving junction in Toxoplasma gondii. Eukaryot Cell. 2006;5:1169\u201373.\n 25. Garzon\u2011 Ospina D, Forero \u2011Rodriguez J, Patarroyo MA. Inferring natural \nselection signals in Plasmodium vivax\u2011 encoded proteins having a poten\u2011\ntial role in merozoite invasion. Infect Genet Evol. 2015;33:182\u20138.\n 26. Gesti\u00f3n para la vigilancia entomol\u00f3gica y control de la transmisi\u00f3n de malaria. Gu\u00eda de Vigilancia Entomol\u00f3gica y Control de Malaria. http://www.ins.gov.co/temas\u2011 de\u2011interes/Documentacin%20Malaria/03%20\nVigilancia%20entomo%20malaria%20.pdf .\n 27. Camargo \u2011Ayala PA, Cubides JR, Nino CH, Camargo M, Rodriguez\u2011 Celis CA, \nQuinones T, et al. High Plasmodium malariae prevalence in an endemic area of the Colombian Amazon region. PLoS ONE. 2016;11:e0159968.\n 28. pGEM\n\u00ae\u2011T and pGEM\u00ae\u2011T Easy Vector Systems, Instructions for Use of Products. \nhttps://www.promega.com/\u2011/media/files/resources/protocols/technical\u2011manuals/0/pgem\u2011t \u2011and\u2011pgem\u2011t \u2011easy\u2011 vector \u2011systems\u2011protocol.pdf .\n 29. Edgar RC. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 2004;32:1792\u20137.\n 30. Suyama M, Torrents D, Bork P . PAL2NAL: robust conversion of protein sequence alignments into the corresponding codon alignments. Nucleic Acids Res. 2006;34:W609\u201312.\n 31. Jorda J, Kajava AV. T \u2011REKS: identification of Tandem REpeats in sequences \nwith a K \u2011meanS based algorithm. Bioinformatics. 2009;25:2632\u20138.\n 32. Librado P , Rozas J. DnaSP v5: a software for comprehensive analysis of DNA polymorphism data. Bioinformatics. 2009;25:1451\u20132.\n 33. Tajima F. Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics. 1989;123:585\u201395.\n 34. Fu YX, Li WH. Statistical tests of neutrality of mutations. Genetics. 1993;133:693\u2013709.\n 35. Fu YX. Statistical tests of neutrality of mutations against popula\u2011tion growth, hitchhiking and background selection. Genetics. 1997;147:915\u201325.\n 36. Fay JC, Wu CI. Hitchhiking under positive Darwinian selection. Genetics. 2000;155:1405\u201313.\n 37. Zhang J, Rosenberg HF, Nei M. Positive Darwinian selection after gene duplication in primate ribonuclease genes. Proc Natl Acad Sci USA. 1998;95:3708\u201313.\n 38. Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: molecular evolutionary genetics analysis version 6.0. Mol Biol Evol. 2013;30:2725\u20139.\n 39. Jukes TH, Cantor CR. Evolution of protein molecules. In: Munro HN, editor. Mammalian protein metabolism. New York: Academic Press; 1969.\n 40. McDonald JH, Kreitman M. Adaptive protein evolution at the Adh locus in Drosophila. Nature. 1991;351:652\u20134.\n 41. Standard & generalized McDonald\u2013Kreitman Test. http://mkt.uab.es/mkt/MKT.asp .Page 12 of 12 Buitrago et al. Malar J  (2016) 15:501 \n 42. Egea R, Casillas S, Barbadilla A. Standard and generalized McDonald\u2013Kre \u2011\nitman test: a website to detect selection by comparing different classes \nof DNA sites. Nucleic Acids Res. 2008;36:W157\u201362.\n 43. Kosakovsky Pond SL, Frost SD. Not so different after all: a comparison of methods for detecting amino acid sites under selection. Mol Biol Evol. 2005;22:1208\u201322.\n 44. Murrell B, Wertheim JO, Moola S, Weighill T, Scheffler K, Kosakovsky Pond SL. Detecting individual sites subject to episodic diversifying selection. PLoS Genet. 2012;8:e1002764.\n 45. Murrell B, Moola S, Mabona A, Weighill T, Sheward D, Kosakovsky Pond SL, et al. FUBAR: a fast, unconstrained bayesian approximation for inferring selection. Mol Biol Evol. 2013;30:1196\u2013205.\n 46. Delport W, Poon AF, Frost SD, Kosakovsky Pond SL. Datamonkey 2010: a suite of phylogenetic analysis tools for evolutionary biology. Bioinformat \u2011\nics. 2010;26:2455\u20137.\n 47. Kosakovsky Pond SL, Murrell B, Fourment M, Frost SD, Delport W, Scheffler K. A random effects branch\u2011site model for detecting episodic diversifying selection. Mol Biol Evol. 2011;28:3033\u201343.\n 48. Pond SL, Frost SD, Muse SV. HyPhy: hypothesis testing using phylogenies. Bioinformatics. 2005;21:676\u20139.\n 49. Novembre JA. Accounting for background nucleotide composition when measuring codon usage bias. Mol Biol Evol. 2002;19:1390\u20134.\n 50. Shields DC, Sharp PM, Higgins DG, Wright F. \u201cSilent\u201d sites in Drosophila genes are not neutral: evidence of selection among synonymous codons. Mol Biol Evol. 1988;5:704\u201316.\n 51. Morton BR. Chloroplast DNA codon use: evidence for selection at the psb A locus based on tRNA availability. J Mol Evol. 1993;37:273\u201380.\n 52. Kelly JK. A test of neutrality based on interlocus associations. Genetics. 1997;146:1197\u2013206.\n 53. Rozas J, Gullaud M, Blandin G, Aguade M. DNA variation at the rp49 gene region of Drosophila simulans: evolutionary inferences from an unusual haplotype structure. Genetics. 2001;158:1147\u201355.\n 54. Hudson RR, Kaplan NL. Statistical properties of the number of recom\u2011bination events in the history of a sample of DNA sequences. Genetics. 1985;111:147\u201364.\n 55. Kosakovsky Pond SL, Posada D, Gravenor MB, Woelk CH, Frost SD. Automated phylogenetic detection of recombination using a genetic algorithm. Mol Biol Evol. 2006;23:1891\u2013901.\n 56. Martin D, Rybicki E. RDP: detection of recombination amongst aligned sequences. Bioinformatics. 2000;16:562\u20133.\n 57. Excoffier L, Laval G, Schneider S. Arlequin (version 3.0): an integrated software package for population genetics data analysis. Evol Bioinform Online. 2005;1:47\u201350.\n 58. Bandelt HJ, Forster P , Rohl A. Median\u2011joining networks for inferring intraspecific phylogenies. Mol Biol Evol. 1999;16:37\u201348.\n 59. Kolaskar AS, Tongaonkar PC. A semi\u2011 empirical method for prediction of \nantigenic determinants on protein antigens. FEBS Lett. 1990;276:172\u20134.\n 60. Parker JM, Guo D, Hodges RS. New hydrophilicity scale derived from high\u2011performance liquid chromatography peptide retention data: correlation of predicted surface residues with antigenicity and X \u2011ray\u2011 derived acces\u2011\nsible sites. Biochemistry. 1986;25:5425\u201332.\n 61. Emini EA, Hughes JV, Perlow DS, Boger J. Induction of hepatitis A virus\u2011neutralizing antibody by a virus\u2011specific synthetic peptide. J Virol. 1985;55:836\u20139.\n 62. Larsen JE, Lund O, Nielsen M. Improved method for predicting linear B\u2011cell epitopes. Immunome Res. 2006;2:2.\n 63. Tonkin ML, Roques M, Lamarque MH, Pugniere M, Douguet D, Crawford J, et al. Host cell invasion by apicomplexan parasites: insights from the co\u2011structure of AMA1 with a RON2 peptide. Science. 2011;333:463\u20137.\n 64. Cowman AF, Crabb BS. Invasion of red blood cells by malaria parasites. Cell. 2006;124:755\u201366.\n 65. Richie TL, Saul A. Progress and challenges for malaria vaccines. Nature. 2002;415:694\u2013701.\n 66. Pacheco MA, Ryan EM, Poe AC, Basco L, Udhayakumar V, Collins WE, et al. Evidence for negative selection on the gene encoding rhoptry\u2011associated protein 1 (RAP \u20111) in Plasmodium spp. Infect Genet Evol. \n2010;10:655\u201361. 67. Garzon\u2011 Ospina D, Romero \u2011Murillo L, Patarroyo MA. Limited genetic poly\u2011\nmorphism of the Plasmodium vivax low molecular weight rhoptry protein complex in the Colombian population. Infect Genet Evol. 2010;10:261\u20137.\n 68. Verra F, Hughes AL. Biased amino acid composition in repeat regions of Plasmodium antigens. Mol Biol Evol. 1999;16:627\u201333.\n 69. Hisaeda H, Yasutomo K, Himeno K. Malaria: immune evasion by parasites. Int J Biochem Cell Biol. 2005;37:700\u20136.\n 70. Ferreira MU, da Silva Nunes M, Wunderlich G. Antigenic diversity and immune evasion by malaria parasites. Clin Diagn Lab Immunol. 2004;11:987\u201395.\n 71. Ramasamy R. Molecular basis for evasion of host immunity and patho \u2011\ngenesis in malaria. Biochim Biophys Acta. 1998;1406:10\u201327.\n 72. Ferguson DJ, Balaban AE, Patzewitz EM, Wall RJ, Hopp CS, Poulin B, et al. The repeat region of the circumsporozoite protein is critical for sporozoite formation and maturation in Plasmodium. PLoS ONE. 2014;9:e113923.\n 73. Aldrich C, Magini A, Emiliani C, Dottorini T, Bistoni F, Crisanti A, et al. Roles of the amino terminal region and repeat region of the Plasmo -\ndium berghei circumsporozoite protein in parasite infectivity. PLoS ONE. 2012;7:e32524.\n 74. Kimura M. The neutral theory of molecular evolution. Cambridge: Cam\u2011bridge University Press; 1983.\n 75. Cornejo OE, Fisher D, Escalante AA. Genome \u2011wide patterns of genetic \npolymorphism and signatures of selection in Plasmodium vivax. Genome Biol Evol. 2015;7:106\u201319.\n 76. Forero \u2011Rodriguez J, Garzon\u2011 Ospina D, Patarroyo MA. Low genetic \ndiversity in the locus encoding the Plasmodium vivax P41 protein in Colombia\u2019s parasite population. Malar J. 2014;13:388.\n 77. Forero \u2011Rodriguez J, Garzon\u2011 Ospina D, Patarroyo MA. Low genetic diver \u2011\nsity and functional constraint in loci encoding Plasmodium vivax P12 and P38 proteins in the Colombian population. Malar J. 2014;13:58.\n 78. Pacheco MA, Elango AP , Rahman AA, Fisher D, Collins WE, Barnwell JW, et al. Evidence of purifying selection on merozoite surface protein 8 (MSP8) and 10 (MSP10) in Plasmodium spp. Infect Genet Evol. 2012;12:978\u201386.\n 79. Graur D, Zheng Y, Price N, Azevedo RB, Zufall RA, Elhaik E. On the immor \u2011\ntality of television sets: \u201cfunction\u201d in the human genome according to the evolution\u2011free gospel of ENCODE. Genome Biol Evol. 2013;5:578\u201390.\n 80. Narum DL, Nguyen V, Zhang Y, Glen J, Shimp RL, Lambert L, et al. Iden\u2011tification and characterization of the Plasmodium yoelii PyP140/RON4 protein, an orthologue of Toxoplasma gondii RON4, whose cysteine \u2011rich \ndomain does not protect against lethal parasite challenge infection. Infect Immun. 2008;76:4876\u201382.\n 81. Muehlenbein MP , Pacheco MA, Taylor JE, Prall SP , Ambu L, Nathan S, et al. Accelerated diversification of nonhuman primate malarias in South\u2011east Asia: adaptive radiation or geographic speciation? Mol Biol Evol. 2015;32:422\u201339.\n 82. Sawai H, Otani H, Arisue N, Palacpac N, de Oliveira Martins L, Pathirana S, et al. Lineage \u2011specific positive selection at the merozoite surface protein \n1 (msp1) locus of Plasmodium vivax and related simian malaria parasites. BMC Evol Biol. 2010;10:52.\n 83. Pacheco MA, Cranfield M, Cameron K, Escalante AA. Malarial parasite diversity in chimpanzees: the value of comparative approaches to ascertain the evolution of Plasmodium falciparum antigens. Malar J. 2013;12:328.\n 84. Mu J, Joy DA, Duan J, Huang Y, Carlton J, Walker J, et al. Host switch leads to emergence of Plasmodium vivax malaria in humans. Mol Biol Evol. 2005;22:1686\u201393.\n 85. Taylor JE, Pacheco MA, Bacon DJ, Beg MA, Machado RL, Fairhurst RM, et al. The evolutionary history of Plasmodium vivax as inferred from mitochon\u2011drial genomes: parasite genetic diversity in the Americas. Mol Biol Evol. 2013;30:2050\u201364.\n 86. Forster P , Torroni A, Renfrew C, Rohl A. Phylogenetic star contrac\u2011tion applied to Asian and Papuan mtDNA evolution. Mol Biol Evol. 2001;18:1864\u201381.RESEARCH Open Access\nPvGAMA reticulocyte binding activity:\npredicting conserved functional regions by\nnatural selection analysis\nLuis A. Baquero1\u2020, Darwin A. Moreno-P\u00e9rez1,2\u2020, Diego Garz\u00f3n-Ospina1,2, Johanna Forero-Rodr\u00edguez1,\nHeidy D. Ortiz-Su\u00e1rez1and Manuel A. Patarroyo1,3*\nAbstract\nBackground: Adhesin proteins are used by Plasmodium parasites to bind and invade target cells. Hence, characterising\nmolecules that participate in reticulocyte interaction is key to understanding the molecular basis of Plasmodium vivax\ninvasion. This study focused on predicting functionally restricted regions of the P. vivax GPI-anchored micronemal\nantigen ( PvGAMA) and characterising their reticulocyte binding activity.\nResults: The pvgama gene was initially found in P. vivax VCG-I strain schizonts. According t o the genetic diversity analysis,\nPvGAMA displayed a size polymorphism very common for antigenic P. vivax proteins. Two regions along the antigen\nsequence were highly conserved among species, having a negat ive natural selection signal. Interestingly, these regions\nrevealed a functional rol e regarding preferential target cell adhesion.\nConclusions: To our knowledge, this study describes PvGAMA reticulocyte binding properties for the first time. Conserved\nfunctional regions were predicted according to natural selection analysis and their binding ability was confirmed. These\nfindings support the notion that PvGAMA may have an important role in P. vivax merozoite adhesion to its target cells.\nKeywords: Adhesin protein, Plasmodium vivax , Genetic diversity, Conserved functional region, Reticulocyte binding activity\nBackground\nPlasmodium vivax is a human malaria-causing parasite\nwhose eradication is a priority on the international health\nagenda [1]. As a strategy for eradicating this species,\nseveral research groups have focused their efforts on\ndeveloping a vaccine, as vaccination has been successful atcontrolling and eradicating other infectious diseases [2].\nIt has been suggested that vaccines should consist of\nkey proteins or their fragments used by infectious agentsto bind to the target cells [3, 4]. Hence, knowledge of\nproteins expressed by the parasite at the end of its intra-\nerythrocyte life-cycle, especially those interacting withred blood cells (RBC), should prove most suitable as\ncandidate vaccine components.\nCurrent efforts to develop an anti-malarial vaccine\nhave mainly focused on P. falciparum , given the avail-\nability of robust in vitro culturing techniques for this\nparasite (currently unavailable for P. vivax ) which has\nled to a large-scale identification of genes [5], transcripts\n[6] and proteins [7]. This information has led to an\nimproved understanding of the molecules involved inP. falciparum merozoite invasion of erythrocytes. For\nexample, several adhesin molecules have been describedin the apical organelles (rhoptries and micronemes), thatfacilitate interaction with cell receptors and promote\nparasite internalisation within the target cell [8]. Several\nof these proteins are immunogenic and are beingevaluated as vaccine candidates in clinical studies [9]. The\nGPI-anchored micronemal antigen (GAMA) represents\none apical protein that has an adhesive role in Plasmo-\ndium and Toxoplasma. Plasmodium falciparum GAMA\n(PfGAMA) binds to human erythrocytes, an interaction\n* Correspondence: mapatarr.fidic@gmail.com\n\u2020Equal contributors\n1Molecular Biology and Immunology Department, Fundaci\u00f3n Instituto de\nInmunolog\u00eda de Colombia (FIDIC), Carrera 50 No. 26-20, Bogot\u00e1 DC,\nColombia\n3Basic Sciences Department, School of Medicine and Health Sciences,\nUniversidad del Rosario, Carrera 24 No. 63C-69, Bogot\u00e1 DC, Colombia\nFull list of author information is available at the end of the article\n\u00a9 The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0\nInternational License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and\nreproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link tothe Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.Baquero et al. Parasites & Vectors  (2017) 10:251 \nDOI 10.1186/s13071-017-2183-8mediated by its binding region which is located in the\namino terminal sequence, and is involved in the sialic\nacid-independent invasion pathway [10]. On the otherhand, GAMA knockouts of T. gondii (TgGAMA) show a\nreduction in the ability of tachyzoites to attach to the hostcell during invasion as well as a delay in the time to deathin an in vivo model, suggesting a function during parasite\nadhesion and invasion [11].\nUnfortunately, basic P. vivax research has been de-\nlayed mainly due to the parasite \u2019s preference for invad-\ning reticulocytes which are difficult to obtain in the\nhigh percentages needed for propagating P. vivax in vitro\n[12, 13]. However, it has been possible to characterise sev-\neral molecules forming part of the parasite \u2019s selective\nhuman reticulocyte invasion route, such as reticulocyte\nbinding proteins (RBPs) [14, 15], merozoite surface pro-\ntein 1 (MSP-1) [16], some proteins from the tryptophan-\nrich antigen (TRAg) family [17] and the recently describedrhoptry neck protein 5 (RON5) [18]. Some of these con-\ntain specific binding regions that have been identified\nusing several strategies, such as mapping using peptideslabelled with radioactive iodine, ELISA, flow cytometry\nor rosetting assays. However, these methodologies are\nlaborious when large molecules must be analysed.Furthermore, sometimes it is not known whether these\nregions are polymorphic between isolates, which would\nbe counterproductive for the development of a broadlyprotective vaccine.\nA new strategy has recently been proposed for identi-\nfying selection signals and that enables the determin-ation of conserved antigens or those having potential\nfunctional regions [19]. Cornejo et al. [20] and Garz\u00f3n-\nOspina et al. [19] identified natural selection signals inP. vivax genes when analysing the sequences of five\ngenomes from different locations [21]. These resultswere supported by earlier studies, increasing the numberof sequences analysed [22 \u201324]. This type of analysis\ncould therefore provide a viable approach for selectingconserved antigens that are subject to functional restrictions.However, no experimental evidence has been produced to\nsupport such approach.\nGiven the importance of conserved functional region pre-\ndiction and the role of adhesin proteins during host-parasite\ninteraction, and considering the interesting features dis-played by GAMA in other apicomplexa, the present study\naimed at characterising P. vivax VCG-I strain GAMA func-\ntional regions by selection signal prediction and then deter-\nmine the role of such regions in binding to reticulocytes.\nMethods\nAn approach to GAMA genetic diversity and evolutionary\nforces\nEvolutionary methods compare the non-synonymous\nmutations rate (d N, mutations altering protein sequences)to the synonymous mutations rate (d S,t h o s ee n c o d i n gt h e\nsame amino acid) in the search for natural selection signals.Deleterious mutations are usually removed from popula-tions by negative natural selection (d\nN<dSor\u03c9<1 ) .\nRegions displaying this kind of selection might have func-tional/structural importanc e, maintaining high sequence\nconservation between species [25]. On the other hand,\nmutations having an adaptive advantage (or a beneficial\nrole) are fixed in a population by positive natural selection(dN > dS or \u03c9> 1). Taking the above into account, func-\ntional regions could be predicted by evolutionary ap-proaches [19]. pvgama gene DNA sequences from 6 P.\nvivax strains (VCG-I, Sal-I, Brazil-I, India-VII, Mauritania-I\nand North Korea [21]) and 5 ph ylogenetically-related\nspecies ( P. cynomolgi ,P. inui ,P. fragile ,P. knowlesi and P.\ncoatneyi ) [26] were obtained by tblastn (except for VCG-I)\nfrom the whole-genome shotgun contigs (wgs) NCBIdatabase for assessing genetic diversity and evolutionaryforces regarding GAMA. The MUSCLE algorithm [27]\nwas used to align the sequences and the alignment was\nmanually corrected. Nucleotide diversity per site ( \u03c0) was\nestimated from the P. vivax sequences and the modified\nNei-Gojobori method [28] was used to assess naturalselection signals by calculating the difference between syn-onymous and non-synonymous substitution rates (d\nN-dS).\nNatural selection was also assessed by estimating the differ-ence between synonymous and non-synonymous diver-gence rates (K\nN-KS) using sequences from P. vivax and\nrelated species through the modified Nei-Gojobori methodand Jukes-Cantor correction [29]. Specific codons undernatural selection amongst species were identified using\ncodon-based Bayesian or maximum likelihood approaches\n(SLAC, FEL, REL [30], MEME [31] and FUBAR [32]),following recombination by the GARD method [33].\nCodon-based methods estimate the evolutionary rate ( \u03c9)a t\neach codon using a statistical test to determine whether \u03c9\nis significantly different to 1 (neutral evolution). TheBranch-site REL algorithm [34] was used to identify\nlineages under episodic positive selection (selectionoccasionally having transient periods of adaptive evo-\nlution masked by negative selection or neutral evolution).\nThe Datamonkey web server was used to perform these\nanalyses [35].\nPrimer design, cloning and sequencing\nThe Plasmodium vivax gama (pvgama ) gene sequence\nwas taken from the PlasmoDB database [36] and\nscanned for PCR priming sites (Table 1) using Generunnersoftware (version 3.05). Primers were designed to amplify\neither the entire pvgama gene or several smaller-sized\nfragments according to the natural selection analysis\n(Fig. 1). The gDNA (extracted using a Wizard Genomic\npurification kit; Promega, Madison, USA) and cDNA\n(synthesised with SuperScript III enzyme (RT+) (Invitrogen,Baquero et al. Parasites & Vectors  (2017) 10:251 Page 2 of 11Carlsbad, USA) samples from P. vivax VCG-I strain\nschizont-stage enriched parasi tes (propagated and obtained\nas previously described [37, 38]) were used as template in\n25\u03bcl PCR reactions containing 1\u00d7 KAPA HiFi HotStart\nReadyMix (KAPA Biosystems, Woburn, MA, USA),0.3\u03bcM primers and DNAse-free water. Temperature\ncycling for PCR involved a denaturing step of 95 \u00b0C for\n5 min, followed by 35 cycles of 98 \u00b0C for 20 s, Tm \u00b0C\n(Table 1) for 15 s and 72 \u00b0C for 30 s or 1 min and 30 sdepending on product size. A Wizard PCR preps kit\n(Promega) was used for purifying amplicons obtained\nfrom PCR with the RT+ and gDNA samples, once qual-ity had been evaluated on agarose gel. Purified products\nwere ligated to the pEXP5 CT/TOPO expression vector or\npGEM (Promega) (for the gene obtained from gDNA) andtransformed in TOP10 E. coli cells (Invitrogen). Several clonesobtained from independent PCR reactions were grown for\npurifying the plasmid using an UltraClean mini plasmid prep\npurification kit (MO BIO Laboratories, California, USA).Insert integrity and correct orientation were then confirmed\nby sequencing, using an ABI-3730 XL sequencer (MACRO-\nGEN, Seoul, South Korea). ClustalW (NPS@) software wasused for comparing gene sequences from Sal-I reference\nstrain and the primate-adap ted VCG-I strain [39]. The\npvgama gene sequence from P. vivax VCG-I strain was\ndeposited in NCBI under accession number KT248546.\nRecombinant protein expression\nThe pEXP- pvgama recombinant plasmids were trans-\nformed in E. coli BL21-DE3 (Invitrogen), according to\nthe manufacturer \u2019s recommendations. Cells were grownTable 1 Primer designed for pvgama gene amplification\nTarget Primer sequence (5 \u2019\u20133\u2019)aMT (\u00b0C) Product size (bp) aa position\npvgama Fwd: ATGAAGTGCAACGCCTCC\nRev: AAAAATGAATAGGAGCAACG58 2313 1 to 771\npvgama -Nt Fwd: ATACGGAATGGAAACAACC\nRev: AGTCGGTTCGTTATTCTCG1284 22 to 449\npvgama -Ct Fwd: CTGCTCAAGAACACGAAC\nRev: GCTTCCACTCTGCAATTC948 434 to 749\npvgama -CR1 Fwd: GACGATCATCTGTGTTCAAAAA\nRev: GACCTCATTTTTGGACTTCTC60 666 87 to 308\npvgama -VR1 Fwd: GGCGCCTTCCTGCAGTC\nRev: CATTAACATGGTGTTGTCGCT438 330 to 475\npvgama -CR2 Fwd: CAGGCGGCCATCTTACTAA\nRev: GCTCCCGTTGACGCCCTT321 482 to 588\npvgama -VR2 Fwd: GCCGCAAACGCAGACGCC\nRev: GTTTGCCGAGAAGCTTCCAC384 626 to 753\nAbbreviations :Nt and Ct amino and carboxyl terminal; CRconserved region, VRvariable region; Fwd forward, Revreverse, MTmelting temperature, bpbase pair, aa\namino acid\naProtein \u2019s expression start codon was included in forward primer \u2019s5 \u2019end\nFig. 1 Evolutionary rate ( \u03c9) sliding window. Intra-species \u03c9values (d N/dS) are represented in blue whilst inter-species \u03c9values (K N/KSbetween\nP. vivax and malarial parasites infecting primates) are shown in purple .A\u03c9value equal 1 means neutral evolution, \u03c9< 1 negative selection whilst\n\u03c9> 1 means positive selection. A diagram of the gene can be observed below the sliding window. Negatively selected inter-species codons are\nshown in green whilst positively selected sites are shown in red. Numbering is based on the alignment in Additional file 1: Figure S1Baquero et al. Parasites & Vectors  (2017) 10:251 Page 3 of 11overnight at 37 \u00b0C in 50 ml Luria Bertani (LB) medium\ncontaining 100 \u03bcg/ml ampicillin using a Lab-line Incu-\nbator Shaker. The initial inoculum was then seeded in\n1 l of LB with ampicillin (100 \u03bcg/ml) and left to grow at\n37 \u00b0C with shaking at ~300\u00d7 rpm until reaching 0.5\nOD 600. The culture was incubated on ice for 30 min and\nthen IPTG 1 mM was used to induce expression by\nincubation for 16 h at room temperature (RT) with\nshaking at ~200\u00d7 rpm. The culture was then spun at\n2400\u00d7 gfor 20 min and the pellet was collected for\nextraction of the recombinant protein.\nDenaturing extraction\nThe cell pellet obtained from E. coli expressing\nPvGAMA-Nt and PvGAMA-Ct fragments was homoge-\nnised in denaturing extraction buffer (DEB) (6 M urea,\n10 mM Tris, 100 mM NaH 2PO4and 20 mM imidazole)\ncontaining the SIGMAFAST protease inhibitor cocktail\n(Sigma-Aldrich, St. Louis, USA) and then lysed by\nincubating with 0.1 mg/ml lysozyme overnight at 4 \u00b0C at\n10\u00d7 rpm using a tube rotator (Fisher Scientific, Waltham,\nUSA). The supernatant was collected by spinning at\n16,000\u00d7 gfor 1 h.\nNative extraction\nPvGAMA-CR1, PvGAMA-VR1, PvGAMA-CR2 and\nPvGAMA-VR2 were extracted using a method for\nobtaining the molecules in native conditions with therespective positive and negative controls (region II and\nIII/IV from the Duffy binding protein, DBP) (unpublisheddata). Briefly, the pellet was frozen/thawed for 3 cycles and\nthen homogenised in native extraction buffer (NEB)\n(50 mM Tris, 300 mM NaCl, 25 mM imidazole, 0.1 mMEGTA and 0.25% Tween-20, pH 8.0). The mixture was\nincubated for 1 h at 4 \u00b0C at 10\u00d7 rpm and the supernatant\nwas collected by spinning at 16,000\u00d7 gfor 1 h.\nProtein purification\nTotal lysate supernatant was incubated with Ni+2-NTA\nresin (Qiagen, Valencia, CA, USA) for purifying theproteins by solid-phase affinity chromatography, once\nprotein expression had been verified by western blot.Briefly, the resin was pre-equilibrated with the respective\nbuffer used for extracting proteins and then incubated\nwith the E. coli lysate overnight at 4 \u00b0C. The protein-\nresin mixture was placed on a column and then weakly\nbound proteins were eluted by washing with 20 ml\nbuffer containing 0.1% Triton X-114 followed by 50 mlof the same buffer without detergent. The proteins\nextracted in denaturing conditions were dialysed on the\ncolumn by passing 20 ml DEB with urea in descendingconcentrations (6 M, 3 M, 1.5 M, 0.75 M and PBS).\nBound proteins were then eluted with PBS containing\nimidazole at increasing concentrations (50 mM to500 mM) in 3 ml fractions; those having a single band\n(confirmed on 12% SDS-PAGE by Coomassie blue\nstaining and by western blot using anti-polyhistidineantibodies) were pooled and dialysed extensively in\nPBS, pH 7.2. A micro BCA protein assay kit (Thermo\nScientific, Rockford, USA) was used for quantifyingeach protein, using the bovine serum albumin (BSA)\ncurve as reference.\nPeptide synthesis\nOne 6 histidine peptide was synthesised according to a\npreviously-established methodology [40], polymerised,lyophilised and characterised by RP-HPLC and MALDI-\nTOF MS. The peptide was homogenised in PBS and\nthen stored at -20 \u00b0C until use.\nBlood sample collection and processing\nIndividuals with a clinical history of P. vivax (37 subjects)\norP. falciparum (30 subjects) malaria, aged 18 to 50 year-\nold and living in malaria-endemic areas of Colombia(Choc\u00f3, Nari\u00f1o, C\u00f3rdoba, Vichada and Guaviare) wereselected for this study. Sera from healthy individuals (16\nadult subjects) who had never been affected by the disease\nand who were living in non-endemic areas were used asnegative controls. The blood samples were collected in BD\nVacutainer tubes without anticoagulant by personnel from\nthe Fundaci\u00f3n Instituto de Inmunolog\u00eda de Colombia(FIDIC) from October 2006 to March 2011 (for P. vivax )\nand June to October 1993 (for P. falciparum )a n ds t o r e d\nat 4 \u00b0C until transport. Samples were then transported toBogot\u00e1 for processing. Total blood was spun at 5000\u00d7 g\nfor 5 min and the serum was then recovered and stored at-80 \u00b0C in FIDIC serum bank (to date).\nEnzyme-linked immunosorbent assay (ELISA)\nPvGAMA antigenicity was evaluated in triplicate using\nserum from patients who had suffered episodes of P.\nvivax orP. falciparum infection. Briefly, 96-well poly-\nsorb plates were covered with 1 \u03bcgrPvGAMA-Nt, or\nrPvGAMA-Ct, overnight at 4 \u00b0C and then incubated at\n37 \u00b0C for 1 h. The dishes were blocked with 200 \u03bcl5 %\nskimmed milk - PBS-0.05% Tween for 1 h at 37 \u00b0C.Antibody reactivity against the recombinant protein\nwas evaluated by incubating the plates with 1:100 dilu-\ntion of each human serum in 5% skimmed milk - PBS-0.05% Tween for 1 h at 37 \u00b0C. The dishes were incu-\nbated with peroxidase-co upled goat anti-human IgG\nmonoclonal secondary antibody (1:10,000) (Catalogue\n1222H, ICN) diluted in 5% skimmed milk - PBS-0.05%\nTween for 1 h at 37 \u00b0C and then a peroxidase substrate\nsolution (KPL Laboratories, Gaithersburg, MD, USA)was added to reveal the reaction, according to the\nmanufacturer \u2019s recommendations. Optical density (OD)\nat 620 nm (detected by MJ ELISA Multiskan Reader) wasBaquero et al. Parasites & Vectors  (2017) 10:251 Page 4 of 11calculated by subtracting the OD value obtained from the\ncontrol well value (no antigen). The cut-off value for\nevaluating the positivity threshold was determined bytaking the average of the OD plus twice the standard\ndeviation (\u00b1 2SD) of healthy individuals \u2019sera reactivity.\nCord blood sample processing\nThe newborn umbilical cord blood samples used in this\nresearch were collected by personnel from the Hemo-centro Distrital (Bogot\u00e1) and then processed by SEPAX\nCell Processing System (Biosafe, Eysins, Switzerland) to\nreduce nucleated cells, according to the manufacturer \u2019s\nrecommendations. The samples were stored at 4 \u00b0C and\nDuffy antigen receptor for chemokines (DARC) presence\nwas determined by agglutination assay using antibodiesdirected against the molecule \u2019s Fya or Fyb fraction. The\npercentage of nucleated cells was scored in 20 fields at100\u00d7 magnification using Wright \u2019s stain before carrying\nout the binding assay.\nCell binding assay\nReticulocyte binding was tested in triplicate by flow cytom-\netry and using the total cells from cord blood sample (Fya-\nFyb+phenotype). Briefly, 5 \u03bcl samples were incubated with\n25\u03bcg of each recombinant protein ( PvGAMA-CR1,\nPvGAMA-VR1, PvGAMA-CR2 and PvGAMA-VR2) for\n16 h at 4 \u00b0C at 4\u00d7 rpm.T w e n t y - f i v e \u03bcg of DBP region II\nand III/IV were used as positive and negative controls, re-spectively. The 6 histidine peptide was also used as control\nonce the recombinant proteins contained a 6-histidine tag.A binding inhibition assay was also performed by incubat-\ningPvGAMA conserved recombinant proteins (CR1 and\nCR2) with a mixture of human sera (1:10 dilution) for 1 h\nat 4 \u00b0C before putting them in contact with cells. The sam-\nples were then incubated with mouse anti-His-PE mono-\nclonal antibody (1:40 dilution) (MACSmolecular-MiltenyiBiotec, San Diego, CA, USA) for 30 min in the dark after\nwashing with 1% BSA-PBS solution (v/v). White cells and\nreticulocytes were stained by incubating with anti-CD45APC clone 2D1 (1:80 dilution) (Becton Dickinson, Franklin\nLakes, NJ, USA) and anti-CD71 APC-H7 clone M-A712\n(1:80 dilution) (Becton Dickinson) monoclonal antibodiesfor 20 min at RT. Subsequently, reticulocyte (CD71 +\nCD45-PE+) and mature erythrocyte (CD71-CD45-PE+)\nbinding was quantified by analysing 1 million events usinga FACSCanto II cytometer (BD, San Diego, CA, USA) and\nFlowjo V10 software. PE signal intensity in the reticulocyte\npopulation was evaluated regarding CD71 signal todetermine CD71 low (CD71\nlo)a n dh i g h( C D 7 1hi) cells.\nStatistical analysis\nMean values and standard deviations (SD) were calcu-\nlated from the measurements of three independent\nexperiments. Statistical significance was assessed bycomparing means using a 0.05 significance level for\ntesting a stated hypothesis. Student \u2019st-test and analysis\nof variance (ANOVA) were used for comparing the\nmeans of each experimental group to those for control.\nTukey \u2019s multiple comparison test was used for multiple\ncomparison of experimental group means to those for\ncontrol. GradhPad Software (San Diego, CA) was used\nfor all statistical analysis.\nResults\nPvGAMA genetic diversity and selection signals\nPvgama sequences were obtained from genomes of 5\ndifferent strains from different geographical regions(North Korea, Brazil, Mauritania and India). These\nwere aligned with the VCG-I strain sequence andorthologous sequences from 5 phylogenetically-related\nspecies. The alignment revealed a size polymorphism in\npvgama due to the [C/T]C[G/C]C[A/T]AA[C/T][C/G][A/\nG/C][G/A]AC[G/C/A] repeat which was not present in P.\ncynomolgi ,P. inui ,P. fragile ,P. knowlesi orP. coatneyi\n(Additional file 1: Figure S1). Regarding P. vivax , 5 segre-\ngating sites and \u03c0= 0.0008 were observed.\nNo significant values were found when evaluating\nsynonymous and non-synonymous substitution rates(d\nN-dS= -0.001 (0.001), P> 0.1). However, synonymous\ndivergence was greater than non-synonymous diver-gence ( P< 0.0001) when comparing pvgama sequences to\neach related species: K\nN-KSP. vivax/P. cynomolgi =- 0 . 0 4 1\n(0.006); K N-KSP. vivax/P. inui = -0.062 (0.008); K N-KSP.\nvivax/P. fragile = -0.030 (0.006); K N-KSP. vivax/P. know-\nlesi= -0.072 (0.009); K N-KSP. vivax/P. coatneyi =- 0 . 0 4 9\n(0.007). The evolutionary rate \u03c9(dN/dS and KN/KS)\nsliding window showed that two highly conserved regionsamongst species (codons 80 \u2013320 and 514 \u2013624) might be\nunder negative selection ( \u03c9< 0.5). Furthermore, 308\nnegatively-selected codons were observed amongst species(Fig. 1); a lot of them were in the conserved regions. The\nBranch-site REL algorithm identified episodic positive\nselection signals in the lineages giving rise to P. knowlesi\nand P. coatneyi as well as the lineage formed by P.\ncynomolgi and P. fragile (Additional file 2: Figure S2). 22\nsites showed evidence of positive selection amongstspecies (Fig. 1).\nAntigenic response was directed against the GAMA\ncarboxyl fragment\nBased on the polymorphism analysis results, it was\nhypothesised that the carboxyl region was more anti-genic than the amino one by the presence of the repeti-\ntive region. Hence, r PvGAMA-Nt and r PvGAMA-Ct\nantigenicity (obtained recombinantly; Additional file 3:\nFigure S3a, b) was evaluated using sera from 37 patients\nsuffering of P. vivax malaria and sera from people who\nhad never suffered the disease. r PvGAMA-Nt reactedBaquero et al. Parasites & Vectors  (2017) 10:251 Page 5 of 11positively with 64.8% of the sera in screening (0.26 cut-off\npoint) whilst 67.5% of them recognised r PvGAMA-Ct\n(0.47 cut-off point). These data agreed with a study of the\nprofile of the humoral immune response for P. vivax in\nwhich r PvGAMA was recognised by 54.5% of the sera\nused in the array [41]. The statistical test for the assay withrPvGAMA-Nt gave a significant difference between the\nmeans ( m) of the groups (ANOVA: F\n(1,41)=4 . 7 3 , P=\n0.035; m= 0.38 for the group of infected patients and m=\n0.12 for the control group). Likewise, there was a signifi-\ncant difference between the means of the groups\n(ANOVA: F(1,41)=1 4 . 7 5 , P=0.0001; m= 0.67 for the\ngroup of infected patients and m=0 . 1 4 f o r t h e c o n t r o l\ngroup) when r PvGAMA-Ct was detected by human sera\n(Fig. 2a). There was also a statistically significant differ-ence when analysing the means of recognition for\nrPvGAMA-Nt and r PvGAMA-Ct (ANOVA: F\n(1,72)=\n16.01, P=0.0002). Taking into account that the response\nwas higher against PvGAMA-Ct, it was decided to\nconfirm whether the antibodies generated during P. falcip-\narum natural infection were able to detect this fragment.\nNo significant difference (ANOVA: F(1,38)=0 . 0 3 6 , P=\n0.850) was seen for PvGAMA-Ct recognition by these sera\n(Fig. 2b). The significant reactivity against the recombi-\nnants by P. vivax -infected individuals \u2019sera indicated that\nthe protein could trigger an antigenic response duringnatural infection, this being higher and species-specificagainst the PvGAMA carboxyl region.\nPvGAMA bound to human reticulocytes\nRed blood cell samples having the Fya-Fyb+phenotype\n(Duffy +) taken from umbilical cord blood were incu-bated with conserved (CR1 and CR2) and variable(VR1 and VR2) regions extracted and purified in theirsoluble form (Additional file 3: Figure S3c), predicted\nby natural selection analysis and then evaluated by\nflow cytometry to quantify the protein-cell interaction.The percentage of each recombinant binding to eryth-\nrocytes was calculated using the gating strategy de-\nscribed in Additional file 4: Figure S4, which enabledselecting the mature (CD71-CD45-) or immature\n(CD71 + CD45-) cell population to which a target pro-\ntein was bound (labelled with anti-His PE antibody).All recombinant proteins had a curve shift when the\nPE signal was compared to control (cells not incu-\nbated with recombinant proteins) in the histogram(Fig. 3). Interestingly, the GAMA fragments bound to\nreticulocytes to a much higher percentage compared\nto mature erythrocytes (CR1: t-test: t\n(4)= 24.9, P=\n0.0001; VR1: t-test: t(4)=9 . 0 2 , P=0 . 0 0 1 ; C R 2 : t-test:\nt(4)= 12.4, P= 0.0001; VR2: t-test: t(4)= 24.8, P=\n0.0001) (Fig. 4a). The conserved regions showed high-est interaction with the reticulocytes compared to\nnegative binding controls (ANOVA-Tukey: F\n(6, 12) =\n72.64, P< 0.0001). CR2 recombinant protein bound to\n10.11% (SD = 1.33) of target cells, which was verysimilar to the positive control ( m\u00b1 SD = 11.8 \u00b1 1.15)\n(P> 0.189), whilst CR1 were able to bind to 6.36%\n(SD = 0.30) of the cells (Fig. 4a). Regarding PvGAMA\nvariable regions, VR1 was able to bind to 3.08% (SD =\n0.54) of the reticulocytes whilst VR2 bound 5.64% (SD =0.37). CR1, CR2 and VR2 fragments had the highest inter-\naction with CD71\nhireticulocytes when binding percent-\nages were analysed as a function of CD71 APC-H7 signal\n(CR1: t-test: t(4)=7 . 3 2 , P=0 . 0 0 2 ; C R 2 : t-test: t(4)=1 6 . 0 4 ,\nP= 0.0001; VR2: t-test: t(4)=3 . 7 1 , P= 0.021), unlike VR1\nand DBP-RII (VR1: t-test: t(4)=1 . 5 2 , P= 0.202; DBP-RII:\nt-test: t(4)=0 . 1 9 , P= 0.853) (as previously found [42])\nFig. 2 PvGAMA antigenicity during natural malaria infection. The dot plot shows OD distribution (Y-axis) for detecting r PvGAMA-Nt or r PvGAMA-Ct\nbyP. vivax (a)o rr PvGAMA-CT by P. falciparum (b)infected (I) and non-infected (NI) patients \u2019sera (X-axis). r PvGAMA-Nt: infected individuals n= 37,\nm\u00b1 SD = 0.38 \u00b1 0.29; control individuals n=6 , m\u00b1 SD = 0.12 \u00b1 0.1. r PvGAMA-Ct: infected individuals n= 37, m\u00b1 SD = 0.67 \u00b1 0.32; control individuals\nn=6 , m\u00b1 SD = 0.14 \u00b1 0.08. r PvGAMA-Ct recognised by P. falciparum infected patients \u2019sera: infected individuals n=3 0 , m\u00b1 SD = 0.06 \u00b1 0.04; control\nindividuals n=1 0 , m\u00b1S D=0 . 0 6\u00b10 . 0 3Baquero et al. Parasites & Vectors  (2017) 10:251 Page 6 of 11(Fig. 4b). These findings suggested that GAMA in P. vivax\nhas a functional role in preferential interaction with\nhuman reticulocytes.\nNatural antibodies did not affect PvGAMA binding activity\nA cytometry adhesion inhibition assay was performed with\nsera from individuals suffering P. vivax malaria to deter-\nmine whether the antibodies produced during natural\ninfection could inhibit functional conserved regions (CR1and CR2) interaction with reticulocytes. Figure 4c shows\nthat conserved recombinant proteins pre-incubated with\nhuman sera were able to bind to target cells (CR1: m\u00b1\nSD = 6.21 \u00b1 0.27; CR2: m\u00b1 SD = 9.83 \u00b1 0.09), giving a simi-\nlar percentage to that for controls (CR1: m\u00b1S D=6 . 5\u00b1\n0.08; CR2: m\u00b1 SD = 10.01 \u00b1 0.95) (CR1: t-test: t(3)=0 . 5 5 ,\nP=0 . 6 1 7 ; C R 2 : t-test: t(4)=0 . 3 7 , P= 0.730), suggesting\nthat the immune response was directed against regionswhich are not implicated in cell binding.\nFig. 3 Flow cytometry analysis. Histograms of conserved ( aand c) and variable ( band d) GAMA fragments compared to control (cells\nnot incubated with the protein). Each figure is representative from three independent experiments\nFig. 4 PvGAMA human reticulocyte binding activity. Flow cytometry analysis showing the recombinant binding percentage to CD71-CD45-\nand CD71 + CD45- cells ( a) and regarding CD71-APCH7 signal (only for CD71 + CD45- cells) ( b). Positive (DBP-RII) and negative (DBP-RIII/IV and\nH (6 histidine peptide)) binding controls are also shown. cCR1 and CR2 reticulocyte binding inhibition assay using human sera ( \u03b1-P. vivax sera). Binding\npercentage in both analyses were expressed as mean \u00b1 SD of three independent experimentsBaquero et al. Parasites & Vectors  (2017) 10:251 Page 7 of 11Discussion\nMerozoite invasion of erythrocytes involves the participa-\ntion of several parasite molecules expressed at the end ofthe intra-erythrocyte lifecycle, mainly those contained in\nthe apical organelles, such as the rhoptries and micro-\nnemes [8]. Only a few of these molecules possessing a re-ticulocyte binding role in P. vivax have been identified\nand their binding domains mapped, suggesting an urgentneed for performing further studies to supplement currentknowledge on P. vivax adhesins. This will improve our\nunderstanding of the molecular basis of parasite invasionof reticulocytes. This study aimed at using natural selec-tion analysis for identifying GAMA functional regions\nplaying a potential role in reticulocyte binding.\nAccording to the phylogenetic analysis, a repeat\nregion (RR) localised between amino acids 591 and 695consisting of residues [A/L]AN[A/G][N/D] was pre-\ndicted. This RR was common in different P. vivax\nstrains but not in phylogenetically-related species\n(Additional file 1: Figure S1). This characteristic has\nbeen found in several P. vivax antigens described in the\nP. vivax VCG-I strain located on the parasite surface\n(Pv12 [12], ARP [43]) or in the apical pole (Pv34 [44],RON1 [45], RON2 [46] and RON4 [47, 48]). DNAsequences from different P. vivax strains and\nphylogenetically-related species were thus compared toascertain whether gama gene diversity has been\nmodulated by immune pressure. Evidence of episodic\npositive selection was found in some parasite lineages\n(Additional file 2: Figure S2). As shown for otherantigens [49 \u201351], the episodic selection found in GAMA\ncould be the outcome of adaptation to different hostsduring malaria-primate evolution [50, 51]. Therefore, theinsertions found in P. vivax could be an adaptation of the\nspecies to humans since the RR in malaria are associatedwith evasion of the host \u2019s immune response, making such\nresponse become directed against functionally unimport-\nant regions [52, 53]. This hypothesis was supported\nb yt h ef a c tt h a tr PvGAMA-Ct (where the RR is lo-\ncated) can trigger a species-specific immune response\n(Fig. 2) which did not inhibit CR2 binding activity to\nreticulocytes (Fig. 4c).\nPolymorphic regions induce high levels of strain-\nspecific antibodies (allele specific) whilst conservedregions (directly implicated in interaction with cell\nreceptors) are usually non-antigenic [54]. Therefore,\nt h ei m m u n er e s p o n s em u s tb ed i r e c t e da g a i n s tc o n -served regions to avoid different parasite strains\nevading immunity, thereby reducing vaccine efficacy.\nAccording to the selection signal identification strategy,low genetic diversity was found in the GAMA-encoding\ngene, comparable to that observed in msp4 [55, 56],\nm s p 7 A / 7K / 7F / 7L [57, 58], msp8 [59], msp10 [57, 59],\npv12 ,pv38 [22, 24], pv41 [23, 24], rap1/2 [60] and ron4[48] which seem involved in host cell invasion. Despitethe lack of statistically significant values for d\nN-dSdiffer-\nence, K Sdivergence amongst species was greater than K N,\nsuggesting negative selection. Many codons were found tobe experiencing negative selection which probably plays\nan important role in GAMA evolution. Two regions alongthe antigen were highly conserved amongst species, giving\na < 0.5 evolutionary rate ( \u03c9) (Fig. 1).\nGiven the polymorphism and selection analysis, it\nwas decided to determine PvGAMA conserved and\nvariable region interaction with reticulocytes to validate\nthe in silico prediction of functional regions (Figs. 3\nand 4) and elucidate the protein \u2019s function. A reticulo-\ncyte sample having a Duffy positive phenotype wasused, given that PvGAMA reportedly has a binding role\nregardless of such antigen \u2019s expression [61]. Unlike\nCheng and his group, the anti-CD71 monoclonal anti-body was included for identifying GAMA regions \u2019prefer-\nence for immature reticulocyte binding as P. vivax\nmerozoites have tropism for this cell type (characterisedby the expression of the CD71 receptor [62]). Given thatthe CD71 marker is also present in activated lymphocytes,\na nucleated cell depleted umbilical cord blood sample was\nused. The anti-CD45 was also included to totally excludethe lymphocytes from the analysis once the Wright stain-\ning revealed 0.4% of such cells (also confirmed by cytome-\ntry analysis) (Additional file 4: Figure S4). It was alsoconfirmed that there was no difference in reticulocyte per-\ncentage by incubating the samples for 4 and 16 h at 4 \u00b0C\n(4 h: m\u00b1 SD = 1.24 \u00b1 0.27; 16 h: m\u00b1 SD = 1.31 \u00b1 0.07) ( t-\ntest: t\n(2)=0 . 3 2 , P> 0.777). However, it was decided to use\na prolonged incubation time to enable complete protein-cell interaction.\nIt was found that all PvGAMA fragments bound to\nmature erythrocytes (CD71-CD45-) though to a lesserextent compared to reticulocytes (CD71 + CD45-)(Fig. 4a), thereby supporting the fact that the protein\npreferentially interacts with the latter cell type. The\nconserved fragment located in the carboxyl region(CR2) had higher reticulocyte binding than the amino\none (CR1) (Fig. 4a) coinciding with that shown recently\nforPvGAMA where this fragment [F2 (aa 345 to 589)\nor F7 (408 to 589) regions in that study] showed higherrosetting activity, unlike the F1 region (aa 22 to 344)(amino fragment) [61]. Interestingly, CR1 and CR2 had\nhigher CD71\nhireticulocyte binding percentages than to\nCD71lo(Fig. 4b), suggesting that GAMA mainly binds\nto such cell type \u2019s most immature stage. It has been\nreported that some reticulocytes \u2019integral membrane\ncomponents decrease as cells mature [63]. Therefore,\nthe findings found here suggest that PvGAMA receptor\nis less abundant in CD71locells unlike CD71hi,a sa\nconsequence of cell maturation. The fact that morethan 69% of the CD71 + CD45- cells were CD71\nlo(m\u00b1Baquero et al. Parasites & Vectors  (2017) 10:251 Page 8 of 11SD = 69.3 \u00b1 3.3) can be the explanation of why\nPvGAMA fragment binding to 100% of the CD71+\nreticulocytes was not found (Fig. 4a). It has been\nobserved that several P. vivax proteins, such as DBP\n[64], MSP-1 [16], RBP1 [14], the erythrocyte bindingprotein (EBP) [42], RBP1a, RBP1b [65] and RBP2 [15],have preferential reticulocyte binding activity, being the\nRBPs particularly important in parasite cell selection.\nTaking the results obtained here into account, it can besuggested that P. vivax target cell selection is not only\ngoverned by the RBPs but other ligands are also takingplace in this process, such as DBP, MSP-1, EBP andnow PvGAMA.\nImmunoreactive proteins are considered potential\ncandidates for developing a vaccine as it has been seenthat an immune response induced during infection is\nrelated to naturally-acquire d immunity [66]. Antigenic-\nity is thus one of the classical parameters for selecting\nmolecules when developing a vaccine. Although there\nw a sa ni m m u n er e s p o n s ea g a i n s t PvGAMA (Fig. 2), this\nwas not sufficient to inhibit the conserved regions\nbinding to reticulocytes (Fig. 4c). It has been observed\nthat P. falciparum proteins \u2019conserved regions (impli-\ncated in target cell binding ) cannot trigger an immune\nresponse when used as vaccine candidates in the Aotus\nmodel whilst non-conserved ones trigger protective\nresponses upon parasite challenge but those are strain-specific [54]. Accordingly, the PvGAMA antibodies\nproduced/induced during natural P. vivax infection\nwere directed against immunodominant epitopes whichare unimportant in binding activity. Bearing in mind\nthat functional regions usually evolve more slowly and\nthat natural negative selection tends to keep these re-gions conserved amongst species [25], our experimental\nfindings suggested that CR1 and CR2 located between\nresidues 80 \u2013320 (40% of negatively selected sites) and\n514 \u2013624 (64.5% of negatively selected sites) are func-\ntionally/structurally restricted and that vaccine designshould thus be focused on them.\nConclusions\nTo our knowledge, this study described PvGAMA\nreticulocyte binding properties for the first time. The\nPvGAMA antigenic response was principally directed\nagainst its carboxyl fragment which comprises by a\nrepetitive region. On the other hand, it was shown\nthat PvGAMA consists of two conserved binding\nfragments that bind preferentially to most immature\nhuman reticulocytes, which is consistent with the P.\nvivax invasion phenotype and highlights the fact that\nfunctional regions can be predicted by analysing nat-ural selection. Further studies aimed at discerning the\nfunction of conserved regions as vaccine components\nare required.Additional files\nAdditional file 1: Figure S1. GAMA antigen alignment. pvgama\nsequences from 6 P. vivax strains were aligned with orthologous sequences\nfrom P. cynomolgi ,P. inui ,P. fragile ,P. coatneyi and P. knowlesi . a DNA\nsequence alignment. b Deduced amino acid alignment. The sequences\nwere obtained from GenBank: access numbers being India-VIIAFBK01000586-AFBK01000587, North Korean AFNJ01000531, Brazil-IAFMK01000508-AFMK01000509, Mauritania-I AFNI01000333-\nAFNI01000334, P. inui NW_0084818881, P. fragile NW_012192586,\nP. cynomolgi BAEJ01000249, P. coatneyi CM0028561 and P. knowlesi\nNC_0119061. (PDF 373 kb)\nAdditional file 2: Figure S2. Lineage-specific positive selection. Branches\nunder positive episodic selection were identified by using the REL-site\nbranch method. Episodic selection acts very quickly and involves a switchfrom negative to positive natural selection and back to negative and mightenable adaptation to a new host. Phylogeny was inferred in MEGA v6 by\nthe maximum likelihood method using the GTR + G evolutionary model.\n\u03c9\n+model: \u03c9rate values. Pr [ \u03c9=\u03c9+]: percentage of sites evolving under\npositive selection. P-value corrected for multiple tests using the Holm-Bonferroni\nmethod. (TIF 470 kb)\nAdditional file 3: Figure S3. Obtaining recombinant proteins. a, b\nRecombinant GAMA protein expression and purification. Lanes 2 \u20133s h o w\nnon-induced and induced cell lysate, respectively. Lanes 4 \u20135 show purified\nrPvGAMA-Nt and -Ct stained with Coomassie blue or analysed by western\nblot using anti-polyhistidine antibodies, respectively. cPurifying conserved\n(CR1 and CR2) and variable (VR1 and VR2) PvGAMA regions. Lanes 2, 4, 6 and\n8 show purified recombinant proteins and lanes 3, 5, 7 and 9 show western\nblot detection. The proteins \u2019molecular markers are indicated in Lane 1 on all\nfigures. (TIF 5327 kb)\nAdditional file 4: Figure S4. Selection strategy for immature and mature\nerythrocyte populations. The doublets were excluded by plotting FSC-H\nagainst FSC-A. Cells were then selected by their granularity, using an\nSSC-A vs FSC-A cytogram. The CD45 vs CD71 signal was plotted forselecting reticulocyte (CD71 + CD45-) and mature erythrocyte (CD71-CD45-)populations and omitting activated lymphocytes (CD71 + CD45+). The\npercentage of cells having bound protein was calculated using the PE signal\n(CD71 + CD45-PE+). A representative histogram from three independentexperiments analysing the PE signal for the CR2 binding assay compared tocontrol is also shown. (TIF 10448 kb)\nAbbreviationsANOVA: Analysis of variance; CD71\nhi: CD71 high; CD71lo: CD71 low;\nCR: Conserved region; DARC: Duffy antigen receptor for chemokines;DBP: Duffy binding protein; DEB: Denaturing extraction buffer;EBP: Erythrocyte binding protein; ELISA: Enzyme-linked immunosorbentassay; LB: Luria bertani; MALDI-TOF: Matrix-assisted laser desorption/\nionization-time of flight; MS: Mass spectrometry; MSP-1: Merozoite surface\nprotein 1; NEB: Native extraction buffer; OD: Optical density; PBS: Phosphatebuffered saline; PvGAMA: P. vivax GPI-anchored micronemal antigen;\nPvgama :Plasmodium vivax gama ; RBP: Reticulocyte binding protein;\nRON5: Rhoptry neck protein 5; RP-HPLC: Reverse phase high-performanceliquid chromatography; RR: Repeat region; RT: Room temperature;SD: Standard deviation; TRAg: Tryptophan-rich antigen; VCG-I: Vivax ColombiaGuaviare 1; VR: Variable region\nAcknowledgements\nWe would like to thank Ana Mar\u00eda Perdomo and Bernardo Camacho forsupplying the umbilical cord blood, Diana D\u00edaz for technical support incytometry and Jason Garry for translating this manuscript.\nFunding\nThis research was financed by the Colombian Science, Technology andInnovation Department (COLCIENCIAS), contract RC#0309-2013. Duringthe course of this research JFR and HDOS were financed via COLCIENCIAS\ncooperation agreement # 0719 \u20132013 and # 0555 \u20132015, respectively. The\nsponsors had no role in study design, collection and analysis or data\ninterpretation.Baquero et al. Parasites & Vectors  (2017) 10:251 Page 9 of 11Availability of data and materials\nAll data generated or analysed during this study are included within this\narticle and its additional files. The pvgama sequence from P. vivax VCG-I\nstrain was deposited in the GenBank database under accession numberKT248546.\nAuthors \u2019contributions\nLAB and DAMP devised and designed the study; LAB, DAMP, DGO, JFR and\nHDOS performed the experiments; LAB, DAMP, DGO and MAP analysed the\nresults and wrote the manuscript. All authors read and approved the final\nmanuscript.\nCompeting interests\nThe authors declare that they have no competing interests.\nConsent for publication\nNot applicable.\nEthics approval and consent to participate\nAll individuals who participated in this research (including progenitorsregarding umbilical cord samples) signed an informed consent form after\nreceiving detailed information regarding the study \u2019s goals. All procedures\nwere approved by FIDIC \u2019s ethics committee.\nPublisher \u2019sN o t e\nSpringer Nature remains neutral with regard to jurisdictional claims in\npublished maps and institutional affiliations.\nAuthor details\n1Molecular Biology and Immunology Department, Fundaci\u00f3n Instituto de\nInmunolog\u00eda de Colombia (FIDIC), Carrera 50 No. 26-20, Bogot\u00e1 DC,\nColombia.2PhD Programme in Biomedical and Biological Sciences,\nUniversidad del Rosario, Carrera 24 No. 63C-69, Bogot\u00e1 DC, Colombia.3Basic\nSciences Department, School of Medicine and Health Sciences, Universidaddel Rosario, Carrera 24 No. 63C-69, Bogot\u00e1 DC, Colombia.\nReceived: 27 October 2016 Accepted: 10 May 2017\nReferences\n1. WHO. World malaria report. 2014.\n2. WHO. State of the art of new vaccine research and development. 2006.3. Patarroyo ME, Bermudez A, Patarroyo MA. Structural and immunological\nprinciples leading to chemically synthesized, multiantigenic, multistage,\nminimal subunit-based vaccine development. Chem Rev. 2011;111:3459 \u2013507.\n4. Lanzavecchia A, Fruhwirth A, Perez L, Corti D. Antibody-guided vaccine design:\nidentification of protective epitopes. Curr Opin Immunol. 2016;41:62 \u20137.\n5. Gardner MJ, Hall N, Fung E, White O, Berriman M, Hyman RW, et al.\nGenome sequence of the human malaria parasite Plasmodium falciparum .\nNature. 2002;419:498 \u2013511.\n6. Bozdech Z, Llinas M, Pulliam BL, Wong ED, Zhu J, DeRisi JL. The transcriptome\nof the intraerythrocytic developmental cycle of Plasmodium falciparum .\nPLoS Biol. 2003;1:E5.\n7. Lasonder E, Ishihama Y, Andersen JS, Vermunt AM, Pain A, Sauerwein RW, et al.\nAnalysis of the Plasmodium falciparum proteome by high-accuracy mass\nspectrometry. Nature. 2002;419:537 \u201342.\n8. Cowman AF, Berry D, Baum J. The cellular and molecular basis for malaria\nparasite invasion of the human red blood cell. J Cell Biol. 2012;198:961 \u201371.\n9. Richards JS, Beeson JG. The future for blood-stage vaccines against malaria.\nImmunol Cell Biol. 2009;87:377 \u201390.\n10. Arumugam TU, Takeo S, Yamasaki T, Thonkukiatkul A, Miura K, Otsuki H, et al.\nDiscovery of GAMA, a Plasmodium falciparum merozoite micronemal protein,\nas a novel blood-stage vaccine candidate antigen. Infect Immun. 2011;79:\n4523 \u201332.\n11. Huynh MH, Carruthers VB. A Toxoplasma gondii Ortholog of Plasmodium\nGAMA contributes to parasite attachment and cell invasion. mSphere.2016;1: doi:10.1128/mSphere.00012-16.\n12. Moreno-Perez DA, Areiza-Rojas R, Florez-Buitrago X, Silva Y, Patarroyo ME,\nPatarroyo MA. The GPI-anchored 6-Cys protein Pv12 is present in detergent-\nresistant microdomains of Plasmodium vivax blood stage schizonts. Protist.\n2013;164:37 \u201348.13. Patarroyo MA, Calder\u00f3n D, More no-P\u00e9rez DA. Vaccines against Plasmodium vivax :\na research challenge. Expert Rev Vaccines. 2012;11:1249 \u201360.\n14. Urquiza M, Patarroyo MA, Mari V, Ocampo M, Suarez J, Lopez R, et al.\nIdentification and polymorphism of Plasmodium vivax RBP-1 peptides which\nbind specifically to reticulocytes. Peptides. 2002;23:2265 \u201377.\n15. Franca CT, He WQ, Gruszczyk J, Lim NT, Lin E, Kiniboro B, et al. Plasmodium\nvivax reticulocyte binding proteins are key targets of naturally acquired\nimmunity in young Papua New Guinean children. PLoS Negl Trop Dis.2016;10:e0005014.\n16. Rodriguez LE, Urquiza M, Ocampo M, Curtidor H, Suarez J, Garcia J, et al.\nPlasmodium vivax MSP-1 peptides have high specific binding activity to\nhuman reticulocytes. Vaccine. 2002;20:1331 \u20139.\n17. Zeeshan M, Tyagi RK, Tyagi K, Alam MS, Sharma YD. Host-parasite interaction:\nselective Pv-fam-a family proteins of Plasmodium vivax bind to a restricted\nnumber of human erythrocyte receptors. J Infect Dis. 2015;211:1111 \u201320.\n18. Arevalo-Pinzon G, Bermudez M, Curtidor H, Patarroyo MA. The Plasmodium\nvivax rhoptry neck protein 5 is expressed in the apical pole of Plasmodium\nvivax VCG-1 strain schizonts and binds to human reticulocytes. Malaria J.\n2015;14:106.\n19. Garzon-Ospina D, Forero-Rodriguez J, Patarroyo MA. Inferring natural\nselection signals in Plasmodium vivax -encoded proteins having a potential\nrole in merozoite invasion. Infect Genet Evol. 2015;33:182 \u20138.\n20. Cornejo OE, Fisher D, Escalante AA. Genom e-wide patterns of genetic polymorphism\nand signatures of selection in Plasmodium vivax .G e n o m eB i o lE v o l .\n2014;7:106 \u201319.\n21. Neafsey DE, Galinsky K, Jiang RH, Young L, Sykes SM, Saif S, et al. The\nmalaria parasite Plasmodium vivax exhibits greater genetic diversity than\nPlasmodium falciparum . Nat Genet. 2012;44:1046 \u201350.\n22. Forero-Rodriguez J, Garzon-Ospina D, Patarroyo MA. Low genetic diversity\nand functional constraint in loci encoding Plasmodium vivax P12 and P38\nproteins in the Colombian population. Malaria J. 2014;13:58.\n23. Forero-Rodriguez J, Garzon-Ospina D, Patarroyo MA. Low genetic diversity\nin the locus encoding the Plasmodium vivax P41 protein in Colombia \u2019s\nparasite population. Malaria J. 2014;13:388.\n24. Wang Y, Ma A, Chen SB, Yang YC, Chen JH, Yin MB. Genetic diversity and\nnatural selection of three blood-stage 6-Cys proteins in Plasmodium vivax\npopulations from the China-Myanmar endemic border. Infect Genet Evol.2014;28:167 \u201374.\n25. Graur D, Zheng Y, Price N, Azevedo RB, Zufall RA, Elhaik E. On the\nimmortality of television sets: \u201cfunction \u201din the human genome according\nto the evolution-free gospel of ENCODE. Genome Biol Evol. 2013;5:578 \u201390.\n26. Escalante AA, Cornejo OE, Freeland DE, Poe AC, Durrego E, Collins WE, et al.\nA monkey \u2019s tale: the origin of Plasmodium vivax as a human malaria\nparasite. Proc Natl Acad Sci USA. 2005;102:1980 \u20135.\n27. Edgar RC. MUSCLE: multiple sequence alignment with high accuracy and\nhigh throughput. Nucleic Acids Res. 2004;32:1792 \u20137.\n28. Zhang J, Rosenberg HF, Nei M. Positive Darwinian selection after gene\nduplication in primate ribonuclease genes. Proc Natl Acad Sci USA. 1998;95:3708 \u201313.\n29. Jukes THaCRC. Evolution of protein molecules. In: Munro HN, editor.\nMammalian protein metabolism. New York: Academic Press; 1969.\n30. Kosakovsky Pond SL, Frost SD. Not so different after all: a comparison of methods\nfor detecting amino acid sites under selection. Mol Biol Evol. 2005;22:1208 \u201322.\n31. Murrell B, Wertheim JO, Moola S, Weighill T, Scheffler K, Kosakovsky Pond\nSL. Detecting individual sites subject to episodic diversifying selection.PLoS Genet. 2012;8:e1002764.\n32. Murrell B, Moola S, Mabona A, Weighill T, Sheward D, Kosakovsky Pond SL,\net al. FUBAR: a fast, unconstrained bayesian approximation for inferring\nselection. Mol Biol Evol. 2013;30:1196 \u2013205.\n33. Kosakovsky Pond SL, Posada D, Gravenor MB, Woelk CH, Frost SD.\nAutomated phylogenetic detection of recombination using a geneticalgorithm. Mol Biol Evol. 2006;23:1891 \u2013901.\n34. Kosakovsky Pond SL, Murrell B, Fourment M, Frost SD, Delport W, Scheffler K.\nA random effects branch-site model for detecting episodic diversifying selection.\nMol Biol Evol. 2011;28:3033 \u201343.\n35. Delport W, Poon AF, Frost SD, Kosakovsky Pond SL. Datamonkey 2010: a\nsuite of phylogenetic analysis tools for evolutionary biology. Bioinformatics.2010;26:2455 \u20137.\n36. Aurrecoechea C, Brestelli J, Brunk BP, Dommer J, Fischer S, Gajria B, et al.\nPlasmoDB: a functional genomic database f or malaria parasites. Nucleic Acids Res.\n2009;37:D539 \u2013543.Baquero et al. Parasites & Vectors  (2017) 10:251 Page 10 of 1137. Moreno-Perez DA, Degano R, Ibarrola N, Muro A, Patarroyo MA. Determining\nthePlasmodium vivax VCG-1 strain blood stage proteome. J Proteomics.\n2014;113C:268 \u201380.\n38. Pico de Coana Y, Rodriguez J, Guerrero E, Barrero C, Rodriguez R, Mendoza\nM, et al. A highly infective Plasmodium vivax strain adapted to Aotus monkeys:\nquantitative haematological and molecular determinations useful for P. vivax\nmalaria vaccine development. Vaccine. 2003;21:3930 \u20137.\n39. Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity\nof progressive multiple sequence alignment through sequence weighting,\nposition-specific gap penalties and weight matrix choice. Nucleic Acids Res.1994;22:4673 \u201380.\n40. Houghten RA. General method for the rapid solid-phase synthesis of large\nnumbers of peptides: specificity of antigen-antibody interaction at the levelof individual amino acids. Proc Natl Acad Sci USA. 1985;82:5131 \u20135.\n41. Lu F, Li J, Wang B, Cheng Y, Kong DH, Cui L, et al. Profiling the humoral\nimmune responses to Plasmodium vivax infection and identification of\ncandidate immunogenic rhoptry-associated membrane antigen (RAMA).\nJ Proteomics. 2014;102C:66 \u201382.\n42. Ntumngia FB, Thomson-Luque R, Torres Lde M, Gunalan K, Carvalho LH,\nAdams JH. A novel erythrocyte binding protein of Plasmodium vivax suggests\nan alternate invasion pathway into Duffy-positive reticulocytes. mBio. 2016;7:\ndoi: 10.1128/mBio.01261-16.\n43. Moreno-Perez DA, Saldarriaga A, Patarroyo MA. Characterizing PvARP,\na novel Plasmodium vivax antigen. Malaria J. 2013;12:165.\n44. Mongui A, Angel DI, Gallego G, Reyes C, Martinez P, Guhl F, et al.\nCharacterization and antigenicity o f the promising vaccine candidate\nPlasmodium vivax 34 kDa rhoptry antigen ( Pv34). Vaccine. 2009;28:415 \u201321.\n45. Moreno-Perez DA, Montenegro M, Patarroyo ME, Patarroyo MA. Identification,\ncharacterization and antigenicity of the Plasmodium vivax rhoptry neck protein\n1(PvRON1). Malaria J. 2011;10:314.\n46. Arevalo-Pinzon G, Curtidor H, Patino LC, Patarroyo MA. PvRON2, a new\nPlasmodium vivax rhoptry neck antigen. Malaria J. 2011;10:60.\n47. Arevalo-Pinzon G, Curtidor H, Abril J, Patarroyo MA. Annotation and\ncharacterization of the Plasmodium vivax rhoptry neck protein 4 ( PvRON4).\nMalaria J. 2013;12:356.\n48. Buitrago SP, Garzon-Ospina D, Patarroyo MA. Size polymorphism and low\nsequence diversity in the locus encoding the Plasmodium vivax rhoptry\nneck protein 4 ( PvRON4) in Colombian isolates. Malaria J. 2016;15:501.\n49. Garzon-Ospina D, Forero-Rodriguez J, Patarroyo MA. Evidence of functional\ndivergence in MSP7 paralogous proteins: a molecular-evolutionary andphylogenetic analysis. BMC Evol Biol. 2016;16:256.\n50. Muehlenbein MP, Pacheco MA, Taylor JE, Prall SP, Ambu L, Nathan S, et al.\nAccelerated diversification of nonhuman primate malarias in Southeast Asia:adaptive radiation or geographic speciation? Mol Biol Evol. 2015;32:422 \u201339.\n51. Sawai H, Otani H, Arisue N, Palacpac N, de Oliveira ML, Pathirana S, et al.\nLineage-specific positive selection at the merozoite surface protein 1 (msp1)locus of Plasmodium vivax and related simian malaria parasites. BMC Evol Biol.\n2010;10:52.\n52. Schofield L. On the function of repetitive domains in protein antigens of\nPlasmodium and other eukaryotic parasites. Parasitol Today. 1991;7:99 \u2013105.\n53. Ferreira MU, da Silva NM, Wunderlich G. Antigenic diversity and immune\nevasion by malaria parasites. Clin Diagn Lab Immunol. 2004;11:987 \u201395.\n54. Patarroyo ME, Patarroyo MA. Emerging rules for subunit-based, multiantigenic,\nmultistage chemically synthesized vaccines. Acc Chem Res. 2008;41:377 \u201386.\n55. Martinez P, Suarez CF, Gomez A, Cardenas PP, Guerrero JE, Patarroyo MA.\nHigh level of conservation in Plasmodium vivax merozoite surface protein 4\n(PvMSP4). Infect Genet Evol. 2005;5:354 \u201361.\n56. Putaporntip C, Jongwutiwes S, Ferreira MU, Kanbara H, Udomsangpetch R,\nCui L. Limited global diversity of the Plasmodium vivax merozoite surface\nprotein 4 gene. Infect Genet Evol. 2009;9:821 \u20136.\n57. Garzon-Ospina D, Romero-Murillo L, Tobon LF, Patarroyo MA. Low genetic\npolymorphism of merozoite surface proteins 7 and 10 in ColombianPlasmodium vivax isolates. Infect Genet Evol. 2011;11:528 \u201331.\n58. Garzon-Ospina D, Forero-Rodriguez J, Patarroyo MA. Heterogeneous genetic\ndiversity pattern in Plasmodium vivax genes encoding merozoite surface\nproteins (MSP) -7E, -7 F and -7 L. Malaria J. 2014;13:495.\n59. Pacheco MA, Elango AP, Rahman AA, Fisher D, Collins WE, Barnwell JW,\net al. Evidence of purifying selection on merozoite surface protein 8 (MSP8)and 10 (MSP10) in Plasmodium spp. Infect Genet Evol. 2012;12:978 \u201386.60. Garzon-Ospina D, Romero-Murillo L, Patarroyo MA. Limited genetic\npolymorphism of the Plasmodium vivax low molecular weight rhoptry\nprotein complex in the Colombian population. Infect Genet Evol.2010;10:261 \u20137.\n61. Cheng Y, Lu F, Wang B, Li J, Han JH, Ito D, et al. Plasmodium vivax\nGPI-anchored micronemal antigen ( PvGAMA) binds human erythrocytes\nindependent of Duffy antigen status. Sci Reports. 2016;6:35581.\n62. Malleret B, Li A, Zhang R, Tan KS, Suwanarusk R, Claser C, et al. Plasmodium\nvivax : restricted tropism and rapid remodeling of CD71-positive reticulocytes.\nBlood. 2015;125:1314 \u201324.\n63. Wilson MC, Trakarnsanga K, Heesom KJ, Cogan N, Green C, Toye AM, et al.\nComparison of the proteome of adult and cord erythroid cells, and changesin the proteome following reticulocyte maturation. Mol Cel Proteomics\nMCP. 2016;15:1938 \u201346.\n64. Ocampo M, Vera R, Eduardo R, Curtidor H, Urquiza M, Suarez J, et al.\nPlasmodium vivax Duffy binding protein peptides specifically bind to\nreticulocytes. Peptides. 2002;23:13 \u201322.\n65. Han JH, Lee SK, Wang B, Muh F, Nyunt MH, Na S, et al. Identification of a\nreticulocyte-specific binding domain of Plasmodium vivax reticulocyte-\nbinding protein 1 that is homologous to the PfRh4 erythrocyte-binding\ndomain. Sci Reports. 2016;6:26993.\n66. Dent AE, Nakajima R, Liang L, Baum E, Moormann AM, Sumba PO, et al.\nPlasmodium falciparum protein microarray antibody profiles correlate with\nprotection from symptomatic malaria in Kenya. J Infect Dis. 2015;212:1429 \u201338.\n\u2022  We accept pre-submission inquiries  \n\u0081  Our selector tool helps you to \ufb01nd the most relevant journal\n\u0081  We provide round the clock customer support \n\u0081  Convenient online submission\n\u0081  Thorough peer review\n\u0081  Inclusion in PubMed and all major indexing services \n\u0081  Maximum visibility for your research\nSubmit your manuscript at\nwww.biomedcentral.com/submitSubmit your next manuscript to BioMed Central \nand we will help you at every step:Baquero et al. Parasites & Vectors  (2017) 10:251 Page 11 of 11ORIGINAL RESEARCH\npublished: 25 January 2018\ndoi: 10.3389/fgene.2018.00010\nFrontiers in Genetics | www.frontiersin.org 1 January 2018 | Volume 9 | Article 10Editedby:\nJos\u00e9M.\u00c1lvarez-Castro,\nUniversidadedeSantiagode\nCompostela,Spain\nReviewedby:\nMarceloR.S.Briones,\nFederalUniversityofS\u00e3oPaulo,Brazil\nGonzaloGajardo,\nUniversityofLosLagos,Chile\n*Correspondence:\nManuelA.Patarroyo\nmapatarr.\ufb01dic@gmail.com\nSpecialtysection:\nThisarticlewassubmittedto\nEvolutionaryandPopulationGenetics,\nasectionofthejournal\nFrontiersinGenetics\nReceived: 24October2017\nAccepted: 09January2018\nPublished: 25January2018\nCitation:\nGarz\u00f3n-OspinaD,BuitragoSP,\nRamosAEandPatarroyoMA(2018)\nIdentifyingPotentialPlasmodiumvivax\nSporozoiteStageVaccineCandidates:\nAnAnalysisofGeneticDiversityand\nNaturalSelection.Front.Genet.9:10.\ndoi:10.3389/fgene.2018.00010Identifying Potential Plasmodium\nvivaxSporozoite Stage Vaccine\nCandidates: An Analysis of Genetic\nDiversity and Natural Selection\nDiegoGarz\u00f3n-Ospina1,2,SindyP.Buitrago1,AndreaE.Ramos1and\nManuelA.Patarroyo1,3*\n1MolecularBiologyandImmunologyLaboratory,Fundaci\u00f3nInst itutodeInmunolog\u00edadeColombia,Bogot\u00e1,Colombia,2PhD\nProgrammeinBiomedicalandBiologicalSciences,Schoolof MedicineandHealthSciences,UniversidaddelRosario,\nBogot\u00e1,Colombia,3BasicSciencesDepartment,SchoolofMedicineandHealthSc iences,UniversidaddelRosario,Bogot\u00e1,\nColombia\nParasite antigen genetic diversity represents a great obst acle when designing a vaccine\nagainst malaria caused by Plasmodiumvivax . Selecting vaccine candidate antigens has\nbeenfocusedonthoseful\ufb01llingaroleininvasionandwhicha reconserved,thusavoiding\nspeci\ufb01c-allele immune responses. Most antigens described to date belong to the blood\nstage, thereby blocking parasite development within red bl ood cells, whilst studying\nantigens from other stages has been quite restricted. Antig ens from different parasite\nstages are required for developing a completely effective v accine; thus, pre-erythrocyte\nstage antigens able to block the \ufb01rst line of infection becom ing established should also\nbe taken into account. However, few antigens from this stage have been studied to\ndate. Several P. falciparum sporozoite antigens are involved in invasion. Since 77%\nof genes are orthologous amongst Plasmodium parasites, P. vivaxsporozoite antigen\northologs to those of P. falciparum might be present in its genome. Although these\ngenesmighthavehighgeneticdiversity,conservedfunctio nally-relevantregions(idealfor\nvaccine development) could be predicted by comparing genet ic diversity patterns and\nevolutionaryrates.Thisstudywasthusaimedatsearchingf orputative P.vivaxsporozoite\ngenes so as to analyse their genetic diversity for determini ng their potential as vaccine\ncandidates. Several DNA sequence polymorphism estimators were computed at each\nlocus. The evolutionary force (drift, selection and recomb ination) drawing the genetic\ndiversity pattern observed was also determined by using tes ts based on polymorphism\nfrequencyspectrumaswellasthetypeofintra-andinter-sp eciessubstitutions.Likewise,\nrecombination was assessed both indirectly and directly. T he results showed that\nsporozoitegenesweremoreconservedthanmerozoitegenese valuatedtodate.Putative\ndomainsimpliedincelltraversal,glidingmotilityandhep atocyteinteractionhadanegative\nselectionsignal,beingconservedamongstdifferentspeci esinthegenus.PvP52,PvP36,\nPvSPATR, PvPLP1, PvMCP1, PvTLP, PvCelTOS, and PvMB2 antige ns or functionally\nrestrictedregionswithinthemwouldthusseempromisingva ccinecandidatesandcould\nbeused whendesigning apre-erythrocyteand/or multi-stag evaccineagainst P.vivaxto\navoid allele-speci\ufb01c immune responses that could reduce va ccine ef\ufb01cacy.\nKeywords: Plasmodiumvivax , genetic diversity, sporozoite, vaccine, natural selecti on, hepatocyte invasionGarz\u00f3n-Ospina et al. Plasmodiumvivax Sporozoite Vaccine Candidates\nINTRODUCTION\nPlasmodium vivax (Pv) is one of the \ufb01ve Plasmodium species\ncausingmalariainhumanbeings[ CoatneyandNationalInstitute\nof Allergy and Infectious Diseases (U.S.), 1971; Rich and Ayal a,\n2003]. Outdoor biting of less-anthropophilic mosquitos (than\nthe main Plasmodium falciparum vectors) transmitting it, and\nendemic regions\u2019 social-economic conditions make P. vivaxan\nemergent public health problem ( Mueller et al., 2015 ). This\nparasite exclusively invades reticulocytes and is characte rized\nby relapses from dormant liver stages; it produces early and\ncontinuous gametocytes ( Price et al., 2009; Patarroyo et al.,\n2012; Adams and Mueller, 2017 ) and has great genetic diversity\nthroughoutitsgenome( Neafseyetal.,2012;Winteretal.,2015 ).\nAll these features make P. vivaxcontrol and elimination a great\nchallenge.\nVaccine development has been considered as one of the most\ncost-e\ufb00ective interventions for controlling malaria. Desi gning a\nvaccine against this disease has focused on selecting antig ens\nable to induce an e\ufb00ective immune response that block invasion\nof target cells. The Plasmodium life-cycle should be considered\nwhen designing an anti-malarial vaccine. Malarial infecti on\nbegins with an infected female mosquito\u2019s bite. Plasmodium\nsporozoites (Spz or pre-erythrocyte stage) in the vertebrate\nbloodstream must migrate to the host\u2019s liver, traversing th e\nendothelial and Kup\ufb00er cells that form the sinusoidal barrier .\nThey then migrate through some hepatocytes before infecting\none of them ( Menard, 2001; Frevert, 2004 ). Inside hepatocytes,\nSpz di\ufb00erentiate into thousands of merozoites (Mrz) whichafte r\ntheir release proceed to invade red blood cells (RBC), initiat ing\nthe erythrocyte or blood stage. Within RBC the Mrz could\ndi\ufb00erentiate in new Mrz which will infect new RBC or into\ngametocytes which can be taken by the mosquito vector to star t\nthesexualstage.\nAs mentioned above, proteins involved in parasite-host cell\ninteractions are the main targets for vaccine development.\nHowever, the genetic diversity found in the parasite has beco me\nAbbreviations: BepiPred, B-cell epitope prediction; CBI, codon bias index;\nENC, e\ufb00ective number of codons; FEL, \ufb01xed e\ufb00ects likelihood; FUB AR, fast,\nunconstrained Bayesian approximation for inferring selection; GAR D, genetic\nalgorithm recombination detection; GPI, glycosylphosphatidylinos itol membrane\nanchor; GTP, guanosine triphosphate; IEDB, immune epitope database and\nanalysis resource; IFEL, internal \ufb01xed e\ufb00ects likelihood; MEME, mixed e\ufb00ects\nmodel of evolution; Mrz, merozoite; pvspect1, gene encoding Plasmodium vivax\nsporozoite protein essential for cell traversal; pvsiap1,gene encoding Plasmodium\nvivaxsporozoiteinvasion-associatedprotein-1; pvp52,geneencoding Plasmodium\nvivax6-cysteine protein P52; pvp36, gene encoding Plasmodium vivax 6-cysteine\nprotein P36; pvspatr, gene encoding Plasmodium vivax secreted protein with\naltered thrombospondin repeat domain; pvtrsp,gene encoding Plasmodium vivax\nthrombospondin-related sporozoite protein; pvtrap, gene encoding Plasmodium\nvivaxthrombospondin-related anonymous protein; pvsiap2, gene encoding\nPlasmodium vivax sporozoite invasion-associated protein-2; pvmaebl, gene\nencoding Plasmodium vivax merozoite adhesive erythrocytic binding protein;\npvplp1, gene encoding Plasmodium vivax perforin-like protein 1; pvmcp1,\ngene encoding Plasmodium vivax merozoite capping protein 1; pvtlp, gene\nencoding Plasmodium vivax thioredoxin-like protein; pvceltos, gene encoding\nPlasmodiumvivax celltraversalproteinforookinetesandsporozoites; pvmb2,gene\nencoding Plasmodium vivax MB2 protein; REL, random e\ufb00ects likelihood; SLAC,\nsingle likelihood ancestor counting; SNP, single nucleotide polymo rphisms; Spz,\nsporozoite.a challenge for designing a fully-e\ufb00ective vaccine ( Patarroyo\net al., 2012; Barry and Arnott, 2014 ). Such polymorphisms\nare typically found within functionally irrelevant gene/pro tein\nregions enabling the evasion of host immune responses,\nwhilst functionally important regions remain conserved due t o\nfunctional/structural constraints ( Garz\u00f3n-Ospina et al., 2012;\nBaquero et al., 2017 ); these regions could therefore be taken\ninto account for vaccine design in order to avoid allele-speci \ufb01c\nimmune responses. Several studies have measured potential\nvaccine candidates\u2019 genetic diversity ( Putaporntip et al., 1997,\n2009, 2010; Gomez et al., 2006; Garz\u00f3n-Ospina et al., 2010,\n2011, 2012, 2014; Dias et al., 2011; Premaratne et al., 2011;\nChenet et al., 2013; Barry and Arnott, 2014; Forero-Rodrigue z\net al., 2014a,b; Buitrago et al., 2016; Chaurio et al., 2016;\nMehrizietal.,2017 ).Likewise,theevolutionaryforces(mutation,\nnatural selection, genetic drift, recombination, and migr ation)\nmodulating polymorphism ( Casillas and Barbadilla, 2017 ) have\nalso been determined. This has been used for monitoring\nanti-malarial vaccine targets ( Barry and Arnott, 2014 ) but\nmight also be used for predicting functional regions which\nare usually conserved amongst species ( Kimura, 1983; Graur\net al., 2013 ). Accordingly, promising vaccine candidates must\nlikely be parasite proteins playing an important role during\ntarget cell invasion but displaying limited genetic diversit y or,\nat least, a domain having such pattern. These genes or domains\nmust thus have a negative selection signal ( \u03c9<1 evolutionary\nrate). Moreover, vaccine candidates should be able to induce an\nimmuneresponseinnaturalorexperimentalinfection( Patarroyo\netal.,2012;BarryandArnott,2014;Weissetal.,2015 ).\nDespite there being three intervention points [pre-\nerythrocyte, blood and gametocyte stages ( Barry and Arnott,\n2014)], potential P. vivax candidates characterized to date\nhave mainly been described for the blood stage to avoid Mrz\nentry to RBC, preventing the disease\u2019s typical symptomatology\n(Patarroyo et al., 2012 ). On the contrary, few pre-erythrocyte\nphase antigens have been studied, in spite of the fact that\nblocking Spz interaction with hepatocytes would greatly reduc e\nthe possibility of developing the disease. This strategy would\nalso avoid P. vivax dormant form formation in the liver and\nhence infected patients\u2019 constant relapses ( Price et al., 2009;\nHulden, 2011 ). Several Spz antigens involved in invasion have\nbeen characterized in P. falciparum and other parasite species\n(Sultan et al., 1997; Wengelnik et al., 1999; Menard, 2001;\nMatuschewski et al., 2002; Romero et al., 2004; Kariu et al.,\n2006; Labaied et al., 2007a,b; Moreira et al., 2008; Rosado et a l.,\n2008; Engelmann et al., 2009; Alba et al., 2011; Curtidor et a l.,\n2011; Aldrich et al., 2012; Annoura et al., 2014; Ferguson et al.,\n2014;Jimahetal.,2016;Kublinetal.,2017;Manzonietal.,2 017;\nYang et al., 2017a ). Since around 77% of Plasmodium genes\nare orthologous ( Carlton et al., 2008 ), many being essential\nfor parasite survival ( Bushell et al., 2017 ), orthologous Spz\nantigens might also be present in the P. vivaxgenome. Given\ntheP. vivax genome\u2019s high genetic diversity ( Neafsey et al.,\n2012),P. vivax Spz genes might also be highly polymorphic;\nhowever, as functionally important regions tend to have low\npolymorphism ( Kimura, 1983; Graur et al., 2013 ),P. vivaxand\nrelatedPlasmodium parasites\u2019 highly conserved regions could\nFrontiers in Genetics | www.frontiersin.org 2 January 2018 | Volume 9 | Article 10Garz\u00f3n-Ospina et al. Plasmodiumvivax Sporozoite Vaccine Candidates\nbe functionally important and should therefore be taken into\naccountforvaccinedevelopment( Patarroyoetal.,2012 ).Asfew\nP. vivaxpre-erythrocyte stage antigens have been described to\ndate (Menard, 2001; Castellanos et al., 2007; Barry and Arnott,\n2014), and because characterizing antigens from this stage is\nlaborious, this study involved a search for orthologous gen es\ninP. vivaxto those previously studied in P. falciparum forin\nsilicocharacterization so as to assess their genetic diversity. T he\nevolutionary forces modulating the variation pattern obser ved\nwere analyzed for identifying conserved and functional reg ions;\nthen proteins\u2019 antigenic potential was predicted for identify ing\nthose potentially able to induce an immune response and\nthus determine which of these antigens should be prioritized\nand taken into account when designing a pre-erythrocyte\nand/or multi-stage vaccine against malaria caused by P.\nvivax.\nMETHODOLOGY\nSequences Data Set and inSilico\nCharacterization of P.vivaxLoci\nFew genes encoding putative Plasmodium vivax Spz stage\nvaccine antigens have been assessed regarding their geneti c\ndiversity. Fifteen P. falciparum proteins have been suggested\nas promising vaccine candidates ( Curtidor et al., 2011 ).\nOrthologoussequencestothese P.falciparum vaccinecandidates\nwere sought in the P. vivaxSalvador I (Sal-I) strain from the\nPlasmoDB database (Release 32). One hundred and seventy-one\nP. vivaxnatural strain DNA sequences from regions worldwide,\nanalyzed by whole genome sequencing ( Chan et al., 2012;\nNeafsey et al., 2012; Hester et al., 2013; Hupalo et al., 2016 )\navailableinthePlasmoDBdatabase,werealsoobtainedfort hese\nputative antigens. Sal-I sequences from these genes were the n\nused as query for searching orthologous sequences in closel y-\nrelated species [ Plasmodium cynomolgi (GCA_000321355.1),\nPlasmodium inui (GCA_000524495.1), Plasmodium fragile\n(GCA_000956335.1) ,Plasmodiumknowlesi (GCA_000006355.1)\nandPlasmodiumcoatneyi (GCA_000725905.1)],usingthewhole\ngenome data available in GenBank. Orthologous sequences\nfrom less related Plasmodium species (Plasmodium berghei,\nPlasmodium yoelii, Plasmodium chabaudi, Plasmodium vinck ei,\nPlasmodium falciparum, Plasmodium reichenowi, Plasmodiu m\ngaboni, andPlasmodium gallinaceum ) were obtained from the\nPlasmoDBdatabase(Release32).\nPotential vaccine candidates described in Mrz are\ncharacterized by having a signal peptide and some have\nmembrane anchoring structures [i.e., transmembrane helic es\nand/or glycosylphosphatidylinositol (GPI) anchor], whilst\nsome others have binding and/or protein-protein interaction\ndomains ( Patarroyo et al., 2012 ), therefore, the Sal-I Spz protein\nsequences were used for in silicocharacterization using several\nbioinformatics tools. SignalP ( Nielsen, 2017 ) and Phobius ( Kall\net al., 2007 ) predictors were used for ascertaining signal peptide\npresence;theBaCelLoalgorithm( Pierleonietal.,2006 )wasused\nfor predicting antigen location. Transmembrane and/or GPI\ndomains were evaluated with Phobius, TMHMM ( Sonnhammeret al., 1998 ) and GPI-SOM ( Fankhauser and Maser, 2005 ) and\nthePfamdatabasewassearchedforputativedomains.\nAlignment and Sequence Analysis\nThe 171 sequences from di\ufb00erent locations worldwide obtaine d\nfor each gene were screened to rule out gene sequences having\nmissing data or ambiguous nucleotides; introns were remove d\nfromthosegeneshavingthem.MultipleDNAalignmentforeach\ngenewasperformedbasedonaminoacid(aa)informationusing\nthe TranslatorX ( Abascal et al., 2010 ) server with the Muscle\nalgorithm( Edgar,2004 ).\nDnaSP v5 software ( Librado and Rozas, 2009 ) was then\nused for calculating several genetic diversity estimators for 14\nSpz loci. On the other hand, the e\ufb00ective number of codons\n(ENC) and codon bias index (CBI) were obtained as a measure\nof selective pressure at translational level ( Novembre, 2002 ).\nTajima (1989) ,Fu and Li (1993) , andFay and Wu (2000)\ntests were used for evaluating a neutral model of molecular\nevolution. Repeat regions or those having insertions/deleti ons\nwerenottakenintoaccountforanalysis.Testsbasedonthet ype\nof nucleotide substitution were used to infer natural select ion\nsignalswithingenes.TheNei-Gojoborimodi\ufb01edmethod( Zhang\net al., 1998 ) was used for calculating the di\ufb00erence between\nnon-synonymous and synonymous substitution rates at intra -\nspecies level (d N-dS). The di\ufb00erence between non-synonymous\nand synonymous divergences rates (K N-KS) was calculated by\nmodi\ufb01ed Nei-Gojobori method with Jukes-Cantor correction\n(Jukes and Cantor, 1969 ), usingP. vivax sequences together\nwithorthologoussequencesfromphylogenetically-closely related\nspecies for determining natural selection signals at inter- species\nlevel. MEGA v6 software ( Tamura et al., 2013 ) was used for all\nsuch analysis. A sliding window for omega rates ( \u03c9=dN/dS\nand/or K N/KS) was used for evaluating the e\ufb00ect of natural\nselectionthroughoutthegene.Likewise,individualsites (codons)\nunder selection were identi\ufb01ed by calculating synonymous a nd\nnon-synonymous substitution rates per codon using SLAC,\nFEL, REL ( Kosakovsky Pond and Frost, 2005 ), MEME ( Murrell\net al., 2012 ) and FUBAR methods ( Murrell et al., 2013 ) in the\nDatamonkeyonlineserver( Delportetal.,2010 ).TheMcDonald-\nKreitman (MK) test ( McDonald and Kreitman, 1991 ) with\nJukes-Cantor correction was also used for evaluating neutrali ty\ndeviations by using the http://mkt.uab.es/mkt/MKT.asp web\nserver(Egeaetal.,2008 ).\nLineage-Speci\ufb01c Positive Selection\nLineages under episodic diversifying selection were assess ed for\neachgeneusingtherandome\ufb00ectslikelihood(REL)-branch-site\nmethod ( Kosakovsky Pond et al., 2011 ). Orthologous sequences\nfrom 13Plasmodium species were aligned using the MUSCLE\nalgorithm; this was then used for inferring the best evoluti onary\nmodel using JModelTest ( Posada, 2008 ). Phylogeny was then\ninferred using the Bayesian method ( Ronquist et al., 2012 )\nwith a corresponding evolutionary model; these were used as\nreferencewhenanalyzinglineage-speci\ufb01cpositiveselectionu sing\ntheHyPhypackage( Pondetal.,2005 ).CIPRESScienceGateway\n(Miller et al., 2010 ) web application was used for choosing the\nevolutionarymodelandBayesiananalysis.\nFrontiers in Genetics | www.frontiersin.org 3 January 2018 | Volume 9 | Article 10Garz\u00f3n-Ospina et al. Plasmodiumvivax Sporozoite Vaccine Candidates\nLinkage Disequilibrium and Recombination\nLinkage disequilibrium (LD) was assessed by using the Z nS\nestimator ( Kelly, 1997 ), followed by linear regression between\nLD and nucleotide distance to ascertain whether intra-gene\nrecombination could have taken place regarding any gene.\nRecombinationwasalsoevaluatedusingtheZZestimator( Rozas\net al., 2001 ), the minimum number of recombination events\n(Rm) (Hudson and Kaplan, 1985 ) and the GARD algorithm\n(KosakovskyPondetal.,2006 ).\nPredicting Proteins\u2019 Antigenic Potential\nA previous study has shown a correlation between predicting\npotential B-cell epitopes and antigenic protein regions in a\nP.vivaxantigen(Rodrigues-da-Silvaetal.,2017 ).Potentiallinear\nB-cell epitopes were therefore predicted by using the immune\nepitopedatabase(IEDB)server( KolaskarandTongaonkar,1990 )\nforeachprotein,usingSal-Ireferencesequencesasquery.\nRESULTS\nP.vivax Spz Loci inSilico Characterization\nThecurrentlyavailableinformationfortheSal-Istrainpub lished\nin PlasmoDB database was used as the source for obtaining\nsequences from Spz genes orthologous to those identi\ufb01ed as\nvaccinecandidatesin P.falciparum (Table1).Anorthologsearch\nin otherPlasmodium species showed that all genes (except for\nsiap2, which was only present in species infecting primates) had\nan ortholog in the Plasmodium species analyzed here. The Sal-I\nproteinsequenceforeachgenewastheninferredfromsearchi ng\nprotein features within them ( Figure1). A positive secretion\nsignal sequence was predicted for all antigens, except PvP36\n(6-Cys protein family member), PvSIAP2 (sporozoite invasion -\nassociated protein 2) and PvMCP1 (merozoite capping protein)\nproteins. In addition to signal peptide, a post-translational\nmodi\ufb01cation (consisting of a C-terminal GPI anchor sequenc e)\nwas predicted for PvP52 (6-Cys protein family member) and\nPvTRSP (thrombospondin-related sporozoite protein), whilst\nseveralproteinsseemedtohaveatransmembranehelix( Figure1\nandTable1); transmembrane helices were found at the N-\nterminal end in PvP36, PvPLP1 (perforin-like protein 1) and\nPvSIAP2. A signal peptide and transmembrane helix were\npredicted at the same position in PvPLP1. The transmembrane\nhelices in PvP36, PvPLP1 and PvSIAP2 could thus have resulte d\nfrom misidenti\ufb01cation and they could actually have been sign al\npeptidesequences.\nPvTRSP, PvTRAP (thrombospondin-related anonymous\nprotein) and PvTLP (thioredoxin-like protein) proteins, havi ng\na transmembrane region, also had a thrombospondin type\n1 putative domain, whilst PvTRAP and PvTLP had a von\nWillebrand factor type A putative domain. A membrane\nattack complex/perforin (MACPF) putative domain was\nfound in PvPLP1 and the AhpC/TSA domain in PvMCP1.\nA single sexual stage antigen s48/45 domain was predicted\nin PvP52 and PvP36. Both elongation factor Tu GTP\n(guanosine triphosphate)-binding domain and translation-\ninitiation factor 2 were predicted for PvMB2 ( Figure1 and\nTable1).Genetic Diversity at P.vivax-Sporozoite\nLoci\nSequences from di\ufb00erent regions worldwide were analyzed for\nquantifyingSpzantigengeneticdiversity( Table2);theseparasite\nantigens have limited genetic diversity ( \u03c0<0.003). According\nto the diversity parameters estimated here, pvtrap,pvsiap2and\npvceltos(cell traversal protein for ookinetes and sporozoites)\ngenes had the highest nucleotide and protein diversity value s\n(\u03c0>0.0015; \u03c1>0.0039);pvspect1(sporozoite protein essential\nfor cell traversal), pvplp1,pvspatr(secreted protein with altered\nthrombospondin repeat domain), pvtlp,pvsiap1, andpvmaebl\n(merozoite adhesive erythrocytic binding protein) genes fo rmed\npart of the most conserved genes/proteins ( \u03c0<0.0009; \u03c1<\n0.0020) (Table2). The haplotype number was low in most loci.\nHowever, pvtrap,pvsiap2,pvplp1,pvmcp1,pvtlp,andpvmb2were\ntheSpzlociwiththehighesthaplotypenumber.\nAssessing Neutral Evolution in\nP.vivax-Sporozoite Loci\nThe ENC and CBI parameters were evaluated to assess whether\ncodon bias had taken place in Spz genes. These parameters\ngave values higher than 47 for ENC and lower than 0.47\nfor CBI ( Table3). Tests based on polymorphism frequency\nspectrum were used with the 14 Spz P. vivaxgenes to assess any\ndeparture from neutral expectations. Six of these 14 genes had\nan overall negative statistically signi\ufb01cant value for at l east one\ntest (Table3), suggesting that natural selection could have been\nactingregardingthesegenes; pvp36andpvmb2geneshadspeci\ufb01c\nregions within each gene having a statistical signi\ufb01cant neg ative\nvalue(SupplementaryMaterial1).\nRegarding d N-dSrates, negative values were found for\npvmaebl,pvplp1, andpvmb2whilst positive values was observed\nfor thepvsiap2gene (Table3). When species divergence was\nassessed, there was evidence of inter-speci\ufb01c negative selec tion\nfor all genes, except trsp,siap2, andceltos; the sliding window\nfor\u03c9rate (Supplementary Material 2) gave values lower than 1\nforthesegenes.Likewise,codon-basedmethodsidenti\ufb01eds everal\ncodons under negative selection with few codons under positiv e\nselection. Many codons under negative selection were locat ed in\nregionsencodingputativedomains(e.g.,thrombospondintype 1\ndomain, Supplementary Material 2). It was found that siap1and\ntraploci had statistically signi\ufb01cant values higher than 1 when\npolymorphismanddivergencewerecomparedbyMKtest,whilst\navaluelowerthan1wasobservedfor maebl.\nLineage-Speci\ufb01c Positive Selection\nPlasmodium species orthologous sequences were used for\nconstructing phylogenies to assess whether positive natural\nselection had taken place during antigen evolutionary histo ry\n(SupplementaryMaterial3).Topologiesgavethreemonophyleti c\nclusters ( siap2did not, since it is only present in primate-\ninfecting parasites); the \ufb01rst involved monkey-malaria para sites,\nthe second clustered Plasmodium species infected rodents\nand the third was formed by hominid-malaria parasites. The\nlatter cluster and the rodent clade represent Plasmodium\nphylogenetic relationships. However, the monkey-malaria\nFrontiers in Genetics | www.frontiersin.org 4 January 2018 | Volume 9 | Article 10Garz\u00f3n-Ospina et al. Plasmodiumvivax Sporozoite Vaccine Candidates\nTABLE 1 | Insilicocharacterization of 14 P.vivaxsporozoite proteins.\nGene Signal peptide (position) Transm helix\n(position)GPI Domain (position) Location\nsiap1 Yes (1\u201322) No No \u2013 Secretory\np52 Yes (1\u201318) No C-ter Sexual stage antigen s48/45 domain (159\u20132 81) Secretory/membrane\np36 No Yes (10\u201332\nand 37\u201359)No Sexual stage antigen s48/45 domain (204\u2013332) Secretory/me mbrane\nspatr Yes (1\u201320) No No \u2013 Secretory\ntrsp Yes (1\u201318) Yes (131\u2013154) C-ter Thrombospondin type 1 domain (59\u2013105) Secretory/membrane\ntrap Yes (1\u201324) Yes (494\u2013515) No von Willebrand factor type A doma in (44\u2013225) and Thrombospondin\ntype 1 domain (241\u2013284)Secretory/membrane\nspect Yes (1\u201319) No No \u2013 Secretory\nsiap2 No Yes (7\u201328) No \u2013 Secretory\nmaebl Yes (1\u201319) Yes\n(1,799\u20131,816)No \u2013 Secretory/membrane\nplp1 Yes (1\u201323) Yes (7\u201326) No Membrane attack complex/perforin (M ACPF) (232\u2013581) Secretory\nmcp1 No No No AhpC/TSA family (9\u2013134) Non cytoplasmic\ntlp Yes (1\u201323) Yes\n(1,426\u20131,445)No Thrombospondin type 1 domain (264\u2013311) and von Willebran d factor\ntype A domain (334\u2013508)Secretory/membrane\nceltos Yes (1\u201335) No No \u2013 Non cytoplasmic\nmb2 Yes (1\u201322) No No Elongation factor Tu GTP binding domain (766 \u2013931) and\nTranslation-initiation factor 2 (1,151\u20131,263)Secretory\nThekeystructuresforapotentialvaccinecandidate(suchasasignalpepti de,atransmembranehelixorglycosylphosphatidylinositol(GPI)anchorand functionaldomains)weredescribed\nfromtheP.vivaxSal\u2013Istrainaasequence.Aprotein\u2019stypeofcellloca tionisalsoindicated.Thenumbersinbracketsindicatethepositionwhereadete rminedstructurewaspredicted.\nparasite topology had di\ufb00erent branch patterns regarding\nmalaria-species relationships which could have resulted fro m\npositive selection ( Sawai et al., 2010 ). Nine of these topologies\nhad lineages (branches) where some sites were under positive\nselection. Most branches having evidence of positive selecti on\nlead to a particular species, whilst few of them were ancestral\nlineages(SupplementaryMaterial3).\nLinkage Disequilibrium and Recombination\nLinkage disequilibrium (LD) at intra-gene level was assess ed\nby Zns estimator ( Table4). Non-random associations between\nSNPs were found for pvmaeblbut not for the remaining genes.\nHowever, there was a decreasing linear regression tendency\nbetween LD and nucleotide distance in all genes, suggesting\nrecombination action. Likewise, most of these genes had at l east\nonerecombinationevent(RM),whiletheZZestimatorjustgave\nstatistically signi\ufb01cant values for pvp52andpvspatr. The GARD\nalgorithm gave one recombination breakpoint for pv52,pvtrap,\npvplp1,pvtlp, andpvceltosand two recombination breakpoints\nforpvmb2(Table4).\nP.vivax-Spz Proteins\u2019 Antigenic Potential\nPreviousstudieshaveshownaB-epitopeandsolventaccessibi lity\npredictioncorrelationwithantigenicregionsinnaturalin fections\n(Rodrigues-da-Silva et al., 2017 ). The Sal-I sequences for each\nSpz protein studied here were thus analyzed by the BepiPred\nserver for determining their antigenic potential (Supplement ary\nMaterial 4). Large-sized proteins, such as MAEBL, TLP, TRAP,\nP52, and MCP1, had regions toward the C-terminal which\ncould be recognized as linear B-epitopes; these aa regions wer ethe regions having greater solvent accessibility (Supplemen tary\nMaterial 4). It was seen that the most exposed PLP1 region\nwas located toward the N-terminal. Smaller proteins, such as\nSPECT1, SPART, and SIAP1/2, did not seem to have clearly-\nde\ufb01ned recognition regions all along their sequences, whilst\n3 regions having antigen potential were observed for CelTOS\n(Supplementary Material 4). Many P36, TRSP, PLP1, MB2\nantigen sequences seemed to be exposed and several regions\nhavingpotentialB-epitopeswerefound.\nDISCUSSION\nA prospective Plasmodium vivax -malarial vaccine has been\ndelayed regarding P. falciparum ; however, knowledge acquired\nconcerningthelatterspeciescouldbeusefulfordesigningafu lly-\ne\ufb00ective anti- P. vivax vaccine. Vaccine development involves\nseveral challenges; for instance, high antigen diversity h as\nmadevaccinesnotfully-protectivesincepolymorphismprovokes\nallele-speci\ufb01c immune responses; genetic diversity is there fore\nan immune avoidance mechanism. Consequently, conserved\nantigens (or regions within them) should be used as vaccines\ncandidates to avoid this kind of response ( Richie and Saul, 2002;\nPatarroyoetal.,2012 ).Evenmore,justoneantigenmightnotbe\nenoughtoproducefullprotectionregardingaparticularvacci ne,\nso several antigens would be necessary. Since malaria parasi tes\nhave multiple stages, a fully-e\ufb00ective vaccine must have sever al\nconserved antigens (or regions containing them) from di\ufb00ere nt\nparasitestages.\nAntigen identi\ufb01cation is not an easy task due to P. vivax\nhaving a complex biology. Most antigens described to date\nFrontiers in Genetics | www.frontiersin.org 5 January 2018 | Volume 9 | Article 10Garz\u00f3n-Ospina et al. Plasmodiumvivax Sporozoite Vaccine Candidates\nFIGURE 1 | Schematic models for Plasmodiumvivax sporozoite antigen encoding genes and their predicted func tionally constrained regions. The 14 putative P.vivax\nsporozoite antigens were characterized insilico. Each antigen\u2019s predicted structure is shown in different c olors and the predicted regions under functional constrain t\n(highly conserved between species, having a \u03c9<1 and several negatively selected codons) are enclosed by a b lack dashed rectangle. In most cases, these regions\ncorrespond with regions having a putative domain. A region e ncoding a transmembrane helix was predicted for pvp36andpvsiap2at the 5\u2032-end, but this could have\nbeen a misleading prediction (i.e., it could actually have b een a signal peptide).\nTABLE 2 | Estimating 14 P.vivaxsporozoite genes\u2019 genetic diversity.\nn Gene Sites Ss S Ps H\nDNA\u03b8W(SD) \u03c0DNA(SD)\nAA\u03c1AA\n15 siap1 2,991 12 8 4 8 2.55 0.0012 (0.0005) 0.0008 (0.0002) 2.00 0.002 0\n86 p52 1,461 9 2 7 13 1.98 0.0012 (0.0012) 0.0014 (0.0001) 1.49 0.003 1\n102 p36 1,059 6 3 3 9 1.13 0.0011 (0.0005) 0.0011 (0.0001) 0.67 0.0019\n91 spatr 822 4 2 2 5 0.21 0.0009 (0.0005) 0.0003 (0.0001) 0.09 0.0003\n63 trsp 480 2 0 2 3 0.59 0.0009 (0.0006) 0.0012 (0.0002) 0.59 0.0037\n81 trap 1,668 28 9 19 20 5.11 0.0036 (0.0011) 0.0031 (0.0002) 3.91 0.0 070\n86 spect1 723 1 0 1 2 0.05 0.0003 (0.0003) 0.0001 (0.0000) 0.05 0.0002\n79 siap2 1,239 25 8 17 25 2.09 0.0041 (0.0013) 0.0017 (0.0002) 1.99 0.0 048\n12 maebl 5,598 25 22 3 6 5.15 0.0015 (0.0006) 0.0009 (0.0005) 2.49 0.00 13\n73 plp1 2,529 13 5 8 14 0.77 0.0011 (0.0004) 0.0003 (0.0001) 0.40 0.00 04\n92 mcp1 1,455 13 4 9 19 1.44 0.0020 (0.0007) 0.0009 (0.0001) 0.84 0.00 17\n57 tlp 4,308 25 11 14 16 2.45 0.0013 (0.0004) 0.0006 (0.0001) 1.68 0. 0012\n101 celtos 588 6 3 3 10 0.89 0.0020 (0.0009) 0.0015 (0.0002) 0.76 0.0039\n45 mb2 4,044 35 16 19 30 5.08 0.0020 (0.0006) 0.0012 (0.0001) 2.28 0. 0017\nThe genetic diversity estimators were calculated from a variable amou nt of sequences for each antigen. n: amount of sequences analyzed. Sites , total of sites analyzed, excluding\ngaps; Ss, amount ofsegregating sites; S, amount ofsingleton sites; Ps, amount ofinformative-parsimonious sites; H,amount ofhaplotypes;\nDNA, The average amount ofnucleotide\ndifferences; \u03b8w, Watterson estimator; \u03c0DNA, The average amount of nucleotide differences per site between two sequen ces;\nAA, The average amount of aa differences; \u03c1AA, The\naverageamountofaadifferencespersitebetweentwosequences;SD, standarddeviation.\nFrontiers in Genetics | www.frontiersin.org 6 January 2018 | Volume 9 | Article 10Garz\u00f3n-Ospina et al. Plasmodiumvivax Sporozoite Vaccine Candidates\nTABLE 3 | Neutrality and codon usage bias tests.\nGene Tajima Fu & Li Fay & Wu d N- dS(ES) K N- KS(ES) MKT ENC CBI\nD D F H NI\nsiap1 \u22121.20 \u22121.71 \u22121.84 \u22120.44 0.000 (0.000) \u22120.153 (0.010)\u2020\u202013.6\u2020\u202052.0 0.27\np52 0.27 1.29 0.94 \u22122.93* 0.000 (0.000) \u22120.023 (0.003)** 2.87 53.6 0.22\np36 \u22120.36 \u22121.80 \u22121.79 0.44 \u22120.001 (0.002) \u22120.023 (0.003)\u2020\u20203.82 54.2 0.23\nspatr \u22121.42 \u22121.47 \u22121.71 \u22120.22 \u22120.001 (0.001) \u22120.034 (0.005)\u2020\u20201,56 49.6 0.39\ntrsp 0.64 0.72 0.81 0.46 0.002 (0.001) \u22120.007 (0.005) Null 50.7 0.45\ntrap \u22120.48 \u22120.24 \u22120.36 \u221211.61** 0.002 (0.001) \u22120.014 (0.004)\u2020\u20206.46\u2020\u202055.8 0.20\nspect1 \u22120.91 0.50 0.09 0.04 0.000 (0.000) \u22120.014 (0.003)\u2020\u2020Null 47.5 0.29\nsiap2 \u22121.80* \u22120.75 \u22121.35 \u22122.07 0.002 (0.001)*** \u22120.003 (0.003) Null\u202047.5 0.36\nmaebl \u22121.68 \u22121.20 \u22121.64 \u221210.21** \u22120.001 (0.000)** \u22120.066 (0.007)\u2020\u20200.39\u202049.1 0.30\nplp1 \u22122.11* \u22120.78 \u22121.46 \u22123.16* \u22120.002 (0.001)* \u22120.033 (0.003)* 2.09 52.3 0.28\nmcp1 \u22121.19 \u22121.44 \u22121.64 0.57 \u22120.001 (0.001) \u22120.045 (0.005)\u2020\u20201.64 47.8 0.28\ntlp \u22121.76 \u22121.39 \u22121.95 \u22125.22** \u22120.0001 (0.000) \u22120.051 (0.004)\u2020\u20201.81 52.7 0.20\nceltos \u22120.80 \u22120.82 \u22120.87 \u22121.49 0.001 (0.001) \u22120.036 (0.0027) 6.36 53.8 0.35\nmb2 \u22121.31 \u22121.67 \u22121.84 \u22123.41 \u22120.001 (0.001)* \u22120.074 (0.004)\u2020\u20201.26 53.4 0.25\nSelectivepressureoneachgenewasinferredfromneutralitytests andestimatingeffectivecodonusage.Non-synonymoussubstitutionrate(d N)andsynonymoussubstitutionrate(d S)\nin P. vivax. Non-synonymous (K N) and synonymous (K S) divergence between P. vivax and the phylogenetically closest specie. N eutrality index (NI) estimated by McDonald-Kreitman\ntest,usingJukes-Cantorcorrection.Thepreferentialuseofthesyn onymouscodonswasevaluatedbyestimatingtheeffectiveamountofcodons(ENC) andthecodonbiasindex(CBI).\nGenesunderselectioninthetestshad *p<0.05,**p<0.01,\u2020p<0.03,***p<0.006,and\u2020\u2020p<0.0001.\nregarding this parasite have been from the blood stage; few\ngenes/proteins from others stages have been characterized.\nAlthough P.vivaxbiologycannotbeassesseddirectly,somenew\ntechnologies enable making inferences about it. Whole geno me\nsequencescouldbeusedtoinferthegenesinaparticularparas ite\nandthusgeneontologycouldprovidecluesaboutitsbiology.A t\nleast 15P. falciparum Spz stage proteins are involved in parasite\ninvasion and could thus become vaccine candidates. Since ma ny\ngenes are shared amongst Plasmodium species (Carlton et al.,\n2008), and several of them seem to be essential for parasite\nsurvival ( Bushell et al., 2017 ), orthologs to the 15 P. falciparum\nSpz antigens might be present in the P. vivax genome and\ncould thus be taken into account for vaccine development.\nFourteen of the 15 P. falciparum Spz genes found in P. vivax\nhad similar gene/protein structures, suggesting that they c ould\nbe involved in a conserved Plasmodium Spz invasion pathway.\nHowever, gene/protein identi\ufb01cation is the \ufb01rst step in vacc ine\ndesign. As P. vivaxgenetic diversity represents an even greater\nchallenge than in P. falciparum concerning vaccine design, the\nnext step in this work was to assess the genetic diversity of t hese\nSpz loci using available whole genome sequences to \ufb01nd out\nwhich of them could be promising vaccine candidates against\nP.vivax.\nP.vivax Spz Loci Genetic Diversity\nIt has been suggested that the P. vivaxgenome\u2019s large genetic\ndiversity would hinder P. vivax control and elimination.\nSeveralP. vivaxblood-stage antigens have been considered as\nvaccine candidates; however, they have high genetic divers ity\n(Putaporntip et al., 1997, 2010; Gomez et al., 2006; Dias et al. ,\n2011; Premaratne et al., 2011; Garz\u00f3n-Ospina et al., 2012,\n2014, 2015 ), representing one of the challenges to be overcomewhen designing a completely-e\ufb00ective anti-malarial vaccine.\nContrasting with the aforementioned antigens, the Spz loci\nanalyzed here had low genetic diversity ( \u03c0<0.003) which is\na desirable feature when designing a fully-e\ufb00ective antimal arial\nvaccine. Few segregating sites were found at each locus; some\nwere singleton sites. This could have resulted from genetic\ndi\ufb00erentiation amongst P. vivaxpopulations worldwide, as has\nbeen shown previously ( Taylor et al., 2013; Hupalo et al., 2016 ).\nNevertheless,fully-conservedregionswerealsoidenti\ufb01abl einall\nloci.TheobservedpolymorphisminSpzgeneswascomparableto\nthat found in the most of the conserved Mrz genes described to\ndate (Putaporntip et al., 2009; Garz\u00f3n-Ospina et al., 2010, 2011,\n2015; Pacheco et al., 2012; Chenet et al., 2013; Forero-Rodri guez\net al., 2014a,b; Buitrago et al., 2016 ) beingpvspect,pvspart,\npvsiap1,pvplp1, andpvtlpthe loci with the lowest diversity.\nThe most polymorphic gene was pvtrap; its diversity pattern has\npreviously been reported for the P. falciparum ortholog ( Ohashi\netal.,2014 ).\nEvolutionary Forces Modulating P.vivax\nSporozoite Diversity\nContrasting with Mrz proteins ( Putaporntip et al., 1997, 2010;\nGomez et al., 2006; Dias et al., 2011; Garz\u00f3n-Ospina et al.,\n2012, 2014, 2015 ), Spz antigens evaluated here displayed low\ndiversity. This could have resulted from various evolution ary\nforces. Taking into account that a low amount of synonymous\nand non-synonymous polymorphism was found, low diversity\ncouldhavebeenaconsequenceofcodonusagebias.ENCandCBI\nparameters were thus estimated for evaluating such hypothesi s.\nENC values close to 61 indicated that all synonymous codons\nfor each aa were used equitably (values close to 0 suggest bias\nor preferential codon use). CBI values range from 0, meaning\nFrontiers in Genetics | www.frontiersin.org 7 January 2018 | Volume 9 | Article 10Garz\u00f3n-Ospina et al. Plasmodiumvivax Sporozoite Vaccine Candidates\nTABLE 4 | LD and intra-gene recombination estimators.\nGene Zns ZZ RM GARD\nsiap1 0.12 \u22120.00 1 \u2013\np52 0.08 \u22120.06* 2 369\u2020\np36 0.01 \u22120.00 1 \u2013\nspatr 0.54 0.18* 0 \u2013\ntrsp 0.04 0.00 0 \u2013\ntrap 0.10 0.06 22 1,200\u2020\nspect1 \u2013 \u2013 \u2013 \u2013\nsiap2 0.03 \u22120.02 2 \u2013\nmaebl 0.73* 0.16 0 \u2013\nplp1 0.03 \u22120.01 2 1,275**\nmcp1 0.02 \u22120.02 2 \u2013\ntlp 0.08 0.12 2 2,551\u2020\nceltos 0.02 0.01 0 355\u2020\nmb2 0.04 0.04 7 1,368\u2020and 2,605\u2020\nGARD,recombinationbreakpointposition. *p<0.04,**p<0.005,\u2020p<0.001.\nuniform synonymous codon usage, to 1 (i.e., maximum codon\nbias) (Morton, 1993 ). Spz genes\u2019 ENC and CBI values suggested\nthat all of them had random synonymous codon usage. Such\nvalues were similar to those previously described for genes\nparticipating in Mrz invasion and the value reported for the\ncomplete genome ( Cornejo et al., 2014 ). This meant continuous\ntranscriptionrelatedtotheseproteins\u2019levelofexpressiond uring\ninvasion ( Gajbhiye et al., 2017; Uddin, 2017 ) which was not\na\ufb00ected by any type of selective pressure or preferential codon\nusage.ThelowgeneticdiversityfoundinSpzgeneswastheref ore\nnotaconsequenceofselectionattranslationlevelandthus other\nevolutionary forces must be causing low genetic diversity i n\nthesesantigens.\nTest of neutral molecular evolution (e.i. Tajima, Fu & Li,\nFay & Wu) gave negative values, just a few being statisticall y\nsigni\ufb01cant; the neutrality could not thus be ruled out in\nantigens lacking signi\ufb01cant values. Since these genes were\nhighly conserved, a functional/structural constraint was likely\n(Kimura, 1983; Graur et al., 2013 ). Although some genes had\nno statistically signi\ufb01cant values, some of them had speci\ufb01c\nregions where neutrality could be ruled out, suggesting tha t\nnegative selection was acting in such regions. Likewise, ge nes\nhaving an overall statistically signi\ufb01cant negative value in\nthese tests suggested that negative selection was responsib le\nfor low protein diversity and consequently functional/stru ctural\nconstrains would also be expected under this kind of selectio n.\nThis was con\ufb01rmed when non-synonymous and synonymous\nrates, as well as evolutionary rate ( \u03c9) sliding windows, were\ncomputed. Synonymous mutations seemed to \ufb01x at a higher\nrate than non-synonymous ones after speciation involving\nmonkey-malaria parasites; this thus agreed with a hypothesis of\nfunctional/structural constraint. Furthermore, several negative\nselectedsites(codons)werefound;manywerelocatedinputa tive\nfunctional domains, suggesting that negative selection is an\nimportantforceformaintainingproteindomainintegrity.Th eseregions had statistically signi\ufb01cant negative values in th e tests\nbased on polymorphism frequency spectrum (e.i. Tajima, Fu &\nLi, Fay & Wu). These patterns could thus be used to predict\nfunctionally important regions. A recent report regarding P.\nvivaxshowed that regions having low \u03c9rates having several\nnegatively selected sites are regions used by the parasite to\nrecognize host cells ( Baquero et al., 2017 ). Consequently, the\nregions from the 14 antigens considered here having low \u03c9\nrates and several codons under negative selection could be\nthose used to recognize hepatocytes. However, these regions\nmight not necessarily be involved in host-parasite interact ion\nand they could have other functions. However, they could be\ntaken into account for P. vivax vaccine development since\nthey had low diversity and were under functional/structura l\nconstraint. The aforementioned results could then also be used\nfor elucidating aspects of P. vivaxsporozoite invasion of target\ncells by assessing the domains having functional constraint in\ninvasionassays.\nFew positively selected sites were found; they could\nhave been \ufb01xed to adapt to di\ufb00erent selective pressures.\nMolecular adaptations could play an important role during\nparasite evolutionary history. Monkey-malaria clades divers ify\nthree to four times more rapidly than those infecting other\nmammalians ( Muehlenbein et al., 2015 ). Taking host species\u2019\nrapid diversi\ufb01cation into account ( Ziegler et al., 2007 ), adaptive\nradiation in monkey-malaria parasites could explain this\naccelerated cladogenesis and therefore several molecular\nadaptationscouldhavearisenduringsuchradiation.Phyloge nies\ninferred for Spz antigens showed that monkey-malaria parasit e\ntopology did not agree with malaria-species relationships whic h\ncould have resulted from positive selection ( Sawai et al., 2010 ).\nThere was evidence of selective sweep in \ufb01ve P. vivax genes;\nthis pattern has already been observed for some of these genes\nin previous studies ( Shen et al., 2017 ). Some mutations \ufb01xed\nin this parasite would thus allow it to adapt to a new host after\nhost-switchdecreasinggeneticdiversity.\nAdditionally, phylogenetically-based analysis could provide\ngreater insight into the role of selection (at these loci) du ring a\nparasite\u2019sevolutionaryhistoryifthiswastheresultofada ptations\nto new hosts and/or environments ( Muehlenbein et al., 2015 ).\nThere was evidence of episodic positive selection for nine of\nthese 14 antigens. Throughout phylogenies, several lineage s had\nsome sites under positive selection; however, few of them wer e\nancestral lineages. Since most branches under selection le ad to\nparticular species, episodic selection could have resulted fro m\nadaptation to di\ufb00erent host, for instance, to avoid immune\nresponse to a particular host during sympatric speciation or to\nrecognize a new host receptor. However, this behavior seems t o\nbe common in the Plasmodium genus and not just for monkey-\nmalariaparasites.\nRecombination is an evolutionary force which can increase\ngenetic diversity. It could be acting on Mrz blood-stage anti gens\nleading to new haplotypes to arise, being maintained in the\nparasite population to evade the host\u2019s immune responses\n(Garz\u00f3n-Ospina et al., 2012 ). Even though low genetic diversity\nwasobserved,someSpzgeneshadalargeamountofhaplotypes.\nNevertheless, larger-sized genes accumulated a greater am ount\nFrontiers in Genetics | www.frontiersin.org 8 January 2018 | Volume 9 | Article 10Garz\u00f3n-Ospina et al. Plasmodiumvivax Sporozoite Vaccine Candidates\nof single nucleotide polymorphisms in their sequences; these\ncharacteristics were not related to the amount of haplotypes.\nSome haplotypes could thus have arisen by recombination.\nEvidence of intra-gene recombination was found for pvp52,\npvplp1,pvtlp,pvceltos, andpvmb2genes. Recombination is thus\nanevolutionaryforceintheselociincreasinggeneticdive rsity.\nP.vivax Spz Antigens\u2019 Putative Roles\nThe mechanism by which these Spz proteins act in P. vivaxis\nnotcertain;however,theirpossiblerolecouldbeelucidate dfrom\nthem having putative domains. SPECT, PLP1, and TLP seem to\nbe essential in di\ufb00erent Plasmodium species for traversing host\ncells (Ishino et al., 2004; Yang et al., 2017a ) since deleting them\nhas reduced parasite capability to traverse the sinusoidal ba rrier\nand thus gain access to hepatocytes ( Ishino et al., 2004; Kaiser\netal.,2004 ).Nodescribeddomainswereidenti\ufb01edforPvSPECT\nand PvSPART and their role thus requires further investigat ion.\nNevertheless, orthologs to these proteins have been implicat ed\nin parasite interaction with epithelial or hepatic host cells i nP.\nfalciparum (Curtidoretal.,2011 ).Eventhoughputativeprotein-\nprotein interaction domains were not identi\ufb01ed, the regions\ninvolved in such interaction can be predicted regarding thei r\ndegreeofconservationbetweenspecies,ascantheirevoluti onary\nrates ( \u03c9) (Graur et al., 2013; Baquero et al., 2017 ). According to\nthe sliding window for the gene encoding to SPART in P. vivax,\ntheC-terminalregionseemedtobefunctionallyrestricted aslow\ngenetic diversity (intra- e inter-species) was observed, as well as\nlowerthan1 \u03c9rateandvarioussitesundernegativeselection(at\ninter-speci\ufb01clevel);thisregioncouldbeimplicatedininte raction\nwith hepatocytes. Additionally, PfSPART is antigenic in nat ural\ninfectionsandantibodiesagainstithaveblockedinteract ionwith\nhepatocytes in vitro(Palaeya et al., 2013 ). Similar to PfSPATR,\nPvSPATR has antigenic potential given the 4 regions along its\nsequence having high solvent accessibility values and poten tial\nlinear B-epitopes, suggesting that PvSPART is a promising\nantigenwhendesigningananti- P.vivaxvaccine.\nSimilar to the aforementioned antigens, particular domains\nwere not found in the whole PvSIAP1 sequence. Orthologs for\nthis protein in Plasmodium spp, are involved in Spz exit from\noocysts, as well as their colonization in a mosquito\u2019s saliv ary\nglands(Engelmannetal.,2009 ).SIAP1inavertebratehostseems\nto be mediated by pathogen-host interaction ( Curtidor et al.,\n2011).Thisprotein\u2019sorthologin P.vivaxhasbeenshowntohave\nlow diversity ( \u03c9<1) throughout its sequence, as well as several\nnegatively-selected sites. However, putative functional r egions\nhavenotbeenclearlyde\ufb01nedduetoalargeamountofsitesund er\npositive selection all along the sequence of the gene encodin g\nthis protein. Nevertheless, the C-terminal region was the re gion\nwhere most codons were found to be under negative selection\nand could thus be the region used for P. vivaxinteraction with a\nparticularhost.\nPLP1 is not required for entry to hepatocytes, but does play\nan important role in exit from transitory vacuoles during cel l\ntraversal ( Risco-Castillo et al., 2015 ). A putative MAC/perforin\ndomain was identi\ufb01ed in P. vivaxwhich had a high sequence\nconservation, several codons under negative selection and a\u03c9\n<1; this functionally restricted region could thus be mediat ingmembranedestabilizationandporeformationin P.vivax,ashas\nbeen suggested in other species ( Rosado et al., 2008; Patarroyo\netal.,2016;Yangetal.,2017a ).\nIt is well known that the TLP ( Moreira et al., 2008 ) and\nTRAP (Sultan et al., 1997 ) are essential for Spz gliding motility\n(Sultan et al., 1997 ).P. falciparum TLP is the most conserved\nmember of the TRAP/MIC2 family and the \ufb01rst to be seen to\nplay a role traversing cells ( Moreira et al., 2008 ).P. vivaxTLP\nwas one of the most conserved proteins of those evaluated here ;\ntheN-terminalregionwashighlyconservedwithinandamongs t\nspecies. Thrombospondin type 1 (TSP1) and von Willebrand\nfactor type A (vWa) domains were observed in this region.\nTheP. falciparum , TSP1 domain mediates glycosaminoglycan\nbinding whilst the vWa domain is involved in cell-cell, cell-\nmatrix, matrix-matrix interactions and includes a metal-i on\ndependent adhesion site. Proteins containing such domains\nmight be associated with parasite invasion ability ( Wengelnik\net al., 1999; Matuschewski et al., 2002; Mongui et al., 2010 ); the\nPvTLP N-terminal region could thus be mediating P. vivaxSpz\ninvasionofhepatocytes.\nUnlike a PvTLP, PvTRAP (having the same domains toward\nthe N-terminal region) was the protein having the greatest\ndiversityofthoseevaluatedhere.Thisgeneishighlypolymo rphic\ninP. falciparum and is under positive selection ( Ohashi et al.,\n2014); the region encoding the vWA domain is where pftrap\ndiversity is concentrated ( Moreira et al., 2008 ). Such pattern\nseems to be similar in P. vivaxand its related species; the sliding\nwindow for this gene showed that this region evolved rapidly,\nhaving several sites under positive selection amongst species .\nThis could have resulted from lineage-speci\ufb01c adaptations fo r\nthe recognition of particular receptors for each host or is the\ntargetregionforimmuneresponses,similartothatwhichocc urs\nin PvDBP ( VanBuskirk et al., 2004; Chootong et al., 2014 ). A\nprediction of B-epitopes and solvent accessibility showed tha t\nTRAP should have a potentially antigenic region toward the N-\nterminalwherethevWadomainwouldbelocated.However,the\nC-terminal region seemed to have greater antigenic potentia l.\nAccording to previous studies PvTRAP can induce an IgG1 and\nIgG3 response following natural infection; producing this type\nof antibody is usually correlated with protection against di sease\nin a hyper-endemic region ( Nazeri et al., 2017 ). This protein\nhasthusbeenproposedasbeinganimportantimmuneresponse\ntargetregardingpre-erythrocytestagesofmalariacausedb yboth\nP. falciparum andP. vivax(Ohashi et al., 2014 ). Nevertheless,\nthe diversity observed in this protein could produce allele-\nspeci\ufb01cimmuneresponsesandwouldthusnotbeagoodvaccine\ncandidate.\nUnlike TRAP and TLP, PvTRSP only has the TSP1 domain,\nthis protein is involved in P. berghei invasion where the deletion\nofpbtrspreduces mutant parasite capability to enter hepatocytes\n(Labaied et al., 2007a ). This gene was highly conserved in P.\nvivax; however, when the sequences from P. vivaxand related\nspecieswerecompared,theTSP1domainwasseentohavea \u03c9>\n1 and few sites under negative selection. On the other hand, t he\nC-terminalregionseemedtobethisprotein\u2019santigenicregi on.\nMAEBL has been described as being a type I membrane\nprotein in P. falciparum , having erythrocyte-binding activity\nFrontiers in Genetics | www.frontiersin.org 9 January 2018 | Volume 9 | Article 10Garz\u00f3n-Ospina et al. Plasmodiumvivax Sporozoite Vaccine Candidates\nand seeming to ful\ufb01ll a function similar to that of AMA1, given\nthe high sequence similarity ( Yang et al., 2017b ). This protein is\nnecessaryforSpzinvasionofamosquito\u2019ssalivaryglandsan dfor\nthemtotraversevertebratehostcells( Yangetal.,2017b ).MAEBL\nhas 4 tandem repeats in P. vivax, located toward the gene\u2019s 3\u2032\nregion, between positions 3,427 and 4,756. Each repeat has 90%\nsimilarity;9imperfectcopiesofGCTAGAAGGGCTGAGGAGT\nresidues, 3 copies of AGAAAGGCGGAAGAGGCA, 17\ncopies of GCAAGGAAGGCAGAGGATGCTAGAAAGGCAG\nAGGCGGCTA and 6 copies of GCTAAAAAGGCTGAA\nGCAGCAAGGAAGGCAGAGGCA residues were found. In\nspite of an accumulation of repeats being responsible for size\npolymorphism, they did not show such polymorphism when\nsequences from di\ufb00erent isolates were analyzed. Calculating\nthe omega rate between P. vivax isolates and related species\nrevealedthatsuchrepeatswerehighlyconservedin Plasmodium ,\nas has been suggested previously ( Leite et al., 2015 ). The fact\nthat this repeat region was found to be under negative selecti on\nsuggested an important role, similar to that already reported for\nCSP (Aldrich et al., 2012; Ferguson et al., 2014 ). A prediction\nof linear epitopes suggested that the C-terminal region where\nthese repeats were located could be antigenic. Even though th e\nrepeats have been suggested as targets distracting an immune\nresponse,thisisstillnotclearbecausetheyarehighlycons erved,\neven between species. Conversely, the maebl5\u2032-end was highly\ndivergent amongst species, having several sites under positi ve\nselection,possiblyresultingfromspecies-speci\ufb01cadaptatio ns.\nMB2(justlikeMAEBL)isoneofthelargestproteinsexpressed\ninPlasmodium spp Spz and is involved in hepatocyte invasion\n(Nguyen et al., 2009 ). It contains a characteristic GTP-binding\ndomain ( Nguyen et al., 2001; Romero et al., 2004 ), that is also\npresent in its P. vivax counterpart; in addition, a translation-\ninitiation factor domain was predicted for PvMB2. Both were\nfunctionally restricted, being conserved in P. vivax as well as\nbetween phylogenetically-related species. Even though it is not\nclear whether these domains are mediated by pathogen-host\ninteraction, they do seem to be important for this protein\u2019s\nfunction. This protein is antigenic in P. falciparum and has been\nrecognized by patients showing protection against Plasmodium\ninfection following experimental immunization ( Nguyen et al.,\n2009). The region so recognized is the N-terminal region, which\nhad antigenic potential in P. vivax, given its solvent accessibility\nand the prediction of B-linear epitopes. Given low PvMB2\ndiversity and its antigenic potential, it could also be taken into\naccountwhendesigningavaccineagainst P.vivax.\nMembers of the 6-cys family are expressed during di\ufb00erent\nPlasmodium spp. stages. Two members of this family (P36\nand P52) are expressed during the pre-erythrocyte stage and\nseem to play an important role in invasion ( Labaied et al.,\n2007b; Annoura et al., 2014; Kublin et al., 2017; Manzoni et a l.,\n2017). Like 6-Cys members expressed in P. vivaxMrz (Forero-\nRodriguezetal.,2014a,b ),pvp36andpvp52displayedlowgenetic\ndiversity, accompanied by low evolutionary rates. The s48/4 5\ndomains, characteristic of this family, seemed to be functi onally\nrestricted (limited diversity, \u03c9<1 and various sites under\nnegative selection) and thus might have been responsible for the\ninteraction between P. vivaxSpz and hepatocytes. The proteinsencoded by these genes also have antigenic potential; the PvP5 2\nC-terminal region seemed to be exposed, having potential linea r\nB-epitopes,whilstthePvP38centralregionandC-terminalco uld\nbe antigenic regions. Thus, the same as other 6-Cys family\nmembers ( Forero-Rodriguez et al., 2014a,b ), PvP36 and PvP52\nwouldseemtobepromisingantigenswhendesigningavaccine.\nIn addition to TRAP, SIAP2, and CELTOS were the antigens\nhavingthehighestdiversityvaluesamongstthoseevaluate dhere.\nTheseproteinsarepredominantlyexpressedduringtheSpzstage\nin other species where they cover parasite surface ( Siau et al.,\n2008). Unlike the other proteins evaluated here, SIAP2 only had\northologs in Plasmodium species infecting primates. This is a\npotential vaccine candidate as it seems to interact speci\ufb01cal ly\nwith heparin sulfate and chondroitin sulfate-type membrane\nreceptors( Siauetal.,2008;Albaetal.,2011 ).Potentialfunctional\nregions could not be de\ufb01ned for SIAP2 (like TRAP) since it had\nmany sites under positive selection amongst species througho ut\nits sequence. Predicted results regarding PvSIAP2 antigen icity\nsuggested that this could be exposed to the immune system,\nhaving various potential B-epitopes along its sequence. Its use\nas vaccine candidate is limited due to its diversity and the l arge\namountofhaplotypesfound.\nCelTOS has been considered a potential vaccine candidate\ngivenitsassociationwithclinicalprotectionregardingna turally-\nacquired immunity ( Kanoi et al., 2017 ). This protein has a sole\nspeci\ufb01cityforphosphatidicacid(alipidfoundpredominantlyon\nplasma membrane inner face) and breaks liposomes consisting\nof phosphatidic acid through pore formation. It has been shown\nthat parasites lacking CelTOS can enter target cells but remain\ntrapped inside. The foregoing supposes that CelTOS targets cell\nmembrane inner lea\ufb02et which can burst due to pore formation\ninside infected cells and favors parasite exit ( Kariu et al., 2006;\nJimah et al., 2016 ). Even though its function seems to be\nintracellular, predictive analysis suggested that PvCelTOS could\nbe exposed to the immune system, having potential B-epitopes\ntowardtheC-terminalregion.\nArecentstudyhasshownacorrelationbetweentheprediction\nand this protein\u2019s antigenic regions. Naturally-infected pa tients\ngenerate immune responses against PvCelTOS, predominantly\ntowardtheprotein\u2019sC-terminalregion( Rodrigues-da-Silvaetal.,\n2017), coinciding with the most exposed regions and having\npotential B-epitopes. This would suggest that PvCelTOS is a\npotential antigen for inclusion in a vaccine against P. vivax.\nThe antigenic region coincided with the gene\u2019s region where\nvarious sites under negative selection were found, suggest ing\nthat the CelTOS functional region could be located in the\nC-terminal region; however, some sites under positive inter-\nspecies selection were found toward this region. If this regi on\nis functionally restricted, but is also the region toward whi ch\nthe immune response is directed in di\ufb00erent species, then some\nsites could have been positively selected in a species-speci\ufb01c\nmanner \ufb01xing speci\ufb01c mutations in each species, resulting in a\npositive selection signal. In addition to its antigenic poten tial,\nPvCelTOS has been shown to have limited diversity within P.\nvivax. The gene encoding this protein in Iran had, on average,\nless than one mutation in paired comparisons ( Mehrizi et al.,\n2017);suchresultsweresimilartothosereportedhere.PvCelTOS\nFrontiers in Genetics | www.frontiersin.org 10 January 2018 | Volume 9 | Article 10Garz\u00f3n-Ospina et al. Plasmodiumvivax Sporozoite Vaccine Candidates\nmightthusbeconsideredavaccinecandidate,givenitsanti genic\ncharacteristicsandlimiteddiversity.\nCONCLUSIONS\nDesigning a completely e\ufb00ective vaccine against P. vivaxmust\nincludeantigensorhighlyconservedregionscontainingth emto\nabolishallele-speci\ufb01cimmuneresponses;antigensfromdi\ufb00er ent\nstages must also be included. As most research has been focus ed\non the blood stage, new strategies must be implemented for\nidentifying potential vaccine candidates from other parasit e\nstages. As genetic diversity is a characteristic to be born i n mind\nwhen designing a vaccine, the present work could be taken as a\nbasis for selecting Spz antigens which might become potential\nvaccinecandidates.\nP.vivaxgeneticdiversitywouldbeexpectedtobehighasithas\nbeen shown in whole genome analysis ( Neafsey et al., 2012 ) and\nin several Mrz antigens ( Gomez et al., 2006; Putaporntip et al.,\n2010; Dias et al., 2011; Premaratne et al., 2011; Garz\u00f3n-Ospi na\net al., 2012 ). However, this study\u2019s results showed that some Spz\nantigens had limited genetic diversity and, consequently, they\ncould be good vaccine candidates, since low genetic diversi ty\nis ideal for avoiding an allele-speci\ufb01c immune response. The\nanalysis described above enabled determining which region s in\nthese proteins could be functionally important. Recent studie s\nhave shown that regions predicted to have functional restric tion\ncoincide with regions used by the parasite to bind to a host\ncell (Baquero et al., 2017 ). Therefore, regions in Spz antigens\nwhich were conserved between species having low \u03c9values and\ncodons under negative selection in the parts of a protein might\nbe thus implicated in these antigens\u2019 function. This could he lp\nto elucidate aspects of P. vivax Spz invasion. Further assays\nregarding interaction with hepatocytes are thus required fo r\ndeterminingwhethersuchregionsareinvolvedinpathogen-h ost\ninteraction.\nPromising antigens to be taken into account for designing\na fully e\ufb00ective vaccine are those having a limited geneticdiversity or at least one domain with such pattern. These\ngenes or domains must have a negative selection signal, as\nwell as a \u03c9<1 (Garz\u00f3n-Ospina et al., 2015 ). Thus, the\nresults reported here suggest that the PvP52, PvP36, PvSPATR ,\nPvPLP1, PvMCP1, PvTLP, PvCelTOS, and PvMB2 antigens (or\nfunctionally restricted regions of them) are promising vacc ine\ncandidates and thus should be prioritized in future studies\naimed at developing a completely e\ufb00ective vaccine against\nP.vivax.\nAUTHOR CONTRIBUTIONS\nDG-O, SB, and AR acquired the genomic data and carried\nout the genetic diversity analyses. DG-O performed the gener al\ninterpretation of the data and together with SB and AR\nparticipated in writing the paper. MP coordinated the study and\nhelped to write the manuscript. All the authors have read and\napprovedthe\ufb01nalversionofthemanuscript.\nFUNDING\nThis work was \ufb01nanced by the Departamento Administrativo\nde Ciencia, Tecnolog\u00eda e Innovaci\u00f3n (COLCIENCIAS), throug h\ngrantRC#0309-2013.\nACKNOWLEDGMENTS\nWewouldliketothankJasonGarryfortranslatingandreview ing\nthemanuscriptandalsothanktheteaminchargeofupdatingthe\nPlasmoDB database for providing the genetic information fro m\nwhichthisworkwascarriedout.\nSUPPLEMENTARY MATERIAL\nThe Supplementary Material for this article can be found\nonline at: https://www.frontiersin.org/articles/10.338 9/fgene.\n2018.00010/full#supplementary-material\nREFERENCES\nAbascal,F.,Zardoya,R.,andTelford,M.J.(2010).TranslatorX:multi plealignment\nof nucleotide sequences guided by amino acid translations. Nucleic Acids Res.\n38,W7\u2013W13.doi:10.1093/nar/gkq291\nAdams,J.H.,andMueller,I.(2017).Thebiologyof plasmodiumvivax .ColdSpring\nHarb.Perspect.Med. 7,1\u201313.doi:10.1101/cshperspect.a025585\nAlba,M.P.,Almonacid,H.,Calder\u00f3n,D.,Chac\u00f3n,E.A.,Poloche,L.A .,Patarroyo,\nM. A., et al. (2011). 3D structure and immunogenicity of Plasmodium\nfalciparum sporozoite induced associated protein peptides as components of\nfully-protective anti-malarial vaccine. Biochem. Biophys. Res. Commun. 416,\n349\u2013355.doi:10.1016/j.bbrc.2011.11.039\nAldrich, C., Magini, A., Emiliani, C., Dottorini, T., Bistoni, F. , Crisanti, A., et al.\n(2012).Rolesoftheaminoterminalregionandrepeatregionofthe Plasmodium\nbergheicircumsporozoite protein in parasite infectivity. PLoS ONE 7:e32524.\ndoi:10.1371/journal.pone.0032524\nAnnoura, T., van Schaijk, B. C., Ploemen, I. H., Sajid, M., Lin, J. W., Vos,\nM. W., et al. (2014). Two Plasmodium 6-Cys family-related proteins hav e\ndistinct and critical roles in liver-stage development. FASEB J. 28, 2158\u20132170.\ndoi:10.1096/fj.13-241570Baquero, L. A., Moreno-P\u00e9rez, D. A., Garz\u00f3n-Ospina, D., Forero-Rod r\u00edguez, J.,\nOrtiz-Su\u00e1rez, H. D., and Patarroyo, M. A. (2017). PvGAMA reticulocy te\nbinding activity: predicting conserved functional regions by natural\nselection analysis. Parasit. Vectors 10:251. doi: 10.1186/s13071-017-\n2183-8\nBarry, A. E., and Arnott, A. (2014). Strategies for designing and monitoring\nmalaria vaccines targeting diverse antigens. Front. Immunol. 5:359.\ndoi:10.3389/\ufb01mmu.2014.00359\nBuitrago, S. P., Garz\u00f3n-Ospina, D., and Patarroyo, M. A. (2016). S ize\npolymorphism and low sequence diversity in the locus encoding the\nPlasmodium vivax rhoptry neck protein 4 (PvRON4) in Colombian isolates.\nMalar.J.15:501.doi:10.1186/s12936-016-1563-4\nBushell,E.,Gomes,A.R.,Sanderson,T.,Anar,B.,Girling,G.,Herd ,C.,etal.(2017).\nFunctionalpro\ufb01lingofaplasmodiumgenomerevealsanabundanceofess ential\ngenes.Cell170,260\u2013272e268.doi:10.1016/j.cell.2017.06.030\nCarlton, J. M., Adams, J. H., Silva, J. C., Bidwell, S. L., Lorenzi, H., C aler, E.,\net al. (2008). Comparative genomics of the neglected human malaria parasi te\nPlasmodiumvivax .Nature455,757\u2013763.doi:10.1038/nature07327\nCasillas,S.,andBarbadilla,A.(2017).Molecularpopulationgeneti cs.Genetics205,\n1003\u20131035.doi:10.1534/genetics.116.196493\nFrontiers in Genetics | www.frontiersin.org 11 January 2018 | Volume 9 | Article 10Garz\u00f3n-Ospina et al. Plasmodiumvivax Sporozoite Vaccine Candidates\nCastellanos, A., Ar\u00e9valo-Herrera, M., Restrepo, N., Gulloso, L., Corradin ,\nG., and Herrera, S. (2007). Plasmodium vivax thrombospondin\nrelated adhesion protein: immunogenicity and protective e\ufb03cacy in\nrodents and Aotus monkeys .Mem. Inst. Oswaldo Cruz 102, 411\u2013416.\ndoi:10.1590/S0074-02762007005000047\nChan, E. R., Menard, D., David, P. H., Ratsimbasoa, A., Kim, S., Ch im, P.,\net al. (2012). Whole genome sequencing of \ufb01eld isolates provides robu st\ncharacterizationofgeneticdiversityin Plasmodiumvivax .PLoSNegl.Trop.Dis.\n6:e1811.doi:10.1371/journal.pntd.0001811\nChaurio, R. A., Pacheco, M. A., Cornejo, O. E., Durrego, E., Stanle y, C. E. Jr.,\nCastillo, A. I., et al. (2016). Evolution of the transmission-block ing vaccine\ncandidates Pvs28 and Pvs25 in Plasmodium vivax : geographic di\ufb00erentiation\nand evidence of positive selection. PLoS Negl. Trop. Dis. 10:e0004786.\ndoi:10.1371/journal.pntd.0004786\nChenet, S. M., Pacheco, M. A., Bacon, D. J., Collins, W. E., Barnw ell, J.\nW., and Escalante, A. A. (2013). The evolution and diversity of a low\ncomplexity vaccine candidate, merozoite surface protein 9 (MSP-9) , in\nPlasmodium vivax and closely related species. Infect. Genet. Evol. 20, 239\u2013248.\ndoi:10.1016/j.meegid.2013.09.011\nChootong,P.,McHenry,A.M.,Ntumngia,F.B.,Sattabongkot,J. ,andAdams,J.H.\n(2014).TheassociationofDu\ufb00ybindingproteinregionIIpolymorphi smsand\nits antigenicity in Plasmodium vivax isolates from Thailand. Parasitol. Int. 63,\n858\u2013864.doi:10.1016/j.parint.2014.07.014\nCoatney, G.R., and National Institute of Allergy and Infectio us Diseases (U.S.)\n(1971).ThePrimateMalarias .Bethesda,MD:U.S.NationalInstituteofAllergy\nandInfectiousDiseases;forsalebytheSupt.ofDocs.,USGove rnmentPrinting\no\ufb00Washington.\nCornejo, O. E., Fisher, D., and Escalante, A. A. (2014). Genome- wide patterns\nof genetic polymorphism and signatures of selection in Plasmodium vivax .\nGenomeBiol.Evol. 7,106\u2013119.doi:10.1093/gbe/evu267\nCurtidor, H., Vanegas, M., Alba, M. P., and Patarroyo, M. E. (2011) . Functional,\nimmunological and three-dimensional analysis of chemically synthes ised\nsporozoite peptides as components of a fully-e\ufb00ective antimalarial vac cine.\nCurr.Med.Chem. 18,4470\u20134502.doi:10.2174/092986711797287575\nDelport, W., Poon, A. F., Frost, S. D., and Kosakovsky Pond, S. L. ( 2010).\nDatamonkey 2010: a suite of phylogenetic analysis tools for evolut ionary\nbiology.Bioinformatics 26,2455\u20132457.doi:10.1093/bioinformatics/btq429\nDias, S., Longacre, S., Escalante, A. A., and Udagama-Randeniya , P. V. (2011).\nGenetic diversity and recombination at the C-terminal fragment of the\nmerozoite surface protein-1 of Plasmodium vivax (PvMSP-1) in Sri Lanka.\nInfect.Genet.Evol. 11,145\u2013156.doi:10.1016/j.meegid.2010.09.007\nEdgar, R. C. (2004). MUSCLE: multiple sequence alignment with high\naccuracy and high throughput. Nucleic Acids Res. 32, 1792\u20131797.\ndoi:10.1093/nar/gkh340\nEgea, R., Casillas, S., and Barbadilla, A. (2008). Standard and ge neralized\nMcDonald-Kreitman test: a website to detect selection by comparing\ndi\ufb00erent classes of DNA sites. Nucleic Acids Res. 36, W157\u2013W162.\ndoi:10.1093/nar/gkn337\nEngelmann,S.,Silvie,O.,andMatuschewski,K.(2009).Disrupti onofPlasmodium\nsporozoitetransmissionbydepletionofsporozoiteinvasion-assoc iatedprotein\n1.EukaryoticCell 8,640\u2013648.doi:10.1128/EC.00347-08\nFankhauser, N., and M\u00e4ser, P. (2005). Identi\ufb01cation of GPI a nchor attachment\nsignals by a Kohonen self-organizing map. Bioinformatics 21, 1846\u20131852.\ndoi:10.1093/bioinformatics/bti299\nFay, J. C., and Wu, C. I. (2000). Hitchhiking under positive Darw inian selection.\nGenetics155,1405\u20131413.\nFerguson, D. J., Balaban, A. E., Patzewitz, E. M., Wall, R. J., Hopp, C. S., Poulin,\nB.,etal.(2014).Therepeatregionofthecircumsporozoiteproteinis criticalfor\nsporozoite formation and maturation in Plasmodium. PLoS ONE 9:e113923.\ndoi:10.1371/journal.pone.0113923\nForero-Rodr\u00edguez, J., Garz\u00f3n-Ospina, D., and Patarroyo, M. A. (201 4a). Low\ngenetic diversity and functional constraint in loci encoding Plasmodium\nvivaxP12 and P38 proteins in the Colombian population. Malar. J. 13:58.\ndoi:10.1186/1475-2875-13-58\nForero-Rodr\u00edguez, J., Garzon-Ospina, D., and Patarroyo, M. A. (201 4b).\nLow genetic diversity in the locus encoding the Plasmodium vivax\nP41 protein in Colombia\u2019s parasite population. Malar. J. 13:388.\ndoi:10.1186/1475-2875-13-388Frevert, U. (2004). Sneaking in through the back entrance: the bio logy of malaria\nliverstages. TrendsParasitol. 20,417\u2013424.doi:10.1016/j.pt.2004.07.007\nFu,Y.X.,andLi,W.H.(1993).Statisticaltestsofneutralityof mutations. Genetics\n133,693\u2013709.\nGajbhiye, S., Patra, P. K., and Yadav, M. K. (2017). New insigh ts into the factors\na\ufb00ecting synonymous codon usage in human infecting Plasmodium s pecies.\nActaTrop. 176,29\u201333.doi:10.1016/j.actatropica.2017.07.025\nGarz\u00f3n-Ospina, D., Forero-Rodr\u00edguez, J., and Patarroyo, M. A. (201 4).\nHeterogeneous genetic diversity pattern in Plasmodium vivax genes encoding\nmerozoite surface proteins (MSP)-7E, -7F and -7L.. Malar. J. 13:495.\ndoi:10.1186/1475-2875-13-495\nGarz\u00f3n-Ospina, D., Forero-Rodr\u00edguez, J., and Patarroyo, M. A. (201 5). Inferring\nnatural selection signals in Plasmodium vivax -encoded proteins having\na potential role in merozoite invasion. Infect. Genet. Evol. 33, 182\u2013188.\ndoi:10.1016/j.meegid.2015.05.001\nGarz\u00f3n-Ospina, D., L\u00f3pez, C., Forero-Rodr\u00edguez, J., and Patarroyo, M. A. (2012).\nGenetic diversity and selection in three Plasmodium vivax merozoite surface\nprotein 7 (Pvmsp-7) genes in a Colombian population. PLoS ONE 7:e45962.\ndoi:10.1371/journal.pone.0045962\nGarz\u00f3n-Ospina, D., Romero-Murillo, L., and Patarroyo, M. A. (2010). L imited\ngeneticpolymorphism ofthe Plasmodium vivax lowmolecular weightrhoptry\nproteincomplexintheColombianpopulation. Infect.Genet.Evol. 10,261\u2013267.\ndoi:10.1016/j.meegid.2009.12.004\nGarzon-Ospina, D., Romero-Murillo, L., T\u00f3bon, L. F., and Patarroyo, M . A.\n(2011). Low genetic polymorphism of merozoite surface proteins 7 and 1 0\nin Colombian Plasmodium vivax isolates.Infect. Genet. Evol. 11, 528\u2013531.\ndoi:10.1016/j.meegid.2010.12.002\nGomez, A., Suarez, C. F., Martinez, P., Saravia, C., and Patarroyo, M. A. (2006).\nHighpolymorphismin Plasmodiumvivax merozoitesurfaceprotein-5(MSP5).\nParasitology 133(Pt6),661\u2013672.doi:10.1017/S0031182006001168\nGraur, D., Zheng, Y., Price, N., Azevedo, R. B., Zufall, R. A., and Elhaik, E.\n(2013).Ontheimmortalityoftelevisionsets:\u201cfunction\u201dintheh umangenome\naccording to the evolution-free gospel of ENCODE. Genome Biol. Evol. 5,\n578\u2013590.doi:10.1093/gbe/evt028\nHester, J., Chan, E. R., Menard, D., Mercereau-Puijalon, O., Barn well, J.,\nZimmerman, P. A., et al. (2013). De novo assembly of a \ufb01eld isolate genome\nreveals novel Plasmodium vivax erythrocyte invasion genes. PLoS Negl. Trop.\nDis.7:e2569.doi:10.1371/journal.pntd.0002569\nHudson, R. R., and Kaplan, N. L. (1985). Statistical properties of th e number of\nrecombination events in the history of a sample of DNA sequences. Genetics\n111,147\u2013164.\nHulden, L. (2011). Activation of the hypnozoite: a part of Plasmodium vivax life\ncycleandsurvival. Malar.J.10:90.doi:10.1186/1475-2875-10-90\nHupalo, D. N., Luo, Z., Melnikov, A., Sutton, P. L., Rogov, P., Esc alante,\nA., et al. (2016). Population genomics studies identify signatu res of global\ndispersal and drug resistance in Plasmodium vivax .Nat. Genet. 48, 953\u2013958.\ndoi:10.1038/ng.3588\nIshino, T., Yano, K., Chinzei, Y., and Yuda, M. (2004). Cell-pas sage activity is\nrequired for the malarial parasite to cross the liver sinusoidal cell lay er.PLoS\nBiol.2:e4.doi:10.1371/journal.pbio.0020004\nJimah, J. R., Salinas, N. D., Sala-Rabanal, M., Jones, N. G., Sible y, L. D.,\nNichols, C. G., et al. (2016). Malaria parasite CelTOS targets the in ner\nlea\ufb02et of cell membranes for pore-dependent disruption. Elife5:e20621.\ndoi:10.7554/eLife.20621\nJukes, T. H., and Cantor, C. R. (1969). \u201cEvolution of protein molecu les,\u201d in\nMammalian Protein Metabolism , ed H. N. Munro (New York, NY: Academic\nPress),21\u2013132.\nKall, L., Krogh, A., and Sonnhammer, E. L. (2007). Advantages of co mbined\ntransmembrane topology and signal peptide prediction\u2013the Phobius\nweb server. Nucleic Acids Res. 35, W429\u2013W432. doi: 10.1093/nar/\ngkm256\nKaiser, K., Camargo, N., Coppens, I., Morrisey, J. M., Vaidya, A. B ., and\nKappe, S. H. I. (2004). A member of a conserved Plasmodium protein family\nwith membrane-attack complex/perforin (MACPF)-like domains localizes\nto the micronemes of sporozoites. Mol. Biochem. Parasitol. 133, 15\u201326.\ndoi:10.1016/j.molbiopara.2003.08.009\nKanoi, B. N., Takashima, E., Morita, M., White, M. T., Palacpac, N . M., Ntege, E.\nH., et al. (2017). Antibody pro\ufb01les to wheat germ cell-free system synt hesized\nFrontiers in Genetics | www.frontiersin.org 12 January 2018 | Volume 9 | Article 10Garz\u00f3n-Ospina et al. Plasmodiumvivax Sporozoite Vaccine Candidates\nPlasmodium falciparum proteins correlate with protection from symptomatic\nmalariainUganda. Vaccine35,873\u2013881.doi:10.1016/j.vaccine.2017.01.001\nKariu, T., Ishino, T., Yano, K., Chinzei, Y., and Yuda, M. (200 6). CelTOS, a novel\nmalarial protein that mediates transmission to mosquito and vertebrate hosts.\nMol.Microbiol. 59,1369\u20131379.doi:10.1111/j.1365-2958.2005.05024.x\nKelly, J. K. (1997). A test of neutrality based on interlocus associ ations.Genetics\n146,1197\u20131206.\nKimura, M. (1983). The Neutral Theory of Molecular Evolution. Cambridge; New\nYork:CambridgeUniversityPress.doi:10.1017/CBO97805116234 86\nKolaskar, A. S., and Tongaonkar, P. C. (1990). A semi-empirical met hod for\nprediction of antigenic determinants on protein antigens. FEBS Lett. 276,\n172\u2013174.doi:10.1016/0014-5793(90)80535-Q\nKosakovsky Pond, S. L., and Frost, S. D. (2005). Not so di\ufb00erent after all: a\ncomparison of methods for detecting amino acid sites under selecti on.Mol.\nBiol.Evol. 22,1208\u20131222.doi:10.1093/molbev/msi105\nKosakovsky Pond, S. L., Murrell, B., Fourment, M., Frost, S. D., Delport ,\nW., and Sche\ufb04er, K. (2011). A random e\ufb00ects branch-site model for\ndetecting episodic diversifying selection. Mol. Biol. Evol. 28, 3033\u20133043.\ndoi:10.1093/molbev/msr125\nKosakovsky Pond, S. L., Posada, D., Gravenor, M. B., Woelk, C. H. , and Frost, S.\nD.(2006).Automatedphylogeneticdetectionofrecombinationus ingagenetic\nalgorithm. Mol.Biol.Evol. 23,1891\u20131901.doi:10.1093/molbev/msl051\nKublin,J.G.,Mikolajczak,S.A.,Sack,B.K.,Fishbaugher,M. E.,Seilie,A.,Shelton,\nL., et al. (2017). Complete attenuation of genetically engineered Plasmodium\nfalciparum sporozoites in human subjects. Sci. Transl. Med. 9:eaad9099.\ndoi:10.1126/scitranslmed.aad9099\nLabaied, M., Camargo, N., and Kappe, S. H. (2007a). Depletion of the\nPlasmodium berghei thrombospondin-related sporozoite protein reveals a\nrole in host cell entry by sporozoites. Mol. Biochem. Parasitol. 153, 158\u2013166.\ndoi:10.1016/j.molbiopara.2007.03.001\nLabaied,M.,Harupa,A.,Dumpit,R.F.,Coppens,I.,Mikolajczak,S. A.,andKappe,\nS. H. (2007b). Plasmodium yoelii sporozoites with simultaneous delet ion of\nP52 and P36 are completely attenuated and confer sterile immunity agai nst\ninfection. Infect.Immun. 75,3758\u20133768.doi:10.1128/IAI.00225-07\nLeite, J. A., Bargieri, D. Y., Carvalho, B. O., Albrecht, L., Lopes , S. C., Kayano,\nA. C., et al. (2015). Immunization with the MAEBL M2 domain protects\nagainst lethal plasmodium yoelii infection. Infect. Immun. 83, 3781\u20133792.\ndoi:10.1128/IAI.00262-15\nLibrado, P., and Rozas, J. (2009). DnaSP v5: a software for compreh ensive\nanalysis of DNA polymorphism data. Bioinformatics 25, 1451\u20131452.\ndoi:10.1093/bioinformatics/btp187\nManzoni, G., Marinach, C., Top\u00e7u, S., Briquet, S., Grand, M., Tolle , M., et al.\n(2017).PlasmodiumP36determineshostcellreceptorusageduringspo rozoite\ninvasion. Elife6.doi:10.7554/eLife.25903\nMatuschewski, K., Nunes, A. C., Nussenzweig, V., and M\u00e9nard, R. (2002).\nPlasmodium sporozoite invasion into insect and mammalian cells is\ndirected by the same dual binding system. EMBO J. 21, 1597\u20131606.\ndoi:10.1093/emboj/21.7.1597\nMcDonald,J.H.,andKreitman,M.(1991).Adaptiveproteinevolution attheAdh\nlocusinDrosophila. Nature351,652\u2013654.doi:10.1038/351652a0\nMehrizi, A. A., Torabi, F., Zakeri, S., and Djadid, N. D. (2017). Limited\ngenetic diversity in the global Plasmodium vivax Cell traversal protein\nof Ookinetes and Sporozoites (CelTOS) sequences; implications fo r\nPvCelTOS-based vaccine development. Infect. Genet. Evol. 53, 239\u2013247.\ndoi:10.1016/j.meegid.2017.06.005\nM\u00e9nard, R. (2001). Gliding motility and cell invasion by Apicomplexa:\ninsights from the Plasmodium sporozoite. Cell. Microbiol. 3, 63\u201373.\ndoi:10.1046/j.1462-5822.2001.00097.x\nMiller, M. A., Pfei\ufb00er, W., and Schwartz, T. (2010). \u201cCreating th e CIPRES science\ngateway for inference of large phylogenetic trees,\u201d in Gateway Computing\nEnvironmentsWorkshop(GCE) (NewOrleans,LA:IEEE),1\u20138.\nMongui,A.,Angel,D.I.,Moreno-Perez,D.A.,Villarreal-Gonzalez,S .,Almonacid,\nH., Vanegas, M., et al. (2010). Identi\ufb01cation and characterizat ion of the\nPlasmodiumvivax thrombospondin-relatedapicalmerozoiteprotein. Malar.J.\n9:283.doi:10.1186/1475-2875-9-283\nMoreira,C.K.,Templeton,T.J.,Lavazec,C.,Hayward,R.E.,Hobbs, C.V.,Kroeze,\nH., et al. (2008). The plasmodium TRAP/MIC2 family member, TRAP-LikeProtein(TLP),isinvolvedintissuetraversalbysporozoites. Cell.Microbiol. 10,\n1505\u20131516.doi:10.1111/j.1462-5822.2008.01143.x\nMorton, B. R. (1993). Chloroplast DNA codon use: evidence for selec tion at\nthe psb A locus based on tRNA availability. J. Mol. Evol. 37, 273\u2013280.\ndoi:10.1007/BF00175504\nMuehlenbein, M. P., Pacheco, M. A., Taylor, J. E., Prall, S. P., Ambu , L., Nathan,\nS., et al. (2015). Accelerated diversi\ufb01cation of nonhuman primate ma larias in\nSoutheastAsia:adaptiveradiationorgeographicspeciation? Mol.Biol.Evol. 32,\n422\u2013439.doi:10.1093/molbev/msu310\nMueller, I., Shakri, A. R., and Chitnis, C. E. (2015). Development o f\nvaccines for Plasmodium vivax malaria. Vaccine 33, 7489\u20137495.\ndoi:10.1016/j.vaccine.2015.09.060\nMurrell, B., Moola, S., Mabona, A., Weighill, T., Sheward, D., Kosako vsky Pond,\nS. L., et al. (2013). FUBAR: a fast, unconstrained bayesian approxi mation\nfor inferring selection. Mol. Biol. Evol. 30, 1196\u20131205. doi: 10.1093/molbev/\nmst030\nMurrell, B., Wertheim, J. O., Moola, S., Weighill, T., Sche\ufb04er, K., and\nKosakovsky Pond, S. L. (2012). Detecting individual sites s ubject to episodic\ndiversifying selection. PLoS Genet. 8:e1002764. doi: 10.1371/journal.pgen.10\n02764\nNazeri, S., Zakeri, S., Mehrizi, A. A., and Djadid, N. D. (2017). Naturally acquired\nimmune responses to thrombospondin-related adhesion protein (TRAP) of\nPlasmodiumvivax inpatientsfromareasofunstablemalariatransmission. Acta\nTrop.173,45\u201354.doi:10.1016/j.actatropica.2017.05.026\nNeafsey, D. E., Galinsky, K., Jiang, R. H., Young, L., Sykes, S. M., Saif,\nS., et al. (2012). The malaria parasite Plasmodium vivax exhibits greater\ngenetic diversity than Plasmodium falciparum .Nat. Genet. 44, 1046\u20131050.\ndoi:10.1038/ng.2373\nNguyen, T. V., Fujioka, H., Kang, A. S., Rogers, W. O., Fidock, D. A., and James,\nA. A. (2001). Stage-dependent localization of a novel gene produc t of the\nmalaria parasite, Plasmodium falciparum .J. Biol. Chem. 276, 26724\u201326731.\ndoi:10.1074/jbc.M103375200\nNguyen, T. V., Sacci, J. B. Jr., de la Vega, P., John, C. C., James, A. A., and Kang,\nA.S.(2009).CharacterizationofimmunoglobulinGantibodiesto Plasmodium\nfalciparum sporozoite surface antigen MB2 in malaria exposed individuals.\nMalar.J.8:235.doi:10.1186/1475-2875-8-235\nNielsen, H. (2017). Predicting secretory proteins with signalP. Methods Mol. Biol.\n1611,59\u201373.doi:10.1007/978-1-4939-7015-5_6\nNovembre, J. A. (2002). Accounting for background nucleotide co mposition\nwhen measuring codon usage bias. Mol. Biol. Evol. 19, 1390\u20131394.\ndoi:10.1093/oxfordjournals.molbev.a004201\nOhashi, J., Suzuki, Y., Naka, I., Hananantachai, H., and Pata rapotikul, J.\n(2014).Diversifyingselectiononthethrombospondin-relatedad hesiveprotein\n(TRAP) gene of Plasmodium falciparum in Thailand. PLoS ONE 9:e90522.\ndoi:10.1371/journal.pone.0090522\nPacheco,M.A.,Elango,A.P.,Rahman,A.A.,Fisher,D.,Collins, W.E.,Barnwell,\nJ.W.,etal.(2012).Evidenceofpurifyingselectiononmerozoites urfaceprotein\n8(MSP8)and10(MSP10)inPlasmodiumspp. Infect.Genet.Evol. 12,978\u2013986.\ndoi:10.1016/j.meegid.2012.02.009\nPalaeya, V., Lau, Y. L., Mahmud, R., Chen, Y., and Fong, M. Y. (20 13). Cloning,\nexpression, and immunocharacterization of surface protein contain ing an\naltered thrombospondin repeat domain (SPATR) from Plasmodium knowlesi .\nMalar.J.12:182.doi:10.1186/1475-2875-12-182\nPatarroyo,M.A.,Calder\u00f3n,D.,andMoreno-P\u00e9rez,D.A.(2012).Vac cinesagainst\nPlasmodium vivax : a research challenge. Expert Rev. Vaccines 11, 1249\u20131260.\ndoi:10.1586/erv.12.91\nPatarroyo, M. E., Ar\u00e9valo-Pinz\u00f3n, G., Reyes, C., Moreno-Vranich, A., and\nPatarroyo, M. A. (2016). Malaria parasite survival depends on conse rved\nbindingpeptides\u2019criticalbiologicalfunctions. Curr.IssuesMol.Biol. 18,57\u201378.\ndoi:10.21775/cimb.018.057\nPierleoni, A., Martelli, P. L., Fariselli, P., and Casadio, R. (2006) . BaCelLo:\na balanced subcellular localization predictor. Bioinformatics 22, e408\u2013e416.\ndoi:10.1093/bioinformatics/btl222\nPond, S. L., Frost, S. D., and Muse, S. V. (2005). HyPhy: hypothes is testing using\nphylogenies. Bioinformatics 21,676\u2013679.doi:10.1093/bioinformatics/bti079\nPosada, D. (2008). jModelTest: phylogenetic model averaging. Mol. Biol. Evol. 25,\n1253\u20131256.doi:10.1093/molbev/msn083\nFrontiers in Genetics | www.frontiersin.org 13 January 2018 | Volume 9 | Article 10Garz\u00f3n-Ospina et al. Plasmodiumvivax Sporozoite Vaccine Candidates\nPremaratne, P. H., Aravinda, B. R., Escalante, A. A., and Udagama, P. V . (2011).\nGenetic diversity of Plasmodium vivax Du\ufb00y Binding Protein II (PvDBPII)\nunder unstable transmission and low intensity malaria in Sri Lanka. Infect.\nGenet.Evol. 11,1327\u20131339.doi:10.1016/j.meegid.2011.04.023\nPrice, R. N., Douglas, N. M., and Anstey, N. M. (2009). New develo pments in\nPlasmodiumvivax malaria:severediseaseandtheriseofchloroquineresistance.\nCurr.Opin.Infect.Dis. 22,430\u2013435.doi:10.1097/QCO.0b013e32832f14c1\nPutaporntip, C., Jongwutiwes, S., Ferreira, M. U., Kanbara, H., Udomsan gpetch,\nR., and Cui, L. (2009). Limited global diversity of the Plasmodium\nvivaxmerozoite surface protein 4 gene. Infect. Genet. Evol. 9, 821\u2013826.\ndoi:10.1016/j.meegid.2009.04.017\nPutaporntip, C., Jongwutiwes, S., Tanabe, K., and Thaithong, S . (1997).\nInterallelic recombination in the merozoite surface protein 1 (MSP-1) gene\nofPlasmodium vivax from Thai isolates. Mol. Biochem. Parasitol. 84, 49\u201356.\ndoi:10.1016/S0166-6851(96)02786-7\nPutaporntip, C., Udomsangpetch, R., Pattanawong, U., Cui, L., and J ongwutiwes,\nS. (2010). Genetic diversity of the Plasmodium vivax merozoite surface\nprotein-5 locus from diverse geographic origins. Gene456, 24\u201335.\ndoi:10.1016/j.gene.2010.02.007\nRich, S. M., and Ayala, F. J. (2003). Progress in malaria research:\nthe case for phylogenetics. Adv. Parasitol. 54, 255\u2013280.\ndoi:10.1016/S0065-308X(03)54005-2\nRichie, T. L., and Saul, A. (2002). Progress and challenges for malari a vaccines.\nNature415,694\u2013701.doi:10.1038/415694a\nRisco-Castillo, V., Top\u00e7u, S., Marinach, C., Manzoni, G., Bigor gne, A. E., Briquet,\nS., et al. (2015). Malaria Sporozoites Traverse Host Cells within Trans ient\nVacuoles. CellHostMicrobe 18,593\u2013603.doi:10.1016/j.chom.2015.10.006\nRodrigues-da-Silva,R.N.,Soares,I.F.,Lopez-Camacho,C.,Mart insdaSilva,J.H.,\nPerce-da-Silva, D. S., T\u00eava, A., et al. (2017). Plasmodium vivax cell-traversal\nprotein for ookinetes and sporozoites: naturally acquired humoral immun e\nresponse and B-cell epitope mapping in brazilian amazon inhabitants. Front.\nImmunol. 8:77.doi:10.3389/\ufb01mmu.2017.00077\nRomero, L. C., Nguyen, T. V., Deville, B., Ogunjumo, O., and James, A .\nA. (2004). The MB2 gene family of Plasmodium species has a unique\ncombination of S1 and GTP-binding domains. BMC Bioinformatics 5:83.\ndoi:10.1186/1471-2105-5-83\nRonquist, F., Teslenko, M., van der Mark, P., Ayres, D. L., Darling , A., H\u00f6hna,\nS., et al. (2012). MrBayes 3.2: e\ufb03cient Bayesian phylogenetic in ference\nand model choice across a large model space. Syst. Biol. 61, 539\u2013542.\ndoi:10.1093/sysbio/sys029\nRosado,C.J.,Kondos,S.,Bull,T.E.,Kuiper,M.J.,Law,R.H.,Bu ckle,A.M.,etal.\n(2008). The MACPF/CDC family of pore-forming toxins. Cell. Microbiol. 10,\n1765\u20131774.doi:10.1111/j.1462-5822.2008.01191.x\nRozas, J., Gullaud, M., Blandin, G., and Aguad\u00e9, M. (2001). DNA v ariation at\nthe rp49 gene region of Drosophila simulans : evolutionary inferences from an\nunusualhaplotypestructure. Genetics158,1147\u20131155.\nSawai,H.,Otani,H.,Arisue,N.,Palacpac,N.,deOliveiraMartins,L .,Pathirana,S.,\netal.(2010).Lineage-speci\ufb01cpositiveselectionatthemerozoit esurfaceprotein\n1(msp1)locusof Plasmodiumvivax andrelatedsimianmalariaparasites. BMC\nEvol.Biol. 10:52.doi:10.1186/1471-2148-10-52\nShen, H. M., Chen, S. B., Wang, Y., Xu, B., Abe, E. M., and Chen, J. H. (2017).\nGenome-wide scans for the identi\ufb01cation of Plasmodium vivax genes under\npositiveselection. Malar.J.16:238.doi:10.1186/s12936-017-1882-0\nSiau, A., Silvie, O., Franetich, J. F., Yalaoui, S., Marinach, C. , Hannoun, L.,\net al. (2008). Temperature shift and host cell contact up-regulate sporo zoite\nexpression of Plasmodium falciparum genes involved in hepatocyte infection.\nPLoSPathog. 4:e1000121.doi:10.1371/journal.ppat.1000121\nSonnhammer,E.L.,vonHeijne,G.,andKrogh,A.(1998).AhiddenM arkovmodel\nfor predicting transmembrane helices in protein sequences. Proc. Int. Conf.\nIntell.Syst.Mol.Biol. 6,175\u2013182.Sultan, A. A., Thathy, V., Frevert, U., Robson, K. J., Crisanti, A. ,\nNussenzweig, V., et al. (1997). TRAP is necessary for gliding\nmotility and infectivity of plasmodium sporozoites. Cell90, 511\u2013522.\ndoi:10.1016/S0092-8674(00)80511-5\nTajima,F.(1989).Statisticalmethodfortestingtheneutralmu tationhypothesisby\nDNApolymorphism. Genetics123,585\u2013595.\nTamura, K., Stecher, G., Peterson, D., Filipski, A., and Kumar, S. (2013). MEGA6:\nmolecular evolutionary genetics analysis version 6.0. Mol. Biol. Evol. 30,\n2725\u20132729.doi:10.1093/molbev/mst197\nTaylor, J. E., Pacheco, M. A., Bacon, D. J., Beg, M. A., Machado , R. L., Fairhurst,\nR. M., et al. (2013). The evolutionary history of Plasmodium vivax as inferred\nfrom mitochondrial genomes: parasite genetic diversity in the Ameri cas.Mol.\nBiol.Evol. 30,2050\u20132064.doi:10.1093/molbev/mst104\nUddin,A.(2017).Codonusagebias:atoolforunderstandingmo lecularevolution.\nJ.ProteomicsBioinform. 10:e32.doi:10.4172/jpb.1000e32\nVanBuskirk, K. M., Sevova, E., and Adams, J. H. (2004). Conserve d residues\nin thePlasmodium vivax Du\ufb00y-binding protein ligand domain are critical\nfor erythrocyte receptor recognition. Proc. Natl. Acad. Sci. U.S.A. 101,\n15754\u201315759.doi:10.1073/pnas.0405421101\nWeiss, G. E., Gilson, P. R., Taechalertpaisarn, T., Tham, W. H., de Jo ng,\nN. W., Harvey, K. L., et al. (2015). Revealing the sequence and\nresulting cellular morphology of receptor-ligand interactions during\nPlasmodium falciparum invasion of erythrocytes. PLoS Pathog. 11:e1004670.\ndoi:10.1371/journal.ppat.1004670\nWengelnik, K., Spaccapelo, R., Naitza, S., Robson, K. J., Janse, C. J., Bistoni,\nF., et al. (1999). The A-domain and the thrombospondin-related motif of\nPlasmodium falciparum TRAP are implicated in the invasion process of\nmosquito salivary glands. EMBO J. 18, 5195\u20135204. doi: 10.1093/emboj/18.\n19.5195\nWinter, D. J., Pacheco, M. A., Vallejo, A. F., Schwartz, R. S., Are valo-Herrera, M.,\nHerrera, S., et al. (2015). Whole genome sequencing of \ufb01eld isolates rev eals\nextensive genetic diversity in Plasmodium vivax from Colombia. PLoS Negl.\nTrop.Dis. 9:e0004252.doi:10.1371/journal.pntd.0004252\nYang,A.S.P.,O\u2019Neill,M.T.,Jennison,C.,Lopaticki,S.,Alliso n,C.C.,Armistead,\nJ. S., et al. (2017a). Cell traversal activity is important for Plasmodium\nfalciparum liver infection in humanized mice. Cell Rep. 18, 3105\u20133116.\ndoi:10.1016/j.celrep.2017.03.017\nYang, A. S. P., Lopaticki, S., O\u2019Neill, M. T., Erickson, S. M., Dou glas, D. N.,\nKneteman, N. M., et al. (2017b). AMA1 and MAEBL are important for\nPlasmodium falciparum sporozoite infection of the liver. Cell. Microbiol.\n19:e12745.doi:10.1111/cmi.12745\nZhang,J.,Rosenberg,H.F.,andNei,M.(1998).PositiveDarwi nianselectionafter\ngeneduplicationinprimateribonucleasegenes. Proc.Natl.Acad.Sci.U.S.A. 95,\n3708\u20133713.doi:10.1073/pnas.95.7.3708\nZiegler, T., Abegg, C., Meijaard, E., Perwitasari-Farajallah, D., Walter, L., Hodges,\nJ. K., et al. (2007). Molecular phylogeny and evolutionary history of Southeast\nAsian macaques forming the M. silenus group. Mol. Phylogenet. Evol . 42,\n807\u2013816.doi:10.1016/j.ympev.2006.11.015\nCon\ufb02ict of Interest Statement: The authors declare that the research was\nconducted in the absence of any commercial or \ufb01nancial relations hips that could\nbeconstruedasapotentialcon\ufb02ictofinterest.\nCopyright\u00a92018Garz\u00f3n-Ospina,Buitrago,RamosandPatarroyo.Th isisanopen-\naccess article distributed under the terms of the Creative C ommons Attribution\nLicense(CCBY).Theuse,distributionorreproductioninot herforumsispermitted,\nprovided the original author(s) or licensor are credited an d that the original\npublication in this journal is cited, in accordance with acc epted academic practice.\nNo use, distribution or reproduction is permitted which doe s not comply with these\nterms.\nFrontiers in Genetics | www.frontiersin.org 14 January 2018 | Volume 9 | Article 10fgene-09-00372 September 7, 2018 Time: 10:57 # 1\nORIGINAL RESEARCH\npublished: 10 September 2018\ndoi: 10.3389/fgene.2018.00372\nEdited by:\nMiguel Arenas,\nUniversity of Vigo, Spain\nReviewed by:\nEduardo Castro-Nallar,\nUniversidad Andr\u00e9s Bello, Chile\nEugenia Lo,\nUniversity of North Carolina\nat Charlotte, United States\nS. Noushin Emami,\nStockholm University, Sweden\n*Correspondence:\nManuel A. Patarroyo\nmapatarr.\ufb01dic@gmail.com\nSpecialty section:\nThis article was submitted to\nEvolutionary and Population Genetics,\na section of the journal\nFrontiers in Genetics\nReceived: 25 May 2018\nAccepted: 23 August 2018\nPublished: 10 September 2018\nCitation:\nCamargo-Ayala PA,\nGarz\u00f3n-Ospina D, Moreno-P\u00e9rez DA,\nRicaurte-Contreras LA, Noya O and\nPatarroyo MA (2018) On the Evolution\nand Function of Plasmodium vivax\nReticulocyte Binding Surface Antigen\n(pvrbsa). Front. Genet. 9:372.\ndoi: 10.3389/fgene.2018.00372\nOn the Evolution and Function of\nPlasmodium vivax Reticulocyte\nBinding Surface Antigen ( pvrbsa )\nPaola Andrea Camargo-Ayala1,2, Diego Garz\u00f3n-Ospina1,3,\nDarwin Andr\u00e9s Moreno-P\u00e9rez1,4, Laura Alejandra Ricaurte-Contreras1, Oscar Noya5and\nManuel A. Patarroyo1,6*\n1Department of Molecular Biology and Immunology, Fundaci\u00f3n Instituto de Inmunolog\u00eda de Colombia (FIDIC), Bogot\u00e1,\nColombia,2Microbiology Postgraduate Programme, Universidad Nacional de Colombia, Bogot\u00e1, Colombia,3PhD\nProgramme in Biomedical and Biological Sciences, Universidad del Rosario, Bogot\u00e1, Colombia,4Livestock Sciences\nFaculty, Universidad de Ciencias Aplicadas y Ambientales, Bogot\u00e1, Colombia,5Instituto de Medicina Tropical, Facultad\nde Medicina, Universidad Central de Venezuela, Caracas, Venezuela,6School of Medicine and Health Sciences, Universidad\ndel Rosario, Bogot\u00e1, Colombia\nThe RBSA protein is encoded by a gene described in Plasmodium species having\ntropism for reticulocytes. Since this protein is antigenic in natural infections and can\nbind to target cells, it has been proposed as a potential candidate for an anti-\nPlasmodium vivax vaccine. However, genetic diversity (a challenge which must be\novercome for ensuring fully effective vaccine design) has not been described at this\nlocus. Likewise, the minimum regions mediating speci\ufb01c parasite-host interaction have\nnot been determined. This is why the rbsa gene\u2019s evolutionary history is being here\ndescribed, as well as the P . vivax rbsa (pvrbsa ) genetic diversity and the speci\ufb01c regions\nmediating parasite adhesion to reticulocytes. Unlike what has previously been reported,\nrbsa was also present in several parasite species belonging to the monkey-malaria\nclade; paralogs were also found in Plasmodium parasites invading reticulocytes. The\npvrbsa locus had less diversity than other merozoite surface proteins where natural\nselection and recombination were the main evolutionary forces involved in causing\nthe observed polymorphism. The N-terminal end (PvRBSA-A) was conserved and\nunder functional constraint; consequently, it was expressed as recombinant protein for\nbinding assays. This protein fragment bound to reticulocytes whilst the C-terminus,\nincluded in recombinant PvRBSA-B (which was not under functional constraint), did\nnot. Interestingly, two PvRBSA-A-derived peptides were able to inhibit protein binding to\nreticulocytes. Speci\ufb01c conserved and functionally important peptides within PvRBSA-A\ncould thus be considered when designing a fully-effective vaccine against P . vivax .\nKeywords: Plasmodium vivax ,rbsa , genetic diversity, evolutionary forces, protein biding, parasite\u2013host\ninteraction, antimalarial vaccine\nAbbreviations: &, omega rate (d N/dSand/or K N/KS); BY , Bayesian method; Chr, chromosome; LD, linkage disequilibrium;\nLRR, leucine-rich region; ML, maximum likelihood; Mrz, merozoite; RBSA, reticulocyte binding surface antigen; rRBSA,\nrecombinant RBSA protein; WB, Western blot.\nFrontiers in Genetics | www.frontiersin.org 1 September 2018 | Volume 9 | Article 372fgene-09-00372 September 7, 2018 Time: 10:57 # 2\nCamargo-Ayala et al. Assessing pvrbsa Genetic Diversity\nINTRODUCTION\nPlasmodium vivax is a parasite which emerged in Asia (Escalante\net al., 2005; Carlton et al., 2013) (although an African origin is\nalso likely, Liu et al., 2014), involving a host-switch from monkeys\nto humans (Mu et al., 2005) around 1.3\u20132.9 million years ago\n(Pacheco et al., 2011), Plasmodium cynomolgi being the most\nphylogenetically related species (Mu et al., 2005; Pacheco et al.,\n2011; Tachibana et al., 2012). P. vivax then reached countries\non the 5 continents through human migration (Rodrigues et al.,\n2018), currently predominating in Asia and America (Guerra\net al., 2010; Gething et al., 2012). This species is considered the\nsecond most important human-malaria parasite worldwide, due\nto the morbidity it causes (WHO, 2017).\nPlasmodium vivax incidence has decreased since 2010. An\nestimated 6\u201311 million cases were attributed to this parasite in\n2016 (around 7 million less than in 2010) (WHO, 2017). Despite\nthat, the social and economic burden of malaria in endemic\ncountries (Suh et al., 2004) could still be huge. Even though\ncontrol measures against this parasite have been shown to be\nuseful, P. vivax elimination (and/or malarial elimination) is not\nan easy task. The most relevant challenges for eliminating malaria\nconcern the social and economic conditions of the places most\na\ufb00ected by this illness, the social and political con\ufb02icts in several\nendemic areas and the anomalous weather patterns (WHO,\n2017). These, together with the spread of insecticide-resistant\nmosquitoes and drug-resistant parasites, could bring about a\nrecurrence of this disease (Maxmen, 2012; Price et al., 2014;\nHuijben and Paaijmans, 2018). Consequently, new interventions\nmust be designed which can reduce the parasite reservoir,\nlimiting the time that a human (or mosquito) host is infectious\n(Barry and Arnott, 2014). This goal could be achieved by\ndeveloping a fully e\ufb00ective antimalarial vaccine which, together\nwith existing control measures, could contribute towards a\nmalaria-free world (Barry and Arnott, 2014; White et al., 2014).\nMalaria-related vaccine research and development e\ufb00orts were\nexclusively focused on Plasmodium falciparum for a long time\n(Galinski and Barnwell, 2008). During the last few decades,\nP. vivax research has been increased and more and more groups\nare studying approaches to an anti- P. vivax vaccine (Galinski\nand Barnwell, 2008; Chen et al., 2010; Valencia et al., 2011;\nThe malERA Consultative Group on Vaccines, 2011; Arnott\net al., 2012; Patarroyo et al., 2012; Nanda Kumar et al., 2016).\nInitial research was based on the knowledge acquired regarding\nP. falciparum (Patarroyo et al., 2012); however, given P. vivax \u2019s\nunique attributes (such as hypnozoite forms in the liver, invasion\npreference for reticulocytes or the rapid gametocyte formation)\n(Galinski et al., 2013) and since P. falciparum andP. vivax have\nhad di\ufb00erent evolutionary paths, research regarding P. vivax -\nexclusive antigens could be relevant. For instance, the Du\ufb00y\nantigen, which is not present in P. falciparum , is essential\nforP. vivax invasion (Chitnis and Miller, 1994). PvDBP-\nconserved epitopes can trigger strong neutralizing antibodies; it\nhas therefore been suggested as one of the main P. vivax vaccine\ncandidates (Chen et al., 2016; Ntumngia et al., 2017).\nOne antigen shared just by P. vivax andP. cynomolgi (both\nhaving reticulocyte predilection) has been characterized recently(Moreno-Perez et al., 2017). This antigen (named reticulocyte\nbinding surface antigen \u2013 RBSA) is encoded by a two-exon\ngene (Moreno-Perez et al., 2017) located on Chr 3. The protein\nproduct has a signal peptide and two transmembrane helices\nand is located on mature Mrz membrane. This protein seems to\nbe involved in Mrz invasion, since recombinant P. vivax RBSA\n(rPvRBSA) binds to a subpopulation of immature reticulocytes\nhaving a Du\ufb00y positive phenotype; it is also recognized by the\nhuman immune system in natural infections. It has thus been\nsuggested as a putative vaccine candidate for anti- P. vivax malaria\nvaccine development (Moreno-Perez et al., 2017).\nHowever, since parasite\u2019s high genetic diversity is one of\nthe challenges to be overcome during P. vivax vaccine design\n(Neafsey et al., 2012); the antigens\u2019 genetic diversity must\ntherefore be assessed (Arnott et al., 2012; Barry and Arnott, 2014)\nfor selecting those having limited polymorphism or the conserved\nfunctional regions within them (Richie and Saul, 2002). pvrbsa\ngenetic diversity has not been assessed to date and, although\nPvRBSA binds to reticulocytes (Moreno-Perez et al., 2017), the\nregions involved in Mrz-host speci\ufb01c interactions have not been\nestablished yet.\nPvRBSA is an Mrz membrane protein and is recognized by the\nhuman immune system in natural infection; it could therefore\nbe a highly polymorphic antigen. Nevertheless, functionally\nimportant parts of the protein (i.e., regions involved in\nhost-parasite interaction) should be functionally constrained,\nbeing maintained by negative selection as highly conserved\nwithin and between species (Graur et al., 2013; Garzon-\nOspina et al., 2015). Consequently, inferring this kind of\nselection on pvrbsa could be used to predict regions under\nfunctional constraint which then might be used as putative\nvaccine candidates. This study evaluated pvrbsa genetic diversity,\nassessed the evolutionary forces involved in causing the observed\npolymorphism and established minimum regions involved in\nprotein\u2013cell interaction.\nMATERIALS AND METHODS\nEthics Approval and Consent to\nParticipate\nAllP. vivax -infected patients who provided us with the blood\nsamples were informed about the purpose of the study and\nall gave their written consent. Regarding newborn umbilical\ncord blood samples, the progenitors signed an informed consent\nform after having received detailed information regarding the\nstudy\u2019s goals. All procedures carried out in this study were\napproved by the ethics committees of the Fundaci\u00f3n Instituto de\nInmunolog\u00eda de Colombia (IRB number: ACTA N\u000e037-CEEPA),\nthe Universidad del Rosario (IRB number: CEI-ABN026-\n0001061) and the Bioethics\u2019 committee from the Instituto de\nMedicina Tropical \u201cDr. F\u00e9lix Pifano\u201d at the Universidad Central\nde Venezuela (IRB number: CEC-IMT11/2018).\nParasite DNA\nOne hundred and sixty-seven peripheral blood samples and/or\nblood drops collected on FTA cards from patients proving\nFrontiers in Genetics | www.frontiersin.org 2 September 2018 | Volume 9 | Article 372fgene-09-00372 September 7, 2018 Time: 10:57 # 3\nCamargo-Ayala et al. Assessing pvrbsa Genetic Diversity\npositive for P. vivax malaria by microscope examination were\ncollected in di\ufb00erent Colombian (Choc\u00f3, n= 37, C\u00f3rdoba,\nn= 39, and Amazonas, n= 41) and Venezuelan (Bolivar, n= 29\nand Venezuela\u2019s coastal area, n= 19) endemic areas between\n2010 and 2016 ( Supplementary Figure S1 ). A Wizard Genomic\nDNA Puri\ufb01cation kit (Promega) was used for obtaining DNA\nfrom Choc\u00f3 and C\u00f3rdoba samples, following the manufacturer\u2019s\ninstructions. A Pure Link Genomic DNA mini kit (Invitrogen)\nwas used for extracting DNA from Amazon samples from each\ndrop of blood collected on the FTA cards, according to the\nmanufacturer\u2019s speci\ufb01cations whilst blood were extracted from\nVenezuelan samples by salting-out, following Welsh and Bunce\nmodi\ufb01cations (Welsh and Bunce, 1999). The recovered DNAs\nwere stored at\u000020\u000eC until use. All samples had a single P. vivax\nmsp3 allele, suggesting that these samples came from single\nP. vivax infection.\nIdentifying the rbsa Gene in Plasmodium\nMonkey Lineage\nA Blast search (using the 1,506 bp from Sal-I- P. vivax rbsa gene\nsequence as query) was carried out using available whole genome\nsequences from P. cynomolgi (GenBank accession number:\nGCA_000321355.1), P. inui (GenBank accession number:\nGCA_000524495.1), P. knowlesi (GenBank accession number:\nGCA_000006355.1), P. coatneyi (GenBank accession number:\nGCA_000725905.1) and P. fragile (GenBank accession number:\nGCA_000956335.1) to identify orthologous in these Plasmodium\nspecies. The MUSCLE method (Edgar, 2004) was used for\naligning the recovering contigs having high identity sequences\n(>60). The best model for DNA substitutions was then selected\nusing the JModelTest v.2.1.3 (Posada, 2008) with the Akaike\u2019s\ninformation criterion and MEGA v.6 software (Tamura et al.,\n2013). Phylogenetic trees were inferred through ML and Bayesian\n(BY) methods, using the GTR and/or the TVM models (selected\nas the best models). MEGA v.6 software was used for ML analysis\nand topology reliability was evaluated by bootstrap, using 1,000\niterations. Bayesian phylogenetic analysis was conducted with\nMrBayes v.3.2 software (Ronquist et al., 2012) and the analysis\nwas run until reaching a lower than 0.01 standard deviation\nof split frequencies value; sump and sumt commands were\nthen used for tabulating posterior probabilities and building a\nconsensus tree.\nPCR Ampli\ufb01cation and Sequencing\nOne hundred and sixty-seven parasite DNAs from endemic\nColombian ( n= 117) and Venezuelan ( n= 50) regions were\nused for amplifying the pvrbsa locus by nested-PCR, as follows.\nThe \ufb01rst reaction involved 3.3 mL of ultrapure water, 5.4 mL\nof KAPA HiFi HotStart Readymix, 0.3 mM of each primer\n(rbsafwd : 50-TTTATTTCATTTTGACGTTGTAACTTG-30and\nrbsarev : 50-TTAAGAAATGATCCCAACTCG-30) and 1 mL of\nDNA. The PCR was carried out as follows: one 5 min step at\n95\u000eC, a second 35 cycle step for 20 s at 98\u000eC, 15 s at 57\u000eC and\n45 s at 72\u000eC, followed by a \ufb01nal step of 10 min at 72\u000eC. Two\nmL of the \ufb01rst PCR product were added to the second PCR\nreaction containing 7.5 mL of ultrapure water, 12.5 mL of KAPAHiFi HotStart Readymix and 0.3 mM of each primer ( rbsa2fwd :\n50-GAAATACAAGATGAAAGGAATAATG-30and rbsa2rev :\n50-GATCCCAACTCGGTTTATC-30). The thermal conditions\nwere the same as those used in the \ufb01rst PCR reaction. PvRBSA\nfragments towards the amino and carboxyl (PvRBSA-A and\nPvRBSA-B, respectively) encoding regions were ampli\ufb01ed using\nKAPA-HiFi HotStart Readymix (KAPA Biosystems) and the\ngenomic DNA previously extracted from the Vivax Colombia\nGuaviare-I (VCG-I) strain (Moreno-Perez et al., 2014). The\n25mL PCR reaction contained 7.5 mL ultrapure water, 12.5 mL\nenzyme, 0.3 mM primer (designed taking into account the\nnatural selection signatures observed for pvrbsa , PvRBSA-A:\nrbsa-a-fwd : 50-GGGGTACCACAGCAAGTAGTGAGTCTCT-30\nand rbsa-a-rev : 50-CCCTCGAGCTCACATTCTCCACCAC\nTTAA-30; PvRBSA-B: rbsa-b-fwd : 50-GGGGTACCCA\nTATAGAAGTAGGATCCGAA-30and rbsa-b- rev: 50-CCCT\nCGAGCAATTGTTCTTCTCCGTATATAT-30) and 50 ng DNA\nas template. Temperature cycling conditions involved 1 step of\n3 min at 95\u000eC, followed by 35 cycles of 20 sec at 98\u000eC, 15 s at 60\u000eC\nand 15 s at 72\u000eC, and a \ufb01nal step of 30 s at 72\u000eC. All amplicons\nwere then puri\ufb01ed by low-melt agarose gel using the Wizard SV\nGel and PCR Clean-Up System (Promega) and then sequenced\nwith a BigDye Terminator kit (Macrogen, Seoul, South Korea) in\nboth directions using the second PCR primers and an internal\nprimer ( rbsaintseq : 50-TTTATATTTACACTATTCCTTTGG-30).\nSingleton SNPs were con\ufb01rmed by an independent PCR\nampli\ufb01cation. The sequences obtained here were deposited\nin the GenBank database (accession numbers MH391806 -\nMH391972).\nObtaining Recombinant Plasmids With\nRBSA Fragments\npvrbsa-A andpvrbsa-B PCR products were digested with KpnI\n(New England Biolabs) and AvaI (NEB) enzymes and then ligated\ninto the pET32bCvector using T4 ligase (NEB). Brie\ufb02y, 0.5 mg\nof each puri\ufb01ed product, 1x of CutSmart bu\ufb00er and 1 U/ mL of\neach enzyme were used in a 25 mL reaction which was incubated\nfor 1 h at 37\u000eC and then inactivated at 80\u000eC for 20 min.\nLigation to pET32bCvector was performed in a 20 mL volume\ncontaining 1x T4 bu\ufb00er, 30 U/ mL T4 ligase and vector/product\nin a 1:3 ratio. The reaction was incubated at 16\u000eC for 16 h\nand then inactivated at 65\u000eC for 20 min. Each recombinant\nplasmid was transformed into Escherichia coli JM109 cells\n(Invitrogen) according to the manufacturer\u2019s recommendations\nand recombinant colonies were then con\ufb01rmed by PCR using\nthe primers from each product. Three positive colonies were\nused for extracting plasmids with an UltraClean 6 Minute\nMini Plasmid Prep kit (MOBIO), following the manufacturer\u2019s\nrecommendations and then sequenced bidirectionally using\npet32b-fwd : 50-CGGTGAAGTGGCGGCAA-30and pet32-Rev :\n50-CCAAGGGGTTATGCTAGT-30primers.\npvrbsa Gene DNA Diversity and\nEvolutionary Analysis\nThree chromatograms (forward, reverse, and internal primer)\nwere obtained from Colombian and Venezuelan samples from\nFrontiers in Genetics | www.frontiersin.org 3 September 2018 | Volume 9 | Article 372fgene-09-00372 September 7, 2018 Time: 10:57 # 4\nCamargo-Ayala et al. Assessing pvrbsa Genetic Diversity\nsequencing; they were assembled using CLC Main workbench\nv.3 software (CLC bio, Cambridge, MA, United States).\nColombian and Venezuelan sequences were compared and\naligned [using the MUSCLE method (Edgar, 2004)] with\nreference strain sequences (Sal-I GenBank accession number:\nAAKM01000020.1, Brazil-I GenBank accession number:\nAFMK01000195.1/AFMK01000194.1, India-VII GenBank\naccession number: AFBK01001271.1 and North Korean\nGenBank accession number: AFNJ01000313.1) (Carlton et al.,\n2008; Neafsey et al., 2012) and with sequences obtained from\nseveral sequencing projects (Chan et al., 2012; Hester et al.,\n2013; Hupalo et al., 2016) available in PlasmoDB database\n(sequences were screened to rule out those having missing data\nor ambiguous nucleotides); 232 sequences from di\ufb00erent regions\naround the world were thus used. Afterwards the intron was\nruled out from all sequences and codon alignments were inferred\nusing the TranslatorX web server (Abascal et al., 2010). This\nalignment was manually edited ( Supplementary Data Sheet 1A )\nto ensure correct repeat alignment for further analysis.\nDnaSP v.5 software (Librado and Rozas, 2009) was used for\ncalculating the amount of singleton sites (s), the amount of\nparsimony-informative sites (Ps), the amount of haplotypes (H),\nthe haplotype diversity (Hd), the nucleotide polymorphism (or\nWatterson estimator, \"w) and the nucleotide diversity per site\n(p) for all available sequences (worldwide samples), as well as\nfor the Colombian and Venezuelan populations and for the\nsubpopulations within both populations. Departure from the\nneutral model of molecular evolution was assessed by Tajima\n(1989); Fu and Li (1993), and Fay and Wu (2000) estimators.\nThese are frequency spectrum-based tests for comparing two\nestimators of the population mutation parameter \"which\ncharacterizes mutation\u2013drift equilibrium (neutral model). Under\nneutrality, several unbiased estimators of \"should be equal.\nRejection of the neutral expectations suggests that selection or\na demographic process could be taking place, the Fay and Wu\ntest being suitable for detecting selective sweep (Fay and Wu,\n2000). On the other hand, since each new polymorphic site has\na high probability of delineating a new haplotype (Depaulis and\nVeuille, 1998), tests based on haplotype distribution have been\ndeveloped [K- and Hd-test (Depaulis and Veuille, 1998) as well\nas Fu\u2019s Fs (Fu, 1997)]. Similar to frequency spectrum-based tests,\ndepartures from neutral expectation could be the consequence\nof selection or demographic history, Fu\u2019s Fs estimator being a\nmore sensitive indicator of population expansion than Tajima\u2019s\ntest (Fu, 1997). DnaSP v.5 and/or ALLELIX software were used\nfor these tests, coalescent simulations being used for obtaining\ncon\ufb01dence intervals (Librado and Rozas, 2009). Sites containing\ngaps or repeats in the alignment were not taken into account.\nThe aforementioned methods do not consider the classes\nof mutations (non-synonymous and synonymous); natural\nselection signatures were therefore also assessed using di\ufb00erent\nmethods which classi\ufb01ed mutations as non-synonymous or\nsynonymous. The aBSREL method (Smith et al., 2015) was\nused to test whether positive selection had occurred on a\npercentage of branches regarding rbsa phylogeny. The modi\ufb01ed\nNei-Gojobori method (Zhang et al., 1998) with Jukes-Cantor\ncorrection (Jukes and Cantor, 1969) was then used for calculatingthe non-synonymous and synonymous substitution di\ufb00erence\nrate (d N-dS) within P. vivax , using a Z-test available in\nMEGA software v.6 (Tamura et al., 2013) to identify signi\ufb01cant\nstatistical values. Two tests were performed for assessing natural\nselection signals comparing di\ufb00erent species; the McDonald\u2013\nKreitman test (McDonald and Kreitman, 1991) was calculated\nusing a web server (Egea et al., 2008) using P. cynomolgi\northologous sequences. Likewise, non-synonymous divergence\nand synonymous divergence substitution di\ufb00erence rates (K N-\nKS) were also calculated, using the Z-test for identifying\nstatistically signi\ufb01cant values. Both tests were carried out taking\nJukes-Cantor divergence correction into account.\nA sliding window for omega ( &) rates (d N/dSand/or K N/KS)\nwas then used for assessing how natural selection acts throughout\nthe gene. The Datamonkey web server (Delport et al., 2010)\nwas used for assessing codon sites under positive or negative\nselection by using codon-based ML and BYs [IFEL (Pond et al.,\n2006), FEL, SLAC, REL (Kosakovsky Pond and Frost, 2005),\nMEME (Murrell et al., 2012) and FUBAR (Murrell et al., 2013)].\nA<0.1p-value was considered signi\ufb01cant for IFEL, FEL, SLAC\nand MEME methods and a >0.9 posterior probability for\nFUBAR. Since ignored recombination can bias d N/dSestimation\n(Anisimova et al., 2003; Arenas and Posada, 2010, 2014), the\nGARD method (Kosakovsky Pond et al., 2006) was considered\nregarding recombination before running these tests.\nLinkage disequilibrium was evaluated by calculating Z NS\n(Kelly, 1997) to assess whether recombination was/is taking place\ninpvrbsa ; this was followed by linear regression between LD\nand nucleotide distances. Evidence of recombination was also\nassessed by the GARD method (Kosakovsky Pond et al., 2006), as\nwell as by ZZ (Rozas et al., 2001) and RM (Hudson and Kaplan,\n1985) tests. The degree of genetic di\ufb00erentiation amongst P. vivax\nmalaria-endemic regions (subpopulations) regarding the pvrbsa\nlocus was evaluated by analysis of molecular variance (AMOV A)\nand by computing Wright\u2019s \ufb01xating index ( FST), using Arlequin\npopulation genetics data analysis v.3.1 software (Exco\ufb03er et al.,\n2007). The mutational pathways giving rise to pvrbsa haplotypes,\ntheir distribution and frequencies were inferred by median\nJoining method, using Network v.5 software (Bandelt et al., 1999).\nAssessing Functional Regions in the\nPvRBSA Protein\nWhole PvRBSA, as well as its A and B regions, were\nrecombinantly expressed and puri\ufb01ed, as previously described\n(Moreno-Perez et al., 2017) with minor modi\ufb01cations. For\nexample, the protein was expressed for 4 h at 37\u000eC (for complete\nPvRBSA) or 30\u000eC (for PvRBSA-A and PvRBSA-B regions) adding\n0.2 mM IPTG. The cell pellet was homogenized in B1 bu\ufb00er\n(20 mM Tris-Cl, 500 mM NaCl and 1 mM EDTA, pH 8.5) during\nnative protein extraction and then lysed by sonication on ice for\n3 min 30 s, with 0.2 s pulses ON, 0.2 s OFF, at 40% amplitude.\nProtein puri\ufb01cation and cell binding assays involved using the\nsame protocols described for PvGAMA and PvRBSA proteins,\nincluding PvDBP-RII as positive control and PvDBP-RIII/IV\nas negative control (Baquero et al., 2017; Moreno-Perez et al.,\n2017). The competition assay was performed by pre-incubating\nFrontiers in Genetics | www.frontiersin.org 4 September 2018 | Volume 9 | Article 372fgene-09-00372 September 7, 2018 Time: 10:57 # 5\nCamargo-Ayala et al. Assessing pvrbsa Genetic Diversity\nrPvRBSA-A-derived peptides 40893 (TASSESLAESNDAPS\nNSYES), 40894 (FPEIRENLTASEESLTSCEE), 40895 (SLTGSN\nESLTGSNE), 40896 (SLTESRESLEASRESLRASR), 40897 (ESL\nAASRESLNDFCGSEESV) and 40898 (ACEGEPNEKTFMGDV\nLSGGE) [synthesized as described (Arevalo-Pinzon et al.,\n2017)] in a 1:20 (protein:peptide) molar ratio with 2 \u0002107\nred blood cells from umbilical cord blood for 1 hour at 4\u000eC\nat 4 rpm using a tube rotator (Fisher Scienti\ufb01c). Furthermore,\na peptide (P7) from Mycobacterium tuberculosis (39266 \u2013\nAPSNETLVKTFSPGEQVTTY) (Carabali-Isajar et al., 2018), was\nalso used as negative control. All cysteine residues were replaced\nby a threonine to avoid RBSA peptide polymerisation. RBSA\nreticulocyte binding activity inhibition percentage was quanti\ufb01ed\nby analysing 100,000 events using a FACS Canto II (Biosciences)\ncytometer and FACSDiva software (BD).\nStatistical Analysis\nDi\ufb00erences between medians ( m) were compared by Kruskal\u2013\nWallis test when comparing multiple groups. Statistical\nsigni\ufb01cance was assessed by comparing m, using a 0.05\nsigni\ufb01cance level. Median values and standard deviations (SD)\nwere calculated from the measurements of three independent\nexperiments.\nRESULTS\nIdentifying the rbsa Gene in Plasmodium\nMonkey Lineage\nThe Sal-I- P. vivax rbsa gene ( pvrbsa ) sequence was used for a\nBlast search of P. vivax phylogenetically related species to identify\northologs in the monkey-parasite lineage. A contig was found in\nP. inui andP. fragile having higher than 60% identity whilst two\ndi\ufb00erent contigs were found in P. cynomolgi having 80% identity\nwith Sal-I pvrbsa (Supplementary Data Sheet 1B ). Interestingly,\nboth P. cynomolgi contigs had the same identity but they did not\nbelong to the same chr; one of the two fragments occurred at\nthe chr3 and the other one at chr10. There was 99.57% identity\nbetween these P. cynomolgi DNA fragments.\nA similar blast search using Sal-I pvrbsa sequence was\nthen performed against other P. vivax reference stains\u2019 whole\ngenome sequences (Neafsey et al., 2012), revealing extra DNA\nfragments having 63% identity at the same chr, lacking the\n\ufb01rst exon and the intron sequences ( Supplementary Data\nSheet 1C ), probably derived from duplication. The duplicated\nfragment was around 4,000 bp ( Figure 1 ,Supplementary Data\nSheet 1C and Supplementary Figure S2 ), taking upstream and\ndownstream DNA regions into account (Sal-I Ch3 GenBank\naccession number: AAKM01000020.1) from pvrbsa and the\npvrbsa paralog ( pvrbsap ). Counterparts to this 4,000 bp-DNA\nfragment were also identi\ufb01ed in P. cynomolgi (at both chr), P. inui\nandP. fragile , which were aligned and used to infer a phylogenetic\ntree ( Supplementary Figure S2 ). Three well-supported groups\nwere identi\ufb01ed in the tree; the \ufb01rst one placed P. vivax sequences\ntogether, the second group clustered P. cynomolgi sequences\nand in the third, P. inui and P. fragile sequences were found\n(Supplementary Figure S2 ).Aligning P. cynomolgi rbsa (pcrbsa, Ch3 GenBank accession\nnumber: BAEJ01000151.1) and pcrbsa paralogue ( pcrbsap , Ch10\nGenBank accession number: BAEJ01000874.1) DNA fragments\nrevealed a 10 Mb DNA region between chr3 and ch10 ( Figure 1 ,\nSupplementary Data Sheet 1D and Supplementary Figure S2 ),\nhaving 98.59% identity.\npvrbsa Gene PCR Ampli\ufb01cation and\nSequencing\nOne hundred and sixty-seven parasite DNAs from endemic\nColombian and Venezuelan regions were used for amplifying\nthepvrbsa locus. The amplicons had 1,454\u20131,580 bp sizes. These\nPCR fragments were then puri\ufb01ed and sequenced. At least\nthree chromatograms were assembled for each sample, thereby\nobtaining a consensus sequence.\npvrbsa Gene DNA Diversity and\nEvolutionary Analysis\nTogether with the 167 sequences obtained here, 65 additional\nsequences recovered from PlasmoDB (Colombia n= 18, Peru\nn= 16, Brazil n= 3, Mexico n= 5, Madagascar n= 2, China\nn= 2, Cambodia n= 2, Thailand n= 8, Papua New Guinea\nn= 6, India n= 1, North Korea n = 1 and the Sal-\nI sequences, Supplementary Data Sheet 1A ) were used to\nassess genetic diversity in pvrbsa . The pvrbsa encoding region\nhad 44 segregating sites whilst just 3 polymorphic sites were\nfound at intron worldwide. pvrbsa had an intermediate diversity\naccording to the nucleotide diversity estimator ( p) (Table 1 ,\np<0.01). The Venezuelan parasite population had a higher\npthan the Colombian population; both subpopulations within\nVenezuela (Bolivar and Venezuelan\u2019s Coastal area) had similar\npvalues. Regarding Colombian subpopulations, parasites from\nMeta (sequences available in PlasmoDB) had the lowest diversity,\nwhilst C\u00f3rdoba had the highest diversity value for Colombian\nsubpopulations ( Table 1 ). The 232 sequences could be clustered\ninto 80 di\ufb00erent haplotypes (70 regarding CDS, Supplementary\nData Sheet 1E ). The Colombian population had 37 haplotypes\nwhilst 25 haplotypes were observed in Venezuela ( Table 1 ).\nSince di\ufb00erent evolutionary forces (drift, selection,\nrecombination and migration) could determine the genetic\ndiversity pattern (Casillas and Barbadilla, 2017) observed in\nnatural populations, several evolutionary tests were performed\nto infer which of them were modulating the pvrbsa gene diversity\nobserved here. Tests based on a neutral molecular evolutionary\nmodel were performed for population and subpopulations\nto assess drift/selection force. The Colombia population had\nnegative statistically signi\ufb01cant values just for the Fay and\nWu test ( Table 2 ) indicating a possible selective sweep. When\nsubpopulations were analyzed separately, Meta had positive\nvalues for the Fu and Li test, being statistically signi\ufb01cant\n(p<0.05) which could have resulted from balancing selection\nor a decrease in population. The Choc\u00f3 subpopulation had a\nvalue lower than 0 ( p<0.03) for Fay and Wu\u2019s Htest ( Table 2 ).\nA sliding window for frequency spectrum-based tests showed\nregions inside pvrbsa having signi\ufb01cant values ( Supplementary\nFigure S3 ). On the other hand, the Fu and Li\u2019s F estimator gave\nFrontiers in Genetics | www.frontiersin.org 5 September 2018 | Volume 9 | Article 372fgene-09-00372 September 7, 2018 Time: 10:57 # 6\nCamargo-Ayala et al. Assessing pvrbsa Genetic Diversity\nFIGURE 1 | Phylogenetic tree mapping the presence/absence of rbsa locus and duplication events. The phylogenetic tree represents Plasmodium evolutionary\nhistory. The branches are colored regarding their vertebrate host. The rbsa locus was found in parasites from monkey-malaria clade, but it was not clear whether the\nrbsa gene became lost from the other clades or arose exclusively in the monkey-malaria clade. rbsa became lost in P . knowlesi andP . coatneyi whilst duplication\nevents occurred in P . vivax andP . cynomolgi . Models of putative ancestral chromosome 3 are displayed, indicating the arrangement after the duplication event (chr\nderived). PlasmoDB genome fragment annotation is also shown. P . cynomolgi rbsa (pcrbsa ) and its paralog ( pcrbsap ) had a premature stop codon regarding P . vivax\nrbsa sequences, indicated by a white rectangle in the pcrbsa andpcrbsap gene models.\nTABLE 1 | Genetic diversity estimators.\nn Aligned length S Ps H \"w (sd) p(sd) Hd (sd)\nWorldwide isolates 232 Gene 1,354 15 32 80 0.0067 (0.0010) 0.0085 (0.0002) 0.970 (0.005)\n232 CDS 1,113 14 30 70 0.0066 (0.0010) 0.0080 (0.0002) 0.962 (0.006)\nColombiaa135 Gene 1,354 13 26 37 0.0061 (0.0010) 0.0079 (0.0002) 0.951 (0.009)\n135 CDS 1,113 12 24 32 0.0059 ( 0.0010) 0.0074 (0.0002) 0.937 (0.010)\nAmazonasb41 Gene 1,391 6 20 13 0.0050 (0.0010) 0.0072 (0.0004) 0.890 (0.028)\n41 CDS 1,170 6 18 13 0.0049 (0.0010) 0.0067 (0.0004) 0.890 (0.028)\nChoc\u00f3b37 Gene 1,354 14 20 18 0.0072 (0.0012) 0.0079 (0.0005) 0.954 (0.024)\n37 CDS 1,113 13 18 16 0.0069 (0.0012) 0.0074 (0.0005) 0.936 (0.024)\nC\u00f3rdobab39 Gene 1,405 3 24 19 0.0053 (0.0010) 0.0080 (0.0006) 0.956 (0.023)\n39 CDS 1,170 3 22 17 0.0051 (0.0010) 0.0076 (0.0006) 0.944 (0.024)\nMetab18 Gene 1,506 0 16 8 0.0036 (0.0009) 0.0055 (0.0003) 0.961 (0.033)\n18 CDS 1,290 0 14 8 0.0034 (0.0008) 0.0050 (0.0003) 0.961 (0.033)\nVenezuelaa50 Gene 1,363 2 28 25 0.0056 (0.0010) 0.0089 (0.0003) 0.958 (0.023)\n50 CDS 1,149 2 26 25 0.0055 (0.0010) 0.0087 (0.0003) 0.958 (0.023)\nBol\u00edvarb29 Gene 1,363 0 27 17 0.0059 (0.0011) 0.0088 (0.0005) 0.975 (0.027)\n29 CDS 1,149 0 25 17 0.0057 (0.0011) 0.0085 (0.0005) 0.975 (0.027)\nCoastal areab19 Gene 1,363 6 22 13 0.0070 (0.0013) 0.0094 (0.0005) 1.000 (0.036)\n19 CDS 1,149 5 21 13 0.0069 (0.0013) 0.0093 (0.0005) 1.000 (0.036)\nGenetic diversity estimators were calculated using all the pvrbsa sequences available (worldwide isolates) as well as for populations (Colombia and Venezuela) and\nsubpopulations (Amazonas, Choc\u00f3, C\u00f3rdoba, Meta, Bolivar, and Venezuela\u2019s coastal area). n, amount of isolates analyzed; aligned length, total sites analyzed, excluding\ngaps; Ss, amount of segregating sites; Ps, amount of informative parsimonious sites; H, amount of haplotypes; \u0012w, nucleotide polymorphism; \u0019, nucleotide diversity per\nsite; Hd, haplotype diversity. sd, standard deviation. Diversity estimates were corrected for sample size by multiplying by n/(n-1). Although nucleotide diversity was not\naffected by sample size, it was also corrected.aPopulations.bSubpopulations.\nstatistically signi\ufb01cant values for the Venezuelan population;\nthis pattern was also observed for the Bolivar subpopulation\n(Table 2 ). The sliding window analysis revealed regions inside\npvrbsa having signi\ufb01cant values for Venezuelan subpopulations.\nTests based on haplotype distribution did not have statistically\nsigni\ufb01cant values ( Table 2 ).\nA test based on non-synonymous and synonymous mutations\nwas also computed to search natural selection signals in pvrbsa .\nThe aBSREL method found evidence of episodic diversifying\nselection on rbsa phylogeny ( Figure 2A ). The d N-dSdi\ufb00erencehad positive values within P. vivax ; however, they were not\nstatistically signi\ufb01cant, except for the Meta subpopulation\n(Table 3 ). A sliding window was then inferred to assess how\ndNand d Shave been accumulated throughout the pvrbsa gene\n(Figure 2B ). The 30-end showed omega ( &) values higher than\n1 (Figure 2B ) which is an indicator of positive selection. The\nregion from nucleotide 200\u20131,100 had &= 0 which is expected\nunder negative selection. Although, the McDonald\u2013Kreitman\ntest did not have signi\ufb01cant values, the K N-KSdi\ufb00erences\n(comparing P. vivax sequences to P. cynomolgi ones) had\nFrontiers in Genetics | www.frontiersin.org 6 September 2018 | Volume 9 | Article 372fgene-09-00372 September 7, 2018 Time: 10:57 # 7\nCamargo-Ayala et al. Assessing pvrbsa Genetic Diversity\nTABLE 2 | Neutrality tests for Colombia, Venezuela, and subpopulations.\nn Tajima Fu and Li Fay and Wu\u2019s H(p-value) Fu\u2019s Fs K-test H-test\nD (p-value) D ( p-value) F ( p-value)(p-value) ( p-value) ( p-value)\nCDS 135 Colombiaa0.637 ( p>0.1)\u00000.779 ( p>0.1)\u00000.304 ( p>0.1)\u000012.819\u0003(p<0.01)\u00003.447 ( p>0.1) 32 ( p>0.05) 0.930 ( p>0.05)\n41 Amazonasb1.192 ( p>0.1) 0.262 ( p>0.1) 0.789 ( p>0.1)\u00004.821 ( p>0.1) 1.192 ( p>0.1) 13 ( p>0.05) 0.868 ( p>0.05)\n37 Choc\u00f3b0.174 ( p>0.1)\u00000.460 ( p>0.1)\u00000.285 ( p>0.1)\u000011.339\u0003(p<0.03)\u00000.755 ( p>0.1) 16 ( p>0.05) 0.911 ( p>0.05)\n39 C\u00f3rdobab1.424 ( p>0.1) 1.046 ( p>0.1) 1.447 ( p>0.1)\u00005.036 ( p>0.1)\u00000.758 ( p>0.1) 17 ( p>0.05) 0.920 ( p>0.05)\n18 Metab1.856 ( p>0.1) 1.543\u0003(p<0.05) 2.118\u0003(p<0.02)\u00001.673 ( p>0.1) 1.050 ( p>0.1) 8 ( p>0.05) 0.908 ( p>0.05)\n50 Venezuelaa1.865 ( p>0.1)\u00005.036 ( p>0.05) 2.168\u0003(p<0.02)\u00004.140 ( p>0.1)\u00003.851 ( p>0.1) 25 ( p>0.05) 0.939 ( p>0.05)\n29 Bol\u00edvarb1.735 ( p>0.05) 1.806\u0003(p<0.02) 2.236\u0003(p<0.02)\u00005.197 ( p>0.1)\u00001.969 ( p>0.1) 17 ( p>0.05) 0.941 ( p>0.05)\n19 Coastal areab1.426 ( p>0.1) 0.910 ( p>0.1) 1.392 ( p>0.1)\u00004.520 ( p>0.1)\u00001.196 ( p>0.1) 13 ( p>0.05) 0.947 ( p>0.05)\nThe tests were carried out with just the rbsa encoding region (CDS).\u0003Statistically signi\ufb01cant values.aPopulations.bSubpopulations.\nFIGURE 2 | Identifying natural selection signatures in the rbsa gene. (A)A phylogeny tree inferred from pvrbsa CDS and its orthologous CDS was analyzed by the\naBSREL method. The shade of each color on branches indicates selection strength [red indicates positive selection ( &>1) and green negative selection ( &<1)].\nThe size of each colored segment represents the percentage of selected sites in the corresponding &class. The Figure shows the &values, the percentage of\npositive selected sites (Pr [ &=&+]) and p-values. Branches have been classi\ufb01ed as undergoing episodic diversifying selection, by the p-value corrected for multiple\ntesting, using the Holm\u2013Bonferroni method at p<0.05. (B)Representation of the rbsa encoding DNA sequence and the sliding window for the &rate. The &rates\nwithin P . vivax (dN/dS) and between the species (K N/KS) are shown. A gene model of the rbsa gene is given below the sliding window, indicating the sites under\npurifying selection (green) and positive selection (red). Gene model and numbering were based on the Supplementary Data Sheet 1E alignment.\npositive selection signals (positive signi\ufb01cant values, Table 4 ).\nA similar result was obtained when P. vivax and all orthologous\nsequences from phylogenetically related species were analyzed\n(Table 4 ). The sliding &(KN/KS) window for this datasetshowed positive selection signatures ( &>1) towards the 50-\nend, as well as in a region between nucleotide 600 \u2013 1,572\n(hereinafter called PvRBSA-B). The region between nucleotide\n200 \u2013 600 (hereinafter called PvRBSA-A) had a negative\nFrontiers in Genetics | www.frontiersin.org 7 September 2018 | Volume 9 | Article 372fgene-09-00372 September 7, 2018 Time: 10:57 # 8\nCamargo-Ayala et al. Assessing pvrbsa Genetic Diversity\nselection signal ( &<1,Figure 2B ). Consequently, the gene\nwas split into two regions (PvRBSA-A and PvRBSA-B) and\ndN-dS(as well as K N-KS) were computed again for each one.\nNo statistically signi\ufb01cant values were observed for d N-dSin\neither of the two regions (except for the Meta subpopulation,\nTable 3 ). Conversely, positive values (indicator of positive\nselection) having a p-value\u00140.045 were found in PvRBSA-\nB when K N-KSwas computed; by contrast, PvRBSA-A had anegative selection signature (negative values having p>0.05,\nTable 4 ).\n&rate was then computed for each codon using codon-\nbased methods. Twenty-one positive selected codons were found\nbetween species whilst another 30 were under negative selection.\nSeveral of the negative selected sites were found in PvRBSA-A\n(Figure 2B ). A protein blast (using NCBI database with Sal-I\nPvRBSA haplotype as query) gave two putative domains in the\nTABLE 3 | dN-dSdifference within P . vivax.\nPopulation PvRBSA-A (196 - 600 bp) PvRBSA-B (601 \u2013 1,353 bp) Full length gene\ndN- dS(se) d N- dS(se) d N- dS(se)\nWorldwide isolates 0.0014 (0.0022) 0.0060 (0.0046) 0.0044 (0.0028)\np= 0.255 p= 0.102 p= 0.062\nColombiana0.0011 (0.002) 0.0050 (0.004) 0.0036 (0.003)\np= 0.318 p= 0.145 p= 0.099\nAmazonasb0.0016 (0.001) 0.0033 (0.005) 0.0027 (0.003)\np= 0.083 p= 0.251 p= 0.177\nChoc\u00f3b0.0023 (0.002) 0.0050 (0.005) 0.0039 (0.003)\np= 0.161 p= 0.133 p= 0.078\nC\u00f3rdobab0.0006 (0.004) 0.0036 (0.005) 0.0027 (0.003)\np= 0.441 p= 0.811 p= 0.173\nMetab\u00000.0024 (0.004) 0.0082 (0.003)\u00030.0045 (0.002)\u0003\np= 0.248 p= 0.009 p= 0.023\nVenezuelaa0.0015 (0.002) 0.0064 (0.005) 0.0046 (0.003)\np= 0.269 p= 0.120 0.070\nBol\u00edvarb0.0023 (0.002) 0.0058 (0.005) 0.0045 (0.003)\np= 0.166 p= 0.124 p= 0.076\nCoastal areab0.0002 (0.003) 0.0070 (0.006) 0.0047 (0.003)\np= 0.472 p= 0.099 p= 0.081\nNon-synonymous substitution rate (d N) and synonymous substitution rate (d S) within P . vivax. se, standard error.\u0003Statistically signi\ufb01cant values.aPopulations.\nbSubpopulations.\nTABLE 4 | KN\u2013KSdifference between Plasmodium species.\nPopulation RBSA-A (196 \u2013 600 bp) RBSA-B (601 \u2013 1,353 bp) Full length gene\nKN\u2013 KS(se) K N\u2013 KS(se) K N\u2013 KS(se)\nP . vivax/P . cynomolgi\nWorldwide isolates \u00000.0010 (0.003) 0.0080 (0.005)\u00030.0053 (0.003)\u0003\np= 0.372 p= 0.045 p= 0.033\nColombian \u00000.0030 (0.004) 0.0080 (0.005)\u00030.0053 (0.003)\u0003\np= 0.249 p= 0.033 p= 0.032\nVenezuela \u00000.0092 (0.010) 0.0150 (0.006)\u00030.0090 (0.004)\u0003\np= 0.188 p= 0.005 p= 0.012\nP . vivax/Plasmodium sp.\nWorldwide isolates \u00000.0031 (0.004) 0.0101 (0.005)\u00030.0068 (0.003)\u0003\np= 0.234 p= 0.017 p= 0.012\nColombian \u00000.0064 (0.007) 0.0118 (0.005)\u00030.0077 (0.003)\u0003\np= 0.184 p= 0.008 p= 0.007\nVenezuela \u00000.0174 (0.002) 0.0238 (0.006)\u00030.0152 (0.005)\u0003\np= 0.167 p= 0.0001 p= 0.001\nNon-synonymous (K N) and synonymous (K S) divergence between P . vivax/P . cynomolgi and P . vivax/phylogenetically (P . cynomolgi/P . inui/P . fragile) related species. se,\nstandard error.\u0003Statistically signi\ufb01cant values.\nFrontiers in Genetics | www.frontiersin.org 8 September 2018 | Volume 9 | Article 372fgene-09-00372 September 7, 2018 Time: 10:57 # 9\nCamargo-Ayala et al. Assessing pvrbsa Genetic Diversity\nFIGURE 3 | Median-joining network for Colombian and Venezuelan subpopulations. The Figure shows the pvrbsa haplotypes identi\ufb01ed from Colombian and\nVenezuelan isolates. Some haplotypes were included within another haplotype using the contraction star algorithm (Forster et al., 2001) for simplifying network\ninterpretation. Each node is a haplotype and its size indicates its frequency. The lines connecting the haplotypes represent the different mutational paths and the\nmedian vectors are the ancestral sequences explaining the relationship and evolutionary origin.\nregions having &<1 (PvRBSA-A). The \ufb01rst belonged to the\nDMP1 domain and the other to a domain containing a LRR.\nRecombination is an evolutionary force which can provide\nfresh opportunities for overcoming selective pressures to adapt\nto new environments and/or hosts by linking (within the\nsame DNA region) independently arising variants (Perez-\nLosada et al., 2015). In fact, it has been observed that\ndiversity levels increase with recombination rate (Hellmann\net al., 2003; Kulathinal et al., 2008; Rao et al., 2011). Several\ntests were thus performed to assess whether this evolutionary\nforce takes/has taken place in pvrbsa . A linear regression\nbetween LD and nucleotide distance showed that LD decreased\nregarding increased nucleotide distance, a pattern expected under\nrecombination. Statistically signi\ufb01cant ZZ values and severalRm were observed for all populations, thereby con\ufb01rming\nrecombination action ( Supplementary Data Sheet 2 ). Two\nbreakpoints were identi\ufb01ed by the GARD method at nucleotides\n618 and 1058 ( p= 0.0004, nucleotide number base in the Sal-I\nsequence) ( Figure 2 ). Recombination was thus taking place at this\nlocus.\nA haplotype network was inferred ( Figure 3 ) and AMOV A\nused for assessing whether migration was also involved in\nshaping pvrbsa locus diversity ( Table 5 ). Several haplotypes\nwere shared between populations (Colombia and Venezuela,\ni.e. H_4) but also amongst subpopulations (Choc\u00f3, C\u00f3rdoba,\nAmazonas, Meta, Bolivar, and the Venezuelan coastal area)\nlacking clear population structure ( Figure 3 ). However, some\nhaplotypes were restricted to particular subpopulations (i.e.\nFrontiers in Genetics | www.frontiersin.org 9 September 2018 | Volume 9 | Article 372fgene-09-00372 September 7, 2018 Time: 10:57 # 10\nCamargo-Ayala et al. Assessing pvrbsa Genetic Diversity\nTABLE 5 | Analysis of molecular variance (AMOVA) analysis and inter-population FSTvalues.\nSource of variation % of variation p-value\nBetween populations ( FCT) 2.81 0.064\nAmongst subpopulations within populations ( FSC) 4.39 0.000\u0003\nAmongst subpopulations ( FST) 92.79 0.001\u0003\nFST\nMeta Choc\u00f3 Amazonas C\u00f3rdoba Bol\u00edvar Coastal area\nMeta 0.286 0.004 0.007 0.000 0.000\nChoc\u00f3 0.007 0.000 0.006 0.000 0.001\nAmazonas 0.074\u00030.055\u00030.000 0.000 0.000\nC\u00f3rdoba 0.041\u00030.027\u00030.086\u00030.000 0.000\nBol\u00edvar 0.057\u00030.049\u00030.083\u00030.061\u00030.146\nCoastal area 0.076\u00030.056\u00030.094\u00030.065\u00030.014\nFSTwas calculated for parasite subpopulations within Colombian and Venezuela. Values close to 0 indicate low genetic differentiation whilst values close to 1 indicate high\ngenetic differentiation. Values below the diagonal correspond to the F STvalue and those above the diagonal represent the respective p-values.\u0003Statistically signi\ufb01cant\nvalues.\nFIGURE 4 | PvRBSA reticulocyte binding activity. (A)Puri\ufb01cation of full rPvRBSA (F) or its fragments (A and B). The Figure shows each puri\ufb01ed molecule analysed by\nCoomassie blue staining (lines 2, 4, and 6) or Western blot (lines 3, 5, and 7). MW, molecular weight marker (line 1). (B)rPvRBSA target cell binding assay. DBP-RII\nand -RIII/IV indicates positive and negative binding controls, respectively. (C)Binding inhibition assay. The Figure shows the rPvRBSA reticulocyte binding inhibition\npercentage using different PvRBSA-A-derived peptides as well as a M. tuberculosis peptide (negative controls). Standard deviation is shown for each assay. C+,\nshows the assay just with the rPvRBSA protein (positive control). P1-P6 indicate peptides 40893, 40894, 40895, 40896, 40897, and 40898, respectively. P7 is a\nM. tuberculosis peptide (39266) used as negative control. All peptides were pre-incubated with cells before incubating with the complete protein.\nH_30, H_23, H_52, H_39) or populations (i.e., H5 - H_8,\nH_41, H_46). AMOV A was then used to address population\ndi\ufb00erentiation ( Table 5 ); analysis showed that the source of\nvariation was between populations (around 4%, p= 0.00),\nthe greatest variation (93%) occurring amongst subpopulations\n(p= 0.00). The FSThad statistically signi\ufb01cant values ( Table 5 ).\nHowever, comparing Meta/Choc\u00f3 (as well as Bolivar/Venezuela\u2019s\ncoastal area) revealed no statistically signi\ufb01cant FSTvalues\n(Table 5 ).\nAssessing PvRBSA Functional Regions\nIt has been shown that immature reticulocytes are P. vivax\ntarget cells, expressing the CD71 receptor abundantly on their\nsurface (Malleret et al., 2015). Therefore, a reticulocyte-binding\nassay was performed by \ufb02ow cytometry to evaluate whether the\nPvRBSA region predicted under negative selection (PvRBSA-A\nhaving a &<1) was able to bind to target cells (labeled with\nanti-CD71 antibody). First, the full PvRBSA protein and the\nPvRBSA-A and PvRBSA-B regions were recombinantly expressed\nand obtained in soluble form. Each protein was puri\ufb01ed\nand recognized by WB using a monoclonal anti-polyhistidineantibody ( Figure 4A ). When proteins were incubated with\numbilical cord blood (containing 6\u20137% reticulocytes), only the\nrPvRBSA ( m\u0006SD = 5.5\u00061.8) and rPvRBSA-A regions\n(m\u0006SD = 13\u00061.7) bound to a CD71 CCD45- cell population\n(reticulocytes), unlike the rPvRBSA-B region ( Figure 4B ). As\ncan be observed, rPvRBSA and rPvRBSA-A binding activity\nhad a statistically signi\ufb01cant di\ufb00erence compared to negative\ncontrol ( m\u0006SD = 2.4\u00061.3) (Kruskal\u2013Wallis: p= 0.014)\n(Figure 4B ). Once the PvRBSA functional region\u2019s reticulocyte\ninteraction activity had been determined, a binding inhibition\nexperiment was performed with PvRBSA-A-derived peptides\nto search for speci\ufb01c regions within this region involved in\ninteraction with target cells ( Figure 4C ). Peptide 40898 was\nable to inhibit protein-cell interaction by 18% whilst peptide\n40894 produced a 35% reduction. Only one peptide (40897)\ninhibited rPvRBSA-reticulocyte interaction by more than 50%.\nThe Mycobacterium peptide was unable to inhibit rPvRBSA\nbinding activity to reticulocytes. Interestingly, synthesized\npeptides 40894 and 40897 were conserved in several P. vivax\nisolates and were located in the PRK15370 putative domain\n(Figure 2B ).\nFrontiers in Genetics | www.frontiersin.org 10 September 2018 | Volume 9 | Article 372fgene-09-00372 September 7, 2018 Time: 10:57 # 11\nCamargo-Ayala et al. Assessing pvrbsa Genetic Diversity\nDISCUSSION\nMalaria remains a public health problem in several tropical\nand subtropical regions worldwide (WHO, 2017). Although\nan antimalarial vaccine appears to be a good cost-e\ufb00ective\nintervention which would help in controlling malaria, a fully\ne\ufb00ective vaccine has not been developed yet. Since P. vivax\nhas a complex biology (Galinski et al., 2013) (for instance,\nit has tropism for reticulocytes, making it di\ufb03cult to obtain\na continuous in vitro culture), antigen identi\ufb01cation and\ncharacterization for an antimalarial vaccine is a slow task\n(Patarroyo et al., 2012). Several antigens suggested as potential\nP. vivax vaccine candidates have been characterized, taking\ninto account the candidates proposed for P. falciparum or\nother Plasmodium species (Arevalo-Pinzon et al., 2011, 2013,\n2015; Patarroyo et al., 2012; Moreno-Perez et al., 2013).\nHowever, P. vivax andP. falciparum have di\ufb00erent features and\nthis could be the consequence of their di\ufb00erent evolutionary\npaths. Consequently, several species-speci\ufb01c antigens could be\nfound in both species. These species-speci\ufb01c antigens could\nthus be taken into account when designing an antimalarial\nvaccine.\nThe RBSA has recently been identi\ufb01ed in species invading\nreticulocytes ( P. vivax and P. cynomolgi ) suggesting that this\nantigen could be speci\ufb01c for invading this kind of host\ncell and could therefore be considered a vaccine candidate\nwhen designing an anti- P. vivax malaria vaccine (Moreno-\nPerez et al., 2017). However, this antigen appears not to be\nexclusive for P. vivax and P. cynomolgi . A Blast search in\nwhole monkey-malaria lineage genomes showed that pvrbsa\northologs were also present in species invading normocytes,\nsuch as P. inui andP. fragile (Supplementary Data Sheet 1B ).\nSince the rbsa gene was present in P. fragile (the most\nbasal species in monkey-malaria lineage, Figure 1 ) (Carlton\net al., 2013; Muehlenbein et al., 2015), this gene could\nbe present in the ancestor of all monkey-malaria parasites\nand, because orthologs were not found in P. knowlesi and\nP. coatneyi , then it has been lost in some species within this\nclade.\nThe rbsa gene was found as a single copy gene in\nP. inui (pirbsa ) and P. fragile (pfrbsa ), but this gene appears\nto be duplicated in P. vivax (pvrbsa ) and P. cynomolgi\n(pcrbsa ). The phylogenetic tree ( Supplementary Figure S2 )\nshowed that pvrbsa was closer to pvrbsap than pcrbsa . This\ncould be the consequence of concerted evolution which can\nhomogenize duplicate gene fragments (Nei and Rooney, 2005).\nHowever, duplication was incomplete or was found at di\ufb00erent\nchromosomes; the duplication event must therefore have taken\nplace after P. vivax and P. cynomolgi divergence. A 4,000 bp\nfragment was duplicated at chr3 in P. vivax (it is present\nin all P. vivax strain genomes available in the PlasmoDB\ndatabase; duplication and pseudogenisation should therefore\nhave been taking place during early P. vivax evolutionary\nhistory); this duplicate ( pvrbsap ) lacked the \ufb01rst exon and the\nintron ( Figure 1 ) and could, consequently, be a pseudogene.\nBy contrast, both pcrbsa copies were complete in P. cynomolgi ;\nin fact, they had 99.91% identity. Furthermore, pcrbsap wasnot found at chr3; instead, it was located at chr10. At least\na 10 Mbp were duplicated for this species; however, the\nmechanism involved in this large fragment\u2019s duplication at\na di\ufb00erent chr is not clear. Likewise, it is not yet clear\nwhether the high identity found in pcrbsa and pcrbsap has\nbeen due to negative selection acting on both copies or has\nbeen due to a recent duplication event. According to the\naforementioned results, two independent duplication events\nmust have happened.\nOn the other hand, the pvrbsa gene was ampli\ufb01ed in 167\nsamples from Colombian and Venezuelan populations. The\nderived sequences were analysed together with 65 sequences\nfrom di\ufb00erent regions around the world. This gene had length\npolymorphism due to repeats located at the 50-end. Worldwide,\nthepvrbsa encoding region had 44 segregating sites (47, taking\nencoding and non-encoding regions into account) giving 70\nhaplotypes ( Supplementary Data Sheet 1E ). The pvrbsa p\nvalue (0.0080\u00060.0002) was lower than that observed for\nother Mrz surface proteins [ pvmsp1 ,p>0.05200 (Valderrama-\nAguirre et al., 2011; Garzon-Ospina et al., 2015); pvmsp3 a,\np>0.0349 (Mascorro et al., 2005; Garzon-Ospina et al.,\n2015); pvmsp7C ,p= 0.0548; pvmsp7H ,p= 0.0357; pvmsp7I ,\np= 0.0430 (Garzon-Ospina et al., 2012); pvmsp7E ,p= 0.0573\n(Garzon-Ospina et al., 2014)], but similar to that found in\npvama1 [p= 0.0067 (Gunasekera et al., 2007; Garzon-Ospina\net al., 2015)] and pvdbp [p= 0.0101 (Nobrega de Sousa\net al., 2011)] and higher than pvmsp7 (\u0000Ap= 0.0002,\u0000K\np= 0.0025,\u0000Fp= 0.0008, and\u0000Lp= 0.0006) (Garzon-Ospina\net al., 2011; Garzon-Ospina et al., 2014), pvmsp8 (p= 0.0022)\n(Pacheco et al., 2012), pvmsp10 (p= 0.0002) (Garzon-Ospina\net al., 2011; Pacheco et al., 2012), pv12 (p= 0.0004), pv38\n(p= 0.0026) and pv41 (p= 0.0037) (Forero-Rodriguez\net al., 2014a,b; Wang et al., 2014) or rhoptry proteins [ rap1 ,\np= 0.00088, rap2 ,p= 0.00141, and ron4 ,p= 0.0004 (Garzon-\nOspina et al., 2010; Pacheco et al., 2010; Buitrago et al.,\n2016)].\nThe Venezuelan subpopulations had more genetic diversity\nthan subpopulations within Colombia regarding this gene\n(Table 1 ); however, the forces causing such diversity seemed\nto be similar. The sliding windows for frequency spectrum-\nbased tests ( Supplementary Figure S3 ) had statistically\nsigni\ufb01cant values within pvrbsa , suggesting that natural\nselection seems to be determining the pattern of diversity.\nThe negative values ( p<0.02) found between nucleotides\n100 and 300 ( Supplementary Figure S3 , numbers based\non Supplementary Data Sheet 1E ) in populations and\nsubpopulations, suggested directional (negative or positive)\nselection; this kind of selection decreased diversity and could\nhave been a consequence of functional constraint. On the other\nhand, the 750\u2013940 nucleotide region was under balancing\nselection, as suggested by positive values for the frequency\nspectrum-based tests for these positions ( Supplementary\nFigure S3 ). Directional selection was also identi\ufb01ed between\nnucleotides 1,000\u20131,090 in the Colombian subpopulations\nwhilst balancing selection was also found between nucleotides\n1,090\u20131,200 in the Venezuelan subpopulations ( Supplementary\nFigure S3 ).\nFrontiers in Genetics | www.frontiersin.org 11 September 2018 | Volume 9 | Article 372fgene-09-00372 September 7, 2018 Time: 10:57 # 12\nCamargo-Ayala et al. Assessing pvrbsa Genetic Diversity\nTests based on non-synonymous and synonymous mutations\ncon\ufb01rmed natural selection. A percentage of sites under positive\nselection were identi\ufb01ed in P. vivax and other species regarding\nthe aBSREL method ( Figure 2A ). This pattern has also been\nobserved in other genes, suggesting species-speci\ufb01c adaptation\nduring parasite evolution (Muehlenbein et al., 2015; Buitrago\net al., 2016; Garzon-Ospina et al., 2016). Evidence of positive\nselection was found in PvRBSA-B ( Figure 2 and Tables 3 ,4),\nagreeing with the frequency spectrum-based test results. All this\ndata ( Figure 2 ,Tables 3 ,4, and Supplementary Figure S3 )\nsuggested that non-synonymous mutations were maintained in\npopulations by balancing (or diversifying) selection, providing\nthe parasite with an advantage to avoid host immune responses,\nas has been proposed for other antigens (Garzon-Ospina et al.,\n2012).\nWhilst PvRBSA-B could be involved in host immune\nevasion, PvRBSA-A might be involved in parasite-host\ninteraction. Negative values were found in d N-dSand K N-\nKStests; however, they were not statistically signi\ufb01cant\n(Tables 3 ,4). Nevertheless, statistically signi\ufb01cant negative\nfrequency spectrum-based test values were observed. The &\nrate was lower than 1 in this region, several codons being\nunder negative selection ( Figure 2 ) according codon-based\nmethods; this suggested that negative selection is/has been\noperating in PvRBSA-A and this region therefore seems\nto be under functional constraint. This premise was also\nsupported because two putative domains were inferred within\nthis region ( Figure 2B ); one was the DMP1 superfamily\ndomain which is found in dentin matrix protein 1 acting as\ntranscriptional component in mammals (Narayanan et al., 2003).\nHowever, how this domain could act in the parasite is not\nclear yet.\nMore interesting was the \ufb01nding of the PRK15370 domain.\nThis domain belongs to the NEL superfamily where family\nmembers have an LRR. The LRR has been involved in host-\npathogen interaction (Kedzierski et al., 2004). Just PvRBSA-\nA bound when PvRBSA-A and -B recombinant protein\nfragments were assessed regarding their ability to bind to\nhuman reticulocytes ( Figure 4 ). The binding percentage for\nPvRBSA-A was higher than that for the complete protein,\nwhich has been observed for other invasion-related Plasmodium\nparasite antigens (Chitnis and Miller, 1994; Fraser et al., 2001;\nKato et al., 2005; Arevalo-Pinzon et al., 2017). An inhibitory\nassay was then performed to identify minimum speci\ufb01c\nregions within PvRBSA-A able to inhibit rPvRBSA-reticulocyte\ninteraction. Two peptides (FPEIRENLTASEESLTSCEE and\nESLAASRESLNDFCGSEESV) were able to decrease rPvRBSA-\nreticulocyte interaction. Both peptides were located in the\nPRK15370 putative domain, the \ufb01rst located towards the\nN-terminal domain whilst the other one was at the end\nof this. Remarkably, this region was found in the PvRBSA\nrepeat region; repeats are usually used by the parasite as\nan immune evasion mechanism. Nevertheless, repeats could\nalso be functionally important, as has been observed in the\nCS protein (Aldrich et al., 2012; Ferguson et al., 2014).\nThe PvRBSA region involved in parasite-host interaction\nwas thus located between amino acids 76 to 176 (numbersbased on Sal-I protein sequences), FPEIRENLTASEESLTSCEE\nand ESLAASRESLNDFCGSEESV peptides (which were fully\nconserved in all P. vivax sequences analyzed here) being critical\nfor binding, meaning that these peptides could be considered in\nvaccine development.\nThe aforementioned results thus suggest that natural selection\nis an evolutionary force modulating pvrbsa genetic diversity\nwhilst negative selection acts at the gene\u2019s 50-end, the 30-end\nis under diversifying or balancing selection. Nonetheless,\nother forces could also be involved. Recombination might\nincrease diversity by interchanging DNA fragments during\nsexual reproduction. LD decreased in pvrbsa as nucleotide\ndistance increased ( Supplementary Data Sheet 2 ), suggesting\nthat recombination was/has been taking place in this gene.\nRecombination was con\ufb01rmed by using ZZ, Rm and GARD\nmethod ( Supplementary Data Sheet 2 ), suggesting that\nrecombination can increase genetic diversity by intra-gene\nrecombination.\nA previous study has suggested that American populations\nare structured (Taylor et al., 2013); this pattern has also been\nobserved in other P. vivax antigens in Colombia (Forero-\nRodriguez et al., 2014a,b; Buitrago et al., 2016), hence\nmigration was the last force evaluated here. The haplotype\nnetwork inferred by using all available sequences did not\nhave clear structuring; pvrbsa haplotypes were shared by\ndi\ufb00erent countries, even around the world. Several haplotypes\nfound on the American continent were also present in Asia;\nconsequently, most haplotypes should have arisen before\nP. vivax spread worldwide. Therefore, due to di\ufb00erent P. vivax\nintroductions to America by human migration (Rodrigues\net al., 2018), pvrbsa haplotypes have reached di\ufb00erent American\ncounties. A structured population was not found when a\nhaplotype network was inferred. In fact, several haplotypes\nwere shared between Colombia and Venezuela, as well as\namongst all subpopulations ( Figure 4 ); however, AMOV A\nsuggested that subpopulations were genetically di\ufb00erent\n(Table 5 ). Statistically signi\ufb01cant values were found for\nmost comparisons ( Table 5 ) when the \ufb01xation index ( FST\nbased on haplotype diversity) was computed. This could\nhave been the consequence of limited gene \ufb02ow amongst\nColombian subpopulations or due to local adaptation.\nSynonymous and non-synonymous mutations were analysed\nindependently to try to determine which event(s) led to this\nstructure ( Supplementary Data Sheet 3 ). Since synonymous\nmutations are typically silent, they are considered to follow\nneutral expectations and, therefore, they could represent\nthe demographic history (migration). On the other hand,\nnon-synonymous mutations are subject to natural selection\nand could consequently represent local adaptations. The\nsynonymous data set showed that Bol\u00edvar and Venezuela\u2019s coastal\narea in Venezuela as well as the Choc\u00f3, C\u00f3rdoba, Amazonas\nand Meta departments in Colombia seem to be genetically\nsimilar populations since non statistically signi\ufb01cant FSTwere\nfound. However, the non-synonymous data set showed that\nall (except Bol\u00edvar and Venezuela\u2019s coastal area as well as\nChoc\u00f3 and Meta) subpopulations were genetically di\ufb00erent.\nThis suggested that local adaptation is responsible for the\nFrontiers in Genetics | www.frontiersin.org 12 September 2018 | Volume 9 | Article 372fgene-09-00372 September 7, 2018 Time: 10:57 # 13\nCamargo-Ayala et al. Assessing pvrbsa Genetic Diversity\nobserved structure. However, limited gene \ufb02ow (partly) might\nalso have provoked such structuring in Colombia. Nevertheless,\nmigration in Venezuela seems to be/have been an important\nforce modulating pvrbsa diversity. Further analysis using neutral\nmarkers within Colombia and Venezuela populations could\ncon\ufb01rm this issue.\nCONCLUSION\nAlthough the RBSA protein has previously been identi\ufb01ed as an\nantigen exclusive to Plasmodium species invading reticulocytes\n(Moreno-Perez et al., 2017), it is actually present in several\nmonkey-malaria lineage species. The encoding gene should\nhave been present in the last monkey-malaria parasite common\nancestor and it then became lost in some species (i.e. P. knowlesi\nand P. coatneyi ). An independent duplication event took\nplace in P. vivax and P. cynomolgi . The pvrbsa paralog\nappears to be a pseudogene whilst the pcrbsa paralog is a\nfunctional gene having just one mutation between pcrbsa and\npcrbsap .\nThepvrbsa locus has lower genetic diversity ( p= 0.008) than\nother Mrz surface proteins (Mascorro et al., 2005; Valderrama-\nAguirre et al., 2011; Garzon-Ospina et al., 2012, 2014); this\ndiversity is modulated by natural selection, recombination and\nmigration (the latter for Venezuela but not for Colombia).\nAccording to Tajima, Fu and Li, K N-KSand codon-based tests\nthe RBSA \u2019s C-terminal end (PvRBSA-B) is under balancing\n(or diversifying) selection, likely due to this region being\ninvolved in immune response evasion whilst PvRBSA-A is\nunder directional selection due to a functional/structural\nconstraint ( &<1). The latter region has the PRK15370\nputative domain (characterized by an LRR) and is involved\nin host-parasite interaction according to binding assays.\nInhibition assays showed that two PRK15370 domain-derived\npeptides which were conserved in P. vivax isolates have\nbeen particularly involved in the speci\ufb01c interaction between\nPvRBSA and reticulocytes. Thus, these minimum regions couldbe considered when designing a fully e\ufb00ective anti- P. vivax\nvaccine.\nAUTHOR CONTRIBUTIONS\nPC-A performed the molecular evolutionary, recombinant\nexpression and binding assays, and wrote the manuscript.\nDG-O devised and designed the study, performed the molecular\nevolutionary analysis, and wrote the manuscript. DM-P devised\nand designed the study, performed recombinant expression and\nbinding assays, and wrote the manuscript. LR-C performed\nrecombinant expression and binding assays and helped in writing\nthe manuscript. ON and MP coordinated the study and helped to\nwrite the manuscript. All the authors have read and approved the\n\ufb01nal version of the manuscript.\nFUNDING\nThis work was \ufb01nanced by the Departamento Administrativo\nde Ciencia, Tecnolog\u00eda e Innovaci\u00f3n (COLCIENCIAS) through\ngrant RC # 0309-2013.\nACKNOWLEDGMENTS\nWe would like to thank the Instituto de Ciencia, Biotecnolog\u00eda\ne Innovaci\u00f3n en Salud (IDCBIS) in Bogot\u00e1 for supplying the\numbilical cord blood and Jason Garry for translating and\nreviewing the manuscript.\nSUPPLEMENTARY MATERIAL\nThe Supplementary Material for this article can be found\nonline at: https://www.frontiersin.org/articles/10.3389/fgene.\n2018.00372/full#supplementary-material\nREFERENCES\nAbascal, F., Zardoya, R., and Telford, M. J. (2010). TranslatorX: multiple\nalignment of nucleotide sequences guided by amino acid translations.\nNucleic Acids Res. 38(Web Server issue), W7\u2013W13. doi: 10.1093/nar/\ngkq291\nAldrich, C., Magini, A., Emiliani, C., Dottorini, T., Bistoni, F., Crisanti, A., et al.\n(2012). Roles of the amino terminal region and repeat region of the Plasmodium\nberghei circumsporozoite protein in parasite infectivity. PLoS One 7:e32524.\ndoi: 10.1371/journal.pone.0032524\nAnisimova, M., Nielsen, R., and Y ang, Z. (2003). E\ufb00ect of recombination on the\naccuracy of the likelihood method for detecting positive selection at amino acid\nsites. Genetics 164, 1229\u20131236.\nArenas, M., and Posada, D. (2010). Coalescent simulation of intracodon\nrecombination. Genetics 184, 429\u2013437. doi: 10.1534/genetics.109.109736\nArenas, M., and Posada, D. (2014). \u201cThe in\ufb02uence of recombination on the\nestimation of selection from coding sequence alignments, \u201d in Natural Selection:\nMethods and Applications , ed. M. A. Fares (Boca Raton, FL: CRC Press/Taylor\n& Francis), 112\u2013125.\nArevalo-Pinzon, G., Bermudez, M., Curtidor, H., and Patarroyo, M. A. (2015). The\nPlasmodium vivax rhoptry neck protein 5 is expressed in the apical pole ofPlasmodium vivax VCG-1 strain schizonts and binds to human reticulocytes.\nMalar. J. 14:106. doi: 10.1186/s12936-015-0619-1\nArevalo-Pinzon, G., Bermudez, M., Hernandez, D., Curtidor, H., and Patarroyo,\nM. A. (2017). Plasmodium vivax ligand-receptor interaction: PvAMA-1\ndomain I contains the minimal regions for speci\ufb01c interaction with CD71 C\nreticulocytes. Sci. Rep. 7:9616. doi: 10.1038/s41598-017-10025-6\nArevalo-Pinzon, G., Curtidor, H., Abril, J., and Patarroyo, M. A. (2013).\nAnnotation and characterization of the Plasmodium vivax rhoptry\nneck protein 4 (PvRON4). Malar. J. 12:356. doi: 10.1186/1475-2875-\n12-356\nArevalo-Pinzon, G., Curtidor, H., Patino, L. C., and Patarroyo, M. A. (2011).\nPvRON2, a new Plasmodium vivax rhoptry neck antigen. Malar. J. 10:60.\ndoi: 10.1186/1475-2875-10-60\nArnott, A., Barry, A. E., and Reeder, J. C. (2012). Understanding the population\ngenetics of Plasmodium vivax is essential for malaria control and elimination.\nMalar. J. 11, 14. doi: 10.1186/1475-2875-11-14\nBandelt, H. J., Forster, P., and Rohl, A. (1999). Median-joining networks for\ninferring intraspeci\ufb01c phylogenies. Mol. Biol. Evol. 16, 37\u201348. doi: 10.1093/\noxfordjournals.molbev.a026036\nBaquero, L. A., Moreno-Perez, D. A., Garzon-Ospina, D., Forero-Rodriguez, J.,\nOrtiz-Suarez, H. D., and Patarroyo, M. A. (2017). PvGAMA reticulocyte\nFrontiers in Genetics | www.frontiersin.org 13 September 2018 | Volume 9 | Article 372fgene-09-00372 September 7, 2018 Time: 10:57 # 14\nCamargo-Ayala et al. Assessing pvrbsa Genetic Diversity\nbinding activity: predicting conserved functional regions by natural selection\nanalysis. Parasit Vectors 10:251. doi: 10.1186/s13071-017-2183-8\nBarry, A. E., and Arnott, A. (2014). Strategies for designing and monitoring malaria\nvaccines targeting diverse antigens. Front. Immunol. 5:359. doi: 10.3389/\ufb01mmu.\n2014.00359\nBuitrago, S. P., Garzon-Ospina, D., and Patarroyo, M. A. (2016). Size\npolymorphism and low sequence diversity in the locus encoding the\nPlasmodium vivax rhoptry neck protein 4 (PvRON4) in Colombian isolates.\nMalar. J. 15:501. doi: 10.1186/s12936-016-1563-4\nCarabali-Isajar, M. L., Ocampo, M., Rodriguez, D. C., Vanegas, M., Curtidor, H.,\nPatarroyo, M. A., et al. (2018). Towards designing a synthetic antituberculosis\nvaccine: The Rv3587c peptide inhibits mycobacterial entry to host cells. Bioorg.\nMed. Chem. 26, 2401\u20132409. doi: 10.1016/j.bmc.2018.03.044\nCarlton, J. M., Adams, J. H., Silva, J. C., Bidwell, S. L., Lorenzi, H., Caler, E.,\net al. (2008). Comparative genomics of the neglected human malaria parasite\nPlasmodium vivax .Nature 455, 757\u2013763. doi: 10.1038/nature07327\nCarlton, J. M., Das, A., and Escalante, A. A. (2013). Genomics, population genetics\nand evolutionary history of Plasmodium vivax .Adv. Parasitol. 81, 203\u2013222.\ndoi: 10.1016/B978-0-12-407826-0.00005-9\nCasillas, S., and Barbadilla, A. (2017). Molecular population genetics. Genetics 205,\n1003\u20131035. doi: 10.1534/genetics.116.196493\nChan, E. R., Menard, D., David, P. H., Ratsimbasoa, A., Kim, S., Chim, P.,\net al. (2012). Whole genome sequencing of \ufb01eld isolates provides robust\ncharacterization of genetic diversity in Plasmodium vivax .PLoS Negl. Trop. Dis.\n6:e1811. doi: 10.1371/journal.pntd.0001811\nChen, E., Salinas, N. D., Huang, Y., Ntumngia, F., Plasencia, M. D., Gross, M. L.,\net al. (2016). Broadly neutralizing epitopes in the Plasmodium vivax vaccine\ncandidate du\ufb00y binding protein. Proc. Natl. Acad. Sci. U.S.A. 113, 6277\u20136282.\ndoi: 10.1073/pnas.1600488113\nChen, J. H., Jung, J. W., Wang, Y., Ha, K. S., Lu, F., Lim, C. S., et al. (2010).\nImmunoproteomics pro\ufb01ling of blood stage Plasmodium vivax infection by\nhigh-throughput screening assays. J. Proteome Res. 9, 6479\u20136489. doi: 10.1021/\npr100705g\nChitnis, C. E., and Miller, L. H. (1994). Identi\ufb01cation of the erythrocyte binding\ndomains of Plasmodium vivax andPlasmodium knowlesi proteins involved in\nerythrocyte invasion. J. Exp. Med. 180, 497\u2013506. doi: 10.1084/jem.180.2.497\nDelport, W., Poon, A. F., Frost, S. D., and Kosakovsky Pond, S. L. (2010).\nDatamonkey 2010: a suite of phylogenetic analysis tools for evolutionary\nbiology. Bioinformatics 26, 2455\u20132457. doi: 10.1093/bioinformatics/btq429\nDepaulis, F., and Veuille, M. (1998). Neutrality tests based on the distribution\nof haplotypes under an in\ufb01nite-site model. Mol. Biol. Evol. 15, 1788\u20131790.\ndoi: 10.1093/oxfordjournals.molbev.a025905\nEdgar, R. C. (2004). MUSCLE: multiple sequence alignment with high accuracy and\nhigh throughput. Nucleic Acids Res. 32, 1792\u20131797. doi: 10.1093/nar/gkh340\nEgea, R., Casillas, S., and Barbadilla, A. (2008). Standard and generalized\nMcDonald-Kreitman test: a website to detect selection by comparing di\ufb00erent\nclasses of DNA sites. Nucleic Acids Res. 36, W157\u2013W162. doi: 10.1093/nar/\ngkn337\nEscalante, A. A., Cornejo, O. E., Freeland, D. E., Poe, A. C., Durrego, E., Collins,\nW. E., et al. (2005). A monkey\u2019s tale: the origin of Plasmodium vivax as a human\nmalaria parasite. Proc. Natl. Acad. Sci. U.S.A. 102, 1980\u20131985. doi: 10.1073/pnas.\n0409652102\nExco\ufb03er, L., Laval, G., and Schneider, S. (2007). Arlequin (version 3.0): an\nintegrated software package for population genetics data analysis. Evol.\nBioinform. Online 1, 47\u201350.\nFay, J. C., and Wu, C. I. (2000). Hitchhiking under positive Darwinian selection.\nGenetics 155, 1405\u20131413.\nFerguson, D. J., Balaban, A. E., Patzewitz, E. M., Wall, R. J., Hopp, C. S., Poulin, B.,\net al. (2014). The repeat region of the circumsporozoite protein is critical for\nsporozoite formation and maturation in Plasmodium .PLoS One 9:e113923.\ndoi: 10.1371/journal.pone.0113923\nForero-Rodriguez, J., Garzon-Ospina, D., and Patarroyo, M. A. (2014a). Low\ngenetic diversity and functional constraint in loci encoding Plasmodium\nvivax P12 and P38 proteins in the Colombian population. Malar. J. 13, 58.\ndoi: 10.1186/1475-2875-13-58\nForero-Rodriguez, J., Garzon-Ospina, D., and Patarroyo, M. A. (2014b). Low\ngenetic diversity in the locus encoding the Plasmodium vivax P41 proteinin Colombia\u2019s parasite population. Malar. J. 13:388. doi: 10.1186/1475-2875-\n13-388\nForster, P., Torroni, A., Renfrew, C., and Rohl, A. (2001). Phylogenetic star\ncontraction applied to Asian and Papuan mtDNA evolution. Mol. Biol. Evol.\n18, 1864\u20131881. doi: 10.1093/oxfordjournals.molbev.a003728\nFraser, T. S., Kappe, S. H., Narum, D. L., VanBuskirk, K. M., and Adams, J. H.\n(2001). Erythrocyte-binding activity of Plasmodium yoelii apical membrane\nantigen-1 expressed on the surface of transfected COS-7 cells. Mol. Biochem.\nParasitol. 117, 49\u201359. doi: 10.1016/S0166-6851(01)00326-7\nFu, Y. X. (1997). Statistical tests of neutrality of mutations against population\ngrowth, hitchhiking and background selection. Genetics 147, 915\u2013925.\nFu, Y. X., and Li, W. H. (1993). Statistical tests of neutrality of mutations. Genetics\n133, 693\u2013709.\nGalinski, M. R., and Barnwell, J. W. (2008). Plasmodium vivax : who cares? Malar J.\n7(Suppl. 1), S9. doi: 10.1186/1475-2875-7-S1-S9\nGalinski, M. R., Meyer, E. V., and Barnwell, J. W. (2013). Plasmodium vivax :\nmodern strategies to study a persistent parasite\u2019s life cycle. Adv. Parasitol. 81,\n1\u201326. doi: 10.1016/B978-0-12-407826-0.00001-1\nGarzon-Ospina, D., Forero-Rodriguez, J., and Patarroyo, M. A. (2014).\nHeterogeneous genetic diversity pattern in Plasmodium vivax genes encoding\nmerozoite surface proteins (MSP) -7E, -7F and -7L. Malar. J. 13, 495. doi:\n10.1186/1475-2875-13-495\nGarzon-Ospina, D., Forero-Rodriguez, J., and Patarroyo, M. A. (2015). Inferring\nnatural selection signals in Plasmodium vivax -encoded proteins having a\npotential role in merozoite invasion. Infect. Genet. Evol. 33, 182\u2013188.\ndoi: 10.1016/j.meegid.2015.05.001\nGarzon-Ospina, D., Forero-Rodriguez, J., and Patarroyo, M. A. (2016). Evidence of\nfunctional divergence in MSP7 paralogous proteins: a molecular-evolutionary\nand phylogenetic analysis. BMC Evol. Biol. 16:256. doi: 10.1186/s12862-016-\n0830-x\nGarzon-Ospina, D., Lopez, C., Forero-Rodriguez, J., and Patarroyo, M. A. (2012).\nGenetic diversity and selection in three Plasmodium vivax merozoite surface\nprotein 7 (Pvmsp-7) genes in a Colombian population. PLoS One 7:e45962.\ndoi: 10.1371/journal.pone.0045962\nGarzon-Ospina, D., Romero-Murillo, L., and Patarroyo, M. A. (2010). Limited\ngenetic polymorphism of the Plasmodium vivax low molecular weight rhoptry\nprotein complex in the Colombian population. Infect. Genet. Evol. 10, 261\u2013267.\ndoi: 10.1016/j.meegid.2009.12.004\nGarzon-Ospina, D., Romero-Murillo, L., Tobon, L. F., and Patarroyo, M. A.\n(2011). Low genetic polymorphism of merozoite surface proteins 7 and 10\nin Colombian Plasmodium vivax isolates. Infect. Genet. Evol. 11, 528\u2013531.\ndoi: 10.1016/j.meegid.2010.12.002\nGething, P. W., Elyazar, I. R., Moyes, C. L., Smith, D. L., Battle, K. E., Guerra,\nC. A., et al. (2012). A long neglected world malaria map: Plasmodium vivax\nendemicity in 2010. PLoS Negl. Trop Dis. 6:e1814. doi: 10.1371/journal.pntd.\n0001814\nGraur, D., Zheng, Y., Price, N., Azevedo, R. B., Zufall, R. A., and Elhaik, E.\n(2013). On the immortality of television sets: \u201cfunction\u201d in the human genome\naccording to the evolution-free gospel of ENCODE. Genome Biol. Evol. 5,\n578\u2013590. doi: 10.1093/gbe/evt028\nGuerra, C. A., Howes, R. E., Patil, A. P., Gething, P. W., Van Boeckel, T. P.,\nTemperley, W. H., et al. (2010). The international limits and population at\nrisk of Plasmodium vivax transmission in 2009. PLoS Negl. Trop Dis. 4:e774.\ndoi: 10.1371/journal.pntd.0000774\nGunasekera, A. M., Wickramarachchi, T., Neafsey, D. E., Ganguli, I., Perera, L.,\nPremaratne, P. H., et al. (2007). Genetic diversity and selection at the\nPlasmodium vivax apical membrane antigen-1 (PvAMA-1) locus in a\nSri Lankan population. Mol. Biol. Evol. 24, 939\u2013947. doi: 10.1093/molbev/\nmsm013\nHellmann, I., Ebersberger, I., Ptak, S. E., Paabo, S., and Przeworski, M. (2003).\nA neutral explanation for the correlation of diversity with recombination\nrates in humans. Am. J. Hum. Genet. 72, 1527\u20131535. doi: 10.1086/37\n5657\nHester, J., Chan, E. R., Menard, D., Mercereau-Puijalon, O., Barnwell, J.,\nZimmerman, P. A., et al. (2013). De novo assembly of a \ufb01eld isolate genome\nreveals novel Plasmodium vivax erythrocyte invasion genes. PLoS Negl. Trop\nDis. 7:e2569. doi: 10.1371/journal.pntd.0002569\nFrontiers in Genetics | www.frontiersin.org 14 September 2018 | Volume 9 | Article 372fgene-09-00372 September 7, 2018 Time: 10:57 # 15\nCamargo-Ayala et al. Assessing pvrbsa Genetic Diversity\nHudson, R. R., and Kaplan, N. L. (1985). Statistical properties of the number of\nrecombination events in the history of a sample of DNA sequences. Genetics\n111, 147\u2013164.\nHuijben, S., and Paaijmans, K. P. (2018). Putting evolution in elimination: winning\nour ongoing battle with evolving malaria mosquitoes and parasites. Evol. Appl.\n11, 415\u2013430. doi: 10.1111/eva.12530\nHupalo, D. N., Luo, Z., Melnikov, A., Sutton, P. L., Rogov, P., Escalante, A., et al.\n(2016). Population genomics studies identify signatures of global dispersal and\ndrug resistance in Plasmodium vivax .Nat. Genet. 48, 953\u2013958. doi: 10.1038/ng.\n3588\nJukes, T. H., and Cantor, C. R. (1969). \u201cEvolution of protein molecules, \u201d in\nMammalian Protein Metabolism , ed. H. N. Munro (New York, NY: Academic\nPress). doi: 10.1016/B978-1-4832-3211-9.50009-7\nKato, K., Mayer, D. C., Singh, S., Reid, M., and Miller, L. H. (2005). Domain\nIII of Plasmodium falciparum apical membrane antigen 1 binds to the\nerythrocyte membrane protein Kx. Proc. Natl. Acad. Sci. U.S.A. 102, 5552\u20135557.\ndoi: 10.1073/pnas.0501594102\nKedzierski, L., Montgomery, J., Curtis, J., and Handman, E. (2004). Leucine-rich\nrepeats in host-pathogen interactions. Arch. Immunol. Ther. Exp. (Warsz) 52,\n104\u2013112.\nKelly, J. K. (1997). A test of neutrality based on interlocus associations. Genetics\n146, 1197\u20131206.\nKosakovsky Pond, S. L., and Frost, S. D. (2005). Not so di\ufb00erent after all: a\ncomparison of methods for detecting amino acid sites under selection. Mol. Biol.\nEvol. 22, 1208\u20131222. doi: 10.1093/molbev/msi105\nKosakovsky Pond, S. L., Posada, D., Gravenor, M. B., Woelk, C. H., and Frost, S. D.\n(2006). Automated phylogenetic detection of recombination using a genetic\nalgorithm. Mol. Biol. Evol. 23, 1891\u20131901. doi: 10.1093/molbev/msl051\nKulathinal, R. J., Bennett, S. M., Fitzpatrick, C. L., and Noor, M. A. (2008). Fine-\nscale mapping of recombination rate in Drosophila re\ufb01nes its correlation to\ndiversity and divergence. Proc. Natl. Acad. Sci. U.S.A. 105, 10051\u201310056. doi:\n10.1073/pnas.0801848105\nLibrado, P., and Rozas, J. (2009). DnaSP v5: a software for comprehensive analysis\nof DNA polymorphism data. Bioinformatics 25, 1451\u20131452. doi: 10.1093/\nbioinformatics/btp187\nLiu, W., Li, Y., Shaw, K. S., Learn, G. H., Plenderleith, L. J., Malenke, J. A., et al.\n(2014). African origin of the malaria parasite Plasmodium vivax .Nat. Commun.\n5:3346. doi: 10.1038/ncomms4346\nMalleret, B., Li, A., Zhang, R., Tan, K. S., Suwanarusk, R., Claser, C., et al. (2015).\nPlasmodium vivax : restricted tropism and rapid remodeling of CD71-positive\nreticulocytes. Blood 125, 1314\u20131324. doi: 10.1182/blood-2014-08-596015\nMascorro, C. N., Zhao, K., Khuntirat, B., Sattabongkot, J., Y an, G., Escalante,\nA. A., et al. (2005). Molecular evolution and intragenic recombination\nof the merozoite surface protein MSP-3alpha from the malaria parasite\nPlasmodium vivax in Thailand. Parasitology 131(Pt 1), 25\u201335. doi: 10.1017/\nS0031182005007547\nMaxmen, A. (2012). Malaria surge feared. Nature 485:293. doi: 10.1038/485293a\nMcDonald, J. H., and Kreitman, M. (1991). Adaptive protein evolution at the Adh\nlocus in Drosophila .Nature 351, 652\u2013654. doi: 10.1038/351652a0\nMoreno-Perez, D. A., Baquero, L. A., Chitiva-Ardila, D. M., and Patarroyo, M. A.\n(2017). Characterising PvRBSA: an exclusive protein from Plasmodium species\ninfecting reticulocytes. Parasit Vect. 10:243. doi: 10.1186/s13071-017-2185-6\nMoreno-Perez, D. A., Degano, R., Ibarrola, N., Muro, A., and Patarroyo, M. A.\n(2014). Determining the Plasmodium vivax VCG-1 strain blood stage proteome.\nJ. Proteomics 113C, 268\u2013280. doi: 10.1016/j.jprot.2014.10.003\nMoreno-Perez, D. A., Saldarriaga, A., and Patarroyo, M. A. (2013). Characterizing\nPvARP , a novel Plasmodium vivax antigen. Malar. J. 12:165. doi: 10.1186/1475-\n2875-12-165\nMu, J., Joy, D. A., Duan, J., Huang, Y., Carlton, J., Walker, J., et al. (2005). Host\nswitch leads to emergence of Plasmodium vivax malaria in humans. Mol. Biol.\nEvol. 22, 1686\u20131693. doi: 10.1093/molbev/msi160\nMuehlenbein, M. P., Pacheco, M. A., Taylor, J. E., Prall, S. P., Ambu, L., Nathan, S.,\net al. (2015). Accelerated diversi\ufb01cation of nonhuman primate malarias in\nSoutheast Asia: adaptive radiation or geographic speciation? Mol. Biol. Evol. 32,\n422\u2013439. doi: 10.1093/molbev/msu310\nMurrell, B., Moola, S., Mabona, A., Weighill, T., Sheward, D., Kosakovsky Pond,\nS. L., et al. (2013). FUBAR: a fast, unconstrained bayesian approximation for\ninferring selection. Mol. Biol. Evol. 30, 1196\u20131205. doi: 10.1093/molbev/mst030Murrell, B., Wertheim, J. O., Moola, S., Weighill, T., Sche\ufb04er, K., and Kosakovsky\nPond, S. L. (2012). Detecting individual sites subject to episodic diversifying\nselection. PLoS Genet 8:e1002764. doi: 10.1371/journal.pgen.1002764\nNanda Kumar, Y., Jeyakodi, G., Gunasekaran, K., and Jambulingam, P. (2016).\nComputational screening and characterization of putative vaccine candidates\nofPlasmodium vivax .J. Biomol. Struct. Dyn. 34, 1736\u20131750. doi: 10.1080/\n07391102.2015.1090344\nNarayanan, K., Ramachandran, A., Hao, J., He, G., Park, K. W., Cho, M., et al.\n(2003). Dual functional roles of dentin matrix protein 1, implications in\nbiomineralization and gene transcription by activation of intracellular Ca2 C\nstore. J. Biol. Chem. 278, 17500\u201317508. doi: 10.1074/jbc.M212700200\nNeafsey, D. E., Galinsky, K., Jiang, R. H., Young, L., Sykes, S. M., Saif, S., et al.\n(2012). The malaria parasite Plasmodium vivax exhibits greater genetic diversity\nthan Plasmodium falciparum .Nat. Genet. 44, 1046\u20131050. doi: 10.1038/ng.2373\nNei, M., and Rooney, A. P. (2005). Concerted and birth-and-death evolution of\nmultigene families. Annu. Rev. Genet. 39, 121\u2013152. doi: 10.1146/annurev.genet.\n39.073003.112240\nNobrega de Sousa, T., Carvalho, L. H., and Alves de Brito, C. F. (2011). Worldwide\ngenetic variability of the Du\ufb00y binding protein: insights into Plasmodium\nvivax vaccine development. PLoS One 6:e22944. doi: 10.1371/journal.pone.\n0022944\nNtumngia, F. B., Pires, C. V., Barnes, S. J., George, M. T., Thomson-Luque, R.,\nKano, F. S., et al. (2017). An engineered vaccine of the Plasmodium vivax Du\ufb00y\nbinding protein enhances induction of broadly neutralizing antibodies. Sci. Rep.\n7:13779. doi: 10.1038/s41598-017-13891-2\nPacheco, M. A., Battistuzzi, F. U., Junge, R. E., Cornejo, O. E., Williams, C. V.,\nLandau, I., et al. (2011). Timing the origin of human malarias: the lemur puzzle.\nBMC Evol. Biol. 11:299. doi: 10.1186/1471-2148-11-299\nPacheco, M. A., Elango, A. P., Rahman, A. A., Fisher, D., Collins, W. E., Barnwell,\nJ. W., et al. (2012). Evidence of purifying selection on merozoite surface protein\n8 (MSP8) and 10 (MSP10) in Plasmodium spp.Infect. Genet. Evol. 12, 978\u2013986.\ndoi: 10.1016/j.meegid.2012.02.009\nPacheco, M. A., Ryan, E. M., Poe, A. C., Basco, L., Udhayakumar, V., Collins,\nW. E., et al. (2010). Evidence for negative selection on the gene encoding\nrhoptry-associated protein 1 (RAP-1) in Plasmodium spp. Infect. Genet. Evol.\n10, 655\u2013661. doi: 10.1016/j.meegid.2010.03.013\nPatarroyo, M. A., Calderon, D., and Moreno-Perez, D. A. (2012). Vaccines against\nPlasmodium vivax : a research challenge. Exp. Rev. Vaccines 11, 1249\u20131260.\ndoi: 10.1586/erv.12.91\nPerez-Losada, M., Arenas, M., Galan, J. C., Palero, F., and Gonzalez-Candelas, F.\n(2015). Recombination in viruses: mechanisms, methods of study, and\nevolutionary consequences. Infect. Genet. Evol. 30, 296\u2013307. doi: 10.1016/j.\nmeegid.2014.12.022\nPond, S. L., Frost, S. D., Grossman, Z., Gravenor, M. B., Richman, D. D., and Brown,\nA. J. (2006). Adaptation to di\ufb00erent human populations by HIV-1 revealed\nby codon-based analyses. PLoS Comput. Biol. 2:e62. doi: 10.1371/journal.pcbi.\n0020062\nPosada, D. (2008). jModelTest: phylogenetic model averaging. Mol. Biol. Evol. 25,\n1253\u20131256. doi: 10.1093/molbev/msn083\nPrice, R. N., von Seidlein, L., Valecha, N., Nosten, F., Baird, J. K., and White, N. J.\n(2014). Global extent of chloroquine-resistant Plasmodium vivax : a systematic\nreview and meta-analysis. Lancet Infect. Dis. 14, 982\u2013991. doi: 10.1016/S1473-\n3099(14)70855-2\nRao, Y., Sun, L., Nie, Q., and Zhang, X. (2011). The in\ufb02uence of recombination on\nSNP diversity in chickens. Hereditas 148, 63\u201369. doi: 10.1111/j.1601-5223.2010.\n02210.x\nRichie, T. L., and Saul, A. (2002). Progress and challenges for malaria vaccines.\nNature 415, 694\u2013701. doi: 10.1038/415694a\nRodrigues, P. T., Valdivia, H. O., de Oliveira, T. C., Alves, J. M. P., Duarte, A.,\nCerutti-Junior, C., et al. (2018). Human migration and the spread of malaria\nparasites to the New World. Sci. Rep. 8:1993. doi: 10.1038/s41598-018-19554-0\nRonquist, F., Teslenko, M., van der Mark, P., Ayres, D. L., Darling, A., Hohna, S.,\net al. (2012). MrBayes 3.2: e\ufb03cient Bayesian phylogenetic inference and model\nchoice across a large model space. Syst. Biol. 61, 539\u2013542. doi: 10.1093/sysbio/\nsys029\nRozas, J., Gullaud, M., Blandin, G., and Aguade, M. (2001). DNA variation at\nthe rp49 gene region of Drosophila simulans: evolutionary inferences from an\nunusual haplotype structure. Genetics 158, 1147\u20131155.\nFrontiers in Genetics | www.frontiersin.org 15 September 2018 | Volume 9 | Article 372fgene-09-00372 September 7, 2018 Time: 10:57 # 16\nCamargo-Ayala et al. Assessing pvrbsa Genetic Diversity\nSmith, M. D., Wertheim, J. O., Weaver, S., Murrell, B., Sche\ufb04er, K., and Kosakovsky\nPond, S. L. (2015). Less is more: an adaptive branch-site random e\ufb00ects model\nfor e\ufb03cient detection of episodic diversifying selection. Mol. Biol. Evol. 32,\n1342\u20131353. doi: 10.1093/molbev/msv022\nSuh, K. N., Kain, K. C., and Keystone, J. S. (2004). Malaria. CMAJ 170, 1693\u20131702.\ndoi: 10.1503/cmaj.1030418\nTachibana, S., Sullivan, S. A., Kawai, S., Nakamura, S., Kim, H. R., Goto, N.,\net al. (2012). Plasmodium cynomolgi genome sequences provide insight into\nPlasmodium vivax and the monkey malaria clade. Nat. Genet. 44, 1051\u20131055.\ndoi: 10.1038/ng.2375\nTajima, F. (1989). Statistical method for testing the neutral mutation hypothesis by\nDNA polymorphism. Genetics 123, 585\u2013595.\nTamura, K., Stecher, G., Peterson, D., Filipski, A., and Kumar, S. (2013). MEGA6:\nmolecular evolutionary genetics analysis version 6.0. Mol. Biol. Evol. 30,\n2725\u20132729. doi: 10.1093/molbev/mst197\nTaylor, J. E., Pacheco, M. A., Bacon, D. J., Beg, M. A., Machado, R. L., Fairhurst,\nR. M., et al. (2013). The evolutionary history of Plasmodium vivax as inferred\nfrom mitochondrial genomes: parasite genetic diversity in the Americas. Mol.\nBiol. Evol. 30, 2050\u20132064. doi: 10.1093/molbev/mst104\nThe malERA Consultative Group on Vaccines (2011). A research agenda for\nmalaria eradication: vaccines. PLoS Med 8:e1000398. doi: 10.1371/journal.\npmed.1000398\nValderrama-Aguirre, A., Zuniga-Soto, E., Marino-Ramirez, L., Moreno, L. A.,\nEscalante, A. A., Arevalo-Herrera, M., et al. (2011). Polymorphism of the\nPv200L fragment of merozoite surface protein-1 of Plasmodium vivax in clinical\nisolates from the Paci\ufb01c coast of Colombia. Am. J. Trop. Med. Hyg. 84, 64\u201370.\ndoi: 10.4269/ajtmh.2011.09-0517\nValencia, S. H., Rodriguez, D. C., Acero, D. L., Ocampo, V., and Arevalo-\nHerrera, M. (2011). Platform for Plasmodium vivax vaccine discovery anddevelopment. Mem. Inst. Oswaldo Cruz 106(Suppl 1), 179\u2013192. doi: 10.1590/\nS0074-02762011000900023\nWang, Y., Ma, A., Chen, S. B., Y ang, Y. C., Chen, J. H., and Yin, M. B.\n(2014). Genetic diversity and natural selection of three blood-stage 6-\nCys proteins in Plasmodium vivax populations from the China-Myanmar\nendemic border. Infect. Genet. Evol. 28, 167\u2013174. doi: 10.1016/j.meegid.2014.\n09.026\nWelsh, K., and Bunce, M. (1999). Molecular typing for the MHC with PCR-SSP.\nRev. Immunogenet. 1, 157\u2013176.\nWhite, N. J., Pukrittayakamee, S., Hien, T. T., Faiz, M. A., Mokuolu, O. A., and\nDondorp, A. M. (2014). Malaria. Lancet 383, 723\u2013735. doi: 10.1016/S0140-\n6736(13)60024-0\nWHO (2017). World Malaria Report 2017 . Geneva: World Health Organization.\nZhang, J., Rosenberg, H. F., and Nei, M. (1998). Positive darwinian\nselection after gene duplication in primate ribonuclease genes.\nProc. Natl. Acad. Sci. U.S.A. 95, 3708\u20133713. doi: 10.1073/pnas.95.7.\n3708\nCon\ufb02ict of Interest Statement: The authors declare that the research was\nconducted in the absence of any commercial or \ufb01nancial relationships that could\nbe construed as a potential con\ufb02ict of interest.\nCopyright \u00a9 2018 Camargo-Ayala, Garz\u00f3n-Ospina, Moreno-P\u00e9rez, Ricaurte-\nContreras, Noya and Patarroyo. This is an open-access article distributed under the\nterms of the Creative Commons Attribution License (CC BY). The use, distribution\nor reproduction in other forums is permitted, provided the original author(s) and\nthe copyright owner(s) are credited and that the original publication in this journal\nis cited, in accordance with accepted academic practice. No use, distribution or\nreproduction is permitted which does not comply with these terms.\nFrontiers in Genetics | www.frontiersin.org 16 September 2018 | Volume 9 | Article 372", "language": "PDF", "image": "PDF", "pagetype": "PDF", "links": "PDF"}